<SEC-DOCUMENT>0001062993-20-001379.txt : 20200317
<SEC-HEADER>0001062993-20-001379.hdr.sgml : 20200317
<ACCEPTANCE-DATETIME>20200317171400
ACCESSION NUMBER:		0001062993-20-001379
CONFORMED SUBMISSION TYPE:	40-F/A
PUBLIC DOCUMENT COUNT:		125
CONFORMED PERIOD OF REPORT:	20191231
FILED AS OF DATE:		20200317
DATE AS OF CHANGE:		20200317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FSD Pharma Inc.
		CENTRAL INDEX KEY:			0001771885
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		40-F/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39152
		FILM NUMBER:		20721959

	BUSINESS ADDRESS:	
		STREET 1:		520 WILLIAM STREET
		CITY:			COBOURG
		STATE:			A6
		ZIP:			K9A 3A5
		BUSINESS PHONE:		(416) 854-8884

	MAIL ADDRESS:	
		STREET 1:		520 WILLIAM STREET
		CITY:			COBOURG
		STATE:			A6
		ZIP:			K9A 3A5
</SEC-HEADER>
<DOCUMENT>
<TYPE>40-F/A
<SEQUENCE>1
<FILENAME>form40fa.htm
<DESCRIPTION>FORM 40-F/A
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Form 40-F/A - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="margin-bottom: 0pt; text-align: center;"><b><font size="5">UNITED STATES</font></b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b><font size="5">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
    <p style="margin-top: 0pt; text-align: center;">Washington, D.C. 20549</p>
    <p style="text-align: center;"><font style="background-color: #ffffff;"><b>AMENDMENT NO. 1</b></font><br><font style="background-color: #ffffff;"><b>TO</b></font><b> </b><br><b><font size="5">FORM 40-F</font></b></p>
    <p style="text-align: center;">[&#160; ]&#160; &#160; Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934</p>
    <p style="text-align: center;">or</p>
    <p style="text-align: center;">[X]&#160; &#160; Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934</p>
    <p style="text-align: center;">For the fiscal year ended <u><b>December 31, 2019</b></u></p>
    <p style="text-align: center;">Commission File Number<u><b> 001-39152</b></u></p>
    <p style="text-align: center;"><b><font size="5"><u>FSD PHARMA INC.</u></font></b><br><br>(Exact name of registrant as specified in its charter)</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 33%; vertical-align: top;">
                <p style="text-align: center;"><u><b>Ontario, Canada</b></u></p>
            </td>
            <td style="width: 33%; vertical-align: top;">
                <p style="text-align: center;"><u><b>2833</b></u></p>
            </td>
            <td style="width: 33%; vertical-align: top;">
                <p style="text-align: center;"><u><b>N/A</b></u></p>
            </td>
        </tr>
        <tr>
            <td style="width: 33%; vertical-align: top;">
                <p style="margin-bottom: 0pt; text-align: center;">(Province or Other Jurisdiction of</p>
                <p style="margin-top: 0pt; text-align: center;">Incorporation or Organization)</p>
            </td>
            <td style="width: 33%; vertical-align: top;">
                <p style="margin-bottom: 0pt; text-align: center;">(Primary Standard Industrial</p>
                <p style="margin-top: 0pt; text-align: center;">Classification Code)</p>
            </td>
            <td style="width: 33%; vertical-align: top;">
                <p style="margin-bottom: 0pt; text-align: center;">(I.R.S. Employer</p>
                <p style="margin-top: 0pt; text-align: center;">Identification No.)</p>
            </td>
        </tr>
    </table>
    <p style="text-align: center;"><b>520 William Street</b><br><br><b>Cobourg, ON K9A 3A5</b><br><br><u><b>Telephone: (416) 854-8884</b></u><br><br>(Address and telephone number of registrant's principal executive offices)</p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>CT Corporation System</b><br><br><b>28 Liberty Street</b><br><br><b>New York, New York 10005</b><br><br><u><b>Telephone: (212) 894-8940</b></u><br><br>(Name, address (including zip code) and telephone number (including area code)</p>
    <p style="margin-top: 0pt; text-align: center;">of agent for service in the United States)</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: center;">Securities registered pursuant to Section 12(b) of the Act:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 40%; vertical-align: bottom;">
                <p style="text-align: center; border-bottom: 1pt solid #000000;"><b>Title of Each Class:</b></p>
            </td>
            <td style="vertical-align: bottom;">
                <p style="text-align: center; border-bottom: 1pt solid #000000;"><b>Trading Symbol(s)</b></p>
            </td>
            <td style="width: 40%; vertical-align: bottom;">
                <p style="text-align: center; border-bottom: 1pt solid #000000;"><b>Name of Each Exchange On Which Registered:</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 40%; vertical-align: top;">
                <p style="text-align: center;"><u><b>Class B Subordinate Voting Shares, no par value</b></u></p>
            </td>
            <td style="vertical-align: top;">
                <p style="text-align: center;"><u><b>HUGE </b></u></p>
            </td>
            <td style="width: 40%; vertical-align: top;">
                <p style="text-align: center;"><u><b>The Nasdaq Stock Market LLC</b></u></p>
            </td>
        </tr>
    </table>
    <p style="text-align: center;">Securities registered pursuant to Section 12(g) of the Act: <u><b>None</b></u></p>
    <p style="text-align: center;">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:<u><b> None</b></u></p>
    <p style="text-align: center;">For annual reports, indicate by check mark the information filed with this form:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%; vertical-align: top;">
                <p style="text-align: center;">[X] Annual Information Form</p>
            </td>
            <td style="width: 50%; vertical-align: top;">
                <p style="text-align: center;">[X] Audited Annual Financial Statements</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">Indicate the number of outstanding shares of each of the registrant's classes of capital or common stock as of the close of the period covered by the annual report: 7,056,245</p>
    <p style="text-align: justify;">Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.</p>
    <p style="text-align: center;">[&#160; ]&#160; Yes&#160; &#160; &#160; &#160; &#160; &#160; [X]&#160; No</p>
    <p style="text-align: justify;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p>
    <p style="text-align: center;">[X]&#160; Yes&#160; &#160; &#160; &#160; &#160; &#160; &#160; [&#160; ] No</p>
    <p style="margin-bottom: 0pt; text-align: justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.&#160; &#160; &#160; &#160; &#160; &#160;</p>
    <p style="margin-top: 0pt; text-align: right;">Emerging growth company [X]</p>
    <p style="text-align: justify;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section 13(a) of the Exchange Act. [&#160; ]</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: center;"><b>EXPLANATORY NOTE </b></p>
    <p style="text-indent: 36pt; text-align: justify;">This Amendment No. 1 to the Annual Report on Form 40-F ("Amendment No. 1") amends the <a style="text-decoration: none;" href="http://www.sec.gov/Archives/edgar/data/1771885/000106299320001241/form40f.htm"><font style="color: #0000ff;"><u>Annual Report on Form 40-F</u></font></a> of FSD Pharma Inc. (the "Registrant") for the year ended December 31, 2019, which was originally filed with the U.S. Securities and Exchange Commission ("SEC") on March 4, 2020 (the "Original Annual Report"). This Amendment No. 1 is being filed solely to include the report of the Registrant's predecessor auditor in respect of the year ended December 31, 2018 in the Audited Consolidated Financial Statements for the years ended December 31, 2019 and 2018, in accordance with applicable Canadian securities laws.</p>
    <p style="text-indent: 36pt; text-align: justify;">Except as described above, the Original Annual Report remains unchanged. This Amendment No. 1 does not reflect events occurring after the filing of the Original Annual Report, or modify or update those disclosures. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Annual Report.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <p style="text-align: center;"><b>EXHIBIT INDEX</b></p>
    <p style="text-indent: 24.5pt; text-align: justify;">The following documents are being filed with the Commission as exhibits to this Amendment No. 1 to the Annual Report on Form 40-F.</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
          <td style="width: 10%;"><u>Exhibits</u></td>
          <td style="width: 90%;"><u>Documents </u></td>
        </tr>
        <tr>
            <td style="background-color: rgb(238, 238, 238); width: 10%;"><a href="http://www.sec.gov/Archives/edgar/data/1771885/000106299320001241/exhibit99-1.htm">99.1*</a></td>
            <td style="background-color: rgb(238, 238, 238); width: 90%;"><a href="http://www.sec.gov/Archives/edgar/data/1771885/000106299320001241/exhibit99-1.htm">Annual Information Form for the year ended December 31, 2019</a></td>
        </tr>
        <tr>
            <td style="width: 10%;"><a href="exhibit99-2.htm">99.2**</a></td>
            <td style="width: 90%;"><a href="exhibit99-2.htm">Audited Consolidated Financial Statements for the years ended December 31, 2019 and 2018 and auditor's report thereon</a></td>
        </tr>
        <tr>
            <td style="background-color: rgb(238, 238, 238); width: 10%;"><a href="http://www.sec.gov/Archives/edgar/data/1771885/000106299320001241/exhibit99-3.htm">99.3*</a></td>
            <td style="background-color: rgb(238, 238, 238); width: 90%;"><a href="http://www.sec.gov/Archives/edgar/data/1771885/000106299320001241/exhibit99-3.htm">Audited Consolidated Financial Statements for the years ended December 31, 2018 and 2017 and auditor's report thereon </a></td>
        </tr>
        <tr>
            <td style="width: 10%;"><a href="http://www.sec.gov/Archives/edgar/data/1771885/000106299320001241/exhibit99-4.htm">99.4*</a></td>
            <td style="width: 90%;"><a href="http://www.sec.gov/Archives/edgar/data/1771885/000106299320001241/exhibit99-4.htm">Management's Discussion and Analysis for the year ended December 31, 2019</a></td>
        </tr>
        <tr>
            <td style="background-color: rgb(238, 238, 238); width: 10%;"><a href="exhibit99-5.htm">99.5**</a></td>
            <td style="background-color: rgb(238, 238, 238); width: 90%;"><a href="exhibit99-5.htm">Certifications of Chief Executive Officer pursuant to Rule 13a-14 or 15d-14 of the Securities Exchange Act of 1934</a></td>
        </tr>
        <tr>
            <td style="width: 10%;"><a href="exhibit99-6.htm">99.6**</a></td>
            <td style="width: 90%;"><a href="exhibit99-6.htm">Certifications of Chief Financial Officer pursuant to Rule 13a-14 or 15d-14 of the Securities Exchange Act of 1934</a></td>
        </tr>
        <tr>
            <td style="background-color: rgb(238, 238, 238); width: 10%;"><a href="exhibit99-7.htm">99.7**</a></td>
            <td style="background-color: rgb(238, 238, 238); width: 90%;"><a href="exhibit99-7.htm">Certifications of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></td>
        </tr>
        <tr>
            <td style="width: 10%;"><a href="exhibit99-8.htm">99.8**</a></td>
            <td style="width: 90%;"><a href="exhibit99-8.htm">Certifications of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></td>
        </tr>
        <tr>
            <td style="background-color: rgb(238, 238, 238); width: 10%;"><a href="exhibit99-9.htm">99.9**</a></td>
            <td style="background-color: rgb(238, 238, 238); width: 90%;"><a href="exhibit99-9.htm">Consent of McGovern Hurley LLP</a></td>
        </tr>
        <tr>
            <td style="width: 10%;"><a href="exhibit99-10.htm">99.10**</a></td>
            <td style="width: 90%;"><a href="exhibit99-10.htm">Consent of MNP LLP</a></td>
        </tr>
        <tr>
            <td style="background-color: rgb(238, 238, 238); width: 10%;">101</td>
            <td style="background-color: rgb(238, 238, 238); width: 90%;">Interactive Data File</td>
        </tr>
        <tr>
            <td style="width: 10%;"><a href="huge-20191231.xml">101.INS</a></td>
            <td style="width: 90%;"><a href="huge-20191231.xml">XBRL Instance Document</a></td>
        </tr>
        <tr>
            <td style="background-color: rgb(238, 238, 238); width: 10%;"><a href="huge-20191231.xsd">101.SCH</a></td>
            <td style="background-color: rgb(238, 238, 238); width: 90%;"><a href="huge-20191231.xsd">XBRL Taxonomy Extension Schema Document</a></td>
        </tr>
        <tr>
            <td style="width: 10%;"><a href="huge-20191231_cal.xml">101.CAL</a></td>
            <td style="width: 90%;"><a href="huge-20191231_cal.xml">XBRL Taxonomy Extension Calculation Linkbase Document</a></td>
        </tr>
        <tr>
            <td style="background-color: rgb(238, 238, 238); width: 10%;"><a href="huge-20191231_def.xml">101.DEF</a></td>
            <td style="background-color: rgb(238, 238, 238); width: 90%;"><a href="huge-20191231_def.xml">XBRL Taxonomy Extension Definition Linkbase Document</a></td>
        </tr>
        <tr>
            <td style="width: 10%;"><a href="huge-20191231_lab.xml">101.LAB</a></td>
            <td style="width: 90%;"><a href="huge-20191231_lab.xml">XBRL Taxonomy Extension Label Linkbase Document</a></td>
        </tr>
        <tr>
            <td style="background-color: rgb(238, 238, 238); width: 10%;"><a href="huge-20191231_pre.xml">101.PRE</a></td>
            <td style="background-color: rgb(238, 238, 238); width: 90%;"><a href="huge-20191231_pre.xml">XBRL Taxonomy Extension Presentation Linkbase Document</a></td>
        </tr>
    </table>
<p style="border-top: 0.75pt solid #000000; text-align: justify;">*&#160; &#160; Previously filed.<br>**&#160; Filed herewith.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_5"></a>
    <p style="text-align: center;"><b>SIGNATURES</b></p>
    <p style="text-indent: 24.5pt; text-align: justify;">Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this Amendment No. 1 to the Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%;">&#160;</td>
            <td colspan="2"><b>FSD PHARMA INC.</b></td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td style="width: 5%;">&#160;</td>
            <td>&#160;</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>By:</td>
            <td style="border-bottom: 1px solid #000000;">/s/ Raza Bokhari</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>Name:</td>
            <td>Raza Bokhari</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td>Title:</td>
            <td>Chief Executive Officer and<br>Executive Co-Chairman</td>
        </tr>
    </table>
    <p style="text-align: justify;">Date: <font style="width: 7.01pt; display: inline-block;">&#160;</font>March 17, 2020</p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>2
<FILENAME>exhibit99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Exhibit 99.2 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <div>
        <p style="text-align: justify;">&#160;</p>
    </div>
    <p style="margin-left: 75.6pt; margin-bottom: 0pt; text-indent: -3.6pt; text-align: justify;"><font style="font-size: 14pt;"><b>FSD Pharma Inc. </b></font></p>
    <p style="margin-top: 0pt; margin-left: 36pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 12pt;"><b>Consolidated financial statements </b></font></p>
    <p style="margin-left: 72pt; margin-bottom: 0pt; text-align: justify;">For the years ended December 31, 2019 and 2018</p>
    <p style="margin-top: 0pt; margin-left: 72pt; text-align: justify;">[expressed in Canadian dollars, except per share amounts]</p>
    <p style="margin-top: 0pt; margin-left: 72pt; text-align: justify;">&#160;</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade">
    <p style="text-align: right;"><img src="exhibit99-2xauditor1.jpg" width="135" height="54"></p>
    <p style="text-align: justify;"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>
    <p style="text-align: justify;">To the Board of Directors and Shareholders of FSD Pharma Inc.</p>
    <p style="text-align: justify;"><b>Opinion on the Consolidated Financial Statements</b></p>
    <p style="text-align: justify; margin-bottom: 0pt;">We have audited the accompanying consolidated statement of financial position of FSD Pharma Inc. (the Company) as of December 31, 2019 and the related consolidated statements of loss, comprehensive loss, shareholders&#8217; equity, and cash flows for the year ended December 31, 2019, and the related notes (collectively referred to as the consolidated financial statements).</p>
    <p style="text-align: justify; margin-top: 0pt;">In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2019, and the results of its consolidated operations and its consolidated cash flows for the year ended December 31, 2019, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.</p>
    <p style="text-align: justify;"><b>Material Uncertainty Related to Going Concern</b></p>
    <p style="text-align: justify;">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has an accumulated deficit of $78.5 million, a net loss of $52 million and a working capital surplus of $2.3 million that raise substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p>
    <p style="text-align: justify;"><b>Basis for Opinion</b></p>
    <p style="text-align: justify; margin-bottom: 0pt;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
    <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p>
    <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provide a reasonable basis for our opinion.</p>
    <p style="text-align: justify; margin-top: 0pt;">We have served as the Company&#8217;s auditor since 2019.</p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
      <tr>
        <td style="width: 50%; vertical-align: bottom;">&#160;</td>
        <td style="width: 50%; vertical-align: bottom;"><img src="exhibit99-2xauditor2.jpg" width="113" height="34"></td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: bottom;"><p style="text-align: left;">Toronto, Ontario</p></td>
        <td style="width: 50%; vertical-align: bottom;"><p style="text-align: left;">Chartered Professional Accountants</p></td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: bottom;"><p style="text-align: left;">March 3, 2020</p></td>
        <td style="width: 50%; vertical-align: bottom;"><p style="text-align: left;">Licensed Public Accountants</p></td>
      </tr>
    </table>
    <p style="text-align: center;"><img src="exhibit99-2xauditor3.jpg" width="745" height="89"></p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade">
    <div>
        <div><img src="tmpxu001.jpg" width="221" height="157"><br></div>
        <p style="text-align: justify;"><b>Report of Independent Registered Public Accounting Firm</b></p>
        <p style="text-align: justify;">To the Board of Directors and Stockholders of FSD Pharma Inc.</p>
        <p style="text-align: justify;"><b>Opinion on the Consolidated Financial Statements</b></p>
        <p style="text-align: justify;">We have audited the accompanying consolidated statements of financial position of FSD Pharma Inc. (the Company) as of December 31, 2018, and the related consolidated statements of operations and comprehensive loss, cash flows and changes in equity for the year December 31, 2018, and the related notes (collectively referred to as the financial statements).</p>
        <p style="text-align: justify;">In our opinion, the financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2018, and the results of its operations and its cash flows for the year ended December 31, 2018, in conformity with International Financial Reporting Standards (&#8220;IFRS&#8221;) as issued by the International Accounting Standards Board.</p>
        <p style="text-align: justify;"><b>Uncertainty Related to Going Concern</b></p>
        <p style="text-align: justify;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company produced a net loss for the year ended December 31, 2018. These conditions, along with other matters as set forth in Note 2, indicate the existence of a material uncertainty that casts substantial doubt on the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p>
        <p style="text-align: justify;"><b>Basis for Opinion</b></p>
        <p style="text-align: justify; margin-bottom: 0pt;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the</p>
        <p style="text-align: justify; margin-top: 0pt;">PCAOB.</p>
        <p style="text-align: justify;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</p>
        <p style="text-align: justify;"><img src="tmpxu002.jpg" width="166" height="82"></p>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade">
    <div>
        <div><img src="tmpxu001.jpg" width="221" height="157"></div>
        <p style="text-align: justify;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>
        <p style="text-align: justify;">We have served as the Company&#8217;s auditor since 2019.</p>
        <p style="text-align: justify;"><b>McGovern Hurley LLP</b></p>
        <p style="text-align: justify; margin-bottom: 0pt;"><b>Chartered Professional Accountants</b></p>
        <p style="text-align: justify; margin-top: 0pt;"><b>Licensed Public Accountants</b></p>
        <p style="text-align: justify; margin-bottom: 0pt;">Toronto, Canada</p>
        <p style="text-align: justify; margin-top: 0pt;">May 3, 2019</p>
        <p style="text-align: justify; margin-top: 0pt;"><img src="tmpxu003.jpg" width="301" height="70"></p>
    </div>


    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade">
    <a name="page_2"></a>
    <div>
        <div>
            <div>
                <div>
                    <p style="text-align: justify;"><b>FSD PHARMA INC.</b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</b></p>
                    <p style="margin-top: 0pt; text-align: center;">As at December 31, 2019 and 2018<br>
                      [expressed in Canadian dollars]<br>
                  [see going concern uncertainty &#8211; note 1]</p>
                    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
                        <tr>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: right;"><b>2019</b></td>
                            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: right;"><b>2018</b></td>
                            <td style="vertical-align: bottom;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">Notes</td>
                            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">$</td>
                            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">$</td>
                            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;"><b>ASSETS</b></td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;"><b>Current assets</b></td>
                            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">Cash&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>7,932,737</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">21,134,930</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">Trade and other receivables&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">6</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>2,070,055</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">990,988</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">Prepaid expenses and deposits</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>430,381</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">444,099</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">Inventory&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">7</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>942,939</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">Biological assets&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">8</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>&#8212;</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#8212;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>11,376,112</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">22,570,017</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;"><b>Non-current assets</b></td>
                            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">Other investments&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">9</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>11,780,864</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">18,064,541</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">Right-of-use asset, net&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">10</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>127,410</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">Property, plant and equipment, net&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">11</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>11,804,145</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">12,141,676</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">Intangible assets, net &#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">12</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>22,358,932</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">&#8212;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>57,447,463</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;">52,776,234</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;"><b>LIABILITIES</b></td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;"><b>Current liabilities</b></td>
                            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">Trade and other payables</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>4,467,826</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">1,743,806</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">Lease obligations&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">13</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>56,207</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">Derivative liability&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">9</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>2,646,269</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">Notes payable</td>
                            <td style="vertical-align: bottom; text-align: center;">14</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>1,908,412</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">&#8212;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>9,078,714</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">1,743,806</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;"><b>Non-current liabilities</b></td>
                            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">Lease obligations&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">13</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>146,662</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#8212;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>9,225,376</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">1,743,806</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;"><b>SHAREHOLDER'S EQUITY</b></td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">Class A share capital&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">15</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>201,500</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">201,500</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">Class B share capital&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">15</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>97,815,149</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">67,916,302</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">Warrant reserve</td>
                            <td style="vertical-align: bottom; text-align: center;">15</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>5,745,034</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">4,442,145</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">Contributed surplus&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">16</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>23,091,099</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">4,977,300</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">Foreign exchange translation reserve</td>
                            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: right;"><b>(112,690</b></td>
                            <td style="vertical-align: bottom;"><b>)</b></td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">Accumulated deficit</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>(78,518,005</b></td>
                            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>)</b></td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(26,504,819</td>
                            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>48,222,087</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">51,032,428</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>57,447,463</b></td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;">52,776,234</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">Commitments and contingencies&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">20</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                        <tr>
                            <td style="vertical-align: bottom;">Subsequent events&#160;</td>
                            <td style="vertical-align: bottom; text-align: center;">25</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                        </tr>
                    </table>
                    <p style="text-align: justify;"><i>The accompanying notes are an integral part of these consolidated financial statements.</i></p>
                    <p style="text-align: justify;">On behalf of the Board:</p>
                    <table style="width: 100%; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
                        <tr>
                            <td style="width: 50%; vertical-align: bottom;">
                                <p style="text-align: center;"><i>"Signed"</i></p>
                            </td>
                            <td style="width: 50%; vertical-align: bottom;">
                                <p style="text-align: center;"><i>"Signed"</i></p>
                            </td>
                        </tr>
                        <tr>
                            <td style="width: 50%; vertical-align: bottom;">
                                <p style="text-align: center;">Director - Raza Bokhari</p>
                            </td>
                            <td style="width: 50%; vertical-align: bottom;">
                                <p style="text-align: center;">Director - Robert Ciaruffoli</p>
                            </td>
                        </tr>
                    </table>
                </div>
                <div>
                    <p style="text-align: center;">2</p>
                </div>
            </div>
        </div>
        <hr style="break-after: page; width: 100%;" size="5" color="black" noshade="noshade">
        <p style="text-align: justify;">&#160;</p>
        <b>FSD PHARMA INC.</b>
        <p>&#160;</p>
        <p style="margin-bottom: 0pt; text-align: center;"><b>CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS</b></p>
        <p style="margin-top: 0pt; text-align: center;">For the years ended December 31, 2019 and 2018<br>
        [expressed in Canadian dollars, except share and per share amounts]</p>
        <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;"><b>2019</b></td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;">2018</td>
                <td style="vertical-align: bottom;">&#160;</td>
            </tr>

            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">Notes</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">$</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">$</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;"><b>Revenue</b></td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>257,099</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Cost of revenue</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>1,959,111</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><b>Gross loss before fair value adjustments</b></td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;"><b>(1,702,012</b></td>
                <td style="vertical-align: bottom;"><b>)</b></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Fair value adjustments on inventory sold</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>22,249</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">Unrealized loss on changes in fair value of biological assets&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">8</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>682,739</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">&#8212;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;"><b>Gross loss&#160;</b></td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><b>(2,407,000</b></td>
                <td style="vertical-align: bottom; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;"><b>Expenses</b></td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">General and administrative&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">18</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>14,811,529</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">18,740,360</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Share-based payments</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">16</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>16,061,319</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">6,440,406</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">Depreciation and amortization</td>
                <td style="vertical-align: bottom; text-align: center;">10, 11, 12</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>3,146,680</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">183,194</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Allowance for impairment of Auxly funds</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">20</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">7,499,977</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">Impairment of property, plant and equipment and right-of-use asset</td>
                <td style="vertical-align: bottom; text-align: center;">10, 11</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>243,468</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">&#8212;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;"><b>Total operating expenses</b></td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>34,262,996</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">32,863,937</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;"><b>Loss from operations</b></td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><b>(36,669,996</b></td>
                <td style="vertical-align: bottom; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(32,863,937</td>
                <td style="vertical-align: bottom; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Other income</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><b>(125,536</b></td>
                <td style="vertical-align: bottom; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(88,763</td>
                <td style="vertical-align: bottom; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">Finance expense</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>206,454</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Loss on settlement of financial liability</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>24,810</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">Loss on change in fair value of derivative liability&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">9</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>3,568,305</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Loss (gain) on changes in fair value of other investments</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">9</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>11,669,157</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(10,064,550</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><b>Net loss</b></td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;"><b>(52,013,186</b></td>
                <td style="vertical-align: bottom;"><b>)</b></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;">(22,710,624</td>
                <td style="vertical-align: bottom;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;"><b>Other comprehensive loss</b></td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Items that may be subsequently reclassified to income:</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160; &#160;Exchange loss on translation of foreign operations</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>(112,690</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000;"><b>)</b></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">&#8212;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;"><b>Comprehensive loss</b></td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>(52,125,876</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;">(22,710,624</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Net loss per share &#8211; basic and diluted</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">17</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><b>(7.37</b></td>
                <td style="vertical-align: bottom; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(3.85</td>
                <td style="vertical-align: bottom; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Weighted average number of shares outstanding &#8211; basic and diluted</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">17</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>7,056,245</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">5,905,252</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
        </table>
      <p style="text-align: justify;"><i>The accompanying notes are an integral part of these consolidated financial statements.</i></p>
        <p style="text-align: center;">3</p>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <div>
        <div><br></div>
        <div>
            <p style="text-align: left;"><b>FSD PHARMA INC.</b></p>
            <p style="text-align: center;"><b>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY<br></b>For the years ended December 31, 2019 and 2018<br>
            [expressed in Canadian dollars, except number of shares]</p>
            <table style="width: 100%; font-size: 8pt; border-collapse: collapse; border-color: #000000;">
                <tr>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="4"><b>Class A shares</b></td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="4"><b>Class B shares</b></td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="4"><b>Warrants</b></td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="3"><b>Contributed surplus</b></td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="3"><b>Foreign exchange<br>translation<br>reserve</b></td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>Accumulated<br>
                    Deficit</b></td>
                  <td style="vertical-align: bottom; text-align: center; white-space: nowrap; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>Total</b></td>
                    <td style="vertical-align: bottom; text-align: center; white-space: nowrap; width: 1%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;"><b>#</b></td>
                    <td style="vertical-align: bottom; width: 1%; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">$</td>
                    <td style="vertical-align: bottom; width: 1%; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;"><b>#</b></td>
                    <td style="vertical-align: bottom; width: 1%; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">$</td>
                    <td style="vertical-align: bottom; width: 1%; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;"><b>#</b></td>
                    <td style="vertical-align: bottom; width: 1%; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">$</td>
                    <td style="vertical-align: bottom; width: 1%; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">$</td>
                    <td style="vertical-align: bottom; width: 1%; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">$</td>
                    <td style="vertical-align: bottom; width: 1%; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">$</td>
                    <td style="vertical-align: bottom; width: 1%; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
                    <td style="vertical-align: bottom; border-top: 1px solid #000000; border-bottom: 1px solid #000000; text-align: center;">$</td>
                    <td style="vertical-align: bottom; width: 1%; border-top: 1px solid #000000; border-bottom: 1px solid #000000;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 1%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;"><b>Balance, December 31, 2017</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>72</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>201,500</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>3,794,846</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>12,794,963</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>354,996</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>2,116,900</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>1,495,300</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><b>(4,195,264</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"><b>)</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>12,413,399</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Share issued</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">2,268,035</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">47,853,745</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">47,853,745</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Share issuance costs</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">(6,634,405</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(6,634,405</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Reverse acquisition</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">545,505</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">9,868,179</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">37,313</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">118,875</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">25,725</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">10,012,779</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Warrant valuations</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">(2,366,670</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">198,835</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">2,366,670</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Share-based payments</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">294,287</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">6,146,119</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">6,440,406</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Share options exercised</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">190,463</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">5,145,825</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(2,288,775</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">2,857,050</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Share options cancelled</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">(401,069</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">401,069</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Warrants exercised</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">44,931</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">1,254,665</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(44,932</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(454,587</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">800,078</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Net comprehensive loss for the period</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 1px solid #000000;">(22,710,624</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">)&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">(22,710,624</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 1px solid #000000;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;"><b>Balance, December 31, 2018</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>72</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>201,500</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>6,843,780</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>67,916,302</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>546,212</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>4,442,145</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>4,977,300</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>&#8212;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>(26,504,819</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">)&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>51,032,428</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;"><b>Balance, December 31, 2018</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>72</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>201,500</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>6,843,780</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>67,916,302</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>546,212</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>4,442,145</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>4,977,300</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>&#8212;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>(26,504,819</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">)&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;"><b>51,032,428</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Shares issued <i>[note 15]</i></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">408,651</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">11,539,417</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">11,539,417</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc. [<i>note 5</i>]</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">510,940</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">16,431,818</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">67,598</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">1,888,086</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">2,567,306</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">20,887,210</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Share-based payments</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">16,061,319</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">16,061,319</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Share options exercised</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">130,189</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">1,782,438</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">(1,049,840</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">732,598</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Warrants exercised</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">12,167</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">145,174</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(12,167</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(50,183</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">94,991</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Warrants expired</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">(134,192</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">(535,014</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">535,014</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Net comprehensive loss for the period</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">(112,690</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff; border-bottom: 1px solid #000000;">(52,013,186</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">)&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">(52,125,876</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff; border-bottom: 1px solid #000000;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;"><b>Balance, December 31, 2019</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000;"><b>72</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000;"><b>201,500</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000;"><b>7,905,727</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000;"><b>97,815,149</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000;"><b>467,451</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000;"><b>5,745,034</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000;"><b>23,091,099</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 2px solid #000000;"><b>(112,690</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;"><b>)</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000;"><b>(78,518,005</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">)&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid #000000;"><b>48,222,087</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid #000000;">&#160;</td>
                </tr>
            </table>
            <p style="text-align: justify;"><i>The accompanying notes are an integral part of these consolidated financial statements.</i></p>
        </div>
        <div>
            <p style="text-align: center;">4</p>
        </div>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <div>
        <div><br></div>
        <div>
            <p style="text-align: left;"><b>FSD PHARMA INC.</b></p>
            <p style="text-align: center;"><b>CONSOLIDATED STATEMENTS OF CASH FLOWS<br></b>For the years ended December 31, 2019 and 2018<br>[expressed in Canadian dollars]</p>
            <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
                <tr>
                    <td style="vertical-align: bottom;"><br><br><br></td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;"><b>2019 </b></td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;"><b>2018 </b></td>
                    <td style="vertical-align: bottom;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">$</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;"><b>Operating activities</b></td>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Net loss</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;"><b>(52,013,186</b></td>
                    <td style="vertical-align: bottom;"><b>)</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">(22,710,624</td>
                    <td style="vertical-align: bottom;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Add (deduct) items not affecting cash</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160; &#160;Depreciation and amortization</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>3,146,680</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">183,194</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160;Impairment of property, plant and equipment and right-of-use asset</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>243,468</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160; &#160;Listing expense</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>&#8212;</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">7,991,791</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160;Interest expense</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>206,454</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160; &#160;Share-based payments</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>16,061,319</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">6,440,406</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160;Change in fair value of other investments</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>11,669,157</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(17,564,529</td>
                    <td style="vertical-align: bottom; background-color: #e6efff;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160; &#160;Change in fair value of derivative liability</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>3,568,305</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160;Change in fair value adjustments on inventory sold</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>22,249</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160; &#160;Change in fair value of biological assets</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>682,739</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160;Loss on settlement of financial liability</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>24,810</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160; &#160;Allowance for impairment of Auxly funds</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>&#8212;</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">7,499,977</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Changes in non-cash working capital balances</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160; &#160; &#160;Trade and other receivables</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;"><b>(1,079,067</b></td>
                    <td style="vertical-align: bottom;"><b>)</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">(664,610</td>
                    <td style="vertical-align: bottom;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160; &#160;Prepaid expenses and deposits</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>39,892</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(99,264</td>
                    <td style="vertical-align: bottom; background-color: #e6efff;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160; &#160; &#160;Inventories</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;"><b>(942,939</b></td>
                    <td style="vertical-align: bottom;"><b>)</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160; &#160;Biological assets</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><b>(682,739</b></td>
                    <td style="vertical-align: bottom; background-color: #e6efff;"><b>)</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160; &#160; &#160;Trade and other payables</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>825,120</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">433,754</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;"><b>Cash used in operating activities</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>(18,227,738</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>)</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(18,489,905</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;"><b>Investing activities</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Cash acquired from acquisition Prismic Pharmaceuticals Inc.</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>2,329</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Reverse Takeover Transaction</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">2,041,501</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Proceeds from sale of investments</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>614,520</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Purchase of other investments</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(7,999,991</td>
                    <td style="vertical-align: bottom; background-color: #e6efff;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Purchase of property, plant and equipment</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;"><b>(534,118</b></td>
                    <td style="vertical-align: bottom;"><b>)</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">(4,032,832</td>
                    <td style="vertical-align: bottom;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Additions to intangible assets</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>(389,640</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>)</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;"><b>Cash used in investing activities</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>(306,909</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000;"><b>)</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">(9,991,322</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;"><b>Financing activities</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Repayment of lease obligation</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><b>(56,207</b></td>
                    <td style="vertical-align: bottom; background-color: #e6efff;"><b>)</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Proceeds from issuance of shares</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>4,593,777</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">44,987,422</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Share issue costs</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;"><b>(32,705</b></td>
                    <td style="vertical-align: bottom; background-color: #e6efff;"><b>)</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; background-color: #e6efff;">(3,768,381</td>
                    <td style="vertical-align: bottom; background-color: #e6efff;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Proceeds from exercise of share options</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>732,598</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">2,857,050</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Proceeds from warrants exercised</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>94,991</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">800,078</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;"><b>Cash provided by financing activities</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>5,332,454</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">44,876,169</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;"><b>Net (decrease) increase in cash during the year</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;"><b>(13,202,193</b></td>
                    <td style="vertical-align: bottom;"><b>)</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">16,394,942</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Cash, beginning of year</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>21,134,930</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">4,739,988</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;"><b>Cash, end of year</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000;"><b>7,932,737</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000;">21,134,930</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
                </tr>
            </table>
            <p style="text-align: justify;"><i>The accompanying notes are an integral part of these consolidated financial statements.</i></p>
        </div>
        <div>
            <p style="text-align: center;">5</p>
        </div>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_5"></a><br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 100%;">
                <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                <p style="text-align: justify;">December 31, 2019 and 2018</p>
            </td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">1.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Nature of business </b></p>
    <p style="text-align: justify;">FSD Pharma Inc. ("FSD" or the "Company"), through their wholly owned subsidiary, FV Pharma Inc. ("FV Pharma"), is a licensed producer of cannabis in Canada under the Cannabis Act (Canada) (together with the regulations promulgated thereunder (the "Cannabis Regulations"), the "Cannabis Act") and associated Cannabis Regulations. FV Pharma is focused on producing and extracting high-quality, hydroponic, pharmaceutical-grade cannabis leaf. The Company, through the their wholly owned subsidiary Prismic Pharmaceuticals Inc. ("Prismic"), is focused on bioscience, including research and development ("R&amp;D") and clinical development of synthetic cannabinoid based treatments of certain disease conditions with an aim to improve patient outcomes. The Company's goal is for these compounds to be approved by the FDA and other international regulatory agencies as prescription medications.</p>
    <p style="text-align: justify;">The Company was incorporated under the provisions of the Business Corporations Act (Ontario) (the "OBCA") on November 1, 1998, pursuant to the amalgamation of Olympic ROM World Inc., 1305206 Ontario Corporation, 1305207 Ontario Inc., Century Financial Capital Group Inc. and Dunberry Graphic Associates Ltd. On May 24, 2018, pursuant to the Articles of Amendment, the Company changed its name to "FSD Pharma Inc.".</p>
    <p style="text-align: justify;">The Company's registered office is located at 1 Rossland Road West, Suite 202, Ajax, Ontario, L1Z 1Z2.</p>
    <p style="text-align: justify;">On October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares. All share and per share amounts for all periods presented in these financial statements have been adjusted retrospectively to reflect the reverse share split.</p>
    <p style="text-align: justify;"><b>Going concern uncertainty</b></p>
    <p style="text-align: justify;">The consolidated financial statements of the Company for the years ended December 31, 2019 and 2018 (the "financial statements") have been prepared on the basis of accounting principles applicable to a going concern, which assumes that the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities and commitments in the normal course of operations. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that would be necessary should the Company be unable to continue as a going concern. Such adjustments could be material.</p>
    <p style="text-align: justify;">The Company is in the preliminary stages of its planned operations and has not yet determined whether its processes and business plans are economically viable. The continued operations of the Company and the recoverability of amounts shown for property and equipment and intangible assets are dependent upon the ability of the Company to obtain sufficient financing to continue its cultivation and production processes and complete the pharmaceutical research and development program centered on the lead asset, micro-palmitoylethanolamide ("micro-PEA").</p>
    <p style="text-align: justify;">As at December 31, 2019, the Company has an accumulated deficit of $78.5 million, a net loss of $52 million and a working capital surplus of $2.3 million. Whether, and when, the Company can attain profitability and positive cash flows from operations is subject to material uncertainty.&#160; The application of the going concern assumption is dependent upon the Company's ability to generate future profitable operations and obtain necessary financing to do so. The Company will need to raise additional capital in order to fund its planned operations and meet its obligations. While the Company has been successful in obtaining financing to date and believes it will be able to obtain sufficient funds in the future and ultimately achieve profitability and positive cash flows from operations, there can be no assurance that the Company will achieve profitability and be able to do so on terms favourable for the Company. The above events and conditions indicate there is a material uncertainty that casts significant doubt about the Company&#8217;s ability to continue as a going concern.</p>
    <div id="footer_page_5">
        <p style="text-align: center;">6</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_6"></a>
    <div id="header_page_6">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;"><b>Subsidiaries</b></p>
    <p style="text-align: justify;">These financial statements are comprised of the financial results of the Company and its subsidiaries, which are the entities over which FSD has control. An investor controls an investee when it is exposed, or has rights, to variable returns from its involvement with the investee and can affect those returns through its power over the investee.</p>
    The Company has the following subsidiaries
    <table style="width: 75%; font-size: 10pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 25%; vertical-align: bottom;"><b>Entity Name</b></td>
            <td style="width: 20%; vertical-align: bottom; text-align: left; white-space: nowrap;"><b>Country </b></td>
            <td style="width: 5%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom; white-space: nowrap;"><b>Ownership<br></b><b>percentage<br></b><b>December 31, 2019</b></td>
            <td style="width: 5%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom; white-space: nowrap;"><b>Ownership<br></b><b>percentage<br></b><b>December 31, 2018</b></td>
        </tr>
        <tr>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: left;">&#160;</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: left;">&#160;</p>
            </td>
            <td style="width: 5%; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><b>%</b></p>
            </td>
            <td style="width: 5%; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><b>%</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 25%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: left;">FV Pharma Inc.</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: left;">Canada</p>
            </td>
            <td style="width: 5%; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">100</p>
            </td>
            <td style="width: 5%; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">100</p>
            </td>
        </tr>
        <tr>
            <td style="width: 25%; vertical-align: bottom;">
                <p style="text-align: left;">Prismic Pharmaceuticals Inc.&nbsp;</p>
          </td>
      <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: left;">USA</p>
            </td>
            <td style="width: 5%; vertical-align: bottom;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">100</p>
            </td>
            <td style="width: 5%; vertical-align: bottom;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">&#8211;</p>
            </td>
        </tr>
        <tr>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="width: 5%; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">2.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Basis of presentation </b></p>
    <p style="text-align: justify;"><b>[a] Statement of compliance </b></p>
    <p style="text-align: justify;">These financial statements have been prepared by management in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB"). The policies set out below have been consistently applied to all periods presented, unless otherwise noted. Certain comparative figures have been reclassified to conform to the current year's presentation.</p>
    <p style="text-align: justify;">These financial statements were approved and authorized for issuance by the Board of Directors of the Company on March 3, 2020.</p>
    <p style="text-align: justify;"><b>[b] Basis of measurement</b></p>
    <p style="text-align: justify;">These financial statements have been prepared on a historical cost basis. Historical costs are generally based upon the fair value of the consideration given in exchange for goods and services.</p>
    <p style="text-align: justify;">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, regardless of whether that price is directly observable or estimated using another valuation technique. In estimating the fair value of an asset or a liability, the Company takes into account the characteristics of the asset or liability if market participants would take those characteristics into account when pricing the asset or liability at the measurement date. Fair value for measurement and/or disclosure purposes in these financial statements is determined on such a basis, except for share-based payment transactions that are within the scope of IFRS 2 <i>Share-based Payment</i> ("IFRS 2") and measurements that have some similarities to fair value, but are not fair value, such as value in use in IAS 36 <i>Impairment of Assets</i>.</p>
    <p style="text-align: justify;"><b>[c] Basis of presentation</b></p>
    <p style="text-align: justify;">The accompanying financial statements include the accounts of FSD and its subsidiaries, FV Pharma and Prismic. The financial statements incorporate the assets and liabilities of the Company and its subsidiaries as at December 31, 2019 and 2018 and the results of these subsidiaries for the years then ended.</p>
    <div id="footer_page_6">
        <p style="text-align: center;">7</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_7"></a>
    <div id="header_page_7">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. All intra-entity assets and liabilities, revenue, expenses and cash flows relating to transactions between subsidiaries of the Company are eliminated in full on consolidation.</p>
    <p style="text-align: justify;"><b>[d] Functional currency and presentation currency</b></p>
    <p style="text-align: justify;">These financial statements are presented in Canadian dollars, which is the functional currency of the Company. The functional currencies of the Company's wholly owned subsidiaries is as follows:</p>
    <table style="width: 50%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%; background-color: #e6efff;">FV Pharma</td>
            <td style="width: 50%; background-color: #e6efff;">Canadian Dollars</td>
        </tr>
        <tr>
            <td style="width: 50%;">Prismic</td>
            <td style="width: 50%;">United States Dollars</td>
        </tr>
    </table>
    <p style="margin-top: 0pt; text-align: justify;">&#160;</p>
    <p style="margin-left: 21.25pt; text-indent: -21.25pt; text-align: justify;"><b>[e] Use of estimates and judgments</b></p>
    <p style="text-align: justify;">The preparation of these financial statements in conformity with IFRS requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities as at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.</p>
    <p style="text-align: justify;">Estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.</p>
    <p style="text-align: justify;">The following are the critical judgments, apart from those involving estimations, that management has made in the process of applying the Company's accounting policies and that have the most significant effect on the amounts recognized in the financial statements:</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[i]<font style="width: 11pt; text-indent: 0pt; display: inline-block;">&#160;</font>Going concern</p>
    <p style="text-align: justify;">At each reporting period, management assesses the basis of preparation of the financial statements. These financial statements have been prepared on a going concern basis in accordance with IFRS. The going concern basis of presentation assumes that the Company will continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in the normal course of business.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[ii]<font style="width: 9pt; text-indent: 0pt; display: inline-block;">&#160;</font>Estimated useful lives, residual values and depreciation of property, plant and equipment</p>
    <p style="text-align: justify;">Depreciation of property, plant and equipment is dependent upon estimates of useful lives and residual values, which are determined through the exercise of judgment. The assessment of any impairment of these assets' is dependent upon estimates of recoverable amounts that take into account factors such as economic and market conditions and the useful lives of assets.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[iii]<font style="width: 7pt; text-indent: 0pt; display: inline-block;">&#160;</font>Biological assets and inventory</p>
    <p style="text-align: justify;">In calculating the value of the biological assets and inventory, management is required to make a number of estimates, including estimating the stage of growth of the cannabis up to the point of harvest, harvesting costs, selling costs, expected selling and list prices and expected yields for the cannabis plants. In assessing the recoverability of final inventory values, management compares the inventory cost to estimated net realizable value. Further information on estimates used in determining the fair value of biological assets is contained in Note 8.</p>
    <div id="footer_page_7">
        <p style="text-align: center;">8</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_8"></a>
    <div id="header_page_8">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[iv]<font style="width: 6.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Estimated useful life and amortization of intangible assets</p>
    <p style="text-align: justify;">The Company employs significant estimates to determine the estimated useful lives of intangible assets, considering the nature of the asset, contractual rights, expected use and review of asset useful lives. The Company reviews amortization methods and useful lives annually or when circumstances change and adjusts its amortization methods and assumptions prospectively.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[v]<font style="width: 8.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Impairment of property, plant and equipment and intangible assets</p>
    <p style="text-indent: 0.05pt; text-align: justify;">Impairment testing requires management to make estimates related to future cash flow projections and market trends. Impairment of property, plant and equipment and intangible assets is influenced by judgment in defining a cash generating unit and determining the indicators of impairment and estimates used to measure impairment losses.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[vi]<font style="width: 4.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Valuation of share-based payments and warrants</p>
    <p style="text-align: justify;">Management measures the costs for share-based payments and warrants using market-based option valuation techniques. Assumptions are made and estimates are used in applying the valuation techniques. These include estimating the future volatility of the share price, expected dividend yield, expected term, expected risk-free interest rate and the rate of forfeiture. Such estimates and assumptions are inherently uncertain. Changes in these assumptions affect the fair value estimates of share-based payments and warrants.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[vii]<font style="width: 2.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Valuation of private company investments</p>
    <p style="text-align: justify;">The financial information of private companies may not always be available, or such information may be insufficient or unreliable for valuation purposes. In determining the fair value of shares held in private company investments, management is required to make certain estimates and assumptions regarding the fair value as of the reporting date. Assumptions are made and estimates are used in applying the valuation techniques to determine fair value. These include the most recently available financial statements of the investee, price for most recently completed financing, as well as closely comparable public companies and general market and economic conditions. Such investments are classified as Level 3 within the fair value hierarchy. The value at which the Company could ultimately realize upon disposition of these investments may differ from their carrying value and such differences could be material.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[viii]<font style="width: 6.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Asset acquisition</p>
    <p style="text-align: justify;">In the acquisition of Prismic on June 28, 2019 judgment was required to determine if the acquisition represented either a business combination or an asset purchase. Management concluded that Prismic did not represent a business as the assets acquired were not an integrated set of activities with inputs, processes and outputs. Since it was concluded that the acquisition represented the purchase of assets, there was no goodwill recognized on the transaction and acquisition costs were capitalized to the assets purchased rather than expensed. The fair values of the net assets acquired were determined using estimates and judgments. Refer to Note 5 for additional information on the Company's asset acquisition.</p>
    <div id="footer_page_8">
        <p style="text-align: center;">9</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_9"></a>
    <div id="header_page_9">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">3.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Significant accounting policies</b></p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[a]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Cash</p>
    <p style="text-align: justify;">Cash consists of cash and cash held in trust accounts. There are no restrictions on cash held in trust.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[b]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Property, Plant and Equipment</p>
    <p style="text-align: justify;">Property, plant and equipment is measured at cost less accumulated depreciation and impairment losses, with the exception of land which is not depreciated.</p>
    <p style="text-align: justify;">When parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) of property, plant and equipment.</p>
    <p style="text-align: justify;">The cost of replacing part of an item of property, plant and equipment is recognized in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Company and its cost can be measured reliably. The carrying amount of the replaced part is derecognized. The costs of the day-to-day servicing of property, plant and equipment are recognized in consolidated statements of loss and comprehensive loss.</p>
    <p style="text-align: justify;">Subsequent costs are included in the asset's carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the consolidated statements of loss and comprehensive loss.</p>
    <p style="text-align: justify;">Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount, and are recognized net within other income in the consolidated statements of loss and comprehensive loss.</p>
    <p style="text-align: justify;">Depreciation is based on the estimated useful lives of the assets provided as follows:</p>
    <table style="margin-left: auto; border-collapse: collapse; font-size: 10pt; width: 90%; margin-right: auto;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="margin-bottom: 0pt; text-align: justify;">Computer equipment</p>
            </td>
            <td style="width: 61%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="margin-bottom: 0pt; text-align: justify;">30% declining balance</p>
            </td>
        </tr>
        <tr>
            <td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">Production equipment</td>
            <td style="width: 61%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">20% declining balance</td>
        </tr>
        <tr>
            <td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">Furniture and fixtures</td>
            <td style="width: 61%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">20% declining balance</td>
        </tr>
        <tr>
            <td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">Facility and related</td>
            <td style="width: 61%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">20 years under straight-line</td>
        </tr>
        <tr>
            <td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="font-size: 10pt;">Land</font></p>
            </td>
            <td style="width: 61%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="font-size: 10pt;">Not amortized</font></p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">An item of property, plant and equipment and any significant part initially recognized are derecognized upon disposal or when no future economic benefits are expected from their use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated statements of loss and comprehensive loss when the asset is derecognized. The assets' residual values, useful lives and methods of depreciation and the depreciation charge are adjusted prospectively, if appropriate.</p>
    <div id="footer_page_9">
        <p style="text-align: center;">10</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_10"></a>
    <div id="header_page_10">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[c]<font style="width: 8.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Finite-lived Intangible Assets</p>
    <p style="text-align: justify;">Finite-lived intangible assets are recorded at cost less accumulated amortization and accumulated impairment losses. Amortization is recognized in profit or loss on a straight-line basis over the following terms:</p>
    <table style="margin-left: auto; border-collapse: collapse; font-size: 10pt; width: 90%; margin-right: auto;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: justify;">Intellectual Property</p>
            </td>
            <td style="width: 61%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: justify;">5 years</p>
            </td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[d]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Revenue Recognition</p>
    <p style="text-align: justify;">The Company's accounting policy for revenue recognition under IFRS 15, Revenue from Contracts with Customers ("IFRS 15") is to follow a five step model to determine the amount and timing of revenue to be recognized i) identify the contract with a customer; ii) identify the performance obligations in the contract; iii) determine the transaction price; iv) allocate the transaction price to the performance obligations in the contract; and v) recognize revenue when (or as) the Company satisfies a performance obligation.</p>
    <p style="text-align: justify;">Revenue from the sale of cannabis is recognized when the Company transfers control of the good to the customer. This is generally considered to have occurred when products have been delivered to the location specified in the sales contract and accepted by the customer.</p>
    <p style="text-align: justify;">The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive taking into account any variation that may result from rights of return.</p>
    <p style="text-align: justify;">The Company is required to remit excise tax to the Canada Revenue Agency on the sale of medical cannabis in Canada. The Company becomes liable for these excise duties when cannabis products are delivered to the customer. In accordance with IFRS 15, revenue presented on the Consolidated Statements of Loss and Comprehensive Loss, represents revenue from the sale of goods less applicable excise tax.</p>
    <p style="text-align: justify;">Areas of judgment include identifying the customer per the definition within IFRS 15 and determining whether control has passed to the customer.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[e]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Foreign Currency Translation</p>
    <p style="text-align: justify;">Foreign currency transactions are translated into Canadian dollars at exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies at the statement of financial position date are translated to Canadian dollars at the foreign exchange rate applicable at that date. Realized and unrealized exchange gains and losses are recognized through profit or loss.</p>
    <p style="text-align: justify;">Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction.</p>
    <p style="text-align: justify;">The assets and liabilities of foreign operations with functional currencies other than Canadian dollars, are translated into Canadian dollars at year-end exchange rates. Income and expenses, and cash flows of such foreign operations are translated into Canadian dollars using average exchange rates for the period. Exchange differences resulting from translating foreign operations are recognized in other comprehensive loss and accumulated in equity.</p>
    <div id="footer_page_10">
        <p style="text-align: center;">11</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_11"></a>
    <div id="header_page_11">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[f]<font style="width: 10.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Financial Instruments</p>
    <p style="text-align: justify;">Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the instruments.</p>
    <p style="text-align: justify;">Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognized immediately in profit or loss.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Financial assets</p>
    <p style="margin-left: 36pt; text-align: justify;">On initial recognition, a financial asset is classified as measured at amortized cost, fair value through other comprehensive income (''FVOCI''), or fair value through profit and loss (''FVTPL''). The classification of financial assets is based on the business model in which a financial asset is managed and its contractual cash flow characteristics.</p>
    <p style="margin-left: 36pt; text-align: justify;">A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 45.14pt; text-align: justify; padding-left: 8.86pt;">It is held within a business model whose objective is to hold assets to collect contractual cash flows; and</li>
        <li style="margin-left: 45.14pt; text-align: justify; padding-left: 8.86pt;">Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.</li>
    </ul>
    <p style="margin-left: 36pt; text-align: justify;">A financial asset (unless it is a trade receivable without a significant financing component that is initially measured at the transaction price) is initially measured at fair value plus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition.</p>
    <p style="text-indent: 36pt; text-align: justify;">The following accounting policies apply to the subsequent measurement of financial assets.</p>
    <table style="margin-left: 36.65pt; border: 0.75pt solid #000000; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 32%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: justify;">Financial assets at FVTPL</p>
            </td>
            <td style="width: 67%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-bottom: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: justify;">Subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.</p>
                <p style="text-align: justify;">&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="width: 32%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-right: 0.75pt solid #000000;">
                <p style="text-align: justify;">Financial assets at amortized cost</p>
            </td>
            <td style="width: 67%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: justify;">Subsequently measured at amortized cost using the effective interest method, less any impairment losses. Interest income, foreign exchange gains and losses and impairment losses are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Financial liabilities</p>
    <p style="margin-left: 36pt; text-align: justify;">The Company initially recognizes financial liabilities at fair value on the date at which the Company becomes a party to the contractual provisions of the instrument.</p>
    <div id="footer_page_11">
        <p style="text-align: center;">12</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_12"></a>
    <div id="header_page_12">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 36pt; text-align: justify;">The Company classifies its financial liabilities as either financial liabilities at FVTPL or amortized cost.</p>
    <p style="margin-left: 36pt; text-align: justify;">Subsequent to initial recognition, other liabilities are measured at amortized cost using the effective interest method. Financial liabilities at FVTPL are stated at fair value with changes being recognized in profit or loss.</p>
    <p style="margin-left: 36pt; text-align: justify;">The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Financial liabilities and equity instruments</p>
    <p style="margin-left: 36pt; text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Classification as debt or equity</p>
    <p style="margin-left: 72pt; text-align: justify;">Debt and equity instruments issued by the Company are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.</p>
    <p style="margin-left: 36pt; text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Equity instruments</p>
    <p style="margin-left: 72pt; text-align: justify;">An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Equity instruments issued by a group entity are recognized at the proceeds received, net of direct issue costs.</p>
    <p style="margin-left: 72pt; text-align: justify;">Repurchase of the Company's own equity instruments is recognized and deducted directly in equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the Company's own equity instruments.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Classification of financial instruments</p>
    <p style="margin-left: 36pt; text-align: justify;">The Company classifies its financial assets and liabilities depending on the purpose for which the financial instruments were acquired, their characteristics and management intent as outlined below:</p>
    <p style="margin-left: 36pt; text-align: justify;"><b>Classification</b></p>
    <table style="width: 70%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%; background-color: #e6efff;">Cash</td>
            <td style="width: 50%; background-color: #e6efff;">Amortized cost</td>
        </tr>
        <tr>
            <td style="width: 50%;">Trade and other receivables</td>
            <td style="width: 50%;">Amortized cost</td>
        </tr>
        <tr>
            <td style="width: 50%; background-color: #e6efff;">Other investments</td>
            <td style="width: 50%; background-color: #e6efff;">Fair value through profit or loss</td>
        </tr>
        <tr>
            <td style="width: 50%;">Trade and other payables</td>
            <td style="width: 50%;">Amortized cost</td>
        </tr>
        <tr>
            <td style="width: 50%; background-color: #e6efff;">Derivative liability</td>
            <td style="width: 50%; background-color: #e6efff;">Fair value through profit or loss</td>
        </tr>
        <tr>
            <td style="width: 50%;">Notes payable</td>
            <td style="width: 50%;">Amortized cost</td>
        </tr>
    </table>
    <p style="margin-top: 0pt; margin-left: 36pt; margin-bottom: 0pt; text-align: justify;">&#160;</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Impairment of financial assets</p>
    <p style="margin-left: 36pt; text-align: justify;">An expected credit loss ("ECL") model applies to financial assets measured at amortized cost. The Company's financial assets measured at amortized cost and subject to the ECL model consist primarily of trade and other receivables. The Company applies the simplified approach to impairment for trade and other receivables by recognizing a loss allowance based on lifetime expected losses at each reporting date taking into considerations historical credit loss experience and financial factors specific to the debtors and general economic conditions. The Company has assessed the impairment of its trade and other receivables using the expected credit loss model, and no material difference was noted.&#160;</p>
    <div id="footer_page_12">
        <p style="text-align: center;">13</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_13"></a>
    <div id="header_page_13">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[g]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Biological Assets</p>
    <p style="text-align: justify;">The Company's biological assets consist of cannabis plants. The Company capitalizes the direct and indirect costs incurred related to the biological transformation of the biological assets between the point of initial recognition and the point of harvest. The Company then measures the biological assets at fair value less cost to sell up to the point of harvest, which becomes the basis for the cost of inventory after harvest. This is determined using a model that estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount by the expected selling price less costs to sell per gram. The net unrealized gains or losses arising from changes in fair value less cost to sell during the year are included in the results of operations of the related period.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[h]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Inventory</p>
    <p style="text-align: justify;">Inventory of harvested work-in-process and finished goods are valued at the lower of cost and net realizable value. Inventory of harvested cannabis is transferred from biological assets at their fair value at harvest, which becomes the initial deemed cost. Any subsequent post-harvest costs are capitalized to inventory to the extent that cost is less than net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Inventory for supplies and consumables are valued at the lower of cost and net realizable value, with cost determined using the average cost basis.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[i]<font style="width: 11pt; text-indent: 0pt; display: inline-block;">&#160;</font>Impairment of long-lived assets</p>
    <p style="text-align: justify;">Long-lived assets, including property, plant and equipment and intangible assets are tested for impairment when there are indicators of impairment at each reporting date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. Intangible assets with an indefinite useful life are tested for impairment at least annually in the fourth quarter and whenever there is an indication that the asset may be impaired.</p>
    <p style="text-align: justify;">For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in net loss equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[j]<font style="width: 11pt; text-indent: 0pt; display: inline-block;">&#160;</font>Income Taxes</p>
    <p style="text-align: justify;">Income tax expense comprises of current and deferred tax. Current tax and deferred tax are recognized in net profit or loss except to the extent that it relates to a business combination or items recognized directly in equity or in other comprehensive loss.</p>
    <div id="footer_page_13">
        <p style="text-align: center;">14</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_14"></a>
    <div id="header_page_14">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">Current income taxes are recognized for the estimated income taxes payable or receivable on taxable income or loss for the current year and any adjustment to income taxes payable in respect of previous years. Current income taxes are determined using tax rates and tax laws that have been enacted or substantively enacted by the year-end date.</p>
    <p style="text-align: justify;">Deferred tax assets and liabilities are recognized where the carrying amount of an asset or liability differs from its tax base, except for taxable temporary differences arising on the initial recognition of goodwill and temporary differences arising on the initial recognition of an asset or liability in a transaction which is not a business combination and at the time of the transaction affects neither accounting nor taxable profit or loss.</p>
    <p style="text-align: justify;">Recognition of deferred tax assets for unused tax losses, tax credits and deductible temporary differences is restricted to those instances where it is probable that future taxable profit will be available against which the deferred tax asset can be utilized. At the end of each reporting period, the Company reassesses unrecognized deferred tax assets. The Company recognizes a previously unrecognized deferred tax asset to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[k]<font style="width: 8.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Share-based Compensation</p>
    <p style="text-align: justify;">Stock options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Stock options and warrants awarded to employees are accounted for using the fair value method.&#160; The fair value of such stock options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[l]<font style="width: 11pt; text-indent: 0pt; display: inline-block;">&#160;</font>Net Loss per Share</p>
    <p style="text-align: justify;">Net loss per share is calculated based on the loss for the financial year and the weighted average number of common shares outstanding during the year. Diluted net loss per share is calculated using the loss for the financial year adjusted for the effect of any dilutive instruments and the weighted average diluted number of shares [ignoring any potential issue of common shares that would be anti-dilutive] during the year.</p>
    <p style="text-align: justify;"><b>New standards, amendments and interpretations adopted by the Company</b></p>
    <p style="text-align: justify;"><i>IFRS 16 - Leases ["IFRS 16"]</i></p>
    <p style="text-align: justify;">The Company has adopted IFRS 16 with an initial adoption date of January 1, 2019. The Company utilized the modified retrospective method to adopt the new standard and therefore, the comparative information has not been restated and continues to be reported under IAS 17, Leases and related interpretations.</p>
    <p style="text-align: justify;">IFRS 16 specifies how leases will be recognized, measured, presented and disclosed and it provides a single lessee model requiring lessees to recognize right-of-use assets and lease liabilities for all major leases. The Company's accounting policy under IFRS 16 is as follows.</p>
    <p style="text-align: justify;">At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of identified asset for a period of time in exchange for consideration. The Company recognized a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of the costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right-of-use assets are depreciated to the earlier of the end of useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of the consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset can be periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, and the Company's incremental borrowing rate. The Company used an incremental borrowing rate to measure the lease liabilities in the opening balance sheet at January 1, 2019 of 7.73%.</p>
    <div id="footer_page_14">
        <p style="text-align: center;">15</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_15"></a>
    <div id="header_page_15">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from the change in an index or rate, if there is a change in the Company's estimate of the amount expected to be payable under a residual value guarantee, or if the Company changes its assessment of whether it will exercise a purchase, extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, unless it has been reduced to zero.</p>
    <p style="text-align: justify;">The Company has elected to apply the practical expedient not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less or to leases of low value assets when applicable. The lease payments associated with those leases is recognized as an expense on a straight-line basis over the lease term. The Company has also elected to apply the practical expedient to grandfather the assessment of which transactions are leases on the date of initial application, as previously assessed under IAS 17 and IFRIC 4 Determining Whether an Arrangement Contains a Lease. The Company applied the definition of a lease under IFRS 16 to contracts entered into or changed on or after January 1, 2019.</p>
    <p style="text-align: justify;">On initial application, the Company has elected to record right-of-use assets at the amount of the corresponding lease liability. Right-of-use assets and lease obligations of $243,818 were recorded as at January 1, 2019. When measuring lease liabilities, the Company discounted lease payments using its incremental borrowing rate at January 1, 2019.</p>
    <p style="text-align: justify;">The following table reconciles the Company's operating lease obligations at December 31, 2018, as previously disclosed in the Company's audited financial statements for the year ended December 31, 2018, to the lease obligations recognized on initial application of IFRS 16 at January 1, 2019:</p>
    <table style="width: 70%; font-size: 10pt; border-collapse: collapse; border-color: #000000; margin-left: auto; margin-right: auto;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Aggregate lease commitments as disclosed at December 31, 2018</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">315,528</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Less: Adjustment to lease commitments</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">(24,528</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; background-color: #e6efff;">Less: Impact of present value</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">(47,182</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left;"><b>Opening IFRS 16 lease obligation as at January 1, 2019</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;"><b>243,818</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">The Company did not have any leases subject to the low-value or short-term lease recognition exemptions upon adoption of IFRS 16 and as at December 31, 2019.</p>
    <div id="footer_page_15">
        <p style="text-align: center;">16</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_16"></a>
    <div id="header_page_16">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify; margin-left: 17.85pt; text-indent: -17.85pt;">4.<font style="width: 10.34pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Reverse Takeover Transaction </b></p>
    <p style="text-align: justify;">Century Financial Capital Group Inc. ("Century") and FV Pharma executed a definitive business combination agreement on March 9, 2018 (the "Definitive Agreement"), whereby FV Pharma would be combined with Century to continue the business of FV Pharma.</p>
    <p style="text-align: justify;">Under the terms of the Definitive Agreement, the Transaction was completed by way of a "three-cornered amalgamation" pursuant to the provisions of the Business Corporations Act (Ontario), whereby 2620756 Ontario Inc., a wholly-owned subsidiary of Century, amalgamated with FV Pharma (the "Amalgamation"), and the amalgamated entity is now a wholly-owned subsidiary of the Company (the "Transaction").</p>
    <p style="text-align: justify;">Pursuant to the terms of the Definitive Agreement and in connection with the Amalgamation:</p>
    <p style="margin-left: 17.85pt; text-align: justify;">&#9679;<font style="width: 12.71pt; display: inline-block;">&#160;</font>Century amended its articles to: (i) amend and designate its outstanding common shares (the "Existing Century Shares") as Class B subordinate voting shares (the "Century Class B Shares"); and (ii) create a new class of Class A multiple voting shares (the "Century Class A Shares");</p>
    <p style="margin-left: 17.85pt; text-align: justify;">&#9679;<font style="width: 12.71pt; display: inline-block;">&#160;</font>holders of outstanding Class A common voting shares of FV Pharma (the "FV Class A Shares") received one (1) Century Class A Share for each one (1) FV Class A Share held;</p>
    <p style="margin-left: 17.85pt; text-align: justify;">&#9679;<font style="width: 12.71pt; display: inline-block;">&#160;</font>holders of outstanding Class B common non-voting shares of FV Pharma (the "FV Class B Shares" and, together with the FV Class A Shares, the "FV Shares"), including FV Class B Shares issued on conversion of the Subscription Receipts, received one (1) Century Class B Share for each one (1) FV Class B Share held; and</p>
    <p style="margin-left: 17.85pt; text-align: justify;">&#9679;<font style="width: 12.71pt; display: inline-block;">&#160;</font>all outstanding options to purchase FV Pharma Class B shares and options to purchase Century shares were exchanged, on an equivalent basis, for options to purchase Class B shares of the Company, and all outstanding warrants to purchase FV Pharma Class B Shares and warrants to purchase Century shares were exchanged, on an equivalent basis, for warrants to purchase Class B shares of the Company.</p>
    <p style="text-align: justify;">The Transaction has been accounted for as a "reverse takeover" as the issuance of shares to the former shareholders of FV Pharma resulted in the former shareholders of FV Pharma holding a majority of the issued and outstanding shares of the Company. Under this method of accounting, FV Pharma (the legal subsidiary) is deemed to be the acquirer and Century (the legal parent) is deemed to be the acquired company.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">5.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Acquisition of Prismic Pharmaceutical</b></p>
    <p style="text-align: justify;">On June 28, 2019, the Company closed the acquisition of Prismic by acquiring all of the issued and outstanding Prismic Shares from the holders thereof. Prismic is a U.S.-based specialty research and development pharmaceutical company that is developing non-addictive prescription drugs for the treatment of pain and inflammation. Prismic's goal is to address the opioid crisis based on formulations utilizing micro-PEA's complimentary effect on certain drugs used to impact the body's endocannabinoid system.</p>
    <p style="text-align: justify;">It was determined that the acquisition of Prismic did not qualify as a business combination in accordance with IFRS 3 <i>Business Combinations </i>["IFRS 3"] and therefore it was accounted for as an asset acquisition. The individual identifiable assets acquired and liabilities assumed were identified and the purchase consideration was allocated based on the relative fair values of the acquired assets and assumed liabilities.</p>
    <p style="text-align: justify;">The total consideration for the purchase of Prismic was $20,887,209. The purchase consideration consisted of $16,431,818 of Class B subordinate voting shares, $2,567,305 of share options and $1,888,086 of warrants. The fair value of the Class B subordinate voting shares was determined based on a total of 510,940 shares issued and a fair value of $32.16 per share, which reflects the share price on the date of acquisition. The fair value of the 89,898 share options and 67,598 warrants issued as part of the consideration were determined using a black-scholes options pricing model with the following assumptions:</p>
    <div id="footer_page_16">
        <p style="text-align: center;">17</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_17"></a>
    <div id="header_page_17">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <div>
        <div><br>
            <div>
                <div><br></div>
                <table style="width: 100%; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
                    <tr>
                        <td style="width: 70%; vertical-align: bottom;">
                            <p style="text-align: left;">&#160;</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">
                            <p style="text-align: right;"><b>Share Options</b></p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">
                            <p style="text-align: right;"><b>Warrants</b></p>
                        </td>
                    </tr>
                    <tr>
                        <td style="width: 70%; vertical-align: bottom; background-color: #e6efff;">
                            <p style="text-align: left;">Grant date share price</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom; background-color: #e6efff;">
                            <p style="text-align: right;">$32.16</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom; background-color: #e6efff;">
                            <p style="text-align: right;">$32.16</p>
                        </td>
                    </tr>
                    <tr>
                        <td style="width: 70%; vertical-align: bottom;">
                            <p style="text-align: left;">Exercise Price</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom;">
                            <p style="text-align: right;">$2.61 - $17.89</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom;">
                            <p style="text-align: right;">$2.61 - $26.73</p>
                        </td>
                    </tr>
                    <tr>
                        <td style="width: 70%; vertical-align: bottom; background-color: #e6efff;">
                            <p style="text-align: left;">Expected dividend yield</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom; background-color: #e6efff;">
                            <p style="text-align: right;">-</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom; background-color: #e6efff;">
                            <p style="text-align: right;">-</p>
                        </td>
                    </tr>
                    <tr>
                        <td style="width: 70%; vertical-align: bottom;">
                            <p style="text-align: left;">Risk free interest rate</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom;">
                            <p style="text-align: right;">1.39% - 1.66%</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom;">
                            <p style="text-align: right;">1.41% - 1.52%</p>
                        </td>
                    </tr>
                    <tr>
                        <td style="width: 70%; vertical-align: bottom; background-color: #e6efff;">
                            <p style="text-align: left;">Expected life (years)</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom; background-color: #e6efff;">
                            <p style="text-align: right;">0.98-16.21</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom; background-color: #e6efff;">
                            <p style="text-align: right;">1.39-6.55</p>
                        </td>
                    </tr>
                    <tr>
                        <td style="width: 70%; vertical-align: bottom;">
                            <p style="text-align: left;">Annualized volatility</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom;">
                            <p style="text-align: right;">100%</p>
                        </td>
                        <td style="width: 15%; vertical-align: bottom;">
                            <p style="text-align: right;">100%</p>
                        </td>
                    </tr>
                </table>
            </div>
            <div>
                <div><br></div>
            </div>
            <p style="text-align: justify;">The allocation of the total purchase consideration to the identifiable assets acquired and liabilities assumed as at the date of acquisition was as follows:</p>
            <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;"><b>Fair value</b></td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;"><b>recongized on</b></td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;"><b>acquisition</b></td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap; width: 12%;"><b>$</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Cash</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">2,329</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">Prepaids</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">26,174</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Intellectual Property</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">24,648,915</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">Trade and other payables</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">(1,867,250</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Short-term notes</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">(195,475</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">Notes payable</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">(1,727,484</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>20,887,209</b></td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
            </table>
            <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">6.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Trade and other receivables</b></p>
            <p style="text-align: justify;">The Company's trade and other receivables include the following:</p>
            <div>
                <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
                    <tr>
                        <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;"><b>December 31,</b></td>
                        <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;">December 31,</td>
                        <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;"><b>2019</b></td>
                        <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;">2018</td>
                        <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">&#160;</td>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap; width: 12%;"><b>$</b></td>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap; width: 12%;">$</td>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Sales tax recoverable</td>
                        <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>2,033,535</b></td>
                        <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">982,663</td>
                        <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="vertical-align: bottom; text-align: left;">Rent receivable</td>
                        <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>12,990</b></td>
                        <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                        <td style="vertical-align: bottom; text-align: right; width: 12%;">8,325</td>
                        <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; background-color: #e6efff;">Other</td>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>23,530</b></td>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">&#8212;</td>
                        <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                    </tr>
                    <tr>
                        <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left;">&#160;</td>
                        <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
                        <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;"><b>2,070,055</b></td>
                        <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
                        <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
                        <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;">990,988</td>
                        <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
                    </tr>
                </table>
            </div>
        </div>
        <br>
    </div>
    <div><br></div>
    <div><br></div>
    <div id="footer_page_17">
        <p style="text-align: center;">18</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_18"></a>
    <div id="header_page_18">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">7.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Inventory</b></p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">Inventory as at December 31, 2019 is as follows:</p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;"><b>Biological asset</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;"><b>fair value</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;"><b>Capitalized cost</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;"><b>adjustment</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;"><b>Impairment</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap; width: 12%;"><b>Carrying value</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap; width: 12%;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap; width: 12%;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap; width: 12%;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap; width: 12%;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><i>Harvested cannabis</i></td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Work in process</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">1,576,556</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">(431,627</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">(605,598</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">539,331</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Finished good</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">82,463</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">15,707</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">(76,979</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">21,191</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">1,659,019</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">(415,920</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">(682,577</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">560,522</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><i>Hemp products</i></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Raw materials</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">100,000</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">100,000</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">100,000</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">100,000</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><i>Other inventory</i></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Supplies</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">282,417</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">282,417</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">282,417</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">282,417</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>2,041,436</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>(415,920</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>(682,577</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>942,939</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Costs of sales primarily relate to production related expenditures not capitalized due to start-up costs, underutilization and impairment charges. Prior to the receipt of the Company's Health Canada cultivation license on October 13, 2017, the Company did not incur production related expenditures.</p>
    <p style="text-align: justify;">During the year ended December 31, 2019 the Company recognized in costs of revenue $1,315,941 (2018 - nil) related to inventory impairment charges.</p>
    <p style="text-align: justify;">There was no inventory as at December 31, 2018.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">8.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Biological assets</b></p>
    <p style="text-align: justify;">Biological assets consist of cannabis plants. The changes in the carrying value of biological assets are as follows:</p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Balance, December 31, 2018</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Capitalized costs</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">1,297,734</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Change in fair value less costs to sell due to biological transformation</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">(682,739</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">Transferred to inventory upon harvest</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">(614,995</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left;"><b>Balance, December 31, 2019</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">The Company measures its biological assets at their fair value less costs to sell. This is determined using a model that estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount by the expected selling price less costs to complete and sell per gram.</p>
    <div id="footer_page_18">
        <p style="text-align: center;">19</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_19"></a>
    <div id="header_page_19">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">The fair value measurements for biological assets have been categorized as Level 3 fair values based on the inputs to the valuation technique used. The Company's method of accounting for biological assets attributes value accretion on a straight-line basis throughout the life of the biological asset from initial cloning to the point of harvest.</p>
    <p style="text-align: justify;">The Company capitalizes costs to biological assets in a manner consistent with the principles in IAS 2 (including but not limited to the determination of what types of costs are capitalized).</p>
    <p style="text-align: justify;">The following table identifies each significant unobservable input used to estimate the fair value of biological assets:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" border="1" cellspacing="0" cellpadding="3">
        <tr>
            <td colspan="2" rowspan="2"><b>Assumptions:</b></td>
            <td style="width: 20%; text-align: center; white-space: nowrap;"><b>As at December 31, 2019</b></td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: center; white-space: nowrap;"><b>Input</b></td>
        </tr>
        <tr>
            <td style="width: 5%; text-align: center;">i</td>
            <td style="width: 75%;">Expected yields for cannabis plants (average grams per plant)</td>
            <td style="width: 20%; text-align: center; white-space: nowrap; vertical-align: bottom;">13 grams dry flower<br>16 grams dry trim</td>
        </tr>
        <tr>
            <td style="width: 5%; text-align: center;">ii</td>
            <td style="width: 75%;">Weighted average number of growing weeks completed as a percentage of total growing weeks as at period end&#160;</td>
            <td style="width: 20%; text-align: center; white-space: nowrap; vertical-align: bottom;">73%</td>
        </tr>
        <tr>
            <td style="width: 5%; text-align: center;">iii</td>
            <td style="width: 75%;">Estimated selling price per gram</td>
            <td style="width: 20%; text-align: center; white-space: nowrap; vertical-align: bottom;">$1.00 for flower<br>$0.50 for trim</td>
        </tr>
        <tr>
            <td style="width: 5%; text-align: center;">iv</td>
            <td style="width: 75%;">After harvest cost to complete and sell per gram</td>
            <td style="width: 20%; text-align: center; white-space: nowrap; vertical-align: bottom;">$1.91 for dry flower<br>$1.25 for dry trim</td>
        </tr>
    </table>
    <p style="text-align: justify;">As at December 31, 2019 the fair value less costs to complete and sell of biological assets was nil. A change of plus or minus 10% of any of the above assumptions would not result in any change in the balance recognized of nil as at December 31, 2019.&#160; &#160;</p>
    <p style="text-align: justify;">The Company estimates the harvest yields for cannabis at various stages of growth. As of December 31, 2019, it is expected that the Company's cannabis plants will yield approximately 19,532 grams of dry flower and 25,002 grams of dry trim when harvested. It was estimated that these plants as of December 31, 2019 had completed 73% of the expected growth cycle, which is estimated at 12 weeks.</p>
    <p style="text-align: justify;">These estimates are subject to volatility in market prices and a number of factors, which could significantly affect the fair value of biological assets in future periods. The Company's estimates are, by their nature, subject to change, and differences from the anticipated yield and the other assumptions will be reflected in the gain or loss on biological assets in future periods.</p>
    <p style="text-align: justify;">The fair value adjustments on biological assets are presented separately on the statements of loss and comprehensive loss.</p>
    <p style="text-align: justify;">Biological assets as at December 31, 2018 were determined to have a fair value of nil.&#160;</p>
    <div id="footer_page_19">
        <p style="text-align: center;">20</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_20"></a>
    <div id="header_page_20">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">9.<font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Other investments</b></p>
    <p style="text-align: justify;">The following table outlines changes in other investments.</p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Balance at</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Change in fair</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Balance at</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>December 31,</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Proceeds</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>value through</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>December 31,</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><b>Entity</b></td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;"><b>Instrument</b></td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;"><b>Note</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>2018</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Additions</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>from sale</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>profit or loss</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>2019</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; white-space: nowrap;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Pharmadrug Inc.</td>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Shares</td>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">(i)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">3,000,000</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">(2,660,940</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">339,060</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Cannara Biotech Inc.</td>
            <td style="vertical-align: bottom; text-align: left;">Shares</td>
            <td style="vertical-align: bottom; text-align: left;">(ii)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">11,215,395</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">(2,146,357</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">9,069,038</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Clover Cannastrip</td>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Shares</td>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">(iii)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">1,500,000</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">(1,500,000</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">High Tide</td>
            <td style="vertical-align: bottom; text-align: left;">Shares</td>
            <td style="vertical-align: bottom; text-align: left;">(iv)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">1,798,040</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">614,520</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">(1,183,520</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">High Tide</td>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Warrants</td>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">(iv)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">251,115</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">(251,115</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">HUGE Shops</td>
            <td style="vertical-align: bottom; text-align: left;">Shares</td>
            <td style="vertical-align: bottom; text-align: left;">(v)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">1,300,000</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">(539,132</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">760,868</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">SciCann Therapeutics</td>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Shares</td>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">(vi)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">1,999,991</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">(1,287,743</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">712,248</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Solarvest BioEnergy Inc.</td>
            <td style="vertical-align: bottom; text-align: left;">Shares</td>
            <td style="vertical-align: bottom; text-align: left;">(vii)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">690,000</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">(255,000</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">435,000</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Solarvest BioEnergy Inc.</td>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Warrants</td>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">(vii)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">385,784</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">(269,134</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">116,650</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">Solarvest BioEnergy Inc.</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">Convertible debenture</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">(vii)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">1,924,216</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">(1,576,216</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">348,000</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>18,064,541</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>6,000,000</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>614,520</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>(11,669,157</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>11,780,864</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">(i) Pharmadrug Inc. (Formerly known as "Aura Health Inc.")</p>
    <p style="text-align: justify;">On April 16, 2019, the Company entered into a share exchange agreement with Aura Health Inc. ("Aura"). Pursuant to the share exchange agreement, FSD acquired 13,562,386 common shares at $0.2212 per share in the capital of Aura in exchange for the issuance of 65,577 Class B shares of the Company at $45.75 for a total value of $3,000,000. The FSD shares issued to Aura were subject to a purchase price adjustment, such that FSD would be required to issue additional shares to Aura should the weighted average trading price of FSD's shares fall below the issue price. As the number of additional shares to be issued under the agreement were dependent on the FSD share price, it was determined that this created a derivative liability. As a result of the decline in the Company's share price, on September 20, 2019, 61,892 additional Class B shares of the Company were issued to Aura as part of the adjustment of purchase price and a corresponding loss on change in fair value of derivative liability of $1,422,036 was recorded in the statements of loss and comprehensive loss. The Company's investment in Aura has been classified as level 1 within the fair value hierarchy - quoted market price. During the fiscal year 2019, Aura announced a name change to Pharmadrug Inc.</p>
    <p style="text-align: justify;">(ii) Cannara Biotech Inc. ("Cannara")</p>
    <p style="text-align: justify;">The Company's investment in 85,003,750 Class B shares of Cannara are subject to an escrow arrangement with timed releases of a predetermined quantity of shares at set intervals over a three-year period. Consequently, unrestricted shares that are not subject to escrow are valued at market price and shares that are held in escrow are subject to a discount rate. The valuation at December 31, 2019 was based on the December 31, 2019 quoted market price of $0.125 per share, subject to an aggregate discount for the escrow conditions determined to be 19.53% ($1,556,431). The 21,250,935 unrestricted Class B shares have been classified as level 1 within the fair value hierarchy - quoted market price. The remaining 63,752,815 Class B shares held in escrow has been classified as level 2 within the fair value hierarchy - valuation technique with observable inputs. The Company was a founder of Cannara and previously had common directors during 2018. Subsequent to December 31, 2019, the Company sold all 85,003,750 Class B shares for gross proceeds of $7,743,492 (refer to Note 25).&#160;</p>
    <div id="footer_page_20">
        <p style="text-align: center;">21</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_21"></a>
    <div id="header_page_21">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">(iii) Clover Cannastrip Thin Film Technologies Corp. ("Clover")</p>
    <p style="text-align: justify;">On September 6, 2018, the Company subscribed for $1,500,000 of equity units in a brokered private placement by Clover. The equity investment is measured at fair value through profit or loss. Clover is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2019, the fair value was determined to be nil based on the financial position of Clover and the Company's ability to recover its investment.</p>
    <p style="text-align: justify;">(iv) High Tide Inc.</p>
    <p style="text-align: justify;">The investment included 4,551,999 shares and 2,000,000 warrants. On November 22, 2019 the Company sold the shares and warrants of High Tide Inc. for total cash proceeds of $614,520.</p>
    <p style="text-align: justify;">(v) HUGE Shops</p>
    <p style="text-align: justify;">The investment includes 17,333,333 shares based on the December 2018 subscription price of $0.075 per share. The equity investment is measured at fair value through profit or loss. Huge Shops is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2019, the Company determined the best information to assess the fair value of the investment was based on movement of comparable public companies share prices and cannabis sector index resulting in decline in the fair value of investment of 41.5% from December 31, 2018. Comparable companies were determined in looking at product offering, relative size of operations, geographical market and other factors. A change in this assumption of plus or minus 10% would result in a corresponding change in fair value of the investment of approximately $54,000.</p>
    <p style="text-align: justify;">(vi) SciCann Therapeutics Inc.</p>
    <p style="text-align: justify;">The investment includes 117,648 shares based on the subscription price in May of 2018 and October of 2018 of $17 per share. The equity investment is measured at fair value through profit or loss. SciCann Therapeutics Inc. is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2019, the Company determined the best information to assess the fair value of the investment was based on movement of comparable public companies share prices and cannabis sector index resulting in decline in the fair value of investment of 64.4% from December 31, 2018. Comparable companies were determined in looking at product offering, relative size of operations, geographical market and other factors. A change in this assumption of plus or minus 10% would result in a corresponding change in fair value of the investment of approximately $129,000.</p>
    <p style="text-align: justify;">(vii) Solarvest BioEnergy Inc. ("Solarvest")</p>
    <p style="text-align: justify;">On May 7, 2019, the Company acquired 3,000,000 common shares, 3,000,000 warrants and a convertible debenture at a principal amount of $2,400,000 for a total fair value of $3,000,000 of Solarvest in exchange for 49,751 Class B common shares of the Company with a fair value of $2,500,000 based on a market price of $50.25 and recognition of a derivative liability of $500,000. Under the terms of the agreement, the Company has guaranteed a minimum liquidation value of its shares to Solarvest of $3,000,000 resulting in recognition of derivative liability. If the liquidation value of the Company's shares is below $3,000,000, the Company would be required to issue additional shares for the difference in actual value realized and the minimum guaranteed value.</p>
    <p style="text-align: justify;">As at December 31, 2019, the fair value of the shares was determined based on the quoted market price of the shares at $0.145 per share. The fair value of the associated warrants is based on the Black-Scholes model with the following assumptions: exercise price $0.25, risk free rate 1.71%, expected volatility 94%, expected life 1.35 years and expected dividend yield of 0%. Fair value of the convertible debenture is calculated as: i) principle amount of debt: $2,400,000 multiplied by ii) conversion ratio of $1 per share multiplied by iii) SVS share price as at December 31, 2019 of $0.145. The shares have been classified as level 1 within the fair value hierarchy - quoted market price, and the warrants and convertible debenture have been classified as level 2 - valuation technique with observable market inputs.</p>
    <p style="text-align: justify;">As at December 31, 2019, the fair value of the derivative liability was $2,646,269 resulting in recognition of loss on change in fair value of derivative liability of $2,146,269. The fair value was determined based on the additional common shares of the Company required to be issued to Solarvest to meet the minimum liquidation value of $3,000,000. Subsequent to December 31, 2019, the Company issued 225,371 shares to Solarvest to settle this derivative liability (refer to Note 25).&#160;</p>
    <div id="footer_page_21">
        <p style="text-align: center;">22</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_22"></a>
    <div id="header_page_22">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">10.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Right-of-use asset</b></p>
    <p style="text-align: justify;">The right-of-use asset as at December 31, 2019 is as follows:</p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Balance &#8211; January 1, 2019</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">243,818</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Depreciation</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">(48,764</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Impairment</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">(67,644</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><b>Balance &#8211; December 31, 2019</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;"><b>127,410</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">The right-of-use asset relates to an office lease. As of December 31, 2019, the Company did not occupy the leased premise and was in the process of subleasing the space. The right-of-use asset has been impaired as of December 31, 2019 and was written down to the present value of the expected future lease payments to be received from subleasing the premise over the remaining term of the lease.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">11.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Property, plant and equipment </b></p>
    <p style="text-align: justify;">Property, plant and equipment as at December 31, 2019 is as follows:</p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Furniture and</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Computer</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Facility and</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Production</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>fixtures</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>equipment</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>related</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>equipment</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Land</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Total</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">$</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">$</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">$</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">$</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">$</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; white-space: nowrap;">$</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Cost</b></td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Balance, December 31, 2017</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">123,218</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">7,068,820</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">1,100,000</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">8,292,038</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt; background-color: #e6efff;">Additions</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">209,795</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">220,150</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">3,350,156</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">252,731</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">4,032,832</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Balance, December 31, 2018</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">333,013</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">220,150</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">10,418,976</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">252,731</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">1,100,000</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">12,324,870</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt; background-color: #e6efff;">Additions</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">126,425</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">73,183</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">142,824</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">191,686</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">534,118</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt;">Impairment</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">(86,730</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">(101,683</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">(26,643</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">(215,056</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Balance, December 31, 2019</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>372,708</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>293,333</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>10,460,117</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>417,774</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>1,100,000</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>12,643,932</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><b>Accumulated depreciation</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Balance, December 31, 2017</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt;">Depreciation</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">76,179</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">66,045</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">40,970</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%;">183,194</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Balance, December 31, 2018</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">76,179</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">66,045</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">40,970</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">183,194</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt;">Depreciation</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">100,652</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">68,186</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">439,903</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">87,084</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">695,825</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt; background-color: #e6efff;">Impairment</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">(27,754</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">(5,084</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">(6,394</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">(39,232</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><b>Balance, December 31, 2019</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>149,077</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>134,231</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>434,819</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>121,660</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>839,787</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Carrying value</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Balance, December 31, 2018</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">256,834</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">154,105</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">10,418,976</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">211,761</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">1,100,000</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">12,141,676</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Balance, December 31, 2019</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>223,631</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>159,102</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>10,025,298</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>296,114</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>1,100,000</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%; background-color: #e6efff;"><b>11,804,145</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">During the year ended December 31, 2019, the Company capitalized $131,955 (2018 - nil) of depreciation to the production of biological assets and inventory.</p>
    <p style="text-align: justify;">During the year, the Company completed a review of the recoverable amount of items of property, plant and equipment for which indicators of impairment were present. The review led to the recognition of an impairment loss of $175,824 which has been recognized in the statement of loss and comprehensive loss.</p>
    <div id="footer_page_22">
        <p style="text-align: center;">23</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_23"></a>
    <div id="header_page_23">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">12.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Intangible asset</b></p>
    <p style="text-align: justify;">Intangible asset as at December 31, 2019 is as follows:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 2px solid #000000;">$</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Cost</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, December 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160;Acquisition of Prismic Pharmaceuticals Inc.</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">24,648,915</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Additions</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">389,640</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160;Effects of foreign exchange</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(186,463</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, December 31, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000;">24,852,092</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Accumulated amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Balance, December 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">2,534,047</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160;Effects of foreign exchange</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(40,887</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, December 31, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000;">2,493,160</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Carrying value</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Balance, December 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance, December 31, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000;">22,358,932</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">The Company acquired intellectual property as part of the acquisition of Prismic on June 28, 2019. Refer to Note 5 for additional details. The life of the intellectual property has been determined to be 5 years. Amortization of the intellectual property commenced on the date of acquisition.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">13.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Lease obligations</b></p>
    <p style="text-align: justify;">The lease obligations as at December 31, 2019 are as follows:</p>
    <div><br></div>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Balance &#8211; January 1, 2019</b></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>243,818</b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Add: Interest Expense</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">15,258</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Less: Lease Payments</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">(56,207</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><b>Balance &#8211; December 31, 2019</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;"><b>202,869</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Current</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">56,207</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Non-current</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">146,662</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><b>Balance &#8211; December 31, 2019</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;"><b>202,869</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Lease obligations are related to the Company's office lease. As of December 31, 2019, the Company did not occupy the leased premise and was in the process of subleasing the space. Subsequent to December 31, 2019 the Company subleased the premise.</p>
    <p style="text-align: justify;">The following table sets out a maturity analysis of the lease payments payable, showing the undiscounted lease payments to be paid on an annual basis, reconciled to the lease obligation.</p>
    <div id="footer_page_23">
        <p style="text-align: center;">24</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_24"></a>
    <div id="header_page_24">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Less than one year</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">56,206</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">One to two years</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">59,642</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Two to three years</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">59,954</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Three to four years</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">59,954</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Therafter</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Total undiscounted lease payments payable</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">235,756</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Less: impact of present value</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">(32,887</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Balance as at December 31, 2019</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;">202,869</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">14.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Notes Payable</b></p>
    <p style="text-align: justify;">Notes payable consists of the following:</p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Short-term notes</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">193,996</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Notes payable</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">1,714,416</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Balance as at December 31, 2019</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">1,908,412</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><i>Short-term notes</i></p>
    <p style="text-align: justify;">The short-term notes represent notes outstanding that the Company assumed on acquisition of Prismic. The notes have matured, are due on demand and accrue interest a rate of 10% per annum. The notes are held by former Directors and Shareholders of Prismic.</p>
    <p style="text-align: justify;"><i>Notes payable</i></p>
    <p style="text-align: justify;">The notes payable represent notes outstanding that the Company assumed on acquisition of Prismic. The notes have matured and are due on demand. The notes accrue interest a rate of 20% per annum. The notes are held by former Directors and Shareholders of Prismic.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">15.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Share capital</b></p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>[a]</b><font style="width: 7pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Authorized</b></p>
    <p style="text-align: justify;">The Company is authorized to issue an unlimited number of Class A multiple voting shares ("Class A shares") and an unlimited number of Class B subordinate voting shares ("Class B shares"), all without par value. All shares are ranked equally with regards to the Company's residual assets.</p>
    <p style="text-align: justify;">The holders of Class A shares are entitled to 276,660 votes per class A share held. Class A shares are held by certain original founders of the Company.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>[b]</b><font style="width: 6.51pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Issued and outstanding</b></p>
    <p style="text-align: justify;">Reconciliation of the Company's share capital is as follows:</p>
    <div id="footer_page_24">
        <p style="text-align: center;">25</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_25"></a>
    <div id="header_page_25">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;" colspan="4"><b>Class A shares</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;" colspan="4"><b>Class B shares</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;" colspan="4"><b>Warrants</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; padding-left: 278.25pt;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;#</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><b>#</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><b>#</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; white-space: nowrap;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Balance, December 31, 2017</b></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">72</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">201,500</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">3,794,846</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">12,794,963</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">354,996</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">2,116,900</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Share issued</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">2,268,035</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">47,853,745</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Share issuance costs</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">(6,634,405</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Reverse acquisition</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">545,505</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">9,868,179</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">37,313</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">118,875</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Warrant valuations</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">(2,366,670</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">198,835</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">2,366,670</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Share-based payments</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">294,287</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Share options exercised</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">190,463</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">5,145,825</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Share options cancelled</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Warrants exercised</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">44,931</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">1,254,665</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">(44,932</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">(454,587</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><b>Balance, December 31, 2018</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>72</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>201,500</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>6,843,780</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>67,916,302</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>546,212</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>4,442,145</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><b>Balance, December 31, 2018</b></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;"><b>72</b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;"><b>201,500</b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;"><b>6,843,780</b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;"><b>67,916,302</b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;"><b>546,212</b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;"><b>4,442,145</b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><i>Shares issued [a] [b] [c] [d] [e]</i></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">408,651</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">11,539,417</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Issued on acquisition of net assets of Prismic</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Pharmaceuticals, Inc. <i>[f]</i></td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">510,940</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">16,431,818</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">67,598</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">1,888,086</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Share options exercised</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">130,189</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">1,782,438</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Warrants exercised</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">&#8212;</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">12,167</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">145,174</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">(12,167</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">(50,183</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Warrants expired</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">(134,192</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 10%; background-color: #e6efff;">(535,014</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;"><b>Balance, December 31, 2019</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>72</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>201,500</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>7,905,727</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>97,815,149</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>467,451</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 10%;"><b>5,745,034</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[a]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>On April 24, 2019, the Company entered into a share exchange agreement with Aura. Pursuant to the share exchange agreement, FSD acquired 13,562,386 common shares at $0.2212 per share in the capital of Aura in exchange for the issuance of 65,577 Class B shares of the Company at $45.75 for a total value of $3,000,000.</p>
    <p style="margin-left: 36pt; text-align: justify;">On September 20, 2019, the Company issued an additional 61,892 Class B shares as part of the adjustment of purchase price related to the share exchange agreement with Aura to settle the related derivative liability. As part of the settlement, the Company recognized a loss on change in the fair value of derivative liability of $1,422,036.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[b]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>On May 7, 2019, the Company entered into an agreement with Solarvest. Per the agreement the Company issued 49,751 Class B Shares to Solarvest in exchange for the investment in Solarvest. Refer to note 9 for details regarding the investment in Solarvest.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[c]<font style="width: 8.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>On October 4, 2019, the Company issued 3,735 Class B shares in settlement for trade payables of $25,000.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[d]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>On October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares. All share and per share amounts for all periods presented in these financial statements have been adjusted retrospectively to reflect the reverse share split.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[e]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>On November 4, 2019, the Company completed a private placement through the issuance of 228,670 Class B shares at a price of $20.10 per share for total gross proceeds of $4,593,777.</p>
    <div id="footer_page_25">
        <p style="text-align: center;">26</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_26"></a>
    <div id="header_page_26">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 36pt; text-align: justify;">Cash transactions costs related to the private placement were $32,705. A portion of the shares issued under the private placement were to related parties of the Company, including Directors and Officers of the Company (refer to Note 21).</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[f]<font style="width: 10.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company acquired all outstanding common and preferred shares of Prismic through the issuance of an aggregate of 510,940 Class B Shares. The Class B Shares issued to the Prismic shareholders were deposited into escrow upon closing of the transaction, and are subject to an 18-month staggered escrow release.</p>
    <p style="text-align: justify;">The changes in the number of warrants outstanding during the years ended December 31, 2019 and 2018 were as follows:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;Number of warrants&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;Weighted average exercise price&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;#&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Outstanding as at December 31, 2017</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">354,996</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">5.80</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Granted</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">236,148</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">16.57</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Exercised</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(44,932</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">17.79</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Outstanding as at December 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">546,212</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">9.47</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Granted</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">67,598</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">10.45</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Exercised</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(12,167</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">7.81</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Expired</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(134,192</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">7.64</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Outstanding as at December 31, 2019</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">467,451</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">10.20</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><b>Measurement of fair values</b></p>
    <p style="text-align: justify;">The fair value of warrants outstanding during the years ended December 31, 2019 and 2018 were estimated at the date of grant using the Black-Scholes option pricing model with the following inputs:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 70%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; width: 15%; text-align: right;">2019</td>
            <td style="border-bottom: 1px solid #000000; width: 15%; text-align: right;">2018</td>
        </tr>
        <tr>
            <td style="width: 70%; background-color: #e6efff;">Grant date share price</td>
            <td style="width: 15%; background-color: #e6efff; text-align: right;">$32.16</td>
            <td style="width: 15%; background-color: #e6efff; text-align: right;">$4.42 - $18.09</td>
        </tr>
        <tr>
            <td style="width: 70%;">Exercise price</td>
            <td style="width: 15%; text-align: right;">$2.61 - $26.73</td>
            <td style="width: 15%; text-align: right;">$4.42 - $26.13</td>
        </tr>
        <tr>
            <td style="width: 70%; background-color: #e6efff;">Expected dividend yield</td>
            <td style="width: 15%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160;&#160;</td>
            <td style="width: 15%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160;&#160;</td>
        </tr>
        <tr>
            <td style="width: 70%;">Risk free interest rate</td>
            <td style="width: 15%; text-align: right;">1.41% - 1.52%</td>
            <td style="width: 15%; text-align: right;">1.70% - 2.17%</td>
        </tr>
        <tr>
            <td style="width: 70%; background-color: #e6efff;">Expected life</td>
            <td style="width: 15%; background-color: #e6efff; text-align: right;">1.39 - 6.55</td>
            <td style="width: 15%; background-color: #e6efff; text-align: right;">2 years</td>
        </tr>
        <tr>
            <td style="width: 70%;">Expected volatility</td>
            <td style="width: 15%; text-align: right;">100%</td>
            <td style="width: 15%; text-align: right;">100%</td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: center;">&#160;&#160;27</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_27"></a>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 100%;">
                <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                <p style="text-align: justify;">December 31, 2019 and 2018</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">The following table is a summary of the Company's warrants outstanding as at December 31, 2019:</p>
    <p style="text-align: center;"><b>Warrants Outstanding</b></p>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%;">Exercise price</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; width: 12%;">Number outstanding</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">Expiry Date</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%;">$</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%;">#</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">November 30, 2020</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">2.61</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">16,787</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">September 15, 2022</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">4.42</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">199,005</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">August 1, 2021</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">5.43</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">4,476</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">September 11, 2023</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">5.43</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">22,382</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">January 5, 2020</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">6.03</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">37,313</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">July 24, 2023</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">13.07</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">3,357</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">May 20, 2023</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">16.08</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">7,311</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">May 24, 2022</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">18.09</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">163,535</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">May 4, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">3,730</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">May 10, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,865</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">May 17, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">3,730</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">May 31, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,865</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">January 16, 2026</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">1,722</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">January 20, 2026</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">26.73</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">373</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">10.20</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">467,451</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">The following table is a summary of the Company's warrants outstanding as at December 31, 2018:</p>
    <p style="margin-top: 0pt; text-align: center;"><b>Warrants Outstanding</b></p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 12%;">Exercise price</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; width: 12%;">Number outstanding</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">Expiry Date</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; width: 12%;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center; width: 12%;">#</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">September 15, 2022</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">4.42</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">199,005</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">October 20, 2019</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">7.56</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">11,970</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">November 1, 2019</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">7.56</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">69,240</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">November 14, 2019</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">7.56</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">52,532</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">November 21, 2019</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">7.56</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">10,263</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">December 12, 2019</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">7.56</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">1,084</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">December 29, 2019</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">7.56</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">1,072</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">January 5, 2020</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">6.03</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;">37,313</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">May 24, 2022</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">18.09</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">163,733</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;">9.47</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;">546,212</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: center;">&#160;28</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_28"></a>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 100%;">
                <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                <p style="text-align: justify;">December 31, 2019 and 2018</p>
            </td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">16.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Share-based compensation</b></p>
    <p style="text-align: justify;">The Company has established a share option plan (the "Option Plan") for directors, officers, employees and consultants of the Company. The Company's Board of Directors determines, among other things, the eligibility of individuals to participate in the Option Plan, the term and vesting periods, and the exercise price of options granted to individuals under the Option Plan.</p>
    <p style="text-align: justify;">Each share option converts into one common share of the Company on exercise. No amounts are paid or payable by the individual on receipt of the option. The options carry neither rights to dividends nor voting rights. Options may be exercised at any time from the date of vesting to the date of their expiry.</p>
    <p style="text-align: justify;"><b>Share-based payment arrangements</b></p>
    <p style="text-align: justify;">The changes in the number of share options during the years ended December 31, 2019 and 2018 were as follows:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>&#160;Number of options&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>&#160;Weighted average exercise price&#160;</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>&#160;#&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>&#160;$&#160;</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Outstanding as at December 31, 2017</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">206,219</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">4.44</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Granted</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">593,781</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">65.80</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Exercised</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(240,214</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">11.31</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Cancelled</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">(74,627</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">10.05</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Outstanding as at December 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">485,159</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">74.53</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Granted</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,363,322</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">20.68</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Exercised</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(82,094</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">10.02</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Forfeited</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(12,438</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">56.28</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Cancelled</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(299,006</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">115.80</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Outstanding as at December 31, 2019</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>1,454,943</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>21.96</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Exercisable as at December 31, 2019</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>1,200,242</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>21.24</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><b>Measurement of fair values</b></p>
    <p style="text-align: justify;">The fair value of share options granted during the years ended December 31, 2019 and 2018 were estimated at the date of grant using the Black-Scholes option pricing model with the following inputs:</p>
    <div id="footer_page_28">
        <p style="text-align: center;">29</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_29"></a>
    <div id="header_page_29">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 70%; vertical-align: bottom;">
                <p style="text-align: left;">&#160;</p>
            </td>
            <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><b>2019</b></p>
            </td>
            <td style="width: 15%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;"><b>2018</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 70%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: left;">Grant date share price</p>
            </td>
            <td style="width: 15%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;"><b>$6.45 &#8212; $75.38</b></p>
            </td>
            <td style="width: 15%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">$10.05 &#8212; $142.71</p>
            </td>
        </tr>
        <tr>
            <td style="width: 70%; vertical-align: bottom;">
                <p style="text-align: left;">Exercise price</p>
            </td>
            <td style="width: 15%; vertical-align: bottom;">
                <p style="text-align: right;"><b>$7.17 &#8212; $75.38</b></p>
            </td>
            <td style="width: 15%; vertical-align: bottom;">
                <p style="text-align: right;">$10.05 &#8212; $148.74</p>
            </td>
        </tr>
        <tr>
            <td style="width: 70%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: left;">Expected dividend yield</p>
            </td>
            <td style="width: 15%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;"><b>&#8212;</b></p>
            </td>
            <td style="width: 15%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">&#8212;</p>
            </td>
        </tr>
        <tr>
            <td style="width: 70%; vertical-align: bottom;">
                <p style="text-align: left;">Risk free interest rate</p>
            </td>
            <td style="width: 15%; vertical-align: bottom;">
                <p style="text-align: right;"><b>1.24% &#8212; 1.90%</b></p>
            </td>
            <td style="width: 15%; vertical-align: bottom;">
                <p style="text-align: right;">1.97% &#8212; 2.41%</p>
            </td>
        </tr>
        <tr>
            <td style="width: 70%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: left;">Expected life</p>
            </td>
            <td style="width: 15%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;"><b>5 years</b></p>
            </td>
            <td style="width: 15%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">5 years</p>
            </td>
        </tr>
        <tr>
            <td style="width: 70%; vertical-align: bottom;">
                <p style="text-align: left;">Expected volatiity</p>
            </td>
            <td style="width: 15%; vertical-align: bottom;">
                <p style="text-align: right;"><b>100%</b></p>
            </td>
            <td style="width: 15%; vertical-align: bottom;">
                <p style="text-align: right;">100%</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">Expected volatility was estimated by using the historical volatility of other companies that the Company considers comparable that have trading and volatility history. The expected option life represents the period of time that options granted are expected to be outstanding. The risk-free interest rate is based on government bonds with a remaining term equal to the expected life of the options.</p>
    <div id="footer_page_29">
        <p style="text-align: center;">30</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_30"></a>
    <div id="header_page_30">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">The following table is a summary of the Company's share options outstanding as at December 31, 2019:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 60%; text-align: center; vertical-align: bottom;" colspan="3"><b>Options outstanding</b></td>
            <td style="width: 40%; text-align: center; vertical-align: bottom;" colspan="2"><b>Options exercisable</b></td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; text-align: right;">Exercise price</td>
            <td style="width: 20%; vertical-align: bottom; text-align: right;">Number outstanding</td>
            <td style="width: 20%; vertical-align: bottom; text-align: right;">Weighted average remaining contractual life [years]</td>
            <td style="width: 20%; vertical-align: bottom; text-align: right;">Exercise price</td>
            <td style="width: 20%; vertical-align: bottom; text-align: right;">Number exercisable</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">$</td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">#</td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">#</td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">$</td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">#</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 2.61</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 35,065</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.49</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 2.61</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 35,065</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.42</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 99,502</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 2.71</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.42</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 99,502</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 5.43</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 16,264</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.49</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 5.43</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 16,264</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 10.65</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3,730</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.49</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 10.65</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3,730</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 13.07</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 10,855</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.49</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 13.07</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 10,855</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 13.47</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,418</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.49</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 13.47</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,418</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 16.08</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 18,409</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.49</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 16.08</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 18,409</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 17.89</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4,178</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.49</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 17.89</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4,178</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 18.09</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 37,313</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.34</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 18.09</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 37,313</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 20.10</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 493,363</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.72</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 20.10</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 493,363</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 21.11</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 12,438</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.67</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 21.11</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 12,438</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 24.12</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 9,950</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.59</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 24.12</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 6,219</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 26.13</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 14,925</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.62</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 26.13</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 14,925</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 40.20</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 29,851</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.45</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 40.20</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 22,388</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 44.22</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 2,488</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.41</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 44.22</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 2,488</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 47.24</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,493</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.37</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 47.24</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,493</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 50.25</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 227,861</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 5.09</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 50.25</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 129,353</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 52.26</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 498</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.21</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 52.26</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 498</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 55.28</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 498</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.12</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 55.28</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 498</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 59.30</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 498</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.96</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 59.30</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 498</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 7.17</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 199,005</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.83</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 7.17</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 199,005</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 7.50</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8212;&#160;&#160;</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8212;&#160;&#160;</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 7.50</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8212;&#160;&#160;</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 75.38</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 498</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.04</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 75.38</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 498</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 7.63</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 203,750</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 5.34</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 7.63</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 58,750</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 86.43</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,244</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.88</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 86.43</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,244</td>
        </tr>
        <tr>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 88.44</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 14,925</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.87</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 88.44</td>
            <td style="width: 20%; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 14,925</td>
        </tr>
        <tr>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 120.60</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 9,950</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.71</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 120.60</td>
            <td style="width: 20%; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 9,950</td>
        </tr>
        <tr>
            <td style="width: 20%; border-bottom: 1px solid #000000; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 142.71</td>
            <td style="width: 20%; border-bottom: 1px solid #000000; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4,974</td>
            <td style="width: 20%; border-bottom: 1px solid #000000; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3.74</td>
            <td style="width: 20%; border-bottom: 1px solid #000000; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 142.71</td>
            <td style="width: 20%; border-bottom: 1px solid #000000; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4,975</td>
        </tr>
        <tr>
            <td style="width: 20%; border-bottom: 2px solid #000000; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 21.96</td>
            <td style="width: 20%; border-bottom: 2px solid #000000; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,454,943</td>
            <td style="width: 20%; border-bottom: 2px solid #000000; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.59</td>
            <td style="width: 20%; border-bottom: 2px solid #000000; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 21.24</td>
            <td style="width: 20%; border-bottom: 2px solid #000000; background-color: #e6efff; text-align: right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,200,242</td>
        </tr>
    </table>
    <p style="text-align: justify;">&#160;</p>
    <div id="footer_page_30">
        <p style="text-align: center;">31</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_31"></a>
    <div id="header_page_31">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">The following table is a summary of the Company's share options outstanding as at December 31, 2018:</p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 20%; vertical-align: bottom; text-align: center; white-space: nowrap;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: center; white-space: nowrap;">
                <p style="text-align: center;"><b>Options outstanding</b></p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: center; white-space: nowrap;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="2">
                <p style="text-align: center;"><b>Options exercisable</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; text-align: center; white-space: nowrap;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: center; white-space: nowrap;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: center; white-space: nowrap;">
                <p style="text-align: center;">Weighted average</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: center; white-space: nowrap;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: left;">&#160;</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: left;">&#160;</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: center;">remaining contractual</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: left;">&#160;</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; text-align: center; white-space: nowrap;">
                <p style="text-align: center;">Exercise price</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: center;">Number outstanding</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; white-space: nowrap;">
                <p style="text-align: center;">life [years]</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: center; white-space: nowrap;">
                <p style="text-align: center;">Exercise price</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: center; white-space: nowrap;">
                <p style="margin-bottom: 0pt; text-align: center;">Number exercisable</p>
            </td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;">
                <p style="text-align: center;">$</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">
                <p style="text-align: center;">#</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">
                <p style="text-align: center;">#</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;">
                <p style="text-align: center;">$</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000; white-space: nowrap;">#</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">4.42</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">149,254</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">3.71</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">4.42</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right; background-color: #e6efff;">149,254</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">5.03</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">2,488</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">0.98</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">5.03</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right;">2,488</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">18.09</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">42,289</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">4.35</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">18.09</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right; background-color: #e6efff;">42,289</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">20.10</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">33,169</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">4.27</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">20.10</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right;">16,584</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">26.13</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">14,925</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">4.62</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">26.13</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right; background-color: #e6efff;">14,925</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">56.28</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">12,438</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">4.91</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">56.28</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right;">&#8212;</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">59.30</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">498</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">4.96</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">59.30</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right; background-color: #e6efff;">498</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">86.43</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">1,244</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">4.88</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">86.43</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right;">1,244</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">88.44</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">14,925</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">4.87</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">88.44</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right; background-color: #e6efff;">14,925</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">120.60</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">9,950</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">4.71</p>
            </td>
            <td style="width: 20%; vertical-align: bottom;">
                <p style="text-align: right;">120.60</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right;">9,950</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">142.71</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">4,975</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">4.74</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; background-color: #e6efff;">
                <p style="text-align: right;">142.71</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right; background-color: #e6efff;">1,658</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;">148.74</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;">199,004</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;">4.70</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 1px solid #000000;">
                <p style="text-align: right;">148.74</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#8212;</td>
        </tr>
        <tr>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 2px solid #000000; background-color: #e6efff;">
                <p style="text-align: right;">74.53</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 2px solid #000000; background-color: #e6efff;">
                <p style="text-align: right;">485,159</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 2px solid #000000; background-color: #e6efff;">
                <p style="text-align: right;">4.32</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 2px solid #000000; background-color: #e6efff;">
                <p style="text-align: right;">19.91</p>
            </td>
            <td style="width: 20%; vertical-align: bottom; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;">253,815</td>
        </tr>
    </table>
    <p style="text-align: justify;">The Company recognized $16,061,319 of share-based compensation expenses during the year ended December 31, 2019 (2018 - $6,440,406), with a corresponding amount recognized in contributed surplus. Included within share-based compensation expense during the year ended December 31, 2019 is $1,730,794 (2018 - nil) for bonus expense to be paid subsequent to December 31, 2019 through the issuance of Class B common shares of the Company.30</p>
    <div id="footer_page_31">
        <p style="text-align: center;">32</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_32"></a>
    <div id="header_page_32">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">17.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Loss per share</b></p>
    <p style="text-align: justify;">Net loss per common share represents net loss attributable to common shareholders divided by the weighted average number of common shares outstanding during the year.</p>
    <p style="text-align: justify;">For all the periods presented, diluted loss per share equals basic loss per share due to the anti-dilutive effect of warrants and share options. The outstanding number and type of securities that could potentially dilute basic net loss per share in the future but would have decreased the loss per share (anti-dilutive) for year ended December 31 presented are as follows:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
<tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2019</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2018</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>#</b></td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>#</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Warrants</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>467,451</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">546,212</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;" colspan="1">Share Options</td>
            <td align="right" style="BORDER-BOTTOM: #000000 1px solid">&#160;</td>
          <td align="right" style="BORDER-BOTTOM: #000000 1px solid"><b>1,454,943</b></td>
          <td align="right" style="BORDER-BOTTOM: #000000 1px solid">&#160;</td>
          <td align="right" style="BORDER-BOTTOM: #000000 1px solid">&#160;</td>
          <td align="right" style="BORDER-BOTTOM: #000000 1px solid">485,159</td>
          <td align="right" style="BORDER-BOTTOM: #000000 1px solid">&#160;</td>
      </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>1,922,394</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;">1,031,371</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
<div>
        <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">18.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>General and administrative<br></b></p>
        <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">Components of general and administrative expenses for the years ended December 31, 2019 and 2018 were as follows:</p>
    </div>
    <div>
        <div>
            <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
                <tr>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;"><b>2019</b></td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;"><b>2018</b></td>
                    <td style="vertical-align: bottom;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Professional fees</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>3,730,556</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">1,955,253</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Stock promotion</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>2,902,453</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">2,803,588</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Salaries, wages and benefits</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>2,267,308</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">1,740,720</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Consulting fees</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>2,288,129</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">2,037,049</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">General office, travel and adminsitration expenditures</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>2,172,824</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">726,509</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Repairs, maintenance and utilities</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>924,945</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">1,360,477</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Shareholder and public company costs</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>440,746</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">124,973</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">Listing expense</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>&#8212;</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">7,991,791</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">Foreign exchange loss</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>84,568</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000;"><b>14,811,529</b></td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000;">18,740,360</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
                </tr>
            </table>
        </div>
    </div>
    <p style="text-align: justify;">&#160;</p>
    <div id="footer_page_32">
        <p style="text-align: center;">33</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_33"></a>
    <div id="header_page_33">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">19.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Income taxes</b></p>
    <p style="text-align: justify;">The reconciliation of income tax expense for the years ended December 31, 2019 and 2018 consists of the following:</p>
    <div>
        <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;"><b>2019</b></td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;"><b>2018</b></td>
                <td style="vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Loss before income taxes</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(52,013,186</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(22,710,624</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000;" colspan="1">Statutory federal and provincial tax rate</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>26.50%</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">26.50%</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;" colspan="1">Income tax recovery at the statutory tax rate</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(13,783,494</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(6,018,315</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">Permanent differences</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>7,797,290</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">2,706,000</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Other adjustments</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>6,334,913</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">-</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000;" colspan="1">Change in tax benefits not recognized</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>(348,709</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;"><b>)</b></td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">3,312,315</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>-</b></td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;">-</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;"><font style="font-size: 10pt;">Deferred taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their tax values. Deferred tax liabilities at December 31, 2019 and 2018 are comprised of the following:</font>&#160;</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2019</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2018</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">Deferred tax liabilities</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160;Other investments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(168,092</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(1,334,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160; &#160;Capital losses carried forward</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>168,092</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">1,334,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; background-color: #e6efff;" colspan="1">Deferred tax liabilities not recognized</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;"><b>-</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p>Deferred taxes are provided as a result of temporary differences that arise due to the differences between the income tax values and the carrying amount of assets and liabilities. Deferred tax assets have not been recognized in respect of the following temporary differences:</p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2019</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2018</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Property, plant and equipment</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;"><b>1,054,843</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Other investments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;"><b>1,287,743</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Share issuance costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;"><b>1,169,642</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">3,772,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Non-capital losses carried forward - Canada</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;"><b>27,518,609</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;">29,272,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Net operating losses carried forward - US</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;"><b>274,454</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Capital losses carried forward</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;"><b>350,465</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;">Unrealized fair value on biological assets and inventory</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>1,098,497</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">-</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; border-bottom: 2px solid #000000;"><b>32,754,253</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; border-bottom: 2px solid #000000;">33,044,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p>The Company&#8217;s Canadian non-capital income tax losses expire as follows:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">2038</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">12,492,296</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">2039</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">15,026,313</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 2px solid #000000; background-color: #e6efff;">27,518,609</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 2px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">20.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Commitments and contingencies</b></p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>Commitments</b></p>
    <p style="text-align: justify;"><i>Supply Agreement with Canntab Therapeutics Ltd. and World Class Extractions Inc. </i></p>
    <p style="text-align: justify;">On February 12, 2019, the Company announced that it had entered into a three-way supply agreement with Canntab Therapeutics Ltd. ("Canntab"), World Class Extractions Inc. ("World Class") (collectively with the Company, the "Purchasers") and a Supplier to purchase up to 1,000 kg of the Supplier's 2018 organic hemp crop, for which the Company has already purchased a quantity with a value of $100,000, which amount has been recorded in its inventory. The Purchasers intend to extract CBD oil from the 2019-2024 organic hemp crops and process the oil into gel capsules and tablets at the Company's facility in Cobourg. The Purchasers have committed to collectively purchase $1,000,000 worth of hemp plus applicable taxes, from the 2019 crop.</p>
    <p style="text-align: justify;">As at December 31, 2019, no hemp has been received by the Company. The Company has provided a deposit of $166,667 to the Supplier as at year-end for hemp product to be received. As of December 31, 2019, the Company has an outstanding commitment to purchase an additional $166,667 of hemp product from the Supplier, representing the Company's share of the Purchasers' collective commitment to purchase $1,000,000 of hemp from the 2019 crop.</p>
    <div id="footer_page_33">
        <p style="text-align: center;">34</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_34"></a>
    <div id="header_page_34">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">Pursuant to the Agreement, the Supplier granted the Purchasers the right and option to purchase up to $5,000,000 of the Supplier's hemp crop for a period of 5 years commencing in 2019 at a purchase price of $100 per kg per 1% of CBD extracted from the flower.</p>
    <p style="text-align: justify;">Canntab is a Canadian cannabis oral dosage formulation company based in Markham, Ontario, engaged in the research and development of pharmaceutical-grade formulations of cannabinoids and trades on the Canadian Securities Exchange under the symbol PILL. World Class is understood to have developed an extraction process to produce quality, potent cannabis extracts using ultrasound to effectively produce extracts from cannabis and hemp and isolate essential compounds found in plant material. World Class trades on the Canadian Securities Exchange under the symbol PUMP. Certain Officers and Directors of the Company also serve as Directors of World Class.</p>
    <p style="text-align: justify;"><i>Epitech License Agreement</i></p>
    <p style="text-align: justify;">Under the terms of the Company's License Agreement with Epitech Group SPA ("Epitech"), the Company has payments due to Epitech pending the achievement of specified milestones. Upon first notification by the Food and Drug Administration ("FDA") of approval of a New Drug Application, the non-refundable sum of USD $700,000 will be due and payable to Epitech. Within ten business days of the first notification of approval of a Supplemental New Drug Application by the FDA, the Company will pay the non-refundable sum of USD $1,000,000 to Epitech.</p>
    <p style="text-align: justify;">For non-prescription drug rights, any one-off lump sum payments received by the Company as consideration for granting a sub-license to a Commercial Partner with respect to a Licensed Product, shall require the Company to pay to Epitech 25% of the lump sum payment received by the Company. For prescription drug rights the Company shall pay 5% of any one-off lump sum payments to Epitech as consideration for granting a sub-license to a Commercial Partner with respect to a Licensed Product. The Company will pay the amounts payable on a quarterly basis within 60 days of the end of each calendar quarter.</p>
    <p style="text-align: justify;">The Company shall pay either a) 7% of Net Sales of the Licensed Product in a Product Regulatory Category other than prescription drugs place on the market by the Company; or b) 25% of Net Receipts received by the Company from Commercial Partners where Licensed Products in a Product Regulatory Category other than prescription drugs are placed on the market by such Commercial Partners; or c) 5% of Net Sales or Net Receipts of the Licensed Products in the Product Regulatory Category of prescription drugs. The Company will pay the amounts payable on a quarterly basis within 60 days of the end of each calendar quarter.&#160; &#160;</p>
    <p style="text-align: justify;"><i>Supply Agreement with Pharmadrug Production GMBH ("Pharmadrug") </i></p>
    <p style="text-align: justify;">FV Pharma has a supply agreement with Pharmadrug whereby FV Pharma has committed to make the following quantities of cannabis available to Pharmadrug to purchase under the terms of the Supply Agreement:</p>
    <table style="width: 70%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 40%;"><u>Year</u></td>
            <td style="width: 60%;"><u>Commitment</u></td>
        </tr>
        <tr>
            <td style="width: 40%; background-color: #e6efff;">2020</td>
            <td style="width: 60%; background-color: #e6efff;">350 kilograms</td>
        </tr>
        <tr>
            <td style="width: 40%;">2021</td>
            <td style="width: 60%;">650 kilograms</td>
        </tr>
        <tr>
            <td style="width: 40%; background-color: #e6efff;">2022</td>
            <td style="width: 60%; background-color: #e6efff;">1,000 kilograms</td>
        </tr>
        <tr>
            <td style="width: 40%;">2023</td>
            <td style="width: 60%;">1,000 kilograms</td>
        </tr>
        <tr>
            <td style="width: 40%; background-color: #e6efff;">2024</td>
            <td style="width: 60%; background-color: #e6efff;">1,000 kilograms</td>
        </tr>
    </table>
    <p style="margin-top: 0pt; text-align: justify;">&#160;</p>
    <div id="footer_page_34">
        <p style="text-align: center;">35</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_35"></a>
    <div id="header_page_35">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;"><i>Heritage Building Restoration Commitment</i></p>
    <p style="text-align: justify;">The Company has a commitment to restore the designated heritage building on the Company's premises. The estimated cost of restoration is $517,000.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>Contingencies</b></p>
    <p style="text-align: justify;"><i>Legal matters</i></p>
    <p style="text-align: justify;">From time to time, the Company is named as a party to claims or involved in proceedings, including legal, regulatory and tax related, in the ordinary course of its business. While the outcome of these matters may not be estimable at the reporting date, the Company makes provisions, where possible, for the estimated outcome of such claims or proceedings. Should a loss result from the resolution of any claims or proceedings that differs from these estimates, the difference will be accounted for as a charge to profit or loss in that period.</p>
    <p style="text-align: justify;"><i>Environmental </i></p>
    <p style="text-align: justify;">Management believes that there are no probable environmental related liabilities that will have a material adverse effect on the financial position or operating results of the Company.</p>
    <p style="text-align: justify;"><i>Claims from suppliers </i></p>
    <p style="text-align: justify;">A dismissed contractor commenced a lien action combined with a breach of contract action in the Cobourg Superior Court of Justice in early 2019 claiming approximately $1,700,000 in various purported damages, with the claim for lien component of $188,309 being registered on November 26, 2018. The Company is defending the action and has taken steps to obtain particulars and inspect documents of the plaintiff which remain unaddressed to date. The Company has paid $235,387 to the Cobourg Superior Court to vacate the lien from title for which the funds stand both as security for the lien claim as well as its costs with the Cobourg Superior Court of Justice. The 2019 breach of contract claim has not been provisioned as the Company believes these proceedings are without merit and intends to defend itself from this claim.</p>
    <p style="text-align: justify;"><i>Former employee </i></p>
    <p style="text-align: justify;">FSD hired an individual by way of employment agreement. The individual's employment was subsequently terminated in the probationary period due to non-performance/cause in February 2019. The individual retained legal counsel in or around February 15, 2019 demanding that he be provided (i) unpaid wages; (ii) unpaid holiday pay, (iii) payment for wrongful dismissal (one week) and (iv) breach of contract.</p>
    <p style="text-align: justify;">A hearing is scheduled for March 13, 2020 in front of the employment tribunal. The Company is of the view that the outcome will be unfavourable to the Company. For the year ended December 31, 2019, the Company recorded a provision of $97,320 in relation to the claimed amounts for unpaid wages and unpaid holiday pay. No amounts have been provisioned in respect of the claims for wrongful dismissal and breach of contract, as the Company is of the position that they will be able to successfully defend themselves from these claims.</p>
    <p style="text-align: justify;"><i>Class Action </i></p>
    <p style="text-align: justify;">On February 22, 2019, a shareholder in FSD commenced a proposed class action proceeding against the Company by issuing a statement of claim in the Ontario Superior Court. Amongst other causes of action, the individual seeks leave to bring a claim pursuant to s.138 of the Ontario Securities Act, alleging the Company made statements containing misrepresentations related to the build-out of the Company's Cobourg facility.</p>
    <div id="footer_page_35">
        <p style="text-align: center;">36</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_36"></a>
    <div id="header_page_36">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">On October 16, 2019 dates for the leave motion were given - May 5-6, 2020. No discoveries have occurred nor has FSD been required to file a statement of defense. Management intends to contest this leave motion, and are in the process of preparing responding materials.&#160; The ultimate outcome of the matter cannot be reliably determined at this time and no provision has been recorded for this matter as at December 31, 2019.</p>
    <p style="text-align: justify;"><i>Auxly Cannabis Group Inc. </i></p>
    <p style="text-align: justify;">On March 3, 2018, FSD entered into a Definitive Strategic Alliance and Streaming Agreement (the "Agreement") with Auxly Cannabis Group Inc. ("Auxly"). On February 6, 2019, the Company delivered to Auxly a Notice of Default, thereby terminating the Agreement effective immediately. Subsequent to the issuance of the Notice of Default, Auxly sent a Notice of Default to the Company on February 6, 2019 in response. To date, neither party has taken further legal action against the counter party.</p>
    <p style="text-align: justify;">To fund the development, Auxly purchased 37,313 Class B shares for the aggregate of $7,500,000 from the Company's treasury by way of private placement, which funds were placed in trust to be spent on construction and development costs. The funds were placed in a trust account to be administered by Auxly. Due to the termination and subsequent negotiations, it is indeterminable at this point as to the amount, if any, of these funds will be released to the Company. Should any funds be released to the Company, those amounts will be recognized in future periods.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">21.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Related party transactions</b></p>
    <p style="text-align: justify;">Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the entity, directly or indirectly.</p>
    <p style="text-align: justify;">Compensation paid or payable to key management and directors comprised the following:</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 12.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company paid the former President and CEO of FV Pharma $770,000 in 2019 as a retirement benefit. The Company also paid the former President and CEO of FV Pharma $54,958 in salaries and benefits through a related entity owned by the former President and CEO on top of $96,250 in salaries and benefits and other allowances of $4,500 paid directly to the Former CEO.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 12.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company paid expenses of $754,311 to a company owned by the CEO for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under various expense line categories. The Company recognized a share-based bonus expense for the year-ended December 31, 2019 in the amount of $1,428,591 to be paid to the CEO by issuance of 200,927 Class B common shares of the Company. The Class B common shares will be issued subsequent to December 31, 2019. As at December 31, 2019 the Company had an outstanding balance of $95,708 due to a Company controlled by the CEO, included in trade and other payables.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 12.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company paid consulting fees of $330,436 to the President of FSD Biosciences for services rendered for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under consulting fees. The Company recognized a share-based bonus expense for the year-ended December 31, 2019 in the amount of $109,892 to be paid to the President of FSD Biosciences by issuance of 15,456 Class B common shares of the Company. The Class B common shares will be issued subsequent to December 31, 2019.</p>
    <div id="footer_page_36">
        <p style="text-align: center;">37</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_37"></a>
    <div id="header_page_37">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 12.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company recognized a share-based bonus expense for the year-ended December 31, 2019 in the amount of $109,892 to be paid to the President of FSD by issuance of 15,456 Class B common shares of the Company. The Class B common shares will be issued subsequent to December 31, 2019.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 12.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company recognized a share-based bonus expense for the year-ended December 31, 2019 in the amount of $54,946 to be paid to the President of FV Pharma by issuance of 7,728 Class B common shares of the Company. The Class B common shares will be issued subsequent to December 31, 2019.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 12.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company paid fees of $196,870 to a company owned by the CFO for services rendered for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under salaries, wages and benefits.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 12.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company paid consulting fees of $90,000 to a company owned by the Chief Operating Consultant for services rendered for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under consulting fees.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 12.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company paid consulting fees of $16,667 to a company owned by the former COO for services rendered for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under consulting fees.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 12.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company pays independent directors $40,000 per annum, with the Chairman of each respective committee receiving an additional $10,000 per annum. Directors fees for the year ended December 31, 2019 were $203,521 (2018 - $66,667). As of December 31, 2019, $98,521 of director's fees were due and payable.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 12.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>On November 4, 2019, the Company completed a private placement by the issuance of 228,670 Class B shares at a price of $20.10 per share for total gross proceeds of $4,598,618. 164,755 Class B Shares were subscribed by the Officers and Directors of the Company.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 12.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company recognized share-based compensation expense of $132,178 for the year-ended December 31, 2019 for services to be provided by a consulting company related to the President of the Company.&#160;</p>
    <p style="text-align: justify;">Key management personnel compensation during the years ended December 31 comprised of:</p>
    <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>2019</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>2018</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Salaries, benefits, bonuses and consulting fees</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>4,836,192</b></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">1,814,115</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">Share-based payments</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>12,476,385</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">3,215,401</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; background-color: #e6efff;"><b>Total</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>17,312,577</b></td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">5,029,516</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">22.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Capital Management</b></p>
    <p style="text-align: justify;">The Company's capital management objectives are to maintain financial flexibility in order to complete development of its facilities and extraction processes and the pharmaceutical research and development program centered on the lead asset, micro-PEA. The Company defines capital as the aggregate of its capital stock and borrowings.</p>
    <div id="footer_page_37">
        <p style="text-align: center;">38</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_38"></a>
    <div id="header_page_38">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">As at December 31, 2019, the Company's Share Capital was $98,016,649 (2018 - $68,117,802). The Company does not have any long-term debt. Outstanding Notes payable were assumed on acquisition of Prismic and are due on demand.</p>
    <p style="text-align: justify;">The Company manages its capital structure in accordance with changes in economic conditions. In order to maintain or adjust its capital structure, the Company may elect to issue or repay financial liabilities, issue shares, repurchase shares, pay dividends or undertake any other activities as deemed appropriate under the specific circumstances. The Company is not subject to any externally imposed capital requirements.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">23.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Financial Instruments and Risk Management </b></p>
    <p style="text-align: justify;"><i>Credit risk</i></p>
    <p style="text-align: justify;">Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from deposits with banks and outstanding receivables. The Company trades only with recognized, creditworthy third parties. The Company does not currently have any material outstanding trade receivables with customers.</p>
    <p style="text-align: justify;">The Company does not hold any collateral as security but mitigates this risk by dealing only with what management believes to be financially sound counterparties and, accordingly, does not anticipate significant loss for non-performance.</p>
    <p style="text-align: justify;"><i>Liquidity risk</i></p>
    <p style="text-align: justify;">Liquidity risk is the risk the Company will not be able to meet its financial obligations as they come due. The Company's exposure to liquidity risk is dependent on the Company's ability to raise additional financing to meet its commitments and sustain operations. The Company mitigates liquidity risk by management of working capital, cash flows, the issuance of share capital and if desired, the issuance of debt. The Company's trade and other payables, derivative liability and notes payables are all due within twelve months from the date of these financial statements.</p>
    <p style="text-align: justify;">If unanticipated events occur that impact the Company's ability to complete development of its production facilities and carrying the planned clinical trials, the Company may need to take additional measures to increase its liquidity and capital resources, including issuing debt or additional equity financing or strategically altering the business forecast and plan. In this case, there is no guarantee that the Company will obtain satisfactory financing terms or adequate financing. Failure to obtain adequate financing on satisfactory terms could have a material adverse effect on the Company's results of operations or financial condition.</p>
    <p style="text-align: justify;"><i>Market risk</i></p>
    <p style="text-align: justify;">Market risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises three types of risk: foreign currency risk, interest rate risk and other price risk.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Foreign currency risk</p>
    <p style="text-align: justify; margin-left: 36.5pt;">Foreign currency risk arises on financial instruments that are denominated in a currency other than the functional currency in which they are measured. The Company's primary exposure with respect to foreign currencies is from US dollar denominated notes payable. A 1% change in the foreign exchange rates would not result in any significant impact to the financial statements.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Interest rate risk</p>
    <div id="footer_page_38">
        <p style="text-align: center;">39</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_39"></a>
    <div id="header_page_39">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify; margin-left: 36.5pt;">Interest rate risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to interest rate risk as at December 31, 2019 as there are no material long-term borrowings outstanding.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Other price risk</p>
    <p style="text-align: justify; margin-left: 36.5pt;">Other price risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices (other than those arising from interest rate risk or currency risk), whether those changes are caused by factors specific to the individual financial instrument or its issuer, or factors affecting all similar financial instruments traded in the market. The Company is not exposed to other price risk as at December 31, 2019.</p>
    <p style="text-align: justify;"><i>Fair values</i></p>
    <p style="text-align: justify;">The carrying values of cash, trade and other receivables, trade and other payables and notes payable approximate fair values due to the short-term nature of these items or they are being carried at fair value or, for notes payable, interest payables are close to the current market rates. The risk of material change in fair value is not considered to be significant. The Company does not use derivative financial instruments to manage this risk.</p>
    <p style="text-align: justify;">Financial instruments recorded at fair value on the consolidated statement of financial position are classified using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company's valuation techniques. A level is assigned to each fair value measurement based on the lowest-level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:</p>
    <p style="margin-left: 72pt; text-align: justify; text-indent: -36pt;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Level 1 - Unadjusted quoted prices as at the measurement date for identical assets or liabilities in active markets.</p>
    <p style="margin-left: 72pt; text-align: justify; text-indent: -36pt;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</p>
    <p style="margin-left: 72pt; text-align: justify; text-indent: -36pt;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Level 3 - Significant unobservable inputs that are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</p>
    <p style="text-align: justify;">The fair value hierarchy requires the use of observable market inputs whenever such inputs exist. A financial instrument is classified to the lowest level of the hierarchy for which a significant input has been considered in measuring fair value.</p>
    <p style="text-align: justify;">Private company investments measured at fair value are classified as Level 3 financial instruments. The valuation method and significant assumptions used to determine the fair value of private company investments have been disclosed in the Other Investments note. During the year, there were no transfers of amounts between levels.</p>
    <div id="footer_page_39">
        <p style="text-align: center;">40</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_40"></a>
    <div id="header_page_40">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 14pt;"><b>Notes to the consolidated financial statements </b></font></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in Canadian dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2019 and 2018</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">24.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Segmented information</b></p>
    <p style="text-align: justify;">The Company reports segment information based on internal reports used by the chief operating decision maker ("CODM") to make operating and resource decisions and to assess performance. The CODM is the Chief Executive Officer of the Company. The CODM makes decisions and assesses performance of the Company on a consolidated basis such that the Company is a single reportable operating segment. For the years ended December 31, 2019 and 2018 all revenues generated by the Company were earned by their subsidiary, FV Pharma, who is domiciled in Canada. For the years ended December 31, 2019 and 2018 all property, plant and equipment were held by FV Pharma and the intangible asset is related to the Company's US domiciled subsidiary, Prismic.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">25.<font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Subsequent events</b></p>
    <p style="text-align: justify;">On January 2, 2020, the Company issued 27,580 Class B Common Shares as share-based compensation to certain Board of Directors for services performed as directors for the year-ended December 31, 2019.</p>
    <p style="text-align: justify;">On January 9, 2020, the Company commenced trading on the NASDAQ under the symbol "HUGE".&#160;</p>
    <p style="text-align: justify;">On February 4, 2020, the Company issued 225,371 Class B Common Shares to Solarvest as settlement under the Share Exchange Agreement to settle derivative liability of $2,646,269. The Company also concurrently announced the appointment of Dr. Edward J. Brennan, President of FSD Pharma's Biosciences Division, to the board of directors of Solarvest.</p>
    <p style="text-align: justify;">On February 5, 2020 the Company executed Share Purchase and Sale Agreements with a consortium of buyers to sell the Company's investment in Cannara, consisting of 85,003,750 Class B shares, for gross proceeds of $7,743,492.&#160;</p>
    <p style="text-align: justify;">Subsequent to December 31, 2019 the Company is considering the continuing use or sale of the Cobourg facility.</p>
    <div id="footer_page_40">
        <p style="text-align: center;">41</p>
    </div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>3
<FILENAME>exhibit99-5.htm
<DESCRIPTION>EXHIBIT 99.5
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Form 40-F/A - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr width="100%" size="3" color="black" noshade="noshade">
<a name="page_6"></a>
<p style="text-align: right;"><b>EXHIBIT 99.5</b></p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>CERTIFICATION </b></p>
    <p style="margin-top: 0pt; text-align: center;"><b>PURSUANT TO RULE 13A-14 OR 15D-14 OF THE SECURITIES EXCHANGE ACT OF 1934 </b></p>
    <p style="text-align: justify;">I, Raza Bokhari, certify that:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>1.</p>
            </td>
            <td style="vertical-align: top;">
                <p>I have reviewed this amendment no. 1 to the annual report on Form 40-F of FSD Pharma Inc.;</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>2.</p>
            </td>
            <td style="vertical-align: top;">
                <p>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>3.</p>
            </td>
            <td style="vertical-align: top;">
                <p>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>4.</p>
            </td>
            <td style="vertical-align: top;">
                <p>The company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 4%; vertical-align: top;">
                <p>a.</p>
            </td>
            <td style="vertical-align: top;">
                <p>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 4%; vertical-align: top;">
                <p>b.</p>
            </td>
            <td style="vertical-align: top;">
                <p>Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 4%; vertical-align: top;">
                <p>c.</p>
            </td>
            <td style="vertical-align: top;">
                <p>Disclosed in this report any change in the company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting; and</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>5.</p>
            </td>
            <td style="vertical-align: top;">
                <p>The company's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of the company's board of directors (or persons performing the equivalent functions):</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 4%; vertical-align: top;">
                <p>a.</p>
            </td>
            <td style="vertical-align: top;">
                <p>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information; and</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 4%; vertical-align: top;">
                <p>b.</p>
            </td>
            <td style="vertical-align: top;">
                <p>Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial reporting.</p>
            </td>
        </tr>
    </table>
    <p>&#160;&#160;</p>
    <table style="width: 40%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 13%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p style="border-bottom: 0.75pt solid #000000;">/s/ Raza Bokhari<font style="display: inline-block; width: 77.35pt;">&#160;</font></p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>Name: Raza Bokhari</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>Title: Executive Co-Chairman and Chief Executive Officer</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>Date: March 17, 2020</p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.6
<SEQUENCE>4
<FILENAME>exhibit99-6.htm
<DESCRIPTION>EXHIBIT 99.6
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Form 40-F/A - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr width="100%" size="3" color="black" noshade="noshade">
<br>
<a name="page_7"></a>
<p style="text-align: right;"><b>EXHIBIT 99.6</b></p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>CERTIFICATION </b></p>
    <p style="margin-top: 0pt; text-align: center;"><b>PURSUANT TO RULE 13A-14 OR 15D-14 OF THE SECURITIES EXCHANGE ACT OF 1934 </b></p>
    <p style="text-align: justify;">I, Donal Carroll, certify that:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>1.</p>
            </td>
            <td style="vertical-align: top;">
                <p>I have reviewed this amendment no. 1 to the annual report on Form 40-F of FSD Pharma Inc.;</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>2.</p>
            </td>
            <td style="vertical-align: top;">
                <p>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>3.</p>
            </td>
            <td style="vertical-align: top;">
                <p>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>4.</p>
            </td>
            <td style="vertical-align: top;">
                <p>The company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 4%; vertical-align: top;">
                <p>a.</p>
            </td>
            <td style="vertical-align: top;">
                <p>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 4%; vertical-align: top;">
                <p>b.</p>
            </td>
            <td style="vertical-align: top;">
                <p>Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 4%; vertical-align: top;">
                <p>c.</p>
            </td>
            <td style="vertical-align: top;">
                <p>Disclosed in this report any change in the company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting; and</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>5.</p>
            </td>
            <td style="vertical-align: top;">
                <p>The company's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of the company's board of directors (or persons performing the equivalent functions):</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 4%; vertical-align: top;">
                <p>a.</p>
            </td>
            <td style="vertical-align: top;">
                <p>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information; and</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
            <td style="width: 4%; vertical-align: top;">
                <p>b.</p>
            </td>
            <td style="vertical-align: top;">
                <p>Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial reporting.</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 40%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 14.78%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p style="border-bottom: 0.75pt solid #000000;">/s/ Donal Carroll<font style="display: inline-block; width: 40.79pt;">&#160;</font></p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>Name: Donal Carroll</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>Title: Chief Financial Officer</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>Date: March 17, 2020</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>&#160;</p>
            </td>
        </tr>
    </table>
    <br>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.7
<SEQUENCE>5
<FILENAME>exhibit99-7.htm
<DESCRIPTION>EXHIBIT 99.7
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Form 40-F/A - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr width="100%" size="3" color="black" noshade="noshade">
<br>
<a name="page_8"></a>
<p style="text-align: right;"><b>EXHIBIT 99.7</b></p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, </b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>AS ENACTED PURSUANT TO </b></p>
    <p style="margin-top: 0pt; text-align: center;"><b>SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 </b></p>
    <p style="text-align: justify;">FSD Pharma Inc. (the "Company") is filing with the U.S. Securities and Exchange Commission on the date hereof, amendment no. 1 to its annual report on Form 40-F for the fiscal year ended December 31, 2019 (the "Report").</p>
    <p style="text-align: justify;">I, Raza Bokhari, Executive Co-Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as enacted pursuant to section 906 of the U.S. Sarbanes-Oxley Act of 2002, that:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>(i)</p>
            </td>
            <td style="vertical-align: top;">
                <p>the Report fully complies with the requirements of section 13(a) or 15(d) of the U.S. Securities Exchange Act of 1934; and</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>(ii)</p>
            </td>
            <td style="vertical-align: top;">
                <p>the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 40%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 14.26%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p style="border-bottom: 0.75pt solid #000000;">/s/ Raza Bokhari</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>Name: Raza Bokhari</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>Title: Executive Co-Chairman and Chief Executive Officer</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>Date: March 17, 2020</p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.8
<SEQUENCE>6
<FILENAME>exhibit99-8.htm
<DESCRIPTION>EXHIBIT 99.8
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Form 40-F/A - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr width="100%" size="3" color="black" noshade="noshade">
<br>
<a name="page_9"></a>
<p style="text-align: right;"><b>EXHIBIT 99.8</b></p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, </b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>AS ENACTED PURSUANT TO </b></p>
    <p style="margin-top: 0pt; text-align: center;"><b>SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 </b></p>
    <p style="text-align: justify;">FSD Pharma Inc. (the "Company") is filing with the U.S. Securities and Exchange Commission on the date hereof, amendment no. 1 to its annual report on Form 40-F for the fiscal year ended December 31, 2019 (the "Report").</p>
    <p style="text-align: justify;">I, Donal Carroll, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as enacted pursuant to section 906 of the U.S. Sarbanes-Oxley Act of 2002, that:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>(i)</p>
            </td>
            <td style="vertical-align: top;">
                <p>the Report fully complies with the requirements of section 13(a) or 15(d) of the U.S. Securities Exchange Act of 1934; and</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 4%; vertical-align: top;">
                <p>(ii)</p>
            </td>
            <td style="vertical-align: top;">
                <p>the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p>
            </td>
        </tr>
    </table>
    <br>
    <table style="width: 40%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 14.26%; vertical-align: middle;">
                <p>&#160;</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p style="border-bottom: 0.75pt solid #000000;">/s/ Donal Carroll</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>Name: Donal Carroll</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>Title: Chief Financial Officer</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top;">
                <p>Date: March 17, 2020</p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.9
<SEQUENCE>7
<FILENAME>exhibit99-9.htm
<DESCRIPTION>EXHIBIT 99.9
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Form 40-F/A - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr width="100%" size="3" color="black" noshade="noshade">
<br>
<a name="page_10"></a>
<p style="text-align: justify;"><img src="form40fax001.jpg" style="width: 221px;" height="157"></p>
    <p style="text-align: justify;"><b>Consent of Independent Auditor</b></p>
    <p style="text-align: justify;">We hereby consent to the inclusion in this Amendment No. 1 to the Annual Report on Form 40-F for the year ended December 31, 2019 of FSD Pharma Inc. (the "Company") of our report dated May 3, 2019 relating to the consolidated financial statements of the Company as at December 31, 2018 and 2017 and for each of the years then ended (the "Report"). We also consent to the incorporation by reference of the Report in the Registration Statement on Form F-10 (No. 333-236780) of the Company.</p>
    <p style="text-align: justify;"><b>McGovern Hurley LLP</b></p>
    <p style="text-align: justify;">/s/ McGovern Hurley LLP</p>
    <p style="margin-bottom: 0pt; text-align: justify;"><b>Chartered Professional Accountants</b></p>
    <p style="margin-top: 0pt; text-align: justify;"><b>Licensed Public Accountants</b></p>
    <p style="margin-bottom: 0pt; text-align: justify;">Toronto, Ontario, Canada</p>
    <p style="margin-top: 0pt; text-align: justify;">March 17, 2020</p>
    <p style="text-align: justify;"><img src="form40fax002.jpg" style="width: 166px;" height="82"></p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.10
<SEQUENCE>8
<FILENAME>exhibit99-10.htm
<DESCRIPTION>EXHIBIT 99.10
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Form 40-F/A - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr width="100%" size="3" color="black" noshade="noshade">
<a name="page_11"></a>
<p style="text-align: right;"><b>EXHIBIT 99.10</b><br><img src="form40fax003.jpg" style="width: 196px;" height="89"><b> </b></p>
    <p style="text-align: justify; background-color: #ffffff;">March 17, 2020</p>
    <p style="text-align: justify; background-color: #ffffff;"><b>Consent of Independent Auditor</b></p>
    <p style="text-align: justify; background-color: #ffffff;">We hereby consent to the inclusion in this Amendment No. 1 to the Annual Report on Form 40-F for the year ended December 31, 2019 of FSD Pharma Inc. (the "Company") of our report dated March 3, 2020 relating to the consolidated financial statements of the Company as at December 31, 2019 and for the year then ended (the "Report"). We also consent to the incorporation by reference of the Report in the Registration Statement on Form F-10 (No. 333-236780) of the Company.</p>
    <table style="width: 40%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: top; background-color: #ffffff;">
                <p style="background-color: #ffffff; border-bottom: 0.75pt solid #000000;">/s/ MNP LLP</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #ffffff;">
                <p style="margin-bottom: 0pt; background-color: #ffffff;">MNP LLP</p>
                <p style="margin-top: 0pt; background-color: #ffffff;">Toronto, Ontario, Canada</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #ffffff;">
                <p style="background-color: #ffffff;">Chartered Professional Accountants</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #ffffff;">
                <p style="background-color: #ffffff;">Licensed Public Accountants</p>
            </td>
        </tr>
    </table>
    <p style="text-align: center;"><img src="form40fax004.jpg" style="width: 563px;" height="56"></p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>9
<FILENAME>huge-20191231.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL-->

<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:huge="http://www.fsdpharma.com/20191231" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































  <link:schemaRef xlink:href="huge-20191231.xsd" xlink:type="simple"></link:schemaRef>
  <context id="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FacilityUnderDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FacilityUnderDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FacilityUnderDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FacilityUnderDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FacilityUnderDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_ReserveOfSharebasedPaymentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfShareCapitalAxis_ClassACommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassACommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassACommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassACommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_WarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtDecember12st2019Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtDecember12st2019Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtDecember29th2019Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtDecember29th2019Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary5th2020Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJanuary5th2020Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay24th2022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay24th2022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember14th2019Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtNovember14th2019Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember1st2019Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtNovember1st2019Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember21st2019Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtNovember21st2019Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtOctober20th2019Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtOctober20th2019Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember15th2022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtSeptember15th2022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:ConvertibleDebentureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CloverCannastripThinFilmTechnologiesCorpMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HugeShopsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEighteenPointZeroNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightyEightPointFortyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightySixPointFortyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyNinePointThirtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftySixPointTwentyEightMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftySixPointTwentyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFourPointFourTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyEightPointSeventyFourMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredFortyEightPointSeventyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredFortyTwoPointSeventyOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredTwentyPointSixtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyPointOneZeroMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentySixPointThirteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFivePointZeroThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_May_2018T00_00_00_TO_31_May_2018T00_00_00_OtherInvestmentsNameOfEntityAxis_ScicannTherapeuticsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-05-31</instant>
    </period>
  </context>
  <context id="Context_As_Of_31_Oct_2018T00_00_00_TO_31_Oct_2018T00_00_00_OtherInvestmentsNameOfEntityAxis_ScicannTherapeuticsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FacilityUnderDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FacilityUnderDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_ReserveOfSharebasedPaymentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_WarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfOrdinarySharesAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEighteenPointZeroNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightyEightPointFortyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightySixPointFortyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyNinePointThirtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftySixPointTwentyEightMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftySixPointTwentyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFivePointZeroThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFourPointFourTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyEightPointSeventyFourMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredFortyEightPointSeventyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredFortyTwoPointSeventyOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredTwentyPointSixtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyPointOneZeroMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentySixPointThirteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="C_20180101to20181231_ifrsfullClassesOfOrdinarySharesAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="C_20180901to20180906_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CloverCannastripThinFilmTechnologiesCorpMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2018-09-06</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_deiLegalEntityAxis_hugeFSDBiosciencesMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:PresidentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">huge:FSDBiosciencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_deiLegalEntityAxis_hugeFvPharmaIncMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentsMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:PresidentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">huge:FvPharmaIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSharesHeldInEscrowMember_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:ClassBSharesHeldInEscrowMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:ClassBSubordinateVotingSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeUnrestrictedClassBSharesMember_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:UnrestrictedClassBSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HugeShopsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:EpitechLicenseAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_hugeTypeOfArrangementsAxis_hugeHeritageBuildingRestorationCommitmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:HeritageBuildingRestorationCommitmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeCanntabTherapeuticsLtdWorldClassExtractionsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SupplyAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">huge:CanntabTherapeuticsLtdWorldClassExtractionsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:ChiefExecutiveOfficersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:ChiefExecutiveOfficersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefFinancialOfficersMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:ChiefFinancialOfficersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefOperatingConsultantMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:ChiefOperatingConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeFormerChiefExecutiveOfficerMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeFormerChiefOperatingOfficerMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:FormerChiefOperatingOfficerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeIndependentDirectorMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:IndependentDirectorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentAndChiefExecutiveOfficerMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:PresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentAndChiefExecutiveOfficerMember_deiLegalEntityAxis_hugeFvPharmaIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:PresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">huge:FvPharmaIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentOfFSDMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:PresidentOfFSDMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:PresidentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentsMember_deiLegalEntityAxis_hugeFSDBiosciencesMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:PresidentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">huge:FSDBiosciencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfContingentLiabilitiesAxis_hugeContingentLiabilityForConstructionAndDevelopmentCostsMember_ifrsfullCounterpartiesAxis_hugeAuxlyCannabisGroupIncMember_hugeTypeOfArrangementsAxis_hugeDefinitiveStrategicAllianceAndStreamingAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:DefinitiveStrategicAllianceAndStreamingAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">huge:ContingentLiabilityForConstructionAndDevelopmentCostsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">huge:AuxlyCannabisGroupIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfContingentLiabilitiesAxis_ifrsfullLegalProceedingsContingentLiabilityMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:ConvertibleDebentureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CloverCannastripThinFilmTechnologiesCorpMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HugeShopsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfOrdinarySharesAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfOrdinarySharesAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFacilityUnderDevelopmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FacilityUnderDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFacilityUnderDevelopmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FacilityUnderDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFurnitureFixturesAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFurnitureFixturesAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullFixturesAndFittingsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassACommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullCounterpartiesAxis_hugePharmadrugProductionGMBHMember_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeFvPharmaIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SupplyAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">huge:PharmadrugProductionGMBHMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">huge:FvPharmaIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">huge:SubsidiariesTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEighteenPointZeroNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightyEightPointFortyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightySixPointFortyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyFivePointTwentyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyNinePointThirtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyPointTwentyFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyTwoPointTwentySixMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFivePointFourThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortyFourPointTwentyTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortyPointTwentyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortySevenPointTwentyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFourPointFourTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredFortyTwoPointSeventyOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredTwentyPointSixtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointSeventeenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointSixtyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSeventeenPointEightNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSeventyFivePointThirtyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSixteenPointZeroEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTenPointSixFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThirteenPointFourSevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThirteenPointZeroSevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyFourPointTwelveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyOnePointElevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyPointOneZeroMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentySixPointThirteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwoPointSixOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>


              <instant>2019-01-02</instant>
    </period>
  </context>
  <context id="C_20190103to20191231">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>



              <startDate>2019-01-03</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190201to20190212_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeCanntabTherapeuticsLtdWorldClassExtractionsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SupplyAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">huge:CanntabTherapeuticsLtdWorldClassExtractionsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-02-01</startDate>
      <endDate>2019-02-12</endDate>
    </period>
  </context>
  <context id="C_20190212_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeCanntabTherapeuticsLtdWorldClassExtractionsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SupplyAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">huge:CanntabTherapeuticsLtdWorldClassExtractionsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-02-12</instant>
    </period>
  </context>
  <context id="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-04-01</startDate>
      <endDate>2019-04-24</endDate>
    </period>
  </context>
  <context id="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:ClassBSubordinateVotingSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-04-01</startDate>
      <endDate>2019-04-24</endDate>
    </period>
  </context>
  <context id="C_20190401to20190424_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-04-01</startDate>
      <endDate>2019-04-24</endDate>
    </period>
  </context>
  <context id="C_20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-04-24</instant>
    </period>
  </context>
  <context id="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-05-01</startDate>
      <endDate>2019-05-07</endDate>
    </period>
  </context>
  <context id="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:ClassBSubordinateVotingSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-05-01</startDate>
      <endDate>2019-05-07</endDate>
    </period>
  </context>
  <context id="C_20190501to20190507_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-05-01</startDate>
      <endDate>2019-05-07</endDate>
    </period>
  </context>
  <context id="C_20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-05-07</instant>
    </period>
  </context>
  <context id="C_20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-05-07</instant>
    </period>
  </context>
  <context id="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-06-01</startDate>
      <endDate>2019-06-28</endDate>
    </period>
  </context>
  <context id="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeClassBVotingSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">huge:ClassBVotingSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-06-01</startDate>
      <endDate>2019-06-28</endDate>
    </period>
  </context>
  <context id="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-06-01</startDate>
      <endDate>2019-06-28</endDate>
    </period>
  </context>
  <context id="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-06-01</startDate>
      <endDate>2019-06-28</endDate>
    </period>
  </context>
  <context id="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-06-28</instant>
    </period>
  </context>
  <context id="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeClassBVotingSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">huge:ClassBVotingSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-06-28</instant>
    </period>
  </context>
  <context id="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-06-28</instant>
    </period>
  </context>
  <context id="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-06-28</instant>
    </period>
  </context>
  <context id="C_20190901to20190920_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:ClassBSubordinateVotingSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2019-09-20</endDate>
    </period>
  </context>
  <context id="C_20190901to20190920_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2019-09-20</endDate>
    </period>
  </context>
  <context id="C_20191001to20191004_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-10-01</startDate>
      <endDate>2019-10-04</endDate>
    </period>
  </context>
  <context id="C_20191001to20191016_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-10-01</startDate>
      <endDate>2019-10-16</endDate>
    </period>
  </context>
  <context id="C_20191101to20191104_ifrsfullCategoriesOfRelatedPartiesAxis_hugeDirectorsAndOfficersMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:DirectorsAndOfficersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-11-01</startDate>
      <endDate>2019-11-04</endDate>
    </period>
  </context>
  <context id="C_20191101to20191104_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-11-01</startDate>
      <endDate>2019-11-04</endDate>
    </period>
  </context>
  <context id="C_20191101to20191122_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-11-01</startDate>
      <endDate>2019-11-22</endDate>
    </period>
  </context>
  <context id="C_20191231">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust1st2021Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtAugust1st2021Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary16th2026Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJanuary16th2026Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary20th2026Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJanuary20th2026Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary5th2020Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJanuary5th2020Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJuly24th2023Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJuly24th2023Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay10th2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay10th2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay17th2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay17th2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay20th2023Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay20th2023Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay24th2022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay24th2022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay31st2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay31st2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay4th2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay4th2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember30th2020Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtNovember30th2020Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember11th2023Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtSeptember11th2023Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember15th2022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtSeptember15th2022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:ClassBSubordinateVotingSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HugeShopsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:EpitechLicenseAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeCanntabTherapeuticsLtdWorldClassExtractionsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SupplyAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">huge:CanntabTherapeuticsLtdWorldClassExtractionsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:TypeOfInventoriesAxis">huge:HarvestedCannabisMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember_ifrsfullMeasurementAxis_hugeBiologicalAssetFairValueAdjustmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfInventoriesAxis">huge:HarvestedCannabisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">huge:BiologicalAssetFairValueAdjustmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember_ifrsfullMeasurementAxis_hugeCapitalizedCostMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfInventoriesAxis">huge:HarvestedCannabisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">huge:CapitalizedCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember_ifrsfullMeasurementAxis_hugeImpairmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfInventoriesAxis">huge:HarvestedCannabisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">huge:ImpairmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfInventoriesAxis_hugeHempProductsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:TypeOfInventoriesAxis">huge:HempProductsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfInventoriesAxis_hugeHempProductsMember_ifrsfullMeasurementAxis_hugeBiologicalAssetFairValueAdjustmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfInventoriesAxis">huge:HempProductsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">huge:BiologicalAssetFairValueAdjustmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfInventoriesAxis_hugeHempProductsMember_ifrsfullMeasurementAxis_hugeCapitalizedCostMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfInventoriesAxis">huge:HempProductsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">huge:CapitalizedCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfInventoriesAxis_hugeHempProductsMember_ifrsfullMeasurementAxis_hugeImpairmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfInventoriesAxis">huge:HempProductsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">huge:ImpairmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfInventoriesAxis_hugeOtherInventoryMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:TypeOfInventoriesAxis">huge:OtherInventoryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfInventoriesAxis_hugeOtherInventoryMember_ifrsfullMeasurementAxis_hugeCapitalizedCostMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfInventoriesAxis">huge:OtherInventoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">huge:CapitalizedCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeTypeOfInventoriesAxis_hugeOtherInventoryMember_ifrsfullMeasurementAxis_hugeImpairmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfInventoriesAxis">huge:OtherInventoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">huge:ImpairmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:ChiefExecutiveOfficersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:ConvertibleDebentureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CloverCannastripThinFilmTechnologiesCorpMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HugeShopsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFacilityUnderDevelopmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FacilityUnderDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFacilityUnderDevelopmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FacilityUnderDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFacilityUnderDevelopmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FacilityUnderDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFurnitureFixturesAndEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFurnitureFixturesAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFurnitureFixturesAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:FurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassACommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">huge:NotesPayableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullMaturityAxis_ifrsfullLaterThanThreeYearsAndNotLaterThanFourYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullMaturityAxis_ifrsfullLaterThanTwoYearsAndNotLaterThanThreeYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullMeasurementAxis_hugeBiologicalAssetFairValueAdjustmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">huge:BiologicalAssetFairValueAdjustmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullMeasurementAxis_hugeBiologicalAssetFairValueAdjustmentMember_hugeTypeOfInventoriesAxis_hugeOtherInventoryMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:TypeOfInventoriesAxis">huge:OtherInventoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">huge:BiologicalAssetFairValueAdjustmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullMeasurementAxis_hugeCapitalizedCostMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">huge:CapitalizedCostMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullMeasurementAxis_hugeImpairmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">huge:ImpairmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFivePointFourThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointFiftyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointFiftyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEighteenPointZeroNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightyEightPointFortyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightySixPointFortyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyFivePointTwentyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyNinePointThirtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyPointTwentyFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyTwoPointTwentySixMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortyFourPointTwentyTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortyPointTwentyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortySevenPointTwentyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFourPointFourTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredFortyTwoPointSeventyOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredTwentyPointSixtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointSeventeenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointSixtyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSeventeenPointEightNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSeventyFivePointThirtyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSixteenPointZeroEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTenPointSixFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThirteenPointFourSevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThirteenPointZeroSevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyFourPointTwelveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyOnePointElevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyPointOneZeroMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentySixPointThirteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwoPointSixOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20200102_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">huge:SubsequentEventsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-01-02</endDate>
    </period>
  </context>
  <context id="C_20200201to20200204_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">huge:SubsequentEventsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-02-01</startDate>
      <endDate>2020-02-04</endDate>
    </period>
  </context>
  <context id="C_20200201to20200205_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:ClassBSubordinateVotingSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">huge:SubsequentEventsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-02-01</startDate>
      <endDate>2020-02-05</endDate>
    </period>
  </context>
  <context id="C_20200201to20200205_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">huge:SubsequentEventsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-02-01</startDate>
      <endDate>2020-02-05</endDate>
    </period>
  </context>
  <context id="C_20200204_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">huge:SubsequentEventsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-02-04</instant>
    </period>
  </context>
  <unit id="CAD">


        <measure>iso4217:CAD</measure>
  </unit>
  <unit id="CAD_per_Share">


        <divide>



              <unitNumerator>


                    <measure>iso4217:CAD</measure>
      </unitNumerator>
      <unitDenominator>


                    <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="Kg">


        <measure>utr:kg</measure>
  </unit>
  <unit id="Pure">


        <measure>pure</measure>
  </unit>
  <unit id="Share">


        <measure>huge:Share</measure>
  </unit>
  <unit id="USD">


        <measure>iso4217:USD</measure>
  </unit>
  <unit id="USD_per_Share">


        <divide>



              <unitNumerator>


                    <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>


                    <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="Year">


        <measure>huge:Year</measure>
  </unit>
  <unit id="g">


        <measure>utr:g</measure>
  </unit>
  <unit id="shares">


        <measure>shares</measure>
  </unit>
  <dei:EntityCentralIndexKey contextRef="C_20190101to20191231" id="Fdei_EntityCentralIndexKey_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">0001771885</dei:EntityCentralIndexKey>
  <dei:EntityCurrentReportingStatus contextRef="C_20190101to20191231" id="Fdei_EntityCurrentReportingStatus_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">Yes</dei:EntityCurrentReportingStatus>
  <dei:CurrentFiscalYearEndDate contextRef="C_20190101to20191231" id="Fdei_CurrentFiscalYearEndDate_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentPeriodEndDate contextRef="C_20190101to20191231" id="Fdei_DocumentPeriodEndDate_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">2019-12-31</dei:DocumentPeriodEndDate>
  <dei:DocumentType contextRef="C_20190101to20191231" id="Fdei_DocumentType_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">40-F/A</dei:DocumentType>
  <dei:AmendmentFlag contextRef="C_20190101to20191231" id="Fdei_AmendmentFlag_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">false</dei:AmendmentFlag>
  <dei:DocumentFiscalYearFocus contextRef="C_20190101to20191231" id="Fdei_DocumentFiscalYearFocus_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">2019</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="C_20190101to20191231" id="Fdei_DocumentFiscalPeriodFocus_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">FY</dei:DocumentFiscalPeriodFocus>
  <dei:EntityEmergingGrowthCompany contextRef="C_20190101to20191231" id="Fdei_EntityEmergingGrowthCompany_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">true</dei:EntityEmergingGrowthCompany>
  <dei:EntityExTransitionPeriod contextRef="C_20190101to20191231" id="Fdei_EntityExTransitionPeriod_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">false</dei:EntityExTransitionPeriod>
  <dei:EntityRegistrantName contextRef="C_20190101to20191231" id="Fdei_EntityRegistrantName_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">FSD Pharma Inc.</dei:EntityRegistrantName>
  <dei:EntityInteractiveDataCurrent contextRef="C_20190101to20191231">Yes</dei:EntityInteractiveDataCurrent>
  <dei:EntityCommonStockSharesOutstanding contextRef="C_20191231" decimals="0" id="Fxbrl_20200304021354315" unitRef="shares">7056245</dei:EntityCommonStockSharesOutstanding>
  <ifrs-full:CashAndCashEquivalents contextRef="C_20191231" decimals="0" id="Fxbrl_20200219223508948" unitRef="CAD">7932737</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:CashAndCashEquivalents contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="F187" unitRef="CAD">21134930</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:CashAndCashEquivalents contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00" decimals="0" id="Fxbrl_20200220180559200" unitRef="CAD">4739988</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:TradeAndOtherCurrentReceivables contextRef="C_20191231" decimals="0" id="Fxbrl_20200219235801125" unitRef="CAD">2070055</ifrs-full:TradeAndOtherCurrentReceivables>
  <ifrs-full:TradeAndOtherCurrentReceivables contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200219235859775" unitRef="CAD">990988</ifrs-full:TradeAndOtherCurrentReceivables>
  <ifrs-full:CurrentPrepaidExpenses contextRef="C_20191231" decimals="0" id="F202" unitRef="CAD">430381</ifrs-full:CurrentPrepaidExpenses>
  <ifrs-full:CurrentPrepaidExpenses contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="F205" unitRef="CAD">444099</ifrs-full:CurrentPrepaidExpenses>
  <ifrs-full:Inventories contextRef="C_20191231" decimals="0" id="Fxbrl_20200219235809137" unitRef="CAD">942939</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember_ifrsfullMeasurementAxis_hugeCapitalizedCostMember" decimals="0" id="Fxbrl_20200220115344928" unitRef="CAD">1659019</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember_ifrsfullMeasurementAxis_hugeBiologicalAssetFairValueAdjustmentMember" decimals="0" id="Fxbrl_20200220115450348" unitRef="CAD">-415920</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember_ifrsfullMeasurementAxis_hugeImpairmentMember" decimals="0" id="Fxbrl_20200220115500416" unitRef="CAD">-682577</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember" decimals="0" id="Fxbrl_20200220115509604" unitRef="CAD">560522</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHempProductsMember_ifrsfullMeasurementAxis_hugeCapitalizedCostMember" decimals="0" id="Fxbrl_20200220115735557" unitRef="CAD">100000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHempProductsMember_ifrsfullMeasurementAxis_hugeBiologicalAssetFairValueAdjustmentMember" decimals="0" id="Fxbrl_20200220115752110" unitRef="CAD">0</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHempProductsMember_ifrsfullMeasurementAxis_hugeImpairmentMember" decimals="0" id="Fxbrl_20200220115802578" unitRef="CAD">0</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHempProductsMember" decimals="0" id="Fxbrl_20200220115811374" unitRef="CAD">100000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeOtherInventoryMember_ifrsfullMeasurementAxis_hugeCapitalizedCostMember" decimals="0" id="Fxbrl_20200220115917500" unitRef="CAD">282417</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_ifrsfullMeasurementAxis_hugeBiologicalAssetFairValueAdjustmentMember_hugeTypeOfInventoriesAxis_hugeOtherInventoryMember" decimals="0" id="Fxbrl_20200220115933460" unitRef="CAD">0</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeOtherInventoryMember_ifrsfullMeasurementAxis_hugeImpairmentMember" decimals="0" id="Fxbrl_20200220120006322" unitRef="CAD">0</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeOtherInventoryMember" decimals="0" id="Fxbrl_20200220120023484" unitRef="CAD">282417</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_ifrsfullMeasurementAxis_hugeCapitalizedCostMember" decimals="0" id="Fxbrl_20200220120043715" unitRef="CAD">2041436</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_ifrsfullMeasurementAxis_hugeBiologicalAssetFairValueAdjustmentMember" decimals="0" id="Fxbrl_20200220120100901" unitRef="CAD">-415920</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231_ifrsfullMeasurementAxis_hugeImpairmentMember" decimals="0" id="Fxbrl_20200220120113796" unitRef="CAD">-682577</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20190212_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeCanntabTherapeuticsLtdWorldClassExtractionsIncMember" decimals="0" id="Fxbrl_20200220123201037" unitRef="CAD">100000</ifrs-full:Inventories>
  <ifrs-full:CurrentBiologicalAssets contextRef="C_20191231" decimals="0" id="Fxbrl_20200219235812673" unitRef="CAD">0</ifrs-full:CurrentBiologicalAssets>
  <ifrs-full:CurrentBiologicalAssets contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200219235903350" unitRef="CAD">0</ifrs-full:CurrentBiologicalAssets>
  <ifrs-full:CurrentAssets contextRef="C_20191231" decimals="0" id="F212" unitRef="CAD">11376112</ifrs-full:CurrentAssets>
  <ifrs-full:CurrentAssets contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="F215" unitRef="CAD">22570017</ifrs-full:CurrentAssets>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231" decimals="0" id="F240" unitRef="CAD">11780864</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200219235905546" unitRef="CAD">18064541</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember" decimals="0" id="Fxbrl_20200219173152499" unitRef="CAD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember" decimals="0" id="Fxbrl_20200219173602304" unitRef="CAD">339060</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember" decimals="0" id="Fxbrl_20200219173155315" unitRef="CAD">11215395</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember" decimals="0" id="Fxbrl_20200219173603775" unitRef="CAD">9069038</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember" decimals="0" id="Fxbrl_20200219173200628" unitRef="CAD">1500000</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember" decimals="0" id="Fxbrl_20200219173607127" unitRef="CAD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20200219173109941" unitRef="CAD">1798040</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20200219173549652" unitRef="CAD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20200219173149111" unitRef="CAD">251115</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20200219173600929" unitRef="CAD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="0" id="Fxbrl_20200219173202365" unitRef="CAD">1300000</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="0" id="Fxbrl_20200219173610642" unitRef="CAD">760868</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="0" id="Fxbrl_20200219173158635" unitRef="CAD">1999991</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="0" id="Fxbrl_20200219173605208" unitRef="CAD">712248</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173207971" unitRef="CAD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173612725" unitRef="CAD">435000</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173210027" unitRef="CAD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173614703" unitRef="CAD">116650</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173214795" unitRef="CAD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173617077" unitRef="CAD">348000</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:RightofuseAssets contextRef="C_20191231" decimals="0" id="Fxbrl_20200219235821934" unitRef="CAD">127410</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200224095921051" unitRef="CAD">0</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="C_20190102" decimals="0" id="Fxbrl_20200220104609395" unitRef="CAD">243818</ifrs-full:RightofuseAssets>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231" decimals="0" id="F249" unitRef="CAD">11804145</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="F252" unitRef="CAD">12141676</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220110744220" unitRef="CAD">123218</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220115314534" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220115608467" unitRef="CAD">7068820</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220115633747" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220115652541" unitRef="CAD">1100000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220115707649" unitRef="CAD">8292038</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220115732928" unitRef="CAD">333013</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220115756673" unitRef="CAD">220150</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220115819084" unitRef="CAD">10418976</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220115837241" unitRef="CAD">252731</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220115924555" unitRef="CAD">1100000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220115947131" unitRef="CAD">12324870</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFurnitureFixturesAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220120007304" unitRef="CAD">372708</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220120045867" unitRef="CAD">293333</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFacilityUnderDevelopmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220120204864" unitRef="CAD">10460117</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember" decimals="0" id="Fxbrl_20200220120224802" unitRef="CAD">417774</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220120304386" unitRef="CAD">1100000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220120432162" unitRef="CAD">12643932</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220123153390" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220124247991" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220124357037" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220125452548" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220125714906" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220130553316" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220123312763" unitRef="CAD">76179</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220124325655" unitRef="CAD">66045</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220124415837" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220125519931" unitRef="CAD">40970</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220125728641" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220130615539" unitRef="CAD">183194</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFurnitureFixturesAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220123333413" unitRef="CAD">149077</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220124311606" unitRef="CAD">134231</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFacilityUnderDevelopmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220124431156" unitRef="CAD">434819</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220125533194" unitRef="CAD">121660</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220125739192" unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220130634364" unitRef="CAD">839787</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember" decimals="0" id="Fxbrl_20200220135906064" unitRef="CAD">256834</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember" decimals="0" id="Fxbrl_20200220140213343" unitRef="CAD">154105</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember" decimals="0" id="Fxbrl_20200220140242399" unitRef="CAD">10418976</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember" decimals="0" id="Fxbrl_20200220140320144" unitRef="CAD">211761</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember" decimals="0" id="Fxbrl_20200220141115738" unitRef="CAD">1100000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFurnitureFixturesAndEquipmentMember" decimals="0" id="Fxbrl_20200220135928294" unitRef="CAD">223631</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" decimals="0" id="Fxbrl_20200221045519238" unitRef="CAD">159102</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFacilityUnderDevelopmentMember" decimals="0" id="Fxbrl_20200220140259819" unitRef="CAD">10025298</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember" decimals="0" id="Fxbrl_20200220140333931" unitRef="CAD">296114</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember" decimals="0" id="Fxbrl_20200220141201072" unitRef="CAD">1100000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20191231" decimals="0" id="Fxbrl_20200219235827575" unitRef="CAD">22358932</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220140114948" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220140315474" unitRef="CAD">24852092</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220140400195" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220140502588" unitRef="CAD">2493160</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220140539466" unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:Assets contextRef="C_20191231" decimals="0" id="F279_52776234" unitRef="CAD">57447463</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="F284_13679694" unitRef="CAD">52776234</ifrs-full:Assets>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20191231" decimals="0" id="F320" unitRef="CAD">4467826</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="F323" unitRef="CAD">1743806</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:CurrentLeaseLiabilities contextRef="C_20191231" decimals="0" id="Fxbrl_20200219235833944" unitRef="CAD">56207</ifrs-full:CurrentLeaseLiabilities>
  <ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="C_20191231" decimals="0" id="Fxbrl_20200219235836550" unitRef="CAD">2646269</ifrs-full:CurrentDerivativeFinancialLiabilities>
  <ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued contextRef="C_20191231" decimals="0" id="Fxbrl_20200219235838578" unitRef="CAD">1908412</ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued>
  <ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued contextRef="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" decimals="0" id="Fxbrl_20200220155507669" unitRef="CAD">193996</ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued>
  <ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued contextRef="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember" decimals="0" id="Fxbrl_20200220155502927" unitRef="CAD">1714416</ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued>
  <ifrs-full:CurrentLiabilities contextRef="C_20191231" decimals="0" id="F330" unitRef="CAD">9078714</ifrs-full:CurrentLiabilities>
  <ifrs-full:CurrentLiabilities contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="F333" unitRef="CAD">1743806</ifrs-full:CurrentLiabilities>
  <ifrs-full:NoncurrentLeaseLiabilities contextRef="C_20191231" decimals="0" id="Fxbrl_20200219235841534" unitRef="CAD">146662</ifrs-full:NoncurrentLeaseLiabilities>
  <ifrs-full:Liabilities contextRef="C_20191231" decimals="0" id="Fxbrl_20200219235843683" unitRef="CAD">9225376</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200219235923181" unitRef="CAD">1743806</ifrs-full:Liabilities>
  <ifrs-full:IssuedCapital contextRef="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="0" id="F358" unitRef="CAD">201500</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassACommonStockSharesMember" decimals="0" id="F361" unitRef="CAD">201500</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="F367" unitRef="CAD">97815149</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="0" id="F370" unitRef="CAD">67916302</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20191231" decimals="0" id="Fxbrl_20200220045842293" unitRef="CAD">98016649</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220045835704" unitRef="CAD">68117802</ifrs-full:IssuedCapital>
  <huge:Warrants contextRef="C_20191231" decimals="0" id="F376" unitRef="CAD">5745034</huge:Warrants>
  <huge:Warrants contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="F379" unitRef="CAD">4442145</huge:Warrants>
  <ifrs-full:SharePremium contextRef="C_20191231" decimals="0" id="F385" unitRef="CAD">23091099</ifrs-full:SharePremium>
  <ifrs-full:SharePremium contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="F388" unitRef="CAD">4977300</ifrs-full:SharePremium>
  <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="C_20191231" decimals="0" id="Fxbrl_20200219235848871" unitRef="CAD">-112690</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
  <ifrs-full:RetainedEarnings contextRef="C_20191231" decimals="0" id="F394_26504819" unitRef="CAD">-78518005</ifrs-full:RetainedEarnings>
  <ifrs-full:RetainedEarnings contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="F397_4195264" unitRef="CAD">-26504819</ifrs-full:RetainedEarnings>
  <ifrs-full:Equity contextRef="C_20191231" decimals="0" id="F404" unitRef="CAD">48222087</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200219235930796" unitRef="CAD">51032428</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfShareCapitalAxis_ClassACommonStockSharesMember" decimals="0" id="Fxbrl_20200220155257986" unitRef="CAD">201500</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220155322458" unitRef="CAD">12794963</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20200220155350025" unitRef="CAD">2116900</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20200220155424631" unitRef="CAD">1495300</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_01_Jan_2017T00_00_00_TO_31_Dec_2017T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember" decimals="0" id="Fxbrl_20200220155612448" unitRef="CAD">-4195264</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00" decimals="0" id="Fxbrl_20200220155742236" unitRef="CAD">12413399</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassACommonStockSharesMember" decimals="0" id="Fxbrl_20200220161444693" unitRef="CAD">201500</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220161532929" unitRef="CAD">67916302</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_WarrantsMember" decimals="0" id="Fxbrl_20200220161616455" unitRef="CAD">4442145</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20200220161634901" unitRef="CAD">4977300</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="Context_As_Of_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember" decimals="0" id="Fxbrl_20200220161653141" unitRef="CAD">-26504819</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="0" id="Fxbrl_20200220163202328" unitRef="CAD">201500</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220163254378" unitRef="CAD">97815149</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20200220164216457" unitRef="CAD">5745034</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20200220164435700" unitRef="CAD">23091099</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" decimals="0" id="Fxbrl_20200220164456080" unitRef="CAD">-112690</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" decimals="0" id="Fxbrl_20200220164606342" unitRef="CAD">-78518005</ifrs-full:Equity>
  <ifrs-full:EquityAndLiabilities contextRef="C_20191231" decimals="0" id="F424_52776234" unitRef="CAD">57447463</ifrs-full:EquityAndLiabilities>
  <ifrs-full:EquityAndLiabilities contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="F429_13679694" unitRef="CAD">52776234</ifrs-full:EquityAndLiabilities>
  <ifrs-full:Revenue contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220212922188" unitRef="CAD">257099</ifrs-full:Revenue>
  <ifrs-full:CostOfSales contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220171515953" unitRef="CAD">1959111</ifrs-full:CostOfSales>
  <huge:GrossLossProfitBeforeFairValueAdjustments contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090613893" unitRef="CAD">-1702012</huge:GrossLossProfitBeforeFairValueAdjustments>
  <huge:FairValueAdjustmentsOnInventorySold contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090601745" unitRef="CAD">22249</huge:FairValueAdjustmentsOnInventorySold>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090551380" unitRef="CAD">682739</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets>
  <ifrs-full:GrossProfit contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090529933" unitRef="CAD">-2407000</ifrs-full:GrossProfit>
  <ifrs-full:GeneralAndAdministrativeExpense contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090407068" unitRef="CAD">14811529</ifrs-full:GeneralAndAdministrativeExpense>
  <ifrs-full:GeneralAndAdministrativeExpense contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200221090419318" unitRef="CAD">18740360</ifrs-full:GeneralAndAdministrativeExpense>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090433525" unitRef="CAD">16061319</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200221090446109" unitRef="CAD">6440406</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090326627" unitRef="CAD">3146680</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200221090343590" unitRef="CAD">183194</ifrs-full:DepreciationAndAmortisationExpense>
  <huge:AllowanceForImpairment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200303185011963" unitRef="CAD">7499977</huge:AllowanceForImpairment>
  <huge:ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090459060" unitRef="CAD">243468</huge:ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset>
  <ifrs-full:ExpenseByNature contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200229122334162" unitRef="CAD">34262996</ifrs-full:ExpenseByNature>
  <ifrs-full:ExpenseByNature contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200229122346929" unitRef="CAD">32863937</ifrs-full:ExpenseByNature>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200227132801207" unitRef="CAD">-36669996</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200227132807580" unitRef="CAD">-32863937</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:OtherIncome contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200227151044379" unitRef="CAD">125536</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200227151110795" unitRef="CAD">88763</ifrs-full:OtherIncome>
  <ifrs-full:FinanceCosts contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090830491" unitRef="CAD">206454</ifrs-full:FinanceCosts>
  <huge:LossOnSettlementOfFinancialLiability contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090818045" unitRef="CAD">24810</huge:LossOnSettlementOfFinancialLiability>
  <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090806672" unitRef="CAD">3568305</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
  <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember" decimals="0" id="Fxbrl_20200219182803868" unitRef="CAD">1422036</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
  <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200303044708058" unitRef="CAD">2146269</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
  <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="C_20190901to20190920_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember" decimals="0" id="Fxbrl_20200228153126645" unitRef="CAD">1422036</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
  <huge:LossGainOnChangesInFairValueOfOtherInvestments contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090755875" unitRef="CAD">11669157</huge:LossGainOnChangesInFairValueOfOtherInvestments>
  <huge:LossGainOnChangesInFairValueOfOtherInvestments contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200221090743059" unitRef="CAD">-10064550</huge:LossGainOnChangesInFairValueOfOtherInvestments>
  <ifrs-full:ProfitLoss contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090726756" unitRef="CAD">-52013186</ifrs-full:ProfitLoss>
  <ifrs-full:ProfitLoss contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200221090733980" unitRef="CAD">-22710624</ifrs-full:ProfitLoss>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090654708" unitRef="CAD">-112690</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <ifrs-full:ComprehensiveIncome contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090706778" unitRef="CAD">-52125876</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200221090715064" unitRef="CAD">-22710624</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember" decimals="0" id="Fxbrl_20200220161334665" unitRef="CAD">-22710624</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" decimals="0" id="Fxbrl_20200220162639912" unitRef="CAD">-112690</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" decimals="0" id="Fxbrl_20200220162710132" unitRef="CAD">-52013186</ifrs-full:ComprehensiveIncome>
  <ifrs-full:BasicAndDilutedEarningsLossPerShare contextRef="C_20190101to20191231" decimals="2" id="Fxbrl_20200221090855139" unitRef="CAD_per_Share">-7.37</ifrs-full:BasicAndDilutedEarningsLossPerShare>
  <ifrs-full:BasicAndDilutedEarningsLossPerShare contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="2" id="Fxbrl_20200221090905944" unitRef="CAD_per_Share">-3.85</ifrs-full:BasicAndDilutedEarningsLossPerShare>
  <ifrs-full:AdjustedWeightedAverageShares contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221090935195" unitRef="shares">7056245</ifrs-full:AdjustedWeightedAverageShares>
  <ifrs-full:AdjustedWeightedAverageShares contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200221090944634" unitRef="shares">5905252</ifrs-full:AdjustedWeightedAverageShares>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220173636660" unitRef="CAD">3146680</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220173656353" unitRef="CAD">183194</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
  <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220173728183" unitRef="CAD">243468</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <huge:AdjustmentsForListingExpense contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220173745603" unitRef="CAD">7991791</huge:AdjustmentsForListingExpense>
  <ifrs-full:AdjustmentsForInterestExpense contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220173812663" unitRef="CAD">206454</ifrs-full:AdjustmentsForInterestExpense>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220173829498" unitRef="CAD">16061319</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220173843362" unitRef="CAD">6440406</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForFairValueGainsLosses contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220173954738" unitRef="CAD">11669157</ifrs-full:AdjustmentsForFairValueGainsLosses>
  <ifrs-full:AdjustmentsForFairValueGainsLosses contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220174000177" unitRef="CAD">-17564529</ifrs-full:AdjustmentsForFairValueGainsLosses>
  <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220174038496" unitRef="CAD">-3568305</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives>
  <huge:AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220174139526" unitRef="CAD">-22249</huge:AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold>
  <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220174209535" unitRef="CAD">-682739</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220174328202" unitRef="CAD">-1079067</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220174354529" unitRef="CAD">-664610</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
  <huge:AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220174451412" unitRef="CAD">39892</huge:AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit>
  <huge:AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220175256536" unitRef="CAD">-99264</huge:AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220175329174" unitRef="CAD">-942939</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220175430416" unitRef="CAD">-682739</ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220175454559" unitRef="CAD">825120</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220175459125" unitRef="CAD">433754</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
  <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220175520201" unitRef="CAD">-18227738</ifrs-full:CashFlowsFromUsedInOperatingActivities>
  <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220175527372" unitRef="CAD">-18489905</ifrs-full:CashFlowsFromUsedInOperatingActivities>
  <huge:CashAcquiredOnAcquisition contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220175537995" unitRef="CAD">2329</huge:CashAcquiredOnAcquisition>
  <huge:ReverseTakeoverTransaction contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220175615972" unitRef="CAD">2041501</huge:ReverseTakeoverTransaction>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220175951906" unitRef="CAD">614520</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember" decimals="0" id="Fxbrl_20200219173346380" unitRef="CAD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember" decimals="0" id="Fxbrl_20200219173350400" unitRef="CAD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember" decimals="0" id="Fxbrl_20200219173402247" unitRef="CAD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20200219173327534" unitRef="CAD">614520</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20200219173340143" unitRef="CAD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="0" id="Fxbrl_20200219173406135" unitRef="CAD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="0" id="Fxbrl_20200219173359140" unitRef="CAD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173408436" unitRef="CAD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173411100" unitRef="CAD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173418937" unitRef="CAD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentProperty contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220183145664" unitRef="CAD">7999991</ifrs-full:PurchaseOfInvestmentProperty>
  <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220180046185" unitRef="CAD">534118</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220180036078" unitRef="CAD">4032832</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200303190536226" unitRef="CAD">389640</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
  <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200303190634462" unitRef="CAD">-306909</ifrs-full:CashFlowsFromUsedInInvestingActivities>
  <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220180133792" unitRef="CAD">-9991322</ifrs-full:CashFlowsFromUsedInInvestingActivities>
  <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200227161115005" unitRef="CAD">56207</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220180246929" unitRef="CAD">4593777</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220180252548" unitRef="CAD">44987422</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20200201to20200205_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="0" id="Fxbrl_20200227172835067" unitRef="CAD">7743492</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20191101to20191104_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200219223035268" unitRef="CAD">4593777</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:PaymentsForShareIssueCosts contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200303191130145" unitRef="CAD">32705</ifrs-full:PaymentsForShareIssueCosts>
  <ifrs-full:PaymentsForShareIssueCosts contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200303191141899" unitRef="CAD">3768381</ifrs-full:PaymentsForShareIssueCosts>
  <ifrs-full:PaymentsForShareIssueCosts contextRef="C_20191101to20191104_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200228150830767" unitRef="CAD">32705</ifrs-full:PaymentsForShareIssueCosts>
  <ifrs-full:ProceedsFromExerciseOfOptions contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220180316247" unitRef="CAD">732598</ifrs-full:ProceedsFromExerciseOfOptions>
  <ifrs-full:ProceedsFromExerciseOfOptions contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220180319285" unitRef="CAD">2857050</ifrs-full:ProceedsFromExerciseOfOptions>
  <huge:ProceedsFromExerciseOfWarrants contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220180333476" unitRef="CAD">94991</huge:ProceedsFromExerciseOfWarrants>
  <huge:ProceedsFromExerciseOfWarrants contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220180336700" unitRef="CAD">800078</huge:ProceedsFromExerciseOfWarrants>
  <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220180351595" unitRef="CAD">5332454</ifrs-full:CashFlowsFromUsedInFinancingActivities>
  <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220180355564" unitRef="CAD">44876169</ifrs-full:CashFlowsFromUsedInFinancingActivities>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220180438663" unitRef="CAD">-13202193</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220180443918" unitRef="CAD">16394942</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
  <ifrs-full:NumberOfSharesOutstanding contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfShareCapitalAxis_ClassACommonStockSharesMember" decimals="INF" id="Fxbrl_20200220155155053" unitRef="shares">72</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200220155201003" unitRef="shares">3794846</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20200220155214238" unitRef="shares">354996</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassACommonStockSharesMember" decimals="INF" id="Fxbrl_20200220161415701" unitRef="shares">72</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200220161514132" unitRef="shares">6843780</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_WarrantsMember" decimals="INF" id="Fxbrl_20200220161552440" unitRef="shares">546212</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="INF" id="Fxbrl_20200220163143722" unitRef="shares">72</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200220163216811" unitRef="shares">7905727</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20200220163319912" unitRef="shares">467451</ifrs-full:NumberOfSharesOutstanding>
  <huge:IssuanceOfShares contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200220155759265" unitRef="shares">2268035</huge:IssuanceOfShares>
  <huge:IssuanceOfShares contextRef="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200220161743109" unitRef="shares">408651</huge:IssuanceOfShares>
  <ifrs-full:IssueOfEquity contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220155830624" unitRef="CAD">47853745</ifrs-full:IssueOfEquity>
  <ifrs-full:IssueOfEquity contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220155911792" unitRef="CAD">47853745</ifrs-full:IssueOfEquity>
  <ifrs-full:IssueOfEquity contextRef="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220161831522" unitRef="CAD">11539417</ifrs-full:IssueOfEquity>
  <ifrs-full:IssueOfEquity contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220161851177" unitRef="CAD">11539417</ifrs-full:IssueOfEquity>
  <ifrs-full:ShareIssueRelatedCost contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220160015855" unitRef="CAD">6634405</ifrs-full:ShareIssueRelatedCost>
  <ifrs-full:ShareIssueRelatedCost contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220160036567" unitRef="CAD">6634405</ifrs-full:ShareIssueRelatedCost>
  <huge:IncreaseDecreaseThroughReverseAcquisitionShares contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200220160107355" unitRef="shares">545505</huge:IncreaseDecreaseThroughReverseAcquisitionShares>
  <huge:IncreaseDecreaseThroughReverseAcquisitionShares contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_WarrantsMember" decimals="INF" id="Fxbrl_20200220160136750" unitRef="shares">37313</huge:IncreaseDecreaseThroughReverseAcquisitionShares>
  <huge:IncreaseDecreaseThroughReverseAcquisition contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220160121927" unitRef="CAD">9868179</huge:IncreaseDecreaseThroughReverseAcquisition>
  <huge:IncreaseDecreaseThroughReverseAcquisition contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_WarrantsMember" decimals="0" id="Fxbrl_20200220160229561" unitRef="CAD">118875</huge:IncreaseDecreaseThroughReverseAcquisition>
  <huge:IncreaseDecreaseThroughReverseAcquisition contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20200220160302464" unitRef="CAD">25725</huge:IncreaseDecreaseThroughReverseAcquisition>
  <huge:IncreaseDecreaseThroughReverseAcquisition contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220160327119" unitRef="CAD">10012779</huge:IncreaseDecreaseThroughReverseAcquisition>
  <huge:IncreaseDecreaseThroughWarrantValuations contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220160343116" unitRef="CAD">-2366670</huge:IncreaseDecreaseThroughWarrantValuations>
  <huge:IncreaseDecreaseThroughWarrantValuations contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_WarrantsMember" decimals="0" id="Fxbrl_20200220160428870" unitRef="CAD">2366670</huge:IncreaseDecreaseThroughWarrantValuations>
  <huge:IncreaseDecreaseThroughWarrantValuationsShares contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_WarrantsMember" decimals="INF" id="Fxbrl_20200220160355144" unitRef="shares">198835</huge:IncreaseDecreaseThroughWarrantValuationsShares>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_WarrantsMember" decimals="0" id="Fxbrl_20200220160515940" unitRef="CAD">294287</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20200220160542799" unitRef="CAD">6146119</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220160557038" unitRef="CAD">6440406</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20200220162029828" unitRef="CAD">16061319</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220162051607" unitRef="CAD">16061319</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <huge:IncreaseDecreaseThroughExerciseOfOptionShares contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200220160617429" unitRef="shares">190463</huge:IncreaseDecreaseThroughExerciseOfOptionShares>
  <huge:IncreaseDecreaseThroughExerciseOfOptionShares contextRef="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200220162107532" unitRef="shares">130189</huge:IncreaseDecreaseThroughExerciseOfOptionShares>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220160639229" unitRef="CAD">5145825</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20200220160700188" unitRef="CAD">-2288775</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220160722698" unitRef="CAD">2857050</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220162126055" unitRef="CAD">1782438</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20200220162144703" unitRef="CAD">-1049840</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220162203260" unitRef="CAD">732598</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <huge:IncreaseDecreaseThroughStockOptionsCancelled contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20200220160745114" unitRef="CAD">-401069</huge:IncreaseDecreaseThroughStockOptionsCancelled>
  <huge:IncreaseDecreaseThroughStockOptionsCancelled contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_RetainedEarningsMember" decimals="0" id="Fxbrl_20200220160811134" unitRef="CAD">401069</huge:IncreaseDecreaseThroughStockOptionsCancelled>
  <huge:IncreaseDecreaseThroughExerciseOfWarrantsShares contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200220160837071" unitRef="shares">44931</huge:IncreaseDecreaseThroughExerciseOfWarrantsShares>
  <huge:IncreaseDecreaseThroughExerciseOfWarrantsShares contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_WarrantsMember" decimals="INF" id="Fxbrl_20200220161040382" unitRef="shares">-44932</huge:IncreaseDecreaseThroughExerciseOfWarrantsShares>
  <huge:IncreaseDecreaseThroughExerciseOfWarrantsShares contextRef="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200220162219502" unitRef="shares">12167</huge:IncreaseDecreaseThroughExerciseOfWarrantsShares>
  <huge:IncreaseDecreaseThroughExerciseOfWarrantsShares contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20200220162303555" unitRef="shares">-12167</huge:IncreaseDecreaseThroughExerciseOfWarrantsShares>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfShareCapitalAxis_ClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220161011747" unitRef="CAD">1254665</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ComponentsOfEquityAxis_WarrantsMember" decimals="0" id="Fxbrl_20200220161143365" unitRef="CAD">-454587</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220161216918" unitRef="CAD">800078</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220162243061" unitRef="CAD">145174</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20200220162347565" unitRef="CAD">-50183</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220162516660" unitRef="CAD">94991</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares contextRef="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200220164843884" unitRef="shares">510940</huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares>
  <huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20200220164920883" unitRef="shares">67598</huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares>
  <huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset contextRef="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200220164859723" unitRef="CAD">16431818</huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset>
  <huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20200220165008286" unitRef="CAD">1888086</huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset>
  <huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20200220165019791" unitRef="CAD">2567306</huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset>
  <huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220165031919" unitRef="CAD">20887210</huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset>
  <huge:IncreaseDecreaseThroughExpiryOfWarrantsShares contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20200220162547560" unitRef="shares">-134192</huge:IncreaseDecreaseThroughExpiryOfWarrantsShares>
  <huge:IncreaseDecreaseThroughExpiryOfWarrantsValue contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20200220162613512" unitRef="CAD">-535014</huge:IncreaseDecreaseThroughExpiryOfWarrantsValue>
  <huge:IncreaseDecreaseThroughExpiryOfWarrantsValue contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20200229164613633" unitRef="CAD">535014</huge:IncreaseDecreaseThroughExpiryOfWarrantsValue>
  <huge:DisclosureOfNatureOfBusinessExplanatoryTextBlock contextRef="C_20190101to20191231" id="Fxbrl_20200220010705019">&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;span style="width:10.49pt;text-indent:0pt;display:inline-block"&gt; &lt;/span&gt;&lt;strong&gt;Nature of business&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;FSD Pharma Inc. ("FSD" or the "Company"), through their wholly owned subsidiary, FV Pharma Inc. ("FV Pharma"), is a licensed producer of cannabis in Canada under the Cannabis Act (Canada) (together with the regulations promulgated thereunder (the "Cannabis Regulations"), the "Cannabis Act") and associated Cannabis Regulations. FV Pharma is focused on producing and extracting high-quality, hydroponic, pharmaceutical-grade cannabis leaf. The Company, through the their wholly owned subsidiary Prismic Pharmaceuticals Inc. ("Prismic"), is focused on bioscience, including research and development ("R&amp;amp;D") and clinical development of synthetic cannabinoid based treatments of certain disease conditions with an aim to improve patient outcomes. The Company's goal is for these compounds to be approved by the FDA and other international regulatory agencies as prescription medications.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company was incorporated under the provisions of the Business Corporations Act (Ontario) (the "OBCA") on November 1, 1998, pursuant to the amalgamation of Olympic ROM World Inc., 1305206 Ontario Corporation, 1305207 Ontario Inc., Century Financial Capital Group Inc. and Dunberry Graphic Associates Ltd. On May 24, 2018, pursuant to the Articles of Amendment, the Company changed its name to "FSD Pharma Inc.".&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's registered office is located at 1 Rossland Road West, Suite 202, Ajax, Ontario, L1Z 1Z2.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares. All share and per share amounts for all periods presented in these financial statements have been adjusted retrospectively to reflect the reverse share split.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Going concern uncertainty&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated financial statements of the Company for the years ended December 31, 2019 and 2018 (the "financial statements") have been prepared on the basis of accounting principles applicable to a going concern, which assumes that the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities and commitments in the normal course of operations. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that would be necessary should the Company be unable to continue as a going concern. Such adjustments could be material.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company is in the preliminary stages of its planned operations and has not yet determined whether its processes and business plans are economically viable. The continued operations of the Company and the recoverability of amounts shown for property and equipment and intangible assets are dependent upon the ability of the Company to obtain sufficient financing to continue its cultivation and production processes and complete the pharmaceutical research and development program centered on the lead asset, micro-palmitoylethanolamide ("micro-PEA").&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at December 31, 2019, the Company has an accumulated deficit of $78.5&amp;#160;million, a net loss of $52&amp;#160;million and a working capital surplus of $2.3 million. Whether, and when, the Company can attain profitability and positive cash flows from operations is subject to material uncertainty. The application of the going concern assumption is dependent upon the Company's ability to generate future profitable operations and obtain necessary financing to do so. The Company will need to raise additional capital in order to fund its planned operations and meet its obligations. While the Company has been successful in obtaining financing to date and believes it will be able to obtain sufficient funds in the future and ultimately achieve profitability and positive cash flows from operations, there can be no assurance that the Company will achieve profitability and be able to do so on terms favourable for the Company. &lt;/span&gt;&lt;/span&gt;The above events and conditions indicate there is a material uncertainty that casts significant doubt about the Company&amp;#x2019;s ability to continue as a going concern.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Subsidiaries&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These financial statements are comprised of the financial results of the Company and its subsidiaries, which are the entities over which FSD has control. An investor controls an investee when it is exposed, or has rights, to variable returns from its involvement with the investee and can affect those returns through its power over the investee.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify;margin-left:2.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-align:start;text-indent:0px;-webkit-text-stroke-width:0px"&gt;&lt;span style="color:#000000"&gt;&lt;span&gt;&lt;span style="font-style:normal"&gt;&lt;span style="font-variant-ligatures:normal"&gt;&lt;span style="font-variant-caps:normal"&gt;&lt;span style="font-weight:400"&gt;&lt;span style="letter-spacing:normal"&gt;&lt;span style="orphans:2"&gt;&lt;span style="text-transform:none"&gt;&lt;span style="white-space:normal"&gt;&lt;span style="widows:2"&gt;&lt;span style="word-spacing:0px"&gt;&lt;span style="text-decoration-style:initial"&gt;&lt;span style="text-decoration-color:initial"&gt;&lt;span style="display:inline"&gt;&lt;span style="float:none"&gt;The Company has the following subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Ownership&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Ownership&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;percentage&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;percentage&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Entity Name&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Country&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;December 31, 2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:2.25pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;FV Pharma Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:2.25pt;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Prismic Pharmaceuticals Inc.&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;USA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</huge:DisclosureOfNatureOfBusinessExplanatoryTextBlock>
  <huge:WorkingCapitalSurplus contextRef="C_20191231" decimals="-5" id="Fxbrl_20200228103241897" unitRef="CAD">2300000</huge:WorkingCapitalSurplus>
  <ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220013139167">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Ownership&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Ownership&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;percentage&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;percentage&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Entity Name&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Country&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;December 31, 2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:2.25pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;FV Pharma Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:2.25pt;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Prismic Pharmaceuticals Inc.&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;USA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="C_20190101to20191231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember" id="Fxbrl_20200220015051516">Canada</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="C_20190101to20191231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesTwoMember" id="Fxbrl_20200220015115020">USA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="C_20190101to20191231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember" decimals="2" id="Fxbrl_20200220015201796" unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember" decimals="2" id="Fxbrl_20200220015220277" unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="C_20190101to20191231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesTwoMember" decimals="2" id="Fxbrl_20200220015233496" unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228104752085">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;span style="width:10.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Basis of presentation &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;[a] Statement of compliance &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These financial statements have been prepared by management in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB"). The policies set out below have been consistently applied to all periods presented, unless otherwise noted. Certain comparative figures have been reclassified to conform to the current year's presentation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These financial statements were approved and authorized for issuance by the Board of Directors of the Company on March 3, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;[b] Basis of measurement&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These financial statements have been prepared on a historical cost basis. Historical costs are generally based upon the fair value of the consideration given in exchange for goods and services.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, regardless of whether that price is directly observable or estimated using another valuation technique. In estimating the fair value of an asset or a liability, the Company takes into account the characteristics of the asset or liability if market participants would take those characteristics into account when pricing the asset or liability at the measurement date. Fair value for measurement and/or disclosure purposes in these financial statements is determined on such a basis, except for share-based payment transactions that are within the scope of IFRS 2 &lt;i&gt;Share-based Payment&lt;/i&gt; ("IFRS 2") and measurements that have some similarities to fair value, but are not fair value, such as value in use in IAS 36 &lt;i&gt;Impairment of Assets&lt;/i&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;[c] Basis of presentation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The accompanying financial statements include the accounts of FSD and its subsidiaries, FV Pharma and Prismic. The financial statements incorporate the assets and liabilities of the Company and its subsidiaries as at December 31, 2019 and 2018 and the results of these subsidiaries for the years then ended.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. All intra-entity assets and liabilities, revenue, expenses and cash flows relating to transactions between subsidiaries of the Company are eliminated in full on consolidation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;[d] Functional currency and presentation currency&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These financial statements are presented in Canadian dollars, which is the functional currency of the Company. The functional currencies of the Company's wholly owned subsidiaries is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:50%;border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;FV Pharma&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Canadian Dollars&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prismic&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United States Dollars&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin-top:0pt;text-align:justify"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-left:21.25pt;text-indent:-21.25pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;[e] Use of estimates and judgments&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of these financial statements in conformity with IFRS requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities as at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following are the critical judgments, apart from those involving estimations, that management has made in the process of applying the Company's accounting policies and that have the most significant effect on the amounts recognized in the financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[i]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Going concern&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At each reporting period, management assesses the basis of preparation of the financial statements. These financial statements have been prepared on a going concern basis in accordance with IFRS. The going concern basis of presentation assumes that the Company will continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in the normal course of business.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[ii]&lt;span style="width:9pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Estimated useful lives, residual values and depreciation of property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation of property, plant and equipment is dependent upon estimates of useful lives and residual values, which are determined through the exercise of judgment. The assessment of any impairment of these assets' is dependent upon estimates of recoverable amounts that take into account factors such as economic and market conditions and the useful lives of assets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[iii]&lt;span style="width:7pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Biological assets and inventory&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In calculating the value of the biological assets and inventory, management is required to make a number of estimates, including estimating the stage of growth of the cannabis up to the point of harvest, harvesting costs, selling costs, expected selling and list prices and expected yields for the cannabis plants. In assessing the recoverability of final inventory values, management compares the inventory cost to estimated net realizable value. Further information on estimates used in determining the fair value of biological assets is contained in Note 8.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[iv]&lt;span style="width:6.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Estimated useful life and amortization of intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company employs significant estimates to determine the estimated useful lives of intangible assets, considering the nature of the asset, contractual rights, expected use and review of asset useful lives. The Company reviews amortization methods and useful lives annually or when circumstances change and adjusts its amortization methods and assumptions prospectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[v]&lt;span style="width:8.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Impairment of property, plant and equipment and intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Impairment testing requires management to make estimates related to future cash flow projections and market trends. Impairment of property, plant and equipment and intangible assets is influenced by judgment in defining a cash generating unit and determining the indicators of impairment and estimates used to measure impairment losses.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[vi]&lt;span style="width:6.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Valuation of share-based payments and warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Management measures the costs for share-based payments and warrants using market-based option valuation techniques. Assumptions are made and estimates are used in applying the valuation techniques. These include estimating the future volatility of the share price, expected dividend yield, expected term, expected risk-free interest rate and the rate of forfeiture. Such estimates and assumptions are inherently uncertain. Changes in these assumptions affect the fair value estimates of share-based payments and warrants.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[vii]&lt;span style="width:4.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Valuation of private company investments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The financial information of private companies may not always be available, or such information may be insufficient or unreliable for valuation purposes. In determining the fair value of shares held in private company investments, management is required to make certain estimates and assumptions regarding the fair value as of the reporting date. Assumptions are made and estimates are used in applying the valuation techniques to determine fair value. These include the most recently available financial statements of the investee, price for most recently completed financing, as well as closely comparable public companies and general market and economic conditions. Such investments are classified as Level 3 within the fair value hierarchy. The value at which the Company could ultimately realize upon disposition of these investments may differ from their carrying value and such differences could be material.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[viii]&lt;span style="width:6.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Asset acquisition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In the acquisition of Prismic on June 28, 2019 judgment was required to determine if the acquisition represented either a business combination or an asset purchase. Management concluded that Prismic did not represent a business as the assets acquired were not an integrated set of activities with inputs, processes and outputs. Since it was concluded that the acquisition represented the purchase of assets, there was no goodwill recognized on the transaction and acquisition costs were capitalized to the assets purchased rather than expensed. The fair values of the net assets acquired were determined using estimates and judgments. Refer to Note 5 for additional information on the Company's asset acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
  <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220043929745">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;span style="width:10.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Significant accounting policies&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[a]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash consists of cash and cash held in trust accounts. There are no restrictions on cash held in trust.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[b]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment is measured at cost less accumulated depreciation and impairment losses, with the exception of land which is not depreciated.&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;When parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) of property, plant and equipment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The cost of replacing part of an item of property, plant and equipment is recognized in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Company and its cost can be measured reliably. The carrying amount of the replaced part is derecognized. The costs of the day-to-day servicing of property, plant and equipment are recognized in consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent costs are included in the asset's carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount, and are recognized net within other income in the consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation is based on the estimated useful lives of the assets provided as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="margin-left:auto;border-collapse:collapse;font-size:10pt;width:90%;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Production equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Facility and related&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20 years under straight-line&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Land&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Not amortized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An item of property, plant and equipment and any significant part initially recognized are derecognized upon disposal or when no future economic benefits are expected from their use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated statements of loss and comprehensive loss when the asset is derecognized. The assets' residual values, useful lives and methods of depreciation and the depreciation charge are adjusted prospectively, if appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[c]&lt;span style="width:8.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Finite-lived Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finite-lived intangible assets are recorded at cost less accumulated amortization and accumulated impairment losses. Amortization is recognized in profit or loss on a straight-line basis over the following terms:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;
              &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="margin-left:auto;border-collapse:collapse;font-size:10pt;width:90%;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intellectual Property&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
              &lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[d]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Revenue Recognition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's accounting policy for revenue recognition under IFRS 15, Revenue from Contracts with Customers ("IFRS 15") is to follow a five step model to determine the amount and timing of revenue to be recognized i) identify the contract with a customer; ii) identify the performance obligations in the contract; iii) determine the transaction price; iv) allocate the transaction price to the performance obligations in the contract; and v) recognize revenue when (or as) the Company satisfies a performance obligation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue from the sale of cannabis is recognized when the Company transfers control of the good to the customer. This is generally considered to have occurred when products have been delivered to the location specified in the sales contract and accepted by the customer.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive taking into account any variation that may result from rights of return.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company is required to remit excise tax to the Canada Revenue Agency on the sale of medical cannabis in Canada. The Company becomes liable for these excise duties when cannabis products are delivered to the customer. In accordance with IFRS 15, revenue presented on the Consolidated Statements of Loss and Comprehensive Loss, represents revenue from the sale of goods less applicable excise tax.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Areas of judgment include identifying the customer per the definition within IFRS 15 and determining whether control has passed to the customer.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[e]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Foreign Currency Translation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transactions are translated into Canadian dollars at exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies at the statement of financial position date are translated to Canadian dollars at the foreign exchange rate applicable at that date. Realized and unrealized exchange gains and losses are recognized through profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The assets and liabilities of foreign operations with functional currencies other than Canadian dollars, are translated into Canadian dollars at year-end exchange rates. Income and expenses, and cash flows of such foreign operations are translated into Canadian dollars using average exchange rates for the period. Exchange differences resulting from translating foreign operations are recognized in other comprehensive loss&amp;#160;and accumulated in equity.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[f]&lt;span style="width:10.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the instruments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognized immediately in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On initial recognition, a financial asset is classified as measured at amortized cost, fair value through other comprehensive income (''FVOCI''), or fair value through profit and loss (''FVTPL''). The classification of financial assets is based on the business model in which a financial asset is managed and its contractual cash flow characteristics.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;ul style="padding-left:0pt" type="disc"&gt;&lt;li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;It is held within a business model whose objective is to hold assets to collect contractual cash flows; and&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A financial asset (unless it is a trade receivable without a significant financing component that is initially measured at the transaction price) is initially measured at fair value plus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following accounting policies apply to the subsequent measurement of financial assets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="margin-left:36.65pt;border:0.75pt solid #000000;border-collapse:collapse;font-size:10pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-right:0.75pt solid #000000;border-bottom:0.75pt solid #000000"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets at FVTPL&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-right:0.75pt solid #000000"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets at amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-left:0.75pt solid #000000"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequently measured at amortized cost using the effective interest method, less any impairment losses. Interest income, foreign exchange gains and losses and impairment losses are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company initially recognizes financial liabilities at fair value on the date at which the Company becomes a party to the contractual provisions of the instrument.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies its financial liabilities as either financial liabilities at FVTPL or amortized cost.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent to initial recognition, other liabilities are measured at amortized cost using the effective interest method. Financial liabilities at FVTPL are stated at fair value with changes being recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial liabilities and equity instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Classification as debt or equity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:72pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Debt and equity instruments issued by the Company are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Equity instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:72pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Equity instruments issued by a group entity are recognized at the proceeds received, net of direct issue costs.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:72pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Repurchase of the Company's own equity instruments is recognized and deducted directly in equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the Company's own equity instruments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Classification of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies its financial assets and liabilities depending on the purpose for which the financial instruments were acquired, their characteristics and management intent as outlined below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Classification&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:70%;border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other investments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value through profit or loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative liability&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value through profit or loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin-top:0pt;margin-left:36pt;margin-bottom:0pt;text-align:justify"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Impairment of financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An expected credit loss ("ECL") model applies to financial assets measured at amortized cost. The Company's financial assets measured at amortized cost and subject to the ECL model consist primarily of trade and other receivables. The Company applies the simplified approach to impairment for trade and other receivables by recognizing a loss allowance based on lifetime expected losses at each reporting date taking into considerations historical credit loss experience and financial factors specific to the debtors and general economic conditions. The Company has assessed the impairment of its trade and other receivables using the expected credit loss model, and no material difference was noted.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[g]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Biological Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's biological assets consist of cannabis plants. The Company capitalizes the direct and indirect costs incurred related to the biological transformation of the biological assets between the point of initial recognition and the point of harvest. The Company then measures the biological assets at fair value less cost to sell up to the point of harvest, which becomes the basis for the cost of inventory after harvest. This is determined using a model that estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount by the expected selling price less costs to sell per gram. The net unrealized gains or losses arising from changes in fair value less cost to sell during the year are included in the results of operations of the related period.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;[h]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory of harvested work-in-process and finished goods are valued at the lower of cost and net realizable value. Inventory of harvested cannabis is transferred from biological assets at their fair value at harvest, which becomes the initial deemed cost. Any subsequent post-harvest costs are capitalized to inventory to the extent that cost is less than net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Inventory for supplies and consumables are valued at the lower of cost and net realizable value, with cost determined using the average cost basis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[i]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-lived assets, including property, plant and equipment and intangible assets are tested for impairment when there are indicators of impairment at each reporting date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. Intangible assets with an indefinite useful life are tested for impairment at least annually in the fourth quarter and whenever there is an indication that the asset may be impaired.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in net&amp;#160;loss&amp;#160;equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[j]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax expense comprises of current and deferred tax. Current tax and deferred tax are recognized in net profit or loss except to the extent that it relates to a business combination or items recognized directly in equity or in other comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current income taxes are recognized for the estimated income taxes payable or receivable on taxable income or loss for the current year and any adjustment to income taxes payable in respect of previous years. Current income taxes are determined using tax rates and tax laws that have been enacted or substantively enacted by the year-end date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax assets and liabilities are recognized where the carrying amount of an asset or liability differs from its tax base, except for taxable temporary differences arising on the initial recognition of goodwill and temporary differences arising on the initial recognition of an asset or liability in a transaction which is not a business combination and at the time of the transaction affects neither accounting nor taxable profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognition of deferred tax assets for unused tax losses, tax credits and deductible temporary differences is restricted to those instances where it is probable that future taxable profit will be available against which the deferred tax asset can be utilized. At the end of each reporting period, the Company reassesses unrecognized deferred tax assets. The Company recognizes a previously unrecognized deferred tax asset to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[k]&lt;span style="width:8.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Share-based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Stock options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Stock options and warrants awarded to employees are accounted for using the fair value method.&amp;#160; The fair value of such stock options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[l]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Net Loss per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss per share is calculated based on the loss for the financial year and the weighted average number of common shares outstanding during the year. Diluted net loss per share is calculated using the loss for the financial year adjusted for the effect of any dilutive instruments and the weighted average diluted number of shares [ignoring any potential issue of common shares that would be anti-dilutive] during the year.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;New standards, amendments and interpretations adopted by the Company&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;IFRS 16 - Leases ["IFRS 16"]&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has adopted IFRS 16 with an initial adoption date of January 1, 2019. The Company utilized the modified retrospective method to adopt the new standard and therefore, the comparative information has not been restated and continues to be reported under IAS 17, Leases and related interpretations.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IFRS 16 specifies how leases will be recognized, measured, presented and disclosed and it provides a single lessee model requiring lessees to recognize right-of-use assets and lease liabilities for all major leases. The Company's accounting policy under IFRS 16 is as follows.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of identified asset for a period of time in exchange for consideration. The Company recognized a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of the costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right-of-use assets are depreciated to the earlier of the end of useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of the consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset can be periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, and the Company's incremental borrowing rate. The Company used an incremental borrowing rate to measure the lease liabilities in the opening balance sheet at January 1, 2019 of 7.73%.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from the change in an index or rate, if there is a change in the Company's estimate of the amount expected to be payable under a residual value guarantee, or if the Company changes its assessment of whether it will exercise a purchase, extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, unless it has been reduced to zero.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has elected to apply the practical expedient not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less or to leases of low value assets when applicable. The lease payments associated with those leases is recognized as an expense on a straight-line basis over the lease term. The Company has also elected to apply the practical expedient to grandfather the assessment of which transactions are leases on the date of initial application, as previously assessed under IAS 17 and IFRIC 4 Determining Whether an Arrangement Contains a Lease. The Company applied the definition of a lease under IFRS 16 to contracts entered into or changed on or after January 1, 2019.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On initial application, the Company has elected to record right-of-use assets at the amount of the corresponding lease liability. Right-of-use assets and lease obligations of $243,818 were recorded as at January 1, 2019. When measuring lease liabilities, the Company discounted lease payments using its incremental borrowing rate at January 1, 2019.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table reconciles the Company's operating lease obligations at December 31, 2018, as previously disclosed in the Company's audited financial statements for the year ended December 31, 2018, to the lease obligations recognized on initial application of IFRS 16 at January 1, 2019:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Aggregate lease commitments as disclosed at December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;315,528&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Adjustment to lease commitments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,528&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Impact of present value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(47,182&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Opening IFRS 16 lease obligation as at January 1, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;243,818&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company did not have any leases subject to the low-value or short-term lease recognition exemptions upon adoption of IFRS 16 and as at December 31, 2019.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="C_20190101to20191231" id="Fxbrl_20200228123600385">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[a]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash consists of cash and cash held in trust accounts. There are no restrictions on cash held in trust.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
  <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228123619688">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[b]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment is measured at cost less accumulated depreciation and impairment losses, with the exception of land which is not depreciated.&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;When parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) of property, plant and equipment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The cost of replacing part of an item of property, plant and equipment is recognized in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Company and its cost can be measured reliably. The carrying amount of the replaced part is derecognized. The costs of the day-to-day servicing of property, plant and equipment are recognized in consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent costs are included in the asset's carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount, and are recognized net within other income in the consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation is based on the estimated useful lives of the assets provided as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="margin-left:auto;border-collapse:collapse;font-size:10pt;width:90%;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Production equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Facility and related&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20 years under straight-line&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Land&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Not amortized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An item of property, plant and equipment and any significant part initially recognized are derecognized upon disposal or when no future economic benefits are expected from their use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated statements of loss and comprehensive loss when the asset is derecognized. The assets' residual values, useful lives and methods of depreciation and the depreciation charge are adjusted prospectively, if appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
  <huge:SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228124141142">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="margin-left:auto;border-collapse:collapse;font-size:10pt;width:90%;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"&gt;&lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Production equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Facility and related&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&amp;#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20 years under straight-line&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Land&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Not amortized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
              &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="margin-left:auto;border-collapse:collapse;font-size:10pt;width:90%;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intellectual Property&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
              </huge:SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" id="Fxbrl_20200228120644906">30%</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember" id="Fxbrl_20200228121743760">20%</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullFixturesAndFittingsMember" id="Fxbrl_20200228121716808">20%</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember" id="Fxbrl_20200228121634176">20 years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DepreciationMethodPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" id="Fxbrl_20200228120726268">declining balance</ifrs-full:DepreciationMethodPropertyPlantAndEquipment>
  <ifrs-full:DepreciationMethodPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember" id="Fxbrl_20200228121759024">declining balance</ifrs-full:DepreciationMethodPropertyPlantAndEquipment>
  <ifrs-full:DepreciationMethodPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullFixturesAndFittingsMember" id="Fxbrl_20200228121730088">declining balance</ifrs-full:DepreciationMethodPropertyPlantAndEquipment>
  <ifrs-full:DepreciationMethodPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember" id="Fxbrl_20200228121657093">straight-line</ifrs-full:DepreciationMethodPropertyPlantAndEquipment>
  <ifrs-full:DepreciationMethodPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember" id="Fxbrl_20200228121615785">Not amortized</ifrs-full:DepreciationMethodPropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228123647456">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[c]&lt;span style="width:8.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Finite-lived Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finite-lived intangible assets are recorded at cost less accumulated amortization and accumulated impairment losses. Amortization is recognized in profit or loss on a straight-line basis over the following terms:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;
              &lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="margin-left:auto;border-collapse:collapse;font-size:10pt;width:90%;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intellectual Property&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
              &lt;/div&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
  <ifrs-full:DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill contextRef="C_20190101to20191231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" id="Fxbrl_20200228121542124">5 years</ifrs-full:DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue contextRef="C_20190101to20191231" id="Fxbrl_20200228123711854">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[d]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Revenue Recognition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's accounting policy for revenue recognition under IFRS 15, Revenue from Contracts with Customers ("IFRS 15") is to follow a five step model to determine the amount and timing of revenue to be recognized i) identify the contract with a customer; ii) identify the performance obligations in the contract; iii) determine the transaction price; iv) allocate the transaction price to the performance obligations in the contract; and v) recognize revenue when (or as) the Company satisfies a performance obligation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue from the sale of cannabis is recognized when the Company transfers control of the good to the customer. This is generally considered to have occurred when products have been delivered to the location specified in the sales contract and accepted by the customer.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive taking into account any variation that may result from rights of return.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company is required to remit excise tax to the Canada Revenue Agency on the sale of medical cannabis in Canada. The Company becomes liable for these excise duties when cannabis products are delivered to the customer. In accordance with IFRS 15, revenue presented on the Consolidated Statements of Loss and Comprehensive Loss, represents revenue from the sale of goods less applicable excise tax.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Areas of judgment include identifying the customer per the definition within IFRS 15 and determining whether control has passed to the customer.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
  <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228123728743">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[e]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Foreign Currency Translation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transactions are translated into Canadian dollars at exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies at the statement of financial position date are translated to Canadian dollars at the foreign exchange rate applicable at that date. Realized and unrealized exchange gains and losses are recognized through profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The assets and liabilities of foreign operations with functional currencies other than Canadian dollars, are translated into Canadian dollars at year-end exchange rates. Income and expenses, and cash flows of such foreign operations are translated into Canadian dollars using average exchange rates for the period. Exchange differences resulting from translating foreign operations are recognized in other comprehensive loss&amp;#160;and accumulated in equity.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228123756998">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[f]&lt;span style="width:10.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the instruments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognized immediately in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On initial recognition, a financial asset is classified as measured at amortized cost, fair value through other comprehensive income (''FVOCI''), or fair value through profit and loss (''FVTPL''). The classification of financial assets is based on the business model in which a financial asset is managed and its contractual cash flow characteristics.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;ul style="padding-left:0pt" type="disc"&gt;&lt;li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;It is held within a business model whose objective is to hold assets to collect contractual cash flows; and&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A financial asset (unless it is a trade receivable without a significant financing component that is initially measured at the transaction price) is initially measured at fair value plus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following accounting policies apply to the subsequent measurement of financial assets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="margin-left:36.65pt;border:0.75pt solid #000000;border-collapse:collapse;font-size:10pt"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-right:0.75pt solid #000000;border-bottom:0.75pt solid #000000"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets at FVTPL&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-right:0.75pt solid #000000"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets at amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-left:0.75pt solid #000000"&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequently measured at amortized cost using the effective interest method, less any impairment losses. Interest income, foreign exchange gains and losses and impairment losses are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company initially recognizes financial liabilities at fair value on the date at which the Company becomes a party to the contractual provisions of the instrument.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies its financial liabilities as either financial liabilities at FVTPL or amortized cost.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent to initial recognition, other liabilities are measured at amortized cost using the effective interest method. Financial liabilities at FVTPL are stated at fair value with changes being recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial liabilities and equity instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Classification as debt or equity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:72pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Debt and equity instruments issued by the Company are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Equity instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:72pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Equity instruments issued by a group entity are recognized at the proceeds received, net of direct issue costs.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:72pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Repurchase of the Company's own equity instruments is recognized and deducted directly in equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the Company's own equity instruments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Classification of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies its financial assets and liabilities depending on the purpose for which the financial instruments were acquired, their characteristics and management intent as outlined below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Classification&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="width:70%;border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other investments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value through profit or loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative liability&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value through profit or loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="margin-top:0pt;margin-left:36pt;margin-bottom:0pt;text-align:justify"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Impairment of financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An expected credit loss ("ECL") model applies to financial assets measured at amortized cost. The Company's financial assets measured at amortized cost and subject to the ECL model consist primarily of trade and other receivables. The Company applies the simplified approach to impairment for trade and other receivables by recognizing a loss allowance based on lifetime expected losses at each reporting date taking into considerations historical credit loss experience and financial factors specific to the debtors and general economic conditions. The Company has assessed the impairment of its trade and other receivables using the expected credit loss model, and no material difference was noted.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228123820103">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[g]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Biological Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's biological assets consist of cannabis plants. The Company capitalizes the direct and indirect costs incurred related to the biological transformation of the biological assets between the point of initial recognition and the point of harvest. The Company then measures the biological assets at fair value less cost to sell up to the point of harvest, which becomes the basis for the cost of inventory after harvest. This is determined using a model that estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount by the expected selling price less costs to sell per gram. The net unrealized gains or losses arising from changes in fair value less cost to sell during the year are included in the results of operations of the related period.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories contextRef="C_20190101to20191231" id="Fxbrl_20200228123837927">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;[h]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory of harvested work-in-process and finished goods are valued at the lower of cost and net realizable value. Inventory of harvested cannabis is transferred from biological assets at their fair value at harvest, which becomes the initial deemed cost. Any subsequent post-harvest costs are capitalized to inventory to the extent that cost is less than net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Inventory for supplies and consumables are valued at the lower of cost and net realizable value, with cost determined using the average cost basis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
  <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228141157503">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[i]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-lived assets, including property, plant and equipment and intangible assets are tested for impairment when there are indicators of impairment at each reporting date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. Intangible assets with an indefinite useful life are tested for impairment at least annually in the fourth quarter and whenever there is an indication that the asset may be impaired.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in net&amp;#160;loss&amp;#160;equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228123901502">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[j]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax expense comprises of current and deferred tax. Current tax and deferred tax are recognized in net profit or loss except to the extent that it relates to a business combination or items recognized directly in equity or in other comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current income taxes are recognized for the estimated income taxes payable or receivable on taxable income or loss for the current year and any adjustment to income taxes payable in respect of previous years. Current income taxes are determined using tax rates and tax laws that have been enacted or substantively enacted by the year-end date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax assets and liabilities are recognized where the carrying amount of an asset or liability differs from its tax base, except for taxable temporary differences arising on the initial recognition of goodwill and temporary differences arising on the initial recognition of an asset or liability in a transaction which is not a business combination and at the time of the transaction affects neither accounting nor taxable profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognition of deferred tax assets for unused tax losses, tax credits and deductible temporary differences is restricted to those instances where it is probable that future taxable profit will be available against which the deferred tax asset can be utilized. At the end of each reporting period, the Company reassesses unrecognized deferred tax assets. The Company recognizes a previously unrecognized deferred tax asset to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228123918766">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[k]&lt;span style="width:8.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Share-based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Stock options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Stock options and warrants awarded to employees are accounted for using the fair value method.&amp;#160; The fair value of such stock options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228123950094">&lt;div&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[l]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Net Loss per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss per share is calculated based on the loss for the financial year and the weighted average number of common shares outstanding during the year. Diluted net loss per share is calculated using the loss for the financial year adjusted for the effect of any dilutive instruments and the weighted average diluted number of shares [ignoring any potential issue of common shares that would be anti-dilutive] during the year.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
  <huge:DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228124006188">&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;New standards, amendments and interpretations adopted by the Company&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;IFRS 16 - Leases ["IFRS 16"]&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has adopted IFRS 16 with an initial adoption date of January 1, 2019. The Company utilized the modified retrospective method to adopt the new standard and therefore, the comparative information has not been restated and continues to be reported under IAS 17, Leases and related interpretations.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IFRS 16 specifies how leases will be recognized, measured, presented and disclosed and it provides a single lessee model requiring lessees to recognize right-of-use assets and lease liabilities for all major leases. The Company's accounting policy under IFRS 16 is as follows.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of identified asset for a period of time in exchange for consideration. The Company recognized a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of the costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right-of-use assets are depreciated to the earlier of the end of useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of the consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset can be periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, and the Company's incremental borrowing rate. The Company used an incremental borrowing rate to measure the lease liabilities in the opening balance sheet at January 1, 2019 of 7.73%.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from the change in an index or rate, if there is a change in the Company's estimate of the amount expected to be payable under a residual value guarantee, or if the Company changes its assessment of whether it will exercise a purchase, extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, unless it has been reduced to zero.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has elected to apply the practical expedient not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less or to leases of low value assets when applicable. The lease payments associated with those leases is recognized as an expense on a straight-line basis over the lease term. The Company has also elected to apply the practical expedient to grandfather the assessment of which transactions are leases on the date of initial application, as previously assessed under IAS 17 and IFRIC 4 Determining Whether an Arrangement Contains a Lease. The Company applied the definition of a lease under IFRS 16 to contracts entered into or changed on or after January 1, 2019.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On initial application, the Company has elected to record right-of-use assets at the amount of the corresponding lease liability. Right-of-use assets and lease obligations of $243,818 were recorded as at January 1, 2019. When measuring lease liabilities, the Company discounted lease payments using its incremental borrowing rate at January 1, 2019.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table reconciles the Company's operating lease obligations at December 31, 2018, as previously disclosed in the Company's audited financial statements for the year ended December 31, 2018, to the lease obligations recognized on initial application of IFRS 16 at January 1, 2019:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Aggregate lease commitments as disclosed at December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;315,528&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Adjustment to lease commitments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,528&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Impact of present value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(47,182&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Opening IFRS 16 lease obligation as at January 1, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;243,818&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company did not have any leases subject to the low-value or short-term lease recognition exemptions upon adoption of IFRS 16 and as at December 31, 2019.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</huge:DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory>
  <huge:IncrementalBorrowingRateToDiscountLeaseLiabilities contextRef="C_20190101to20191231" decimals="4" id="Fxbrl_20200228121141315" unitRef="Pure">0.0773</huge:IncrementalBorrowingRateToDiscountLeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200228121106074" unitRef="CAD">243818</ifrs-full:LeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="C_20191231" decimals="0" id="Fxbrl_20200220135531565" unitRef="CAD">202869</ifrs-full:LeaseLiabilities>
  <ifrs-full:ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228124110643">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Aggregate lease commitments as disclosed at December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;315,528&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Adjustment to lease commitments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,528&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Impact of present value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(47,182&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Opening IFRS 16 lease obligation as at January 1, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;243,818&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory>
  <ifrs-full:GrossLoanCommitments contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200228121254726" unitRef="CAD">315528</ifrs-full:GrossLoanCommitments>
  <huge:AdjustmentToLeaseCommitments contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200228121323330" unitRef="CAD">-24528</huge:AdjustmentToLeaseCommitments>
  <huge:ImpactOfPresentValueOnLeaseObligations contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200228121351479" unitRef="CAD">-47182</huge:ImpactOfPresentValueOnLeaseObligations>
  <huge:DisclosureOfReverseTakeoverTransactionExplanatory contextRef="C_20190101to20191231" id="F9fd8c7a1-52f9-11ea-80c4-2d332cd66d90">&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.&lt;span style="width:28.5pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Reverse Takeover Transaction&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Century Financial Capital Group Inc. ("Century") and FV Pharma executed a definitive business combination agreement on March 9, 2018 (the "Definitive Agreement"), whereby FV Pharma would be combined with Century to continue the business of FV Pharma.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the terms of the Definitive Agreement, the Transaction was completed by way of a "three-cornered amalgamation" pursuant to the provisions of the Business Corporations Act (Ontario), whereby 2620756 Ontario Inc., a wholly-owned subsidiary of Century, amalgamated with FV Pharma (the "Amalgamation"), and the amalgamated entity is now a wholly-owned subsidiary of the Company (the "Transaction").&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to the terms of the Definitive Agreement and in connection with the Amalgamation:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify;text-indent:-18pt;margin-left:36pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:14.25pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Century amended its articles to: (i) amend and designate its outstanding common shares (the "Existing Century Shares") as Class B subordinate voting shares (the "Century Class B Shares"); and (ii) create a new class of Class A multiple voting shares (the "Century Class A Shares");&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify;text-indent:-18pt;margin-left:36pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:14.25pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;holders of outstanding Class A common voting shares of FV Pharma (the "FV Class A Shares") received one (1) Century Class A Share for each one (1) FV Class A Share held;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:14.25pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;holders of outstanding Class B common non-voting shares of FV Pharma (the "FV Class B Shares" and, together with the FV Class A Shares, the "FV Shares"), including FV Class B Shares issued on conversion of the Subscription Receipts, received one (1) Century Class B Share for each one (1) FV Class B Share held; and&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:14.25pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;all outstanding options to purchase FV Pharma Class B shares and options to purchase Century shares were exchanged, on an equivalent basis, for options to purchase Class B shares of the Company, and all outstanding warrants to purchase FV Pharma Class B Shares and warrants to purchase Century shares were exchanged, on an equivalent basis, for warrants to purchase Class B shares of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Transaction has been accounted for as a "reverse takeover" as the issuance of shares to the former shareholders of FV Pharma resulted in the former shareholders of FV Pharma holding a majority of the issued and outstanding shares of the Company. Under this method of accounting, FV Pharma (the legal subsidiary) is deemed to be the acquirer and Century (the legal parent) is deemed to be the acquired company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</huge:DisclosureOfReverseTakeoverTransactionExplanatory>
  <ifrs-full:DisclosureOfBusinessCombinationsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220061908014">&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5&lt;strong&gt;.&lt;/strong&gt;&lt;span style="width:10.5pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Acquisition of Prismic Pharmaceutical&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On June 28, 2019, the Company closed the acquisition of Prismic by acquiring all of the issued and outstanding Prismic Shares from the holders thereof. Prismic is a U.S.-based specialty research and development pharmaceutical company that is developing non-addictive prescription drugs for the treatment of pain and inflammation. Prismic's goal is to address the opioid crisis based on formulations utilizing micro-PEA's complimentary effect on certain drugs used to impact the body's endocannabinoid system.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;It was determined that the acquisition of Prismic did not qualify as a business combination in accordance with IFRS 3 &lt;i&gt;Business Combinations &lt;/i&gt;["IFRS 3"] and therefore it was accounted for as an asset acquisition. The individual identifiable assets acquired and liabilities assumed were identified and the purchase consideration was allocated based on the relative fair values of the acquired assets and assumed liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The total consideration for the purchase of Prismic was&lt;span&gt;&lt;span&gt; $20,887,209. &lt;/span&gt;&lt;/span&gt;The purchase consideration consisted of&lt;span&gt;&lt;span&gt; $16,431,818 &lt;/span&gt;&lt;/span&gt;of Class B subordinate voting shares,&lt;span&gt;&lt;span&gt; $2,567,305 &lt;/span&gt;&lt;/span&gt;of share options and&lt;span&gt;&lt;span&gt; $1,888,086 of warrants. &lt;/span&gt;&lt;/span&gt;The fair value of the Class B subordinate voting shares was determined based on a total of 510,940 shares issued and a fair value of $32.16 per share, which reflects the share price on the date of acquisition. The fair value of the 89,898 share options and 67,598 warrants issued as part of the consideration were determined using a black-scholes options pricing model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="border:0px;width:100%;margin:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Share Options&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Warrants&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Grant date share price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$32.16&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$32.16&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$2.61 - $17.89&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$2.61 - $26.73&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Risk free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.39% - 1.66%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.41% - 1.52%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected life (years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.98&amp;#x2014;16.21&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.39&amp;#x2014;6.55&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Annualized volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The allocation of the total purchase consideration to the identifiable assets acquired and liabilities assumed as at the date of acquisition was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:2.25pt"&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-left:auto;margin-right:auto;width:100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Fair value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;recongized on&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;acquisition&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2,329&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Prepaids&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;26,174&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Intellectual Property&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;24,648,915&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,867,250&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Short-term notes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(195,475&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes payable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,727,484&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;20,887,209&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfBusinessCombinationsExplanatory>
  <ifrs-full:EquityInterestsOfAcquirer contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220061955632" unitRef="CAD">20887209</ifrs-full:EquityInterestsOfAcquirer>
  <ifrs-full:EquityInterestsOfAcquirer contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeClassBVotingSharesMember" decimals="0" id="Fxbrl_20200220062006924" unitRef="CAD">16431818</ifrs-full:EquityInterestsOfAcquirer>
  <ifrs-full:EquityInterestsOfAcquirer contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeStockOptionsMember" decimals="0" id="Fxbrl_20200220062009866" unitRef="CAD">2567305</ifrs-full:EquityInterestsOfAcquirer>
  <ifrs-full:EquityInterestsOfAcquirer contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20200220062013143" unitRef="CAD">1888086</ifrs-full:EquityInterestsOfAcquirer>
  <huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeClassBVotingSharesMember" decimals="0" id="Fxbrl_20200228174249252" unitRef="shares">510940</huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares>
  <huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares contextRef="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200219211843835" unitRef="shares">510940</huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares>
  <huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20200219211855470" unitRef="shares">67598</huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares>
  <huge:ShareIssuePricePerShare contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeClassBVotingSharesMember" decimals="2" id="Fxbrl_20200228174418781" unitRef="CAD_per_Share">32.16</huge:ShareIssuePricePerShare>
  <huge:ShareIssuePricePerShare contextRef="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember" decimals="2" id="Fxbrl_20200219182725541" unitRef="CAD_per_Share">45.75</huge:ShareIssuePricePerShare>
  <huge:ShareIssuePricePerShare contextRef="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember" decimals="2" id="Fxbrl_20200227190254215" unitRef="CAD_per_Share">50.25</huge:ShareIssuePricePerShare>
  <huge:ShareIssuePricePerShare contextRef="C_20190401to20190424_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember" decimals="2" id="Fxbrl_20200221122526942" unitRef="CAD_per_Share">45.75</huge:ShareIssuePricePerShare>
  <huge:ShareIssuePricePerShare contextRef="C_20191101to20191104_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="2" id="Fxbrl_20200224144443755" unitRef="CAD_per_Share">20.10</huge:ShareIssuePricePerShare>
  <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20200228174437534" unitRef="Share">89898</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
  <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20200228174534811" unitRef="Share">67598</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
  <huge:DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228181510836">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="border:0px;width:100%;margin:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Share Options&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Warrants&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Grant date share price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$32.16&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$32.16&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$2.61 - $17.89&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$2.61 - $26.73&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Risk free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.39% - 1.66%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.41% - 1.52%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected life (years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.98&amp;#x2014;16.21&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.39&amp;#x2014;6.55&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Annualized volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</huge:DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory>
  <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="2" id="Fxbrl_20200228175851300" unitRef="CAD_per_Share">32.16</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
  <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="C_20190101to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200220125741490" unitRef="CAD_per_Share">6.45</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
  <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200220125811637" unitRef="CAD_per_Share">75.38</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
  <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20200220125824335" unitRef="CAD_per_Share">10.05</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
  <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200220125826395" unitRef="CAD_per_Share">142.71</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
  <huge:WeightedAverageSharePriceOfWarrants contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="2" id="Fxbrl_20200228180039983" unitRef="CAD_per_Share">32.16</huge:WeightedAverageSharePriceOfWarrants>
  <huge:WeightedAverageSharePriceOfWarrants contextRef="C_20191231" decimals="2" id="Fxbrl_20200303145139754" unitRef="CAD_per_Share">32.16</huge:WeightedAverageSharePriceOfWarrants>
  <huge:WeightedAverageSharePriceOfWarrants contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20200303145151944" unitRef="CAD_per_Share">4.42</huge:WeightedAverageSharePriceOfWarrants>
  <huge:WeightedAverageSharePriceOfWarrants contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200303145154452" unitRef="CAD_per_Share">18.09</huge:WeightedAverageSharePriceOfWarrants>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20200228180155132" unitRef="CAD_per_Share">2.61</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200228180226004" unitRef="CAD_per_Share">17.89</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="C_20190101to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200220125840704" unitRef="CAD_per_Share">7.17</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200220125932480" unitRef="CAD_per_Share">75.38</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20200220125940967" unitRef="CAD_per_Share">10.05</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200220125943395" unitRef="CAD_per_Share">148.74</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <huge:ExercisePriceOfWarrantsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20200228180204572" unitRef="CAD_per_Share">2.61</huge:ExercisePriceOfWarrantsGranted>
  <huge:ExercisePriceOfWarrantsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200228180456653" unitRef="CAD_per_Share">26.73</huge:ExercisePriceOfWarrantsGranted>
  <huge:ExercisePriceOfWarrantsGranted contextRef="C_20190101to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20200303145208366" unitRef="CAD_per_Share">2.61</huge:ExercisePriceOfWarrantsGranted>
  <huge:ExercisePriceOfWarrantsGranted contextRef="C_20190101to20191231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200303145647496" unitRef="CAD_per_Share">26.73</huge:ExercisePriceOfWarrantsGranted>
  <huge:ExercisePriceOfWarrantsGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20200303145229003" unitRef="CAD_per_Share">4.42</huge:ExercisePriceOfWarrantsGranted>
  <huge:ExercisePriceOfWarrantsGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200303145223932" unitRef="CAD_per_Share">26.13</huge:ExercisePriceOfWarrantsGranted>
  <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="2" id="Fxbrl_20200228180426077" unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
  <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200220125956825" unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
  <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="2" id="Fxbrl_20200220130004382" unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
  <huge:ExpectedDividendYieldOfWarrantsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="2" id="Fxbrl_20200228180434610" unitRef="Pure">0</huge:ExpectedDividendYieldOfWarrantsGranted>
  <huge:ExpectedDividendYieldOfWarrantsGranted contextRef="C_20190101to20191231" decimals="2" id="Fxbrl_20200303145244081" unitRef="Pure">0</huge:ExpectedDividendYieldOfWarrantsGranted>
  <huge:ExpectedDividendYieldOfWarrantsGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="2" id="Fxbrl_20200303145314295" unitRef="Pure">0</huge:ExpectedDividendYieldOfWarrantsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="4" id="Fxbrl_20200228180607315" unitRef="Pure">0.0139</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="4" id="Fxbrl_20200228180620070" unitRef="Pure">0.0166</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20190101to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="4" id="Fxbrl_20200220130255000" unitRef="Pure">0.0124</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="4" id="Fxbrl_20200220130327510" unitRef="Pure">0.0190</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="4" id="Fxbrl_20200220130330966" unitRef="Pure">0.0197</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="4" id="Fxbrl_20200220130333939" unitRef="Pure">0.0241</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="4" id="Fxbrl_20200228180614495" unitRef="Pure">0.0141</huge:RiskFreeInterestRateOfWarrantsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="4" id="Fxbrl_20200228180633126" unitRef="Pure">0.0152</huge:RiskFreeInterestRateOfWarrantsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="C_20190101to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="4" id="Fxbrl_20200303145329362" unitRef="Pure">0.0141</huge:RiskFreeInterestRateOfWarrantsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="C_20190101to20191231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="4" id="Fxbrl_20200303145335493" unitRef="Pure">0.0152</huge:RiskFreeInterestRateOfWarrantsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="4" id="Fxbrl_20200303145340268" unitRef="Pure">0.0170</huge:RiskFreeInterestRateOfWarrantsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="4" id="Fxbrl_20200303145343436" unitRef="Pure">0.0217</huge:RiskFreeInterestRateOfWarrantsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20200228180859683" unitRef="Year">0.98</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200228181011219" unitRef="Year">16.21</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="0" id="Fxbrl_20200220132130682" unitRef="Year">5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="0" id="Fxbrl_20200220132353350" unitRef="Year">5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <huge:ExpectedLifeOfWarrants contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" id="Fxbrl_20200228180909206">P1Y4M20D</huge:ExpectedLifeOfWarrants>
  <huge:ExpectedLifeOfWarrants contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" id="Fxbrl_20200228180953133">P6Y6M18D</huge:ExpectedLifeOfWarrants>
  <huge:ExpectedLifeOfWarrants contextRef="C_20190101to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" id="Fxbrl_20200303145354122">P1Y4M20D</huge:ExpectedLifeOfWarrants>
  <huge:ExpectedLifeOfWarrants contextRef="C_20190101to20191231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" id="Fxbrl_20200303145401117">P6Y6M18D</huge:ExpectedLifeOfWarrants>
  <huge:ExpectedLifeOfWarrants contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" id="Fxbrl_20200303145404334">P2Y</huge:ExpectedLifeOfWarrants>
  <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="2" id="Fxbrl_20200228180722339" unitRef="Pure">1</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
  <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200220130428563" unitRef="Pure">1</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
  <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="2" id="Fxbrl_20200220132532015" unitRef="Pure">1</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
  <huge:ExpectedVolatilityOfWarrantsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="2" id="Fxbrl_20200228180728624" unitRef="Pure">1</huge:ExpectedVolatilityOfWarrantsGranted>
  <huge:ExpectedVolatilityOfWarrantsGranted contextRef="C_20190101to20191231" decimals="2" id="Fxbrl_20200303145412345" unitRef="Pure">1</huge:ExpectedVolatilityOfWarrantsGranted>
  <huge:ExpectedVolatilityOfWarrantsGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="2" id="Fxbrl_20200303145420540" unitRef="Pure">1</huge:ExpectedVolatilityOfWarrantsGranted>
  <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220061924801">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-left:auto;margin-right:auto;width:100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Fair value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;recongized on&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;acquisition&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2,329&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Prepaids&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;26,174&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Intellectual Property&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;24,648,915&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,867,250&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Short-term notes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(195,475&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes payable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,727,484&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;20,887,209&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
  <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062120410" unitRef="CAD">2329</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
  <ifrs-full:CurrentAssetsRecognisedAsOfAcquisitionDate contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062142654" unitRef="CAD">26174</ifrs-full:CurrentAssetsRecognisedAsOfAcquisitionDate>
  <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062144259" unitRef="CAD">24648915</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
  <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062146011" unitRef="CAD">1867250</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
  <ifrs-full:CurrentLiabilitiesRecognisedAsOfAcquisitionDate contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062148706" unitRef="CAD">195475</ifrs-full:CurrentLiabilitiesRecognisedAsOfAcquisitionDate>
  <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062150851" unitRef="CAD">1727484</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
  <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062153313" unitRef="CAD">20887209</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
  <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200219170838089">&lt;div&gt;&lt;p style="text-align:justify;margin-left:2.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.&lt;strong&gt; Trade and other receivables&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify;margin-left:2.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's trade and other receivables include the following:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:2.25pt"&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;December 31,&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sales tax recoverable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,033,535&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;982,663&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rent receivable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;12,990&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,325&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;23,530&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,070,055&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;990,988&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
  <huge:DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200219173609171">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;December 31,&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sales tax recoverable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,033,535&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;982,663&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rent receivable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;12,990&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,325&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;23,530&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,070,055&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;990,988&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</huge:DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory>
  <huge:SalesTaxRecoverable contextRef="C_20191231" decimals="0" id="Fxbrl_20200219173818246" unitRef="CAD">2033535</huge:SalesTaxRecoverable>
  <huge:SalesTaxRecoverable contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200219173847019" unitRef="CAD">982663</huge:SalesTaxRecoverable>
  <huge:RentReceivable contextRef="C_20191231" decimals="0" id="Fxbrl_20200219174957636" unitRef="CAD">12990</huge:RentReceivable>
  <huge:RentReceivable contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200219175006006" unitRef="CAD">8325</huge:RentReceivable>
  <ifrs-full:OtherReceivables contextRef="C_20191231" decimals="0" id="Fxbrl_20200219180425879" unitRef="CAD">23530</ifrs-full:OtherReceivables>
  <ifrs-full:OtherReceivables contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200219180435967" unitRef="CAD">0</ifrs-full:OtherReceivables>
  <ifrs-full:TradeAndOtherReceivables contextRef="C_20191231" decimals="0" id="Fxbrl_20200219180444924" unitRef="CAD">2070055</ifrs-full:TradeAndOtherReceivables>
  <ifrs-full:TradeAndOtherReceivables contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200219180455623" unitRef="CAD">990988</ifrs-full:TradeAndOtherReceivables>
  <ifrs-full:DisclosureOfInventoriesExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220122450744">&lt;div&gt;&lt;p style="text-align:justify;margin-left:2.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.&lt;strong&gt; &amp;#160; &amp;#160;&amp;#160;Inventory&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify;margin-left:2.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory as at December 31, 2019 is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-align:justify;margin-left:2.25pt"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:100%;font-size:10pt;border-collapse:collapse;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Biological asset&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;fair value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Capitalized&amp;#160;&lt;/strong&gt;&lt;strong style="font-size:10pt"&gt;cost&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;adjustment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Impairment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Carrying&amp;#160;&lt;/strong&gt;&lt;strong style="font-size:10pt"&gt;value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Harvested cannabis&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Work in process&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,576,556&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(431,627&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(605,598&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;539,331&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished good&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;82,463&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,707&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(76,979&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,191&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,659,019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(415,920&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(682,577&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;560,522&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Hemp products&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw materials&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Other inventory&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Supplies&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;282,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;282,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;282,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;282,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,041,436&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(415,920&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(682,577&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;942,939&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="text-align:justify;margin-left:2.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Costs of sales primarily relate to production related expenditures not capitalized due to start-up costs, underutilization and impairment charges. Prior to the receipt of the Company's Health Canada cultivation license on October 13, 2017, the Company did not incur production related expenditures.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify;margin-left:2.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the year ended December 31, 2019 the Company recognized in costs of revenue $1,315,941 (2018 &amp;#x2013; nil) related to inventory impairment charges.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify;margin-left:2.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;There was no inventory as at December 31, 2018.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfInventoriesExplanatory>
  <huge:DisclosureOfDetailedInformationAboutInventoriesExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220174525640">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:100%;font-size:10pt;border-collapse:collapse;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Biological asset&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;fair value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Capitalized&amp;#160;&lt;/strong&gt;&lt;strong style="font-size:10pt"&gt;cost&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;adjustment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Impairment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Carrying&amp;#160;&lt;/strong&gt;&lt;strong style="font-size:10pt"&gt;value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Harvested cannabis&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Work in process&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,576,556&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(431,627&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(605,598&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;539,331&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished good&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;82,463&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,707&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(76,979&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,191&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,659,019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(415,920&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(682,577&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;560,522&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Hemp products&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw materials&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Other inventory&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Supplies&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;282,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;282,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;282,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;282,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,041,436&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(415,920&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(682,577&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;942,939&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</huge:DisclosureOfDetailedInformationAboutInventoriesExplanatory>
  <ifrs-full:WorkInProgress contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember_ifrsfullMeasurementAxis_hugeCapitalizedCostMember" decimals="0" id="Fxbrl_20200220114806434" unitRef="CAD">1576556</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember_ifrsfullMeasurementAxis_hugeBiologicalAssetFairValueAdjustmentMember" decimals="0" id="Fxbrl_20200220114814470" unitRef="CAD">-431627</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember_ifrsfullMeasurementAxis_hugeImpairmentMember" decimals="0" id="Fxbrl_20200220114828124" unitRef="CAD">-605598</ifrs-full:WorkInProgress>
  <ifrs-full:WorkInProgress contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember" decimals="0" id="Fxbrl_20200220114845035" unitRef="CAD">539331</ifrs-full:WorkInProgress>
  <ifrs-full:FinishedGoods contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember_ifrsfullMeasurementAxis_hugeCapitalizedCostMember" decimals="0" id="Fxbrl_20200220114911586" unitRef="CAD">82463</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember_ifrsfullMeasurementAxis_hugeBiologicalAssetFairValueAdjustmentMember" decimals="0" id="Fxbrl_20200220114936506" unitRef="CAD">15707</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember_ifrsfullMeasurementAxis_hugeImpairmentMember" decimals="0" id="Fxbrl_20200220114949436" unitRef="CAD">-76979</ifrs-full:FinishedGoods>
  <ifrs-full:FinishedGoods contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHarvestedCannabisMember" decimals="0" id="Fxbrl_20200220115004510" unitRef="CAD">21191</ifrs-full:FinishedGoods>
  <ifrs-full:RawMaterials contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHempProductsMember_ifrsfullMeasurementAxis_hugeCapitalizedCostMember" decimals="0" id="Fxbrl_20200220115555778" unitRef="CAD">100000</ifrs-full:RawMaterials>
  <ifrs-full:RawMaterials contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHempProductsMember_ifrsfullMeasurementAxis_hugeBiologicalAssetFairValueAdjustmentMember" decimals="0" id="Fxbrl_20200220115621549" unitRef="CAD">0</ifrs-full:RawMaterials>
  <ifrs-full:RawMaterials contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHempProductsMember_ifrsfullMeasurementAxis_hugeImpairmentMember" decimals="0" id="Fxbrl_20200220115649454" unitRef="CAD">0</ifrs-full:RawMaterials>
  <ifrs-full:RawMaterials contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeHempProductsMember" decimals="0" id="Fxbrl_20200220115710293" unitRef="CAD">100000</ifrs-full:RawMaterials>
  <ifrs-full:ProductionSupplies contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeOtherInventoryMember_ifrsfullMeasurementAxis_hugeCapitalizedCostMember" decimals="0" id="Fxbrl_20200220115831892" unitRef="CAD">282417</ifrs-full:ProductionSupplies>
  <ifrs-full:ProductionSupplies contextRef="C_20191231_hugeTypeOfInventoriesAxis_hugeOtherInventoryMember" decimals="0" id="Fxbrl_20200220115900181" unitRef="CAD">282417</ifrs-full:ProductionSupplies>
  <ifrs-full:InventoryWritedown2011 contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220122256214" unitRef="CAD">1315941</ifrs-full:InventoryWritedown2011>
  <ifrs-full:InventoryWritedown2011 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" id="Fxbrl_20200221174908708" unitRef="CAD" xsi:nil="true"></ifrs-full:InventoryWritedown2011>
  <ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220150609098">&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:black"&gt;8.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:black"&gt; &lt;strong&gt;Biological assets&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Biological assets consist of cannabis plants. The changes in the carrying value of biological assets are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-left:60pt;margin-right:40pt;border:0px;width:90%" width="80%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:12" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:212" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:25" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capitalized costs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:12" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:212" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,297,734&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:25" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in fair value less costs to sell due to biological transformation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:12" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:212" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(682,739&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:25" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transferred to inventory upon harvest&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:12" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:212" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(614,995&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:25" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:12" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:212" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:25" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:12" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:212" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:25" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company measures its biological assets at their fair value less costs to sell. This is determined using a model that estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount by the expected selling price less costs to complete and&amp;#160;sell per gram.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value measurements for biological assets have been categorized as Level 3 fair values based on the inputs to the valuation technique used. The Company's method of accounting for biological assets attributes value accretion on a straight-line basis throughout the life of the biological asset from initial cloning to the point of harvest.&lt;br/&gt;&lt;br/&gt;The Company capitalizes costs to biological assets in a manner consistent with the principles in IAS 2 (including but not limited to the determination of what types of costs are capitalized).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table identifies each significant unobservable input used to estimate the fair value of biological assets:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;table border="1" cellpadding="3" cellspacing="0" style="border:0px;width:90%;margin:auto"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td colspan="2" rowspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Assumptions:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;As at December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Input&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected yields for cannabis plants (average grams per plant)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13 grams dry flower&lt;br/&gt;16 grams dry trim&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ii&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average number of growing weeks completed as a percentage of total growing weeks as at period end&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;73%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;iii&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Estimated selling price per gram&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;border:1pt solid black"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.00 for flower&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.50 for trim&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;iv&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;After harvest cost to complete and sell per gram&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;border:1pt solid black"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.91 for dry flower&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.25 for dry trim&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at December 31, 2019 the fair value less costs to complete and sell of biological assets was nil. A change of plus or minus 10% of any of&amp;#160;the&amp;#160;above assumptions would not result in any change in the balance recognized of nil as at December 31, 2019.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company estimates the harvest yields for cannabis at various stages of growth. As of December 31, 2019, it is expected that the Company's cannabis plants will yield approximately 19,532  grams of dry flower and 25,002&amp;#160;grams of dry trim when harvested. It was estimated that these plants as of December 31, 2019 had completed 73% of the expected growth cycle, which is estimated at 12 weeks.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These estimates are subject to volatility in market prices and a number of factors, which could significantly affect the fair value of biological assets in future periods. The Company's estimates are, by their nature, subject to change, and differences from the anticipated yield and the other assumptions will be reflected in the gain or loss on biological assets in future periods.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value adjustments on biological assets are presented separately on the statements of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Biological assets as at December 31, 2018 were determined to have a fair value of nil. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory>
  <huge:DisclosureOfBiologicalAssetsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220150632360">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-left:60pt;margin-right:40pt;border:0px;width:90%" width="80%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:12" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:212" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:25" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capitalized costs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:12" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:212" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,297,734&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:25" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in fair value less costs to sell due to biological transformation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:12" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:212" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(682,739&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:25" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transferred to inventory upon harvest&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:12" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:212" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(614,995&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:25" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:12" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:212" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:25" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:12" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:212" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:25" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</huge:DisclosureOfBiologicalAssetsExplanatory>
  <ifrs-full:BiologicalAssets contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220150741942" unitRef="CAD">0</ifrs-full:BiologicalAssets>
  <ifrs-full:BiologicalAssets contextRef="C_20191231" decimals="0" id="Fxbrl_20200220150844423" unitRef="CAD">0</ifrs-full:BiologicalAssets>
  <ifrs-full:AdditionsFromPurchasesBiologicalAssets contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220150812114" unitRef="CAD">1297734</ifrs-full:AdditionsFromPurchasesBiologicalAssets>
  <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200224161733268" unitRef="CAD">682739</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets>
  <ifrs-full:DecreaseDueToHarvestBiologicalAssets contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220150817567" unitRef="CAD">614995</ifrs-full:DecreaseDueToHarvestBiologicalAssets>
  <huge:DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228164926185">&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;table border="1" cellpadding="3" cellspacing="0" style="border:0px;width:90%;margin:auto"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td colspan="2" rowspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Assumptions:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;As at December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Input&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected yields for cannabis plants (average grams per plant)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13 grams dry flower&lt;br/&gt;16 grams dry trim&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ii&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average number of growing weeks completed as a percentage of total growing weeks as at period end&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;73%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;iii&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Estimated selling price per gram&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;border:1pt solid black"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.00 for flower&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.50 for trim&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;iv&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;After harvest cost to complete and sell per gram&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;border:1pt solid black"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.91 for dry flower&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.25 for dry trim&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</huge:DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory>
  <huge:ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200228175248201" unitRef="g">13</huge:ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant>
  <huge:ExpectedYieldForCannabisPlantsOfDryTrimPerPlant contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200228175257823" unitRef="g">16</huge:ExpectedYieldForCannabisPlantsOfDryTrimPerPlant>
  <huge:ExpectedGrowthCycleCompleted contextRef="C_20191231" decimals="2" id="Fxbrl_20200228175308254" unitRef="Pure">0.73</huge:ExpectedGrowthCycleCompleted>
  <huge:ExpectedSellingPricePerGramOfDriedFlower contextRef="C_20190101to20191231" decimals="2" id="Fxbrl_20200228175836856" unitRef="CAD">1</huge:ExpectedSellingPricePerGramOfDriedFlower>
  <huge:ExpectedSellingPricePerGramOfTrim contextRef="C_20190101to20191231" decimals="2" id="Fxbrl_20200228175952024" unitRef="CAD">0.50</huge:ExpectedSellingPricePerGramOfTrim>
  <huge:AfterHarvestCostToCompleteAndSellPerGramForDryFlower contextRef="C_20190101to20191231" decimals="2" id="Fxbrl_20200228180202452" unitRef="CAD">1.91</huge:AfterHarvestCostToCompleteAndSellPerGramForDryFlower>
  <huge:AfterHarvestCostToCompleteAndSellPerGramForDryTrim contextRef="C_20190101to20191231" decimals="2" id="Fxbrl_20200228180210305" unitRef="CAD">1.25</huge:AfterHarvestCostToCompleteAndSellPerGramForDryTrim>
  <huge:ExpectedYieldOfDryFlower contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220151004641" unitRef="g">19532</huge:ExpectedYieldOfDryFlower>
  <huge:ExpectedYieldOfDryTrim contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200224151215766" unitRef="g">25002</huge:ExpectedYieldOfDryTrim>
  <huge:ExpectedGrowthCycle contextRef="C_20190101to20191231" id="Fxbrl_20200220151108222">P84D</huge:ExpectedGrowthCycle>
  <ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory contextRef="C_20190101to20191231" id="F9fd93cd0-52f9-11ea-80c4-2d332cd66d90">&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;9.&lt;span style="width:28.5pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Other investments&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The following table outlines changes in other investments.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:0px"&gt;&lt;table style="border-collapse:collapse;border:0px;width:100%" width="1440"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Balance at&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Change in fair&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Balance at&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Proceeds &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;value through&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Entity&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Instrument&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;2018&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;from sale&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:25px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:11px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;profit or loss&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;2019&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:25px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:11px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Pharmadrug Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(i)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2,660,940&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;339,060&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cannara Biotech Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(ii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;11,215,395&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2,146,357&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;9,069,038&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Clover Cannastrip&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(iii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,500,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,500,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;High Tide&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(iv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,798,040&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;614,520&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,183,520&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;High Tide&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(iv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;251,115&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(251,115&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;HUGE Shops&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(v)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,300,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(539,132&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;760,868&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;SciCann Therapeutics&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(vi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,999,991&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,287,743&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;712,248&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;690,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(255,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;435,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;385,784&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(269,134&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;116,650&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Convertible debenture&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,924,216&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,576,216&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;348,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;18,064,541&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;6,000,000&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;614,520&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;(11,669,157 &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;11,780,864 &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(i) &amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;Pharmadrug Inc. (Formerly known as "Aura Health Inc.")&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:40pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On April 16, 2019, &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;the Company entered into a share exchange agreement with Aura Health Inc. ("Aura").&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt; Pursuant to the share exchange agreement, FSD acquired 13,562,386 common shares at $0.2212 per share in the capital of Aura in exchange for the issuance of 65,577 Class B shares of the Company at $45.75 for a total value of $3,000,000. The FSD shares issued to Aura were subject to a purchase price adjustment, such that FSD would be required to issue additional shares to Aura should the weighted average trading price of FSD's shares fall below the issue price. As the number of additional shares to be issued under the agreement were dependent on the FSD share price, it was determined that this created a derivative liability. As a result of the decline in the Company's share price, on September 20, 2019, 61,892 additional Class B shares of the Company were issued to Aura&amp;#160;as part of the adjustment of purchase price and a corresponding loss on change in fair value of derivative liability of $1,422,036 was recorded in the statements of loss and comprehensive loss. The Company's investment in Aura has been classified as level 1 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;within the fair value hierarchy - quoted market price. During the fiscal year 2019, Aura announced a name change to Pharmadrug Inc.&lt;/p&gt;&lt;p style="text-align:justify;margin-bottom:0pt;margin-left:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(ii)&lt;span style="width:6.75pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Cannara Biotech Inc. ("Cannara")&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify;margin-top:0pt;margin-left:40pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company's investment in 85,003,750 Class B shares of Cannara are subject to an escrow arrangement with timed releases &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;of a predetermined quantity of shares at set intervals over a three-year period.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consequently, unrestricted shares that are not subject to escrow are valued at market price and shares that are held in escrow are subject to a discount rate.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The valuation at December 31, 2019 was based on the December 31, 2019 quoted market price of&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$0.125 per share, &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;subject to an aggregate discount for the escrow conditions determined to be&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt; 19.53% ($1,556,431). &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The 21,250,935 unrestricted Class B shares have been classified as level 1 within the fair value hierarchy - quoted market price. The remaining 63,752,815 Class B shares held in escrow has been classified as level 2 within the fair value hierarchy - valuation technique with observable inputs. The Company was a founder of Cannara and previously had common directors during 2018. Subsequent to December 31, 2019, the Company sold all 85,003,750 Class B shares for gross proceeds of $7,743,492 (refer to Note 25).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify;margin-bottom:0pt;margin-left:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(iii)&lt;span style="width:6.75pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Clover Cannastrip Thin Film Technologies Corp. ("Clover")&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:40pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On September 6, 2018, the Company subscribed for $1,500,000 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;of equity units in a brokered private placement by Clover. The equity investment is measured at fair value through profit or loss. Clover is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy.As at December 31, 2019, the fair value was determined to be nil based on the financial position of Clover and the Company's ability to recover its investment.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:40pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify;margin-bottom:0pt;margin-left:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(iv)&lt;span style="width:7.5pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;High Tide Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify;margin-bottom:0pt;margin-left:40pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The investment included&lt;span&gt;&lt;span&gt; 4,551,999 shares and 2,000,000 warrants. &lt;/span&gt;&lt;/span&gt;On November 22, 2019 the Company sold the shares and warrants of High Tide Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;for total cash proceeds of&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt; $614,520.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify;margin-bottom:0pt;margin-left:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(v)&lt;span style="width:6.75pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;HUGE Shops&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify;margin-top:0pt;margin-left:36pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The investment includes 17,333,333 shares based on the December 2018 subscription price of $0.075 per share. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The equity investment is measured at fair value through profit or loss. Huge Shops is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2019, the Company determined the best information to assess the fair value of the investment was based on movement of comparable public companies share prices and cannabis sector index resulting in decline in the fair value of investment of 41.5% from December 31, 2018. Comparable companies were determined in looking at product offering, relative size of operations, geographical market and other factors. A change in this assumption of plus or minus 10% would result in a corresponding change in fair value of the investment of approximately $54,000.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify;margin-bottom:0pt;margin-left:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(vi)&lt;span style="width:6.75pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;SciCann Therapeutics Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify;margin-bottom:0pt;margin-left:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The investment includes 117,648 shares based on the subscription price in May &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;of 2018&amp;#160;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;and October &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;of&amp;#160;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2018 of $17 per share. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The equity investment is measured at fair value through profit or loss. SciCann Therapeutics Inc. is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2019, the Company determined the best information to assess the fair value of the investment was based on movement of comparable public companies share prices and cannabis sector index resulting in decline in the fair value of investment of 64.4% from December 31, 2018. Comparable companies were determined in looking at product offering, relative size of operations, geographical market and other factors. A change in this assumption of plus or minus 10% would result in a corresponding change in fair value of the investment of approximately $129,000.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify;margin-bottom:0pt;margin-left:40pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(vii) &amp;#160;Solarvest BioEnergy Inc. ("Solarvest")&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt"&gt;On May 7, 2019, the Company acquired&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#160;3,000,000 common shares, 3,000,000 warrants and a convertible debenture at a principal amount of $2,400,000&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;for a total fair value of $3,000,000 of Solarvest in exchange for 49,751 Class B common shares of the Company with a fair value of $2,500,000 based on a market price of $50.25 and recognition of a derivative liability of $500,000. Under the terms of the agreement, the Company has guaranteed a minimum liquidation value of its shares to Solarvest of $3,000,000 resulting in recognition of derivative liability. If the liquidation value of the Company's shares is below $3,000,000, the Company would be required to issue additional shares for the difference in actual value realized and the minimum guaranteed value.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt"&gt;As at December 31, 2019, the fair value of the shares was determined based on the quoted market price of the shares at&amp;#160;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$0.145 per share. The fair value of the associated warrants is based on the Black-Scholes model with the following assumptions: exercise price $0.25, risk free rate 1.71%, expected volatility 94%, expected life 1.35 years and expected dividend yield of 0%. Fair value of the convertible debenture is calculated as: i) principle amount of debt: $2,400,000 multiplied by ii) &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;conversion&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt; ratio of $1 per share multiplied by iii) SVS share price as at December 31, 2019 of $0.145. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;The shares have been classified as level 1 within the fair value hierarchy - quoted market price, and the warrants and convertible debenture have been classified as level 2 - valuation technique with observable market inputs.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt"&gt;As at December 31, 2019, the fair value of the derivative liability was $2,646,269 resulting in recognition of loss on change in fair value of derivative liability of $2,146,269. The fair value was determined based on the additional common shares of the Company required to be issued to Solarvest to meet the minimum liquidation value of $3,000,000. Subsequent to December 31, 2019, the Company issued 225,371 shares to Solarvest to settle this derivative liability (refer to Note 25).&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt"&gt;&amp;#160;&lt;/p&gt;</ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory>
  <huge:DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200221120335462">&lt;table style="border-collapse:collapse;border:0px;width:100%" width="1440"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Balance at&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Change in fair&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Balance at&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Proceeds &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;value through&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Entity&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Instrument&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;2018&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;from sale&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:25px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:11px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;profit or loss&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;2019&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:25px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:11px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Pharmadrug Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(i)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,000,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2,660,940&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;339,060&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cannara Biotech Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(ii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;11,215,395&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2,146,357&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;9,069,038&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Clover Cannastrip&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(iii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,500,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,500,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;High Tide&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(iv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,798,040&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;614,520&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,183,520&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;High Tide&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(iv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;251,115&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(251,115&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;HUGE Shops&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(v)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,300,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(539,132&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;760,868&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;SciCann Therapeutics&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(vi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,999,991&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,287,743&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;712,248&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;690,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(255,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;435,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;385,784&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(269,134&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;116,650&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Convertible debenture&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,924,216&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,576,216&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;348,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;18,064,541&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;6,000,000&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;614,520&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;(11,669,157 &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;11,780,864 &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</huge:DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember" decimals="0" id="Fxbrl_20200219173308527" unitRef="CAD">3000000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember" decimals="0" id="Fxbrl_20200219173247640" unitRef="CAD">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember" decimals="0" id="Fxbrl_20200219173254807" unitRef="CAD">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20200219173227694" unitRef="CAD">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20200219173245520" unitRef="CAD">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="0" id="Fxbrl_20200219173256687" unitRef="CAD">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="0" id="Fxbrl_20200219173252543" unitRef="CAD">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173258631" unitRef="CAD">690000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173301263" unitRef="CAD">385784</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173303226" unitRef="CAD">1924216</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200219173304746" unitRef="CAD">6000000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember" decimals="0" id="Fxbrl_20200219173437986" unitRef="CAD">-2660940</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember" decimals="0" id="Fxbrl_20200219173440180" unitRef="CAD">-2146357</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember" decimals="0" id="Fxbrl_20200219173514424" unitRef="CAD">-1500000</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20200219173431656" unitRef="CAD">-1183520</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20200219173436402" unitRef="CAD">-251115</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="0" id="Fxbrl_20200219173516369" unitRef="CAD">-539132</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="0" id="Fxbrl_20200219173512774" unitRef="CAD">-1287743</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173517950" unitRef="CAD">-255000</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173520174" unitRef="CAD">-269134</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219173522190" unitRef="CAD">-1576216</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200219173524870" unitRef="CAD">-11669157</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:NumberOfSharesAcquired contextRef="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember" decimals="INF" id="Fxbrl_20200219182635591" unitRef="shares">13562386</huge:NumberOfSharesAcquired>
  <huge:SharePrices contextRef="C_20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember" decimals="4" id="Fxbrl_20200219182645710" unitRef="CAD_per_Share">0.2212</huge:SharePrices>
  <huge:SharePrices contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="3" id="Fxbrl_20200219195506154" unitRef="CAD_per_Share">0.145</huge:SharePrices>
  <huge:NumberOfSharesIssuedInShareExchange contextRef="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember" decimals="INF" id="Fxbrl_20200219182711893" unitRef="shares">65577</huge:NumberOfSharesIssuedInShareExchange>
  <huge:NumberOfSharesIssuedInShareExchange contextRef="C_20190901to20190920_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember" decimals="INF" id="Fxbrl_20200219182752509" unitRef="shares">61892</huge:NumberOfSharesIssuedInShareExchange>
  <huge:NumberOfSharesIssuedInShareExchange contextRef="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember" decimals="INF" id="Fxbrl_20200227183831228" unitRef="shares">49751</huge:NumberOfSharesIssuedInShareExchange>
  <huge:NumberOfSharesIssuedInShareExchange contextRef="C_20190401to20190424_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember" decimals="INF" id="Fxbrl_20200221122512544" unitRef="shares">65577</huge:NumberOfSharesIssuedInShareExchange>
  <huge:NumberOfSharesIssuedInShareExchange contextRef="C_20190901to20190920_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember" decimals="INF" id="Fxbrl_20200221122603592" unitRef="shares">61892</huge:NumberOfSharesIssuedInShareExchange>
  <huge:NumberOfSharesIssuedInShareExchange contextRef="C_20190501to20190507_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200228160752709" unitRef="shares">49751</huge:NumberOfSharesIssuedInShareExchange>
  <huge:ValueOfSharesIssuedInShareExchange contextRef="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember" decimals="0" id="Fxbrl_20200219182736753" unitRef="CAD">3000000</huge:ValueOfSharesIssuedInShareExchange>
  <huge:ValueOfSharesIssuedInShareExchange contextRef="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember" decimals="0" id="Fxbrl_20200227185731815" unitRef="CAD">2500000</huge:ValueOfSharesIssuedInShareExchange>
  <huge:ValueOfSharesIssuedInShareExchange contextRef="C_20190401to20190424_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember" decimals="0" id="Fxbrl_20200221122544710" unitRef="CAD">3000000</huge:ValueOfSharesIssuedInShareExchange>
  <huge:NumberOfSharesHeldSubjectToEscrowArrangement contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember" decimals="0" id="F3121_85003750" unitRef="shares">85003750</huge:NumberOfSharesHeldSubjectToEscrowArrangement>
  <huge:NumberOfSharesHeldSubjectToEscrowArrangement contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeUnrestrictedClassBSharesMember_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" decimals="INF" id="Fxbrl_20200227171507397" unitRef="shares">21250935</huge:NumberOfSharesHeldSubjectToEscrowArrangement>
  <huge:NumberOfSharesHeldSubjectToEscrowArrangement contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSharesHeldInEscrowMember_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" decimals="INF" id="Fxbrl_20200227171513892" unitRef="shares">63752815</huge:NumberOfSharesHeldSubjectToEscrowArrangement>
  <huge:QuotedMarketPriceOfInvestments contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember" decimals="3" id="F3121_018" unitRef="CAD_per_Share">0.125</huge:QuotedMarketPriceOfInvestments>
  <huge:QuotedMarketPriceOfInvestments contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="3" id="Fxbrl_20200219191923957" unitRef="CAD_per_Share">0.145</huge:QuotedMarketPriceOfInvestments>
  <huge:PercentageOfAggregateDiscountForSharesInEscrow contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember" decimals="4" id="F3121_267" unitRef="Pure">0.1953</huge:PercentageOfAggregateDiscountForSharesInEscrow>
  <huge:AggregateDiscountForSharesInEscrow contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinateVotingSharesMember" decimals="0" id="F3121_4084605" unitRef="CAD">1556431</huge:AggregateDiscountForSharesInEscrow>
  <huge:ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement contextRef="C_20180901to20180906_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember" decimals="0" id="Fxbrl_20200219183910995" unitRef="CAD">1500000</huge:ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement>
  <huge:NumberOfSharesHeld contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="F3127_4551999" unitRef="shares">4551999</huge:NumberOfSharesHeld>
  <huge:NumberOfSharesHeld contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="0" id="F3130_17333333" unitRef="shares">17333333</huge:NumberOfSharesHeld>
  <huge:NumberOfSharesHeld contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="0" id="F3133_117647" unitRef="shares">117648</huge:NumberOfSharesHeld>
  <huge:NumberOfSharesHeld contextRef="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="INF" id="Fxbrl_20200219190212211" unitRef="shares">3000000</huge:NumberOfSharesHeld>
  <huge:NumberOfWarrantsHeld contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="F3127_2000000" unitRef="shares">2000000</huge:NumberOfWarrantsHeld>
  <huge:NumberOfWarrantsHeld contextRef="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="INF" id="Fxbrl_20200219190220443" unitRef="shares">3000000</huge:NumberOfWarrantsHeld>
  <huge:ProceedsFromSaleOfSharesAndWarrants contextRef="C_20191101to20191122_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20200219185728529" unitRef="CAD">614520</huge:ProceedsFromSaleOfSharesAndWarrants>
  <huge:SubscriptionPricePerShare contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="3" id="F3130_0075" unitRef="CAD_per_Share">0.075</huge:SubscriptionPricePerShare>
  <huge:SubscriptionPricePerShare contextRef="Context_As_Of_31_May_2018T00_00_00_TO_31_May_2018T00_00_00_OtherInvestmentsNameOfEntityAxis_ScicannTherapeuticsIncMember" decimals="0" id="Fxbrl_202002191900337810" unitRef="CAD_per_Share">17</huge:SubscriptionPricePerShare>
  <huge:SubscriptionPricePerShare contextRef="Context_As_Of_31_Oct_2018T00_00_00_TO_31_Oct_2018T00_00_00_OtherInvestmentsNameOfEntityAxis_ScicannTherapeuticsIncMember" decimals="0" id="Fxbrl_20200219190033781" unitRef="CAD_per_Share">17</huge:SubscriptionPricePerShare>
  <huge:PercentageOfDeclineInFairValueOfInvestment contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="3" id="Fxbrl_20200227182633030" unitRef="Pure">0.415</huge:PercentageOfDeclineInFairValueOfInvestment>
  <huge:PercentageOfDeclineInFairValueOfInvestment contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="3" id="Fxbrl_20200227182706258" unitRef="Pure">0.644</huge:PercentageOfDeclineInFairValueOfInvestment>
  <huge:ChangeInFairValueOfInvestment contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="0" id="Fxbrl_20200227181508992" unitRef="CAD">54000</huge:ChangeInFairValueOfInvestment>
  <huge:ChangeInFairValueOfInvestment contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="0" id="Fxbrl_20200227182714109" unitRef="CAD">129000</huge:ChangeInFairValueOfInvestment>
  <huge:PrincipalAmountOfBorrowings contextRef="C_20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219190531545" unitRef="CAD">2400000</huge:PrincipalAmountOfBorrowings>
  <huge:PrincipalAmountOfBorrowings contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219192227795" unitRef="CAD">2400000</huge:PrincipalAmountOfBorrowings>
  <huge:FairValueOfSharesAndWarrantsAcquired contextRef="C_20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200227183433682" unitRef="CAD">3000000</huge:FairValueOfSharesAndWarrantsAcquired>
  <ifrs-full:DerivativeFinancialLiabilities contextRef="C_20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember" decimals="0" id="Fxbrl_20200227190602979" unitRef="CAD">500000</ifrs-full:DerivativeFinancialLiabilities>
  <huge:GuaranteedMinimumLiquidationValueOfShares contextRef="C_20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember" decimals="0" id="Fxbrl_20200227190755388" unitRef="CAD">3000000</huge:GuaranteedMinimumLiquidationValueOfShares>
  <huge:GuaranteedMinimumLiquidationValueOfShares contextRef="C_20191231_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200303002954049" unitRef="CAD">3000000</huge:GuaranteedMinimumLiquidationValueOfShares>
  <huge:ExercisePriceOfWarrants contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="2" id="Fxbrl_20200219195714677" unitRef="CAD_per_Share">0.25</huge:ExercisePriceOfWarrants>
  <huge:RiskFreeRateOfWarrants contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="4" id="Fxbrl_20200219192132464" unitRef="Pure">0.0171</huge:RiskFreeRateOfWarrants>
  <huge:ExpectedVolatilityOfWarrants contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="2" id="Fxbrl_20200219192142680" unitRef="Pure">0.94</huge:ExpectedVolatilityOfWarrants>
  <huge:ExpectedTermOfWarrants contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" id="Fxbrl_20200219192156004">P1Y4M6D</huge:ExpectedTermOfWarrants>
  <huge:ExpectedDividendYieldOfWarrants contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="2" id="Fxbrl_20200219192205944" unitRef="Pure">0</huge:ExpectedDividendYieldOfWarrants>
  <huge:DebtConversionRatio contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20200219192925146" unitRef="Pure">1</huge:DebtConversionRatio>
  <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220104442090">&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;10.&lt;strong&gt; Right-of-use asset&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;The right-of-use asset as at December 31, 2019 is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:1.5pt"&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:60%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Balance &amp;#x2013; January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;243,818&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(48,764&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(67,644&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance &amp;#x2013; December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;127,410&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;br/&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;The right-of-use asset relates to an office lease. As of December 31, 2019 the Company did not occupy the leased premise and was in the process of subleasing the space. The right-of-use asset has been impaired as of December 31, 2019 and was written down to the present value of the expected future lease payments to be received from subleasing the premise&amp;#160;&lt;/span&gt;&lt;/span&gt;over the remaining term of the lease.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
  <huge:DisclosureOfDetailedInformationAboutRightOfUseAssets contextRef="C_20190101to20191231" id="Fxbrl_20200220104526154">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:60%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Balance &amp;#x2013; January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;243,818&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(48,764&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(67,644&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance &amp;#x2013; December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;127,410&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</huge:DisclosureOfDetailedInformationAboutRightOfUseAssets>
  <ifrs-full:DepreciationRightofuseAssets contextRef="C_20190103to20191231" decimals="0" id="Fxbrl_20200220104621703" unitRef="CAD">48764</ifrs-full:DepreciationRightofuseAssets>
  <huge:ImpairmentLossRecognisedInRightOfUseAsset contextRef="C_20190103to20191231" decimals="0" id="Fxbrl_20200220104629551" unitRef="CAD">67644</huge:ImpairmentLossRecognisedInRightOfUseAsset>
  <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220141406527">&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.&lt;span style="width:5.25pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Property, plant and equipment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment as at December 31, 2019 is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:100%;font-size:10pt;border-collapse:collapse;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Furniture and&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Computer&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Facility and&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Production&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;fixtures&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;equipment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;related&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;equipment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Land&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Cost&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;123,218&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,068,820&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,292,038&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;209,795&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;220,150&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,350,156&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;252,731&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,032,832&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;333,013&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;220,150&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,418,976&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;252,731&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,324,870&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;126,425&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;73,183&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;142,824&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;191,686&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;534,118&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(86,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(101,683&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,643&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(215,056&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;372,708&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;293,333&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;10,460,117&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;417,774&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,100,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;12,643,932&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Accumulated depreciation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76,179&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,045&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,970&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,194&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76,179&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,045&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,970&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,194&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100,652&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;68,186&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;439,903&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87,084&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;695,825&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(27,754&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,084&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,394&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(39,232&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;149,077&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;134,231&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;434,819&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;121,660&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;839,787&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Carrying value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;256,834&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;154,105&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,418,976&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;211,761&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,141,676&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;223,631&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;159,102&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;10,025,298&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;296,114&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,100,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;11,804,145&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the year ended December 31, 2019 the Company capitalized $131,955 (2018 - nil) of depreciation to the production of biological assets and inventory.&lt;br/&gt;&lt;br/&gt;During the year, the Company completed a review of the recoverable amount of items of property, plant and equipment for which indicators of impairment were present. The review led to the recognition of an impairment loss of $175,824 which has been recognized in the statement of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
  <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220141349305">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:100%;font-size:10pt;border-collapse:collapse;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Furniture and&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Computer&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Facility and&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Production&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;fixtures&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;equipment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;related&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;equipment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Land&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Cost&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;123,218&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,068,820&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,292,038&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;209,795&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;220,150&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,350,156&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;252,731&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,032,832&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;333,013&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;220,150&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,418,976&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;252,731&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,324,870&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;126,425&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;73,183&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;142,824&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;191,686&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;534,118&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(86,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(101,683&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,643&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(215,056&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;372,708&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;293,333&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;10,460,117&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;417,774&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,100,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;12,643,932&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Accumulated depreciation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76,179&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,045&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,970&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,194&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76,179&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,045&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,970&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,194&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100,652&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;68,186&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;439,903&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87,084&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;695,825&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(27,754&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,084&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,394&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(39,232&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;149,077&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;134,231&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;434,819&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;121,660&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;839,787&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Carrying value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;256,834&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;154,105&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,418,976&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;211,761&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,141,676&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;223,631&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;159,102&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;10,025,298&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;296,114&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,100,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;11,804,145&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220120500794" unitRef="CAD">209795</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220120617160" unitRef="CAD">220150</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220120957471" unitRef="CAD">3350156</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220121743596" unitRef="CAD">252731</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220122656324" unitRef="CAD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220122729101" unitRef="CAD">4032832</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFurnitureFixturesAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220120726215" unitRef="CAD">126425</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220120930453" unitRef="CAD">73183</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFacilityUnderDevelopmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220121724051" unitRef="CAD">142824</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220122008296" unitRef="CAD">191686</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220122712093" unitRef="CAD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220213307456" unitRef="CAD">534118</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFurnitureFixturesAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220122824907" unitRef="CAD">86730</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220122854543" unitRef="CAD">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFacilityUnderDevelopmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220122916064" unitRef="CAD">101683</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220122922588" unitRef="CAD">26643</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220122926660" unitRef="CAD">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220122936220" unitRef="CAD">215056</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFurnitureFixturesAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220140003472" unitRef="CAD">27754</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220140010060" unitRef="CAD">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFacilityUnderDevelopmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220140014276" unitRef="CAD">5084</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220140018262" unitRef="CAD">6394</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220140022237" unitRef="CAD">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220140026773" unitRef="CAD">39232</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200228225040329" unitRef="CAD">175824</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FurnitureFixturesAndEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220123357448" unitRef="CAD">76179</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220123524112" unitRef="CAD">66045</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_FacilityUnderDevelopmentMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220124447687" unitRef="CAD">0</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220125550065" unitRef="CAD">40970</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ClassesOfPropertyPlantAndEquipmentAxis_LandMember_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220125639072" unitRef="CAD">0</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220130659830" unitRef="CAD">183194</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFurnitureFixturesAndEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220123444465" unitRef="CAD">100652</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220123544257" unitRef="CAD">68186</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeFacilityUnderDevelopmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220124511652" unitRef="CAD">439903</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220125608256" unitRef="CAD">87084</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220125656320" unitRef="CAD">0</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="C_20190101to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220130717339" unitRef="CAD">695825</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DepreciationBiologicalAssets contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220141928692" unitRef="CAD">131955</ifrs-full:DepreciationBiologicalAssets>
  <ifrs-full:DepreciationBiologicalAssets contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" id="Fxbrl_20200221192905967" unitRef="CAD" xsi:nil="true"></ifrs-full:DepreciationBiologicalAssets>
  <ifrs-full:DisclosureOfIntangibleAssetsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220141045207">&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.&lt;strong&gt; Intangible asset&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible asset as at December 31, 2019 is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;border-bottom:2pt solid black;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;border-bottom:2pt solid black;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;border-bottom:2pt solid black;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Acquisition of Prismic Pharmaceuticals Inc.&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;24,648,915&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;389,640&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(186,463&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;24,852,092&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Accumulated amortization&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,534,047&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,887&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,493,160&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Carrying value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;22,358,932&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company acquired intellectual property as part of the acquisition of Prismic on June 28, 2019. Refer to Note 5 for additional details.&amp;#160;The life of the intellectual property has been determined to be 5 years. Amortization of the intellectual property commenced on the date of acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
  <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220174809481">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;border-bottom:2pt solid black;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;border-bottom:2pt solid black;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;border-bottom:2pt solid black;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Acquisition of Prismic Pharmaceuticals Inc.&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;24,648,915&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;389,640&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(186,463&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;24,852,092&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Accumulated amortization&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,534,047&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,887&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,493,160&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Carrying value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;22,358,932&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
  <huge:AcquisitionOfPrismicPharmaceuticalsInc contextRef="C_20190101to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200303011044426" unitRef="CAD">24648915</huge:AcquisitionOfPrismicPharmaceuticalsInc>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="C_20190101to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220140208646" unitRef="CAD">389640</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="C_20190101to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20200220140302830" unitRef="CAD">-186463</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="C_20190101to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220140449704" unitRef="CAD">-40887</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="C_20190101to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20200220140422625" unitRef="CAD">2534047</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="C_20190101to20191231" id="Fxbrl_20200220140855137">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DisclosureOfLeasesExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220141721748">&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.&lt;span style="width:5.25pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Lease obligations&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The lease obligations as at December 31, 2019 are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:50%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:528px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:3px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:3px;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance &amp;#x2013; January 1, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:3px;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;243,818&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Add: Interest Expense&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,258&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Lease Payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56,207&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance &amp;#x2013; December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:3px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;202,869&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:528px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:3px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,207&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;146,662&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance &amp;#x2013; December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;202,869&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Lease obligations are related to the Company's office lease. As of December 31, 2019, the Company did not occupy the leased premise and was in the process of subleasing the space. Subsequent to December 31, 2019 the Company subleased the premise.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table sets out a maturity analysis of the lease payments payable, showing the undiscounted lease payments to be paid on an annual basis, reconciled to the lease obligation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:1.5pt"&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:90%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than one year&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,206&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;One to two years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59,642&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Two to three years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59,954&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Three to four years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59,954&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Therafter&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total undiscounted lease payments payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;235,756&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: impact of present value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(32,887&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;202,869&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;br/&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfLeasesExplanatory>
  <huge:DisclosureOfOperatingLeaseObligationsTableTextBlock contextRef="C_20190101to20191231" id="Fxbrl_20200220141550897">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:50%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:528px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:3px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:3px;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance &amp;#x2013; January 1, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:3px;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;243,818&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Add: Interest Expense&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,258&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Lease Payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56,207&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance &amp;#x2013; December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:3px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;202,869&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:528px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:3px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,207&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;146,662&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance &amp;#x2013; December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;202,869&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</huge:DisclosureOfOperatingLeaseObligationsTableTextBlock>
  <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220135553253" unitRef="CAD">15258</ifrs-full:InterestExpenseOnLeaseLiabilities>
  <ifrs-full:CashOutflowForLeases contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220135612934" unitRef="CAD">56207</ifrs-full:CashOutflowForLeases>
  <ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220141615238">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:90%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than one year&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,206&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;One to two years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59,642&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Two to three years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59,954&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Three to four years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59,954&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Therafter&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total undiscounted lease payments payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;235,756&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: impact of present value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(32,887&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;202,869&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;br/&gt;&amp;#160;&lt;/div&gt;</ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory>
  <huge:UndiscountedLeasePaymentsPayable contextRef="C_20191231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" decimals="0" id="Fxbrl_20200220135825810" unitRef="CAD">56206</huge:UndiscountedLeasePaymentsPayable>
  <huge:UndiscountedLeasePaymentsPayable contextRef="C_20191231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" decimals="0" id="Fxbrl_20200220135831927" unitRef="CAD">59642</huge:UndiscountedLeasePaymentsPayable>
  <huge:UndiscountedLeasePaymentsPayable contextRef="C_20191231_ifrsfullMaturityAxis_ifrsfullLaterThanTwoYearsAndNotLaterThanThreeYearsMember" decimals="0" id="Fxbrl_20200220135838172" unitRef="CAD">59954</huge:UndiscountedLeasePaymentsPayable>
  <huge:UndiscountedLeasePaymentsPayable contextRef="C_20191231_ifrsfullMaturityAxis_ifrsfullLaterThanThreeYearsAndNotLaterThanFourYearsMember" decimals="0" id="Fxbrl_20200220135841588" unitRef="CAD">59954</huge:UndiscountedLeasePaymentsPayable>
  <huge:UndiscountedLeasePaymentsPayable contextRef="C_20191231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" decimals="0" id="Fxbrl_20200220140038923" unitRef="CAD">0</huge:UndiscountedLeasePaymentsPayable>
  <huge:UndiscountedLeasePaymentsPayable contextRef="C_20191231" decimals="0" id="Fxbrl_20200220135855959" unitRef="CAD">235756</huge:UndiscountedLeasePaymentsPayable>
  <huge:OperatingLeaseImpactOfPresentValue contextRef="C_20191231" decimals="0" id="Fxbrl_20200220200600857" unitRef="CAD">32887</huge:OperatingLeaseImpactOfPresentValue>
  <ifrs-full:DisclosureOfBorrowingsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220155026693">&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt; Notes Payable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes payable consists of the following:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:1.5pt"&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:449px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:4px;border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:449px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term notes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:4px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;193,996&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:449px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Notes payable&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:4px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,714,416&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:449px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:4px;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,908,412&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align:justify"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Short-term notes&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The short-term notes represent notes outstanding that the Company assumed on acquisition of Prismic. The notes have matured, are due on demand and accrue interest a rate of&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt; 10% per annum.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The notes are held by former Directors and Shareholders of Prismic.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Notes payable&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The notes payable represent notes outstanding that the Company assumed on acquisition of Prismic. The notes have matured and are due on demand. The notes accrue interest a rate of 20% per annum. The notes are held by former Directors and Shareholders of Prismic.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfBorrowingsExplanatory>
  <ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220155315924">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:449px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:4px;border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:449px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term notes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:4px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;193,996&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:449px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Notes payable&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:4px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,714,416&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:449px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:4px;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,908,412&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory>
  <ifrs-full:BorrowingsInterestRate contextRef="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" decimals="2" id="Fxbrl_20200220160941513" unitRef="Pure">0.10</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:BorrowingsInterestRate contextRef="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember" decimals="2" id="Fxbrl_20200228152415919" unitRef="Pure">0.20</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200303195607682">&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;15.&lt;span style="width:5.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Share capital&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;[a]&lt;/strong&gt;&lt;span style="width:7pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Authorized&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company is authorized to issue an unlimited number of Class A multiple voting shares ("Class A shares") and an unlimited number of Class B subordinate voting shares ("Class B shares"), all without par value. All shares are ranked equally with regards to the Company's residual assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The holders of Class A shares are entitled to 276,660 votes per class A share held.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;Class A shares are held by certain original founders of the Company.&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong style="color:#000000;font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;letter-spacing:normal;orphans:2;text-align:justify;text-indent:-24px;text-transform:none;white-space:normal;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;text-decoration-style:initial;text-decoration-color:initial"&gt;[b]&lt;/strong&gt;&lt;span style="color:#000000;font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;letter-spacing:normal;orphans:2;text-align:justify;text-transform:none;white-space:normal;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;text-decoration-style:initial;text-decoration-color:initial;width:6.51pt;text-indent:0pt;display:inline-block"&gt; &lt;/span&gt;&lt;strong style="color:#000000;font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;letter-spacing:normal;orphans:2;text-align:justify;text-indent:-24px;text-transform:none;white-space:normal;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;text-decoration-style:initial;text-decoration-color:initial"&gt;Issued and outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reconciliation of the Company's share capital is as follows:&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:100%;font-size:10pt;border-collapse:collapse;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Class A shares&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Class B shares&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Warrants&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance, December 31, 2017&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;201,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,794,846&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;12,794,963&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;354,996&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2,116,900&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share issued&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2,268,035&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;47,853,745&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(6,634,405&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Reverse acquisition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;545,505&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;9,868,179&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;37,313&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;118,875&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrant valuations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2,366,670&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;198,835&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2,366,670&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share-based payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;294,287&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share options exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;190,463&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5,145,825&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share options cancelled&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrants exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;44,931&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,254,665&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(44,932&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(454,587&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance, December 31, 2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;201,500&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;6,843,780&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;67,916,302&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;546,212&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;4,442,145&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance, December 31, 2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;201,500&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;6,843,780&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;67,916,302&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;546,212&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;4,442,145&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;i&gt;Shares issued [a] [b] [c] [d] [e] &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;408,651&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;11,539,417&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Issued on acquisition of net assets of Prismic&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pharmaceuticals, Inc. &lt;i&gt;[f]&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;510,940&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;16,431,818&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;67,598&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,888,086&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share options exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;130,189&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,782,438&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrants exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;12,167&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;145,174&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(12,167&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(50,183&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrants expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(134,192&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(535,014&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;201,500&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;7,905,727&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;97,815,149&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;467,451&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;5,745,034&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;[a]&lt;span style="width:7.75pt;display:inline-block"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;On April 24, 2019, the Company entered into a share exchange agreement with Aura. Pursuant to the share exchange agreement, FSD acquired&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt; 13,562,386 common shares at $0.2212 per share &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;in the capital of Aura in exchange for the issuance of&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt; 65,577 Class B shares of the Company at $45.75 for a total value of $3,000,000.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On September 20, 2019, the Company issued an additional&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt; 61,892 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;Class B shares as part of the adjustment of purchase price related to the share exchange agreement with Aura to settle the related derivative liability. As part of the settlement, the Company recognized a loss on change in the fair value of derivative liability of $1,422,036.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;[b]&lt;span style="width:7.75pt;display:inline-block"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;On May 7, 2019, the Company entered into an agreement with Solarvest. Per the agreement the Company issued 49,751 Class B Shares to Solarvest in exchange for the investment in Solarvest. Refer to note 9 for details regarding the investment in Solarvest.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;[c]&lt;span style="width:7.75pt;display:inline-block"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;On October 4, 2019, the Company issued 3,735 Class B shares in settlement for trade payables of $25,000.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;[d]&lt;span style="width:6.75pt;display:inline-block"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;On October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares. All share and per share amounts for all periods presented in these financial statements have been adjusted retrospectively to reflect the reverse share split.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;[e]&lt;span style="width:7.75pt;display:inline-block"&gt; &lt;/span&gt;On November 4, 2019, the Company completed a private placement &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;through&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt; the issuance of 228,670 Class B shares at a price of $20.10 per share for total gross proceeds of $4,593,777.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash transactions costs related to the private placement were $32,705. A portion of the shares issued under the private placement were to related parties of the Company, including Directors and Officers of the Company (refer to Note 21).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;[f]&lt;span style="width:8.5pt;display:inline-block"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;The Company acquired all outstanding common and preferred shares of Prismic through the issuance of an aggregate of 510,940 Class B Shares. The Class B Shares issued to the Prismic shareholders were deposited into escrow upon closing of the transaction, and are subject to an 18-month staggered escrow release.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;The changes in the number of warrants outstanding during the years ended December 31, 2019 and 2018 were as follows:&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)"&gt;Number of warrants&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:16px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)"&gt;Weighted average exercise price&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;#&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:16px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;$&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;Outstanding as at December 31, 2017&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)"&gt;354,996&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)"&gt;5.80&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;Granted&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)"&gt;236,148&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)"&gt;16.57&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;Exercised&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)"&gt;(44,932&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)"&gt;)&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)"&gt;17.79&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;Outstanding as at December 31, 2018&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)"&gt;546,212&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)"&gt;9.47&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;Granted&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)"&gt;67,598&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)"&gt;10.45&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;Exercised&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)"&gt;(12,167&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255)"&gt;)&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)"&gt;7.81&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;Expired&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)"&gt;(134,192&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)"&gt;)&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)"&gt;7.64&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;Outstanding as at December 31, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;467,451&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;10.20&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Measurement of fair values&lt;/strong&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;The fair value of warrants outstanding during the years ended December 31, 2019 and 2018 were estimated at the date of grant using the Black-Scholes option pricing model with the following inputs:&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;2018&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(204, 238, 255)"&gt;Grant date share price&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(204, 238, 255)"&gt;$32.16&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(204, 238, 255)"&gt;$4.42 - $18.09&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)"&gt;Exercise price&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255)"&gt;$2.61 - $26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255)"&gt;$4.42 - $26.13&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(204, 238, 255)"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255)"&gt;1.41% - 1.52%&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255)"&gt;1.70% - 2.17%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(204, 238, 255)"&gt;Expected life&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(204, 238, 255)"&gt;1.39 - 6.55&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(204, 238, 255)"&gt;2 years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)"&gt;Expected volatility&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255)"&gt;100%&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255)"&gt;100%&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:center;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;The following table is a summary of the Company's warrants outstanding as at December 31, 2019:&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:center;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Warrants Outstanding&lt;/strong&gt;&lt;/p&gt;&amp;#160;&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;Exercise price&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;Number outstanding&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:693px"&gt;Expiry Date&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;$&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;#&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;November 30, 2020&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;2.61&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;16,787&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;September 15, 2022&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;4.42&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;199,005&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;August 1, 2021&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;5.43&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;4,476&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;September 11, 2023&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;5.43&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;22,382&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;January 5, 2020&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;6.03&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;37,313&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;July 24, 2023&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;13.07&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;3,357&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;May 20, 2023&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;16.08&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;7,311&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;May 24, 2022&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;18.09&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;163,535&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;May 4, 2025&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;3,730&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;May 10, 2025&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;1,865&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;May 17, 2025&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;3,730&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;May 31, 2025&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;1,865&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;January 16, 2026&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;1,722&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;January 20, 2026&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;373&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;10.20&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;467,451&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;br/&gt;The following table is a summary of the Company's warrants outstanding as at December 31, 2018:&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:center;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Warrants Outstanding&lt;/strong&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)"&gt;Exercise price&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)"&gt;Number outstanding&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;Expiry Date&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;$&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;#&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)"&gt;September 15, 2022&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)"&gt;4.42&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)"&gt;199,005&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;October 20, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)"&gt;7.56&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)"&gt;11,970&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)"&gt;November 1, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)"&gt;7.56&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)"&gt;69,240&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;November 14, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)"&gt;7.56&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)"&gt;52,532&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)"&gt;November 21, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)"&gt;7.56&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)"&gt;10,263&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;December 12, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)"&gt;7.56&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)"&gt;1,084&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)"&gt;December 29, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)"&gt;7.56&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)"&gt;1,072&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;January 5, 2020&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)"&gt;6.03&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)"&gt;37,313&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)"&gt;May 24, 2022&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)"&gt;18.09&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)"&gt;163,733&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;9.47&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;546,212&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
  <huge:DescriptionOfVotingRights contextRef="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" id="Fxbrl_20200221121542591">The holders of Class A shares are entitled to 276,660 votes per class A share held.</huge:DescriptionOfVotingRights>
  <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200303195705573">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:100%;font-size:10pt;border-collapse:collapse;border-color:#000000"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Class A shares&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Class B shares&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Warrants&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance, December 31, 2017&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;201,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,794,846&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;12,794,963&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;354,996&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2,116,900&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share issued&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2,268,035&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;47,853,745&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(6,634,405&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Reverse acquisition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;545,505&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;9,868,179&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;37,313&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;118,875&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrant valuations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2,366,670&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;198,835&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2,366,670&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share-based payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;294,287&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share options exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;190,463&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5,145,825&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share options cancelled&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrants exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;44,931&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,254,665&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(44,932&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(454,587&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance, December 31, 2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;201,500&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;6,843,780&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;67,916,302&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;546,212&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;4,442,145&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance, December 31, 2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;201,500&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;6,843,780&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;67,916,302&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;546,212&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;4,442,145&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;i&gt;Shares issued [a] [b] [c] [d] [e] &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;408,651&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;11,539,417&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Issued on acquisition of net assets of Prismic&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pharmaceuticals, Inc. &lt;i&gt;[f]&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;510,940&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;16,431,818&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;67,598&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,888,086&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share options exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;130,189&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,782,438&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrants exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;12,167&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;145,174&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(12,167&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(50,183&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrants expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(134,192&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(535,014&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;201,500&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;7,905,727&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;97,815,149&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;467,451&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;5,745,034&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
  <huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsValue contextRef="C_20190101to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200219211848895" unitRef="CAD">16431818</huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsValue>
  <huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsValue contextRef="C_20190101to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20200219211850923" unitRef="CAD">1888086</huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsValue>
  <huge:NumberOfSharesIssuedForDebtSettlement contextRef="C_20191001to20191004_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200228150957389" unitRef="shares">3735</huge:NumberOfSharesIssuedForDebtSettlement>
  <huge:ValueOfSharesIssuedForDebtSettlement contextRef="C_20191001to20191004_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200228154458612" unitRef="CAD">25000</huge:ValueOfSharesIssuedForDebtSettlement>
  <huge:DescriptionOfReverseShareSplit contextRef="C_20191001to20191016_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" id="Fxbrl_20200302160622484">October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares.</huge:DescriptionOfReverseShareSplit>
  <huge:NumberOfSharesIssuedInPrivatePlacement contextRef="C_20191101to20191104_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200219222957637" unitRef="shares">228670</huge:NumberOfSharesIssuedInPrivatePlacement>
  <huge:DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200303195900440">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)"&gt;Number of warrants&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:16px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)"&gt;Weighted average exercise price&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;#&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:16px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;$&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;Outstanding as at December 31, 2017&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)"&gt;354,996&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)"&gt;5.80&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;Granted&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)"&gt;236,148&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)"&gt;16.57&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;Exercised&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)"&gt;(44,932&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)"&gt;)&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)"&gt;17.79&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;Outstanding as at December 31, 2018&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)"&gt;546,212&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)"&gt;9.47&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;Granted&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)"&gt;67,598&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)"&gt;10.45&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;Exercised&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)"&gt;(12,167&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255)"&gt;)&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)"&gt;7.81&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;Expired&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)"&gt;(134,192&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)"&gt;)&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)"&gt;7.64&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;Outstanding as at December 31, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;467,451&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;10.20&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</huge:DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory>
  <huge:NumberOfWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00" decimals="INF" id="Fxbrl_20200303142706780" unitRef="shares">354996</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="INF" id="Fxbrl_20200303142712799" unitRef="shares">546212</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231" decimals="INF" id="Fxbrl_20200303142714491" unitRef="shares">467451</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember30th2020Member" decimals="INF" id="Fxbrl_20200303155831423" unitRef="shares">16787</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember15th2022Member" decimals="INF" id="Fxbrl_20200303155848103" unitRef="shares">199005</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust1st2021Member" decimals="INF" id="Fxbrl_20200303155849818" unitRef="shares">4476</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember11th2023Member" decimals="INF" id="Fxbrl_20200303155852002" unitRef="shares">22382</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary5th2020Member" decimals="INF" id="Fxbrl_20200303155853938" unitRef="shares">37313</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJuly24th2023Member" decimals="INF" id="Fxbrl_20200303155855738" unitRef="shares">3357</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay20th2023Member" decimals="INF" id="Fxbrl_20200303155857595" unitRef="shares">7311</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay24th2022Member" decimals="INF" id="Fxbrl_20200303155859444" unitRef="shares">163535</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay4th2025Member" decimals="INF" id="Fxbrl_20200303155901179" unitRef="shares">3730</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay10th2025Member" decimals="INF" id="Fxbrl_20200303155903083" unitRef="shares">1865</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay17th2025Member" decimals="INF" id="Fxbrl_20200303155905403" unitRef="shares">3730</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay31st2025Member" decimals="INF" id="Fxbrl_20200303155907785" unitRef="shares">1865</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary16th2026Member" decimals="INF" id="Fxbrl_20200303155909785" unitRef="shares">1722</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary20th2026Member" decimals="INF" id="Fxbrl_20200303155911849" unitRef="shares">373</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember15th2022Member" decimals="INF" id="Fxbrl_20200303155917311" unitRef="shares">199005</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtOctober20th2019Member" decimals="INF" id="Fxbrl_20200303155919050" unitRef="shares">11970</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember1st2019Member" decimals="INF" id="Fxbrl_20200303155921002" unitRef="shares">69240</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember14th2019Member" decimals="INF" id="Fxbrl_20200303155922754" unitRef="shares">52532</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember21st2019Member" decimals="INF" id="Fxbrl_20200303155924978" unitRef="shares">10263</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtDecember12st2019Member" decimals="INF" id="Fxbrl_20200303155926922" unitRef="shares">1084</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtDecember29th2019Member" decimals="INF" id="Fxbrl_20200303155928652" unitRef="shares">1072</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary5th2020Member" decimals="INF" id="Fxbrl_20200303155930617" unitRef="shares">37313</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay24th2022Member" decimals="INF" id="Fxbrl_20200303155932370" unitRef="shares">163733</huge:NumberOfWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00" decimals="2" id="Fxbrl_20200303142837993" unitRef="CAD_per_Share">5.80</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="2" id="Fxbrl_20200303142857817" unitRef="CAD_per_Share">9.47</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231" decimals="2" id="Fxbrl_20200303142901004" unitRef="CAD_per_Share">10.20</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember30th2020Member" decimals="2" id="Fxbrl_20200303155656555" unitRef="CAD_per_Share">2.61</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember15th2022Member" decimals="2" id="Fxbrl_20200303155716878" unitRef="CAD_per_Share">4.42</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust1st2021Member" decimals="2" id="Fxbrl_20200303155718788" unitRef="CAD_per_Share">5.43</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember11th2023Member" decimals="2" id="Fxbrl_20200303155720404" unitRef="CAD_per_Share">5.43</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary5th2020Member" decimals="2" id="Fxbrl_20200303155722227" unitRef="CAD_per_Share">6.03</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJuly24th2023Member" decimals="2" id="Fxbrl_20200303155726404" unitRef="CAD_per_Share">13.07</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay20th2023Member" decimals="2" id="Fxbrl_20200303155728892" unitRef="CAD_per_Share">16.08</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay24th2022Member" decimals="2" id="Fxbrl_20200303155730572" unitRef="CAD_per_Share">18.09</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay4th2025Member" decimals="2" id="Fxbrl_20200303155732236" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay10th2025Member" decimals="2" id="Fxbrl_20200303155733756" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay17th2025Member" decimals="2" id="Fxbrl_20200303155735796" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay31st2025Member" decimals="2" id="Fxbrl_20200303155737899" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary16th2026Member" decimals="2" id="Fxbrl_20200303155739556" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary20th2026Member" decimals="2" id="Fxbrl_20200303155741411" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember15th2022Member" decimals="2" id="Fxbrl_20200303155752002" unitRef="CAD_per_Share">4.42</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtOctober20th2019Member" decimals="2" id="Fxbrl_20200303155753591" unitRef="CAD_per_Share">7.56</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember1st2019Member" decimals="2" id="Fxbrl_20200303155755461" unitRef="CAD_per_Share">7.56</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember14th2019Member" decimals="2" id="Fxbrl_20200303155757280" unitRef="CAD_per_Share">7.56</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember21st2019Member" decimals="2" id="Fxbrl_20200303155759323" unitRef="CAD_per_Share">7.56</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtDecember12st2019Member" decimals="2" id="Fxbrl_20200303155801483" unitRef="CAD_per_Share">7.56</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtDecember29th2019Member" decimals="2" id="Fxbrl_20200303155804356" unitRef="CAD_per_Share">7.56</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary5th2020Member" decimals="2" id="Fxbrl_20200303155806298" unitRef="CAD_per_Share">6.03</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay24th2022Member" decimals="2" id="Fxbrl_20200303155808538" unitRef="CAD_per_Share">18.09</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:NumberOfWarrantsGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="INF" id="Fxbrl_20200303142612252" unitRef="shares">236148</huge:NumberOfWarrantsGranted>
  <huge:NumberOfWarrantsGranted contextRef="C_20190101to20191231" decimals="INF" id="Fxbrl_20200303142801956" unitRef="shares">67598</huge:NumberOfWarrantsGranted>
  <huge:WeightedAverageExercisePricesWarrantGranted contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="2" id="Fxbrl_20200303142929313" unitRef="CAD_per_Share">16.57</huge:WeightedAverageExercisePricesWarrantGranted>
  <huge:WeightedAverageExercisePricesWarrantGranted contextRef="C_20190101to20191231" decimals="2" id="Fxbrl_20200303142949768" unitRef="CAD_per_Share">10.45</huge:WeightedAverageExercisePricesWarrantGranted>
  <huge:NumberOfWarrantsExercised contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="INF" id="Fxbrl_20200303142745107" unitRef="shares">44932</huge:NumberOfWarrantsExercised>
  <huge:NumberOfWarrantsExercised contextRef="C_20190101to20191231" decimals="INF" id="Fxbrl_20200303142810391" unitRef="shares">12167</huge:NumberOfWarrantsExercised>
  <huge:WeightedAverageExercisePricesWarrantExercised contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="2" id="Fxbrl_20200303142937816" unitRef="CAD_per_Share">17.79</huge:WeightedAverageExercisePricesWarrantExercised>
  <huge:WeightedAverageExercisePricesWarrantExercised contextRef="C_20190101to20191231" decimals="2" id="Fxbrl_20200303143022193" unitRef="CAD_per_Share">7.81</huge:WeightedAverageExercisePricesWarrantExercised>
  <huge:NumberOfWarrantsExpired contextRef="C_20190101to20191231" decimals="INF" id="Fxbrl_20200303142818271" unitRef="shares">134192</huge:NumberOfWarrantsExpired>
  <huge:WeightedAverageExercisePricesWarrantExpired contextRef="C_20190101to20191231" decimals="2" id="Fxbrl_20200303143037600" unitRef="CAD_per_Share">7.64</huge:WeightedAverageExercisePricesWarrantExpired>
  <huge:DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200303195924144">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;2018&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(204, 238, 255)"&gt;Grant date share price&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(204, 238, 255)"&gt;$32.16&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(204, 238, 255)"&gt;$4.42 - $18.09&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)"&gt;Exercise price&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255)"&gt;$2.61 - $26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255)"&gt;$4.42 - $26.13&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(204, 238, 255)"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255)"&gt;1.41% - 1.52%&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255)"&gt;1.70% - 2.17%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(204, 238, 255)"&gt;Expected life&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(204, 238, 255)"&gt;1.39 - 6.55&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(204, 238, 255)"&gt;2 years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)"&gt;Expected volatility&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255)"&gt;100%&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255)"&gt;100%&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:center;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</huge:DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory>
  <huge:DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200303195951768">&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;The following table is a summary of the Company's warrants outstanding as at December 31, 2019:&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:center;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Warrants Outstanding&lt;/strong&gt;&lt;/p&gt;&amp;#160;&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;Exercise price&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;Number outstanding&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:693px"&gt;Expiry Date&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;$&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;#&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;November 30, 2020&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;2.61&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;16,787&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;September 15, 2022&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;4.42&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;199,005&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;August 1, 2021&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;5.43&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;4,476&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;September 11, 2023&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;5.43&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;22,382&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;January 5, 2020&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;6.03&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;37,313&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;July 24, 2023&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;13.07&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;3,357&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;May 20, 2023&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;16.08&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;7,311&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;May 24, 2022&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;18.09&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;163,535&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;May 4, 2025&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;3,730&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;May 10, 2025&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;1,865&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;May 17, 2025&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;3,730&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;May 31, 2025&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;1,865&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;January 16, 2026&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)"&gt;26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)"&gt;1,722&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px"&gt;January 20, 2026&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)"&gt;26.73&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)"&gt;373&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;10.20&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;467,451&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;br/&gt;The following table is a summary of the Company's warrants outstanding as at December 31, 2018:&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:center;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Warrants Outstanding&lt;/strong&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)"&gt;Exercise price&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)"&gt;Number outstanding&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;Expiry Date&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;$&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;#&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)"&gt;September 15, 2022&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)"&gt;4.42&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)"&gt;199,005&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;October 20, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)"&gt;7.56&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)"&gt;11,970&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)"&gt;November 1, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)"&gt;7.56&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)"&gt;69,240&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;November 14, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)"&gt;7.56&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)"&gt;52,532&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)"&gt;November 21, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)"&gt;7.56&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)"&gt;10,263&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;December 12, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)"&gt;7.56&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)"&gt;1,084&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)"&gt;December 29, 2019&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)"&gt;7.56&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)"&gt;1,072&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;January 5, 2020&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)"&gt;6.03&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)"&gt;37,313&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)"&gt;May 24, 2022&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)"&gt;18.09&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)"&gt;163,733&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;9.47&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;546,212&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;</huge:DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory>
  <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200303014409835">&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;16.&lt;span style="width:5.49pt;text-indent:0pt;display:inline-block"&gt; &lt;/span&gt;&lt;strong&gt;Share-based compensation&lt;/strong&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;The Company has established a share option plan (the "Option Plan") for directors, officers, employees and consultants of the Company. The Company's Board of Directors determines, among other things, the eligibility of individuals to participate in the Option Plan, the term and vesting periods, and the exercise price of options granted to individuals under the Option Plan.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;Each share option converts into one common share of the Company on exercise. No amounts are paid or payable by the individual on receipt of the option. The options carry neither rights to dividends nor voting rights. Options may be exercised at any time from the date of vesting to the date of their expiry.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;Share-based payment arrangements&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The changes in the number of share options during the years ended December 31, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="border:0px;width:100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Number of&lt;/strong&gt;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;options&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Weighted average&lt;/strong&gt;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;exercise price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Outstanding as at December 31, 2017&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;206,219&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;593,781&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;65.80&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(240,214&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11.31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Cancelled&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(74,627&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.05&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Outstanding as at December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;485,159&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;74.53&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,363,322&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20.68&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(82,094&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.02&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(12,438&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;56.28&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cancelled&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(299,006&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;115.80&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Outstanding as at December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;1,454,943&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;21.96&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Exercisable&amp;#160;&lt;/strong&gt;&lt;strong style="font-size:10pt"&gt;as at December 31, 2019&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;1,200,242&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;21.24&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Measurement of fair values&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The fair value of share options granted during the years ended December 31, 2019 and 2018 were estimated at the date of grant using the Black-Scholes option pricing model with the following inputs:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="border:0px;width:100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Grant date share price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$6.45 &amp;#x2014; $75.38&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$10.05 &amp;#x2014; $142.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$7.17 &amp;#x2014; $75.38&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$10.05 &amp;#x2014; $148.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Risk free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;1.24% &amp;#x2014; 1.90%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.97% &amp;#x2014; 2.41%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;5 years&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected volatiity&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;100%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected volatility was estimated by using the historical volatility of other companies that the Company considers comparable that have trading and volatility history. The expected option life represents the period of time that options granted are expected to be outstanding. The risk-free interest rate is based on government bonds with a remaining term equal to the expected life of the options.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The following table is a summary of the Company&amp;#x2019;s share options outstanding as at December 31, 2019:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border:0px;width:100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Options outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:245px"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:493px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Options exercisable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:213px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:228px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:245px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Weighted average&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:241px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:252px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:213px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:228px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:245px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;remaining contractual&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:241px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:252px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;Exercise price&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:228px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;Number outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:245px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;life [years]&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:241px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;Exercise price&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:252px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;Number exercisable&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px;border-bottom:1pt solid black"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:228px;border-bottom:1pt solid black"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;#&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:245px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;#&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:241px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:252px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;#&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;35,065&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;35,065&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;99,502&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;99,502&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;16,264&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;16,264&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.65&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.65&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,855&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,855&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13.47&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13.47&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18,409&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18,409&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;17.89&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,178&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;17.89&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,178&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;37,313&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.34&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;37,313&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;493,363&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.72&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;493,363&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;21.11&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,438&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.67&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;21.11&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,438&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;24.12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.59&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;24.12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,219&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;26.13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.62&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;26.13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;40.20&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;29,851&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.45&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;40.20&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;22,388&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;44.22&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,488&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.41&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;44.22&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,488&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;47.24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,493&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.37&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;47.24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,493&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;50.25&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;227,861&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;50.25&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;129,353&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.21&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;55.28&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;55.28&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.96&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.17&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.83&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.17&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;75.38&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.04&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;75.38&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.63&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;203,750&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.34&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.63&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;58,750&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.88&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;88.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.87&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;88.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;120.60&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;120.60&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,974&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,975&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;21.96&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,454,943&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.59&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;21.24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,200,242&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;p&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The following table is a summary of the Company's share options outstanding as at December 31, 2018:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border:0px;width:100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Options outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:494px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Options exercisable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Weighted average&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:251px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;remaining contractual&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:251px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exercise price&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Number outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;life [years]&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exercise price&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:251px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Number exercisable&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:213px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:229px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;#&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:243px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;#&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:243px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:251px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;#&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;149,254&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;149,254&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.03&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,488&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.98&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.03&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,488&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;42,289&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;42,289&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;33,169&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.27&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;16,584&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;26.13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.62&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;26.13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;56.28&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,438&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.91&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;56.28&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.96&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.88&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;88.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.87&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;88.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;120.60&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;120.60&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,975&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,658&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;148.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;199,004&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.70&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;148.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;74.53&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;485,159&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.32&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;19.91&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;253,815&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company recognized $16,061,319 of share-based compensation expenses during the year ended December 31, 2019 (2018 -&amp;#160;$6,440,406), with a corresponding amount recognized in contributed surplus.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Included within share-based compensation expense during the year ended December 31, 2019 is $1,730,794 (2018 - nil) for bonus expense to be paid subsequent to December 31, 2019 through the issuance of Class B common shares of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
  <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200229042452573">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="border:0px;width:100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Number of&lt;/strong&gt;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;options&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Weighted average&lt;/strong&gt;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;exercise price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Outstanding as at December 31, 2017&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;206,219&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;593,781&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;65.80&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(240,214&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11.31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Cancelled&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(74,627&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.05&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Outstanding as at December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;485,159&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;74.53&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,363,322&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20.68&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(82,094&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.02&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(12,438&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;56.28&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cancelled&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(299,006&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;115.80&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Outstanding as at December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;1,454,943&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;21.96&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Exercisable&amp;#160;&lt;/strong&gt;&lt;strong style="font-size:10pt"&gt;as at December 31, 2019&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;1,200,242&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;21.24&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="INF" id="Fxbrl_20200219203155401" unitRef="Share">206219</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="INF" id="Fxbrl_20200219203201399" unitRef="Share">485159</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20200219203208500" unitRef="Share">1454943</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember" decimals="INF" id="Fxbrl_20200220170503442" unitRef="Share">35065</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember" decimals="INF" id="Fxbrl_20200220170527725" unitRef="Share">99502</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20200220170529488" unitRef="Share">16264</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember" decimals="INF" id="Fxbrl_20200220170531181" unitRef="Share">3730</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember" decimals="INF" id="Fxbrl_20200220170532836" unitRef="Share">10855</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember" decimals="INF" id="Fxbrl_20200220170534628" unitRef="Share">1418</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember" decimals="INF" id="Fxbrl_20200220170536253" unitRef="Share">18409</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember" decimals="INF" id="Fxbrl_20200220170538004" unitRef="Share">4178</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember" decimals="INF" id="Fxbrl_20200220170539756" unitRef="Share">37313</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember" decimals="INF" id="Fxbrl_20200220170541612" unitRef="Share">493363</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember" decimals="INF" id="Fxbrl_20200220170543364" unitRef="Share">12438</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember" decimals="INF" id="Fxbrl_20200220170544972" unitRef="Share">9950</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember" decimals="INF" id="Fxbrl_20200220170546916" unitRef="Share">14925</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember" decimals="INF" id="Fxbrl_20200220170548750" unitRef="Share">29851</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember" decimals="INF" id="Fxbrl_20200220170554934" unitRef="Share">2488</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember" decimals="INF" id="Fxbrl_20200220170556851" unitRef="Share">1493</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember" decimals="INF" id="Fxbrl_20200220170558691" unitRef="Share">227861</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember" decimals="INF" id="Fxbrl_20200220170601116" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember" decimals="INF" id="Fxbrl_20200220170604011" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember" decimals="INF" id="Fxbrl_20200220170605772" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember" decimals="INF" id="Fxbrl_20200220170636857" unitRef="Share">199005</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointFiftyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20200220170638613" unitRef="Share">0</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember" decimals="INF" id="Fxbrl_20200220170640639" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember" decimals="INF" id="Fxbrl_20200220170642356" unitRef="Share">203750</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember" decimals="INF" id="Fxbrl_20200220170644580" unitRef="Share">1244</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember" decimals="INF" id="Fxbrl_20200220170646861" unitRef="Share">14925</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember" decimals="INF" id="Fxbrl_20200220170648949" unitRef="Share">9950</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember" decimals="INF" id="Fxbrl_20200220170652011" unitRef="Share">4974</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember" decimals="INF" id="Fxbrl_20200221130156571" unitRef="Share">149254</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember" decimals="INF" id="Fxbrl_20200220181931596" unitRef="Share">2488</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember" decimals="INF" id="Fxbrl_20200220181933014" unitRef="Share">42289</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember" decimals="INF" id="Fxbrl_20200220181934584" unitRef="Share">33169</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember" decimals="INF" id="Fxbrl_20200220181936063" unitRef="Share">14925</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftySixPointTwentyEightMember" decimals="INF" id="Fxbrl_20200220181937856" unitRef="Share">12438</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember" decimals="INF" id="Fxbrl_20200220181939416" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember" decimals="INF" id="Fxbrl_20200220181941055" unitRef="Share">1244</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember" decimals="INF" id="Fxbrl_20200220181942631" unitRef="Share">14925</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember" decimals="INF" id="Fxbrl_20200220181944863" unitRef="Share">9950</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember" decimals="INF" id="Fxbrl_20200220181946903" unitRef="Share">4975</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyEightPointSeventyFourMember" decimals="INF" id="Fxbrl_20200220181948548" unitRef="Share">199004</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2017T00_00_00_TO_31_Dec_2017T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="2" id="Fxbrl_20200219203618356" unitRef="CAD_per_Share">4.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="2" id="Fxbrl_20200219203624298" unitRef="CAD_per_Share">74.53</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200219203629819" unitRef="CAD_per_Share">21.96</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember" decimals="2" id="Fxbrl_20200220170223034" unitRef="CAD_per_Share">2.61</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember" decimals="2" id="Fxbrl_20200220170239854" unitRef="CAD_per_Share">4.42</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200220170242183" unitRef="CAD_per_Share">5.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember" decimals="2" id="Fxbrl_20200220170245956" unitRef="CAD_per_Share">10.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember" decimals="2" id="Fxbrl_20200220170247724" unitRef="CAD_per_Share">13.07</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember" decimals="2" id="Fxbrl_20200220170249570" unitRef="CAD_per_Share">13.47</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember" decimals="2" id="Fxbrl_20200220170251852" unitRef="CAD_per_Share">16.08</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember" decimals="2" id="Fxbrl_20200220170253804" unitRef="CAD_per_Share">17.89</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember" decimals="2" id="Fxbrl_20200220170255518" unitRef="CAD_per_Share">18.09</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember" decimals="2" id="Fxbrl_20200220170257363" unitRef="CAD_per_Share">20.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember" decimals="2" id="Fxbrl_20200220170259188" unitRef="CAD_per_Share">21.11</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember" decimals="2" id="Fxbrl_20200220170301108" unitRef="CAD_per_Share">24.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember" decimals="2" id="Fxbrl_20200220170303156" unitRef="CAD_per_Share">26.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember" decimals="2" id="Fxbrl_20200220170305364" unitRef="CAD_per_Share">40.20</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember" decimals="2" id="Fxbrl_20200220170307084" unitRef="CAD_per_Share">44.22</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember" decimals="2" id="Fxbrl_20200220170309160" unitRef="CAD_per_Share">47.24</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember" decimals="2" id="Fxbrl_20200220170310849" unitRef="CAD_per_Share">50.25</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember" decimals="2" id="Fxbrl_20200220170322251" unitRef="CAD_per_Share">52.26</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember" decimals="2" id="Fxbrl_20200220170323916" unitRef="CAD_per_Share">55.28</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember" decimals="2" id="Fxbrl_20200220170325633" unitRef="CAD_per_Share">59.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember" decimals="2" id="Fxbrl_20200220170331611" unitRef="CAD_per_Share">7.17</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointFiftyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200220170436011" unitRef="CAD_per_Share">7.50</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember" decimals="2" id="Fxbrl_20200220170438115" unitRef="CAD_per_Share">75.38</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember" decimals="2" id="Fxbrl_20200220170439965" unitRef="CAD_per_Share">7.63</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember" decimals="2" id="Fxbrl_20200220170441574" unitRef="CAD_per_Share">86.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember" decimals="2" id="Fxbrl_20200220170443540" unitRef="CAD_per_Share">88.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember" decimals="2" id="Fxbrl_20200220170445118" unitRef="CAD_per_Share">120.60</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember" decimals="2" id="Fxbrl_20200220170446798" unitRef="CAD_per_Share">142.71</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember" decimals="2" id="Fxbrl_20200220181747999" unitRef="CAD_per_Share">4.42</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember" decimals="2" id="Fxbrl_20200220181805636" unitRef="CAD_per_Share">5.03</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember" decimals="2" id="Fxbrl_20200220181807096" unitRef="CAD_per_Share">18.09</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember" decimals="2" id="Fxbrl_20200220181808596" unitRef="CAD_per_Share">20.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember" decimals="2" id="Fxbrl_20200220181810111" unitRef="CAD_per_Share">26.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftySixPointTwentyEightMember" decimals="2" id="Fxbrl_20200220181811928" unitRef="CAD_per_Share">56.28</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember" decimals="2" id="Fxbrl_20200220181813938" unitRef="CAD_per_Share">59.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember" decimals="2" id="Fxbrl_20200220181815456" unitRef="CAD_per_Share">86.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember" decimals="2" id="Fxbrl_20200220181820544" unitRef="CAD_per_Share">88.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember" decimals="2" id="Fxbrl_20200220181822336" unitRef="CAD_per_Share">120.60</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember" decimals="2" id="Fxbrl_20200220181824113" unitRef="CAD_per_Share">142.71</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyEightPointSeventyFourMember" decimals="2" id="Fxbrl_20200220181825921" unitRef="CAD_per_Share">148.74</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="INF" id="Fxbrl_20200219203434205" unitRef="Share">593781</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20200219203439232" unitRef="Share">1363322</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="2" id="Fxbrl_20200219203642617" unitRef="CAD_per_Share">65.80</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200219203814874" unitRef="CAD_per_Share">20.68</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="INF" id="Fxbrl_20200219203452623" unitRef="Share">240214</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20200219203458951" unitRef="Share">82094</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="2" id="Fxbrl_20200219203730092" unitRef="CAD_per_Share">11.31</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200219204520976" unitRef="CAD_per_Share">10.02</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="INF" id="Fxbrl_20200219203524831" unitRef="Share">74627</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20200219203552929" unitRef="Share">299006</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="2" id="Fxbrl_20200219203745523" unitRef="CAD_per_Share">10.05</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200219204618572" unitRef="CAD_per_Share">115.80</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20200219203538974" unitRef="Share">12438</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200219204549144" unitRef="CAD_per_Share">56.28</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20200219203604716" unitRef="Share">1200242</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember" decimals="INF" id="Fxbrl_20200220171607115" unitRef="Share">35065</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember" decimals="INF" id="Fxbrl_20200220172043767" unitRef="Share">99502</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20200220172045445" unitRef="Share">16264</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember" decimals="INF" id="Fxbrl_20200220172047189" unitRef="Share">3730</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember" decimals="INF" id="Fxbrl_20200220172048885" unitRef="Share">10855</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember" decimals="INF" id="Fxbrl_20200220172054621" unitRef="Share">1418</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember" decimals="INF" id="Fxbrl_20200220172817608" unitRef="Share">18409</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember" decimals="INF" id="Fxbrl_20200220172821173" unitRef="Share">4178</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember" decimals="INF" id="Fxbrl_20200220172822791" unitRef="Share">37313</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember" decimals="INF" id="Fxbrl_20200220172830100" unitRef="Share">493363</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember" decimals="INF" id="Fxbrl_20200220172838498" unitRef="Share">12438</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember" decimals="INF" id="Fxbrl_20200220172839911" unitRef="Share">6219</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember" decimals="INF" id="Fxbrl_20200220172841277" unitRef="Share">14925</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember" decimals="INF" id="Fxbrl_20200220172842679" unitRef="Share">22388</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember" decimals="INF" id="Fxbrl_20200220172844302" unitRef="Share">2488</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember" decimals="INF" id="Fxbrl_20200220172845837" unitRef="Share">1493</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember" decimals="INF" id="Fxbrl_20200220172847381" unitRef="Share">129353</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember" decimals="INF" id="Fxbrl_20200220172848837" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember" decimals="INF" id="Fxbrl_20200220172850299" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember" decimals="INF" id="Fxbrl_20200220172855221" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember" decimals="INF" id="Fxbrl_20200220172902877" unitRef="Share">199005</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointFiftyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20200220172905517" unitRef="Share">0</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember" decimals="INF" id="Fxbrl_20200220172907060" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember" decimals="INF" id="Fxbrl_20200220172908998" unitRef="Share">58750</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember" decimals="INF" id="Fxbrl_20200220172910445" unitRef="Share">1244</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember" decimals="INF" id="Fxbrl_20200220172912021" unitRef="Share">14925</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember" decimals="INF" id="Fxbrl_20200220172913503" unitRef="Share">9950</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember" decimals="INF" id="Fxbrl_20200220172915213" unitRef="Share">4975</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember" decimals="INF" id="Fxbrl_20200220182233181" unitRef="Share">149254</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember" decimals="INF" id="Fxbrl_20200220182241052" unitRef="Share">2488</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember" decimals="INF" id="Fxbrl_20200220182242713" unitRef="Share">42289</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember" decimals="INF" id="Fxbrl_20200220182244855" unitRef="Share">16584</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember" decimals="INF" id="Fxbrl_20200220182246639" unitRef="Share">14925</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftySixPointTwentyEightMember" decimals="INF" id="Fxbrl_20200220182249783" unitRef="Share">0</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember" decimals="INF" id="Fxbrl_20200220182251527" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember" decimals="INF" id="Fxbrl_20200220182253455" unitRef="Share">1244</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember" decimals="INF" id="Fxbrl_20200220182255567" unitRef="Share">14925</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember" decimals="INF" id="Fxbrl_20200220182257464" unitRef="Share">9950</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember" decimals="INF" id="Fxbrl_20200220182301041" unitRef="Share">1658</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyEightPointSeventyFourMember" decimals="INF" id="Fxbrl_20200220182302682" unitRef="Share">0</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="INF" id="Fxbrl_20200220182304471" unitRef="Share">253815</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200219204633886" unitRef="CAD_per_Share">21.24</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember" decimals="2" id="Fxbrl_20200220171428301" unitRef="CAD_per_Share">2.61</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember" decimals="2" id="Fxbrl_20200220171443404" unitRef="CAD_per_Share">4.42</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200220171445957" unitRef="CAD_per_Share">5.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember" decimals="2" id="Fxbrl_20200220171449652" unitRef="CAD_per_Share">10.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember" decimals="2" id="Fxbrl_20200220171451706" unitRef="CAD_per_Share">13.07</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember" decimals="2" id="Fxbrl_20200220171453344" unitRef="CAD_per_Share">13.47</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember" decimals="2" id="Fxbrl_20200220171454943" unitRef="CAD_per_Share">16.08</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember" decimals="2" id="Fxbrl_20200220171456508" unitRef="CAD_per_Share">17.89</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember" decimals="2" id="Fxbrl_20200220171458212" unitRef="CAD_per_Share">18.09</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember" decimals="2" id="Fxbrl_20200220171500090" unitRef="CAD_per_Share">20.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember" decimals="2" id="Fxbrl_20200220171501700" unitRef="CAD_per_Share">21.11</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember" decimals="2" id="Fxbrl_20200220171503430" unitRef="CAD_per_Share">24.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember" decimals="2" id="Fxbrl_20200220171505276" unitRef="CAD_per_Share">26.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember" decimals="2" id="Fxbrl_20200220171507204" unitRef="CAD_per_Share">40.20</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember" decimals="2" id="Fxbrl_20200220171509964" unitRef="CAD_per_Share">44.22</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember" decimals="2" id="Fxbrl_20200220171511869" unitRef="CAD_per_Share">47.24</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember" decimals="2" id="Fxbrl_20200220171514221" unitRef="CAD_per_Share">50.25</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember" decimals="2" id="Fxbrl_20200220171515973" unitRef="CAD_per_Share">52.26</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember" decimals="2" id="Fxbrl_20200220171517716" unitRef="CAD_per_Share">55.28</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember" decimals="2" id="Fxbrl_20200220171519404" unitRef="CAD_per_Share">59.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember" decimals="2" id="Fxbrl_20200220171525564" unitRef="CAD_per_Share">7.17</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointFiftyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20200220171528095" unitRef="CAD_per_Share">7.50</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember" decimals="2" id="Fxbrl_20200220171530116" unitRef="CAD_per_Share">75.38</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember" decimals="2" id="Fxbrl_20200220171531756" unitRef="CAD_per_Share">7.63</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember" decimals="2" id="Fxbrl_20200220171533572" unitRef="CAD_per_Share">86.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember" decimals="2" id="Fxbrl_20200220171535385" unitRef="CAD_per_Share">88.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember" decimals="2" id="Fxbrl_20200220171537476" unitRef="CAD_per_Share">120.60</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember" decimals="2" id="Fxbrl_20200220171539249" unitRef="CAD_per_Share">142.71</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember" decimals="2" id="Fxbrl_20200220182144085" unitRef="CAD_per_Share">4.42</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember" decimals="2" id="Fxbrl_20200220182149062" unitRef="CAD_per_Share">5.03</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember" decimals="2" id="Fxbrl_20200220182150760" unitRef="CAD_per_Share">18.09</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember" decimals="2" id="Fxbrl_20200220182152473" unitRef="CAD_per_Share">20.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember" decimals="2" id="Fxbrl_20200220182154111" unitRef="CAD_per_Share">26.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftySixPointTwentyEightMember" decimals="2" id="Fxbrl_20200220182156168" unitRef="CAD_per_Share">56.28</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember" decimals="2" id="Fxbrl_20200220182157800" unitRef="CAD_per_Share">59.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember" decimals="2" id="Fxbrl_20200220182159680" unitRef="CAD_per_Share">86.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember" decimals="2" id="Fxbrl_20200220182201440" unitRef="CAD_per_Share">88.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember" decimals="2" id="Fxbrl_20200220182203144" unitRef="CAD_per_Share">120.60</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember" decimals="2" id="Fxbrl_20200220182205256" unitRef="CAD_per_Share">142.71</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyEightPointSeventyFourMember" decimals="2" id="Fxbrl_20200220182207081" unitRef="CAD_per_Share">148.74</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" decimals="2" id="Fxbrl_20200220182208664" unitRef="CAD_per_Share">19.91</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220134135147">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="border:0px;width:100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Grant date share price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$6.45 &amp;#x2014; $75.38&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$10.05 &amp;#x2014; $142.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$7.17 &amp;#x2014; $75.38&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$10.05 &amp;#x2014; $148.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Risk free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;1.24% &amp;#x2014; 1.90%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.97% &amp;#x2014; 2.41%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;5 years&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected volatiity&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;100%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
  <ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220141552831">&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The following table is a summary of the Company&amp;#x2019;s share options outstanding as at December 31, 2019:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border:0px;width:100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Options outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:245px"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:493px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Options exercisable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:213px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:228px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:245px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Weighted average&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:241px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:252px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:213px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:228px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:245px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;remaining contractual&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:241px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:252px;text-align:right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;Exercise price&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:228px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;Number outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:245px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;life [years]&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:241px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;Exercise price&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:252px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;Number exercisable&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px;border-bottom:1pt solid black"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:228px;border-bottom:1pt solid black"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;#&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:245px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;#&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:241px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:252px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;#&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;35,065&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;35,065&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;99,502&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;99,502&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;16,264&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;16,264&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.65&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.65&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,855&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,855&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13.47&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13.47&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18,409&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18,409&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;17.89&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,178&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;17.89&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,178&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;37,313&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.34&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;37,313&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;493,363&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.72&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;493,363&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;21.11&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,438&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.67&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;21.11&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,438&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;24.12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.59&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;24.12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,219&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;26.13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.62&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;26.13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;40.20&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;29,851&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.45&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;40.20&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;22,388&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;44.22&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,488&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.41&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;44.22&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,488&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;47.24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,493&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.37&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;47.24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,493&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;50.25&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;227,861&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;50.25&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;129,353&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.21&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;55.28&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;55.28&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.96&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.17&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.83&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.17&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;75.38&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.04&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;75.38&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.63&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;203,750&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.34&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.63&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;58,750&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.88&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;88.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.87&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;88.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;120.60&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;120.60&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,974&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,975&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;21.96&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:228px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,454,943&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:245px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.59&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:241px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;21.24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:252px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,200,242&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;p&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The following table is a summary of the Company's share options outstanding as at December 31, 2018:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border:0px;width:100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Options outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:494px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Options exercisable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Weighted average&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:251px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;remaining contractual&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:251px"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exercise price&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Number outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;life [years]&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exercise price&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:251px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Number exercisable&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:213px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:229px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;#&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:243px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;#&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:243px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:251px"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;#&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;149,254&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;149,254&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.03&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,488&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.98&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.03&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,488&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;42,289&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;42,289&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;33,169&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.27&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;16,584&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;26.13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.62&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;26.13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;56.28&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,438&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.91&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;56.28&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.96&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.88&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;88.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.87&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;88.44&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;120.60&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;120.60&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,975&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,658&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;148.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;199,004&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.70&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;148.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:213px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;74.53&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:229px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;485,159&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.32&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:243px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;19.91&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:251px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;253,815&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember" id="Fxbrl_20200220170710890">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember" id="Fxbrl_20200220170757756">P2Y8M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember" id="Fxbrl_20200220170759384">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember" id="Fxbrl_20200220170801033">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember" id="Fxbrl_20200220170802830">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember" id="Fxbrl_20200220170804756">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember" id="Fxbrl_20200220170806468">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember" id="Fxbrl_20200220170815500">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember" id="Fxbrl_20200220170817215">P3Y4M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember" id="Fxbrl_20200220170819236">P4Y8M19D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember" id="Fxbrl_20200220170820942">P4Y8M1D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember" id="Fxbrl_20200220170823268">P4Y7M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember" id="Fxbrl_20200220170825508">P3Y7M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember" id="Fxbrl_20200220170827212">P4Y5M12D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember" id="Fxbrl_20200220170828868">P3Y4M28D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember" id="Fxbrl_20200220170830940">P4Y4M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember" id="Fxbrl_20200220170836619">P5Y1M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember" id="Fxbrl_20200220170838590">P4Y2M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember" id="Fxbrl_20200220170840292">P4Y1M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember" id="Fxbrl_20200220170842236">P3Y11M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember" id="Fxbrl_20200220170848083">P4Y9M29D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember" id="Fxbrl_20200220170914607">P4Y14D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember" id="Fxbrl_20200220170917116">P5Y4M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember" id="Fxbrl_20200220170919180">P3Y10M17D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember" id="Fxbrl_20200220170921509">P3Y10M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember" id="Fxbrl_20200220170923660">P3Y8M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember" id="Fxbrl_20200220170928348">P3Y8M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190101to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20200220170930068">P4Y7M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember" id="Fxbrl_20200220182006757">P3Y8M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember" id="Fxbrl_20200220182026732">P0Y11M23D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember" id="Fxbrl_20200220182028425">P4Y4M6D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember" id="Fxbrl_20200220182030367">P4Y3M7D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember" id="Fxbrl_20200220182032151">P4Y7M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftySixPointTwentyEightMember" id="Fxbrl_20200220182034672">P4Y10M28D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember" id="Fxbrl_20200220182036896">P4Y11M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember" id="Fxbrl_20200220182038760">P4Y10M17D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember" id="Fxbrl_20200220182040784">P4Y10M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember" id="Fxbrl_20200220182045161">P4Y8M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember" id="Fxbrl_20200220182047560">P4Y8M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyEightPointSeventyFourMember" id="Fxbrl_20200220182051528">P4Y8M12D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_TypesOfSharebasedPaymentArrangementsAxis_StockOptionsMember" id="Fxbrl_20200220182053368">P4Y3M25D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <huge:BonusExpenseToBePaidInSubsequentPeriod contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200228132833176" unitRef="CAD">1730794</huge:BonusExpenseToBePaidInSubsequentPeriod>
  <huge:BonusExpenseToBePaidInSubsequentPeriod contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" id="Fxbrl_20200228132925527" unitRef="CAD" xsi:nil="true"></huge:BonusExpenseToBePaidInSubsequentPeriod>
  <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220154924867">&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17.&amp;#160;&lt;strong&gt;Loss per share&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss per common share represents net loss attributable to common shareholders divided by the weighted average number of common shares outstanding during the year.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For all the periods presented, diluted loss per share equals basic loss per share due to the anti-dilutive effect of warrants and share options. The outstanding number and type of securities that could potentially dilute basic net loss per share in the future but would have decreased the loss per share (anti-dilutive) for year ended December 31 presented are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:60%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;467,451&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;546,212&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share Options&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,454,943&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;485,159&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,922,394&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,031,371&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
  <ifrs-full:EarningsPerShareExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220155021226">&lt;div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:60%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;467,451&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;546,212&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share Options&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,454,943&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;485,159&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,922,394&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,031,371&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:EarningsPerShareExplanatory>
  <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares contextRef="C_20190101to20191231_ifrsfullClassesOfOrdinarySharesAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20200220154350768" unitRef="shares">467451</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares contextRef="C_20180101to20181231_ifrsfullClassesOfOrdinarySharesAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20200220154357686" unitRef="shares">546212</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220154434138" unitRef="shares">1922394</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220154427906" unitRef="shares">1031371</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares contextRef="C_20190101to20191231_ifrsfullClassesOfOrdinarySharesAxis_hugeStockOptionsMember" decimals="0" id="Fxbrl_20200220154453089" unitRef="shares">1454943</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00_ifrsfullClassesOfOrdinarySharesAxis_hugeStockOptionsMember" decimals="0" id="Fxbrl_20200220154424234" unitRef="shares">485159</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
  <ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220052546210">&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.&lt;span style="width:5.25pt;display:inline-block"&gt; &lt;/span&gt;&lt;strong&gt;General and administrative&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Components of general and administrative expenses for the years ended December 31, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;3,730,556&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,955,253&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Stock promotion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,902,453&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,803,588&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries, wages and benefits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,267,308&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,740,720&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consulting fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,288,129&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,037,049&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;General office, travel and adminsitration expenditures&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,172,824&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;726,509&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Repairs, maintenance and utilities&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;924,945&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,360,477&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Shareholder and public company costs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;440,746&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;124,973&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Listing expense&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,991,791&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign exchange loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;84,568&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:11px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;14,811,529&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,740,360&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory>
  <ifrs-full:ProfessionalFeesExpense contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220055103333" unitRef="CAD">3730556</ifrs-full:ProfessionalFeesExpense>
  <ifrs-full:ProfessionalFeesExpense contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220055109039" unitRef="CAD">1955253</ifrs-full:ProfessionalFeesExpense>
  <huge:StockPromotionExpenses contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220055151392" unitRef="CAD">2902453</huge:StockPromotionExpenses>
  <huge:StockPromotionExpenses contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220055118987" unitRef="CAD">2803588</huge:StockPromotionExpenses>
  <ifrs-full:WagesAndSalaries contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220055153288" unitRef="CAD">2267308</ifrs-full:WagesAndSalaries>
  <ifrs-full:WagesAndSalaries contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220055120802" unitRef="CAD">1740720</ifrs-full:WagesAndSalaries>
  <huge:ConsultingFeesExpenses contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220055155224" unitRef="CAD">2288129</huge:ConsultingFeesExpenses>
  <huge:ConsultingFeesExpenses contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220055122873" unitRef="CAD">2037049</huge:ConsultingFeesExpenses>
  <huge:ConsultingFeesExpenses contextRef="C_20190101to20191231_deiLegalEntityAxis_hugeFSDBiosciencesMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentsMember" decimals="0" id="Fxbrl_20200220174715476" unitRef="CAD">330436</huge:ConsultingFeesExpenses>
  <huge:ConsultingFeesExpenses contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefOperatingConsultantMember" decimals="0" id="Fxbrl_20200220174749724" unitRef="CAD">90000</huge:ConsultingFeesExpenses>
  <huge:ConsultingFeesExpenses contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeFormerChiefOperatingOfficerMember" decimals="0" id="Fxbrl_20200220174809171" unitRef="CAD">16667</huge:ConsultingFeesExpenses>
  <ifrs-full:AdministrativeExpense contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220055157000" unitRef="CAD">2172824</ifrs-full:AdministrativeExpense>
  <ifrs-full:AdministrativeExpense contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220055127632" unitRef="CAD">726509</ifrs-full:AdministrativeExpense>
  <ifrs-full:RepairsAndMaintenanceExpense contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220055158992" unitRef="CAD">924945</ifrs-full:RepairsAndMaintenanceExpense>
  <ifrs-full:RepairsAndMaintenanceExpense contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220055129272" unitRef="CAD">1360477</ifrs-full:RepairsAndMaintenanceExpense>
  <huge:ShareholdersAndPublicCompanyCosts contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220055202869" unitRef="CAD">440746</huge:ShareholdersAndPublicCompanyCosts>
  <huge:ShareholdersAndPublicCompanyCosts contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220055132648" unitRef="CAD">124973</huge:ShareholdersAndPublicCompanyCosts>
  <huge:ListingExpense contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200221040114446" unitRef="CAD">0</huge:ListingExpense>
  <huge:ListingExpense contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220055142267" unitRef="CAD">7991791</huge:ListingExpense>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220055215056" unitRef="CAD">84568</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200221040127095" unitRef="CAD">0</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228155150932">&lt;div&gt;&lt;p style="text-align:justify;margin-top:0pt;margin-left:5.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19.&lt;span style="width:5.25pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Income taxes&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align:justify;margin-left:2.25pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The reconciliation of income tax expense for the years ended December 31, 2019 and 2018 consists of the following:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div style="margin-left:39pt"&gt;&amp;#160;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:90%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss before income taxes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(52,013,186&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,710,624&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Statutory federal and provincial tax rate&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;26.50%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.50%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Income tax recovery at the statutory tax rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(13,783,494&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,018,315&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Permanent&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;differences&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;7,797,290&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;2,706,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:0pt;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other adjustment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,334,913&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:0t;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Change in tax benefits not recognized&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(348,709&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;)&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;3,312,315&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Deferred taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their tax values. Deferred tax liabilities at December 31, 2019 and 2018 are comprised of the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:90%;word-spacing:0px;margin:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;2018&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Deferred tax liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;$&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;Other investments&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&lt;strong&gt;(168,092&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;(1,334,000&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Capital losses carried forward&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;168,092&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;1,334,000&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Deferred tax liabilities not recognized&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Deferred taxes are provided as a result of temporary differences that arise due to the differences between the income tax values and the carrying amount of assets and liabilities. Deferred tax assets have not been recognized in respect of the following temporary differences:&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;table style="border:0px;width:100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;2018&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;width:959px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;border-bottom:1pt solid black;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;border-bottom:1pt solid black;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)"&gt;Property, plant and equipment&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;1,054,843&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)"&gt;Other investments&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;1,287,743&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)"&gt;Share issuance costs&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;1,169,642&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)"&gt;3,772,000&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)"&gt;Non-capital losses carried forward - Canada&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;27,518,609&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)"&gt;29,272,000&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)"&gt;Net operating losses carried forward - US&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;274,454&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)"&gt;Capital losses carried forward&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;350,465&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)"&gt;Unrealized fair value on biological assets and inventory&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;1,098,497&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:959px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;32,754,253&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;text-align:right;background-color:rgb(255, 255, 255)"&gt;33,044,000&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;The Company&amp;#x2019;s Canadian non-capital income tax losses expire as follows:&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:90%;word-spacing:0px;margin:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;$&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;2038&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border:1pt none;background-color:rgb(204, 238, 255)"&gt;12,492,296&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)"&gt;2039&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;15,026,313&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;27,518,609&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
  <huge:DisclosureOfProvisionForIncomeTaxesExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220142321860">&lt;div&gt;&lt;div style="margin-left:39pt"&gt;&amp;#160;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="width:90%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss before income taxes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(52,013,186&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,710,624&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Statutory federal and provincial tax rate&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;26.50%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.50%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Income tax recovery at the statutory tax rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(13,783,494&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,018,315&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Permanent&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;differences&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;7,797,290&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;2,706,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:0pt;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other adjustment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,334,913&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:0t;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Change in tax benefits not recognized&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(348,709&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;)&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;3,312,315&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</huge:DisclosureOfProvisionForIncomeTaxesExplanatory>
  <ifrs-full:AccountingProfit contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200219175757800" unitRef="CAD">-52013186</ifrs-full:AccountingProfit>
  <ifrs-full:AccountingProfit contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200219175805745" unitRef="CAD">-22710624</ifrs-full:AccountingProfit>
  <ifrs-full:ApplicableTaxRate contextRef="C_20190101to20191231" decimals="4" id="Fxbrl_20200219175933392" unitRef="Pure">0.2650</ifrs-full:ApplicableTaxRate>
  <ifrs-full:ApplicableTaxRate contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="4" id="Fxbrl_20200219175939314" unitRef="Pure">0.2650</ifrs-full:ApplicableTaxRate>
  <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200219180734238" unitRef="CAD">-13783494</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
  <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200219180738163" unitRef="CAD">-6018315</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
  <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200219181817759" unitRef="CAD">7797290</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
  <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200228165031015" unitRef="CAD">2706000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
  <huge:TaxEffectOfTemporaryDifferences contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200219180348452" unitRef="CAD">6334913</huge:TaxEffectOfTemporaryDifferences>
  <huge:TaxEffectOfTemporaryDifferences contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200219180014434" unitRef="CAD">0</huge:TaxEffectOfTemporaryDifferences>
  <huge:TaxEffectOfDeferredTaxAssetNotRecognized contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200302233159151" unitRef="CAD">-348709</huge:TaxEffectOfDeferredTaxAssetNotRecognized>
  <huge:TaxEffectOfDeferredTaxAssetNotRecognized contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200228165118964" unitRef="CAD">3312315</huge:TaxEffectOfDeferredTaxAssetNotRecognized>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200219183112387" unitRef="CAD">0</ifrs-full:DeferredTaxExpenseIncome>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200228160732578" unitRef="CAD">0</ifrs-full:DeferredTaxExpenseIncome>
  <ifrs-full:DisclosureOfDeferredTaxesExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228170237268">&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:90%;word-spacing:0px;margin:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;2018&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Deferred tax liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;$&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;Other investments&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&lt;strong&gt;(168,092&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;(1,334,000&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Capital losses carried forward&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;168,092&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;1,334,000&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Deferred tax liabilities not recognized&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ifrs-full:DisclosureOfDeferredTaxesExplanatory>
  <huge:DeferredTaxAssetsOtherInvestments contextRef="C_20191231" decimals="0" id="Fxbrl_20200302235952130" unitRef="CAD">-168092</huge:DeferredTaxAssetsOtherInvestments>
  <huge:DeferredTaxAssetsOtherInvestments contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200228182041465" unitRef="CAD">-1334000</huge:DeferredTaxAssetsOtherInvestments>
  <huge:DeferredTaxLiabilitiesCapitalLossesCarriedForward contextRef="C_20191231" decimals="0" id="Fxbrl_20200302234117049" unitRef="CAD">168092</huge:DeferredTaxLiabilitiesCapitalLossesCarriedForward>
  <huge:DeferredTaxLiabilitiesCapitalLossesCarriedForward contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200302234430695" unitRef="CAD">1334000</huge:DeferredTaxLiabilitiesCapitalLossesCarriedForward>
  <huge:DeferredTaxAssetLiabilityNotRecognized contextRef="C_20191231" decimals="0" id="Fxbrl_20200302234128974" unitRef="CAD">0</huge:DeferredTaxAssetLiabilityNotRecognized>
  <huge:DeferredTaxAssetLiabilityNotRecognized contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200302234403393" unitRef="CAD">0</huge:DeferredTaxAssetLiabilityNotRecognized>
  <huge:DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200303205633311">&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;table style="border:0px;width:100%"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;2018&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;width:959px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;border-bottom:1pt solid black;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;border-bottom:1pt solid black;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)"&gt;Property, plant and equipment&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;1,054,843&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)"&gt;Other investments&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;1,287,743&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)"&gt;Share issuance costs&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;1,169,642&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)"&gt;3,772,000&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)"&gt;Non-capital losses carried forward - Canada&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;27,518,609&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)"&gt;29,272,000&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)"&gt;Net operating losses carried forward - US&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;274,454&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)"&gt;Capital losses carried forward&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;350,465&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)"&gt;Unrealized fair value on biological assets and inventory&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;1,098,497&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#x2014;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:959px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;32,754,253&lt;/strong&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;text-align:right;background-color:rgb(255, 255, 255)"&gt;33,044,000&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;</huge:DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory>
  <huge:DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20200303211505754" unitRef="CAD">1054843</huge:DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20200303211535003" unitRef="CAD">1287743</huge:DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20200303211546442" unitRef="CAD">1169642</huge:DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200303211605311" unitRef="CAD">3772000</huge:DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20200303211647167" unitRef="CAD">27518609</huge:DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200303211651165" unitRef="CAD">29272000</huge:DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20200303211757900" unitRef="CAD">274454</huge:DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20200303211806927" unitRef="CAD">350465</huge:DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20200303211829759" unitRef="CAD">1098497</huge:DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised>
  <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20200303211844296" unitRef="CAD">32754253</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
  <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="Context_As_Of_31_Dec_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200303211850322" unitRef="CAD">33044000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
  <huge:ScheduleOfNonCapitalLossCarryforwardsTableTextBlock contextRef="C_20190101to20191231" id="Fxbrl_20200228170309981">&lt;div&gt;&lt;table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:90%;word-spacing:0px;margin:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;$&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;2038&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border:1pt none;background-color:rgb(204, 238, 255)"&gt;12,492,296&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)"&gt;2039&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;15,026,313&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;27,518,609&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</huge:ScheduleOfNonCapitalLossCarryforwardsTableTextBlock>
  <huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight contextRef="C_20191231" decimals="0" id="Fxbrl_20200303002109155" unitRef="CAD">12492296</huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight>
  <huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine contextRef="C_20191231" decimals="0" id="Fxbrl_20200303002117793" unitRef="CAD">15026313</huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine>
  <huge:NonCapitalLossCarryforwards contextRef="C_20191231" decimals="0" id="Fxbrl_20200303001148742" unitRef="CAD">27518609</huge:NonCapitalLossCarryforwards>
  <ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory contextRef="C_20190101to20191231" id="F9fd9b204-52f9-11ea-80c4-2d332cd66d90">&lt;div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.&lt;strong&gt; Commitments and contingencies&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Commitments&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Supply Agreement with Canntab Therapeutics Ltd. and World Class Extractions Inc.&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;On February 12, 2019, the Company announced that it had entered into a three-way supply agreement with Canntab Therapeutics Ltd. ("Canntab"), World Class Extractions Inc. ("World Class") (collectively with the Company, the "Purchasers") and a Supplier to purchase up to 1,000 kg of the Supplier's 2018 organic hemp crop, for which the Company has already purchased a quantity with a value of&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt; $100,000, &lt;/span&gt;&lt;/span&gt;which amount has been recorded in its inventory. The Purchasers intend to extract CBD oil from the 2019-2024 organic hemp crops and process the oil into gel capsules and tablets at the Company's facility in Cobourg. The Purchasers have committed to collectively purchase&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt; $1,000,000 &lt;/span&gt;&lt;/span&gt;worth of hemp plus applicable taxes, from the 2019 crop.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at December 31, 2019, no hemp has been received by the Company. The Company has provided a deposit of $166,667 to the Supplier as at year-end&amp;#160;&lt;/span&gt;&lt;/span&gt;for hemp product to be received. As of December 31, 2019, the Company has an outstanding commitment to purchase an additional $166,667 of hemp product from the Supplier, representing the Company's share of the Purchasers' collective commitment to purchase $1,000,000 of hemp from the 2019 crop.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to the Agreement, the Supplier granted the Purchasers the right and option to purchase up to $5,000,000 of the Supplier's hemp crop for a period of 5 years commencing in 2019 at a purchase price of $100 per kg per 1% of CBD extracted from the flower.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;Canntab is a Canadian cannabis oral dosage formulation company based in Markham, Ontario, engaged in the research and development of pharmaceutical-grade formulations of cannabinoids and trades on the Canadian Securities Exchange under the symbol PILL. World Class is understood to have developed an extraction process to produce quality, potent cannabis extracts using ultrasound to effectively produce extracts from cannabis and hemp and isolate essential compounds found in plant material. World Class trades on the Canadian Securities Exchange under the symbol PUMP. Certain Officers and Directors of the Company also serve as Directors of World Class.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;i&gt;Epitech License Agreement&lt;/i&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Under the terms of the Company's License Agreement with Epitech Group SPA ("Epitech"), the Company has payments due to Epitech pending the achievement of specified milestones. Upon first notification by the Food and Drug Administration ("FDA") of approval of a New Drug Application, the non-refundable sum of USD $700,000 will be due and payable to Epitech. Within ten business days of the first notification of approval of a Supplemental New Drug Application by the FDA, the Company will pay the non-refundable sum of USD $1,000,000 to Epitech.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;For non-prescription drug rights, any one-off lump sum payments received by the Company as consideration for granting a sub-license to a Commercial Partner with respect to a Licensed Product, shall require the Company to pay to Epitech 25% of the lump sum payment received by the Company. For prescription drug rights the Company shall pay 5% of any one-off lump sum payments to Epitech as consideration for granting a sub-license to a Commercial Partner with respect to a Licensed Product. The Company will pay the amounts payable on a quarterly basis within 60 days of the end of each calendar quarter.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;The Company shall pay either a) 7% of Net Sales of the Licensed Product in a Product Regulatory Category other than prescription drugs place on the market by the Company; or b) 25% of Net Receipts received by the Company from Commercial Partners where Licensed Products in a Product Regulatory Category other than prescription drugs are placed on the market by such Commercial Partners; or c) 5% of Net Sales or Net Receipts of the Licensed Products in the Product Regulatory Category of prescription drugs. The Company will pay the amounts payable on a quarterly basis within 60 days of the end of each calendar quarter.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;i&gt;Supply Agreement with Pharmadrug Production GMBH ("Pharmadrug")&lt;/i&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;FV Pharma has a supply agreement with Pharmadrug whereby FV Pharma has committed to make the following quantities of cannabis available to Pharmadrug to purchase under the terms of the Supply Agreement:&lt;/p&gt;&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border:0px;width:406px;margin:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="text-decoration:underline"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="text-decoration:underline"&gt;Commitment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(204, 238, 255)"&gt;2020&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(204, 238, 255)"&gt;350 kilograms&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(255, 255, 255)"&gt;2021&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(255, 255, 255)"&gt;650 kilograms&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(204, 238, 255)"&gt;2022&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(204, 238, 255)"&gt;1,000 kilograms&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(255, 255, 255)"&gt;2023&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(255, 255, 255)"&gt;1,000 kilograms&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(204, 238, 255)"&gt;2024&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(204, 238, 255)"&gt;1,000 kilograms&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;i&gt;Heritage Building Restoration Commitment&lt;/i&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;The Company has a commitment to restore the designated heritage building on the Company's premises. The estimated cost of restoration is $517,000.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Contingencies&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Legal matters&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;From time to time, the Company is named as a party to claims or involved in proceedings, including legal, regulatory and tax related, in the ordinary course of its business. While the outcome of these matters may not be estimable at the reporting date, the Company makes provisions, where possible, for the estimated outcome of such claims or proceedings. Should a loss result from the resolution of any claims or proceedings that differs from these estimates, the difference will be accounted for as a charge to profit or loss in that period.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Environmental&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Management believes that there are no probable environmental related liabilities that will have a material adverse effect on the financial position or operating results of the Company.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Claims from suppliers&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;A dismissed contractor commenced a lien action combined with a breach of contract action in the Cobourg Superior Court of Justice in early 2019 claiming approximately&amp;#160;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1,700,000 &lt;/span&gt;&lt;/span&gt;in various purported damages, with the claim for lien component of&amp;#160;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$188,309 &lt;/span&gt;&lt;/span&gt;being registered on November 26, 2018. The Company is defending the action and has taken steps to obtain particulars and inspect documents of the plaintiff which remain unaddressed to date. The Company has paid&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt; $235,387 &lt;/span&gt;&lt;/span&gt;to the Cobourg Superior Court to vacate the lien from title for which the funds stand both as security for the lien claim as well as its costs with the Cobourg Superior Court of Justice. . The 2019 breach of contract claim has not been provisioned as the Company believes these proceedings are without merit and intends to defend itself from this claim.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Former employee&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;FSD hired an individual by way of employment agreement. The individual's employment was subsequently terminated in the probationary period due to non-performance/cause in February 2019. The individual retained legal counsel in or around February 15, 2019 demanding that he be provided (i) unpaid wages; (ii) unpaid holiday pay, (iii) payment for wrongful dismissal (one week) and (iv) breach of contract.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;A hearing is scheduled for March 13, 2020 in front of the employment tribunal. The Company is of the view that the outcome will be unfavourable to the Company. For the year ended December 31, 2019, the Company recorded a provision of&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt; $97,320&amp;#160;&lt;/span&gt;&lt;/span&gt;in relation to the claimed amounts for unpaid wages and unpaid holiday pay. No amounts have been provisioned in respect of the claims for wrongful dismissal and breach of contract, as the Company is of the position that they will be able to successfully defend themselves from these claims.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Class Action&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;On February 22, 2019, a shareholder in FSD commenced a proposed class action proceeding against the Company by issuing a statement of claim in the Ontario Superior Court. Amongst other causes of action, the individual seeks leave to bring a claim pursuant to s.138 of the Ontario Securities Act, alleging the Company made statements containing misrepresentations related to the build-out of the Company's Cobourg facility.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;On October 16, 2019 dates for the leave motion were given - May 5-6, 2020. No discoveries have occurred nor has FSD been required to file a statement of defense. Management intends to contest this leave motion, and are in the process of preparing responding materials. The ultimate outcome of the matter cannot be reliably determined at this time and no provision has been recorded for this matter as at December 31, 2019.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Auxly Cannabis Group Inc.&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;On March 3, 2018, FSD entered into a Definitive Strategic Alliance and Streaming Agreement (the "Agreement") with Auxly Cannabis Group Inc. ("Auxly"). On February 6, 2019, the Company delivered to Auxly a Notice of Default, thereby terminating the Agreement effective immediately. Subsequent to the issuance of the Notice of Default, Auxly sent a Notice of Default to the Company on February 6, 2019 in response. To date, neither party has taken further legal action against the counter party.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;To fund the development, Auxly purchased 37,313 Class B shares for the aggregate of $7,500,000 &lt;/span&gt;&lt;/span&gt;from the Company's treasury by way of private placement, which funds were placed in trust to be spent on construction and development costs. The funds were placed in a trust account to be administered by Auxly. Due to the termination and subsequent negotiations, it is indeterminable at this point as to the amount, if any, of these funds will be released to the Company. Should any funds be released to the Company, those amounts will be recognized in future periods.&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory>
  <huge:AnticipatedPurchasePricePlusApplicableTaxesValue contextRef="C_20190201to20190212_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeCanntabTherapeuticsLtdWorldClassExtractionsIncMember" decimals="0" id="Fxbrl_20200220115201418" unitRef="CAD">1000000</huge:AnticipatedPurchasePricePlusApplicableTaxesValue>
  <huge:AmountOfDepositPaidToSupplier contextRef="C_20190101to20191231_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeCanntabTherapeuticsLtdWorldClassExtractionsIncMember" decimals="0" id="Fxbrl_20200220150537273" unitRef="CAD">166667</huge:AmountOfDepositPaidToSupplier>
  <huge:OutstandingCommitmentToPurchaseAdditionalProduct contextRef="C_20191231_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeCanntabTherapeuticsLtdWorldClassExtractionsIncMember" decimals="0" id="Fxbrl_20200228160743284" unitRef="CAD">166667</huge:OutstandingCommitmentToPurchaseAdditionalProduct>
  <huge:CollectiveCommitmentToPurchaseProduct contextRef="C_20191231_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeCanntabTherapeuticsLtdWorldClassExtractionsIncMember" decimals="0" id="Fxbrl_20200228160754610" unitRef="CAD">1000000</huge:CollectiveCommitmentToPurchaseProduct>
  <huge:SupplyAgreementOptionToPurchaseAmount contextRef="C_20190201to20190212_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeCanntabTherapeuticsLtdWorldClassExtractionsIncMember" decimals="0" id="Fxbrl_20200220115247792" unitRef="CAD">5000000</huge:SupplyAgreementOptionToPurchaseAmount>
  <huge:SupplyAgreementOptionToPurchasePeriod contextRef="C_20190201to20190212_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeCanntabTherapeuticsLtdWorldClassExtractionsIncMember" id="Fxbrl_20200220115510040">P5Y</huge:SupplyAgreementOptionToPurchasePeriod>
  <huge:SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted contextRef="C_20190201to20190212_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeCanntabTherapeuticsLtdWorldClassExtractionsIncMember" decimals="0" id="Fxbrl_20200220155540862" unitRef="CAD">100</huge:SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted>
  <huge:NonRefundableSumDueAndPayableUponFirstNotificationOfFDA contextRef="C_20191231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="0" id="Fxbrl_20200228165749176" unitRef="USD">700000</huge:NonRefundableSumDueAndPayableUponFirstNotificationOfFDA>
  <huge:NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA contextRef="C_20191231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="0" id="Fxbrl_20200228165802034" unitRef="USD">1000000</huge:NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA>
  <huge:PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights contextRef="C_20191231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="2" id="Fxbrl_20200228170925404" unitRef="Pure">0.25</huge:PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights>
  <huge:PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights contextRef="C_20191231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="2" id="Fxbrl_20200228170946982" unitRef="Pure">0.05</huge:PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights>
  <huge:PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition contextRef="C_20190101to20191231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="2" id="Fxbrl_20200228183808351" unitRef="Pure">0.07</huge:PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition>
  <huge:PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition contextRef="C_20190101to20191231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="2" id="Fxbrl_20200228183840853" unitRef="Pure">0.25</huge:PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition>
  <huge:PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition contextRef="C_20190101to20191231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="2" id="Fxbrl_20200228184007350" unitRef="Pure">0.05</huge:PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition>
  <huge:DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200302181247895">&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="border:0px;width:406px;margin:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="text-decoration:underline"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(255, 255, 255)"&gt;&lt;span style="text-decoration:underline"&gt;Commitment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(204, 238, 255)"&gt;2020&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(204, 238, 255)"&gt;350 kilograms&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(255, 255, 255)"&gt;2021&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(255, 255, 255)"&gt;650 kilograms&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(204, 238, 255)"&gt;2022&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(204, 238, 255)"&gt;1,000 kilograms&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(255, 255, 255)"&gt;2023&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(255, 255, 255)"&gt;1,000 kilograms&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(204, 238, 255)"&gt;2024&lt;/td&gt;&lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(204, 238, 255)"&gt;1,000 kilograms&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;</huge:DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory>
  <huge:QuantitiesAvailableToSupplyInNextFiscalYear contextRef="C_20190101to20191231_ifrsfullCounterpartiesAxis_hugePharmadrugProductionGMBHMember_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeFvPharmaIncMember" decimals="0" id="Fxbrl_20200228180147390" unitRef="Kg">350</huge:QuantitiesAvailableToSupplyInNextFiscalYear>
  <huge:QuantitiesAvailableToSupplyInSecondFiscalYear contextRef="C_20190101to20191231_ifrsfullCounterpartiesAxis_hugePharmadrugProductionGMBHMember_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeFvPharmaIncMember" decimals="0" id="Fxbrl_20200228181101219" unitRef="Kg">650</huge:QuantitiesAvailableToSupplyInSecondFiscalYear>
  <huge:QuantitiesAvailableToSupplyInThirdFiscalYear contextRef="C_20190101to20191231_ifrsfullCounterpartiesAxis_hugePharmadrugProductionGMBHMember_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeFvPharmaIncMember" decimals="0" id="Fxbrl_20200228181119658" unitRef="Kg">1000</huge:QuantitiesAvailableToSupplyInThirdFiscalYear>
  <huge:QuantitiesAvailableToSupplyInFifthFiscalYear contextRef="C_20190101to20191231_ifrsfullCounterpartiesAxis_hugePharmadrugProductionGMBHMember_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeFvPharmaIncMember" decimals="0" id="Fxbrl_20200228181146190" unitRef="Kg">1000</huge:QuantitiesAvailableToSupplyInFifthFiscalYear>
  <huge:QuantitiesAvailableToSupplyInFourthFiscalYear contextRef="C_20190101to20191231_ifrsfullCounterpartiesAxis_hugePharmadrugProductionGMBHMember_hugeTypeOfArrangementsAxis_hugeSupplyAgreementMember_deiLegalEntityAxis_hugeFvPharmaIncMember" decimals="0" id="Fxbrl_20200228181202625" unitRef="Kg">1000</huge:QuantitiesAvailableToSupplyInFourthFiscalYear>
  <huge:EstimatedCostOfRestorationInCommitment contextRef="C_20190101to20191231_hugeTypeOfArrangementsAxis_hugeHeritageBuildingRestorationCommitmentMember" decimals="0" id="Fxbrl_20200228181849877" unitRef="CAD">517000</huge:EstimatedCostOfRestorationInCommitment>
  <huge:ClaimIssuedByContractorForVariousPurportedDamages contextRef="C_20190101to20191231_ifrsfullClassesOfContingentLiabilitiesAxis_ifrsfullLegalProceedingsContingentLiabilityMember" decimals="0" id="Fxbrl_20200220151017701" unitRef="CAD">1700000</huge:ClaimIssuedByContractorForVariousPurportedDamages>
  <huge:ClaimForLienComponent contextRef="C_20190101to20191231_ifrsfullClassesOfContingentLiabilitiesAxis_ifrsfullLegalProceedingsContingentLiabilityMember" decimals="0" id="Fxbrl_20200220151022076" unitRef="CAD">188309</huge:ClaimForLienComponent>
  <huge:SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees contextRef="C_20190101to20191231_ifrsfullClassesOfContingentLiabilitiesAxis_ifrsfullLegalProceedingsContingentLiabilityMember" decimals="0" id="Fxbrl_20200220140929241" unitRef="CAD">235387</huge:SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees>
  <huge:EmployeeRelatedLiability contextRef="C_20191231" decimals="0" id="Fxbrl_20200220142412493" unitRef="CAD">97320</huge:EmployeeRelatedLiability>
  <huge:NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement contextRef="C_20190101to20191231_ifrsfullClassesOfContingentLiabilitiesAxis_hugeContingentLiabilityForConstructionAndDevelopmentCostsMember_ifrsfullCounterpartiesAxis_hugeAuxlyCannabisGroupIncMember_hugeTypeOfArrangementsAxis_hugeDefinitiveStrategicAllianceAndStreamingAgreementMember" decimals="0" id="Fxbrl_20200220125604820" unitRef="shares">37313</huge:NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement>
  <huge:AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement contextRef="C_20190101to20191231_ifrsfullClassesOfContingentLiabilitiesAxis_hugeContingentLiabilityForConstructionAndDevelopmentCostsMember_ifrsfullCounterpartiesAxis_hugeAuxlyCannabisGroupIncMember_hugeTypeOfArrangementsAxis_hugeDefinitiveStrategicAllianceAndStreamingAgreementMember" decimals="0" id="Fxbrl_20200220125621403" unitRef="CAD">7500000</huge:AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement>
  <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="C_20190101to20191231" id="F9fd98af0-52f9-11ea-80c4-2d332cd66d90">&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;21.&lt;span style="width:5.25pt;display:inline-block"&gt; &lt;/span&gt;&lt;strong&gt;Related party transactions&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the entity, directly or indirectly.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Compensation paid or payable to key management and directors comprised the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:40pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2022;&lt;span style="width:12.75pt;text-indent:0pt;display:inline-block"&gt; &lt;/span&gt;The Company paid the former President and CEO of FV Pharma&amp;#160;$770,000 in 2019 as a retirement benefit. The Company also paid the former President and CEO of FV Pharma $54,958 in salaries and benefits through a related entity owned by the former President and CEO on top of $96,250 in salaries and benefits and other allowances of $4,500 paid directly to the Former CEO.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:40pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2022;&lt;span style="width:12.75pt;display:inline-block"&gt; &lt;/span&gt;The Company paid expenses of $754,311 to a company owned by the CEO for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under various expense line &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;categories. The Company recognized a share-based bonus expense for the year-ended December 31, 2019 in the amount of $1,428,591 to be paid to the CEO by issuance of 200,927 Class B common shares of the Company. The Class B common shares will be issued subsequent to December 31, 2019. As at December 31, 2019 the Company had an outstanding balance of $95,708 due to a Company controlled by the CEO, included in trade and other payables.&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:40pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2022;&lt;span style="width:12.75pt;display:inline-block"&gt; &lt;/span&gt;The Company paid consulting fees of $330,436 to the President of FSD Biosciences for services rendered for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under consulting fees.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;The Company recognized a share-based bonus expense for the year-ended December 31, 2019 in the amount of $109,892 to be paid to the President of FSD Biosciences by issuance of 15,456 Class B common shares of the Company. The Class B common shares will be issued subsequent to December 31, 2019.&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#x2022;&lt;span style="width:12.56pt;text-indent:0pt;display:inline-block"&gt; &lt;/span&gt;The Company recognized a share-based bonus expense for the year-ended December 31, 2019 in the amount of $109,892 to be paid to the President of FSD by issuance of 15,456 Class B common shares of the Company. The Class B common shares will be issued subsequent to December 31, 2019.&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#x2022;&lt;span style="width:12.56pt;text-indent:0pt;display:inline-block"&gt; &lt;/span&gt;The Company recognized a share-based bonus expense for the year-ended December 31, 2019 in the amount of $54,946 to be paid to the President of FV Pharma by issuance of 7,728 Class B common shares of the Company. The Class B common shares will be issued subsequent to December 31, 2019.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2022;&lt;span style="width:12.75pt;display:inline-block"&gt; &lt;/span&gt;The Company paid fees of $196,870 to a company owned by the CFO for services rendered for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under salaries, wages and benefits.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&amp;#160;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2022;&lt;span style="width:12.75pt;display:inline-block"&gt; &lt;/span&gt;The Company paid consulting fees of $90,000 to a company owned by the Chief Operating Consultant for services rendered for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under consulting fees.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&amp;#160;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2022;&lt;span style="width:12.75pt;display:inline-block"&gt; &lt;/span&gt;The Company paid consulting fees of $16,667 to a company owned by the former COO for services rendered for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under consulting fees.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&amp;#160;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2022;&lt;span style="width:12.75pt;display:inline-block"&gt; &lt;/span&gt;The Company pays independent directors&amp;#160;$40,000 per annum, with the Chairman of each respective committee receiving an additional $10,000 per &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;annum&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;. Directors fees for the year ended December 31, 2019 were $203,521 (2018 - $66,667). As of December 31, 2019, $98,521 of &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;director's&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt; fees &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;were due and payable.&lt;/p&gt;&amp;#160;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2022;&lt;span style="width:12.75pt;display:inline-block"&gt; &lt;/span&gt;On November 4, 2019, the Company completed a private placement by the issuance of 228,670 Class B shares at a price of $20.10 per share for total gross proceeds of $4,598,618. 164,755 Class B Shares were subscribed by the Officers and Directors of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#x2022;&lt;span style="width:12.56pt;text-indent:0pt;display:inline-block"&gt; &lt;/span&gt;The Company recognized share-based compensation expense of $132,178 for the year-ended December 31, 2019 for services to be provided by a consulting company related to the President of the Company.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Key management personnel compensation during the years ended December 31 comprised of:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries, benefits, bonuses and consulting fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,836,192&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,814,115&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,476,385&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,215,401&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;17,312,577&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;5,029,516&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
  <ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentAndChiefExecutiveOfficerMember_deiLegalEntityAxis_hugeFvPharmaIncMember" decimals="0" id="Fxbrl_20200220154431869" unitRef="CAD">770000</ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentAndChiefExecutiveOfficerMember_deiLegalEntityAxis_hugeFvPharmaIncMember" decimals="0" id="Fxbrl_20200220173455979" unitRef="CAD">54958</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentAndChiefExecutiveOfficerMember" decimals="0" id="Fxbrl_20200220173510527" unitRef="CAD">96250</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200228114631028" unitRef="CAD">17312577</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200228114652381" unitRef="CAD">5029516</ifrs-full:KeyManagementPersonnelCompensation>
  <huge:OtherAllowances contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeFormerChiefExecutiveOfficerMember" decimals="0" id="Fxbrl_20200220173527700" unitRef="CAD">4500</huge:OtherAllowances>
  <huge:PaymentOfExpenses contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember" decimals="0" id="Fxbrl_20200220173551955" unitRef="CAD">754311</huge:PaymentOfExpenses>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200228143731994" unitRef="CAD">1428591</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentsMember_deiLegalEntityAxis_hugeFSDBiosciencesMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200228143825551" unitRef="CAD">109892</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentOfFSDMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200228143850861" unitRef="CAD">109892</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="C_20190101to20191231_deiLegalEntityAxis_hugeFvPharmaIncMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentsMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200228143858741" unitRef="CAD">54946</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220164402824" unitRef="CAD">4836192</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220164450330" unitRef="CAD">1814115</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200228143759609" unitRef="Share">200927</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentsMember_deiLegalEntityAxis_hugeFSDBiosciencesMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200228143832446" unitRef="Share">15456</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentOfFSDMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200228143946953" unitRef="Share">15456</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement contextRef="C_20190101to20191231_deiLegalEntityAxis_hugeFvPharmaIncMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentsMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200228143954959" unitRef="Share">7728</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement contextRef="C_20200101to20200102_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="INF" id="Fxbrl_20200220025942779" unitRef="Share">27580</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:TradeAndOtherPayables contextRef="C_20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember" decimals="0" id="Fxbrl_20200228143814041" unitRef="CAD">95708</ifrs-full:TradeAndOtherPayables>
  <huge:ManagementFees contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefFinancialOfficersMember" decimals="0" id="Fxbrl_20200220174731436" unitRef="CAD">196870</huge:ManagementFees>
  <ifrs-full:DirectorsRemunerationExpense contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeIndependentDirectorMember" decimals="0" id="Fxbrl_20200220174827819" unitRef="CAD">40000</ifrs-full:DirectorsRemunerationExpense>
  <ifrs-full:DirectorsRemunerationExpense contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220173005279" unitRef="CAD">203521</ifrs-full:DirectorsRemunerationExpense>
  <ifrs-full:DirectorsRemunerationExpense contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220154516084" unitRef="CAD">66667</ifrs-full:DirectorsRemunerationExpense>
  <huge:AdditionalRemuneration contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeIndependentDirectorMember" decimals="0" id="Fxbrl_20200220174844068" unitRef="CAD">10000</huge:AdditionalRemuneration>
  <huge:DirectorsRemunerationPayable contextRef="C_20191231" decimals="0" id="Fxbrl_20200220175037839" unitRef="CAD">98521</huge:DirectorsRemunerationPayable>
  <huge:ValueOfSharesIssuedInPrivatePlacement contextRef="C_20191101to20191104_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200228193739019" unitRef="CAD">4598618</huge:ValueOfSharesIssuedInPrivatePlacement>
  <huge:NumberOfSharesSubscribed contextRef="C_20191101to20191104_ifrsfullCategoriesOfRelatedPartiesAxis_hugeDirectorsAndOfficersMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200220175239653" unitRef="shares">164755</huge:NumberOfSharesSubscribed>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="C_20190101to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentsMember" decimals="0" id="Fxbrl_20200228145738171" unitRef="CAD">132178</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="C_20190101to20191231" decimals="0" id="Fxbrl_20200220164515570" unitRef="CAD">12476385</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00" decimals="0" id="Fxbrl_20200220164547955" unitRef="CAD">3215401</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220164842801">&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"&gt;&lt;tbody&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2018&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(204, 238, 255)"&gt;&lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries, benefits, bonuses and consulting fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,836,192&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,814,115&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color:rgb(255, 255, 255)"&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,476,385&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,215,401&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;17,312,577&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;5,029,516&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory>
  <ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory contextRef="C_20190101to20191231" id="F9fd915c1-52f9-11ea-80c4-2d332cd66d90">&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22.&lt;strong&gt;&lt;span style="width:5.25pt;display:inline-block"&gt; &lt;/span&gt;Capital Management&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;The Company's capital management objectives are to maintain financial flexibility in order to complete development of its facilities and extraction processes and the pharmaceutical research and development program centered on the lead asset, micro-PEA. The Company defines capital as the aggregate of its capital stock and borrowings.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;As at December 31, 2019, the Company's Share Capital was&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt; $98,016,649 (2018 - $68,117,802). &lt;/span&gt;&lt;/span&gt;The Company does not have any long-term debt. Outstanding Notes payable were assumed on acquisition of Prismic and are due on demand.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;The Company manages its capital structure in accordance with changes in economic conditions. In order to maintain or adjust its capital structure, the Company may elect to issue or repay financial liabilities, issue shares, repurchase shares, pay dividends or undertake any other activities as deemed appropriate under the specific circumstances. The Company is not subject to any externally imposed capital requirements.&lt;/p&gt;</ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory>
  <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200220043414270">&lt;div&gt;&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;23.&lt;span style="width:5.25pt;display:inline-block"&gt; &lt;/span&gt;&lt;strong&gt;Financial Instruments and Risk Management&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;i&gt;Credit risk&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from deposits with banks and outstanding receivables. The Company trades only with recognized, creditworthy third parties. The Company does not currently have any material outstanding trade receivables with customers.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company does not hold any collateral as security but mitigates this risk by dealing only with what management believes to be financially sound counterparties and, accordingly, does not anticipate significant loss for non-performance.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;i&gt;Liquidity risk&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liquidity risk is the risk the Company will not be able to meet its financial obligations as they come due. The Company's exposure to liquidity risk is dependent on the Company's ability to raise additional financing to meet its commitments and sustain operations. The Company mitigates liquidity risk by management of working capital, cash flows, the issuance of share capital and if desired, the issuance of debt. The Company's trade and other payables, derivative liability and notes payables are all due within twelve months from the date of these financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;If unanticipated events occur that impact the Company's ability to complete development of its production facilities and carrying the planned clinical trials, the Company may need to take additional measures to increase its liquidity and capital resources, including issuing debt or additional equity financing or strategically altering the business forecast and plan. In this case, there is no guarantee that the Company will obtain satisfactory financing terms or adequate financing. Failure to obtain adequate financing on satisfactory terms could have a material adverse effect on the Company's results of operations or financial condition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;i&gt;Market risk&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Market risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises three types of risk: foreign currency risk, interest rate risk and other price risk.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt; &lt;/span&gt;Foreign currency risk&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency risk arises on financial instruments that are denominated in a currency other than the functional currency in which they are measured. The Company's primary exposure with respect to foreign currencies is from US dollar denominated notes payable. A 1% change in the foreign exchange rates would not result in any significant impact to the financial statements.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt; &lt;/span&gt;Interest rate risk&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest rate risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to interest rate risk as at December 31, 2019 as there are no material long-term borrowings outstanding.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt; &lt;/span&gt;Other price risk&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other price risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices (other than those arising from interest rate risk or currency risk), whether those changes are caused by factors specific to the individual financial instrument or its issuer, or factors affecting all similar financial instruments traded in the market. The Company is not exposed to other price risk as at December 31, 2019.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:48px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;i&gt;Fair values&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The carrying values of cash, trade and other receivables, trade and other payables and notes payable approximate fair values due to the short-term nature of these items or they are being carried at fair value or, for notes payable, interest payables are close to the current market rates. The risk of material change in fair value is not considered to be significant. The Company does not use derivative financial instruments to manage this risk.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial instruments recorded at fair value on the consolidated statement of financial position are classified using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company's valuation techniques. A level is assigned to each fair value measurement based on the lowest-level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:51px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2022;&lt;span style="width:14.25pt;display:inline-block"&gt; &lt;/span&gt;Level 1 &amp;#x2013; Unadjusted quoted prices as at the measurement date for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2022;&lt;span style="width:14.25pt;display:inline-block"&gt; &lt;/span&gt;Level 2 &amp;#x2013; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can&lt;br/&gt;be corroborated by observable market data.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:51px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2022;&lt;span style="width:14.25pt;display:inline-block"&gt; &lt;/span&gt;Level 3 &amp;#x2013; Significant unobservable inputs that are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:51px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The fair value hierarchy requires the use of observable market inputs whenever such inputs exist. A financial instrument is classified to the lowest level of the hierarchy for which a significant input has been considered in measuring fair value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Private company investments measured at fair value are classified as Level 3 financial instruments. The valuation method and significant assumptions used to determine the fair value of private company investments have been disclosed in the Other Investments note. During the year, there were no transfers of amounts between levels.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
  <ifrs-full:DisclosureOfOperatingSegmentsExplanatory contextRef="C_20190101to20191231" id="Fxbrl_20200228002343318">&lt;div&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;24.&lt;span style="width:5.49pt;text-indent:0pt;display:inline-block"&gt; &lt;/span&gt;&lt;strong&gt;Segmented information&lt;/strong&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;The Company reports segment information based on internal reports used by the chief operating decision maker ("CODM") to make operating and resource decisions and to assess performance. The CODM is the Chief Executive Officer of the Company. The CODM makes decisions and assesses performance of the Company on a consolidated basis such that the Company is a single reportable operating segment. For the years ended December 31, 2019 and 2018 all revenues generated by the Company were earned by their subsidiary, FV Pharma, who is domiciled in Canada. For the years ended December 31, 2019 and 2018 all property, plant and equipment were held by FV Pharma and the intangible asset is related to the Company's US domiciled subsidiary, Prismic.&lt;/p&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
  <ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory contextRef="C_20190101to20191231" id="F9fd9d910-52f9-11ea-80c4-2d332cd66d90">&lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25.&lt;span style="width:5.25pt;display:inline-block"&gt; &lt;/span&gt;&lt;strong&gt;Subsequent events&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 2, 2020, the Company issued 27,580 Class B Common Shares as &lt;/span&gt;&lt;/span&gt;share-based compensation to certain Board of Directors for services performed as directors for the year-ended December 31, 2019.&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 9, 2020, the Company commenced trading on the NASDAQ under the symbol "HUGE".&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 4, 2020, the Company issued 225,371 Class B Common Shares to Solarvest as settlement under the Share Exchange Agreement to settle derivative liability of $2,646,269.&amp;#160;&lt;/span&gt;&lt;/span&gt;The Company also concurrently announced the appointment of Dr. Edward J. Brennan, President of FSD Pharma's Biosciences Division, to the board of directors of Solarvest.&lt;br/&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 5, 2020 the Company executed Share Purchase and Sale Agreements with a consortium of buyers to sell the Company's investment in Cannara, consisting of 85,003,750 Class B shares, for gross proceeds of $7,743,492.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Subsequent to December 31, 2019 the Company is considering the continuing use or sale of the Cobourg facility.&lt;/p&gt;</ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory>
  <huge:NumberOfAdditionalSharesIssuedToSettleDerivativeLiability contextRef="C_20200201to20200204_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="INF" id="Fxbrl_20200220025952705" unitRef="shares">225371</huge:NumberOfAdditionalSharesIssuedToSettleDerivativeLiability>
  <huge:DerivativeLiabilitiesSettledThroughIssuanceOfShares contextRef="C_20200204_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="0" id="Fxbrl_20200220025956938" unitRef="CAD">2646269</huge:DerivativeLiabilitiesSettledThroughIssuanceOfShares>
  <huge:NumberOfSharesSold contextRef="C_20200201to20200205_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="INF" id="Fxbrl_20200227235512601" unitRef="shares">85003750</huge:NumberOfSharesSold>
  <ifrs-full:ProceedsFromIssueOfOrdinaryShares contextRef="C_20200201to20200205_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="0" id="Fxbrl_20200227235520776" unitRef="CAD">7743492</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>huge-20191231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:huge="http://www.fsdpharma.com/20191231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" targetNamespace="http://www.fsdpharma.com/20191231" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd"/>
  <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
  <import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd"/>
  <import namespace="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.fsdpharma.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0001 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" id="CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION">
        <link:definition>0002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS" id="CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS">
        <link:definition>0003 - Statement - CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" id="CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
        <link:definition>0004 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NatureOfBusiness" id="NatureOfBusiness">
        <link:definition>0006 - Disclosure - Nature of business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/BasisOfPresentation" id="BasisOfPresentation">
        <link:definition>0007 - Disclosure - Basis of presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>0008 - Disclosure - Significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ReverseTakeoverTransaction" id="ReverseTakeoverTransaction">
        <link:definition>0009 - Disclosure - Reverse Takeover Transaction</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceutical" id="AcquisitionOfPrismicPharmaceutical">
        <link:definition>0010 - Disclosure - Acquisition of Prismic Pharmaceutical</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivables" id="TradeAndOtherReceivables">
        <link:definition>0011 - Disclosure - Trade and other receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/Inventory" id="Inventory">
        <link:definition>0012 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/BiologicalAssets" id="BiologicalAssets">
        <link:definition>0013 - Disclosure - Biological assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/OtherInvestments" id="OtherInvestments">
        <link:definition>0014 - Disclosure - Other investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RightofuseAsset" id="RightofuseAsset">
        <link:definition>0015 - Disclosure - Right-of-use asset</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/PropertyPlantAndEquipment" id="PropertyPlantAndEquipment">
        <link:definition>0016 - Disclosure - Property, plant and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IntangibleAssets" id="IntangibleAssets">
        <link:definition>0017 - Disclosure - Intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LeaseObligations" id="LeaseObligations">
        <link:definition>0018 - Disclosure - Lease obligations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NotesPayable" id="NotesPayable">
        <link:definition>0019 - Disclosure - Notes Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapital" id="ShareCapital">
        <link:definition>0020 - Disclosure - Share capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SharebasedCompensation" id="SharebasedCompensation">
        <link:definition>0021 - Disclosure - Share-based compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LossPerShare" id="LossPerShare">
        <link:definition>0022 - Disclosure - Loss per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/GeneralAndAdministrative" id="GeneralAndAdministrative">
        <link:definition>0023 - Disclosure - General and administrative</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>0024 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>0025 - Disclosure - Commitments and contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>0026 - Disclosure - Related party transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CapitalManagement" id="CapitalManagement">
        <link:definition>0027 - Disclosure - Capital Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskManagement" id="FinancialInstrumentsAndRiskManagement">
        <link:definition>0028 - Disclosure - Financial Instruments and Risk Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SegmentedInformation" id="SegmentedInformation">
        <link:definition>0029 - Disclosure - Segmented information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>0030 - Disclosure - Subsequent events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
        <link:definition>0031 - Disclosure - Significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NatureOfBusinessTable" id="NatureOfBusinessTable">
        <link:definition>0032 - Disclosure - Nature of business (Table)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
        <link:definition>0033 - Disclosure - Significant accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalTables" id="AcquisitionOfPrismicPharmaceuticalTables">
        <link:definition>0034 - Disclosure - Acquisition of Prismic Pharmaceutical (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivablesTables" id="TradeAndOtherReceivablesTables">
        <link:definition>0035 - Disclosure - Trade and other receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/InventoryTables" id="InventoryTables">
        <link:definition>0036 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/BiologicalAssetsTables" id="BiologicalAssetsTables">
        <link:definition>0037 - Disclosure - Biological assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/OtherinvestmentsTables" id="OtherinvestmentsTables">
        <link:definition>0038 - Disclosure - Other investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RightofuseAssetTables" id="RightofuseAssetTables">
        <link:definition>0039 - Disclosure - Right-of-use asset (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/PropertyplantandequipmentTables" id="PropertyplantandequipmentTables">
        <link:definition>0040 - Disclosure - Property, plant and equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
        <link:definition>0041 - Disclosure - Intangible assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LeaseObligationsTables" id="LeaseObligationsTables">
        <link:definition>0042 - Disclosure - Lease obligations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NotesPayableTables" id="NotesPayableTables">
        <link:definition>0043 - Disclosure - Notes Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapitalTables" id="ShareCapitalTables">
        <link:definition>0044 - Disclosure - Share capital (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SharebasedCompensationTables" id="SharebasedCompensationTables">
        <link:definition>0045 - Disclosure - Share-based compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LossPerShareTables" id="LossPerShareTables">
        <link:definition>0046 - Disclosure - Loss per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/GeneralAndAdministrativeTables" id="GeneralAndAdministrativeTables">
        <link:definition>0047 - Disclosure - General and administrative (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncometaxesTables" id="IncometaxesTables">
        <link:definition>0048 - Disclosure - Income taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
        <link:definition>0049 - Disclosure - Commitments and contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsTables" id="RelatedPartyTransactionsTables">
        <link:definition>0050 - Disclosure - Related party transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NatureOfBusinessNarrativeDetails" id="NatureOfBusinessNarrativeDetails">
        <link:definition>0051 - Disclosure - Nature of business (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesNarrativeDetails" id="SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0052 - Disclosure - Significant accounting policies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalNarrativeDetails" id="AcquisitionOfPrismicPharmaceuticalNarrativeDetails">
        <link:definition>0053 - Disclosure - Acquisition of Prismic Pharmaceutical (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/InventoryNarrativeDetails" id="InventoryNarrativeDetails">
        <link:definition>0054 - Disclosure - Inventory (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/BiologicalAssetsNarrativeDetails" id="BiologicalAssetsNarrativeDetails">
        <link:definition>0055 - Disclosure - Biological assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails" id="OtherInvestmentsNarrativeDetails">
        <link:definition>0056 - Disclosure - Other investments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/PropertyplantandequipmentDetails1" id="PropertyplantandequipmentDetails1">
        <link:definition>0057 - Disclosure - Property, plant and equipment (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IntangibleAssetsNarrativeDetails" id="IntangibleAssetsNarrativeDetails">
        <link:definition>0058 - Disclosure - Intangible assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NotesPayableNarrativeDetails" id="NotesPayableNarrativeDetails">
        <link:definition>0059 - Disclosure - Notes Payable (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails" id="ShareCapitalNarrativeDetails">
        <link:definition>0060 - Disclosure - Share capital (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails" id="SharebasedCompensationNarrativeDetails">
        <link:definition>0061 - Disclosure - Share-based compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails" id="CommitmentsAndContingenciesNarrativeDetails">
        <link:definition>0062 - Disclosure - Commitments and contingencies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails" id="RelatedPartyTransactionsNarrativeDetails">
        <link:definition>0063 - Disclosure - Related party transactions (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CapitalManagementNarrativeDetails" id="CapitalManagementNarrativeDetails">
        <link:definition>0064 - Disclosure - Capital management (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresNarrativeDetails" id="FinancialInstrumentsAndRiskExposuresNarrativeDetails">
        <link:definition>0065 - Disclosure - Financial instruments and risk exposures (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails" id="SubsequentEventsNarrativeDetails">
        <link:definition>0066 - Disclosure - Subsequent events (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails" id="NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails">
        <link:definition>0067 - Disclosure - Nature of business - Schedule of ownership percentage in subsidiaries (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails" id="SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails">
        <link:definition>0068 - Disclosure - Significant accounting policies - Schedule of estimated useful lives of assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfAppliedTheDefinitionOfALeaseUnderIFRS16ToContractsDetails" id="SignificantAccountingPoliciesScheduleOfAppliedTheDefinitionOfALeaseUnderIFRS16ToContractsDetails">
        <link:definition>0069 - Disclosure - Significant accounting policies - Schedule of applied the definition of a lease under IFRS 16 to contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails" id="AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails">
        <link:definition>0070 - Disclosure - Acquisition of Prismic Pharmaceutical - Schedule of black scholes options pricing model (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" id="AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails">
        <link:definition>0071 - Disclosure - Acquisition of Prismic Pharmaceutical - Schedule of identifiable assets acquired and liabilities assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails" id="TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails">
        <link:definition>0072 - Disclosure - Trade and other receivables- Schedule of trade and other receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/InventoryScheduleOfInventoriesDetails" id="InventoryScheduleOfInventoriesDetails">
        <link:definition>0073 - Disclosure - Inventory - Schedule of inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/BiologicalAssetsScheduleOfBiologicalAssetsDetails" id="BiologicalAssetsScheduleOfBiologicalAssetsDetails">
        <link:definition>0074 - Disclosure - Biological assets - Schedule of biological assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/BiologicalAssetsScheduleOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsDetails" id="BiologicalAssetsScheduleOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsDetails">
        <link:definition>0075 - Disclosure - Biological assets - Schedule of unobservable input used to estimate fair value of biological assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails" id="OtherInvestmentsScheduleOfOtherInvestmentsDetails">
        <link:definition>0076 - Disclosure - Other investments - Schedule of Other investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RightofuseAssetScheduleOfRightofuseAssetDetails" id="RightofuseAssetScheduleOfRightofuseAssetDetails">
        <link:definition>0077 - Disclosure - Right-of-use asset - Schedule of right-of-use asset (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/PropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" id="PropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails">
        <link:definition>0078 - Disclosure - Property, plant and equipment - Schedule of property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails" id="IntangibleAssetsScheduleOfIntangibleAssetsDetails">
        <link:definition>0079 - Disclosure - Intangible assets - Schedule of intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfLeaseObligationsDetails" id="LeaseObligationsScheduleOfLeaseObligationsDetails">
        <link:definition>0080 - Disclosure - Lease obligations - Schedule of lease obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails" id="LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails">
        <link:definition>0081 - Disclosure - Lease obligations - Schedule of maturity analysis of operating lease payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NotesPayableScheduleOfNotesPayableDetails" id="NotesPayableScheduleOfNotesPayableDetails">
        <link:definition>0082 - Disclosure - Notes Payable - Schedule of notes payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails" id="ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails">
        <link:definition>0083 - Disclosure - Share capital - Schedule of reconciliation of the share capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails" id="ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails">
        <link:definition>0084 - Disclosure - Share capital - Schedule of changes in number of warrants outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails" id="ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails">
        <link:definition>0085 - Disclosure - Share capital - Schedule of fair value assumptions of warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails" id="ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails">
        <link:definition>0086 - Disclosure - Share capital - Schedule of warrants outstanding and exercise price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails" id="SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails">
        <link:definition>0087 - Disclosure - Share-based compensation - Schedule of changes in number of share options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails" id="SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails">
        <link:definition>0088 - Disclosure - Share-based compensation - Schedule of fair value assumptions of share options granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails" id="SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails">
        <link:definition>0089 - Disclosure - Share-based compensation - Schedule of exercise price and weighted average contractual term of share options outstanding  and exercisable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LossPerShareDetails" id="LossPerShareDetails">
        <link:definition>0090 - Disclosure - Loss per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/GeneralAndAdministrativeDetails" id="GeneralAndAdministrativeDetails">
        <link:definition>0091 - Disclosure - General and administrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" id="IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails">
        <link:definition>0092 - Disclosure - Income taxes - Schedule of provision for income taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails" id="IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails">
        <link:definition>0093 - Disclosure - Income taxes - Schedule of deferred tax assets (liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails" id="IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails">
        <link:definition>0094 - Disclosure - Income taxes - Schedule of temporary differences for which deferred tax assets not recognised (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails" id="IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails">
        <link:definition>0095 - Disclosure - Income taxes - Schedule of non-capital loss carryforwards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails" id="CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails">
        <link:definition>0096 - Disclosure - Commitments and contingencies - Schedule of quantities of cannabis available to supply by fiscal period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails" id="RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails">
        <link:definition>0097 - Disclosure - Related party transactions - Schedule of key management personnel compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfFinancialObligationsBasedOnTheirDueDatesDetails" id="FinancialInstrumentsAndRiskExposuresScheduleOfFinancialObligationsBasedOnTheirDueDatesDetails">
        <link:definition>0098 - Disclosure - Financial instruments and risk exposures - Schedule of financial obligations based on their due dates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfFinancialAssetsAndFinancialLiabilitiesDetails" id="FinancialInstrumentsAndRiskExposuresScheduleOfFinancialAssetsAndFinancialLiabilitiesDetails">
        <link:definition>0099 - Disclosure - Financial instruments and risk exposures - Schedule of financial assets and financial liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfCreditRiskDetails" id="FinancialInstrumentsAndRiskExposuresScheduleOfCreditRiskDetails">
        <link:definition>0100 - Disclosure - Financial instruments and risk exposures - Schedule of credit risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/FinancialinstrumentsandriskexposuresTables" id="FinancialinstrumentsandriskexposuresTables">
        <link:definition>0101 - Disclosure - Financial instruments and risk exposures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="huge-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="huge-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="huge-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="huge-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AcquisitionOfPrismicPharmaceuticalsInc" id="huge_AcquisitionOfPrismicPharmaceuticalsInc" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionalInvestmentInExchangeForShares" id="huge_AdditionalInvestmentInExchangeForShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionalRemuneration" id="huge_AdditionalRemuneration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset" id="huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets" id="huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit" id="huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits" id="huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable" id="huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" id="huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentsForListingExpense" id="huge_AdjustmentsForListingExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentToExpectedIncomeTaxBenefitAbstract" id="huge_AdjustmentToExpectedIncomeTaxBenefitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized" id="huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments" id="huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability" id="huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts" id="huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation" id="huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentToLeaseCommitments" id="huge_AdjustmentToLeaseCommitments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AfterHarvestCostToCompleteAndSellPerGramForDryFlower" id="huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AfterHarvestCostToCompleteAndSellPerGramForDryTrim" id="huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AggregateDiscountForSharesInEscrow" id="huge_AggregateDiscountForSharesInEscrow" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AggregateUnpaidAccounts" id="huge_AggregateUnpaidAccounts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AllowanceForImpairment" id="huge_AllowanceForImpairment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmortizedCostOfFinancialAssetsMember" id="huge_AmortizedCostOfFinancialAssetsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmortizedCostOfFinancialLiabilitiesMember" id="huge_AmortizedCostOfFinancialLiabilitiesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities" id="huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfAgreementFallBelowMinimumValue" id="huge_AmountOfAgreementFallBelowMinimumValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmountOfBrokerWarrantsRepresentingFeesAndCommissions" id="huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfDepositPaidToSupplier" id="huge_AmountOfDepositPaidToSupplier" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation" id="huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AmountOfPurchasePricePaidAsSupplierLoan" id="huge_AmountOfPurchasePricePaidAsSupplierLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement" id="huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AnthonyDurkaczMember" id="huge_AnthonyDurkaczMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AnticipatedPurchasePricePlusApplicableTaxesValue" id="huge_AnticipatedPurchasePricePlusApplicableTaxesValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="Apr82018Member" id="huge_Apr82018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Apr92018Member" id="huge_Apr92018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="April182018Member" id="huge_April182018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Aug142018Member" id="huge_Aug142018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Aug152018Member" id="huge_Aug152018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Aug82018Member" id="huge_Aug82018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AuraHealthIncMember" id="huge_AuraHealthIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AuxlyCannabisGroupIncMember" id="huge_AuxlyCannabisGroupIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AverageExpectedLifeOfWarrants" id="huge_AverageExpectedLifeOfWarrants" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BasisOfPresentationAbstract" id="huge_BasisOfPresentationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BiologicalAssetFairValueAdjustmentMember" id="huge_BiologicalAssetFairValueAdjustmentMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BonusExpenseToBePaidInSubsequentPeriod" id="huge_BonusExpenseToBePaidInSubsequentPeriod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BrokerWarrants" id="huge_BrokerWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BrokerWarrantsIssuedInPrivatePlacements" id="huge_BrokerWarrantsIssuedInPrivatePlacements" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BusinessAcquisitionDomain" id="huge_BusinessAcquisitionDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BusinessAcquisitionsAxis" id="huge_BusinessAcquisitionsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="BusinessAcquisitionsBenefitsAxis" id="huge_BusinessAcquisitionsBenefitsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="BusinessAcquisitionsBenefitsDomain" id="huge_BusinessAcquisitionsBenefitsDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BusinessLicenseFees" id="huge_BusinessLicenseFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CannaraBiotechIncMember" id="huge_CannaraBiotechIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CanntabTherapeuticsLtdWorldClassExtractionsIncMember" id="huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CapitalizedCostMember" id="huge_CapitalizedCostMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CapitalizedCosts" id="huge_CapitalizedCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashAcquiredOnAcquisition" id="huge_CashAcquiredOnAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CenturyAndFvPharmaMember" id="huge_CenturyAndFvPharmaMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangeInFairValueOfInvestment" id="huge_ChangeInFairValueOfInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" id="huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ChangesInNonCashWorkingCapitalItemsAbstract" id="huge_ChangesInNonCashWorkingCapitalItemsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangesInShareCapitalTransactionDateAxis" id="huge_ChangesInShareCapitalTransactionDateAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="ChangesInShareCapitalTransactionDateDomain" id="huge_ChangesInShareCapitalTransactionDateDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChiefExecutiveOfficerAndExecutiveCoChairmanMember" id="huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChiefExecutiveOfficersMember" id="huge_ChiefExecutiveOfficersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChiefFinancialOfficersMember" id="huge_ChiefFinancialOfficersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChiefOperatingConsultantMember" id="huge_ChiefOperatingConsultantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClaimForLienComponent" id="huge_ClaimForLienComponent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClaimIssuedByContractorForVariousPurportedDamages" id="huge_ClaimIssuedByContractorForVariousPurportedDamages" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts" id="huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClassACommonStockSharesMember" id="huge_ClassACommonStockSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassBCommonStockSharesMember" id="huge_ClassBCommonStockSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassBSharesHeldInEscrowMember" id="huge_ClassBSharesHeldInEscrowMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassBSubordinateVotingSharesMember" id="huge_ClassBSubordinateVotingSharesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassBVotingSharesMember" id="huge_ClassBVotingSharesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassesOfInventoriesLineItems" id="huge_ClassesOfInventoriesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassesOfInventoriesTable" id="huge_ClassesOfInventoriesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="ClassesOfWarrantsAxis" id="huge_ClassesOfWarrantsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="ClassesOfWarrantsDomain" id="huge_ClassesOfWarrantsDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CloverCannastripThinFilmTechnologiesCorpMember" id="huge_CloverCannastripThinFilmTechnologiesCorpMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CollectiveCommitmentToPurchaseProduct" id="huge_CollectiveCommitmentToPurchaseProduct" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CommitmentsEquityInstruments" id="huge_CommitmentsEquityInstruments" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommitmentsLineItems" id="huge_CommitmentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommitmentsTable" id="huge_CommitmentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="CommitmentToIssueSharesMinimumValueUponLiquidation" id="huge_CommitmentToIssueSharesMinimumValueUponLiquidation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ConsultingFeesExpenses" id="huge_ConsultingFeesExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ContingentLiabilityForConstructionAndDevelopmentCostsMember" id="huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContractualCapitalCommitmentsEqualMonthlyInstalments" id="huge_ContractualCapitalCommitmentsEqualMonthlyInstalments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ConvertibleDebentureMember" id="huge_ConvertibleDebentureMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleNotes" id="huge_ConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ConvertibleNotesMember" id="huge_ConvertibleNotesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CorporateInformationAndNatureOfOperationsAbstract" id="huge_CorporateInformationAndNatureOfOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CriticalAccountingEstimatesAndJudgmentsAbstract" id="huge_CriticalAccountingEstimatesAndJudgmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CurrentNotesPayable" id="huge_CurrentNotesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DateOfExpiryOfShareOptions" id="huge_DateOfExpiryOfShareOptions" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DebtConversionRatio" id="huge_DebtConversionRatio" type="xbrli:pureItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Dec122017Member" id="huge_Dec122017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Dec152018Member" id="huge_Dec152018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Dec212017Member" id="huge_Dec212017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Dec232017Member" id="huge_Dec232017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Dec292017Member" id="huge_Dec292017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="December292017Member" id="huge_December292017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeferredTaxAssetLiabilityNotRecognized" id="huge_DeferredTaxAssetLiabilityNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeferredTaxAssetNotRecognized" id="huge_DeferredTaxAssetNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxAssetPropertyPlantAndEquipments" id="huge_DeferredTaxAssetPropertyPlantAndEquipments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxAssetsLiabilitiesAxis" id="huge_DeferredTaxAssetsLiabilitiesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="DeferredTaxAssetsLiabilitiesDomain" id="huge_DeferredTaxAssetsLiabilitiesDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeferredTaxAssetsOtherInvestments" id="huge_DeferredTaxAssetsOtherInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxLiabilitiesCapitalLossesCarriedForward" id="huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DefinitiveBusinessCombinationAgreementMember" id="huge_DefinitiveBusinessCombinationAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DefinitiveCollaborationProfitSharingAgreementMember" id="huge_DefinitiveCollaborationProfitSharingAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DefinitiveStrategicAllianceAndStreamingAgreementMember" id="huge_DefinitiveStrategicAllianceAndStreamingAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DerivativeLiabilitiesSettledThroughIssuanceOfShares" id="huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DescriptionOfExpectedVolatilityWarrantsGranted" id="huge_DescriptionOfExpectedVolatilityWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfOptionLifeWarrantsGranted" id="huge_DescriptionOfOptionLifeWarrantsGranted" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory" id="huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfReverseShareSplit" id="huge_DescriptionOfReverseShareSplit" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfRiskFreeInterestRateWarrantsGranted" id="huge_DescriptionOfRiskFreeInterestRateWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfVotingRights" id="huge_DescriptionOfVotingRights" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DirectorsAndOfficersMember" id="huge_DirectorsAndOfficersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DirectorsRemunerationPayable" id="huge_DirectorsRemunerationPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DisclosureOfBiologicalAssetsExplanatory" id="huge_DisclosureOfBiologicalAssetsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCapitalManagementAbstract" id="huge_DisclosureOfCapitalManagementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" id="huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCommitmentsAbstract" id="huge_DisclosureOfCommitmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCommitmentsAndContingentLiabilitiesAbstract" id="huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory" id="huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory" id="huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutInventoriesExplanatory" id="huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutNotesPayableExplanatory" id="huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory" id="huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutRightOfUseAssets" id="huge_DisclosureOfDetailedInformationAboutRightOfUseAssets" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" id="huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutWarrantActivityExplanatory" id="huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory" id="huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory" id="huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory" id="huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock" id="huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfFinancialAssetsAndLiabilitiesExplanatory" id="huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfGeneralAndAdministrativeExpenses" id="huge_DisclosureOfGeneralAndAdministrativeExpenses" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNatureOfBusinessAbstract" id="huge_DisclosureOfNatureOfBusinessAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNatureOfBusinessExplanatoryTextBlock" id="huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNatureOfBusinessLineItems" id="huge_DisclosureOfNatureOfBusinessLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNatureOfBusinessTable" id="huge_DisclosureOfNatureOfBusinessTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory" id="huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory" id="huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" id="huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOperatingLeaseObligationsTableTextBlock" id="huge_DisclosureOfOperatingLeaseObligationsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOtherInvestmentsAbstract" id="huge_DisclosureOfOtherInvestmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOtherInvestmentsLineItems" id="huge_DisclosureOfOtherInvestmentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOtherInvestmentsTable" id="huge_DisclosureOfOtherInvestmentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DisclosureOfProvisionForIncomeTaxesExplanatory" id="huge_DisclosureOfProvisionForIncomeTaxesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory" id="huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfReverseTakeoverTransactionAbstract" id="huge_DisclosureOfReverseTakeoverTransactionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfReverseTakeoverTransactionExplanatory" id="huge_DisclosureOfReverseTakeoverTransactionExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfShareBasedCompensationAndWarrantReserveAbstract" id="huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory" id="huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory" id="huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory" id="huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory" id="huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfWarrantsLineItems" id="huge_DisclosureOfWarrantsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfWarrantsTable" id="huge_DisclosureOfWarrantsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DiscountOnProceedsOfSharesAndWarrantsSold" id="huge_DiscountOnProceedsOfSharesAndWarrantsSold" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DocumentAndEntityInformationAbstract" id="huge_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares" id="huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeeRelatedLiability" id="huge_EmployeeRelatedLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EpitechLicenseAgreementMember" id="huge_EpitechLicenseAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EstimatedCostOfRestorationInCommitment" id="huge_EstimatedCostOfRestorationInCommitment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExercisePriceEighteenPointZeroNineMember" id="huge_ExercisePriceEighteenPointZeroNineMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceEightyEightPointFortyFourMember" id="huge_ExercisePriceEightyEightPointFortyFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceEightySixPointFortyThreeMember" id="huge_ExercisePriceEightySixPointFortyThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFiftyFivePointTwentyEightMember" id="huge_ExercisePriceFiftyFivePointTwentyEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFiftyNinePointThirtyMember" id="huge_ExercisePriceFiftyNinePointThirtyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFiftyPointTwentyFiveMember" id="huge_ExercisePriceFiftyPointTwentyFiveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFiftySixPointTwentyEightMember" id="huge_ExercisePriceFiftySixPointTwentyEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFiftyTwoPointTwentySixMember" id="huge_ExercisePriceFiftyTwoPointTwentySixMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFivePointFourThreeMember" id="huge_ExercisePriceFivePointFourThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFivePointZeroThreeMember" id="huge_ExercisePriceFivePointZeroThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFortyFourPointTwentyTwoMember" id="huge_ExercisePriceFortyFourPointTwentyTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFortyPointTwentyMember" id="huge_ExercisePriceFortyPointTwentyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFortySevenPointTwentyFourMember" id="huge_ExercisePriceFortySevenPointTwentyFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFourPointFourTwoMember" id="huge_ExercisePriceFourPointFourTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOfExercisableShareOptions" id="huge_ExercisePriceOfExercisableShareOptions" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOfWarrants" id="huge_ExercisePriceOfWarrants" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOfWarrantsGranted" id="huge_ExercisePriceOfWarrantsGranted" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOneHundredFortyEightPointSeventyFourMember" id="huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOneHundredFortyTwoPointSeventyOneMember" id="huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOneHundredTwentyPointSixtyMember" id="huge_ExercisePriceOneHundredTwentyPointSixtyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSevenPointFiftyMember" id="huge_ExercisePriceSevenPointFiftyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSevenPointSeventeenMember" id="huge_ExercisePriceSevenPointSeventeenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSevenPointSixtyThreeMember" id="huge_ExercisePriceSevenPointSixtyThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSevenPointZeroZeroMember" id="huge_ExercisePriceSevenPointZeroZeroMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSeventeenPointEightNineMember" id="huge_ExercisePriceSeventeenPointEightNineMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSeventyFivePointThirtyEightMember" id="huge_ExercisePriceSeventyFivePointThirtyEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSeventyOnePointZeroSevenMember" id="huge_ExercisePriceSeventyOnePointZeroSevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSixPointSixteenMember" id="huge_ExercisePriceSixPointSixteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSixteenPointZeroEightMember" id="huge_ExercisePriceSixteenPointZeroEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSixtyEightPointZeroOneMember" id="huge_ExercisePriceSixtyEightPointZeroOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTenPointSixFiveMember" id="huge_ExercisePriceTenPointSixFiveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceThirteenPointFourSevenMember" id="huge_ExercisePriceThirteenPointFourSevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceThirteenPointZeroSevenMember" id="huge_ExercisePriceThirteenPointZeroSevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwentyFourPointTwelveMember" id="huge_ExercisePriceTwentyFourPointTwelveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwentyOnePointElevenMember" id="huge_ExercisePriceTwentyOnePointElevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwentyOnePointNinetyOneMember" id="huge_ExercisePriceTwentyOnePointNinetyOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwentyOnePointTwentyTwoMember" id="huge_ExercisePriceTwentyOnePointTwentyTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwentyPointOneZeroMember" id="huge_ExercisePriceTwentyPointOneZeroMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwentySixPointThirteenMember" id="huge_ExercisePriceTwentySixPointThirteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwoPointSixOneMember" id="huge_ExercisePriceTwoPointSixOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedDividendAsPercentageWarrantsGranted" id="huge_ExpectedDividendAsPercentageWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedDividendYieldOfWarrants" id="huge_ExpectedDividendYieldOfWarrants" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedDividendYieldOfWarrantsGranted" id="huge_ExpectedDividendYieldOfWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedGrowthCycle" id="huge_ExpectedGrowthCycle" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedGrowthCycleCompleted" id="huge_ExpectedGrowthCycleCompleted" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedLifeOfWarrants" id="huge_ExpectedLifeOfWarrants" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedNetSellingPricePerGramOfDriedFlower" id="huge_ExpectedNetSellingPricePerGramOfDriedFlower" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExpectedNetSellingPricePerGramOfTrim" id="huge_ExpectedNetSellingPricePerGramOfTrim" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExpectedSellingPricePerGramOfDriedFlower" id="huge_ExpectedSellingPricePerGramOfDriedFlower" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExpectedSellingPricePerGramOfTrim" id="huge_ExpectedSellingPricePerGramOfTrim" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExpectedTermOfWarrants" id="huge_ExpectedTermOfWarrants" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedVolatilityOfWarrants" id="huge_ExpectedVolatilityOfWarrants" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedVolatilityOfWarrantsGranted" id="huge_ExpectedVolatilityOfWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant" id="huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedYieldForCannabisPlantsOfDryTrimPerPlant" id="huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedYieldOfDryFlower" id="huge_ExpectedYieldOfDryFlower" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedYieldOfDryTrim" id="huge_ExpectedYieldOfDryTrim" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpiryDateOfWarrants" id="huge_ExpiryDateOfWarrants" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpiryTermOfWarrantsGranted" id="huge_ExpiryTermOfWarrantsGranted" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FacilityRelatedExpenditures" id="huge_FacilityRelatedExpenditures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FacilityUnderDevelopmentMember" id="huge_FacilityUnderDevelopmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueAdjustmentsOnInventorySold" id="huge_FairValueAdjustmentsOnInventorySold" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueOfShares" id="huge_FairValueOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfSharesAndWarrantsAcquired" id="huge_FairValueOfSharesAndWarrantsAcquired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueOfWarrants" id="huge_FairValueOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="Feb252018Member" id="huge_Feb252018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FindersFee" id="huge_FindersFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FindersFeeShares" id="huge_FindersFeeShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FirstRepublicCapitalCorporationMember" id="huge_FirstRepublicCapitalCorporationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FormerCEOMember" id="huge_FormerCEOMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FormerChiefExecutiveOfficerMember" id="huge_FormerChiefExecutiveOfficerMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FormerChiefOperatingOfficerMember" id="huge_FormerChiefOperatingOfficerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FSDBiosciencesMember" id="huge_FSDBiosciencesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FurnitureFixturesAndEquipmentMember" id="huge_FurnitureFixturesAndEquipmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FvPharmaIncMember" id="huge_FvPharmaIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GainLossOnChangeInFairValueOfDerivativeLiability" id="huge_GainLossOnChangeInFairValueOfDerivativeLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GrantDateAxis" id="huge_GrantDateAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="GrantDateDomain" id="huge_GrantDateDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrossLossProfitBeforeFairValueAdjustments" id="huge_GrossLossProfitBeforeFairValueAdjustments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GuaranteedMinimumLiquidationValueOfShares" id="huge_GuaranteedMinimumLiquidationValueOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="HarvestedCannabisMember" id="huge_HarvestedCannabisMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HempProductsMember" id="huge_HempProductsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HeritageBuildingRestorationCommitmentMember" id="huge_HeritageBuildingRestorationCommitmentMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HighTideIncMember" id="huge_HighTideIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HugeShopsMember" id="huge_HugeShopsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ImpactOfPresentValue" id="huge_ImpactOfPresentValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ImpactOfPresentValueOnLeaseObligations" id="huge_ImpactOfPresentValueOnLeaseObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset" id="huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ImpairmentLossRecognisedInRightOfUseAsset" id="huge_ImpairmentLossRecognisedInRightOfUseAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ImpairmentMember" id="huge_ImpairmentMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseInFairValueOfOtherInvestments" id="huge_IncreaseDecreaseInFairValueOfOtherInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" id="huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughAcquisitionOfNetAssetsValue" id="huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughExerciseOfOptionShares" id="huge_IncreaseDecreaseThroughExerciseOfOptionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughExerciseOfWarrantsShares" id="huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughExpiryOfWarrantsShares" id="huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughExpiryOfWarrantsValue" id="huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset" id="huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares" id="huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughReverseAcquisition" id="huge_IncreaseDecreaseThroughReverseAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughReverseAcquisitionShares" id="huge_IncreaseDecreaseThroughReverseAcquisitionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughShareIssueRelatedCostShares" id="huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughStockOptionsCancelled" id="huge_IncreaseDecreaseThroughStockOptionsCancelled" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughWarrantValuations" id="huge_IncreaseDecreaseThroughWarrantValuations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughWarrantValuationsShares" id="huge_IncreaseDecreaseThroughWarrantValuationsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncrementalBorrowingRateToDiscountLeaseLiabilities" id="huge_IncrementalBorrowingRateToDiscountLeaseLiabilities" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IndependentDirectorMember" id="huge_IndependentDirectorMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfShares" id="huge_IssuanceOfShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Jan52018Member" id="huge_Jan52018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Jan52018WarrantMember" id="huge_Jan52018WarrantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Jun112018Member" id="huge_Jun112018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Jun122018Member" id="huge_Jun122018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="KeyManagementPersonnelCarAllowance" id="huge_KeyManagementPersonnelCarAllowance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LeaseTermOnOfficeSpace" id="huge_LeaseTermOnOfficeSpace" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LegalEntitiesAxis" id="huge_LegalEntitiesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="LegalEntitiesDomain" id="huge_LegalEntitiesDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ListingExpense" id="huge_ListingExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LossGainOnChangesInFairValueOfOtherInvestments" id="huge_LossGainOnChangesInFairValueOfOtherInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LossOnSettlementOfFinancialLiability" id="huge_LossOnSettlementOfFinancialLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ManagementAndConsultingContractsMember" id="huge_ManagementAndConsultingContractsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ManagementFees" id="huge_ManagementFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="Mar222018Member" id="huge_Mar222018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Mar282018Member" id="huge_Mar282018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="March262018Member" id="huge_March262018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="March282018Member" id="huge_March282018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="March92018Member" id="huge_March92018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MarketPriceOfShares" id="huge_MarketPriceOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MarketPriceOfWarrants" id="huge_MarketPriceOfWarrants" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MarketPriceShareOptionsGranted" id="huge_MarketPriceShareOptionsGranted" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="May242018Member" id="huge_May242018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="May242018WarrantMember" id="huge_May242018WarrantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="May82018Member" id="huge_May82018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MealsAndEntertainment" id="huge_MealsAndEntertainment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MinimumInvestmentReceivable" id="huge_MinimumInvestmentReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NetSellingPricePerGramForDryFlowerAfterHarvestCost" id="huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NetSellingPricePerGramForDryTrimAfterHarvestCost" id="huge_NetSellingPricePerGramForDryTrimAfterHarvestCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight" id="huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine" id="huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalLossCarryforwards" id="huge_NonCapitalLossCarryforwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalLossCarryForwardsMember" id="huge_NonCapitalLossCarryForwardsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonCapitalLossesMember" id="huge_NonCapitalLossesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonRefundableSumDueAndPayableUponFirstNotificationOfFDA" id="huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA" id="huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NotesPayableMember" id="huge_NotesPayableMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Nov12017Member" id="huge_Nov12017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Nov122018Member" id="huge_Nov122018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Nov142017Member" id="huge_Nov142017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Nov152018Member" id="huge_Nov152018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Nov212017Member" id="huge_Nov212017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Nov262018Member" id="huge_Nov262018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" id="huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfAgreement" id="huge_NumberOfAgreement" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfBrokerWarrantsGrantedForFeesAndCommissions" id="huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesAcquired" id="huge_NumberOfSharesAcquired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesHeld" id="huge_NumberOfSharesHeld" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesHeldSubjectToEscrowArrangement" id="huge_NumberOfSharesHeldSubjectToEscrowArrangement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedAsFindersFee" id="huge_NumberOfSharesIssuedAsFindersFee" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" id="huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedForDebtSettlement" id="huge_NumberOfSharesIssuedForDebtSettlement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement" id="huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedInPrivatePlacement" id="huge_NumberOfSharesIssuedInPrivatePlacement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedInShareExchange" id="huge_NumberOfSharesIssuedInShareExchange" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesOutstandingSubjectToEscrowConditions" id="huge_NumberOfSharesOutstandingSubjectToEscrowConditions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesSold" id="huge_NumberOfSharesSold" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesSubscribed" id="huge_NumberOfSharesSubscribed" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsAcquired" id="huge_NumberOfWarrantsAcquired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsExercised" id="huge_NumberOfWarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsExpired" id="huge_NumberOfWarrantsExpired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsGranted" id="huge_NumberOfWarrantsGranted" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsHeld" id="huge_NumberOfWarrantsHeld" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsOutstanding" id="huge_NumberOfWarrantsOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Oct202017Member" id="huge_Oct202017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OfficeAndGeneralExpenses" id="huge_OfficeAndGeneralExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OfficeLeaseAgreementMember" id="huge_OfficeLeaseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OperatingLeaseImpactOfPresentValue" id="huge_OperatingLeaseImpactOfPresentValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherAllowances" id="huge_OtherAllowances" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherFinancialLiabilitiesMember" id="huge_OtherFinancialLiabilitiesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherGeneralAndAdministrativeExpenses" id="huge_OtherGeneralAndAdministrativeExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherInventoryMember" id="huge_OtherInventoryMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherInvestmentMember" id="huge_OtherInvestmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherInvestmentsNameOfEntityAxis" id="huge_OtherInvestmentsNameOfEntityAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="OtherInvestmentsNameOfEntityDomain" id="huge_OtherInvestmentsNameOfEntityDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OutstandingCommitmentToPurchaseAdditionalProduct" id="huge_OutstandingCommitmentToPurchaseAdditionalProduct" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PatentMaintenanceFee" id="huge_PatentMaintenanceFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PaymentOfExpenses" id="huge_PaymentOfExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PaymentOfOperatingLease" id="huge_PaymentOfOperatingLease" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PercentageOfAggregateDiscountForSharesInEscrow" id="huge_PercentageOfAggregateDiscountForSharesInEscrow" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfDeclineInFairValueOfInvestment" id="huge_PercentageOfDeclineInFairValueOfInvestment" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold" id="huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights" id="huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition" id="huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition" id="huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition" id="huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights" id="huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PermanentDifferences" id="huge_PermanentDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PharmadrugIncMember" id="huge_PharmadrugIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PharmadrugProductionGMBHMember" id="huge_PharmadrugProductionGMBHMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PharmastripCorpMember" id="huge_PharmastripCorpMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PresidentAndChiefExecutiveOfficerMember" id="huge_PresidentAndChiefExecutiveOfficerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PresidentAndDirectorMember" id="huge_PresidentAndDirectorMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PresidentOfFsdBiosciencesMember" id="huge_PresidentOfFsdBiosciencesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PresidentOfFSDMember" id="huge_PresidentOfFSDMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PresidentOfFVPharmaMember" id="huge_PresidentOfFVPharmaMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PresidentsMember" id="huge_PresidentsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrincipalAmountOfBorrowings" id="huge_PrincipalAmountOfBorrowings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PrismicPharmaceuticalMember" id="huge_PrismicPharmaceuticalMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrismicPharmaceuticalsIncMember" id="huge_PrismicPharmaceuticalsIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProceedsFromExerciseOfWarrants" id="huge_ProceedsFromExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromSaleOfSharesAndWarrants" id="huge_ProceedsFromSaleOfSharesAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProductionAndGrowingExpense" id="huge_ProductionAndGrowingExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProductionAndGrowingExpenses" id="huge_ProductionAndGrowingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProductionEquipmentMember" id="huge_ProductionEquipmentMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PropertyPlantAndEquipmentsMember" id="huge_PropertyPlantAndEquipmentsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="QuantitiesAvailableToSupplyInFifthFiscalYear" id="huge_QuantitiesAvailableToSupplyInFifthFiscalYear" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="QuantitiesAvailableToSupplyInFourthFiscalYear" id="huge_QuantitiesAvailableToSupplyInFourthFiscalYear" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="QuantitiesAvailableToSupplyInNextFiscalYear" id="huge_QuantitiesAvailableToSupplyInNextFiscalYear" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="QuantitiesAvailableToSupplyInSecondFiscalYear" id="huge_QuantitiesAvailableToSupplyInSecondFiscalYear" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="QuantitiesAvailableToSupplyInThirdFiscalYear" id="huge_QuantitiesAvailableToSupplyInThirdFiscalYear" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="QuotedMarketPriceOfInvestments" id="huge_QuotedMarketPriceOfInvestments" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RecognitionOfLossOnChangeInFairValueOfDerivativeLiability" id="huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability" type="xbrli:monetaryItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RentReceivable" id="huge_RentReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ResearchAndDevelopmentAgreementMember" id="huge_ResearchAndDevelopmentAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReverseTakeoverTransaction" id="huge_ReverseTakeoverTransaction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RightOfUseAssetsAndLeaseObligations" id="huge_RightOfUseAssetsAndLeaseObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RiskFreeInterestRateOfWarrants" id="huge_RiskFreeInterestRateOfWarrants" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RiskFreeInterestRateOfWarrantsGranted" id="huge_RiskFreeInterestRateOfWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RiskFreeRateOfWarrants" id="huge_RiskFreeRateOfWarrants" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SalesTaxRecoverable" id="huge_SalesTaxRecoverable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ScheduleOfNonCapitalLossCarryforwardsTableTextBlock" id="huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfStockClassLineItems" id="huge_ScheduleOfStockClassLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfStockClassTable" id="huge_ScheduleOfStockClassTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="ScheduleOfWarrantTable" id="huge_ScheduleOfWarrantTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory" id="huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScicannTherapeuticsIncMember" id="huge_ScicannTherapeuticsIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecuritiesExchangeAgreementMember" id="huge_SecuritiesExchangeAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees" id="huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="Sep102018Member" id="huge_Sep102018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sep112018Member" id="huge_Sep112018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sep142018Member" id="huge_Sep142018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sep152017Member" id="huge_Sep152017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sep152018Member" id="huge_Sep152018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sep172017Member" id="huge_Sep172017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sep262018Member" id="huge_Sep262018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="September292018Member" id="huge_September292018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="September302017Member" id="huge_September302017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareholderAndPublicCompanyCosts" id="huge_ShareholderAndPublicCompanyCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareholdersAndPublicCompanyCosts" id="huge_ShareholdersAndPublicCompanyCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareIssueCostsMember" id="huge_ShareIssueCostsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareIssuePricePerShare" id="huge_ShareIssuePricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareOptionsAbstract" id="huge_ShareOptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePriceOfSharesAndWarrants" id="huge_SharePriceOfSharesAndWarrants" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePrices" id="huge_SharePrices" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePurchaseAndSaleAgreementsMember" id="huge_SharePurchaseAndSaleAgreementsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareSplitRatio" id="huge_ShareSplitRatio" type="xbrli:pureItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShortTermNotes" id="huge_ShortTermNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SolarvestBioEnergyIncMember" id="huge_SolarvestBioEnergyIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SpecialWarrantsMember" id="huge_SpecialWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockOptionsMember" id="huge_StockOptionsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockOptionsOfAcquirer" id="huge_StockOptionsOfAcquirer" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockPromotionExpenses" id="huge_StockPromotionExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="StrategicInvestmentValue" id="huge_StrategicInvestmentValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SubscriptionPricePerShare" id="huge_SubscriptionPricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsequentEventsMember" id="huge_SubsequentEventsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesOneMember" id="huge_SubsidiariesOneMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesTwoMember" id="huge_SubsidiariesTwoMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SummaryOfSignificantAccountingPoliciesAbstract" id="huge_SummaryOfSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SummaryOfSignificantAccountingPoliciesTable" id="huge_SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="SupplementalInformationAbstract" id="huge_SupplementalInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SupplyAgreementMember" id="huge_SupplyAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SupplyAgreementOptionToPurchaseAmount" id="huge_SupplyAgreementOptionToPurchaseAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SupplyAgreementOptionToPurchasePeriod" id="huge_SupplyAgreementOptionToPurchasePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted" id="huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TaxEffectOfDeferredTaxAssetNotRecognized" id="huge_TaxEffectOfDeferredTaxAssetNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TaxEffectOfTemporaryDifferences" id="huge_TaxEffectOfTemporaryDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TemporaryDifferences" id="huge_TemporaryDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TermsOfWarrantGranted" id="huge_TermsOfWarrantGranted" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThomasFairfullMember" id="huge_ThomasFairfullMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TypeOfArrangementsAxis" id="huge_TypeOfArrangementsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="TypeOfArrangementsDomain" id="huge_TypeOfArrangementsDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TypeOfInventoriesAxis" id="huge_TypeOfInventoriesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="TypeOfInventoriesDomain" id="huge_TypeOfInventoriesDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UndiscountedLeasePaymentsPayable" id="huge_UndiscountedLeasePaymentsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock" id="huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnrealizedLossOnChangesInFairValueOfBiologicalAssets" id="huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="UnrestrictedClassBSharesMember" id="huge_UnrestrictedClassBSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ValueOfBrokerWarrantsIssuedInPrivatePlacements" id="huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ValueOfSharesAcquired" id="huge_ValueOfSharesAcquired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ValueOfSharesIssued" id="huge_ValueOfSharesIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" id="huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfSharesIssuedForDebtSettlement" id="huge_ValueOfSharesIssuedForDebtSettlement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfSharesIssuedInPrivatePlacement" id="huge_ValueOfSharesIssuedInPrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ValueOfSharesIssuedInShareExchange" id="huge_ValueOfSharesIssuedInShareExchange" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfStockOptionsExercised" id="huge_ValueOfStockOptionsExercised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement" id="huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfWarrantsExercised" id="huge_ValueOfWarrantsExercised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="WarrantExercisePrice" id="huge_WarrantExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantLineItems" id="huge_WarrantLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Warrants" id="huge_Warrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="WarrantsAbstract" id="huge_WarrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtAugust1st2021Member" id="huge_WarrantsByExpiryDateAtAugust1st2021Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtDecember12st2019Member" id="huge_WarrantsByExpiryDateAtDecember12st2019Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtDecember29th2019Member" id="huge_WarrantsByExpiryDateAtDecember29th2019Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtJanuary16th2026Member" id="huge_WarrantsByExpiryDateAtJanuary16th2026Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtJanuary20th2026Member" id="huge_WarrantsByExpiryDateAtJanuary20th2026Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtJanuary5th2020Member" id="huge_WarrantsByExpiryDateAtJanuary5th2020Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtJuly24th2023Member" id="huge_WarrantsByExpiryDateAtJuly24th2023Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtMay10th2025Member" id="huge_WarrantsByExpiryDateAtMay10th2025Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtMay17th2025Member" id="huge_WarrantsByExpiryDateAtMay17th2025Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtMay20th2023Member" id="huge_WarrantsByExpiryDateAtMay20th2023Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtMay24th2022Member" id="huge_WarrantsByExpiryDateAtMay24th2022Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtMay31st2025Member" id="huge_WarrantsByExpiryDateAtMay31st2025Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtMay4th2025Member" id="huge_WarrantsByExpiryDateAtMay4th2025Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtNovember14th2019Member" id="huge_WarrantsByExpiryDateAtNovember14th2019Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtNovember1st2019Member" id="huge_WarrantsByExpiryDateAtNovember1st2019Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtNovember21st2019Member" id="huge_WarrantsByExpiryDateAtNovember21st2019Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtNovember30th2020Member" id="huge_WarrantsByExpiryDateAtNovember30th2020Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtOctober20th2019Member" id="huge_WarrantsByExpiryDateAtOctober20th2019Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtSeptember11th2023Member" id="huge_WarrantsByExpiryDateAtSeptember11th2023Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtSeptember15th2022Member" id="huge_WarrantsByExpiryDateAtSeptember15th2022Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsIssueDateAxis" id="huge_WarrantsIssueDateAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="WarrantsIssueDateDomain" id="huge_WarrantsIssueDateDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsMember" id="huge_WarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsOptionsOfAcquirer" id="huge_WarrantsOptionsOfAcquirer" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="WeightedAverageExercisePricesWarrantExercised" id="huge_WeightedAverageExercisePricesWarrantExercised" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePricesWarrantExpired" id="huge_WeightedAverageExercisePricesWarrantExpired" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePricesWarrantGranted" id="huge_WeightedAverageExercisePricesWarrantGranted" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePriceWarrantsOutstanding" id="huge_WeightedAverageExercisePriceWarrantsOutstanding" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageSharePriceOfWarrants" id="huge_WeightedAverageSharePriceOfWarrants" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WorkingCapitalSurplus" id="huge_WorkingCapitalSurplus" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ZeeshanSaeedMember" id="huge_ZeeshanSaeedMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>huge-20191231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails" roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails" roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForListingExpense" xlink:label="loc_huge_AdjustmentsForListingExpense_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="loc_ifrs-full_AdjustmentsForInterestExpense_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" xlink:label="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LossOnSettlementOfFinancialLiability" xlink:label="loc_huge_LossOnSettlementOfFinancialLiability_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AllowanceForImpairment" xlink:label="loc_huge_AllowanceForImpairment_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CashAcquiredOnAcquisition" xlink:label="loc_huge_CashAcquiredOnAcquisition_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ReverseTakeoverTransaction" xlink:label="loc_huge_ReverseTakeoverTransaction_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PaymentOfOperatingLease" xlink:label="loc_huge_PaymentOfOperatingLease_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentProperty" xlink:label="loc_ifrs-full_PurchaseOfInvestmentProperty_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:label="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_30"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProceedsFromExerciseOfWarrants" xlink:label="loc_huge_ProceedsFromExerciseOfWarrants_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_32"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_ProfitLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_huge_AdjustmentsForListingExpense_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForInterestExpense_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_8" order="70" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_9" order="80" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_10" order="90" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_huge_LossOnSettlementOfFinancialLiability_11" order="100" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_12" order="110" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_13" order="120" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_14" order="130" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_15" order="140" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_16" order="150" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_huge_AllowanceForImpairment_17" order="160" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_19" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_19" xlink:to="loc_huge_CashAcquiredOnAcquisition_19" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_19" xlink:to="loc_huge_ReverseTakeoverTransaction_20" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_19" xlink:to="loc_huge_PaymentOfOperatingLease_21" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_19" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_22" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_19" xlink:to="loc_ifrs-full_PurchaseOfInvestmentProperty_23" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_19" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_24" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_19" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_25" order="60" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_27" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_28" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_29" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_30" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_huge_ProceedsFromExerciseOfWarrants_31" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfOptions_32" order="50" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_19"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_RightofuseAssets_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_CurrentAssets_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_5" xlink:to="loc_ifrs-full_CashAndCashEquivalents_5" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_5" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_6" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_5" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_7" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_5" xlink:to="loc_ifrs-full_Inventories_8" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_5" xlink:to="loc_ifrs-full_CurrentBiologicalAssets_9" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_11" xlink:to="loc_ifrs-full_Liabilities_12" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_12" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_12" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_12" xlink:to="loc_ifrs-full_CurrentLiabilities_13" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_13" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_13" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_14" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_13" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_15" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_13" xlink:to="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_16" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_11" xlink:to="loc_ifrs-full_Equity_19" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_GrossLossProfitBeforeFairValueAdjustments" xlink:label="loc_huge_GrossLossProfitBeforeFairValueAdjustments_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FairValueAdjustmentsOnInventorySold" xlink:label="loc_huge_FairValueAdjustmentsOnInventorySold_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-full_ExpenseByNature_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AllowanceForImpairment" xlink:label="loc_huge_AllowanceForImpairment_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LossGainOnChangesInFairValueOfOtherInvestments" xlink:label="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LossOnSettlementOfFinancialLiability" xlink:label="loc_huge_LossOnSettlementOfFinancialLiability_19"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_0" xlink:to="loc_ifrs-full_ProfitLoss_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_2" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_2" xlink:to="loc_ifrs-full_GrossProfit_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_2" xlink:to="loc_huge_GrossLossProfitBeforeFairValueAdjustments_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_GrossLossProfitBeforeFairValueAdjustments_2" xlink:to="loc_ifrs-full_Revenue_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_GrossLossProfitBeforeFairValueAdjustments_2" xlink:to="loc_ifrs-full_CostOfSales_3" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_2" xlink:to="loc_huge_FairValueAdjustmentsOnInventorySold_5" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_2" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_6" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_2" xlink:to="loc_ifrs-full_ExpenseByNature_8" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_8" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_8" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_8" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_9" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_8" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_10" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_8" xlink:to="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_11" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_8" xlink:to="loc_huge_AllowanceForImpairment_12" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_2" xlink:to="loc_ifrs-full_OtherIncome_15" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_2" xlink:to="loc_ifrs-full_FinanceCosts_16" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_2" xlink:to="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_17" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_2" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_18" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_2" xlink:to="loc_huge_LossOnSettlementOfFinancialLiability_19" order="50" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxAssetsOtherInvestments" xlink:label="loc_huge_DeferredTaxAssetsOtherInvestments_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward" xlink:label="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxAssetLiabilityNotRecognized" xlink:label="loc_huge_DeferredTaxAssetLiabilityNotRecognized_3"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_0" xlink:to="loc_huge_DeferredTaxAssetsOtherInvestments_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_0" xlink:to="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_0" xlink:to="loc_huge_DeferredTaxAssetLiabilityNotRecognized_3" order="20" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonCapitalLossCarryforwards" xlink:label="loc_huge_NonCapitalLossCarryforwards_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_NonCapitalLossCarryforwards_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_NonCapitalLossCarryforwards_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TaxEffectOfTemporaryDifferences" xlink:label="loc_huge_TaxEffectOfTemporaryDifferences_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TaxEffectOfDeferredTaxAssetNotRecognized" xlink:label="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_0" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_0" xlink:to="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_0" xlink:to="loc_huge_TaxEffectOfTemporaryDifferences_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_0" xlink:to="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_4" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_7"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_7" order="60" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SalesTaxRecoverable" xlink:label="loc_huge_SalesTaxRecoverable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivable" xlink:label="loc_ifrs-full_InterestReceivable_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RentReceivable" xlink:label="loc_huge_RentReceivable_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_0" xlink:to="loc_huge_SalesTaxRecoverable_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_0" xlink:to="loc_ifrs-full_InterestReceivable_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_0" xlink:to="loc_huge_RentReceivable_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_0" xlink:to="loc_ifrs-full_OtherReceivables_4" order="30" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>huge-20191231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#AcquisitionOfPrismicPharmaceuticalNarrativeDetails" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#BiologicalAssetsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/BiologicalAssetsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CommitmentsAndContingenciesNarrativeDetails" roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails" roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#FinancialInstrumentsAndRiskExposuresNarrativeDetails" roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#FinancialInstrumentsAndRiskExposuresScheduleOfCreditRiskDetails" roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfCreditRiskDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#FinancialInstrumentsAndRiskExposuresScheduleOfFinancialAssetsAndFinancialLiabilitiesDetails" roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfFinancialAssetsAndFinancialLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#FinancialInstrumentsAndRiskExposuresScheduleOfFinancialObligationsBasedOnTheirDueDatesDetails" roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfFinancialObligationsBasedOnTheirDueDatesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IntangibleAssetsScheduleOfIntangibleAssetsDetails" roleURI="http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#InventoryScheduleOfInventoriesDetails" roleURI="http://www.fsdpharma.com/role/InventoryScheduleOfInventoriesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails" roleURI="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#LossPerShareDetails" roleURI="http://www.fsdpharma.com/role/LossPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#NatureOfBusinessNarrativeDetails" roleURI="http://www.fsdpharma.com/role/NatureOfBusinessNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails" roleURI="http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#NotesPayableNarrativeDetails" roleURI="http://www.fsdpharma.com/role/NotesPayableNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#NotesPayableScheduleOfNotesPayableDetails" roleURI="http://www.fsdpharma.com/role/NotesPayableScheduleOfNotesPayableDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#OtherInvestmentsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#OtherInvestmentsScheduleOfOtherInvestmentsDetails" roleURI="http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#PropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" roleURI="http://www.fsdpharma.com/role/PropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#RelatedPartyTransactionsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SharebasedCompensationNarrativeDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ShareCapitalNarrativeDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ShareCapitalTables" roleURI="http://www.fsdpharma.com/role/ShareCapitalTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails" roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SubsequentEventsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBVotingSharesMember" xlink:label="loc_huge_ClassBVotingSharesMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsGranted" xlink:label="loc_huge_NumberOfWarrantsGranted_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_huge_ClassBVotingSharesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_huge_StockOptionsMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_huge_WarrantsMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_huge_ShareIssuePricePerShare_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_IssueOfEquity_15" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_huge_NumberOfWarrantsGranted_16" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_17" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareOptionsAbstract" xlink:label="loc_huge_ShareOptionsAbstract_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsAbstract" xlink:label="loc_huge_WarrantsAbstract_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageSharePriceOfWarrants" xlink:label="loc_huge_WeightedAverageSharePriceOfWarrants_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedDividendYieldOfWarrantsGranted" xlink:label="loc_huge_ExpectedDividendYieldOfWarrantsGranted_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_21"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_22"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_RangeAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_5" xlink:to="loc_ifrs-full_RangesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_5" xlink:to="loc_ifrs-full_BottomOfRangeMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_5" xlink:to="loc_ifrs-full_TopOfRangeMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_huge_ShareOptionsAbstract_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ShareOptionsAbstract_10" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ShareOptionsAbstract_10" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ShareOptionsAbstract_10" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ShareOptionsAbstract_10" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ShareOptionsAbstract_10" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ShareOptionsAbstract_10" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_huge_WarrantsAbstract_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantsAbstract_17" xlink:to="loc_huge_WeightedAverageSharePriceOfWarrants_17" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantsAbstract_17" xlink:to="loc_huge_ExercisePriceOfWarrantsGranted_18" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantsAbstract_17" xlink:to="loc_huge_ExpectedDividendYieldOfWarrantsGranted_19" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantsAbstract_17" xlink:to="loc_huge_RiskFreeInterestRateOfWarrantsGranted_20" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantsAbstract_17" xlink:to="loc_huge_ExpectedLifeOfWarrants_21" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantsAbstract_17" xlink:to="loc_huge_ExpectedVolatilityOfWarrantsGranted_22" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_12" order="70" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/BiologicalAssetsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsByGroupAxis" xlink:label="loc_ifrs-full_BiologicalAssetsByGroupAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsGroupMember" xlink:label="loc_ifrs-full_BiologicalAssetsGroupMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlantsMember" xlink:label="loc_ifrs-full_PlantsMember_1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_1" xlink:to="loc_ifrs-full_BiologicalAssetsByGroupAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BiologicalAssetsByGroupAxis_1" xlink:to="loc_ifrs-full_BiologicalAssetsGroupMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BiologicalAssetsGroupMember_1" xlink:to="loc_ifrs-full_PlantsMember_1" order="0" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember" xlink:label="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AuxlyCannabisGroupIncMember" xlink:label="loc_huge_AuxlyCannabisGroupIncMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementMember" xlink:label="loc_huge_SupplyAgreementMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_EpitechLicenseAgreementMember" xlink:label="loc_huge_EpitechLicenseAgreementMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DefinitiveStrategicAllianceAndStreamingAgreementMember" xlink:label="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HeritageBuildingRestorationCommitmentMember" xlink:label="loc_huge_HeritageBuildingRestorationCommitmentMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember" xlink:label="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AnticipatedPurchasePricePlusApplicableTaxesValue" xlink:label="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_23"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfPurchasePricePaidAsSupplierLoan" xlink:label="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_24"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfDepositPaidToSupplier" xlink:label="loc_huge_AmountOfDepositPaidToSupplier_25"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OutstandingCommitmentToPurchaseAdditionalProduct" xlink:label="loc_huge_OutstandingCommitmentToPurchaseAdditionalProduct_26"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CollectiveCommitmentToPurchaseProduct" xlink:label="loc_huge_CollectiveCommitmentToPurchaseProduct_27"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementOptionToPurchaseAmount" xlink:label="loc_huge_SupplyAgreementOptionToPurchaseAmount_28"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementOptionToPurchasePeriod" xlink:label="loc_huge_SupplyAgreementOptionToPurchasePeriod_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted" xlink:label="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_30"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA" xlink:label="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA_31"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA" xlink:label="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA_32"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_33"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_34"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_35"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition" xlink:label="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_36"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_37"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdditionalInvestmentInExchangeForShares" xlink:label="loc_huge_AdditionalInvestmentInExchangeForShares_38"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_EstimatedCostOfRestorationInCommitment" xlink:label="loc_huge_EstimatedCostOfRestorationInCommitment_39"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClaimIssuedByContractorForVariousPurportedDamages" xlink:label="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_40"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClaimForLienComponent" xlink:label="loc_huge_ClaimForLienComponent_41"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees" xlink:label="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_42"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_EmployeeRelatedLiability" xlink:label="loc_huge_EmployeeRelatedLiability_43"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_44"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_45"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_1" xlink:to="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_1" xlink:to="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_CounterpartiesAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_6" xlink:to="loc_ifrs-full_CounterpartiesMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_6" xlink:to="loc_huge_AuxlyCannabisGroupIncMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_6" xlink:to="loc_ifrs-full_CounterpartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_TypeOfArrangementsAxis_10" xlink:to="loc_huge_TypeOfArrangementsDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_10" xlink:to="loc_huge_SupplyAgreementMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_10" xlink:to="loc_huge_EpitechLicenseAgreementMember_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_10" xlink:to="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_10" xlink:to="loc_huge_HeritageBuildingRestorationCommitmentMember_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_TypeOfArrangementsAxis_10" xlink:to="loc_huge_TypeOfArrangementsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_dei_LegalEntityAxis_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_17" xlink:to="loc_dei_EntityDomain_17" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_17" xlink:to="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_17" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_17" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_Inventories_22" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_23" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_24" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_AmountOfDepositPaidToSupplier_25" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_OutstandingCommitmentToPurchaseAdditionalProduct_26" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_CollectiveCommitmentToPurchaseProduct_27" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_SupplyAgreementOptionToPurchaseAmount_28" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_SupplyAgreementOptionToPurchasePeriod_29" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_30" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA_31" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA_32" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_33" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_34" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_35" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_36" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_37" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_AdditionalInvestmentInExchangeForShares_38" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_EstimatedCostOfRestorationInCommitment_39" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_40" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_ClaimForLienComponent_41" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_42" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_EmployeeRelatedLiability_43" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_44" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_45" order="240" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PharmadrugProductionGMBHMember" xlink:label="loc_huge_PharmadrugProductionGMBHMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementMember" xlink:label="loc_huge_SupplyAgreementMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FvPharmaIncMember" xlink:label="loc_huge_FvPharmaIncMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInNextFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInSecondFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInThirdFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInFifthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInFourthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_CounterpartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_1" xlink:to="loc_ifrs-full_CounterpartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_1" xlink:to="loc_huge_PharmadrugProductionGMBHMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_4" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_TypeOfArrangementsAxis_4" xlink:to="loc_huge_TypeOfArrangementsDomain_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_4" xlink:to="loc_huge_SupplyAgreementMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_TypeOfArrangementsAxis_4" xlink:to="loc_huge_TypeOfArrangementsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_dei_LegalEntityAxis_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8" xlink:to="loc_dei_EntityDomain_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8" xlink:to="loc_huge_FvPharmaIncMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_16" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_17" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_21"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughReverseAcquisition" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisition_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughReverseAcquisitionShares" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_23"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughWarrantValuations" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuations_24"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughWarrantValuationsShares" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_27"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_28"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfStockOptionsExercised" xlink:label="loc_huge_ValueOfStockOptionsExercised_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughStockOptionsCancelled" xlink:label="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_31"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_32"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfWarrantsExercised" xlink:label="loc_huge_ValueOfWarrantsExercised_33"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_34"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_36"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassACommonStockSharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_6" xlink:to="loc_ifrs-full_EquityMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_6" xlink:to="loc_huge_WarrantsMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_6" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_6" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_6" xlink:to="loc_ifrs-full_RetainedEarningsMember_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_6" xlink:to="loc_ifrs-full_EquityMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_Equity_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IssueOfEquity_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IssuanceOfShares_17" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_18" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_19" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_20" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_21" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughReverseAcquisition_22" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_23" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughWarrantValuations_24" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_25" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_26" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_27" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_28" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_ValueOfStockOptionsExercised_29" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_30" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_31" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_32" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_ValueOfWarrantsExercised_33" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_34" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_35" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ComprehensiveIncome_36" order="230" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScheduleOfStockClassLineItems" xlink:label="loc_huge_ScheduleOfStockClassLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScheduleOfStockClassTable" xlink:label="loc_huge_ScheduleOfStockClassTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_30"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Warrants" xlink:label="loc_huge_Warrants_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_37"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_ScheduleOfStockClassLineItems_0" xlink:to="loc_huge_ScheduleOfStockClassTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_ScheduleOfStockClassTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassACommonStockSharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ScheduleOfStockClassLineItems_0" xlink:to="loc_ifrs-full_AssetsAbstract_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_6" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_6" xlink:to="loc_ifrs-full_CashAndCashEquivalents_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_6" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_6" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_6" xlink:to="loc_ifrs-full_Inventories_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_6" xlink:to="loc_ifrs-full_CurrentBiologicalAssets_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_6" xlink:to="loc_ifrs-full_CurrentAssets_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_6" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_13" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_13" xlink:to="loc_ifrs-full_RightofuseAssets_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_13" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_13" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_6" xlink:to="loc_ifrs-full_Assets_18" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ScheduleOfStockClassLineItems_0" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_20" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_LiabilitiesAbstract_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_20" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_22" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_23" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_CurrentLiabilities_24" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_20" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_26" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_26" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_26" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_26" xlink:to="loc_ifrs-full_Liabilities_27" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_EquityAbstract_30" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_30" xlink:to="loc_ifrs-full_IssuedCapital_30" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_30" xlink:to="loc_huge_Warrants_31" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_30" xlink:to="loc_ifrs-full_SharePremium_32" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_30" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_33" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_30" xlink:to="loc_ifrs-full_RetainedEarnings_34" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_30" xlink:to="loc_ifrs-full_Equity_35" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_EquityAndLiabilities_37" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MarketRiskMember" xlink:label="loc_ifrs-full_MarketRiskMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ValueAtRisk" xlink:label="loc_ifrs-full_ValueAtRisk_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1" xlink:to="loc_ifrs-full_TypesOfRisksMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_1" xlink:to="loc_ifrs-full_MarketRiskMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_4" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_4" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_6" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_ValueAtRisk_11" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfCreditRiskDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanOneYearMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CreditRiskMember" xlink:label="loc_ifrs-full_CreditRiskMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentReceivablesFromTaxesOtherThanIncomeTax" xlink:label="loc_ifrs-full_NoncurrentReceivablesFromTaxesOtherThanIncomeTax_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_5" xlink:to="loc_ifrs-full_TypesOfRisksMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_5" xlink:to="loc_ifrs-full_CreditRiskMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_NoncurrentReceivablesFromTaxesOtherThanIncomeTax_10" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfFinancialAssetsAndFinancialLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesCategoryMember" xlink:label="loc_ifrs-full_FinancialLiabilitiesCategoryMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmortizedCostOfFinancialLiabilitiesMember" xlink:label="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherFinancialLiabilitiesMember" xlink:label="loc_huge_OtherFinancialLiabilitiesMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmortizedCostOfFinancialAssetsMember" xlink:label="loc_huge_AmortizedCostOfFinancialAssetsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LoansAndReceivablesCategoryMember" xlink:label="loc_ifrs-full_LoansAndReceivablesCategoryMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_14"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_1" xlink:to="loc_ifrs-full_FinancialLiabilitiesCategoryMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialLiabilitiesCategoryMember_1" xlink:to="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialLiabilitiesCategoryMember_1" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialLiabilitiesCategoryMember_1" xlink:to="loc_huge_OtherFinancialLiabilitiesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_6" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_huge_AmortizedCostOfFinancialAssetsMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_ifrs-full_LoansAndReceivablesCategoryMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_14" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfFinancialObligationsBasedOnTheirDueDatesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-full_LiquidityRiskMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_6" xlink:to="loc_ifrs-full_TypesOfRisksMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_6" xlink:to="loc_ifrs-full_LiquidityRiskMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_10" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AcquisitionOfPrismicPharmaceuticalsInc" xlink:label="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_11" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/InventoryScheduleOfInventoriesDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfInventoriesLineItems" xlink:label="loc_huge_ClassesOfInventoriesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfInventoriesTable" xlink:label="loc_huge_ClassesOfInventoriesTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfInventoriesAxis" xlink:label="loc_huge_TypeOfInventoriesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfInventoriesDomain" xlink:label="loc_huge_TypeOfInventoriesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HarvestedCannabisMember" xlink:label="loc_huge_HarvestedCannabisMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HempProductsMember" xlink:label="loc_huge_HempProductsMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInventoryMember" xlink:label="loc_huge_OtherInventoryMember_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfInventoriesDomain" xlink:label="loc_huge_TypeOfInventoriesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CapitalizedCostMember" xlink:label="loc_huge_CapitalizedCostMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BiologicalAssetFairValueAdjustmentMember" xlink:label="loc_huge_BiologicalAssetFairValueAdjustmentMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ImpairmentMember" xlink:label="loc_huge_ImpairmentMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RawMaterials" xlink:label="loc_ifrs-full_RawMaterials_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WorkInProgress" xlink:label="loc_ifrs-full_WorkInProgress_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductionSupplies" xlink:label="loc_ifrs-full_ProductionSupplies_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_ClassesOfInventoriesLineItems_0" xlink:to="loc_huge_ClassesOfInventoriesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_ClassesOfInventoriesTable_1" xlink:to="loc_huge_TypeOfInventoriesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_TypeOfInventoriesAxis_1" xlink:to="loc_huge_TypeOfInventoriesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfInventoriesDomain_1" xlink:to="loc_huge_HarvestedCannabisMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfInventoriesDomain_1" xlink:to="loc_huge_HempProductsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfInventoriesDomain_1" xlink:to="loc_huge_OtherInventoryMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_TypeOfInventoriesAxis_1" xlink:to="loc_huge_TypeOfInventoriesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_ClassesOfInventoriesTable_1" xlink:to="loc_ifrs-full_MeasurementAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_7" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_7" xlink:to="loc_huge_CapitalizedCostMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_7" xlink:to="loc_huge_BiologicalAssetFairValueAdjustmentMember_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_7" xlink:to="loc_huge_ImpairmentMember_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_7" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfInventoriesLineItems_0" xlink:to="loc_ifrs-full_RawMaterials_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfInventoriesLineItems_0" xlink:to="loc_ifrs-full_WorkInProgress_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfInventoriesLineItems_0" xlink:to="loc_ifrs-full_FinishedGoods_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfInventoriesLineItems_0" xlink:to="loc_ifrs-full_ProductionSupplies_17" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfInventoriesLineItems_0" xlink:to="loc_ifrs-full_Inventories_18" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_UndiscountedLeasePaymentsPayable" xlink:label="loc_huge_UndiscountedLeasePaymentsPayable_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OperatingLeaseImpactOfPresentValue" xlink:label="loc_huge_OperatingLeaseImpactOfPresentValue_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_huge_UndiscountedLeasePaymentsPayable_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_huge_OperatingLeaseImpactOfPresentValue_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_LeaseLiabilities_12" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LossPerShareDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareTable" xlink:label="loc_ifrs-full_EarningsPerShareTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_ifrs-full_EarningsPerShareTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_EarningsPerShareTable_1" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" xlink:to="loc_ifrs-full_OrdinarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OrdinarySharesMember_1" xlink:to="loc_huge_WarrantsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OrdinarySharesMember_1" xlink:to="loc_huge_StockOptionsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" xlink:to="loc_ifrs-full_OrdinarySharesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_8" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NatureOfBusinessNarrativeDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessLineItems" xlink:label="loc_huge_DisclosureOfNatureOfBusinessLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessTable" xlink:label="loc_huge_DisclosureOfNatureOfBusinessTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfReverseShareSplit" xlink:label="loc_huge_DescriptionOfReverseShareSplit_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WorkingCapitalSurplus" xlink:label="loc_huge_WorkingCapitalSurplus_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfNatureOfBusinessLineItems_0" xlink:to="loc_huge_DisclosureOfNatureOfBusinessTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfNatureOfBusinessTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfNatureOfBusinessLineItems_0" xlink:to="loc_huge_DescriptionOfReverseShareSplit_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfNatureOfBusinessLineItems_0" xlink:to="loc_ifrs-full_RetainedEarnings_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfNatureOfBusinessLineItems_0" xlink:to="loc_ifrs-full_ProfitLoss_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfNatureOfBusinessLineItems_0" xlink:to="loc_huge_WorkingCapitalSurplus_9" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SubsidiariesMember" xlink:label="loc_ifrs-full_SubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubsidiariesOneMember" xlink:label="loc_huge_SubsidiariesOneMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubsidiariesTwoMember" xlink:label="loc_huge_SubsidiariesTwoMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_ifrs-full_SubsidiariesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_huge_SubsidiariesOneMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_huge_SubsidiariesTwoMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_8" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NotesPayableNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConvertibleNotesMember" xlink:label="loc_huge_ConvertibleNotesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NotesPayableMember" xlink:label="loc_huge_NotesPayableMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_huge_ConvertibleNotesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_ifrs-full_ShorttermBorrowingsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_huge_NotesPayableMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRate_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NotesPayableScheduleOfNotesPayableDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConvertibleNotesMember" xlink:label="loc_huge_ConvertibleNotesMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NotesPayableMember" xlink:label="loc_huge_NotesPayableMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_ifrs-full_ShorttermBorrowingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_huge_ConvertibleNotesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_huge_NotesPayableMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsLineItems" xlink:label="loc_huge_DisclosureOfOtherInvestmentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsTable" xlink:label="loc_huge_DisclosureOfOtherInvestmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HighTideIncMember" xlink:label="loc_huge_HighTideIncMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HugeShopsMember" xlink:label="loc_huge_HugeShopsMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScicannTherapeuticsIncMember" xlink:label="loc_huge_ScicannTherapeuticsIncMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePurchaseAndSaleAgreementsMember" xlink:label="loc_huge_SharePurchaseAndSaleAgreementsMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBSubordinateVotingSharesMember" xlink:label="loc_huge_ClassBSubordinateVotingSharesMember_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_UnrestrictedClassBSharesMember" xlink:label="loc_huge_UnrestrictedClassBSharesMember_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBSharesHeldInEscrowMember" xlink:label="loc_huge_ClassBSharesHeldInEscrowMember_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_27"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubsequentEventsMember" xlink:label="loc_huge_SubsequentEventsMember_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_31"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesAcquired" xlink:label="loc_huge_NumberOfSharesAcquired_36"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_37"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesAcquired" xlink:label="loc_huge_ValueOfSharesAcquired_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_39"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssued" xlink:label="loc_huge_ValueOfSharesIssued_40"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedInShareExchange" xlink:label="loc_huge_NumberOfSharesIssuedInShareExchange_41"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_42"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssuedInShareExchange" xlink:label="loc_huge_ValueOfSharesIssuedInShareExchange_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_44"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement" xlink:label="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_45"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesHeld" xlink:label="loc_huge_NumberOfSharesHeld_46"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsHeld" xlink:label="loc_huge_NumberOfWarrantsHeld_47"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePriceOfSharesAndWarrants" xlink:label="loc_huge_SharePriceOfSharesAndWarrants_48"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DiscountOnProceedsOfSharesAndWarrantsSold" xlink:label="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_49"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProceedsFromSaleOfSharesAndWarrants" xlink:label="loc_huge_ProceedsFromSaleOfSharesAndWarrants_50"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubscriptionPricePerShare" xlink:label="loc_huge_SubscriptionPricePerShare_51"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfDeclineInFairValueOfInvestment" xlink:label="loc_huge_PercentageOfDeclineInFairValueOfInvestment_52"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChangeInFairValueOfInvestment" xlink:label="loc_huge_ChangeInFairValueOfInvestment_53"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsAcquired" xlink:label="loc_huge_NumberOfWarrantsAcquired_54"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PrincipalAmountOfBorrowings" xlink:label="loc_huge_PrincipalAmountOfBorrowings_55"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FairValueOfSharesAndWarrantsAcquired" xlink:label="loc_huge_FairValueOfSharesAndWarrantsAcquired_56"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOfWarrants" xlink:label="loc_huge_ExercisePriceOfWarrants_57"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesHeldSubjectToEscrowArrangement" xlink:label="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_58"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuotedMarketPriceOfInvestments" xlink:label="loc_huge_QuotedMarketPriceOfInvestments_59"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfAggregateDiscountForSharesInEscrow" xlink:label="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_60"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AggregateDiscountForSharesInEscrow" xlink:label="loc_huge_AggregateDiscountForSharesInEscrow_61"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_62"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FairValueOfShares" xlink:label="loc_huge_FairValueOfShares_63"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FairValueOfWarrants" xlink:label="loc_huge_FairValueOfWarrants_64"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_MarketPriceOfShares" xlink:label="loc_huge_MarketPriceOfShares_65"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_66"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_GuaranteedMinimumLiquidationValueOfShares" xlink:label="loc_huge_GuaranteedMinimumLiquidationValueOfShares_67"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RiskFreeRateOfWarrants" xlink:label="loc_huge_RiskFreeRateOfWarrants_68"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedVolatilityOfWarrants" xlink:label="loc_huge_ExpectedVolatilityOfWarrants_69"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedTermOfWarrants" xlink:label="loc_huge_ExpectedTermOfWarrants_70"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedDividendYieldOfWarrants" xlink:label="loc_huge_ExpectedDividendYieldOfWarrants_71"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DebtConversionRatio" xlink:label="loc_huge_DebtConversionRatio_72"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" xlink:label="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_73"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_74"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_DisclosureOfOtherInvestmentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_PharmadrugIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_CannaraBiotechIncMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_HighTideIncMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_HugeShopsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_ScicannTherapeuticsIncMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_SolarvestBioEnergyIncMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_TypeOfArrangementsAxis_11" xlink:to="loc_huge_TypeOfArrangementsDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_11" xlink:to="loc_huge_SecuritiesExchangeAgreementMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_11" xlink:to="loc_huge_SharePurchaseAndSaleAgreementsMember_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_TypeOfArrangementsAxis_11" xlink:to="loc_huge_TypeOfArrangementsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_16" xlink:to="loc_ifrs-full_OrdinarySharesMember_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OrdinarySharesMember_16" xlink:to="loc_huge_ClassBSubordinateVotingSharesMember_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OrdinarySharesMember_16" xlink:to="loc_huge_UnrestrictedClassBSharesMember_17" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OrdinarySharesMember_16" xlink:to="loc_huge_ClassBSharesHeldInEscrowMember_18" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_16" xlink:to="loc_ifrs-full_OrdinarySharesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_22" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_22" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_22" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_22" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_22" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_22" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_23" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_22" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_27" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_27" xlink:to="loc_ifrs-full_NonadjustingEventsMember_27" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_27" xlink:to="loc_huge_SubsequentEventsMember_27" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_27" xlink:to="loc_ifrs-full_NonadjustingEventsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_31" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_31" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_31" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_31" xlink:to="loc_huge_ClassBCommonStockSharesMember_31" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_31" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfSharesAcquired_36" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_SharePrices_37" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_ValueOfSharesAcquired_38" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_39" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_ValueOfSharesIssued_40" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedInShareExchange_41" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_ShareIssuePricePerShare_42" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_ValueOfSharesIssuedInShareExchange_43" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_44" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_45" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfSharesHeld_46" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfWarrantsHeld_47" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_SharePriceOfSharesAndWarrants_48" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_49" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_ProceedsFromSaleOfSharesAndWarrants_50" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_SubscriptionPricePerShare_51" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_PercentageOfDeclineInFairValueOfInvestment_52" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_ChangeInFairValueOfInvestment_53" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfWarrantsAcquired_54" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_PrincipalAmountOfBorrowings_55" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_FairValueOfSharesAndWarrantsAcquired_56" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_ExercisePriceOfWarrants_57" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_58" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_QuotedMarketPriceOfInvestments_59" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_60" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_AggregateDiscountForSharesInEscrow_61" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_62" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_FairValueOfShares_63" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_FairValueOfWarrants_64" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_MarketPriceOfShares_65" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_66" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_GuaranteedMinimumLiquidationValueOfShares_67" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_RiskFreeRateOfWarrants_68" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_ExpectedVolatilityOfWarrants_69" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_ExpectedTermOfWarrants_70" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_ExpectedDividendYieldOfWarrants_71" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_DebtConversionRatio_72" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_73" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_74" order="390" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsLineItems" xlink:label="loc_huge_DisclosureOfOtherInvestmentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsTable" xlink:label="loc_huge_DisclosureOfOtherInvestmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HighTideIncMember" xlink:label="loc_huge_HighTideIncMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HugeShopsMember" xlink:label="loc_huge_HugeShopsMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScicannTherapeuticsIncMember" xlink:label="loc_huge_ScicannTherapeuticsIncMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConvertibleDebentureMember" xlink:label="loc_huge_ConvertibleDebentureMember_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_24"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_25"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_DisclosureOfOtherInvestmentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_ifrs-full_MeasurementAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_1" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_1" xlink:to="loc_ifrs-full_AtFairValueMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_1" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_5" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_PharmadrugIncMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_CannaraBiotechIncMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_HighTideIncMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_HugeShopsMember_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_ScicannTherapeuticsIncMember_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_SolarvestBioEnergyIncMember_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_5" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_15" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_15" xlink:to="loc_ifrs-full_OrdinarySharesMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_15" xlink:to="loc_huge_WarrantsMember_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_15" xlink:to="loc_huge_ConvertibleDebentureMember_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_15" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_22" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_23" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_24" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_0" xlink:to="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_25" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/PropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FurnitureFixturesAndEquipmentMember" xlink:label="loc_huge_FurnitureFixturesAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FacilityUnderDevelopmentMember" xlink:label="loc_huge_FacilityUnderDevelopmentMember_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProductionEquipmentMember" xlink:label="loc_huge_ProductionEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-full_LandMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_huge_FurnitureFixturesAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ComputerEquipmentMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_huge_FacilityUnderDevelopmentMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_huge_ProductionEquipmentMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_LandMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9" xlink:to="loc_ifrs-full_CarryingAmountMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_9" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_9" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_19" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FvPharmaIncMember" xlink:label="loc_huge_FvPharmaIncMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FSDBiosciencesMember" xlink:label="loc_huge_FSDBiosciencesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PresidentAndChiefExecutiveOfficerMember" xlink:label="loc_huge_PresidentAndChiefExecutiveOfficerMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FormerChiefExecutiveOfficerMember" xlink:label="loc_huge_FormerChiefExecutiveOfficerMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChiefExecutiveOfficersMember" xlink:label="loc_huge_ChiefExecutiveOfficersMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PresidentsMember" xlink:label="loc_huge_PresidentsMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PresidentOfFSDMember" xlink:label="loc_huge_PresidentOfFSDMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChiefFinancialOfficersMember" xlink:label="loc_huge_ChiefFinancialOfficersMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChiefOperatingConsultantMember" xlink:label="loc_huge_ChiefOperatingConsultantMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FormerChiefOperatingOfficerMember" xlink:label="loc_huge_FormerChiefOperatingOfficerMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IndependentDirectorMember" xlink:label="loc_huge_IndependentDirectorMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DirectorsAndOfficersMember" xlink:label="loc_huge_DirectorsAndOfficersMember_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_25"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherAllowances" xlink:label="loc_huge_OtherAllowances_26"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PaymentOfExpenses" xlink:label="loc_huge_PaymentOfExpenses_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_30"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConsultingFeesExpenses" xlink:label="loc_huge_ConsultingFeesExpenses_31"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ManagementFees" xlink:label="loc_huge_ManagementFees_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_33"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdditionalRemuneration" xlink:label="loc_huge_AdditionalRemuneration_34"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DirectorsRemunerationPayable" xlink:label="loc_huge_DirectorsRemunerationPayable_35"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedInPrivatePlacement_36"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_37"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_ValueOfSharesIssuedInPrivatePlacement_38"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesSubscribed" xlink:label="loc_huge_NumberOfSharesSubscribed_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_40"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_dei_LegalEntityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_huge_FvPharmaIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_huge_FSDBiosciencesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_PresidentAndChiefExecutiveOfficerMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_FormerChiefExecutiveOfficerMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_ChiefExecutiveOfficersMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_PresidentsMember_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_PresidentOfFSDMember_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_ChiefFinancialOfficersMember_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_ChiefOperatingConsultantMember_12" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_FormerChiefOperatingOfficerMember_13" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_IndependentDirectorMember_14" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_DirectorsAndOfficersMember_15" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_19" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_19" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_19" xlink:to="loc_huge_ClassBCommonStockSharesMember_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_19" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_24" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_25" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_OtherAllowances_26" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_PaymentOfExpenses_27" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_28" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_29" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherPayables_30" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_ConsultingFeesExpenses_31" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_ManagementFees_32" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DirectorsRemunerationExpense_33" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_AdditionalRemuneration_34" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_DirectorsRemunerationPayable_35" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedInPrivatePlacement_36" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_ShareIssuePricePerShare_37" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_ValueOfSharesIssuedInPrivatePlacement_38" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_NumberOfSharesSubscribed_39" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_40" order="170" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_6" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_7" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_8" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_9" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_10" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_11" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_12" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_13" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_14" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_15" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_16" order="120" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwoPointSixOneMember" xlink:label="loc_huge_ExercisePriceTwoPointSixOneMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFourPointFourTwoMember" xlink:label="loc_huge_ExercisePriceFourPointFourTwoMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFivePointZeroThreeMember" xlink:label="loc_huge_ExercisePriceFivePointZeroThreeMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFivePointFourThreeMember" xlink:label="loc_huge_ExercisePriceFivePointFourThreeMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTenPointSixFiveMember" xlink:label="loc_huge_ExercisePriceTenPointSixFiveMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceThirteenPointZeroSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointZeroSevenMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceThirteenPointFourSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointFourSevenMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSixteenPointZeroEightMember" xlink:label="loc_huge_ExercisePriceSixteenPointZeroEightMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSeventeenPointEightNineMember" xlink:label="loc_huge_ExercisePriceSeventeenPointEightNineMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceEighteenPointZeroNineMember" xlink:label="loc_huge_ExercisePriceEighteenPointZeroNineMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyPointOneZeroMember" xlink:label="loc_huge_ExercisePriceTwentyPointOneZeroMember_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyOnePointElevenMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointElevenMember_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyFourPointTwelveMember" xlink:label="loc_huge_ExercisePriceTwentyFourPointTwelveMember_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentySixPointThirteenMember" xlink:label="loc_huge_ExercisePriceTwentySixPointThirteenMember_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFortyPointTwentyMember" xlink:label="loc_huge_ExercisePriceFortyPointTwentyMember_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFortyFourPointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFortySevenPointTwentyFourMember" xlink:label="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_21"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftyPointTwentyFiveMember" xlink:label="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftyTwoPointTwentySixMember" xlink:label="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_23"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftyFivePointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_24"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftySixPointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_25"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftyNinePointThirtyMember" xlink:label="loc_huge_ExercisePriceFiftyNinePointThirtyMember_26"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSixPointSixteenMember" xlink:label="loc_huge_ExercisePriceSixPointSixteenMember_27"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSevenPointZeroZeroMember" xlink:label="loc_huge_ExercisePriceSevenPointZeroZeroMember_28"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSevenPointSeventeenMember" xlink:label="loc_huge_ExercisePriceSevenPointSeventeenMember_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSevenPointFiftyMember" xlink:label="loc_huge_ExercisePriceSevenPointFiftyMember_30"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSeventyFivePointThirtyEightMember" xlink:label="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_31"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSevenPointSixtyThreeMember" xlink:label="loc_huge_ExercisePriceSevenPointSixtyThreeMember_32"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceEightySixPointFortyThreeMember" xlink:label="loc_huge_ExercisePriceEightySixPointFortyThreeMember_33"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceEightyEightPointFortyFourMember" xlink:label="loc_huge_ExercisePriceEightyEightPointFortyFourMember_34"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOneHundredTwentyPointSixtyMember" xlink:label="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_35"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_36"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyOnePointNinetyOneMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_37"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyOnePointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_38"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_39"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSixtyEightPointZeroOneMember" xlink:label="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_40"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSeventyOnePointZeroSevenMember" xlink:label="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_46"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_47"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_48"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_49"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_50"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_5" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwoPointSixOneMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFourPointFourTwoMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFivePointZeroThreeMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFivePointFourThreeMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTenPointSixFiveMember_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceThirteenPointZeroSevenMember_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceThirteenPointFourSevenMember_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSixteenPointZeroEightMember_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSeventeenPointEightNineMember_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceEighteenPointZeroNineMember_14" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwentyPointOneZeroMember_15" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwentyOnePointElevenMember_16" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwentyFourPointTwelveMember_17" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwentySixPointThirteenMember_18" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFortyPointTwentyMember_19" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_20" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_21" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_22" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_23" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_24" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_25" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFiftyNinePointThirtyMember_26" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSixPointSixteenMember_27" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSevenPointZeroZeroMember_28" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSevenPointSeventeenMember_29" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSevenPointFiftyMember_30" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_31" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSevenPointSixtyThreeMember_32" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceEightySixPointFortyThreeMember_33" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceEightyEightPointFortyFourMember_34" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_35" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_36" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_37" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_38" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_39" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_40" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_41" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_5" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_46" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_47" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_48" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_49" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_50" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_14"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangeAxis_4" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_4" xlink:to="loc_ifrs-full_RangesMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_4" xlink:to="loc_ifrs-full_BottomOfRangeMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_4" xlink:to="loc_ifrs-full_TopOfRangeMember_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_12" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_13" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_14" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfVotingRights" xlink:label="loc_huge_DescriptionOfVotingRights_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesAcquired" xlink:label="loc_huge_NumberOfSharesAcquired_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesAcquired" xlink:label="loc_huge_ValueOfSharesAcquired_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedInShareExchange" xlink:label="loc_huge_NumberOfSharesIssuedInShareExchange_21"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssuedInShareExchange" xlink:label="loc_huge_ValueOfSharesIssuedInShareExchange_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_NumberOfSharesIssuedForDebtSettlement_23"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_ValueOfSharesIssuedForDebtSettlement_24"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareSplitRatio" xlink:label="loc_huge_ShareSplitRatio_25"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfReverseShareSplit" xlink:label="loc_huge_DescriptionOfReverseShareSplit_26"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedInPrivatePlacement_27"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_28"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssued" xlink:label="loc_huge_ValueOfSharesIssued_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_32"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability" xlink:label="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_33"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_34"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassACommonStockSharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_TypeOfArrangementsAxis_6" xlink:to="loc_huge_TypeOfArrangementsDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_6" xlink:to="loc_huge_SecuritiesExchangeAgreementMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_TypeOfArrangementsAxis_6" xlink:to="loc_huge_TypeOfArrangementsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_10" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_10" xlink:to="loc_huge_PharmadrugIncMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_10" xlink:to="loc_huge_SolarvestBioEnergyIncMember_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_10" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_DescriptionOfVotingRights_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_NumberOfSharesAcquired_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_SharePrices_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ValueOfSharesAcquired_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_20" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedInShareExchange_21" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ValueOfSharesIssuedInShareExchange_22" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedForDebtSettlement_23" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ValueOfSharesIssuedForDebtSettlement_24" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ShareSplitRatio_25" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_DescriptionOfReverseShareSplit_26" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedInPrivatePlacement_27" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ShareIssuePricePerShare_28" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ValueOfSharesIssued_29" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_30" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_31" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_32" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_33" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_34" order="190" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfWarrantsLineItems" xlink:label="loc_huge_DisclosureOfWarrantsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfWarrantsTable" xlink:label="loc_huge_DisclosureOfWarrantsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageSharePriceOfWarrants" xlink:label="loc_huge_WeightedAverageSharePriceOfWarrants_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedDividendYieldOfWarrantsGranted" xlink:label="loc_huge_ExpectedDividendYieldOfWarrantsGranted_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_DisclosureOfWarrantsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfWarrantsTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_WeightedAverageSharePriceOfWarrants_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_ExercisePriceOfWarrantsGranted_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_ExpectedDividendYieldOfWarrantsGranted_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_RiskFreeInterestRateOfWarrantsGranted_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_ExpectedLifeOfWarrants_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_ExpectedVolatilityOfWarrantsGranted_12" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughReverseAcquisition" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisition_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughReverseAcquisitionShares" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughWarrantValuations" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuations_21"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughWarrantValuationsShares" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_24"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_25"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughStockOptionsCancelled" xlink:label="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_27"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_28"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_30"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_huge_WarrantsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_5" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_5" xlink:to="loc_huge_ClassACommonStockSharesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_5" xlink:to="loc_huge_ClassBCommonStockSharesMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_5" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_Equity_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IssueOfEquity_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IssuanceOfShares_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_16" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_17" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_18" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughReverseAcquisition_19" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_20" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughWarrantValuations_21" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_22" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_23" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_24" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_25" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_26" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_27" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_28" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_29" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_30" order="200" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfWarrantsLineItems" xlink:label="loc_huge_DisclosureOfWarrantsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfWarrantsTable" xlink:label="loc_huge_DisclosureOfWarrantsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfWarrantsAxis" xlink:label="loc_huge_ClassesOfWarrantsAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfWarrantsDomain" xlink:label="loc_huge_ClassesOfWarrantsDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtNovember30th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember30th2020Member_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtSeptember15th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember15th2022Member_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtAugust1st2021Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust1st2021Member_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtSeptember11th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember11th2023Member_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtJanuary5th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary5th2020Member_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtJuly24th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJuly24th2023Member_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay20th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay20th2023Member_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay24th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay24th2022Member_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay4th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay4th2025Member_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay10th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay10th2025Member_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay17th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay17th2025Member_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay31st2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay31st2025Member_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtJanuary16th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary16th2026Member_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtJanuary20th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary20th2026Member_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtOctober20th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtOctober20th2019Member_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtNovember1st2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember1st2019Member_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtNovember14th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember14th2019Member_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtNovember21st2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember21st2019Member_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtDecember12st2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember12st2019Member_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtDecember29th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember29th2019Member_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfWarrantsDomain" xlink:label="loc_huge_ClassesOfWarrantsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_25"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_26"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_DisclosureOfWarrantsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfWarrantsTable_1" xlink:to="loc_huge_ClassesOfWarrantsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_ClassesOfWarrantsAxis_1" xlink:to="loc_huge_ClassesOfWarrantsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember30th2020Member_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtSeptember15th2022Member_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtAugust1st2021Member_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtSeptember11th2023Member_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJanuary5th2020Member_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJuly24th2023Member_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay20th2023Member_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay24th2022Member_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay4th2025Member_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay10th2025Member_10" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay17th2025Member_11" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay31st2025Member_12" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJanuary16th2026Member_13" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJanuary20th2026Member_14" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtOctober20th2019Member_15" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember1st2019Member_16" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember14th2019Member_17" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember21st2019Member_18" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtDecember12st2019Member_19" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtDecember29th2019Member_20" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_ClassesOfWarrantsAxis_1" xlink:to="loc_huge_ClassesOfWarrantsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_25" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_NumberOfWarrantsOutstanding_26" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassACommonStockSharesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_7" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProductionEquipmentMember" xlink:label="loc_huge_ProductionEquipmentMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-full_ConstructionInProgressMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-full_LandMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationMethodPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" xlink:to="loc_ifrs-full_ComputerEquipmentMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" xlink:to="loc_huge_ProductionEquipmentMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" xlink:to="loc_ifrs-full_ConstructionInProgressMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" xlink:to="loc_ifrs-full_LandMember_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_16" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubsequentEventsMember" xlink:label="loc_huge_SubsequentEventsMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePurchaseAndSaleAgreementsMember" xlink:label="loc_huge_SharePurchaseAndSaleAgreementsMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" xlink:label="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares" xlink:label="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesIncurred" xlink:label="loc_ifrs-full_LiabilitiesIncurred_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesSold" xlink:label="loc_huge_NumberOfSharesSold_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_24"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_4" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_4" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_SolarvestBioEnergyIncMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_CannaraBiotechIncMember_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_4" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_9" xlink:to="loc_ifrs-full_NonadjustingEventsMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_9" xlink:to="loc_huge_SubsequentEventsMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_TypeOfArrangementsAxis_12" xlink:to="loc_huge_TypeOfArrangementsDomain_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_12" xlink:to="loc_huge_SecuritiesExchangeAgreementMember_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_12" xlink:to="loc_huge_SharePurchaseAndSaleAgreementsMember_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_TypeOfArrangementsAxis_12" xlink:to="loc_huge_TypeOfArrangementsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_18" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_19" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_20" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_21" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_LiabilitiesIncurred_22" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_huge_NumberOfSharesSold_23" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_24" order="70" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>huge-20191231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AcquisitionOfPrismicPharmaceuticalsInc" xlink:label="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdditionalInvestmentInExchangeForShares" xlink:label="loc_huge_AdditionalInvestmentInExchangeForShares_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdditionalRemuneration" xlink:label="loc_huge_AdditionalRemuneration_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_21"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_23"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" xlink:label="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_24"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForListingExpense" xlink:label="loc_huge_AdjustmentsForListingExpense_25"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitAbstract" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_26"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_27"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_28"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_30"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_31"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentToLeaseCommitments" xlink:label="loc_huge_AdjustmentToLeaseCommitments_32"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower" xlink:label="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_33"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim" xlink:label="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_34"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AggregateDiscountForSharesInEscrow" xlink:label="loc_huge_AggregateDiscountForSharesInEscrow_35"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AggregateUnpaidAccounts" xlink:label="loc_huge_AggregateUnpaidAccounts_36"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AllowanceForImpairment" xlink:label="loc_huge_AllowanceForImpairment_37"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmortizedCostOfFinancialAssetsMember" xlink:label="loc_huge_AmortizedCostOfFinancialAssetsMember_38"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmortizedCostOfFinancialLiabilitiesMember" xlink:label="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_39"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities" xlink:label="loc_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_40"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfAgreementFallBelowMinimumValue" xlink:label="loc_huge_AmountOfAgreementFallBelowMinimumValue_41"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions" xlink:label="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_42"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfDepositPaidToSupplier" xlink:label="loc_huge_AmountOfDepositPaidToSupplier_43"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation" xlink:label="loc_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_44"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfPurchasePricePaidAsSupplierLoan" xlink:label="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_45"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_46"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AnthonyDurkaczMember" xlink:label="loc_huge_AnthonyDurkaczMember_47"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AnticipatedPurchasePricePlusApplicableTaxesValue" xlink:label="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_48"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Apr82018Member" xlink:label="loc_huge_Apr82018Member_49"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Apr92018Member" xlink:label="loc_huge_Apr92018Member_50"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_April182018Member" xlink:label="loc_huge_April182018Member_51"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Aug142018Member" xlink:label="loc_huge_Aug142018Member_52"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Aug152018Member" xlink:label="loc_huge_Aug152018Member_53"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Aug82018Member" xlink:label="loc_huge_Aug82018Member_54"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AuraHealthIncMember" xlink:label="loc_huge_AuraHealthIncMember_55"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AuxlyCannabisGroupIncMember" xlink:label="loc_huge_AuxlyCannabisGroupIncMember_56"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AverageExpectedLifeOfWarrants" xlink:label="loc_huge_AverageExpectedLifeOfWarrants_57"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BasisOfPresentationAbstract" xlink:label="loc_huge_BasisOfPresentationAbstract_58"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BiologicalAssetFairValueAdjustmentMember" xlink:label="loc_huge_BiologicalAssetFairValueAdjustmentMember_59"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BonusExpenseToBePaidInSubsequentPeriod" xlink:label="loc_huge_BonusExpenseToBePaidInSubsequentPeriod_60"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BrokerWarrants" xlink:label="loc_huge_BrokerWarrants_61"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BrokerWarrantsIssuedInPrivatePlacements" xlink:label="loc_huge_BrokerWarrantsIssuedInPrivatePlacements_62"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BusinessAcquisitionDomain" xlink:label="loc_huge_BusinessAcquisitionDomain_63"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BusinessAcquisitionsAxis" xlink:label="loc_huge_BusinessAcquisitionsAxis_64"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BusinessAcquisitionsBenefitsAxis" xlink:label="loc_huge_BusinessAcquisitionsBenefitsAxis_65"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BusinessAcquisitionsBenefitsDomain" xlink:label="loc_huge_BusinessAcquisitionsBenefitsDomain_66"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BusinessLicenseFees" xlink:label="loc_huge_BusinessLicenseFees_67"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_68"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember" xlink:label="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_69"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CapitalizedCostMember" xlink:label="loc_huge_CapitalizedCostMember_70"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CapitalizedCosts" xlink:label="loc_huge_CapitalizedCosts_71"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CashAcquiredOnAcquisition" xlink:label="loc_huge_CashAcquiredOnAcquisition_72"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CenturyAndFvPharmaMember" xlink:label="loc_huge_CenturyAndFvPharmaMember_73"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChangeInFairValueOfInvestment" xlink:label="loc_huge_ChangeInFairValueOfInvestment_74"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_75"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChangesInNonCashWorkingCapitalItemsAbstract" xlink:label="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_76"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChangesInShareCapitalTransactionDateAxis" xlink:label="loc_huge_ChangesInShareCapitalTransactionDateAxis_77"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChangesInShareCapitalTransactionDateDomain" xlink:label="loc_huge_ChangesInShareCapitalTransactionDateDomain_78"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember" xlink:label="loc_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_79"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChiefExecutiveOfficersMember" xlink:label="loc_huge_ChiefExecutiveOfficersMember_80"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChiefFinancialOfficersMember" xlink:label="loc_huge_ChiefFinancialOfficersMember_81"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChiefOperatingConsultantMember" xlink:label="loc_huge_ChiefOperatingConsultantMember_82"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClaimForLienComponent" xlink:label="loc_huge_ClaimForLienComponent_83"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClaimIssuedByContractorForVariousPurportedDamages" xlink:label="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_84"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts" xlink:label="loc_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_85"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_86"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_87"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBSharesHeldInEscrowMember" xlink:label="loc_huge_ClassBSharesHeldInEscrowMember_88"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBSubordinateVotingSharesMember" xlink:label="loc_huge_ClassBSubordinateVotingSharesMember_89"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBVotingSharesMember" xlink:label="loc_huge_ClassBVotingSharesMember_90"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfInventoriesLineItems" xlink:label="loc_huge_ClassesOfInventoriesLineItems_91"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfInventoriesTable" xlink:label="loc_huge_ClassesOfInventoriesTable_92"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfWarrantsAxis" xlink:label="loc_huge_ClassesOfWarrantsAxis_93"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfWarrantsDomain" xlink:label="loc_huge_ClassesOfWarrantsDomain_94"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_95"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CollectiveCommitmentToPurchaseProduct" xlink:label="loc_huge_CollectiveCommitmentToPurchaseProduct_96"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CommitmentsEquityInstruments" xlink:label="loc_huge_CommitmentsEquityInstruments_97"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CommitmentsLineItems" xlink:label="loc_huge_CommitmentsLineItems_98"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CommitmentsTable" xlink:label="loc_huge_CommitmentsTable_99"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CommitmentToIssueSharesMinimumValueUponLiquidation" xlink:label="loc_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_100"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConsultingFeesExpenses" xlink:label="loc_huge_ConsultingFeesExpenses_101"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember" xlink:label="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_102"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ContractualCapitalCommitmentsEqualMonthlyInstalments" xlink:label="loc_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_103"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConvertibleDebentureMember" xlink:label="loc_huge_ConvertibleDebentureMember_104"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConvertibleNotes" xlink:label="loc_huge_ConvertibleNotes_105"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConvertibleNotesMember" xlink:label="loc_huge_ConvertibleNotesMember_106"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CorporateInformationAndNatureOfOperationsAbstract" xlink:label="loc_huge_CorporateInformationAndNatureOfOperationsAbstract_107"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CriticalAccountingEstimatesAndJudgmentsAbstract" xlink:label="loc_huge_CriticalAccountingEstimatesAndJudgmentsAbstract_108"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CurrentNotesPayable" xlink:label="loc_huge_CurrentNotesPayable_109"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DateOfExpiryOfShareOptions" xlink:label="loc_huge_DateOfExpiryOfShareOptions_110"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DebtConversionRatio" xlink:label="loc_huge_DebtConversionRatio_111"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Dec122017Member" xlink:label="loc_huge_Dec122017Member_112"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Dec152018Member" xlink:label="loc_huge_Dec152018Member_113"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Dec212017Member" xlink:label="loc_huge_Dec212017Member_114"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Dec232017Member" xlink:label="loc_huge_Dec232017Member_115"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Dec292017Member" xlink:label="loc_huge_Dec292017Member_116"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_December292017Member" xlink:label="loc_huge_December292017Member_117"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_118"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_119"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_120"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_121"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_122"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_123"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_124"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxAssetLiabilityNotRecognized" xlink:label="loc_huge_DeferredTaxAssetLiabilityNotRecognized_125"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxAssetNotRecognized" xlink:label="loc_huge_DeferredTaxAssetNotRecognized_126"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxAssetPropertyPlantAndEquipments" xlink:label="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_127"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxAssetsLiabilitiesAxis" xlink:label="loc_huge_DeferredTaxAssetsLiabilitiesAxis_128"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxAssetsLiabilitiesDomain" xlink:label="loc_huge_DeferredTaxAssetsLiabilitiesDomain_129"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxAssetsOtherInvestments" xlink:label="loc_huge_DeferredTaxAssetsOtherInvestments_130"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward" xlink:label="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_131"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DefinitiveBusinessCombinationAgreementMember" xlink:label="loc_huge_DefinitiveBusinessCombinationAgreementMember_132"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DefinitiveCollaborationProfitSharingAgreementMember" xlink:label="loc_huge_DefinitiveCollaborationProfitSharingAgreementMember_133"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DefinitiveStrategicAllianceAndStreamingAgreementMember" xlink:label="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_134"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares" xlink:label="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_135"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfExpectedVolatilityWarrantsGranted" xlink:label="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_136"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfOptionLifeWarrantsGranted" xlink:label="loc_huge_DescriptionOfOptionLifeWarrantsGranted_137"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory" xlink:label="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_138"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfReverseShareSplit" xlink:label="loc_huge_DescriptionOfReverseShareSplit_139"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfRiskFreeInterestRateWarrantsGranted" xlink:label="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_140"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfVotingRights" xlink:label="loc_huge_DescriptionOfVotingRights_141"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DirectorsAndOfficersMember" xlink:label="loc_huge_DirectorsAndOfficersMember_142"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DirectorsRemunerationPayable" xlink:label="loc_huge_DirectorsRemunerationPayable_143"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfBiologicalAssetsExplanatory" xlink:label="loc_huge_DisclosureOfBiologicalAssetsExplanatory_144"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfCapitalManagementAbstract" xlink:label="loc_huge_DisclosureOfCapitalManagementAbstract_145"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_146"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfCommitmentsAbstract" xlink:label="loc_huge_DisclosureOfCommitmentsAbstract_147"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract" xlink:label="loc_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_148"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory" xlink:label="loc_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_149"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_150"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_151"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_152"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_153"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailedInformationAboutRightOfUseAssets" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_154"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_155"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_156"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory" xlink:label="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_157"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory" xlink:label="loc_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_158"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory" xlink:label="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_159"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock" xlink:label="loc_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_160"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory" xlink:label="loc_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_161"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfGeneralAndAdministrativeExpenses" xlink:label="loc_huge_DisclosureOfGeneralAndAdministrativeExpenses_162"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessAbstract" xlink:label="loc_huge_DisclosureOfNatureOfBusinessAbstract_163"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock" xlink:label="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_164"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessLineItems" xlink:label="loc_huge_DisclosureOfNatureOfBusinessLineItems_165"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessTable" xlink:label="loc_huge_DisclosureOfNatureOfBusinessTable_166"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory" xlink:label="loc_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_167"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_168"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_169"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOperatingLeaseObligationsTableTextBlock" xlink:label="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_170"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsAbstract" xlink:label="loc_huge_DisclosureOfOtherInvestmentsAbstract_171"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsLineItems" xlink:label="loc_huge_DisclosureOfOtherInvestmentsLineItems_172"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsTable" xlink:label="loc_huge_DisclosureOfOtherInvestmentsTable_173"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfProvisionForIncomeTaxesExplanatory" xlink:label="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_174"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory" xlink:label="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_175"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfReverseTakeoverTransactionAbstract" xlink:label="loc_huge_DisclosureOfReverseTakeoverTransactionAbstract_176"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfReverseTakeoverTransactionExplanatory" xlink:label="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_177"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract" xlink:label="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_178"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory" xlink:label="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_179"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory" xlink:label="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_180"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory" xlink:label="loc_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory_181"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory" xlink:label="loc_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_182"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfWarrantsLineItems" xlink:label="loc_huge_DisclosureOfWarrantsLineItems_183"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfWarrantsTable" xlink:label="loc_huge_DisclosureOfWarrantsTable_184"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DiscountOnProceedsOfSharesAndWarrantsSold" xlink:label="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_185"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DocumentAndEntityInformationAbstract" xlink:label="loc_huge_DocumentAndEntityInformationAbstract_186"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares" xlink:label="loc_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_187"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_EmployeeRelatedLiability" xlink:label="loc_huge_EmployeeRelatedLiability_188"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_EpitechLicenseAgreementMember" xlink:label="loc_huge_EpitechLicenseAgreementMember_189"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_EstimatedCostOfRestorationInCommitment" xlink:label="loc_huge_EstimatedCostOfRestorationInCommitment_190"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceEighteenPointZeroNineMember" xlink:label="loc_huge_ExercisePriceEighteenPointZeroNineMember_191"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceEightyEightPointFortyFourMember" xlink:label="loc_huge_ExercisePriceEightyEightPointFortyFourMember_192"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceEightySixPointFortyThreeMember" xlink:label="loc_huge_ExercisePriceEightySixPointFortyThreeMember_193"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftyFivePointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_194"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftyNinePointThirtyMember" xlink:label="loc_huge_ExercisePriceFiftyNinePointThirtyMember_195"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftyPointTwentyFiveMember" xlink:label="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_196"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftySixPointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_197"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftyTwoPointTwentySixMember" xlink:label="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_198"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFivePointFourThreeMember" xlink:label="loc_huge_ExercisePriceFivePointFourThreeMember_199"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFivePointZeroThreeMember" xlink:label="loc_huge_ExercisePriceFivePointZeroThreeMember_200"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFortyFourPointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_201"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFortyPointTwentyMember" xlink:label="loc_huge_ExercisePriceFortyPointTwentyMember_202"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFortySevenPointTwentyFourMember" xlink:label="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_203"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFourPointFourTwoMember" xlink:label="loc_huge_ExercisePriceFourPointFourTwoMember_204"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOfExercisableShareOptions" xlink:label="loc_huge_ExercisePriceOfExercisableShareOptions_205"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOfWarrants" xlink:label="loc_huge_ExercisePriceOfWarrants_206"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_207"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_208"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_209"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOneHundredTwentyPointSixtyMember" xlink:label="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_210"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSevenPointFiftyMember" xlink:label="loc_huge_ExercisePriceSevenPointFiftyMember_211"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSevenPointSeventeenMember" xlink:label="loc_huge_ExercisePriceSevenPointSeventeenMember_212"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSevenPointSixtyThreeMember" xlink:label="loc_huge_ExercisePriceSevenPointSixtyThreeMember_213"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSevenPointZeroZeroMember" xlink:label="loc_huge_ExercisePriceSevenPointZeroZeroMember_214"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSeventeenPointEightNineMember" xlink:label="loc_huge_ExercisePriceSeventeenPointEightNineMember_215"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSeventyFivePointThirtyEightMember" xlink:label="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_216"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSeventyOnePointZeroSevenMember" xlink:label="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_217"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSixPointSixteenMember" xlink:label="loc_huge_ExercisePriceSixPointSixteenMember_218"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSixteenPointZeroEightMember" xlink:label="loc_huge_ExercisePriceSixteenPointZeroEightMember_219"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSixtyEightPointZeroOneMember" xlink:label="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_220"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTenPointSixFiveMember" xlink:label="loc_huge_ExercisePriceTenPointSixFiveMember_221"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceThirteenPointFourSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointFourSevenMember_222"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceThirteenPointZeroSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointZeroSevenMember_223"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyFourPointTwelveMember" xlink:label="loc_huge_ExercisePriceTwentyFourPointTwelveMember_224"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyOnePointElevenMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointElevenMember_225"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyOnePointNinetyOneMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_226"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyOnePointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_227"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyPointOneZeroMember" xlink:label="loc_huge_ExercisePriceTwentyPointOneZeroMember_228"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentySixPointThirteenMember" xlink:label="loc_huge_ExercisePriceTwentySixPointThirteenMember_229"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwoPointSixOneMember" xlink:label="loc_huge_ExercisePriceTwoPointSixOneMember_230"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedDividendAsPercentageWarrantsGranted" xlink:label="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_231"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedDividendYieldOfWarrants" xlink:label="loc_huge_ExpectedDividendYieldOfWarrants_232"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedDividendYieldOfWarrantsGranted" xlink:label="loc_huge_ExpectedDividendYieldOfWarrantsGranted_233"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedGrowthCycle" xlink:label="loc_huge_ExpectedGrowthCycle_234"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedGrowthCycleCompleted" xlink:label="loc_huge_ExpectedGrowthCycleCompleted_235"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_236"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedNetSellingPricePerGramOfDriedFlower" xlink:label="loc_huge_ExpectedNetSellingPricePerGramOfDriedFlower_237"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedNetSellingPricePerGramOfTrim" xlink:label="loc_huge_ExpectedNetSellingPricePerGramOfTrim_238"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedSellingPricePerGramOfDriedFlower" xlink:label="loc_huge_ExpectedSellingPricePerGramOfDriedFlower_239"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedSellingPricePerGramOfTrim" xlink:label="loc_huge_ExpectedSellingPricePerGramOfTrim_240"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedTermOfWarrants" xlink:label="loc_huge_ExpectedTermOfWarrants_241"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedVolatilityOfWarrants" xlink:label="loc_huge_ExpectedVolatilityOfWarrants_242"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_243"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant" xlink:label="loc_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_244"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant" xlink:label="loc_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_245"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedYieldOfDryFlower" xlink:label="loc_huge_ExpectedYieldOfDryFlower_246"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedYieldOfDryTrim" xlink:label="loc_huge_ExpectedYieldOfDryTrim_247"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpiryDateOfWarrants" xlink:label="loc_huge_ExpiryDateOfWarrants_248"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpiryTermOfWarrantsGranted" xlink:label="loc_huge_ExpiryTermOfWarrantsGranted_249"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FacilityRelatedExpenditures" xlink:label="loc_huge_FacilityRelatedExpenditures_250"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FacilityUnderDevelopmentMember" xlink:label="loc_huge_FacilityUnderDevelopmentMember_251"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FairValueAdjustmentsOnInventorySold" xlink:label="loc_huge_FairValueAdjustmentsOnInventorySold_252"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FairValueOfShares" xlink:label="loc_huge_FairValueOfShares_253"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FairValueOfSharesAndWarrantsAcquired" xlink:label="loc_huge_FairValueOfSharesAndWarrantsAcquired_254"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FairValueOfWarrants" xlink:label="loc_huge_FairValueOfWarrants_255"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Feb252018Member" xlink:label="loc_huge_Feb252018Member_256"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FindersFee" xlink:label="loc_huge_FindersFee_257"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FindersFeeShares" xlink:label="loc_huge_FindersFeeShares_258"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FirstRepublicCapitalCorporationMember" xlink:label="loc_huge_FirstRepublicCapitalCorporationMember_259"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FormerCEOMember" xlink:label="loc_huge_FormerCEOMember_260"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FormerChiefExecutiveOfficerMember" xlink:label="loc_huge_FormerChiefExecutiveOfficerMember_261"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FormerChiefOperatingOfficerMember" xlink:label="loc_huge_FormerChiefOperatingOfficerMember_262"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FSDBiosciencesMember" xlink:label="loc_huge_FSDBiosciencesMember_263"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FurnitureFixturesAndEquipmentMember" xlink:label="loc_huge_FurnitureFixturesAndEquipmentMember_264"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FvPharmaIncMember" xlink:label="loc_huge_FvPharmaIncMember_265"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_GainLossOnChangeInFairValueOfDerivativeLiability" xlink:label="loc_huge_GainLossOnChangeInFairValueOfDerivativeLiability_266"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_GrantDateAxis" xlink:label="loc_huge_GrantDateAxis_267"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_GrantDateDomain" xlink:label="loc_huge_GrantDateDomain_268"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_GrossLossProfitBeforeFairValueAdjustments" xlink:label="loc_huge_GrossLossProfitBeforeFairValueAdjustments_269"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_GuaranteedMinimumLiquidationValueOfShares" xlink:label="loc_huge_GuaranteedMinimumLiquidationValueOfShares_270"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HarvestedCannabisMember" xlink:label="loc_huge_HarvestedCannabisMember_271"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HempProductsMember" xlink:label="loc_huge_HempProductsMember_272"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HeritageBuildingRestorationCommitmentMember" xlink:label="loc_huge_HeritageBuildingRestorationCommitmentMember_273"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HighTideIncMember" xlink:label="loc_huge_HighTideIncMember_274"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HugeShopsMember" xlink:label="loc_huge_HugeShopsMember_275"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ImpactOfPresentValue" xlink:label="loc_huge_ImpactOfPresentValue_276"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ImpactOfPresentValueOnLeaseObligations" xlink:label="loc_huge_ImpactOfPresentValueOnLeaseObligations_277"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_278"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ImpairmentLossRecognisedInRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_279"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ImpairmentMember" xlink:label="loc_huge_ImpairmentMember_280"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseInFairValueOfOtherInvestments" xlink:label="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_281"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_282"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_283"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_284"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_285"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_286"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_287"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_288"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_289"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughReverseAcquisition" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisition_290"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughReverseAcquisitionShares" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_291"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_292"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughStockOptionsCancelled" xlink:label="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_293"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughWarrantValuations" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuations_294"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughWarrantValuationsShares" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_295"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncrementalBorrowingRateToDiscountLeaseLiabilities" xlink:label="loc_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_296"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IndependentDirectorMember" xlink:label="loc_huge_IndependentDirectorMember_297"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_298"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Jan52018Member" xlink:label="loc_huge_Jan52018Member_299"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Jan52018WarrantMember" xlink:label="loc_huge_Jan52018WarrantMember_300"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Jun112018Member" xlink:label="loc_huge_Jun112018Member_301"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Jun122018Member" xlink:label="loc_huge_Jun122018Member_302"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_KeyManagementPersonnelCarAllowance" xlink:label="loc_huge_KeyManagementPersonnelCarAllowance_303"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LeaseTermOnOfficeSpace" xlink:label="loc_huge_LeaseTermOnOfficeSpace_304"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_305"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_306"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ListingExpense" xlink:label="loc_huge_ListingExpense_307"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LossGainOnChangesInFairValueOfOtherInvestments" xlink:label="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_308"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LossOnSettlementOfFinancialLiability" xlink:label="loc_huge_LossOnSettlementOfFinancialLiability_309"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ManagementAndConsultingContractsMember" xlink:label="loc_huge_ManagementAndConsultingContractsMember_310"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ManagementFees" xlink:label="loc_huge_ManagementFees_311"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Mar222018Member" xlink:label="loc_huge_Mar222018Member_312"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Mar282018Member" xlink:label="loc_huge_Mar282018Member_313"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_March262018Member" xlink:label="loc_huge_March262018Member_314"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_March282018Member" xlink:label="loc_huge_March282018Member_315"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_March92018Member" xlink:label="loc_huge_March92018Member_316"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_MarketPriceOfShares" xlink:label="loc_huge_MarketPriceOfShares_317"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_MarketPriceOfWarrants" xlink:label="loc_huge_MarketPriceOfWarrants_318"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_MarketPriceShareOptionsGranted" xlink:label="loc_huge_MarketPriceShareOptionsGranted_319"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_May242018Member" xlink:label="loc_huge_May242018Member_320"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_May242018WarrantMember" xlink:label="loc_huge_May242018WarrantMember_321"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_May82018Member" xlink:label="loc_huge_May82018Member_322"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_MealsAndEntertainment" xlink:label="loc_huge_MealsAndEntertainment_323"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_MinimumInvestmentReceivable" xlink:label="loc_huge_MinimumInvestmentReceivable_324"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost" xlink:label="loc_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_325"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NetSellingPricePerGramForDryTrimAfterHarvestCost" xlink:label="loc_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_326"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_327"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_328"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonCapitalLossCarryforwards" xlink:label="loc_huge_NonCapitalLossCarryforwards_329"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonCapitalLossCarryForwardsMember" xlink:label="loc_huge_NonCapitalLossCarryForwardsMember_330"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonCapitalLossesMember" xlink:label="loc_huge_NonCapitalLossesMember_331"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA" xlink:label="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA_332"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA" xlink:label="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA_333"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NotesPayableMember" xlink:label="loc_huge_NotesPayableMember_334"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Nov12017Member" xlink:label="loc_huge_Nov12017Member_335"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Nov122018Member" xlink:label="loc_huge_Nov122018Member_336"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Nov142017Member" xlink:label="loc_huge_Nov142017Member_337"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Nov152018Member" xlink:label="loc_huge_Nov152018Member_338"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Nov212017Member" xlink:label="loc_huge_Nov212017Member_339"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Nov262018Member" xlink:label="loc_huge_Nov262018Member_340"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" xlink:label="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_341"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfAgreement" xlink:label="loc_huge_NumberOfAgreement_342"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions" xlink:label="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_343"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesAcquired" xlink:label="loc_huge_NumberOfSharesAcquired_344"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesHeld" xlink:label="loc_huge_NumberOfSharesHeld_345"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesHeldSubjectToEscrowArrangement" xlink:label="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_346"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedAsFindersFee" xlink:label="loc_huge_NumberOfSharesIssuedAsFindersFee_347"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" xlink:label="loc_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_348"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_NumberOfSharesIssuedForDebtSettlement_349"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_350"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedInPrivatePlacement_351"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedInShareExchange" xlink:label="loc_huge_NumberOfSharesIssuedInShareExchange_352"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesOutstandingSubjectToEscrowConditions" xlink:label="loc_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_353"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesSold" xlink:label="loc_huge_NumberOfSharesSold_354"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesSubscribed" xlink:label="loc_huge_NumberOfSharesSubscribed_355"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsAcquired" xlink:label="loc_huge_NumberOfWarrantsAcquired_356"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsExercised" xlink:label="loc_huge_NumberOfWarrantsExercised_357"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsExpired" xlink:label="loc_huge_NumberOfWarrantsExpired_358"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsGranted" xlink:label="loc_huge_NumberOfWarrantsGranted_359"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsHeld" xlink:label="loc_huge_NumberOfWarrantsHeld_360"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_361"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Oct202017Member" xlink:label="loc_huge_Oct202017Member_362"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OfficeAndGeneralExpenses" xlink:label="loc_huge_OfficeAndGeneralExpenses_363"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OfficeLeaseAgreementMember" xlink:label="loc_huge_OfficeLeaseAgreementMember_364"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OperatingLeaseImpactOfPresentValue" xlink:label="loc_huge_OperatingLeaseImpactOfPresentValue_365"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherAllowances" xlink:label="loc_huge_OtherAllowances_366"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherFinancialLiabilitiesMember" xlink:label="loc_huge_OtherFinancialLiabilitiesMember_367"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherGeneralAndAdministrativeExpenses" xlink:label="loc_huge_OtherGeneralAndAdministrativeExpenses_368"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInventoryMember" xlink:label="loc_huge_OtherInventoryMember_369"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentMember" xlink:label="loc_huge_OtherInvestmentMember_370"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_371"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_372"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OutstandingCommitmentToPurchaseAdditionalProduct" xlink:label="loc_huge_OutstandingCommitmentToPurchaseAdditionalProduct_373"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PatentMaintenanceFee" xlink:label="loc_huge_PatentMaintenanceFee_374"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PaymentOfExpenses" xlink:label="loc_huge_PaymentOfExpenses_375"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PaymentOfOperatingLease" xlink:label="loc_huge_PaymentOfOperatingLease_376"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfAggregateDiscountForSharesInEscrow" xlink:label="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_377"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfDeclineInFairValueOfInvestment" xlink:label="loc_huge_PercentageOfDeclineInFairValueOfInvestment_378"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold" xlink:label="loc_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_379"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_380"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition" xlink:label="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_381"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_382"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_383"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_384"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PermanentDifferences" xlink:label="loc_huge_PermanentDifferences_385"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_386"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PharmadrugProductionGMBHMember" xlink:label="loc_huge_PharmadrugProductionGMBHMember_387"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PharmastripCorpMember" xlink:label="loc_huge_PharmastripCorpMember_388"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PresidentAndChiefExecutiveOfficerMember" xlink:label="loc_huge_PresidentAndChiefExecutiveOfficerMember_389"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PresidentAndDirectorMember" xlink:label="loc_huge_PresidentAndDirectorMember_390"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PresidentOfFsdBiosciencesMember" xlink:label="loc_huge_PresidentOfFsdBiosciencesMember_391"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PresidentOfFSDMember" xlink:label="loc_huge_PresidentOfFSDMember_392"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PresidentOfFVPharmaMember" xlink:label="loc_huge_PresidentOfFVPharmaMember_393"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PresidentsMember" xlink:label="loc_huge_PresidentsMember_394"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PrincipalAmountOfBorrowings" xlink:label="loc_huge_PrincipalAmountOfBorrowings_395"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_396"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PrismicPharmaceuticalsIncMember" xlink:label="loc_huge_PrismicPharmaceuticalsIncMember_397"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProceedsFromExerciseOfWarrants" xlink:label="loc_huge_ProceedsFromExerciseOfWarrants_398"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProceedsFromSaleOfSharesAndWarrants" xlink:label="loc_huge_ProceedsFromSaleOfSharesAndWarrants_399"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProductionAndGrowingExpense" xlink:label="loc_huge_ProductionAndGrowingExpense_400"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProductionAndGrowingExpenses" xlink:label="loc_huge_ProductionAndGrowingExpenses_401"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProductionEquipmentMember" xlink:label="loc_huge_ProductionEquipmentMember_402"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PropertyPlantAndEquipmentsMember" xlink:label="loc_huge_PropertyPlantAndEquipmentsMember_403"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInFifthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_404"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInFourthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_405"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInNextFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_406"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInSecondFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_407"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInThirdFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_408"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuotedMarketPriceOfInvestments" xlink:label="loc_huge_QuotedMarketPriceOfInvestments_409"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability" xlink:label="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_410"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RentReceivable" xlink:label="loc_huge_RentReceivable_411"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ResearchAndDevelopmentAgreementMember" xlink:label="loc_huge_ResearchAndDevelopmentAgreementMember_412"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ReverseTakeoverTransaction" xlink:label="loc_huge_ReverseTakeoverTransaction_413"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RightOfUseAssetsAndLeaseObligations" xlink:label="loc_huge_RightOfUseAssetsAndLeaseObligations_414"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RiskFreeInterestRateOfWarrants" xlink:label="loc_huge_RiskFreeInterestRateOfWarrants_415"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_416"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RiskFreeRateOfWarrants" xlink:label="loc_huge_RiskFreeRateOfWarrants_417"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SalesTaxRecoverable" xlink:label="loc_huge_SalesTaxRecoverable_418"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock" xlink:label="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_419"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScheduleOfStockClassLineItems" xlink:label="loc_huge_ScheduleOfStockClassLineItems_420"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScheduleOfStockClassTable" xlink:label="loc_huge_ScheduleOfStockClassTable_421"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScheduleOfWarrantTable" xlink:label="loc_huge_ScheduleOfWarrantTable_422"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory" xlink:label="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_423"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScicannTherapeuticsIncMember" xlink:label="loc_huge_ScicannTherapeuticsIncMember_424"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_425"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees" xlink:label="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_426"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Sep102018Member" xlink:label="loc_huge_Sep102018Member_427"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Sep112018Member" xlink:label="loc_huge_Sep112018Member_428"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Sep142018Member" xlink:label="loc_huge_Sep142018Member_429"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Sep152017Member" xlink:label="loc_huge_Sep152017Member_430"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Sep152018Member" xlink:label="loc_huge_Sep152018Member_431"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Sep172017Member" xlink:label="loc_huge_Sep172017Member_432"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Sep262018Member" xlink:label="loc_huge_Sep262018Member_433"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_September292018Member" xlink:label="loc_huge_September292018Member_434"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_September302017Member" xlink:label="loc_huge_September302017Member_435"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareholderAndPublicCompanyCosts" xlink:label="loc_huge_ShareholderAndPublicCompanyCosts_436"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareholdersAndPublicCompanyCosts" xlink:label="loc_huge_ShareholdersAndPublicCompanyCosts_437"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareIssueCostsMember" xlink:label="loc_huge_ShareIssueCostsMember_438"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_439"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareOptionsAbstract" xlink:label="loc_huge_ShareOptionsAbstract_440"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePriceOfSharesAndWarrants" xlink:label="loc_huge_SharePriceOfSharesAndWarrants_441"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_442"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePurchaseAndSaleAgreementsMember" xlink:label="loc_huge_SharePurchaseAndSaleAgreementsMember_443"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareSplitRatio" xlink:label="loc_huge_ShareSplitRatio_444"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShortTermNotes" xlink:label="loc_huge_ShortTermNotes_445"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_446"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SpecialWarrantsMember" xlink:label="loc_huge_SpecialWarrantsMember_447"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_448"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsOfAcquirer" xlink:label="loc_huge_StockOptionsOfAcquirer_449"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockPromotionExpenses" xlink:label="loc_huge_StockPromotionExpenses_450"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StrategicInvestmentValue" xlink:label="loc_huge_StrategicInvestmentValue_451"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubscriptionPricePerShare" xlink:label="loc_huge_SubscriptionPricePerShare_452"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubsequentEventsMember" xlink:label="loc_huge_SubsequentEventsMember_453"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubsidiariesOneMember" xlink:label="loc_huge_SubsidiariesOneMember_454"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubsidiariesTwoMember" xlink:label="loc_huge_SubsidiariesTwoMember_455"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_456"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesTable_457"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplementalInformationAbstract" xlink:label="loc_huge_SupplementalInformationAbstract_458"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementMember" xlink:label="loc_huge_SupplyAgreementMember_459"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementOptionToPurchaseAmount" xlink:label="loc_huge_SupplyAgreementOptionToPurchaseAmount_460"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementOptionToPurchasePeriod" xlink:label="loc_huge_SupplyAgreementOptionToPurchasePeriod_461"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted" xlink:label="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_462"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TaxEffectOfDeferredTaxAssetNotRecognized" xlink:label="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_463"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TaxEffectOfTemporaryDifferences" xlink:label="loc_huge_TaxEffectOfTemporaryDifferences_464"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TemporaryDifferences" xlink:label="loc_huge_TemporaryDifferences_465"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TermsOfWarrantGranted" xlink:label="loc_huge_TermsOfWarrantGranted_466"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ThomasFairfullMember" xlink:label="loc_huge_ThomasFairfullMember_467"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_468"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_469"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfInventoriesAxis" xlink:label="loc_huge_TypeOfInventoriesAxis_470"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfInventoriesDomain" xlink:label="loc_huge_TypeOfInventoriesDomain_471"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_UndiscountedLeasePaymentsPayable" xlink:label="loc_huge_UndiscountedLeasePaymentsPayable_472"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock" xlink:label="loc_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_473"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets" xlink:label="loc_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_474"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_UnrestrictedClassBSharesMember" xlink:label="loc_huge_UnrestrictedClassBSharesMember_475"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements" xlink:label="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_476"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesAcquired" xlink:label="loc_huge_ValueOfSharesAcquired_477"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssued" xlink:label="loc_huge_ValueOfSharesIssued_478"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" xlink:label="loc_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_479"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_ValueOfSharesIssuedForDebtSettlement_480"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_ValueOfSharesIssuedInPrivatePlacement_481"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssuedInShareExchange" xlink:label="loc_huge_ValueOfSharesIssuedInShareExchange_482"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfStockOptionsExercised" xlink:label="loc_huge_ValueOfStockOptionsExercised_483"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement" xlink:label="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_484"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfWarrantsExercised" xlink:label="loc_huge_ValueOfWarrantsExercised_485"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantExercisePrice" xlink:label="loc_huge_WarrantExercisePrice_486"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantLineItems" xlink:label="loc_huge_WarrantLineItems_487"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Warrants" xlink:label="loc_huge_Warrants_488"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsAbstract" xlink:label="loc_huge_WarrantsAbstract_489"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtAugust1st2021Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust1st2021Member_490"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtDecember12st2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember12st2019Member_491"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtDecember29th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember29th2019Member_492"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtJanuary16th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary16th2026Member_493"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtJanuary20th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary20th2026Member_494"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtJanuary5th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary5th2020Member_495"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtJuly24th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJuly24th2023Member_496"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay10th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay10th2025Member_497"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay17th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay17th2025Member_498"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay20th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay20th2023Member_499"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay24th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay24th2022Member_500"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay31st2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay31st2025Member_501"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay4th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay4th2025Member_502"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtNovember14th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember14th2019Member_503"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtNovember1st2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember1st2019Member_504"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtNovember21st2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember21st2019Member_505"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtNovember30th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember30th2020Member_506"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtOctober20th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtOctober20th2019Member_507"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtSeptember11th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember11th2023Member_508"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtSeptember15th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember15th2022Member_509"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsIssueDateAxis" xlink:label="loc_huge_WarrantsIssueDateAxis_510"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsIssueDateDomain" xlink:label="loc_huge_WarrantsIssueDateDomain_511"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_512"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsOptionsOfAcquirer" xlink:label="loc_huge_WarrantsOptionsOfAcquirer_513"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageExercisePricesWarrantExercised" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantExercised_514"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageExercisePricesWarrantExpired" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantExpired_515"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageExercisePricesWarrantGranted" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantGranted_516"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_517"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageSharePriceOfWarrants" xlink:label="loc_huge_WeightedAverageSharePriceOfWarrants_518"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WorkingCapitalSurplus" xlink:label="loc_huge_WorkingCapitalSurplus_519"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ZeeshanSaeedMember" xlink:label="loc_huge_ZeeshanSaeedMember_520"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccountingProfit" xlink:label="loc_ifrs-full_AccountingProfit_521"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_522"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_523"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_524"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsFromPurchasesBiologicalAssets" xlink:label="loc_ifrs-full_AdditionsFromPurchasesBiologicalAssets_525"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_526"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_527"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_528"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_529"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_530"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_531"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_532"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense_533"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_534"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_535"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_536"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_537"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_538"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_539"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="loc_ifrs-full_AdjustmentsForInterestExpense_540"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_541"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_542"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdministrativeExpense" xlink:label="loc_ifrs-full_AdministrativeExpense_543"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdvertisingExpense" xlink:label="loc_ifrs-full_AdvertisingExpense_544"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_545"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_546"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_547"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_548"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_549"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_550"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_551"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_552"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_553"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicAndDilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare_554"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_555"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssets" xlink:label="loc_ifrs-full_BiologicalAssets_556"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsByGroupAxis" xlink:label="loc_ifrs-full_BiologicalAssetsByGroupAxis_557"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsGroupMember" xlink:label="loc_ifrs-full_BiologicalAssetsGroupMember_558"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsAbstract" xlink:label="loc_ifrs-full_BorrowingsAbstract_559"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_560"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_561"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_562"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_563"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsMember" xlink:label="loc_ifrs-full_BusinessCombinationsMember_564"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_565"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_566"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_567"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAbstract" xlink:label="loc_ifrs-full_CashAbstract_568"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_569"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_570"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_571"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_572"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_573"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_574"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_575"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_576"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_577"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:label="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_578"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_579"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_580"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_581"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_582"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_583"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_584"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_585"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_586"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_587"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_588"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_589"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_590"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_591"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_592"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-full_ClosingForeignExchangeRate_593"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CommercialPapersIssued" xlink:label="loc_ifrs-full_CommercialPapersIssued_594"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_595"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_596"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_597"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_598"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-full_ConstructionInProgressMember_599"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_600"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContractualCapitalCommitments" xlink:label="loc_ifrs-full_ContractualCapitalCommitments_601"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_602"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_603"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_604"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_605"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CreditRiskMember" xlink:label="loc_ifrs-full_CreditRiskMember_606"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_607"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_608"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_609"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_610"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued" xlink:label="loc_ifrs-full_CurrentDebtInstrumentsIssued_611"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_612"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_613"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_614"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_615"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_616"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_617"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_618"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_619"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_620"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_621"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_622"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_623"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_624"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_625"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationBiologicalAssets" xlink:label="loc_ifrs-full_DepreciationBiologicalAssets_626"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-full_DepreciationExpense_627"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationMethodPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_628"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_629"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_630"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_631"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_632"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory_633"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_634"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_635"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_636"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_637"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_638"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_639"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_640"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_641"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_642"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_643"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_644"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_645"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_646"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_647"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_648"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_649"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_650"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_651"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_652"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_653"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements" xlink:label="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_654"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_655"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_656"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_657"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_658"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_659"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_660"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_661"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_662"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_663"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_664"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_665"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_666"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_667"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_668"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_669"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_670"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_671"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_672"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsExplanatory_673"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_674"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_675"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_676"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_677"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_678"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_679"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_680"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_681"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_682"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_683"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_684"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_685"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_686"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_687"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_688"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_689"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_690"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_691"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_692"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_693"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_694"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_695"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_696"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_697"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_698"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_699"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_700"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_701"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_702"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_703"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_704"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_705"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_706"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_707"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfLiquidityRiskExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLiquidityRiskExplanatory_708"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_709"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_710"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_711"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_712"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_713"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_714"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_715"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_716"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_717"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_718"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_719"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_720"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_721"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_722"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_723"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_724"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_725"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_726"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_727"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_728"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_729"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_730"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_731"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_732"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_733"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_734"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_735"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_736"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_737"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_738"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_739"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_740"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_741"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_742"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_743"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_744"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_745"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_746"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_747"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_748"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_749"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DistributionCosts" xlink:label="loc_ifrs-full_DistributionCosts_750"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_751"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_752"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_753"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareTable" xlink:label="loc_ifrs-full_EarningsPerShareTable_754"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_755"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_756"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_757"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_758"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_759"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_760"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_761"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_762"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_763"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_764"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_765"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_766"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-full_ExpenseByNature_767"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_768"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_769"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExplanationOfDesignatedFinancialAssetsThatAreHeldOutsideLegalEntityThatIssuesContractsWithinScopeOfIFRS4" xlink:label="loc_ifrs-full_ExplanationOfDesignatedFinancialAssetsThatAreHeldOutsideLegalEntityThatIssuesContractsWithinScopeOfIFRS4_770"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory" xlink:label="loc_ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory_771"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FairValueOfAcquiredReceivables" xlink:label="loc_ifrs-full_FairValueOfAcquiredReceivables_772"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_773"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_774"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_775"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_776"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesCategoryMember" xlink:label="loc_ifrs-full_FinancialLiabilitiesCategoryMember_777"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_778"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_779"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_780"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_781"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_782"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_783"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_784"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_785"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossLoanCommitments" xlink:label="loc_ifrs-full_GrossLoanCommitments_786"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_787"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_788"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_789"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="loc_ifrs-full_ImpairmentLoss_790"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_791"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_792"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_793"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_794"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_795"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_796"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_797"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_798"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_799"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_800"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InsuranceExpense" xlink:label="loc_ifrs-full_InsuranceExpense_801"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_802"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_803"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_804"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_805"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivable" xlink:label="loc_ifrs-full_InterestReceivable_806"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_807"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryWritedown2011" xlink:label="loc_ifrs-full_InventoryWritedown2011_808"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_809"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_810"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_811"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_812"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_813"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_814"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-full_LandMember_815"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_816"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_817"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_818"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_819"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanOneYearMember_820"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_821"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_822"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_823"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_824"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_825"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_826"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_827"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_828"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_829"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_830"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_831"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_832"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_833"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesIncurred" xlink:label="loc_ifrs-full_LiabilitiesIncurred_834"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-full_LiquidityRiskMember_835"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LoansAndReceivablesCategoryMember" xlink:label="loc_ifrs-full_LoansAndReceivablesCategoryMember_836"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_837"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MachineryMember" xlink:label="loc_ifrs-full_MachineryMember_838"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MarketRiskMember" xlink:label="loc_ifrs-full_MarketRiskMember_839"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_840"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_841"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MediaProductionExpense" xlink:label="loc_ifrs-full_MediaProductionExpense_842"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_843"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_844"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_845"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_846"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_847"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_848"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_849"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_850"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotesAndDebenturesIssued" xlink:label="loc_ifrs-full_NotesAndDebenturesIssued_851"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_852"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_853"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_854"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_855"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_856"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_857"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_858"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_859"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_860"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_861"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_862"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_863"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_864"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_865"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_866"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OccupancyExpense" xlink:label="loc_ifrs-full_OccupancyExpense_867"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_868"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_869"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_870"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_871"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_872"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherTangibleOrIntangibleAssetsTransferred" xlink:label="loc_ifrs-full_OtherTangibleOrIntangibleAssetsTransferred_873"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_874"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_875"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_876"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlantsMember" xlink:label="loc_ifrs-full_PlantsMember_877"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_878"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_879"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_880"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_881"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_882"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductionSupplies" xlink:label="loc_ifrs-full_ProductionSupplies_883"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_884"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_885"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAbstract" xlink:label="loc_ifrs-full_ProfitLossAbstract_886"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_887"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_888"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_889"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_890"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_891"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_892"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_893"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_894"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentProperty" xlink:label="loc_ifrs-full_PurchaseOfInvestmentProperty_895"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_896"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_897"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_898"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_899"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_900"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_901"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RawMaterials" xlink:label="loc_ifrs-full_RawMaterials_902"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RentalIncome" xlink:label="loc_ifrs-full_RentalIncome_903"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepairsAndMaintenanceExpense" xlink:label="loc_ifrs-full_RepairsAndMaintenanceExpense_904"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_905"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_906"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_907"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_908"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_909"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_910"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_911"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_912"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SeparateManagementEntitiesAxis" xlink:label="loc_ifrs-full_SeparateManagementEntitiesAxis_913"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SeparateManagementEntitiesMember" xlink:label="loc_ifrs-full_SeparateManagementEntitiesMember_914"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_915"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_916"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_917"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_918"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_919"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_920"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_921"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_922"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_923"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_924"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SubsidiariesMember" xlink:label="loc_ifrs-full_SubsidiariesMember_925"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_926"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_927"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_928"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_929"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_930"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_931"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_932"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_933"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_934"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_935"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_936"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_937"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TravelExpense" xlink:label="loc_ifrs-full_TravelExpense_938"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_939"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_940"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_941"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived" xlink:label="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_942"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_943"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_944"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ValueAtRisk" xlink:label="loc_ifrs-full_ValueAtRisk_945"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_946"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_947"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_948"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_949"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_950"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_951"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_952"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_953"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_954"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_955"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_956"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:label="loc_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_957"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WorkInProgress" xlink:label="loc_ifrs-full_WorkInProgress_958"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_PresidentMember" xlink:label="loc_srt_PresidentMember_959"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain_0" xml:lang="en-US">Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityExTransitionPeriod_0" xml:lang="en-US">Entity Ex Transition Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis_0" xml:lang="en-US">Legal Entity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AcquisitionOfPrismicPharmaceuticalsInc_0" xml:lang="en-US">Acquisition of Prismic Pharmaceuticals Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AcquisitionOfPrismicPharmaceuticalsInc_1" xml:lang="en-US">Represents amount of Acquisition of Prismic Pharmaceuticals Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AcquisitionOfPrismicPharmaceuticalsInc_2" xml:lang="en-US">Acquisition of Prismic Pharmaceuticals Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdditionalInvestmentInExchangeForShares_0" xml:lang="en-US">Additional Investment In Exchange For Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdditionalInvestmentInExchangeForShares_1" xml:lang="en-US">Represents the amount related to additional investment in exchange for shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdditionalInvestmentInExchangeForShares_2" xml:lang="en-US">Additional investment in exchange for shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdditionalRemuneration_0" xml:lang="en-US">Amount of additional remuneration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdditionalRemuneration_1" xml:lang="en-US">Additional Remuneration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AdditionalRemuneration_2" xml:lang="en-US">Additional remuneration as Chairman</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_0" xml:lang="en-US">Adjustments for decrease (increase) in prepaid and deposits to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_1" xml:lang="en-US">AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_0" xml:lang="en-US">Adjustments for decrease (increase) in prepaid and other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_1" xml:lang="en-US">Adjustments For Decrease Increase In Prepaid And Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_2" xml:lang="en-US">Adjustments For Decrease Increase In Prepaid And Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_3" xml:lang="en-US">Prepaid and other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_0" xml:lang="en-US">Adjustments for decrease (increase) in prepaid and deposits to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_1" xml:lang="en-US">Adjustments For Decrease Increase In Prepaid Expenses and deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_2" xml:lang="en-US">Prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits_0" xml:lang="en-US">Adjustments For Decrease Increase In Prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_0" xml:lang="en-US">Represents adjustments for decrease increase in sales taxes recoverable during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_1" xml:lang="en-US">Adjustments For Decrease Increase In Sales Taxes Recoverable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_2" xml:lang="en-US">Income taxes refund, classified as operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_3" xml:lang="en-US">Sales taxes recoverable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_0" xml:lang="en-US">Adjustments for gains losses on changes in the fair value of inventory sold to reconcile profit (loss) to net cash flow from used in operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_1" xml:lang="en-US">Change in fair value adjustments on inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_2" xml:lang="en-US">Adjustments For Gains Losses On Change In Fair Value Of Inventory Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_3" xml:lang="en-US">Change in fair value adjustments on inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForListingExpense_0" xml:lang="en-US">Represents adjustments for listing expense during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForListingExpense_1" xml:lang="en-US">Adjustments For Listing Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForListingExpense_2" xml:lang="en-US">Listing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_0" xml:lang="en-US">Adjustment To Expected Income Tax Benefit [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_1" xml:lang="en-US">Adjustment to expected income tax benefit:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_0" xml:lang="en-US">Adjustment to expected income tax benefit Change in benefit of tax assets not recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_1" xml:lang="en-US">Adjustment To Expected Income Tax Benefit Change In Benefit Of Tax Assets Not Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_2" xml:lang="en-US">Change in benefit of tax assets not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_3" xml:lang="en-US">Change in Benefit of tax assets not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_0" xml:lang="en-US">Represents Adjustment To Expected Income Tax Benefit fair value change of investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_1" xml:lang="en-US">Adjustment To Expected Income Tax Benefit Fair Value Change Of Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_2" xml:lang="en-US">Fair value change of investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_0" xml:lang="en-US">Represents adjustment to income tax benefit Loss on derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_1" xml:lang="en-US">Adjustment To Expected Income Tax Benefit Loss on derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_2" xml:lang="en-US">Loss on derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_0" xml:lang="en-US">The amount of Adjustment to expected income tax benefit Share issue costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_1" xml:lang="en-US">Adjustment To Expected Income Tax Benefit Share Issue Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_2" xml:lang="en-US">Share issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_0" xml:lang="en-US">The amount of Adjustment to expected income tax benefit Stock Based Compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_1" xml:lang="en-US">Adjustment To Expected Income Tax Benefit Stock Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_2" xml:lang="en-US">Share based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentToLeaseCommitments_0" xml:lang="en-US">Represents adjustment to lease commitments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToLeaseCommitments_1" xml:lang="en-US">Adjustment To Lease Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToLeaseCommitments_2" xml:lang="en-US">Less: Adjustment to lease commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_0" xml:lang="en-US">After harvest cost to complete and sell per gram for dry flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_1" xml:lang="en-US">Represents after harvest cost to complete and sell per gram for dry flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_2" xml:lang="en-US">After harvest cost to complete and sell per gram for dry flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_0" xml:lang="en-US">After harvest cost to complete and sell per gram for dry trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_1" xml:lang="en-US">Represents after harvest cost to complete and sell per gram for dry trim.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_2" xml:lang="en-US">After harvest cost to complete and sell per gram for dry trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AggregateDiscountForSharesInEscrow_0" xml:lang="en-US">Represents the amount related to aggregate discount for shares in escrow.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AggregateDiscountForSharesInEscrow_1" xml:lang="en-US">Aggregate Discount For Shares In Escrow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AggregateDiscountForSharesInEscrow_2" xml:lang="en-US">Aggregate discount for shares in escrow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AggregateUnpaidAccounts_0" xml:lang="en-US">Represents the amount related to unpaid accounts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AggregateUnpaidAccounts_1" xml:lang="en-US">Aggregate Unpaid Accounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AggregateUnpaidAccounts_2" xml:lang="en-US">Aggregate unpaid accounts with respect to stainless steel table manufacturing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AllowanceForImpairment_0" xml:lang="en-US">Allowance for impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AllowanceForImpairment_1" xml:lang="en-US">Represents the amount related to allowance for impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AllowanceForImpairment_2" xml:lang="en-US">Allowance for impairment of Auxly funds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmortizedCostOfFinancialAssetsMember_0" xml:lang="en-US">Represents information regarding amortized cost of financial assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmortizedCostOfFinancialAssetsMember_1" xml:lang="en-US">Amortized Cost Of Financial Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmortizedCostOfFinancialAssetsMember_2" xml:lang="en-US">Amortized cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmortizedCostOfFinancialLiabilitiesMember_0" xml:lang="en-US">Represents information reagarding amortized cost of financial liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmortizedCostOfFinancialLiabilitiesMember_1" xml:lang="en-US">Amortized Cost Of Financial Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmortizedCostOfFinancialLiabilitiesMember_2" xml:lang="en-US">Amortized cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_0" xml:lang="en-US">Information related to amount of additional shares issued against outstanding liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_1" xml:lang="en-US">Amount Of Additional Shares Issued Against Outstanding Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_2" xml:lang="en-US">Amount of additional shares issued against outstanding liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfAgreementFallBelowMinimumValue_0" xml:lang="en-US">It represents amount of agreement fall below minimum value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfAgreementFallBelowMinimumValue_1" xml:lang="en-US">Amount Of Agreement Fall Below Minimum Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmountOfAgreementFallBelowMinimumValue_2" xml:lang="en-US">Amount of agreement fall below minimum value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_0" xml:lang="en-US">Amount of broker warrants representing fees and commissions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_1" xml:lang="en-US">Broker warrants fees and commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_2" xml:lang="en-US">Amount Of Broker Warrants Representing Fees And Commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_3" xml:lang="en-US">Share issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_4" xml:lang="en-US">Amount Of Broker Warrants Representing Fees And Commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfDepositPaidToSupplier_0" xml:lang="en-US">Information about amount of deposit paid to supplier.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfDepositPaidToSupplier_1" xml:lang="en-US">Amount Of Deposit Paid To Supplier</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmountOfDepositPaidToSupplier_2" xml:lang="en-US">Amount of deposit paid to supplier</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_0" xml:lang="en-US">It represents amount of minimum issue of additional common shares upon liquidation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_1" xml:lang="en-US">Amount Of Minimum Issue Of Additional Common Shares Upon liquidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_2" xml:lang="en-US">Amount of minimum issue of additional common shares upon liquidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfPurchasePricePaidAsSupplierLoan_0" xml:lang="en-US">Information about amount of purchase price paid as supplier loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfPurchasePricePaidAsSupplierLoan_1" xml:lang="en-US">Amount Of Purchase Price Paid As Supplier Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmountOfPurchasePricePaidAsSupplierLoan_2" xml:lang="en-US">Amount of purchase price paid as supplier loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_0" xml:lang="en-US">Represents the amount of shares issued from entity's treasury by way of private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_1" xml:lang="en-US">Amount Of Shares Issued From Treasury Under Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_2" xml:lang="en-US">Amount of Class B shares issued from treasury under private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AnthonyDurkaczMember_0" xml:lang="en-US">Represents information of anthony durkacz.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AnthonyDurkaczMember_1" xml:lang="en-US">Anthony Durkacz [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AnthonyDurkaczMember_2" xml:lang="en-US">Anthony Durkacz</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_0" xml:lang="en-US">Information about anticipated purchase price plus applicable taxes value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_1" xml:lang="en-US">Anticipated Purchase Price Plus Applicable Taxes Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_2" xml:lang="en-US">Anticipated purchase price plus applicable taxes value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Apr82018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Apr82018Member_1" xml:lang="en-US">Apr 8 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Apr82018Member_2" xml:lang="en-US">Apr 8 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Apr92018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Apr92018Member_1" xml:lang="en-US">Apr 9 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Apr92018Member_2" xml:lang="en-US">Apr 9 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_April182018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_April182018Member_1" xml:lang="en-US">April 18, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_April182018Member_2" xml:lang="en-US">April 18, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Aug142018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Aug142018Member_1" xml:lang="en-US">Aug 14 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Aug142018Member_2" xml:lang="en-US">Aug 14 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Aug152018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Aug152018Member_1" xml:lang="en-US">Aug 15 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Aug152018Member_2" xml:lang="en-US">Aug 15 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Aug82018Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Aug82018Member_1" xml:lang="en-US">Aug 8 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Aug82018Member_2" xml:lang="en-US">Aug 8 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AuraHealthIncMember_0" xml:lang="en-US">Information about Aura Health Inc. ("Aura").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AuraHealthIncMember_1" xml:lang="en-US">Aura Health Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AuraHealthIncMember_2" xml:lang="en-US">Aura Health Inc ("Aura")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AuxlyCannabisGroupIncMember_0" xml:lang="en-US">Auxly Cannabis Group Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AuxlyCannabisGroupIncMember_1" xml:lang="en-US">Auxly Cannabis Group Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AuxlyCannabisGroupIncMember_2" xml:lang="en-US">Auxly Cannabis Group Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AverageExpectedLifeOfWarrants_0" xml:lang="en-US">Represents average expected life of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AverageExpectedLifeOfWarrants_1" xml:lang="en-US">Average Expected Life Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AverageExpectedLifeOfWarrants_2" xml:lang="en-US">Average Expected Life (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BasisOfPresentationAbstract_0" xml:lang="en-US">Basis Of Presentation [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BiologicalAssetFairValueAdjustmentMember_0" xml:lang="en-US">This member stands for Biological asset fair value adjustment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BiologicalAssetFairValueAdjustmentMember_1" xml:lang="en-US">Biological Asset Fair Value Adjustment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_BiologicalAssetFairValueAdjustmentMember_2" xml:lang="en-US">Biological asset fair value adjustment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BonusExpenseToBePaidInSubsequentPeriod_0" xml:lang="en-US">Bonus Expense To Be Paid in subsequent period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BonusExpenseToBePaidInSubsequentPeriod_1" xml:lang="en-US">Represents the amount related to bonus expense to be paid in subsequent period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_BonusExpenseToBePaidInSubsequentPeriod_2" xml:lang="en-US">Bonus expense to be paid in subsequent period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BrokerWarrants_0" xml:lang="en-US">Represents amount related to broker warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BrokerWarrants_1" xml:lang="en-US">Broker warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BrokerWarrantsIssuedInPrivatePlacements_0" xml:lang="en-US">Number of broker warrants issued in private placements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BrokerWarrantsIssuedInPrivatePlacements_1" xml:lang="en-US">Broker Warrants Issued In Private Placements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_BrokerWarrantsIssuedInPrivatePlacements_2" xml:lang="en-US">Number of broker warrants issued in private placements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BusinessAcquisitionDomain_0" xml:lang="en-US">Represents business acquisition domain.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BusinessAcquisitionDomain_1" xml:lang="en-US">Business Acquisition [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BusinessAcquisitionsAxis_0" xml:lang="en-US">Represents Business Acquisition Axis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BusinessAcquisitionsAxis_1" xml:lang="en-US">Business Acquisitions [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BusinessAcquisitionsBenefitsAxis_0" xml:lang="en-US">Represents Business Acquisitions axis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BusinessAcquisitionsBenefitsAxis_1" xml:lang="en-US">Business Acquisitions benefits [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BusinessAcquisitionsBenefitsDomain_0" xml:lang="en-US">Represents business acquisitions domain.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BusinessAcquisitionsBenefitsDomain_1" xml:lang="en-US">Business Acquisitions benefits [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BusinessLicenseFees_0" xml:lang="en-US">Information about business license fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BusinessLicenseFees_1" xml:lang="en-US">Business License Fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_BusinessLicenseFees_2" xml:lang="en-US">Business license fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CannaraBiotechIncMember_0" xml:lang="en-US">Cannara Biotech Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CannaraBiotechIncMember_1" xml:lang="en-US">Cannara Biotech Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CannaraBiotechIncMember_2" xml:lang="en-US">Cannara Biotech Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_0" xml:lang="en-US">Information about Canntab Therapeutics Ltd. and World Class Extractions Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_1" xml:lang="en-US">Canntab Therapeutics Ltd World Class Extractions Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_2" xml:lang="en-US">Canntab Therapeutics Ltd ("Canntab") World Class Extractions Inc ("World Class")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CapitalizedCostMember_0" xml:lang="en-US">This member stands for capitalized cost.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CapitalizedCostMember_1" xml:lang="en-US">Capitalized Cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CapitalizedCostMember_2" xml:lang="en-US">Capitalized Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CapitalizedCosts_0" xml:lang="en-US">Represents amount of capitalized costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CapitalizedCosts_1" xml:lang="en-US">Capitalized costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CapitalizedCosts_2" xml:lang="en-US">Capitalized costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CashAcquiredOnAcquisition_0" xml:lang="en-US">Represents amount related to cash inflow during acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CashAcquiredOnAcquisition_1" xml:lang="en-US">Cash acquired On acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_CashAcquiredOnAcquisition_2" xml:lang="en-US">Cash acquired from acquisition Prismic Pharmaceuticals Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CenturyAndFvPharmaMember_0" xml:lang="en-US">Name of companies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CenturyAndFvPharmaMember_1" xml:lang="en-US">Century And Fv Pharma [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CenturyAndFvPharmaMember_2" xml:lang="en-US">Century and FV Pharma</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChangeInFairValueOfInvestment_0" xml:lang="en-US">Change in fair value of investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChangeInFairValueOfInvestment_1" xml:lang="en-US">Represents the amount related to change in fair value of the investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0" xml:lang="en-US">Represents the amount related to change in fair value through profit or loss of investments other than investments accounted for using equity method.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1" xml:lang="en-US">Change in fair value through profit or loss of investments other than investments accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2" xml:lang="en-US">Change in fair value through profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChangesInNonCashWorkingCapitalItemsAbstract_0" xml:lang="en-US">Changes In Non Cash Working Capital Items Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ChangesInNonCashWorkingCapitalItemsAbstract_1" xml:lang="en-US">Changes in non-cash working capital balances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChangesInShareCapitalTransactionDateAxis_0" xml:lang="en-US">Represents information of changes in share capital transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChangesInShareCapitalTransactionDateAxis_1" xml:lang="en-US">Changes In Share Capital Transaction Date [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChangesInShareCapitalTransactionDateDomain_0" xml:lang="en-US">Represents information of changes in share capital transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChangesInShareCapitalTransactionDateDomain_1" xml:lang="en-US">Changes In Share Capital Transaction Date [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_0" xml:lang="en-US">This member stands for chief executive officer and executive co-chairman.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_1" xml:lang="en-US">Chief Executive Officer And Executive Co Chairman [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_2" xml:lang="en-US">Chief Executive Officer and Executive Co-Chairman</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChiefExecutiveOfficersMember_0" xml:lang="en-US">This member stands for chief executive officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChiefExecutiveOfficersMember_1" xml:lang="en-US">Chief Executive Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ChiefExecutiveOfficersMember_2" xml:lang="en-US">Chief Executive Officer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChiefFinancialOfficersMember_0" xml:lang="en-US">This member stands for chief financial officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChiefFinancialOfficersMember_1" xml:lang="en-US">Chief Financial Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ChiefFinancialOfficersMember_2" xml:lang="en-US">Chief Financial Officer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChiefOperatingConsultantMember_0" xml:lang="en-US">Chief Operating Consultant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChiefOperatingConsultantMember_1" xml:lang="en-US">Chief Operating Consultant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ChiefOperatingConsultantMember_2" xml:lang="en-US">Chief Operating Consultant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClaimForLienComponent_0" xml:lang="en-US">Represents information about claim for lien component.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClaimForLienComponent_1" xml:lang="en-US">claim for lien component</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ClaimForLienComponent_2" xml:lang="en-US">Claim for lien component</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClaimIssuedByContractorForVariousPurportedDamages_0" xml:lang="en-US">Represents information about claim issued by contractor for various purported damages.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClaimIssuedByContractorForVariousPurportedDamages_1" xml:lang="en-US">claim issued by contractor for various purported damages</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClaimIssuedByContractorForVariousPurportedDamages_2" xml:lang="en-US">Claim issued by contractor for various purported damages</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_0" xml:lang="en-US">Represents the amount related to claim issued by creditor for alleging non-payment of accounts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_1" xml:lang="en-US">Claim Issued By Creditor For Alleging Nonpayment Of Accounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_2" xml:lang="en-US">Claim issued by creditor for alleging nonpayment of accounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassACommonStockSharesMember_0" xml:lang="en-US">Represents information of Class A Common Stock Shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassACommonStockSharesMember_1" xml:lang="en-US">Class A Common Stock Shares Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassACommonStockSharesMember_2" xml:lang="en-US">Class A shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassBCommonStockSharesMember_0" xml:lang="en-US">Represents information of class B common stock shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassBCommonStockSharesMember_1" xml:lang="en-US">Class B Common Stock Shares Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassBCommonStockSharesMember_2" xml:lang="en-US">Class B shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassBSharesHeldInEscrowMember_0" xml:lang="en-US">Class B shares held in escrow [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassBSharesHeldInEscrowMember_1" xml:lang="en-US">Class B shares held in escrow.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassBSharesHeldInEscrowMember_2" xml:lang="en-US">Class B shares held in escrow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassBSubordinateVotingSharesMember_0" xml:lang="en-US">Class B subordinate voting shares ("Class B shares").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassBSubordinateVotingSharesMember_1" xml:lang="en-US">Class B Subordinate Voting Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassBSubordinateVotingSharesMember_2" xml:lang="en-US">Class B shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassBVotingSharesMember_0" xml:lang="en-US">Represents Class B subordinate voting shares member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassBVotingSharesMember_1" xml:lang="en-US">Class B voting shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassBVotingSharesMember_2" xml:lang="en-US">Class B subordinate voting shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassesOfInventoriesLineItems_0" xml:lang="en-US">Represents class of inventory line item.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassesOfInventoriesLineItems_1" xml:lang="en-US">Classes Of Inventories [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassesOfInventoriesTable_0" xml:lang="en-US">Represents class of inventories table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassesOfInventoriesTable_1" xml:lang="en-US">Classes of inventories [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassesOfWarrantsAxis_0" xml:lang="en-US">Classes of warrants [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassesOfWarrantsAxis_1" xml:lang="en-US">Represents different classes of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassesOfWarrantsDomain_0" xml:lang="en-US">Classes of warrants [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassesOfWarrantsDomain_1" xml:lang="en-US">Represents the different classes of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_0" xml:lang="en-US">Clover Cannastrip Thin Film Technologies Corp.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_1" xml:lang="en-US">Clover Cannastrip Thin Film Technologies Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_2" xml:lang="en-US">Clover Cannastrip</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_3" xml:lang="en-US">Clover Cannastrip Thin Film Technologies Corp.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CollectiveCommitmentToPurchaseProduct_0" xml:lang="en-US">Collective commitment to purchase product</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CollectiveCommitmentToPurchaseProduct_1" xml:lang="en-US">Represents the amount related to collective commitment to purchase product.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CommitmentsEquityInstruments_0" xml:lang="en-US">Represents amount of commitments, equity instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CommitmentsEquityInstruments_1" xml:lang="en-US">Commitments Equity Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CommitmentsEquityInstruments_2" xml:lang="en-US">Commitments, equity instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CommitmentsLineItems_0" xml:lang="en-US">Commitments [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CommitmentsTable_0" xml:lang="en-US">Commitments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_0" xml:lang="en-US">Commitment to issue shares, minimum value upon liquidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_1" xml:lang="en-US">Represents the amount related to commitment to issue shares, minimum value upon liquidation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_2" xml:lang="en-US">Commitment to issue shares, minimum value upon liquidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ConsultingFeesExpenses_0" xml:lang="en-US">Amount of expenses of consulting fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ConsultingFeesExpenses_1" xml:lang="en-US">Consulting Fees Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ConsultingFeesExpenses_2" xml:lang="en-US">Consulting fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ConsultingFeesExpenses_3" xml:lang="en-US">Consulting fees expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_0" xml:lang="en-US">Contingent liability for construction and development costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_1" xml:lang="en-US">Contingent Liability For Construction And Development Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_2" xml:lang="en-US">Contingent liability for construction and development costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_0" xml:lang="en-US">Information about contractual capital commitments equal monthly instalments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_1" xml:lang="en-US">Contractual Capital Commitments Equal Monthly Instalments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_2" xml:lang="en-US">Commitments, equal monthly instalments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ConvertibleDebentureMember_0" xml:lang="en-US">Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ConvertibleDebentureMember_1" xml:lang="en-US">Convertible debenture [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ConvertibleDebentureMember_2" xml:lang="en-US">Convertible debenture</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ConvertibleNotes_0" xml:lang="en-US">Represents convertible notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_ConvertibleNotes_1" xml:lang="en-US">Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ConvertibleNotes_2" xml:lang="en-US">Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ConvertibleNotes_3" xml:lang="en-US">Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ConvertibleNotesMember_0" xml:lang="en-US">This member stands for convertible notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ConvertibleNotesMember_1" xml:lang="en-US">Convertible Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ConvertibleNotesMember_2" xml:lang="en-US">Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CorporateInformationAndNatureOfOperationsAbstract_0" xml:lang="en-US">Corporate Information And Nature Of Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CriticalAccountingEstimatesAndJudgmentsAbstract_0" xml:lang="en-US">Critical Accounting Estimates And Judgments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CurrentNotesPayable_0" xml:lang="en-US">Represents amount related to notes payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CurrentNotesPayable_1" xml:lang="en-US">current Notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_CurrentNotesPayable_2" xml:lang="en-US">Balance as at December 31, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CurrentNotesPayable_3" xml:lang="en-US">Notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DateOfExpiryOfShareOptions_0" xml:lang="en-US">Date of expiry of share options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DateOfExpiryOfShareOptions_1" xml:lang="en-US">Date Of Expiry Of Share Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DateOfExpiryOfShareOptions_2" xml:lang="en-US">Expiry Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DebtConversionRatio_0" xml:lang="en-US">Represents the Debt conversion ratio.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DebtConversionRatio_1" xml:lang="en-US">Debt conversion ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Dec122017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Dec122017Member_1" xml:lang="en-US">Dec 12 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Dec122017Member_2" xml:lang="en-US">Dec 12 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Dec152018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Dec152018Member_1" xml:lang="en-US">Dec 15 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Dec152018Member_2" xml:lang="en-US">Dec 15 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Dec212017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Dec212017Member_1" xml:lang="en-US">Dec 21 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Dec212017Member_2" xml:lang="en-US">Dec 21 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Dec232017Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Dec232017Member_1" xml:lang="en-US">Dec 23 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Dec232017Member_2" xml:lang="en-US">Dec 23 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Dec292017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Dec292017Member_1" xml:lang="en-US">Dec 29 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Dec292017Member_2" xml:lang="en-US">Dec 29 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_December292017Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_December292017Member_1" xml:lang="en-US">December 29, 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_December292017Member_2" xml:lang="en-US">December 29, 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Capital losses carried forward, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Capital losses carried forward</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Domestic Non capital losses carried forward, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of domestic non-capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Net operating losses carried forward - US</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Foreign Non capital losses carried forward, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of foreign non-capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Non-capital losses carried forward - Canada</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Other Investments, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of other Investments for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences of property, Plant And Equipment, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of Property, plant and equipment for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Share issuance costs, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of share issuance costs for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Share issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Unrealized fair value on biological assets and inventory, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of unrealized fair value on biological assets and inventory for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Unrealized fair value on biological assets and inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxAssetLiabilityNotRecognized_0" xml:lang="en-US">Deferred tax asset liability not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxAssetLiabilityNotRecognized_1" xml:lang="en-US">Deferred tax (asset) / liability not recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DeferredTaxAssetLiabilityNotRecognized_2" xml:lang="en-US">Deferred tax liabilities not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_DeferredTaxAssetLiabilityNotRecognized_3" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxAssetNotRecognized_0" xml:lang="en-US">Deferred tax asset not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxAssetNotRecognized_1" xml:lang="en-US">Deferred tax asset not recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DeferredTaxAssetNotRecognized_2" xml:lang="en-US">Deferred tax asset not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_0" xml:lang="en-US">Deferred Tax Asset, Property, Plant and Equipments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_1" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_3" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxAssetsLiabilitiesAxis_0" xml:lang="en-US">Axis for deferred tax assets/liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxAssetsLiabilitiesAxis_1" xml:lang="en-US">Deferred Tax Assets Liabilities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxAssetsLiabilitiesDomain_0" xml:lang="en-US">Domain for deferred tax assets/liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxAssetsLiabilitiesDomain_1" xml:lang="en-US">Deferred Tax Assets Liabilities [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxAssetsOtherInvestments_0" xml:lang="en-US">Deferred Tax Assets Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxAssetsOtherInvestments_1" xml:lang="en-US">Amount of other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DeferredTaxAssetsOtherInvestments_2" xml:lang="en-US">Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_DeferredTaxAssetsOtherInvestments_3" xml:lang="en-US">Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_0" xml:lang="en-US">Deferred Tax Liabilities Capital Losses Carried Forward</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_1" xml:lang="en-US">Represents amount of capital losses carried forward.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_2" xml:lang="en-US">Capital losses carried forward</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_3" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DefinitiveBusinessCombinationAgreementMember_0" xml:lang="en-US">Type of agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DefinitiveBusinessCombinationAgreementMember_1" xml:lang="en-US">Definitive Business Combination Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DefinitiveBusinessCombinationAgreementMember_2" xml:lang="en-US">Definitive business combination agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DefinitiveCollaborationProfitSharingAgreementMember_0" xml:lang="en-US">Information about definitive collaboration and profit sharing agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DefinitiveCollaborationProfitSharingAgreementMember_1" xml:lang="en-US">Definitive Collaboration Profit Sharing Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DefinitiveCollaborationProfitSharingAgreementMember_2" xml:lang="en-US">Definitive collaboration and profit sharing agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_0" xml:lang="en-US">Definitive Strategic Alliance and Streaming Agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_1" xml:lang="en-US">Definitive Strategic Alliance And Streaming Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_2" xml:lang="en-US">Definitive Strategic Alliance and Streaming Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_0" xml:lang="en-US">Derivative liabilities settled through issuance of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_1" xml:lang="en-US">Represents the amount related to derivative liabilities settled through issuance of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_0" xml:lang="en-US">The expected volatility of the share price used to calculate the fair value of the warrants granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_1" xml:lang="en-US">Description Of Expected Volatility Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_2" xml:lang="en-US">Expected volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_3" xml:lang="en-US">Expected Volatility Range</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DescriptionOfOptionLifeWarrantsGranted_0" xml:lang="en-US">The option life of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DescriptionOfOptionLifeWarrantsGranted_1" xml:lang="en-US">Description Of Option Life Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DescriptionOfOptionLifeWarrantsGranted_2" xml:lang="en-US">Expected maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DescriptionOfOptionLifeWarrantsGranted_3" xml:lang="en-US">Average Expected Life (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_0" xml:lang="en-US">Represents description of recent accounting pronouncements adopted policy.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_1" xml:lang="en-US">Description Of Recent Accounting Pronouncements Adopted Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_2" xml:lang="en-US">New standards, amendments and interpretations adopted by the Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DescriptionOfReverseShareSplit_0" xml:lang="en-US">Description of reverse share split</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DescriptionOfReverseShareSplit_1" xml:lang="en-US">Represents the description of reverse share split.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_0" xml:lang="en-US">The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for warrants granted is expressed, with a remaining term equal to the expected term of the warrants being valued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_1" xml:lang="en-US">Description Of Risk Free Interest Rate Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_2" xml:lang="en-US">Risk free interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_3" xml:lang="en-US">Risk Free Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DescriptionOfVotingRights_0" xml:lang="en-US">Description of voting rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DescriptionOfVotingRights_1" xml:lang="en-US">Description Of Voting Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DescriptionOfVotingRights_2" xml:lang="en-US">Description of voting rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DirectorsAndOfficersMember_0" xml:lang="en-US">This member stands for directors and officers.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DirectorsAndOfficersMember_1" xml:lang="en-US">Directors And Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DirectorsAndOfficersMember_2" xml:lang="en-US">Directors and officers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DirectorsAndOfficersMember_3" xml:lang="en-US">Officers and Directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DirectorsRemunerationPayable_0" xml:lang="en-US">Represents the value of directors remuneration payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DirectorsRemunerationPayable_1" xml:lang="en-US">Directors Remuneration Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DirectorsRemunerationPayable_2" xml:lang="en-US">Director's remuneration payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfBiologicalAssetsExplanatory_0" xml:lang="en-US">Represents information related to Biological assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfBiologicalAssetsExplanatory_1" xml:lang="en-US">Disclosure Of Biological Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfBiologicalAssetsExplanatory_2" xml:lang="en-US">Schedule of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfCapitalManagementAbstract_0" xml:lang="en-US">Disclosure Of Capital Management [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_0" xml:lang="en-US">Disclosure of changes in warrants outstanding and weighted average exercise price explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of changes in warrants outstanding and weighted average exercise price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_2" xml:lang="en-US">Disclosure of changes in warrants outstanding and weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfCommitmentsAbstract_0" xml:lang="en-US">Disclosure Of Commitments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_0" xml:lang="en-US">Disclosure Of Commitments And Contingent Liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_0" xml:lang="en-US">Represents information related to corporate and nature of operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_1" xml:lang="en-US">Disclosure Of Corporate Information And Nature Of Operations Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_2" xml:lang="en-US">Corporate information and nature of operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_0" xml:lang="en-US">Represents information of fair value of warrants estimated on dates of issue using the Black Scholes option pricing model.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Fair Value Of Warrants Warrants Estimated On Dates Of Issue Using Black Scholes Option Pricing Model Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_2" xml:lang="en-US">Schedule of warrants estimated on dates of issue using the black scholes option pricing model</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_0" xml:lang="en-US">Represents the tabular disclosure of inventories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Inventories Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_2" xml:lang="en-US">Schedule of inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_0" xml:lang="en-US">The entire disclosure for notes payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Notes Payable Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_2" xml:lang="en-US">Schedule of notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_0" xml:lang="en-US">Represents the tabular disclosure of other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Other Investments Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_2" xml:lang="en-US">Schedule of interests held in other companies related to cannabis industry</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_3" xml:lang="en-US">Schedule of Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_0" xml:lang="en-US">Disclosure Of Detailed Information About Right Of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_1" xml:lang="en-US">Represents information on right of use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_2" xml:lang="en-US">Schedule of Right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_0" xml:lang="en-US">Disclosure Of Detailed Information About Share Options And Warrants Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1" xml:lang="en-US">The disclosure of detailed information about Share Options and Warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_2" xml:lang="en-US">Schedule of share options and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_0" xml:lang="en-US">The disclosure of detailed information about warrant activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Warrant Activity Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_2" xml:lang="en-US">Schedule of warrant activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_0" xml:lang="en-US">The entire disclosure for trade and other receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_1" xml:lang="en-US">Disclosure of detail information about trade and other receivables explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_2" xml:lang="en-US">Schedule of trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_0" xml:lang="en-US">Disclosure of details information about Right of use asset Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_1" xml:lang="en-US">Schedule of Right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_0" xml:lang="en-US">Disclosure Of fair value assumptions of warrants outstanding explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of fair value assumption of warrants outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_2" xml:lang="en-US">Disclosure of fair value assumptions of warrants outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_0" xml:lang="en-US">Represents information related to Acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_1" xml:lang="en-US">Disclosure Of Fair Value Recognized On Acquisition [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_2" xml:lang="en-US">Schedule of allocation total purchase consideration to identifiable assets acquired and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_0" xml:lang="en-US">Represents detailed information of financial assets and liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure Of Financial Assets And Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_2" xml:lang="en-US">Schedule of financial assets and financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfGeneralAndAdministrativeExpenses_0" xml:lang="en-US">Disclosure Of General And Administrative Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DisclosureOfGeneralAndAdministrativeExpenses_1" xml:lang="en-US">Schedule of general and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfNatureOfBusinessAbstract_0" xml:lang="en-US">Represents Nature of business abstract.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNatureOfBusinessAbstract_1" xml:lang="en-US">Disclosure of Nature of business [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfNatureOfBusinessAbstract_2" xml:lang="en-US">Nature of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_0" xml:lang="en-US">Represents nature of business.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_1" xml:lang="en-US">Disclosure Of Nature Of Business Explanatory [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_2" xml:lang="en-US">Nature of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNatureOfBusinessLineItems_0" xml:lang="en-US">Disclosure of nature of business [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNatureOfBusinessTable_0" xml:lang="en-US">Disclosure of nature of business [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfNatureOfBusinessTable_1" xml:lang="en-US">Represents the tabular information of nature of business.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_0" xml:lang="en-US">The disclosure of the number and weighted average remaining contractual life of outstanding and exercisable share options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_1" xml:lang="en-US">Disclosure Of Number And Weighted Average Remaining Contractual Life Of Outstanding And Exercisable Share Options Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_2" xml:lang="en-US">Schedule of number and weighted average remaining contractual life of outstanding and exercisable share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_0" xml:lang="en-US">Disclosure Of number of warrants outstanding and exercise price explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of number of warrants outstanding and exercise price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_2" xml:lang="en-US">Disclosure of number of warrants outstanding and exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_0" xml:lang="en-US">Disclosure Of Number Of Warrants Outstanding And Weighted average exercise price explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of number of warrants outstanding and its weighted average exercise price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_2" xml:lang="en-US">Disclosure of number of warrants outstanding and weighted average exercise price explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_0" xml:lang="en-US">The disclosure of operating lease obligations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_1" xml:lang="en-US">Disclosure Of Operating Lease obligations [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_2" xml:lang="en-US">Schedule of lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfOtherInvestmentsAbstract_0" xml:lang="en-US">Disclosure Of Other Investments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfOtherInvestmentsLineItems_0" xml:lang="en-US">Disclosure Of Other Investments [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfOtherInvestmentsTable_0" xml:lang="en-US">Represents the tabular information of other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfOtherInvestmentsTable_1" xml:lang="en-US">Disclosure Of Other Investments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_0" xml:lang="en-US">Represents the tabular disclosure of provision for income taxes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_1" xml:lang="en-US">Disclosure Of Provision For Income Taxes Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_2" xml:lang="en-US">Schedule of provision for income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_0" xml:lang="en-US">Disclosure Of Quantities Available To Supply By Fiscal Period Under Commitment Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of quantities available to supply by fiscal period, under the supply commitment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_2" xml:lang="en-US">Disclosure of quantities available to supply by fiscal period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfReverseTakeoverTransactionAbstract_0" xml:lang="en-US">Disclosure Of Reverse Takeover Transaction [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_0" xml:lang="en-US">Disclosure Of Reverse Takeover Transaction Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_1" xml:lang="en-US">Represents information of reverse takeover transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_2" xml:lang="en-US">Reverse Takeover Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_3" xml:lang="en-US">Acquisition of Prismic Pharmaceutical</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xml:lang="en-US">Disclosure of Share based compensation and warrant reserve [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_0" xml:lang="en-US">Disclosure of Share based compensation and warrant reserve explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_1" xml:lang="en-US">Represents the entire disclosure of share based compensation and warrant reserve.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_0" xml:lang="en-US">Disclosure of temporary differences for which no deferred tax asset is recognised explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of temporary differences for which no deferred tax asset is recognised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_2" xml:lang="en-US">Schedule of temporary differences for which no deferred tax asset is recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory_0" xml:lang="en-US">Disclosure Of Unobservable Input Used To Estimate Fair Value Of Biological Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of unobservable input used to estimate fair value of biological assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory_2" xml:lang="en-US">Schedule of unobservable input used to estimate fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_0" xml:lang="en-US">Represents the tabular disclosure of unrecognized temporary tax differences.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_1" xml:lang="en-US">Disclosure Of Unrecognized Temporary Tax Differences Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_2" xml:lang="en-US">Schedule of unrecognized temporary tax differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfWarrantsLineItems_0" xml:lang="en-US">Disclosure of warrants [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfWarrantsLineItems_1" xml:lang="en-US">Disclosure of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfWarrantsTable_0" xml:lang="en-US">Disclosure of warrants [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfWarrantsTable_1" xml:lang="en-US">Represents the tabular information of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DiscountOnProceedsOfSharesAndWarrantsSold_0" xml:lang="en-US">Discount on proceeds of shares and warrants sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DiscountOnProceedsOfSharesAndWarrantsSold_1" xml:lang="en-US">Represents the percentage for discount on proceeds of shares and warrants sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DiscountOnProceedsOfSharesAndWarrantsSold_2" xml:lang="en-US">Discount on proceeds of shares and warrants sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DocumentAndEntityInformationAbstract_0" xml:lang="en-US">Document And Entity Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_0" xml:lang="en-US">Effect of shares issued during period on weighted average number of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_1" xml:lang="en-US">Effect Of Shares Issued During Period On Weighted Average Number Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_2" xml:lang="en-US">Effect of common shares issued during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_EmployeeRelatedLiability_0" xml:lang="en-US">Information about employee related liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_EmployeeRelatedLiability_1" xml:lang="en-US">Employee Related Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_EpitechLicenseAgreementMember_0" xml:lang="en-US">Epitech License Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_EpitechLicenseAgreementMember_1" xml:lang="en-US">Epitech License Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_EpitechLicenseAgreementMember_2" xml:lang="en-US">Epitech License Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_EstimatedCostOfRestorationInCommitment_0" xml:lang="en-US">Estimated cost of restoration in commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_EstimatedCostOfRestorationInCommitment_1" xml:lang="en-US">Represents the amount related to estimated cost of restoration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceEighteenPointZeroNineMember_0" xml:lang="en-US">Exercise price 18.09</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceEighteenPointZeroNineMember_1" xml:lang="en-US">Exercise Price Eighteen Point Zero Nine [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceEighteenPointZeroNineMember_2" xml:lang="en-US">18.09</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceEightyEightPointFortyFourMember_0" xml:lang="en-US">Exercise price 88.44</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceEightyEightPointFortyFourMember_1" xml:lang="en-US">Exercise Price Eighty eight point forty four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceEightyEightPointFortyFourMember_2" xml:lang="en-US">88.44</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceEightySixPointFortyThreeMember_0" xml:lang="en-US">Exercise price 86.43</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceEightySixPointFortyThreeMember_1" xml:lang="en-US">Exercise Price Eighty Six Point Forty Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceEightySixPointFortyThreeMember_2" xml:lang="en-US">86.43</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFiftyFivePointTwentyEightMember_0" xml:lang="en-US">Exercise price 55.28</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFiftyFivePointTwentyEightMember_1" xml:lang="en-US">Exercise Price Fifty Five Point Twenty Eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFiftyFivePointTwentyEightMember_2" xml:lang="en-US">55.28</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFiftyNinePointThirtyMember_0" xml:lang="en-US">Exercise price 59.30</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFiftyNinePointThirtyMember_1" xml:lang="en-US">Exercise Price Fifty Nine Point Thirty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFiftyNinePointThirtyMember_2" xml:lang="en-US">59.30</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFiftyPointTwentyFiveMember_0" xml:lang="en-US">Exercise price 50.25</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFiftyPointTwentyFiveMember_1" xml:lang="en-US">Exercise Price Fifty Point Twenty Five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFiftyPointTwentyFiveMember_2" xml:lang="en-US">50.25</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFiftySixPointTwentyEightMember_0" xml:lang="en-US">Exercise price 56.28</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFiftySixPointTwentyEightMember_1" xml:lang="en-US">Exercise price Fifty Six Point Twenty Eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFiftySixPointTwentyEightMember_2" xml:lang="en-US">56.28</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFiftyTwoPointTwentySixMember_0" xml:lang="en-US">Exercise price 52.26</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFiftyTwoPointTwentySixMember_1" xml:lang="en-US">Exercise Price Fifty Two Point Twenty Six [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFiftyTwoPointTwentySixMember_2" xml:lang="en-US">52.26</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFivePointFourThreeMember_0" xml:lang="en-US">Exercise price 5.43</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFivePointFourThreeMember_1" xml:lang="en-US">Exercise Price Five Point Four Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFivePointFourThreeMember_2" xml:lang="en-US">5.43</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFivePointZeroThreeMember_0" xml:lang="en-US">Exercise price 5.03</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFivePointZeroThreeMember_1" xml:lang="en-US">Exercise price Five Point Zero Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFivePointZeroThreeMember_2" xml:lang="en-US">5.03</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFortyFourPointTwentyTwoMember_0" xml:lang="en-US">Exercise price 44.22</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFortyFourPointTwentyTwoMember_1" xml:lang="en-US">Exercise Price Forty Four Point Twenty Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFortyFourPointTwentyTwoMember_2" xml:lang="en-US">44.22</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFortyPointTwentyMember_0" xml:lang="en-US">Exercise price 40.20</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFortyPointTwentyMember_1" xml:lang="en-US">Exercise Price Forty Point Twenty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFortyPointTwentyMember_2" xml:lang="en-US">40.20</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFortySevenPointTwentyFourMember_0" xml:lang="en-US">Exercise price 47.24</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFortySevenPointTwentyFourMember_1" xml:lang="en-US">Exercise Price Forty Seven Point Twenty Four [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFortySevenPointTwentyFourMember_2" xml:lang="en-US">47.24</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFourPointFourTwoMember_0" xml:lang="en-US">Exercise price 4.42</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFourPointFourTwoMember_1" xml:lang="en-US">Exercise Price Four Point Four Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFourPointFourTwoMember_2" xml:lang="en-US">4.42</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOfExercisableShareOptions_0" xml:lang="en-US">Exercise price of exercisable Share options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOfExercisableShareOptions_1" xml:lang="en-US">Exercise price of exercisable Share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOfWarrants_0" xml:lang="en-US">Represents the price per share of excercise price of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOfWarrants_1" xml:lang="en-US">Exercise price of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOfWarrantsGranted_0" xml:lang="en-US">Exercise price of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOfWarrantsGranted_1" xml:lang="en-US">Represents the exercise price of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExercisePriceOfWarrantsGranted_2" xml:lang="en-US">Exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_0" xml:lang="en-US">Exercise price 148.74</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_1" xml:lang="en-US">Exercise Price One Hundred Forty Eight Point Seventy Four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_2" xml:lang="en-US">148.74</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_0" xml:lang="en-US">Exercise price 142.71</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_1" xml:lang="en-US">Exercise Price One Hundred Forty Two Point Seventy One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_2" xml:lang="en-US">142.71</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOneHundredTwentyPointSixtyMember_0" xml:lang="en-US">Exercise price 120.60</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOneHundredTwentyPointSixtyMember_1" xml:lang="en-US">Exercise Price One Hundred Twenty Point Sixty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceOneHundredTwentyPointSixtyMember_2" xml:lang="en-US">120.60</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSevenPointFiftyMember_0" xml:lang="en-US">Exercise price 7.50</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSevenPointFiftyMember_1" xml:lang="en-US">Exercise Price Seven Point Fifty [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSevenPointFiftyMember_2" xml:lang="en-US">7.50</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSevenPointSeventeenMember_0" xml:lang="en-US">Exercise price 7.17</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSevenPointSeventeenMember_1" xml:lang="en-US">Exercise Price Seven Point Seventeen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSevenPointSeventeenMember_2" xml:lang="en-US">7.17</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSevenPointSixtyThreeMember_0" xml:lang="en-US">Exercise price 7.63</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSevenPointSixtyThreeMember_1" xml:lang="en-US">Exercise price Seven Point Sixty Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSevenPointSixtyThreeMember_2" xml:lang="en-US">7.63</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSevenPointZeroZeroMember_0" xml:lang="en-US">Exercise price 7.00</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSevenPointZeroZeroMember_1" xml:lang="en-US">Exercise Price Seven Point Zero Zero [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSevenPointZeroZeroMember_2" xml:lang="en-US">7.00</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSeventeenPointEightNineMember_0" xml:lang="en-US">Exercise price 17.89</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSeventeenPointEightNineMember_1" xml:lang="en-US">Exercise Price Seventeen Point Eight Nine [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSeventeenPointEightNineMember_2" xml:lang="en-US">17.89</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSeventyFivePointThirtyEightMember_0" xml:lang="en-US">Exercise price 75.38</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSeventyFivePointThirtyEightMember_1" xml:lang="en-US">Exercise price seventy five point thirty eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSeventyFivePointThirtyEightMember_2" xml:lang="en-US">75.38</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSeventyOnePointZeroSevenMember_0" xml:lang="en-US">Exercise price 71.07</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSeventyOnePointZeroSevenMember_1" xml:lang="en-US">Exercise Price Seventy One Point Zero Seven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSeventyOnePointZeroSevenMember_2" xml:lang="en-US">71.07</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSixPointSixteenMember_0" xml:lang="en-US">Exercise price 6.16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSixPointSixteenMember_1" xml:lang="en-US">Exercise Price Six Point Sixteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSixPointSixteenMember_2" xml:lang="en-US">6.16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSixteenPointZeroEightMember_0" xml:lang="en-US">Exercise price 16.08</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSixteenPointZeroEightMember_1" xml:lang="en-US">Exercise Price Sixteen Point Zero Eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSixteenPointZeroEightMember_2" xml:lang="en-US">16.08</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSixtyEightPointZeroOneMember_0" xml:lang="en-US">Exercise price 68.01</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSixtyEightPointZeroOneMember_1" xml:lang="en-US">Exercise Price Sixty Eight Point Zero One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSixtyEightPointZeroOneMember_2" xml:lang="en-US">68.01</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTenPointSixFiveMember_0" xml:lang="en-US">Exercise price 10.65</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTenPointSixFiveMember_1" xml:lang="en-US">Exercise Price Ten point six five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExercisePriceTenPointSixFiveMember_2" xml:lang="en-US">10.65</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceThirteenPointFourSevenMember_0" xml:lang="en-US">Exercise price 13.47</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceThirteenPointFourSevenMember_1" xml:lang="en-US">Exercise Price Thirteen Point Four Seven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceThirteenPointFourSevenMember_2" xml:lang="en-US">13.47</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceThirteenPointZeroSevenMember_0" xml:lang="en-US">Exercise price 13.07</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceThirteenPointZeroSevenMember_1" xml:lang="en-US">Exercise Price Thirteen Point Zero Seven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceThirteenPointZeroSevenMember_2" xml:lang="en-US">13.07</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwentyFourPointTwelveMember_0" xml:lang="en-US">24.12</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwentyFourPointTwelveMember_1" xml:lang="en-US">Exercise price Twenty Four Point Twelve [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwentyFourPointTwelveMember_2" xml:lang="en-US">24.12</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwentyOnePointElevenMember_0" xml:lang="en-US">Exercise price 21.11</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwentyOnePointElevenMember_1" xml:lang="en-US">Exercise Price Twenty One Point Eleven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwentyOnePointElevenMember_2" xml:lang="en-US">21.11</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwentyOnePointNinetyOneMember_0" xml:lang="en-US">Exercise price 21.91</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwentyOnePointNinetyOneMember_1" xml:lang="en-US">Exercise Price Twenty One Point Ninety One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwentyOnePointNinetyOneMember_2" xml:lang="en-US">21.91</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwentyOnePointTwentyTwoMember_0" xml:lang="en-US">Exercise price 21.22</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwentyOnePointTwentyTwoMember_1" xml:lang="en-US">Exercise Price Twenty One Point Twenty Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwentyOnePointTwentyTwoMember_2" xml:lang="en-US">21.22</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwentyPointOneZeroMember_0" xml:lang="en-US">Exercise price 20.10</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwentyPointOneZeroMember_1" xml:lang="en-US">Exercise Price Twenty Point One Zero [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwentyPointOneZeroMember_2" xml:lang="en-US">20.10</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwentySixPointThirteenMember_0" xml:lang="en-US">Exercise price 26.13</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwentySixPointThirteenMember_1" xml:lang="en-US">Exercise price Twenty Six Point Thirteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwentySixPointThirteenMember_2" xml:lang="en-US">26.13</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwoPointSixOneMember_0" xml:lang="en-US">Exercise price 2.61</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwoPointSixOneMember_1" xml:lang="en-US">Exercise Price Two Point Six One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwoPointSixOneMember_2" xml:lang="en-US">2.61</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_0" xml:lang="en-US">The percentage of an expected dividend used to calculate the fair value of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_1" xml:lang="en-US">Expected Dividend As Percentage Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_2" xml:lang="en-US">Expected dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_3" xml:lang="en-US">Expected Dividend Yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedDividendYieldOfWarrants_0" xml:lang="en-US">Expected dividend yield of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedDividendYieldOfWarrants_1" xml:lang="en-US">Expected Dividend Yield Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedDividendYieldOfWarrants_2" xml:lang="en-US">Expected dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedDividendYieldOfWarrantsGranted_0" xml:lang="en-US">Expected dividend yield of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedDividendYieldOfWarrantsGranted_1" xml:lang="en-US">Represents expected dividend yield of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExpectedDividendYieldOfWarrantsGranted_2" xml:lang="en-US">Expected dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedGrowthCycle_0" xml:lang="en-US">Represents period of expected growth cycle.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedGrowthCycle_1" xml:lang="en-US">Expected growth cycle</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedGrowthCycle_2" xml:lang="en-US">Expected growth cycle</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedGrowthCycleCompleted_0" xml:lang="en-US">Represents expected growth cycle completed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedGrowthCycleCompleted_1" xml:lang="en-US">Expected growth cycle completed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedGrowthCycleCompleted_2" xml:lang="en-US">Expected growth cycle completed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedLifeOfWarrants_0" xml:lang="en-US">Expected life of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedLifeOfWarrants_1" xml:lang="en-US">Represents expected life of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExpectedLifeOfWarrants_2" xml:lang="en-US">Expected life (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedNetSellingPricePerGramOfDriedFlower_0" xml:lang="en-US">Represents expected net selling price per gram of dried flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedNetSellingPricePerGramOfDriedFlower_1" xml:lang="en-US">Expected net selling price per gram of dried flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedNetSellingPricePerGramOfTrim_0" xml:lang="en-US">Represents expected net selling price per gram of trim.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedNetSellingPricePerGramOfTrim_1" xml:lang="en-US">Expected net selling price per gram of trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedNetSellingPricePerGramOfTrim_2" xml:lang="en-US">Expected net selling price per gram of trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedSellingPricePerGramOfDriedFlower_0" xml:lang="en-US">Expected selling price per gram of dried flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedSellingPricePerGramOfDriedFlower_1" xml:lang="en-US">Represents expected selling price per gram of dried flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedSellingPricePerGramOfTrim_0" xml:lang="en-US">Expected selling price per gram of trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedSellingPricePerGramOfTrim_1" xml:lang="en-US">Represents expected selling price per gram of trim.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedSellingPricePerGramOfTrim_2" xml:lang="en-US">Expected selling price per gram of trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedTermOfWarrants_0" xml:lang="en-US">Represents the expected term of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedTermOfWarrants_1" xml:lang="en-US">Expected Term Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedTermOfWarrants_2" xml:lang="en-US">Expected term of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedVolatilityOfWarrants_0" xml:lang="en-US">Represents expected volatility of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedVolatilityOfWarrants_1" xml:lang="en-US">Expected Volatility Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExpectedVolatilityOfWarrants_2" xml:lang="en-US">Expected volatility of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedVolatilityOfWarrants_3" xml:lang="en-US">Expected Volatility Range</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedVolatilityOfWarrantsGranted_0" xml:lang="en-US">Expected volatility of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedVolatilityOfWarrantsGranted_1" xml:lang="en-US">Represents expected volatility of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExpectedVolatilityOfWarrantsGranted_2" xml:lang="en-US">Annualized volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_0" xml:lang="en-US">Expected yield for cannabis plants of dry flower, per plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_1" xml:lang="en-US">Represents expected yield for cannabis plants of dry flower, per plant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_2" xml:lang="en-US">Expected yield for cannabis plants of dry flower, per plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_0" xml:lang="en-US">Expected yield for cannabis plants of dry trim, per plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_1" xml:lang="en-US">Represents expected yield for cannabis plants of dry trim, per plant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_2" xml:lang="en-US">Expected yield for cannabis plants of dry trim, per plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedYieldOfDryFlower_0" xml:lang="en-US">Represents expected yield of dry flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedYieldOfDryFlower_1" xml:lang="en-US">Expected yield of dry flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedYieldOfDryFlower_2" xml:lang="en-US">Expected yield of dry flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedYieldOfDryTrim_0" xml:lang="en-US">Represents expected yield of dry trim.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedYieldOfDryTrim_1" xml:lang="en-US">Expected yield of dry trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedYieldOfDryTrim_2" xml:lang="en-US">Expected yield of dry trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpiryDateOfWarrants_0" xml:lang="en-US">Represents expiry date of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpiryDateOfWarrants_1" xml:lang="en-US">Expiry Date Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpiryDateOfWarrants_2" xml:lang="en-US">Expiry Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpiryTermOfWarrantsGranted_0" xml:lang="en-US">Represents term of expiry of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpiryTermOfWarrantsGranted_1" xml:lang="en-US">Expiry Term Of Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpiryTermOfWarrantsGranted_2" xml:lang="en-US">Expiry term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FacilityRelatedExpenditures_0" xml:lang="en-US">information about facility related expenditures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FacilityRelatedExpenditures_1" xml:lang="en-US">Facility related expenditures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_FacilityRelatedExpenditures_2" xml:lang="en-US">Facility related expenditures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FacilityUnderDevelopmentMember_0" xml:lang="en-US">This member stands for Facility under development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FacilityUnderDevelopmentMember_1" xml:lang="en-US">Facility Under Development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FacilityUnderDevelopmentMember_2" xml:lang="en-US">Facility and related</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueAdjustmentsOnInventorySold_0" xml:lang="en-US">Represents amount of Fair value adjustments on inventory sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_FairValueAdjustmentsOnInventorySold_1" xml:lang="en-US">Fair value adjustments on inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueAdjustmentsOnInventorySold_2" xml:lang="en-US">Fair value adjustments on inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueAdjustmentsOnInventorySold_3" xml:lang="en-US">Fair value adjustments on inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfShares_0" xml:lang="en-US">Represents the amount related to fair value of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfShares_1" xml:lang="en-US">Fair Value Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfShares_2" xml:lang="en-US">Fair value of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfSharesAndWarrantsAcquired_0" xml:lang="en-US">Fair Value Of Shares And Warrants acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfSharesAndWarrantsAcquired_1" xml:lang="en-US">Represents the fair value of shares and warrants acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfSharesAndWarrantsAcquired_2" xml:lang="en-US">Fair value of shares and warrants acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfWarrants_0" xml:lang="en-US">Represents fair value of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfWarrants_1" xml:lang="en-US">Fair Value Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_FairValueOfWarrants_2" xml:lang="en-US">Fair Values</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfWarrants_3" xml:lang="en-US">Fair value of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Feb252018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Feb252018Member_1" xml:lang="en-US">Feb 25 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Feb252018Member_2" xml:lang="en-US">Feb 25 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FindersFee_0" xml:lang="en-US">Information about finders fee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FindersFee_1" xml:lang="en-US">Finders Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FindersFee_2" xml:lang="en-US">Finder's fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FindersFeeShares_0" xml:lang="en-US">Represents amount related to finders fee shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FindersFeeShares_1" xml:lang="en-US">Finders fee shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FirstRepublicCapitalCorporationMember_0" xml:lang="en-US">This member stands for first republic capital corporation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FirstRepublicCapitalCorporationMember_1" xml:lang="en-US">First Republic Capital Corporation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_FirstRepublicCapitalCorporationMember_2" xml:lang="en-US">FRCC</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FormerCEOMember_0" xml:lang="en-US">Former CEO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FormerCEOMember_1" xml:lang="en-US">Represents Former Chief Executive Officer member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FormerChiefExecutiveOfficerMember_0" xml:lang="en-US">Represents information about former chief executive officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FormerChiefExecutiveOfficerMember_1" xml:lang="en-US">Former Chief executive Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FormerChiefExecutiveOfficerMember_2" xml:lang="en-US">Former CEO</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FormerChiefOperatingOfficerMember_0" xml:lang="en-US">This members stands for former chief operating officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FormerChiefOperatingOfficerMember_1" xml:lang="en-US">Former Chief Operating Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_FormerChiefOperatingOfficerMember_2" xml:lang="en-US">Former Chief Operating Officer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FSDBiosciencesMember_0" xml:lang="en-US">FSD Biosciences [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FSDBiosciencesMember_1" xml:lang="en-US">FSD Biosciences [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FSDBiosciencesMember_2" xml:lang="en-US">FSD Biosciences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FurnitureFixturesAndEquipmentMember_0" xml:lang="en-US">This member stands for furniture fixtures and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FurnitureFixturesAndEquipmentMember_1" xml:lang="en-US">Furniture Fixtures And Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FurnitureFixturesAndEquipmentMember_2" xml:lang="en-US">Furniture and fixtures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FvPharmaIncMember_0" xml:lang="en-US">Represents information for FV Pharma Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FvPharmaIncMember_1" xml:lang="en-US">Fv Pharma Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_FvPharmaIncMember_2" xml:lang="en-US">FV Pharma Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GainLossOnChangeInFairValueOfDerivativeLiability_0" xml:lang="en-US">Represents the amount related to gain (loss) on change in fair value of derivative liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GainLossOnChangeInFairValueOfDerivativeLiability_1" xml:lang="en-US">Gain (loss) on change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GrantDateAxis_0" xml:lang="en-US">Information by date or year award under share-based payment arrangement is granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GrantDateAxis_1" xml:lang="en-US">Grant Date [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GrantDateDomain_0" xml:lang="en-US">Date or year award under share-based payment arrangement is granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GrantDateDomain_1" xml:lang="en-US">Grant Date [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GrossLossProfitBeforeFairValueAdjustments_0" xml:lang="en-US">Represents amount of Gross (loss) profit before fair value adjustments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GrossLossProfitBeforeFairValueAdjustments_1" xml:lang="en-US">Gross loss profit before fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_huge_GrossLossProfitBeforeFairValueAdjustments_2" xml:lang="en-US">Gross loss before fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GuaranteedMinimumLiquidationValueOfShares_0" xml:lang="en-US">Guaranteed minimum liquidation value of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GuaranteedMinimumLiquidationValueOfShares_1" xml:lang="en-US">Represents guaranteed minimum liquidation value of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_HarvestedCannabisMember_0" xml:lang="en-US">This member stands for Harvested cannabis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_HarvestedCannabisMember_1" xml:lang="en-US">Harvested cannabis [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_HarvestedCannabisMember_2" xml:lang="en-US">Harvested cannabis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_HempProductsMember_0" xml:lang="en-US">This member stands for Hemp products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_HempProductsMember_1" xml:lang="en-US">Hemp products [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_HempProductsMember_2" xml:lang="en-US">Hemp products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_HeritageBuildingRestorationCommitmentMember_0" xml:lang="en-US">Heritage Building Restoration Commitment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_HeritageBuildingRestorationCommitmentMember_1" xml:lang="en-US">Heritage Building Restoration Commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_HeritageBuildingRestorationCommitmentMember_2" xml:lang="en-US">Heritage Building Restoration Commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_HighTideIncMember_0" xml:lang="en-US">High Tide Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_HighTideIncMember_1" xml:lang="en-US">High Tide Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_HighTideIncMember_2" xml:lang="en-US">High Tide Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_HugeShopsMember_0" xml:lang="en-US">HUGE Shops</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_HugeShopsMember_1" xml:lang="en-US">Huge Shops [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_HugeShopsMember_2" xml:lang="en-US">HUGE Shops</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ImpactOfPresentValue_0" xml:lang="en-US">Represents impact of present value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ImpactOfPresentValue_1" xml:lang="en-US">Impact of present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ImpactOfPresentValue_2" xml:lang="en-US">Less: Impact of present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ImpactOfPresentValueOnLeaseObligations_0" xml:lang="en-US">Impact of present value on lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ImpactOfPresentValueOnLeaseObligations_1" xml:lang="en-US">Represents the amount related to impact of present value on lease obligations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ImpactOfPresentValueOnLeaseObligations_2" xml:lang="en-US">Less: Impact of present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_0" xml:lang="en-US">Impairment Loss of property, plant and equipment and right of use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_1" xml:lang="en-US">Represents the amount related to impairment Loss of property, plant and equipment and right-of-use asset.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_2" xml:lang="en-US">Impairment of property, plant and equipment and right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_0" xml:lang="en-US">Impairment Loss Recognised In Right of use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_1" xml:lang="en-US">Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_2" xml:lang="en-US">Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ImpairmentMember_0" xml:lang="en-US">This member stands for impairment member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ImpairmentMember_1" xml:lang="en-US">Impairment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ImpairmentMember_2" xml:lang="en-US">Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_0" xml:lang="en-US">Amount of increase Decrease In Fair Value of other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_1" xml:lang="en-US">Increase in fair value of other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_2" xml:lang="en-US">Increase Decrease In Fair Value Of Other Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_3" xml:lang="en-US">Increase in fair value of other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_0" xml:lang="en-US">The increase (decrease) in equity shares resulting from acquisition of net assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_1" xml:lang="en-US">Increase (decrease) Through acquisition of net assets, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_2" xml:lang="en-US">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_0" xml:lang="en-US">The increase (decrease) in equity resulting from acquisition of net assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_1" xml:lang="en-US">Increase (decrease) Through acquisition of net assets, Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_2" xml:lang="en-US">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_0" xml:lang="en-US">The increase (decrease) in equity resulting from exercise of option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_1" xml:lang="en-US">Increase Decrease Through Exercise Of Option Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_2" xml:lang="en-US">Stock options exercised (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_3" xml:lang="en-US">Share options exercised (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_0" xml:lang="en-US">The increase (decrease) in equity shares resulting from warrants exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_1" xml:lang="en-US">Increase Decrease Through Exercise Of Warrants Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_2" xml:lang="en-US">Warrants exercised (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_0" xml:lang="en-US">The increase (decrease) in equity shares resulting from warrants expired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_1" xml:lang="en-US">Increase (decrease) Through expiry Of Warrants Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_2" xml:lang="en-US">Warrants expired (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_0" xml:lang="en-US">The increase (decrease) in equity resulting from warrants expired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_1" xml:lang="en-US">Increase (decrease) Through expiry Of Warrants Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_2" xml:lang="en-US">Warrants expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_0" xml:lang="en-US">It represents Increase Decrease Through issued on acquisition of net assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_1" xml:lang="en-US">Increase Decrease Through issued on acquisition of net asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_2" xml:lang="en-US">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_0" xml:lang="en-US">It represents Increase Decrease Through issued on acquisition of net assets shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_1" xml:lang="en-US">Increase Decrease Through issued on acquisition of net assets shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_2" xml:lang="en-US">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc. (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisition_0" xml:lang="en-US">The increase (decrease) in equity resulting from reverse acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisition_1" xml:lang="en-US">Increase Decrease Through Reverse Acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisition_2" xml:lang="en-US">Reverse acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_0" xml:lang="en-US">The increase (decrease) in equity shares resulting from reverse acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_1" xml:lang="en-US">Increase Decrease Through Reverse Acquisition Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_2" xml:lang="en-US">Reverse acquisition (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_3" xml:lang="en-US">Warrant valuations (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_0" xml:lang="en-US">Increase decrease through share issue related cost shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_1" xml:lang="en-US">Increase Decrease Through Share Issue Related Cost Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_2" xml:lang="en-US">Number of broker warrants representing fees and commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_3" xml:lang="en-US">Share issuance costs (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_0" xml:lang="en-US">The increase (decrease) in equity resulting from stock options cancelled.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_1" xml:lang="en-US">Increase Decrease Through Stock Options Cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_2" xml:lang="en-US">Stock options cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_3" xml:lang="en-US">Share options cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuations_0" xml:lang="en-US">The increase (decrease) in equity resulting from warrant valuations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuations_1" xml:lang="en-US">Increase Decrease Through Warrant Valuations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuations_2" xml:lang="en-US">Warrant valuations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_0" xml:lang="en-US">The increase (decrease) in equity shares resulting from warrant valuations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_1" xml:lang="en-US">Increase Decrease Through Warrant Valuations Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_2" xml:lang="en-US">Warrant valuations (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_3" xml:lang="en-US">Increase Decrease Through Warrant Valuations Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_0" xml:lang="en-US">Incremental borrowing rate to discount lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_1" xml:lang="en-US">Represents the percentage related to incremental borrowing rate to discount the lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_2" xml:lang="en-US">Incremental borrowing rate to discount lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IndependentDirectorMember_0" xml:lang="en-US">This member stands for independent director.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IndependentDirectorMember_1" xml:lang="en-US">Independent Director [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IndependentDirectorMember_2" xml:lang="en-US">Former Chief Operating Officer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IndependentDirectorMember_3" xml:lang="en-US">Independent directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IssuanceOfShares_0" xml:lang="en-US">Number of shares issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IssuanceOfShares_1" xml:lang="en-US">Issuance Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IssuanceOfShares_2" xml:lang="en-US">Shares issued (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Jan52018Member_0" xml:lang="en-US">Represents the information of grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Jan52018Member_1" xml:lang="en-US">Jan 5 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Jan52018Member_2" xml:lang="en-US">Jan 5 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Jan52018WarrantMember_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Jan52018WarrantMember_1" xml:lang="en-US">Jan 5 2018 Warrant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Jan52018WarrantMember_2" xml:lang="en-US">Jan 5 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Jun112018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Jun112018Member_1" xml:lang="en-US">Jun 11 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Jun112018Member_2" xml:lang="en-US">Jun 11 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Jun122018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Jun122018Member_1" xml:lang="en-US">Jun 12 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Jun122018Member_2" xml:lang="en-US">Jun 12 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_KeyManagementPersonnelCarAllowance_0" xml:lang="en-US">The amount of car allowance to key management personnel.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_KeyManagementPersonnelCarAllowance_1" xml:lang="en-US">Key Management Personnel Car Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_KeyManagementPersonnelCarAllowance_2" xml:lang="en-US">Amount of car allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_LeaseTermOnOfficeSpace_0" xml:lang="en-US">Information about lease term on office space.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_LeaseTermOnOfficeSpace_1" xml:lang="en-US">Lease Term On Office Space</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_LeaseTermOnOfficeSpace_2" xml:lang="en-US">Lease term on office space</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_LegalEntitiesAxis_0" xml:lang="en-US">Represents legal entities axis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_LegalEntitiesAxis_1" xml:lang="en-US">Legal Entities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_LegalEntitiesDomain_0" xml:lang="en-US">Represents legal entities domain.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_LegalEntitiesDomain_1" xml:lang="en-US">Legal Entities [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ListingExpense_0" xml:lang="en-US">Listing expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ListingExpense_1" xml:lang="en-US">Listing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ListingExpense_2" xml:lang="en-US">Listing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_0" xml:lang="en-US">Represents amount of Loss (gain) on changes in fair value of other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_1" xml:lang="en-US">Change in fair value of other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_2" xml:lang="en-US">Loss gain on changes in fair value of other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_3" xml:lang="en-US">Loss (gain) on changes in fair value of other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_LossOnSettlementOfFinancialLiability_0" xml:lang="en-US">Represents amount of Loss on settlement of financial liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_LossOnSettlementOfFinancialLiability_1" xml:lang="en-US">Loss on settlement of financial liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_LossOnSettlementOfFinancialLiability_2" xml:lang="en-US">Loss on settlement of financial liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ManagementAndConsultingContractsMember_0" xml:lang="en-US">Information of management and consulting contracts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ManagementAndConsultingContractsMember_1" xml:lang="en-US">Management And Consulting Contracts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ManagementAndConsultingContractsMember_2" xml:lang="en-US">Management and consulting contracts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ManagementFees_0" xml:lang="en-US">Amount paid for management fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ManagementFees_1" xml:lang="en-US">Management Fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ManagementFees_2" xml:lang="en-US">Management fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Mar222018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Mar222018Member_1" xml:lang="en-US">Mar 22 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Mar222018Member_2" xml:lang="en-US">Mar 22 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Mar282018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Mar282018Member_1" xml:lang="en-US">Mar 28 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Mar282018Member_2" xml:lang="en-US">Mar 28 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_March262018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_March262018Member_1" xml:lang="en-US">March 26, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_March262018Member_2" xml:lang="en-US">March 26, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_March282018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_March282018Member_1" xml:lang="en-US">March 28, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_March282018Member_2" xml:lang="en-US">March 28, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_March92018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_March92018Member_1" xml:lang="en-US">March 9, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_March92018Member_2" xml:lang="en-US">March 9, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_MarketPriceOfShares_0" xml:lang="en-US">Market price of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_MarketPriceOfShares_1" xml:lang="en-US">Represents the market price of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_MarketPriceOfShares_2" xml:lang="en-US">Market price of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_MarketPriceOfWarrants_0" xml:lang="en-US">Represents market price of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_MarketPriceOfWarrants_1" xml:lang="en-US">Market Price Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_MarketPriceOfWarrants_2" xml:lang="en-US">Market Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_MarketPriceShareOptionsGranted_0" xml:lang="en-US">The market price share options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_MarketPriceShareOptionsGranted_1" xml:lang="en-US">Market Price Share Options Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_MarketPriceShareOptionsGranted_2" xml:lang="en-US">Market Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_May242018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_May242018Member_1" xml:lang="en-US">May 24, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_May242018Member_2" xml:lang="en-US">May 24, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_May242018WarrantMember_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_May242018WarrantMember_1" xml:lang="en-US">May 24 2018 Warrant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_May242018WarrantMember_2" xml:lang="en-US">May 24 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_May82018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_May82018Member_1" xml:lang="en-US">May 8, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_May82018Member_2" xml:lang="en-US">May 8, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_MealsAndEntertainment_0" xml:lang="en-US">Meals and entertainment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_MealsAndEntertainment_1" xml:lang="en-US">Meals and entertainment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_MealsAndEntertainment_2" xml:lang="en-US">Meals and entertainment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_MinimumInvestmentReceivable_0" xml:lang="en-US">Minimum investment receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_MinimumInvestmentReceivable_1" xml:lang="en-US">Represents the amount of minimum investment receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_MinimumInvestmentReceivable_2" xml:lang="en-US">Minimum investment receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_0" xml:lang="en-US">net selling price per gram for dry flower After harvest cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_1" xml:lang="en-US">Represents amount related to after harvest cost to sell flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_2" xml:lang="en-US">Net selling price per gram for dry flower after harvest cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_0" xml:lang="en-US">net selling price per gram for dry trim After harvest cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_1" xml:lang="en-US">Represents amount related to net selling price per gram for dry trim after harvest cost.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_2" xml:lang="en-US">Net selling price per gram for dry trim After harvest cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_0" xml:lang="en-US">Non Capital Income Tax Losses Expire on Two Thousand Thirty Eight</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1" xml:lang="en-US">Represents amount of Non capital income tax losses expire on 2038.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_2" xml:lang="en-US">2038</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_0" xml:lang="en-US">Non capital income tax losses expire On Two Thousand Thirty Nine</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_1" xml:lang="en-US">Represents amount of Non capital income tax losses expire on 2039.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_2" xml:lang="en-US">2039</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalLossCarryforwards_0" xml:lang="en-US">Non Capital loss carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalLossCarryforwards_1" xml:lang="en-US">Amount of non-capital loss carryforwards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_huge_NonCapitalLossCarryforwards_2" xml:lang="en-US">Non-capital income tax losses expire</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalLossCarryForwardsMember_0" xml:lang="en-US">Non-capital loss carry-forwards member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalLossCarryForwardsMember_1" xml:lang="en-US">Non Capital Loss Carry Forwards [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NonCapitalLossCarryForwardsMember_2" xml:lang="en-US">Non-capital loss carry-forwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalLossesMember_0" xml:lang="en-US">Information about Non-Capital Losses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalLossesMember_1" xml:lang="en-US">Non Capital Losses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NonCapitalLossesMember_2" xml:lang="en-US">Non-capital losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA_0" xml:lang="en-US">Non refundable sum due and payable upon first notification of FDA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA_1" xml:lang="en-US">Represents amount related to non refundable sum due and payable upon first notification of FDA.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA_0" xml:lang="en-US">Non refundable sum payable within ten business days of first notification FDA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA_1" xml:lang="en-US">Represents the amount related to non refundable sum payable within ten business days of first notification FDA.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NotesPayableMember_0" xml:lang="en-US">Notes payable [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NotesPayableMember_1" xml:lang="en-US">A written promise to pay a note to a bank.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NotesPayableMember_2" xml:lang="en-US">Notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Nov12017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Nov12017Member_1" xml:lang="en-US">Nov 1 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Nov12017Member_2" xml:lang="en-US">Nov 1 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Nov122018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Nov122018Member_1" xml:lang="en-US">Nov 12 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Nov122018Member_2" xml:lang="en-US">Nov 12 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Nov142017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Nov142017Member_1" xml:lang="en-US">Nov 14 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Nov142017Member_2" xml:lang="en-US">Nov 14 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Nov152018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Nov152018Member_1" xml:lang="en-US">Nov 15 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Nov152018Member_2" xml:lang="en-US">Nov 15 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Nov212017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Nov212017Member_1" xml:lang="en-US">Nov 21 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Nov212017Member_2" xml:lang="en-US">Nov 21 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Nov262018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Nov262018Member_1" xml:lang="en-US">Nov 26 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Nov262018Member_2" xml:lang="en-US">Nov 26 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_0" xml:lang="en-US">Number Of Additional Shares Issued to settle derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_1" xml:lang="en-US">Represents the number of additional shares issued to settle derivative liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_2" xml:lang="en-US">Number of additional shares issued to settle derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfAgreement_0" xml:lang="en-US">It represents number of agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfAgreement_1" xml:lang="en-US">Number of agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_0" xml:lang="en-US">The Number of broker warrants granted for fees and commissions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_1" xml:lang="en-US">Number Of Broker Warrants Granted For Fees And Commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_2" xml:lang="en-US">Number of broker warrants representing fees and commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_3" xml:lang="en-US">Share issuance costs (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesAcquired_0" xml:lang="en-US">Number of shares acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesAcquired_1" xml:lang="en-US">Number Of Shares Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesAcquired_2" xml:lang="en-US">Number of shares acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesHeld_0" xml:lang="en-US">Represents the number of shares held.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesHeld_1" xml:lang="en-US">Number Of Shares Held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesHeld_2" xml:lang="en-US">Number of shares held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesHeldSubjectToEscrowArrangement_0" xml:lang="en-US">Represents the number of shares held subject to escrow arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesHeldSubjectToEscrowArrangement_1" xml:lang="en-US">Number Of Shares Held Subject To Escrow Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesHeldSubjectToEscrowArrangement_2" xml:lang="en-US">Number of shares held subject to escrow arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedAsFindersFee_0" xml:lang="en-US">Represents number of shares issued as finders fee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedAsFindersFee_1" xml:lang="en-US">Number Of Shares Issued As Finders Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesIssuedAsFindersFee_2" xml:lang="en-US">Number of shares issued as finder's fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_0" xml:lang="en-US"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1" xml:lang="en-US">Number Of Shares Issued For Acquisition Of Century Financial Capital Group Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_2" xml:lang="en-US">Number of shares issued for Acquisition of Century Financial Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedForDebtSettlement_0" xml:lang="en-US">Represents the number of shares issued for debt settlement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedForDebtSettlement_1" xml:lang="en-US">Number of shares issued for debt settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NumberOfSharesIssuedForDebtSettlement_2" xml:lang="en-US">Number of shares issued for debt settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_0" xml:lang="en-US">Represents the number of shares issued from entity's treasury by way of private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_1" xml:lang="en-US">Number Of Shares Issued From Treasury Under Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_2" xml:lang="en-US">Number of Class B shares issued from treasury under private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedInPrivatePlacement_0" xml:lang="en-US">Represents number of shares issued in private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedInPrivatePlacement_1" xml:lang="en-US">Number Of Shares Issued In Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NumberOfSharesIssuedInPrivatePlacement_2" xml:lang="en-US">Number of shares issued in private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesIssuedInPrivatePlacement_3" xml:lang="en-US">Number of shares issued in private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedInShareExchange_0" xml:lang="en-US">Number of shares issued in share exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedInShareExchange_1" xml:lang="en-US">Represents the number of shares issued in share exchange.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesIssuedInShareExchange_2" xml:lang="en-US">Number of shares issued in share exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_0" xml:lang="en-US">Number of shares outstanding subject to escrow conditions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_1" xml:lang="en-US">Number Of Shares Outstanding Subject To Escrow Conditions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_2" xml:lang="en-US">Number of shares outstanding subject to escrow conditions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesSold_0" xml:lang="en-US">Number Of Shares Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesSold_1" xml:lang="en-US">Represents number of shares sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesSold_2" xml:lang="en-US">Number of shares sold for investment in Cannara</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesSubscribed_0" xml:lang="en-US">Represents amount of number of shares subscribed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_huge_NumberOfSharesSubscribed_1" xml:lang="en-US">Number of Shares, ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_huge_NumberOfSharesSubscribed_2" xml:lang="en-US">Number of Shares, beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesSubscribed_3" xml:lang="en-US">Number Of Shares Subscribed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NumberOfSharesSubscribed_4" xml:lang="en-US">Number of shares subscribed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesSubscribed_5" xml:lang="en-US">Number of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfWarrantsAcquired_0" xml:lang="en-US">Number of warrants acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfWarrantsAcquired_1" xml:lang="en-US">Represents the number of warrants acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfWarrantsExercised_0" xml:lang="en-US">Number of warrants Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfWarrantsExercised_1" xml:lang="en-US">Represents number of number of warrants exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfWarrantsExercised_2" xml:lang="en-US">Warrants, Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_NumberOfWarrantsExercised_3" xml:lang="en-US">Warrants, Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfWarrantsExpired_0" xml:lang="en-US">Number of warrants Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfWarrantsExpired_1" xml:lang="en-US">Represents number of warrants expired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfWarrantsExpired_2" xml:lang="en-US">Warrants, Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_NumberOfWarrantsExpired_3" xml:lang="en-US">Warrants, Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfWarrantsGranted_0" xml:lang="en-US">Number Of Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfWarrantsGranted_1" xml:lang="en-US">Represents number of warrants granted during period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfWarrantsGranted_2" xml:lang="en-US">Warrants, Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NumberOfWarrantsGranted_3" xml:lang="en-US">Number of warrants issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfWarrantsHeld_0" xml:lang="en-US">Represents the number of warrants held.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfWarrantsHeld_1" xml:lang="en-US">Number Of Warrants Held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfWarrantsHeld_2" xml:lang="en-US">Number of warrants held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfWarrantsOutstanding_0" xml:lang="en-US">Number of warrants Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfWarrantsOutstanding_1" xml:lang="en-US">Represents number of warrants outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_huge_NumberOfWarrantsOutstanding_2" xml:lang="en-US">Warrants outstanding, Opening balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_huge_NumberOfWarrantsOutstanding_3" xml:lang="en-US">Warrants outstanding, Closing Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfWarrantsOutstanding_4" xml:lang="en-US">Number of warrants outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Oct202017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Oct202017Member_1" xml:lang="en-US">Oct 20 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Oct202017Member_2" xml:lang="en-US">Oct 20 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OfficeAndGeneralExpenses_0" xml:lang="en-US">Information about office and general expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OfficeAndGeneralExpenses_1" xml:lang="en-US">Office And General expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_OfficeAndGeneralExpenses_2" xml:lang="en-US">Office and general</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OfficeLeaseAgreementMember_0" xml:lang="en-US">Information about agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OfficeLeaseAgreementMember_1" xml:lang="en-US">Office Lease Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_OfficeLeaseAgreementMember_2" xml:lang="en-US">Office lease agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OperatingLeaseImpactOfPresentValue_0" xml:lang="en-US">Represents operating lease impact of present value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OperatingLeaseImpactOfPresentValue_1" xml:lang="en-US">Operating Lease impact of present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_OperatingLeaseImpactOfPresentValue_2" xml:lang="en-US">Less: impact of present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_OperatingLeaseImpactOfPresentValue_3" xml:lang="en-US">Less: impact of present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherAllowances_0" xml:lang="en-US">Represents the value of other allowances.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherAllowances_1" xml:lang="en-US">Other allowances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherFinancialLiabilitiesMember_0" xml:lang="en-US">This member stands for Other financial liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherFinancialLiabilitiesMember_1" xml:lang="en-US">Other Financial Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_OtherFinancialLiabilitiesMember_2" xml:lang="en-US">Other liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherGeneralAndAdministrativeExpenses_0" xml:lang="en-US">Other general and administrative expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherGeneralAndAdministrativeExpenses_1" xml:lang="en-US">Other General And Administrative Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_OtherGeneralAndAdministrativeExpenses_2" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherInventoryMember_0" xml:lang="en-US">This member stands for Other inventory member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherInventoryMember_1" xml:lang="en-US">Other inventory [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_OtherInventoryMember_2" xml:lang="en-US">Other inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherInvestmentMember_0" xml:lang="en-US">Other investments member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherInvestmentMember_1" xml:lang="en-US">Other Investment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_OtherInvestmentMember_2" xml:lang="en-US">Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherInvestmentsNameOfEntityAxis_0" xml:lang="en-US">Represents the name of entities in which company hold interests in other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherInvestmentsNameOfEntityAxis_1" xml:lang="en-US">Other Investments, Name Of Entity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherInvestmentsNameOfEntityDomain_0" xml:lang="en-US">Represents the name of entities in which company hold interests in other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherInvestmentsNameOfEntityDomain_1" xml:lang="en-US">Other Investments, Name Of Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OutstandingCommitmentToPurchaseAdditionalProduct_0" xml:lang="en-US">Outstanding commitment to purchase additional product</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OutstandingCommitmentToPurchaseAdditionalProduct_1" xml:lang="en-US">Represents the amount related to outstanding commitment to purchase an additional product.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PatentMaintenanceFee_0" xml:lang="en-US">Patent maintenance fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PatentMaintenanceFee_1" xml:lang="en-US">Represents amount related to patent maintenance fee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PatentMaintenanceFee_2" xml:lang="en-US">Patent maintenance fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PaymentOfExpenses_0" xml:lang="en-US">Represents the amount of payment of expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PaymentOfExpenses_1" xml:lang="en-US">Payment of expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PaymentOfOperatingLease_0" xml:lang="en-US">Represents operating lease payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_PaymentOfOperatingLease_1" xml:lang="en-US">Less: Lease Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_huge_PaymentOfOperatingLease_2" xml:lang="en-US">Repayment of lease obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PaymentOfOperatingLease_3" xml:lang="en-US">Payment of operating lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PaymentOfOperatingLease_4" xml:lang="en-US">Repayment of lease obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PaymentOfOperatingLease_5" xml:lang="en-US">Less: Lease Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfAggregateDiscountForSharesInEscrow_0" xml:lang="en-US">Represents the percentage of Percentage of aggregate discount for shares in escrow.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfAggregateDiscountForSharesInEscrow_1" xml:lang="en-US">Percentage Of Aggregate Discount For Shares In Escrow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PercentageOfAggregateDiscountForSharesInEscrow_2" xml:lang="en-US">Percentage of aggregate discount for escrow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfDeclineInFairValueOfInvestment_0" xml:lang="en-US">Percentage Of Decline In Fair value of investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfDeclineInFairValueOfInvestment_1" xml:lang="en-US">Represents the percentage of decline in fair value of investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PercentageOfDeclineInFairValueOfInvestment_2" xml:lang="en-US">Percentage of decline in fair value of investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_0" xml:lang="en-US">Represents the amount related to percentage of discount for total proceeds of shares and warrants sold during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_1" xml:lang="en-US">Percentage Of Discount for total proceeds of shares and warrants sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_0" xml:lang="en-US">Percentage of lump sum payment received to pay for non prescription drug rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_1" xml:lang="en-US">Represents the percentage of lump sum payment received to pay for non prescription drug rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_0" xml:lang="en-US">Percentage of net receipts from commercial partners as second payment condition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_1" xml:lang="en-US">Represents the percentage of net receipts from commercial partners as second payment condition under the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_0" xml:lang="en-US">Percentage of net sales of Licensed Product as first payment condition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_1" xml:lang="en-US">Represents the percentage of net sale of licensed product as first payment condition under the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_0" xml:lang="en-US">Percentage of net sales or net receipts of licensed products as third payment condition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_1" xml:lang="en-US">Represents the percentage of net sales of net receipts of licensed products as third payment condition under the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_0" xml:lang="en-US">Percentage of one off lump sum payment to pay for prescription drug rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_1" xml:lang="en-US">Represents the percentage of one off lump sum payment to pay for prescription drug rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PermanentDifferences_0" xml:lang="en-US">Permanent Differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PermanentDifferences_1" xml:lang="en-US">Permanent differences between income tax expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PermanentDifferences_2" xml:lang="en-US">Permanent differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PharmadrugIncMember_0" xml:lang="en-US">Pharmadrug Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PharmadrugIncMember_1" xml:lang="en-US">Pharmadrug Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PharmadrugIncMember_2" xml:lang="en-US">Pharmadrug Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PharmadrugProductionGMBHMember_0" xml:lang="en-US">Pharmadrug Production GMBH [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PharmadrugProductionGMBHMember_1" xml:lang="en-US">Pharmadrug Production GMBH</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PharmadrugProductionGMBHMember_2" xml:lang="en-US">Pharmadrug Production GMBH</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PharmastripCorpMember_0" xml:lang="en-US">Information about pharmastrip corp.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PharmastripCorpMember_1" xml:lang="en-US">Pharmastrip Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PharmastripCorpMember_2" xml:lang="en-US">Pharmastrip Corp. ("Pharmastrip")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PresidentAndChiefExecutiveOfficerMember_0" xml:lang="en-US">This member stands for president and chief executive officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PresidentAndChiefExecutiveOfficerMember_1" xml:lang="en-US">President And Chief Executive Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PresidentAndChiefExecutiveOfficerMember_2" xml:lang="en-US">Former President and CEO</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PresidentAndDirectorMember_0" xml:lang="en-US">This member stands for president and director.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PresidentAndDirectorMember_1" xml:lang="en-US">President And Director [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PresidentAndDirectorMember_2" xml:lang="en-US">President and director</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PresidentOfFsdBiosciencesMember_0" xml:lang="en-US">President Of Fsd Biosciences [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PresidentOfFsdBiosciencesMember_1" xml:lang="en-US">Represents president of fsd biosciences member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PresidentOfFsdBiosciencesMember_2" xml:lang="en-US">President of FSD Biosciences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PresidentOfFSDMember_0" xml:lang="en-US">President of FSD [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PresidentOfFSDMember_1" xml:lang="en-US">Represents president of FSD member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PresidentOfFSDMember_2" xml:lang="en-US">President of FSD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PresidentOfFVPharmaMember_0" xml:lang="en-US">President of FV Pharma [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PresidentOfFVPharmaMember_1" xml:lang="en-US">Represents president of fv pharma member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PresidentOfFVPharmaMember_2" xml:lang="en-US">President of FV Pharma</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PresidentsMember_0" xml:lang="en-US">Presidents [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PresidentsMember_1" xml:lang="en-US">President</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PrincipalAmountOfBorrowings_0" xml:lang="en-US">Represents the amount related to principal amount of borrowings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PrincipalAmountOfBorrowings_1" xml:lang="en-US">Principal amount of borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PrincipalAmountOfBorrowings_2" xml:lang="en-US">Principal amount of convertible debenture</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PrismicPharmaceuticalMember_0" xml:lang="en-US">Represents prismic pharmaceutical member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PrismicPharmaceuticalMember_1" xml:lang="en-US">Prismic Pharmaceutical [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PrismicPharmaceuticalMember_2" xml:lang="en-US">Prismic Pharmaceuticals Inc. ("Prismic")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PrismicPharmaceuticalsIncMember_0" xml:lang="en-US">Information about Prismic Pharmaceuticals Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PrismicPharmaceuticalsIncMember_1" xml:lang="en-US">Prismic Pharmaceuticals Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PrismicPharmaceuticalsIncMember_2" xml:lang="en-US">Prismic Pharmaceuticals Inc. ("Prismic")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProceedsFromExerciseOfWarrants_0" xml:lang="en-US">Represents proceeds from exercise of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProceedsFromExerciseOfWarrants_1" xml:lang="en-US">Proceeds From Exercise Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ProceedsFromExerciseOfWarrants_2" xml:lang="en-US">Proceeds from warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProceedsFromSaleOfSharesAndWarrants_0" xml:lang="en-US">Represents the amount related to proceeds from sale of shares and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProceedsFromSaleOfSharesAndWarrants_1" xml:lang="en-US">Proceeds from sale of shares and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProductionAndGrowingExpense_0" xml:lang="en-US">Production and growing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProductionAndGrowingExpense_1" xml:lang="en-US">Represents the amount related to production and growing expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ProductionAndGrowingExpense_2" xml:lang="en-US">Production and growing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProductionAndGrowingExpenses_0" xml:lang="en-US">The amount of expense arising from production and growing expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProductionAndGrowingExpenses_1" xml:lang="en-US">Production And Growing Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ProductionAndGrowingExpenses_2" xml:lang="en-US">Production and growing expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProductionEquipmentMember_0" xml:lang="en-US">Represents production equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProductionEquipmentMember_1" xml:lang="en-US">Production equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ProductionEquipmentMember_2" xml:lang="en-US">Production equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ProductionEquipmentMember_3" xml:lang="en-US">Production equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PropertyPlantAndEquipmentsMember_0" xml:lang="en-US">Property, plant and equipment member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PropertyPlantAndEquipmentsMember_1" xml:lang="en-US">Property Plant And Equipments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PropertyPlantAndEquipmentsMember_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_0" xml:lang="en-US">Quantities available to supply in fifth fiscal year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_1" xml:lang="en-US">Represents the quantities available to supply in fifth fiscal year from the balance sheet fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_2" xml:lang="en-US">2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_0" xml:lang="en-US">Quantities available to supply in fourth fiscal year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_1" xml:lang="en-US">Represents the quantities available to supply in fourth fiscal year from the balance sheet fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_2" xml:lang="en-US">2024</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_QuantitiesAvailableToSupplyInNextFiscalYear_0" xml:lang="en-US">Quantities Available To Supply in Next Fiscal Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_QuantitiesAvailableToSupplyInNextFiscalYear_1" xml:lang="en-US">Represents the quantities available to supply in next fiscal year from the balance sheet fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_QuantitiesAvailableToSupplyInNextFiscalYear_2" xml:lang="en-US">2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_0" xml:lang="en-US">Quantities available to supply in second fiscal year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_1" xml:lang="en-US">Represents the quantities available to supply in second fiscal year from the balance sheet fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_2" xml:lang="en-US">2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_0" xml:lang="en-US">Quantities available to supply in third fiscal year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_1" xml:lang="en-US">Represents the quantities available to supply in third fiscal year from the balance sheet fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_2" xml:lang="en-US">2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_QuotedMarketPriceOfInvestments_0" xml:lang="en-US">Represents the price per share related to quoted market price of investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_QuotedMarketPriceOfInvestments_1" xml:lang="en-US">Quoted Market Price Of Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_QuotedMarketPriceOfInvestments_2" xml:lang="en-US">Quoted market price of investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_0" xml:lang="en-US">recognition of loss on change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_1" xml:lang="en-US">Represents amount of recognition of loss on change in fair value of derivative liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_2" xml:lang="en-US">Recognition of loss on change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RentReceivable_0" xml:lang="en-US">Amount of rent receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RentReceivable_1" xml:lang="en-US">Rent receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_RentReceivable_2" xml:lang="en-US">Rent receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ResearchAndDevelopmentAgreementMember_0" xml:lang="en-US">This member stands for Research and Development Agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ResearchAndDevelopmentAgreementMember_1" xml:lang="en-US">Research and Development Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ResearchAndDevelopmentAgreementMember_2" xml:lang="en-US">Research and Development Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ReverseTakeoverTransaction_0" xml:lang="en-US">Represents information about reverse takeover transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ReverseTakeoverTransaction_1" xml:lang="en-US">Reverse Takeover Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ReverseTakeoverTransaction_2" xml:lang="en-US">Reverse Takeover Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RightOfUseAssetsAndLeaseObligations_0" xml:lang="en-US">Represents Right-of-use assets and lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RightOfUseAssetsAndLeaseObligations_1" xml:lang="en-US">Right of use assets and lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_RightOfUseAssetsAndLeaseObligations_2" xml:lang="en-US">Right of use assets and lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RiskFreeInterestRateOfWarrants_0" xml:lang="en-US">Represents risk free interest rate of warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RiskFreeInterestRateOfWarrants_1" xml:lang="en-US">Risk Free Interest Rate Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_RiskFreeInterestRateOfWarrants_2" xml:lang="en-US">Risk Free Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RiskFreeInterestRateOfWarrantsGranted_0" xml:lang="en-US">Risk free interest rate of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RiskFreeInterestRateOfWarrantsGranted_1" xml:lang="en-US">Represents risk free interest rate of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_RiskFreeInterestRateOfWarrantsGranted_2" xml:lang="en-US">Risk free interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RiskFreeRateOfWarrants_0" xml:lang="en-US">Represents the risk free rate of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RiskFreeRateOfWarrants_1" xml:lang="en-US">Risk Free Rate Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_RiskFreeRateOfWarrants_2" xml:lang="en-US">Risk free rate of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SalesTaxRecoverable_0" xml:lang="en-US">The amount for sales taxes recoverable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SalesTaxRecoverable_1" xml:lang="en-US">Sales tax recoverable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_SalesTaxRecoverable_2" xml:lang="en-US">Sales tax recoverable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SalesTaxRecoverable_3" xml:lang="en-US">Sales taxes recoverable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_0" xml:lang="en-US">Schedule Of Non Capital Loss Carryforwards [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_1" xml:lang="en-US">Schedule of non-capital loss carryforwards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_2" xml:lang="en-US">Schedule of non-capital loss carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScheduleOfStockClassLineItems_0" xml:lang="en-US">Represents schedule of stock by class [Line item].</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScheduleOfStockClassLineItems_1" xml:lang="en-US">Schedule Of Stock Class [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScheduleOfStockClassTable_0" xml:lang="en-US">Represents schedule of stock by class [Table].</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScheduleOfStockClassTable_1" xml:lang="en-US">Schedule Of Stock Class [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScheduleOfWarrantTable_0" xml:lang="en-US">Represents information of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScheduleOfWarrantTable_1" xml:lang="en-US">Schedule Of Warrant [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_0" xml:lang="en-US">Represents information related to estimated useful lives of assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1" xml:lang="en-US">Schedules Of Estimated Useful Lives Of Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_2" xml:lang="en-US">Schedule of estimated useful lives of assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScicannTherapeuticsIncMember_0" xml:lang="en-US">SciCann Therapeutics Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScicannTherapeuticsIncMember_1" xml:lang="en-US">Scicann Therapeutics Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ScicannTherapeuticsIncMember_2" xml:lang="en-US">SciCann Therapeutics Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SecuritiesExchangeAgreementMember_0" xml:lang="en-US">Securities Exchange Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SecuritiesExchangeAgreementMember_1" xml:lang="en-US">Share Exchange Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_0" xml:lang="en-US">Represents the amount of security deposit with the court in respect of amount claimed and estimated legal fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_1" xml:lang="en-US">Security Deposit In Respect Of Amount Claimed And Estimated Legal Fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_2" xml:lang="en-US">Security deposit in respect of amount claimed and estimated legal fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Sep102018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep102018Member_1" xml:lang="en-US">Sep 10 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep102018Member_2" xml:lang="en-US">Sep 10 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Sep112018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep112018Member_1" xml:lang="en-US">Sep 11 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep112018Member_2" xml:lang="en-US">Sep 11 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep142018Member_0" xml:lang="en-US">Sep 14 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep142018Member_1" xml:lang="en-US">Sep 14 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Sep152017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep152017Member_1" xml:lang="en-US">Sep 15 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep152017Member_2" xml:lang="en-US">Sep 15 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Sep152018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep152018Member_1" xml:lang="en-US">Sep 15 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep152018Member_2" xml:lang="en-US">Sep 15 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Sep172017Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep172017Member_1" xml:lang="en-US">Sep 17 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep172017Member_2" xml:lang="en-US">Sep 17 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Sep262018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep262018Member_1" xml:lang="en-US">Sep 26 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep262018Member_2" xml:lang="en-US">Sep 26 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_September292018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_September292018Member_1" xml:lang="en-US">September 29, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_September292018Member_2" xml:lang="en-US">September 29, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_September302017Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_September302017Member_1" xml:lang="en-US">September 30, 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_September302017Member_2" xml:lang="en-US">September 30, 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareholderAndPublicCompanyCosts_0" xml:lang="en-US">Amount of expenses related to shareholder and public company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareholderAndPublicCompanyCosts_1" xml:lang="en-US">Shareholder And Public Company Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ShareholderAndPublicCompanyCosts_2" xml:lang="en-US">Shareholder and public company costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareholdersAndPublicCompanyCosts_0" xml:lang="en-US">Information about shareholder and public company costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareholdersAndPublicCompanyCosts_1" xml:lang="en-US">Shareholders And Public Company Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ShareholdersAndPublicCompanyCosts_2" xml:lang="en-US">Shareholder and public company costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareIssueCostsMember_0" xml:lang="en-US">Share Issue Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareIssueCostsMember_1" xml:lang="en-US">Share Issue Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ShareIssueCostsMember_2" xml:lang="en-US">Share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareIssuePricePerShare_0" xml:lang="en-US">Represents the price per share of shares issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareIssuePricePerShare_1" xml:lang="en-US">Share issue price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareOptionsAbstract_0" xml:lang="en-US">Share Options [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SharePriceOfSharesAndWarrants_0" xml:lang="en-US">Represents the price per share related to share price of shares and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SharePriceOfSharesAndWarrants_1" xml:lang="en-US">Share price of shares and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SharePrices_0" xml:lang="en-US">Represents Share price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SharePrices_1" xml:lang="en-US">Share Prices</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_SharePrices_2" xml:lang="en-US">Share price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SharePrices_3" xml:lang="en-US">Par value of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SharePurchaseAndSaleAgreementsMember_0" xml:lang="en-US">Share Purchase and Sale Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SharePurchaseAndSaleAgreementsMember_1" xml:lang="en-US">This member stands for share purchase and sale agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SharePurchaseAndSaleAgreementsMember_2" xml:lang="en-US">Share Purchase and Sale Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareSplitRatio_0" xml:lang="en-US">Represents the share split ratio.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareSplitRatio_1" xml:lang="en-US">Share Split Ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ShareSplitRatio_2" xml:lang="en-US">Share split ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShortTermNotes_0" xml:lang="en-US">Represents Short-term notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_ShortTermNotes_1" xml:lang="en-US">Short-term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShortTermNotes_2" xml:lang="en-US">Short term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ShortTermNotes_3" xml:lang="en-US">Short-term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SolarvestBioEnergyIncMember_0" xml:lang="en-US">Solarvest BioEnergy Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SolarvestBioEnergyIncMember_1" xml:lang="en-US">Solarvest BioEnergy Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SolarvestBioEnergyIncMember_2" xml:lang="en-US">Solarvest BioEnergy Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SpecialWarrantsMember_0" xml:lang="en-US">Represents information of special warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SpecialWarrantsMember_1" xml:lang="en-US">Special Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_SpecialWarrantsMember_2" xml:lang="en-US">Special warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_StockOptionsMember_0" xml:lang="en-US">Represenr the information of stock option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_StockOptionsMember_1" xml:lang="en-US">Stock Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_StockOptionsMember_2" xml:lang="en-US">Stock options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_StockOptionsOfAcquirer_0" xml:lang="en-US">The fair value, at the acquisition date, of stock options of the acquirer transferred as consideration in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_StockOptionsOfAcquirer_1" xml:lang="en-US">Stock Options Of Acquirer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_StockOptionsOfAcquirer_2" xml:lang="en-US">Exchange of stock options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_StockPromotionExpenses_0" xml:lang="en-US">Information about stock promotion.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_StockPromotionExpenses_1" xml:lang="en-US">Stock Promotion expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_StockPromotionExpenses_2" xml:lang="en-US">Stock promotion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_StrategicInvestmentValue_0" xml:lang="en-US">Information about strategic investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_StrategicInvestmentValue_1" xml:lang="en-US">Strategic Investment Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_StrategicInvestmentValue_2" xml:lang="en-US">Strategic investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SubscriptionPricePerShare_0" xml:lang="en-US">Represents the subscription price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SubscriptionPricePerShare_1" xml:lang="en-US">Subscription Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SubscriptionPricePerShare_2" xml:lang="en-US">Subscription price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SubsequentEventsMember_0" xml:lang="en-US">Information about subsequent events.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SubsequentEventsMember_1" xml:lang="en-US">Subsequent Events [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SubsequentEventsMember_2" xml:lang="en-US">Subsequent events</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SubsidiariesOneMember_0" xml:lang="en-US">Subsidiaries one [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SubsidiariesOneMember_1" xml:lang="en-US">Diagnostic Illumination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SubsidiariesTwoMember_0" xml:lang="en-US">Represents subsidiaries two member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SubsidiariesTwoMember_1" xml:lang="en-US">Subsidiaries two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SubsidiariesTwoMember_2" xml:lang="en-US">Prismic Pharmaceuticals Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xml:lang="en-US">Summary Of Significant Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SummaryOfSignificantAccountingPoliciesTable_0" xml:lang="en-US">Represents summary of significant accounting policies table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SummaryOfSignificantAccountingPoliciesTable_1" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SupplementalInformationAbstract_0" xml:lang="en-US">Supplemental Information Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_SupplementalInformationAbstract_1" xml:lang="en-US">Supplemental information</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SupplyAgreementMember_0" xml:lang="en-US">Information about supply agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SupplyAgreementMember_1" xml:lang="en-US">Supply Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SupplyAgreementMember_2" xml:lang="en-US">Supply agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SupplyAgreementOptionToPurchaseAmount_0" xml:lang="en-US">Information about supplier grants Purchasers right and option to purchase amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SupplyAgreementOptionToPurchaseAmount_1" xml:lang="en-US">Supply Agreement Option To Purchase Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SupplyAgreementOptionToPurchaseAmount_2" xml:lang="en-US">Supply agreement, option to purchase amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SupplyAgreementOptionToPurchasePeriod_0" xml:lang="en-US">Information about supplier grants Purchasers right and option to purchase period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SupplyAgreementOptionToPurchasePeriod_1" xml:lang="en-US">Supply Agreement Option To Purchase Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_SupplyAgreementOptionToPurchasePeriod_2" xml:lang="en-US">Supply agreement, option purchase period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_0" xml:lang="en-US">Information about supplier grants purchasers right and option to purchase price per kg per 1% of CBD extracted from the flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_1" xml:lang="en-US">Supply Agreement Option To Purchase Price Per Kilogram Per Percent Of Cannabidiol Extracted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_2" xml:lang="en-US">Purchase price per kg per 1% of CBD extracted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TaxEffectOfDeferredTaxAssetNotRecognized_0" xml:lang="en-US">Tax effect of deferred tax asset not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TaxEffectOfDeferredTaxAssetNotRecognized_1" xml:lang="en-US">Represents the amount related to tax effect of deferred tax asset not recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_TaxEffectOfDeferredTaxAssetNotRecognized_2" xml:lang="en-US">Change in tax benefits not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TaxEffectOfTemporaryDifferences_0" xml:lang="en-US">Tax effect of temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TaxEffectOfTemporaryDifferences_1" xml:lang="en-US">Represents the amount related to tax effect of temporary differences.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_TaxEffectOfTemporaryDifferences_2" xml:lang="en-US">Other adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TemporaryDifferences_0" xml:lang="en-US">Temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TemporaryDifferences_1" xml:lang="en-US">Differences between the carrying amount of an asset or liability in the statement of financial position and its tax base.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_TemporaryDifferences_2" xml:lang="en-US">Temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TermsOfWarrantGranted_0" xml:lang="en-US">Represents term of warrant granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TermsOfWarrantGranted_1" xml:lang="en-US">Terms Of Warrant Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_TermsOfWarrantGranted_2" xml:lang="en-US">Terms of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ThomasFairfullMember_0" xml:lang="en-US">This member stands for thomas fairfull.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ThomasFairfullMember_1" xml:lang="en-US">Thomas Fairfull [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ThomasFairfullMember_2" xml:lang="en-US">Thomas Fairfull</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TypeOfArrangementsAxis_0" xml:lang="en-US">Type Of Arrangements [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TypeOfArrangementsDomain_0" xml:lang="en-US">Type Of Arrangements [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TypeOfInventoriesAxis_0" xml:lang="en-US">The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TypeOfInventoriesAxis_1" xml:lang="en-US">Type of inventories [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TypeOfInventoriesDomain_0" xml:lang="en-US">This member stands for all inventories when disaggregated by type. It also represents the standard value for the 'inventories by type' axis if no other member is used.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TypeOfInventoriesDomain_1" xml:lang="en-US">Type of Inventories [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_UndiscountedLeasePaymentsPayable_0" xml:lang="en-US">Undiscounted lease payments payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_UndiscountedLeasePaymentsPayable_1" xml:lang="en-US">Represents the amount related to undiscounted lease payments payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_UndiscountedLeasePaymentsPayable_2" xml:lang="en-US">Total undiscounted lease payments payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_0" xml:lang="en-US">unobservable input used to estimate fair value of biological assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_1" xml:lang="en-US">Represents unobservable input used to estimate the fair value of biological assets table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_2" xml:lang="en-US">Schedule of unobservable input used to estimate fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_0" xml:lang="en-US">Unrealized loss on changes in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_1" xml:lang="en-US">Represents information about unrealized loss on changes in fair value of biological assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_2" xml:lang="en-US">Unrealized loss on changes in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_UnrestrictedClassBSharesMember_0" xml:lang="en-US">Unrestricted Class B Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_UnrestrictedClassBSharesMember_1" xml:lang="en-US">Represents unrestricted Class B shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_UnrestrictedClassBSharesMember_2" xml:lang="en-US">Unrestricted Class B shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_0" xml:lang="en-US">Represents amount of broker warrants issued in private placements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_1" xml:lang="en-US">Broker warrants issued in private placements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_2" xml:lang="en-US">Value Of Broker Warrants Issued In Private Placements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_3" xml:lang="en-US">Broker warrants issued in private placements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSharesAcquired_0" xml:lang="en-US">Represents value of shares acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSharesAcquired_1" xml:lang="en-US">Value Of Shares Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfSharesAcquired_2" xml:lang="en-US">Value of shares acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSharesIssued_0" xml:lang="en-US">Represents the amount related to shares issued during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSharesIssued_1" xml:lang="en-US">Value of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_0" xml:lang="en-US">Represents value of shares issued for acquisition of Century Financial Capital Group Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1" xml:lang="en-US">Value Of Shares Issued For Acquisition Of Century Financial Capital Group Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_2" xml:lang="en-US">Value of shares issued for acquisition of Century Financial Capital Group Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSharesIssuedForDebtSettlement_0" xml:lang="en-US">Value of shares issued for debt settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSharesIssuedForDebtSettlement_1" xml:lang="en-US">Represents amount of shares issued for debt settlement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfSharesIssuedForDebtSettlement_2" xml:lang="en-US">Value of shares issued for debt settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSharesIssuedInPrivatePlacement_0" xml:lang="en-US">Represents value of shares issued in private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSharesIssuedInPrivatePlacement_1" xml:lang="en-US">Value Of Shares Issued In Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfSharesIssuedInPrivatePlacement_2" xml:lang="en-US">Value of shares issued in private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSharesIssuedInShareExchange_0" xml:lang="en-US">Value of shares issued in share exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSharesIssuedInShareExchange_1" xml:lang="en-US">Represents the amount related to shares issued in share exchange.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfSharesIssuedInShareExchange_2" xml:lang="en-US">Value of shares issued in share exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfStockOptionsExercised_0" xml:lang="en-US">Represents value of stock options exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfStockOptionsExercised_1" xml:lang="en-US">Value Of Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfStockOptionsExercised_2" xml:lang="en-US">Value of stock options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_0" xml:lang="en-US">Represents the value of subscribed equity units in brokered private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_1" xml:lang="en-US">Value Of Subscribed equity units in brokered private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_2" xml:lang="en-US">Value of subscribed equity units in brokered private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfWarrantsExercised_0" xml:lang="en-US">Represents value of warrants exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfWarrantsExercised_1" xml:lang="en-US">Value Of Warrants Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfWarrantsExercised_2" xml:lang="en-US">Value of warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantExercisePrice_0" xml:lang="en-US">Exercise price per warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantExercisePrice_1" xml:lang="en-US">Warrant Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantExercisePrice_2" xml:lang="en-US">Warrant exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantLineItems_0" xml:lang="en-US">Represents information of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantLineItems_1" xml:lang="en-US">Warrant [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Warrants_0" xml:lang="en-US">Represents amount related to warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Warrants_1" xml:lang="en-US">Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Warrants_2" xml:lang="en-US">Warrant reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsAbstract_0" xml:lang="en-US">Warrants [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtAugust1st2021Member_0" xml:lang="en-US">Warrants by expiry date at August 1st 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtAugust1st2021Member_1" xml:lang="en-US">Warrants by expiry date at August 1st 2021.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtAugust1st2021Member_2" xml:lang="en-US">Warrants by expiry date at August 1, 2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtDecember12st2019Member_0" xml:lang="en-US">Warrants by expiry date at December 12st 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtDecember12st2019Member_1" xml:lang="en-US">Warrants by expiry date at December 12st 2019.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtDecember12st2019Member_2" xml:lang="en-US">Warrants by expiry date at December 12, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtDecember29th2019Member_0" xml:lang="en-US">Warrants by expiry date at December 29th 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtDecember29th2019Member_1" xml:lang="en-US">Warrants by expiry date at December 29th 2019.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtDecember29th2019Member_2" xml:lang="en-US">Warrants by expiry date at December 29, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary16th2026Member_0" xml:lang="en-US">Warrants by expiry date at January 16th 2026 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary16th2026Member_1" xml:lang="en-US">Warrants by expiry date at January 16th 2026.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary16th2026Member_2" xml:lang="en-US">Warrants by expiry date at January 16, 2026</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary20th2026Member_0" xml:lang="en-US">Warrants by expiry date at January 20th 2026 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary20th2026Member_1" xml:lang="en-US">Warrants by expiry date at January 20th 2026.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary20th2026Member_2" xml:lang="en-US">Warrants by expiry date at January 20, 2026</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary5th2020Member_0" xml:lang="en-US">Warrants by expiry date at January 5th 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary5th2020Member_1" xml:lang="en-US">Warrants by expiry date at January 5th 2020.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary5th2020Member_2" xml:lang="en-US">Warrants by expiry date at January 5, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtJuly24th2023Member_0" xml:lang="en-US">Warrants by expiry date at July 24th 2023 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtJuly24th2023Member_1" xml:lang="en-US">Warrants by expiry date at July 24th 2023.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtJuly24th2023Member_2" xml:lang="en-US">Warrants by expiry date at July 24, 2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtMay10th2025Member_0" xml:lang="en-US">Warrants by expiry date at May 10th 2025 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtMay10th2025Member_1" xml:lang="en-US">Warrants by expiry date at May 10th 2025.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtMay10th2025Member_2" xml:lang="en-US">Warrants by expiry date at May 10, 2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtMay17th2025Member_0" xml:lang="en-US">Warrants by expiry date at May 17th, 2025 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtMay17th2025Member_1" xml:lang="en-US">Warrants by expiry date at May 17th, 2025.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtMay17th2025Member_2" xml:lang="en-US">Warrants by expiry date at May 17, 2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtMay20th2023Member_0" xml:lang="en-US">Warrants by expiry date at May 20th 2023 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtMay20th2023Member_1" xml:lang="en-US">Warrants by expiry date at May 20th 2023.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtMay20th2023Member_2" xml:lang="en-US">Warrants by expiry date at May 20, 2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtMay24th2022Member_0" xml:lang="en-US">Warrants by expiry date at May 24th 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtMay24th2022Member_1" xml:lang="en-US">Warrants by expiry date at May 24th 2022.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtMay24th2022Member_2" xml:lang="en-US">Warrants by expiry date at May 24, 2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtMay31st2025Member_0" xml:lang="en-US">Warrants by expiry date at May 31st 2025 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtMay31st2025Member_1" xml:lang="en-US">Warrants by expiry date at May 31st 2025.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtMay31st2025Member_2" xml:lang="en-US">Warrants by expiry date at May 31, 2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtMay4th2025Member_0" xml:lang="en-US">Warrants by expiry date at May 4th 2025 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtMay4th2025Member_1" xml:lang="en-US">Warrants by expiry date at May 4th 2025.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtMay4th2025Member_2" xml:lang="en-US">Warrants by expiry date at May 4, 2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember14th2019Member_0" xml:lang="en-US">Warrants by expiry date at November 14th 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember14th2019Member_1" xml:lang="en-US">Warrants by expiry date at November 14th 2019.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember14th2019Member_2" xml:lang="en-US">Warrants by expiry date at November 14, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember1st2019Member_0" xml:lang="en-US">Warrants by expiry date at November 1st 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember1st2019Member_1" xml:lang="en-US">Warrants by expiry date at November 1st 2019.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember1st2019Member_2" xml:lang="en-US">Warrants by expiry date at November 1, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember21st2019Member_0" xml:lang="en-US">Warrants by expiry date at November 21st 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember21st2019Member_1" xml:lang="en-US">Warrants by expiry date at November 21st 2019.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember21st2019Member_2" xml:lang="en-US">Warrants by expiry date at November 21, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember30th2020Member_0" xml:lang="en-US">Warrants by expiry date at November 30th 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember30th2020Member_1" xml:lang="en-US">Warrants by expiry date at November 30th 2020.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember30th2020Member_2" xml:lang="en-US">Warrants by expiry date at November 30, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtOctober20th2019Member_0" xml:lang="en-US">Warrants by expiry date at October 20th 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtOctober20th2019Member_1" xml:lang="en-US">Warrants by expiry date at October 20th 2019.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtOctober20th2019Member_2" xml:lang="en-US">Warrants by expiry date at October 20, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtSeptember11th2023Member_0" xml:lang="en-US">Warrants by expiry date at September 11th 2023 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtSeptember11th2023Member_1" xml:lang="en-US">Warrants by expiry date at September 11th 2023.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtSeptember11th2023Member_2" xml:lang="en-US">Warrants by expiry date at September 11, 2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtSeptember15th2022Member_0" xml:lang="en-US">Warrants by expiry date at September 15th 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtSeptember15th2022Member_1" xml:lang="en-US">Warrants by expiry date at September 15th 2022.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtSeptember15th2022Member_2" xml:lang="en-US">Warrants by expiry date at September 15, 2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsIssueDateAxis_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsIssueDateAxis_1" xml:lang="en-US">Warrants Issue Date [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsIssueDateDomain_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsIssueDateDomain_1" xml:lang="en-US">Warrants Issue Date [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsMember_0" xml:lang="en-US">Represents information of warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsMember_1" xml:lang="en-US">Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_WarrantsMember_2" xml:lang="en-US">Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsMember_3" xml:lang="en-US">Options or warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsOptionsOfAcquirer_0" xml:lang="en-US">The fair value, at the acquisition date, of warrants of the acquirer transferred as consideration in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsOptionsOfAcquirer_1" xml:lang="en-US">Warrants Options Of Acquirer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsOptionsOfAcquirer_2" xml:lang="en-US">Exchange of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantExercised_0" xml:lang="en-US">Weighted Average Exercise Prices Warrant Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantExercised_1" xml:lang="en-US">Represents weighted average exercise price warrants exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantExercised_2" xml:lang="en-US">Weighted average exercise price warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantExpired_0" xml:lang="en-US">Weighted Average Exercise Prices Warrant Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantExpired_1" xml:lang="en-US">Represents weighted average exercise price warrants expired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantExpired_2" xml:lang="en-US">Weighted average exercise price warrants expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantGranted_0" xml:lang="en-US">Weighted Average Exercise Prices Warrant Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantGranted_1" xml:lang="en-US">Represents weighted average exercise price warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantGranted_2" xml:lang="en-US">Weighted average exercise price warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_0" xml:lang="en-US">Weighted average exercise Price warrants Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_1" xml:lang="en-US">Represents weighted average exercise Price warrants outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_2" xml:lang="en-US">Weighted average exercise price, Warrants outstanding opening balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_3" xml:lang="en-US">Weighted average exercise price, Warrants outstanding closing balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_4" xml:lang="en-US">Exercise price of warrants outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WeightedAverageSharePriceOfWarrants_0" xml:lang="en-US">Weighted average share price of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WeightedAverageSharePriceOfWarrants_1" xml:lang="en-US">Represents the weighted average share price of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_WeightedAverageSharePriceOfWarrants_2" xml:lang="en-US">Grant date share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WorkingCapitalSurplus_0" xml:lang="en-US">Working Capital Surplus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WorkingCapitalSurplus_1" xml:lang="en-US">Represents amount of working capital surplus.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_WorkingCapitalSurplus_2" xml:lang="en-US">Working capital surplus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ZeeshanSaeedMember_0" xml:lang="en-US">This member stands for Zeeshan Saeed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ZeeshanSaeedMember_1" xml:lang="en-US">Zeeshan Saeed [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ZeeshanSaeedMember_2" xml:lang="en-US">Zeeshan Saeed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccountingProfit_0" xml:lang="en-US">Accounting profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AccountingProfit_1" xml:lang="en-US">Loss before income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_0" xml:lang="en-US">Accumulated depreciation and amortisation [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_1" xml:lang="en-US">Accumulated amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2" xml:lang="en-US">Accumulated depreciation:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0" xml:lang="en-US">Consideration transferred, acquisition-date fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1" xml:lang="en-US">Total consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_2" xml:lang="en-US">Total consideration transferred, acquisition-date fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_3" xml:lang="en-US">Total consideration transferred, acquisition-date fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_0" xml:lang="en-US">Acquisition-related costs recognised as expense for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1" xml:lang="en-US">Listing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_2" xml:lang="en-US">Listing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsFromPurchasesBiologicalAssets_0" xml:lang="en-US">Additions from purchases, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsFromPurchasesBiologicalAssets_1" xml:lang="en-US">Capitalized costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_0" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_0" xml:lang="en-US">Adjusted weighted average number of ordinary shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_1" xml:lang="en-US">Weighted average number of shares outstanding - diluted (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_2" xml:lang="en-US">Balance, end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_3" xml:lang="en-US">Weighted average number of shares outstanding - basic and diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_0" xml:lang="en-US">Adjustments for decrease (increase) in biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_2" xml:lang="en-US">Change in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1" xml:lang="en-US">Adjustments for decrease (increase) in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_2" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_0" xml:lang="en-US">Adjustments for decrease (increase) in trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_0" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationExpense_0" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_0" xml:lang="en-US">Adjustments for fair value losses (gains)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_1" xml:lang="en-US">Change in fair value of other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_0" xml:lang="en-US">Change in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1" xml:lang="en-US">Unrealized loss on changes in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_2" xml:lang="en-US">Adjustments for gains (losses) on change in fair value less costs to sell, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_3" xml:lang="en-US">Unrealized loss on changes in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_4" xml:lang="en-US">Change in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_0" xml:lang="en-US">Change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_1" xml:lang="en-US">Adjustments for gains (losses) on change in fair value of derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_2" xml:lang="en-US">Change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0" xml:lang="en-US">Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_2" xml:lang="en-US">Impairment of property, plant and equipment and right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_0" xml:lang="en-US">Adjustments for increase (decrease) in derivative financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_1" xml:lang="en-US">Change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_0" xml:lang="en-US">Adjustments For Increase Decrease In Trade And Other Payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1" xml:lang="en-US">Adjustments for increase (decrease) in trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_2" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForInterestExpense_0" xml:lang="en-US">Adjustments for interest expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForInterestExpense_1" xml:lang="en-US">Interest expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0" xml:lang="en-US">Adjustments for:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_1" xml:lang="en-US">Add (deduct) items not affecting cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_0" xml:lang="en-US">Adjustments for share based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_1" xml:lang="en-US">Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_2" xml:lang="en-US">Adjustments for share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdministrativeExpense_0" xml:lang="en-US">Administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdministrativeExpense_1" xml:lang="en-US">Administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdministrativeExpense_2" xml:lang="en-US">General office, travel and adminsitration expenditures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdvertisingExpense_0" xml:lang="en-US">Advertising expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdvertisingExpense_1" xml:lang="en-US">Advertising and promotion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AggregatedMeasurementMember_0" xml:lang="en-US">Aggregated measurement [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AggregatedTimeBandsMember_0" xml:lang="en-US">Aggregated time bands [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember_0" xml:lang="en-US">All levels of fair value hierarchy [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Amortisation, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Amortisation, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_0" xml:lang="en-US">Amounts payable, related party transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_1" xml:lang="en-US">Related party payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ApplicableTaxRate_0" xml:lang="en-US">Statutory Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ApplicableTaxRate_1" xml:lang="en-US">Statutory federal and provincial tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Assets_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Assets_1" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAbstract_0" xml:lang="en-US">ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AtFairValueMember_0" xml:lang="en-US">At fair value [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AtFairValueMember_1" xml:lang="en-US">Fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare_0" xml:lang="en-US">Basic and diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare_1" xml:lang="en-US">Basic and diluted loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare_2" xml:lang="en-US">Total basic and diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare_3" xml:lang="en-US">Net loss per share - basic and diluted (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_0" xml:lang="en-US">Basic earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_1" xml:lang="en-US">Net (loss) income per share - basic (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_BiologicalAssets_0" xml:lang="en-US">Biological assets at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_BiologicalAssets_1" xml:lang="en-US">Biological assets at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BiologicalAssets_2" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BiologicalAssets_3" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BiologicalAssetsByGroupAxis_0" xml:lang="en-US">Biological assets by group [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BiologicalAssetsGroupMember_0" xml:lang="en-US">Biological assets, group [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsAbstract_0" xml:lang="en-US">Borrowings [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsInterestRate_0" xml:lang="en-US">Borrowings, interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingsInterestRate_1" xml:lang="en-US">Notes payable, interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Borrowings recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BottomOfRangeMember_0" xml:lang="en-US">Bottom of range [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BottomOfRangeMember_1" xml:lang="en-US">Bottom of range</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BusinessCombinationsAxis_0" xml:lang="en-US">Business combinations [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BusinessCombinationsMember_0" xml:lang="en-US">Business combinations [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_0" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountMember_0" xml:lang="en-US">Carrying amount [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Cash_0" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Cash_1" xml:lang="en-US">Total cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Cash_2" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAbstract_0" xml:lang="en-US">Cash [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_0" xml:lang="en-US">Cash, end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_1" xml:lang="en-US">Cash, beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalents_2" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_3" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_4" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Cash and cash equivalents recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Total cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xml:lang="en-US">Cash provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_2" xml:lang="en-US">Cash flows from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">Cash provided by (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1" xml:lang="en-US">Financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_0" xml:lang="en-US">Cash flows from (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_1" xml:lang="en-US">Cash used in investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1" xml:lang="en-US">Investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xml:lang="en-US">Cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Cash provided by (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xml:lang="en-US">Operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashOutflowForLeases_0" xml:lang="en-US">Cash outflow for leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CashOutflowForLeases_1" xml:lang="en-US">Less: Lease Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_CashOutflowForLeases_2" xml:lang="en-US">Repayment of lease obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashOutflowForLeases_3" xml:lang="en-US">Repayment of lease obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashOutflowForLeases_4" xml:lang="en-US">Less: Lease Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_0" xml:lang="en-US">Advance from shareholder</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_1" xml:lang="en-US">Cash repayments of advances and loans from related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashTransferred_0" xml:lang="en-US">Cash transferred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_0" xml:lang="en-US">Categories of financial assets [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_0" xml:lang="en-US">Categories of financial liabilities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0" xml:lang="en-US">Categories of related parties [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0" xml:lang="en-US">Changes in intangible assets other than goodwill [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfContingentLiabilitiesAxis_0" xml:lang="en-US">Classes of contingent liabilities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_0" xml:lang="en-US">Classes of financial instruments [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsMember_0" xml:lang="en-US">Financial instruments, class [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_0" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfInventoriesAbstract_0" xml:lang="en-US">Classes of current inventories [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfOrdinarySharesAxis_0" xml:lang="en-US">Classes of ordinary shares [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_0" xml:lang="en-US">Classes of property, plant and equipment [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis_0" xml:lang="en-US">Classes of share capital [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfShareCapitalMember_0" xml:lang="en-US">Share capital [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClosingForeignExchangeRate_0" xml:lang="en-US">Closing foreign exchange rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClosingForeignExchangeRate_1" xml:lang="en-US">Exchange rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CommercialPapersIssued_0" xml:lang="en-US">Commercial papers issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CommercialPapersIssued_1" xml:lang="en-US">Short-term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis_0" xml:lang="en-US">Components of equity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_0" xml:lang="en-US">Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_1" xml:lang="en-US">Items that may be subsequently reclassified to income:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncome_0" xml:lang="en-US">Comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_1" xml:lang="en-US">Loss before the undernoted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_2" xml:lang="en-US">Comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_3" xml:lang="en-US">Net comprehensive loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComputerEquipmentMember_0" xml:lang="en-US">Computer equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComputerEquipmentMember_1" xml:lang="en-US">Computer hardware and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComputerEquipmentMember_2" xml:lang="en-US">Computer equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ConstructionInProgressMember_0" xml:lang="en-US">Construction in progress [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ConstructionInProgressMember_1" xml:lang="en-US">Facility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContingentLiabilitiesMember_0" xml:lang="en-US">Contingent liabilities [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContractualCapitalCommitments_0" xml:lang="en-US">Contractual capital commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ContractualCapitalCommitments_1" xml:lang="en-US">Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ContractualCapitalCommitments_2" xml:lang="en-US">Total rent payments on office space</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_0" xml:lang="en-US">Copyrights, patents and other industrial property rights, service and operating rights [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_1" xml:lang="en-US">Intellectual Property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CostOfSales_0" xml:lang="en-US">Cost of revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfSales_1" xml:lang="en-US">Cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CostOfSales_2" xml:lang="en-US">Cost of revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CounterpartiesAxis_0" xml:lang="en-US">Counterparties [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CounterpartiesMember_0" xml:lang="en-US">Counterparties [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CreditRiskMember_0" xml:lang="en-US">Credit risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CreditRiskMember_1" xml:lang="en-US">Credit risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssets_0" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentAssets_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsAbstract_0" xml:lang="en-US">Current Assets Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentAssetsAbstract_1" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Current assets recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Prepaids</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_CurrentBiologicalAssets_0" xml:lang="en-US">Biological assets at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_CurrentBiologicalAssets_1" xml:lang="en-US">Biological assets at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentBiologicalAssets_2" xml:lang="en-US">Current biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentBiologicalAssets_3" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentDebtInstrumentsIssued_0" xml:lang="en-US">Current debt instruments issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentDebtInstrumentsIssued_1" xml:lang="en-US">Short-term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_0" xml:lang="en-US">Current derivative financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_1" xml:lang="en-US">Derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_0" xml:lang="en-US">Current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_1" xml:lang="en-US">Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_2" xml:lang="en-US">Lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilities_0" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentLiabilities_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_0" xml:lang="en-US">Current Liabilities Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_1" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Current liabilities recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Short-term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Short-term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_0" xml:lang="en-US">Current notes and debentures issued and current portion of non-current notes and debentures issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_1" xml:lang="en-US">Balance as at December 31, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_2" xml:lang="en-US">Notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses_0" xml:lang="en-US">Current prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses_1" xml:lang="en-US">Prepaids</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses_2" xml:lang="en-US">Prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_0" xml:lang="en-US">Decrease due to harvest, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_1" xml:lang="en-US">Decrease due to harvest, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2" xml:lang="en-US">Transferred to inventory upon harvest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_3" xml:lang="en-US">Transferred to inventory upon harvest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible temporary differences for which no deferred tax asset is recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">Deductible temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Deductible temporary differences for which no deferred tax asset is recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_3" xml:lang="en-US">Deductible temporary differences for which no deferred tax asset is recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DeferredTaxAssets_0" xml:lang="en-US">Deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxAssets_1" xml:lang="en-US">Deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome_0" xml:lang="en-US">Deferred income tax provision (recovery)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome_1" xml:lang="en-US">Deferred income tax provision (recovery)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome_2" xml:lang="en-US">Total Income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_0" xml:lang="en-US">Deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_1" xml:lang="en-US">Deferred income tax liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_0" xml:lang="en-US">Deferred tax liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_1" xml:lang="en-US">Deferred income tax liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_2" xml:lang="en-US">Net deferred tax liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_3" xml:lang="en-US">Deferred tax liability (asset) at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_4" xml:lang="en-US">Deferred tax liability (asset) at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_5" xml:lang="en-US">Deferred tax assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_0" xml:lang="en-US">Depreciation and amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_1" xml:lang="en-US">Depreciation and amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_2" xml:lang="en-US">Total depreciation and amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_3" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DepreciationBiologicalAssets_0" xml:lang="en-US">Depreciation, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationBiologicalAssets_1" xml:lang="en-US">Depreciation, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationBiologicalAssets_2" xml:lang="en-US">Depreciation on production of biological assets and inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationExpense_0" xml:lang="en-US">Depreciation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationExpense_1" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_0" xml:lang="en-US">Depreciation method, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_1" xml:lang="en-US">Method of amortized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_0" xml:lang="en-US">Depreciation, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_1" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_0" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_1" xml:lang="en-US">Depreciation, right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_2" xml:lang="en-US">Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities_0" xml:lang="en-US">Derivative financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_0" xml:lang="en-US">Description of accounting policy for biological assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_1" xml:lang="en-US">Biological Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory_0" xml:lang="en-US">Restoration, rehabilitation and environmental obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_0" xml:lang="en-US">Derecognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_0" xml:lang="en-US">Earnings/loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_1" xml:lang="en-US">Net Loss per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_0" xml:lang="en-US">Description of accounting policy for financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_1" xml:lang="en-US">Financial Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_0" xml:lang="en-US">Description of accounting policy for foreign currency translation [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_1" xml:lang="en-US">Foreign Currency Translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_0" xml:lang="en-US">Description of accounting policy for impairment of assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_1" xml:lang="en-US">Impairment of long-lived assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_0" xml:lang="en-US">Impairment of financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_0" xml:lang="en-US">Impairment of non-financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_0" xml:lang="en-US">Income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_1" xml:lang="en-US">Income Taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_1" xml:lang="en-US">Finite-lived Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_0" xml:lang="en-US">Description of accounting policy for investments other than investments accounted for using equity method [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1" xml:lang="en-US">Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_0" xml:lang="en-US">Share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0" xml:lang="en-US">Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Description Of Accounting Policy For Property Plant And Equipment Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Property, Plant and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_0" xml:lang="en-US">Provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_0" xml:lang="en-US">Classification</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0" xml:lang="en-US">Description of accounting policy for recognition of revenue [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_1" xml:lang="en-US">Revenue Recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0" xml:lang="en-US">Description Of Accounting Policy For Sharebased Payment Transactions Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2" xml:lang="en-US">Share-based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0" xml:lang="en-US">Description Of Accounting Policy To Determine Components Of Cash And Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_0" xml:lang="en-US">Expected volatility, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_1" xml:lang="en-US">Annualized volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2" xml:lang="en-US">Expected Volatility Range</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_0" xml:lang="en-US">Option life, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_1" xml:lang="en-US">Expected maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_2" xml:lang="en-US">Expected life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_0" xml:lang="en-US">Accounting Standards Issued But Not Yet Applied</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_0" xml:lang="en-US">Risk free interest rate, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_1" xml:lang="en-US">Risk free interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_2" xml:lang="en-US">Risk Free Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Description of useful life, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Estimated useful lives for intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_0" xml:lang="en-US">Description of useful life, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_1" xml:lang="en-US">Estimated useful lives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_0" xml:lang="en-US">Diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_1" xml:lang="en-US">Total diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_2" xml:lang="en-US">Net (loss) income per share - diluted (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_0" xml:lang="en-US">Dilutive effect of convertible instruments on number of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_1" xml:lang="en-US">Dilutive effect of convertible instruments on number of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_0" xml:lang="en-US">Dilutive effect of share options on number of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DirectorsRemunerationExpense_0" xml:lang="en-US">Directors' remuneration expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DirectorsRemunerationExpense_1" xml:lang="en-US">Directors' remuneration expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_0" xml:lang="en-US">Disclosure of accounting judgements and estimates [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_1" xml:lang="en-US">Critical accounting estimates and judgments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_0" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1" xml:lang="en-US">Basis of presentation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_0" xml:lang="en-US">Disclosure of borrowings [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_1" xml:lang="en-US">Notes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xml:lang="en-US">Disclosure of detailed information about business combination [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_1" xml:lang="en-US">Nature of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_0" xml:lang="en-US">Disclosure of business combinations [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1" xml:lang="en-US">Reverse Takeover Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_2" xml:lang="en-US">Acquisition of Prismic Pharmaceutical</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_0" xml:lang="en-US">Disclosure of detailed information about business combination [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_0" xml:lang="en-US">Disclosure of classes of share capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1" xml:lang="en-US">Schedule of changes in share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xml:lang="en-US">Disclosure of classes of share capital [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0" xml:lang="en-US">Disclosure of classes of share capital [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_0" xml:lang="en-US">Disclosure of commitments and contingent liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1" xml:lang="en-US">Commitments and contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsExplanatory_0" xml:lang="en-US">Disclosure of commitments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsExplanatory_1" xml:lang="en-US">Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xml:lang="en-US">Disclosure of contingent liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_0" xml:lang="en-US">Disclosure of contingent liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_1" xml:lang="en-US">Contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xml:lang="en-US">Disclosure of contingent liabilities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesTable_0" xml:lang="en-US">Disclosure of contingent liabilities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExplanatory_0" xml:lang="en-US">Disclosure of credit risk [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExplanatory_1" xml:lang="en-US">Schedule of credit risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_0" xml:lang="en-US">Disclosure of deferred taxes [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_1" xml:lang="en-US">Schedule of deferred tax assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_0" xml:lang="en-US">Disclosure of derivative financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_1" xml:lang="en-US">Derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xml:lang="en-US">Disclosure of detailed information about biological assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about biological assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0" xml:lang="en-US">Disclosure of detailed information about biological assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_0" xml:lang="en-US">Disclosure of detailed information about biological assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xml:lang="en-US">Disclosure of detailed information about borrowings [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about borrowings [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1" xml:lang="en-US">Notes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_2" xml:lang="en-US">Schedule of notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about business combination [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_1" xml:lang="en-US">Acquisition of Prismic Pharmaceutical</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2" xml:lang="en-US">Schedule of identifiable assets acquired and liabilities assumed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1" xml:lang="en-US">Schedule of intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Schedule of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_0" xml:lang="en-US">Disclosure of earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1" xml:lang="en-US">Loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_2" xml:lang="en-US">Basic and diluted loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_0" xml:lang="en-US">Disclosure of financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1" xml:lang="en-US">Financial Instruments and Risk Management</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_0" xml:lang="en-US">Disclosure of financial liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_0" xml:lang="en-US">Disclosure of financial liabilities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesTable_0" xml:lang="en-US">Disclosure of financial liabilities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_0" xml:lang="en-US">Disclosure of general and administrative expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_2" xml:lang="en-US">Schedule of general and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_0" xml:lang="en-US">Disclosure of income tax [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_1" xml:lang="en-US">Income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_0" xml:lang="en-US">Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_1" xml:lang="en-US">Disclosure of fair values of options granted using the Black-Scholes option pricing model</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_0" xml:lang="en-US">Disclosure of information about key management personnel [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1" xml:lang="en-US">Schedule of key management personnel compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_0" xml:lang="en-US">Disclosure of intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1" xml:lang="en-US">Intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory_0" xml:lang="en-US">Disclosure of inventories [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_0" xml:lang="en-US">Disclosure of investments other than investments accounted for using equity method [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1" xml:lang="en-US">Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory_0" xml:lang="en-US">Disclosure of leases [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory_1" xml:lang="en-US">Lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfLiquidityRiskExplanatory_0" xml:lang="en-US">Disclosure of liquidity risk [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfLiquidityRiskExplanatory_1" xml:lang="en-US">Schedule of financial obligations based on their due dates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_1" xml:lang="en-US">Schedule of maturity analysis of operating lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2" xml:lang="en-US">Schedule of office lease commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1" xml:lang="en-US">Subsequent events</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_0" xml:lang="en-US">Disclosure of number and weighted average exercise prices of share options [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1" xml:lang="en-US">Disclosure of stock options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_0" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_1" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding and exercisable share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_0" xml:lang="en-US">Disclosure of objectives, policies and processes for managing capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_1" xml:lang="en-US">Capital Management</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xml:lang="en-US">Disclosure of operating segments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_0" xml:lang="en-US">Disclosure of operating segments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1" xml:lang="en-US">Segmented information</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1" xml:lang="en-US">Right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_0" xml:lang="en-US">Disclosure of reconciliation of changes in biological assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_0" xml:lang="en-US">Disclosure of related party [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_1" xml:lang="en-US">Related party transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_0" xml:lang="en-US">Disclosure of repurchase and reverse repurchase agreements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_1" xml:lang="en-US">Reverse Takeover Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_2" xml:lang="en-US">Acquisition of Prismic Pharmaceutical</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xml:lang="en-US">Disclosure of reserves within equity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_0" xml:lang="en-US">Disclosure of share-based payment arrangements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_0" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1" xml:lang="en-US">Share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_2" xml:lang="en-US">Share capital and reserves</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_0" xml:lang="en-US">Disclosure of subsidiaries [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1" xml:lang="en-US">Schedule of ownership percentage in subsidiaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xml:lang="en-US">Disclosure of subsidiaries [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_0" xml:lang="en-US">Disclosure of subsidiaries [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_0" xml:lang="en-US">Disclosure of significant accounting policies [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1" xml:lang="en-US">Significant accounting policies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1" xml:lang="en-US">Schedule of recognized deferred tax assets and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_0" xml:lang="en-US">Disclosure of trade and other receivables [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xml:lang="en-US">Disclosure of transactions between related parties [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xml:lang="en-US">Disclosure of transactions between related parties [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0" xml:lang="en-US">Disclosure of transactions between related parties [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_0" xml:lang="en-US">Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_1" xml:lang="en-US">Schedule of acquisition breakdown of transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_0" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_1" xml:lang="en-US">Disposals, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_2" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DistributionCosts_0" xml:lang="en-US">Distribution costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DistributionCosts_1" xml:lang="en-US">Distribution costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareAbstract_0" xml:lang="en-US">Earnings per share [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EarningsPerShareAbstract_1" xml:lang="en-US">Income (loss) per Class B share:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory_0" xml:lang="en-US">Earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory_1" xml:lang="en-US">Schedule of loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory_2" xml:lang="en-US">Schedule of basic and diluted loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareLineItems_0" xml:lang="en-US">Earnings per share [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareTable_0" xml:lang="en-US">Earnings per share [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember_0" xml:lang="en-US">Entity's total for business combinations [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_0" xml:lang="en-US">Entity's total for related parties [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForSubsidiariesMember_0" xml:lang="en-US">Entity's total for subsidiaries [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Equity_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Equity_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Equity_2" xml:lang="en-US">Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Equity_3" xml:lang="en-US">Balances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Equity_4" xml:lang="en-US">Total equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Equity_5" xml:lang="en-US">Total equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAbstract_0" xml:lang="en-US">SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilities_0" xml:lang="en-US">Equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EquityAndLiabilities_1" xml:lang="en-US">Total equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract_0" xml:lang="en-US">Equity And Liabilities Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract_1" xml:lang="en-US">Equity and liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_0" xml:lang="en-US">Equity interests of acquirer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_1" xml:lang="en-US">Exchange of Class B shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_2" xml:lang="en-US">Total consideration transferred, acquisition-date fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_3" xml:lang="en-US">Total consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_4" xml:lang="en-US">Consideration transferred, acquisition-date fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityMember_0" xml:lang="en-US">Equity [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_0" xml:lang="en-US">Exercise price of outstanding share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_0" xml:lang="en-US">Exercise price, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_1" xml:lang="en-US">Exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_0" xml:lang="en-US">Expected dividend as percentage, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_1" xml:lang="en-US">Expected dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_2" xml:lang="en-US">Expected dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseByNature_0" xml:lang="en-US">Expenses, by nature</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ExpenseByNature_1" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseByNatureAbstract_0" xml:lang="en-US">Expenses by nature [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseByNatureAbstract_1" xml:lang="en-US">Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_0" xml:lang="en-US">Expense from share-based payment transactions with employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_1" xml:lang="en-US">Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2" xml:lang="en-US">Share-based compensation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExplanationOfDesignatedFinancialAssetsThatAreHeldOutsideLegalEntityThatIssuesContractsWithinScopeOfIFRS4_0" xml:lang="en-US">Explanation of designated financial assets that are held outside legal entity that issues contracts within scope of IFRS 4</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory_0" xml:lang="en-US">Explanation of difference between operating lease commitments disclosed applying IAS 17 and lease liabilities recognised at date of initial application of IFRS 16 [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory_1" xml:lang="en-US">Schedule of applied the definition of a lease under IFRS 16 to contracts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FairValueOfAcquiredReceivables_0" xml:lang="en-US">Fair value of acquired receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_FairValueOfAcquiredReceivables_1" xml:lang="en-US">Total fair value recognized on acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinanceCosts_0" xml:lang="en-US">Finance expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceCosts_1" xml:lang="en-US">Finance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinanceCosts_2" xml:lang="en-US">Finance expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_0" xml:lang="en-US">Financial assets at fair value through profit or loss, category [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_1" xml:lang="en-US">Assets at fair value through profit/loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsCategoryMember_0" xml:lang="en-US">Financial assets, category [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_0" xml:lang="en-US">Financial liabilities at fair value through profit or loss, category [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_1" xml:lang="en-US">Liabilities at fair value through profit/loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialLiabilitiesCategoryMember_0" xml:lang="en-US">Financial liabilities, category [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinishedGoods_0" xml:lang="en-US">Current finished goods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinishedGoods_1" xml:lang="en-US">Finished good</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FixturesAndFittingsMember_0" xml:lang="en-US">Fixtures and fittings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FixturesAndFittingsMember_1" xml:lang="en-US">Furniture and fixtures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_0" xml:lang="en-US">Foreign exchange gain (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_1" xml:lang="en-US">Foreign exchange loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_0" xml:lang="en-US">Gains (losses) on fair value adjustment attributable to physical changes, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/commentaryGuidance" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_1" xml:lang="en-US">A positive or negative XBRL value can be entered for this element. Refer to the standard element label to determine the correct sign. Use a negative value for terms in brackets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2" xml:lang="en-US">Total gains (losses) on fair value adjustment, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_3" xml:lang="en-US">Change in fair value less costs to sell due to biological transformation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_4" xml:lang="en-US">Change in fair value less costs to sell due to biological transformation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_0" xml:lang="en-US">Gains (losses) on fair value adjustment, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_1" xml:lang="en-US">Total gains (losses) on fair value adjustment, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2" xml:lang="en-US">Change in fair value less costs to sell due to biological transformation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_3" xml:lang="en-US">Change in fair value less costs to sell due to biological transformation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense_1" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_0" xml:lang="en-US">Gross carrying amount [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_1" xml:lang="en-US">Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_2" xml:lang="en-US">Cost:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossLeaseLiabilities_0" xml:lang="en-US">Gross lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossLoanCommitments_0" xml:lang="en-US">Gross loan commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GrossLoanCommitments_1" xml:lang="en-US">Aggregate lease commitments as disclosed at December 31, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_GrossProfit_0" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossProfit_1" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GrossProfit_2" xml:lang="en-US">Gross loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_1" xml:lang="en-US">Net assets received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Identifiable intangible assets recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Intangible assets other than goodwill at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Total intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_3" xml:lang="en-US">Intangible assets other than goodwill at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_4" xml:lang="en-US">Intellectual Property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_5" xml:lang="en-US">Intangible assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLoss_0" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ImpairmentLoss_1" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ImpairmentLoss_2" xml:lang="en-US">Impairment of property, plant and equipment and right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_0" xml:lang="en-US">Impairment loss on financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_1" xml:lang="en-US">Cost of inventory impairment charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_0" xml:lang="en-US">Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1" xml:lang="en-US">Impairment loss recognised in profit or loss, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeStatementAbstract_0" xml:lang="en-US">Income Statement [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xml:lang="en-US">Income taxes paid (refund) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1" xml:lang="en-US">Net (decrease) increase in cash during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_0" xml:lang="en-US">Increase (decrease) through exercise of options, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_1" xml:lang="en-US">Share options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_2" xml:lang="en-US">Value of stock options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0" xml:lang="en-US">Increase (decrease) through exercise of warrants, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1" xml:lang="en-US">Warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_2" xml:lang="en-US">Warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Effects of foreign exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0" xml:lang="en-US">Increase (decrease) through share-based payment transactions, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_1" xml:lang="en-US">Share based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_0" xml:lang="en-US">Increase (decrease) through other changes, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_1" xml:lang="en-US">Unrealized loss on changes in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InsuranceExpense_0" xml:lang="en-US">Insurance expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InsuranceExpense_1" xml:lang="en-US">Insurance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_3" xml:lang="en-US">Intellectual Property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_4" xml:lang="en-US">Total intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_5" xml:lang="en-US">Intangible assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_0" xml:lang="en-US">Intangible assets other than goodwill [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_0" xml:lang="en-US">Intangible assets with indefinite useful life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_1" xml:lang="en-US">Estimated useful lives for intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_0" xml:lang="en-US">Interest expense on lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_1" xml:lang="en-US">Add: Interest Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestReceivable_0" xml:lang="en-US">Interest receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InterestReceivable_1" xml:lang="en-US">Interest receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Inventories_0" xml:lang="en-US">Current inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Inventories_1" xml:lang="en-US">Total current inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Inventories_2" xml:lang="en-US">Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InventoryWritedown2011_0" xml:lang="en-US">Inventory write-down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InventoryWritedown2011_1" xml:lang="en-US">Cost of inventory impairment charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_IssuedCapital_0" xml:lang="en-US">Share Capital, ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_IssuedCapital_1" xml:lang="en-US">Share Capital, beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapital_2" xml:lang="en-US">Issued capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IssuedCapital_3" xml:lang="en-US">Share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssueOfEquity_0" xml:lang="en-US">Issue of equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssueOfEquity_1" xml:lang="en-US">Shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation_0" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation_1" xml:lang="en-US">Salaries and benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation_2" xml:lang="en-US">Key management personnel compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_0" xml:lang="en-US">Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_1" xml:lang="en-US">Key management personnel compensation, share-based payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2" xml:lang="en-US">Salaries, benefits, bonuses and consulting fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_3" xml:lang="en-US">Share-based payments expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_0" xml:lang="en-US">Key management personnel compensation, short-term employee benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" xml:lang="en-US">Bonuses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2" xml:lang="en-US">Amount of bonus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_3" xml:lang="en-US">Salaries, benefits, bonuses and consulting fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_0" xml:lang="en-US">Key management personnel compensation, termination benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_1" xml:lang="en-US">Key management personnel compensation, retirement benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LandMember_0" xml:lang="en-US">Land [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LandMember_1" xml:lang="en-US">Land</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember_0" xml:lang="en-US">Later than five years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember_1" xml:lang="en-US">Therafter</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember_2" xml:lang="en-US">More than 5 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_0" xml:lang="en-US">Later than four years and not later than five years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_1" xml:lang="en-US">More than four year and not later than five years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_0" xml:lang="en-US">Later than one year and not later than five years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1" xml:lang="en-US">1-5 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0" xml:lang="en-US">Later than one year and not later than two years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_1" xml:lang="en-US">More than one year and not later than two years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2" xml:lang="en-US">One to two years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearMember_0" xml:lang="en-US">Later than one year [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearMember_1" xml:lang="en-US">2020 to 2023 inclusive</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearMember_2" xml:lang="en-US">More than 1 year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_0" xml:lang="en-US">Later than three years and not later than four years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_1" xml:lang="en-US">More than three year and not later than four years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2" xml:lang="en-US">Three to four years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_0" xml:lang="en-US">Later than two years and not later than three years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_1" xml:lang="en-US">More than two year and not later than three years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_2" xml:lang="en-US">Two to three years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_0" xml:lang="en-US">Balance - December 31, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_1" xml:lang="en-US">Balance - January 1, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilities_2" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_3" xml:lang="en-US">Balance - December 31, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_4" xml:lang="en-US">Total lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_5" xml:lang="en-US">Lease obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilitiesAbstract_0" xml:lang="en-US">Lease liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LegalProceedingsContingentLiabilityMember_0" xml:lang="en-US">Legal proceedings contingent liability [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LegalProceedingsContingentLiabilityMember_1" xml:lang="en-US">Legal proceedings contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Level1OfFairValueHierarchyMember_0" xml:lang="en-US">Level 1 of fair value hierarchy [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Level1OfFairValueHierarchyMember_1" xml:lang="en-US">Level 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Level2OfFairValueHierarchyMember_0" xml:lang="en-US">Level 2 of fair value hierarchy [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Level2OfFairValueHierarchyMember_1" xml:lang="en-US">Level 2</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember_0" xml:lang="en-US">Level 3 of fair value hierarchy [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember_1" xml:lang="en-US">Level 3</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_0" xml:lang="en-US">Levels of fair value hierarchy [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Liabilities_1" xml:lang="en-US">Liabilities at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Liabilities_2" xml:lang="en-US">Liabilities at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Liabilities_3" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Liabilities_4" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Liabilities_5" xml:lang="en-US">Balance as at December 31, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Liabilities_6" xml:lang="en-US">Total Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesAbstract_0" xml:lang="en-US">Liabilities Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LiabilitiesAbstract_1" xml:lang="en-US">LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_0" xml:lang="en-US">Liabilities arising from financing activities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_0" xml:lang="en-US">Liabilities arising from financing activities [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesIncurred_0" xml:lang="en-US">Liabilities incurred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LiabilitiesIncurred_1" xml:lang="en-US">Liabilities assumed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LiabilitiesIncurred_2" xml:lang="en-US">Settle derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiquidityRiskMember_0" xml:lang="en-US">Liquidity risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LiquidityRiskMember_1" xml:lang="en-US">Liquidity risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LoansAndReceivablesCategoryMember_0" xml:lang="en-US">Loans and receivables, category [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LoansAndReceivablesCategoryMember_1" xml:lang="en-US">Loans and receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_0" xml:lang="en-US">Losses on change in fair value of derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_1" xml:lang="en-US">Losses on change in fair value of derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_2" xml:lang="en-US">Loss on change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MachineryMember_0" xml:lang="en-US">Machinery [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MachineryMember_1" xml:lang="en-US">Production equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MarketRiskMember_0" xml:lang="en-US">Market risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_MarketRiskMember_1" xml:lang="en-US">Market price risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaturityAxis_0" xml:lang="en-US">Maturity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MeasurementAxis_0" xml:lang="en-US">Measurement [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MediaProductionExpense_0" xml:lang="en-US">Media production expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MediaProductionExpense_1" xml:lang="en-US">Production and growing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsMember_0" xml:lang="en-US">Non-adjusting events after reporting period [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssets_0" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentAssets_1" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract_0" xml:lang="en-US">Non-current assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract_1" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0" xml:lang="en-US">Balance at December 31, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1" xml:lang="en-US">Balance at December 31, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2" xml:lang="en-US">Non-current investments other than investments accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_3" xml:lang="en-US">Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_0" xml:lang="en-US">Non-current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_1" xml:lang="en-US">Non-current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_2" xml:lang="en-US">Lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilities_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilities_1" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract_0" xml:lang="en-US">Non-current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract_1" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotesAndDebenturesIssued_0" xml:lang="en-US">Notes and debentures issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NotesAndDebenturesIssued_1" xml:lang="en-US">Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_0" xml:lang="en-US">Not later than one year [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_1" xml:lang="en-US">2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_2" xml:lang="en-US">Less than one year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share issued for share-based bonus expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_0" xml:lang="en-US">Number of instruments or interests issued or issuable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_1" xml:lang="en-US">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0" xml:lang="en-US">Number of other equity instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1" xml:lang="en-US">Number of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2" xml:lang="en-US">Warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_0" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of other equity instruments exercised or vested in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_3" xml:lang="en-US">Number of warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_0" xml:lang="en-US">Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of other equity instruments expired in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_2" xml:lang="en-US">Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_0" xml:lang="en-US">Closing Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_1" xml:lang="en-US">Opening Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2" xml:lang="en-US">Number of other equity instruments outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_0" xml:lang="en-US">Closing Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_1" xml:lang="en-US">Opening Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_2" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_0" xml:lang="en-US">Opening Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2" xml:lang="en-US">Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_0" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3" xml:lang="en-US">Number of stock options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_0" xml:lang="en-US">Cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options expired in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2" xml:lang="en-US">Expired / cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_1" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of stock options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_0" xml:lang="en-US">Number of Shares, ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_1" xml:lang="en-US">Number of Shares, beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesIssued_2" xml:lang="en-US">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_3" xml:lang="en-US">Number of shares subscribed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_4" xml:lang="en-US">Total number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_5" xml:lang="en-US">Number of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_0" xml:lang="en-US">Ending balance (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_1" xml:lang="en-US">Beginning balance (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_2" xml:lang="en-US">Number of shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_3" xml:lang="en-US">Number of Class B shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_4" xml:lang="en-US">Balance, beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OccupancyExpense_0" xml:lang="en-US">Occupancy expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OccupancyExpense_1" xml:lang="en-US">Occupancy costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OrdinarySharesMember_0" xml:lang="en-US">Ordinary shares [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OrdinarySharesMember_1" xml:lang="en-US">Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract_0" xml:lang="en-US">Other comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_0" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_1" xml:lang="en-US">Exchange loss on translation of foreign operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2" xml:lang="en-US">Items that may be subsequently reclassified to income:Exchange loss on translation of foreign operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherIncome_0" xml:lang="en-US">Other income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherIncome_1" xml:lang="en-US">Other income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherIncome_2" xml:lang="en-US">Other income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_OtherIncome_3" xml:lang="en-US">Other income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherReceivables_0" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherReceivables_1" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherTangibleOrIntangibleAssetsTransferred_0" xml:lang="en-US">Other tangible or intangible assets transferred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_0" xml:lang="en-US">Share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_1" xml:lang="en-US">Costs of issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_2" xml:lang="en-US">Payments for share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_3" xml:lang="en-US">Share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0" xml:lang="en-US">Payments of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2" xml:lang="en-US">Repayment of lease obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_0" xml:lang="en-US">Percentage of voting equity interests acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1" xml:lang="en-US">Percentage of voting equity interests acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PlantsMember_0" xml:lang="en-US">Plants [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PlantsMember_1" xml:lang="en-US">Cannabis plants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_0" xml:lang="en-US">Principal place of business of subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_1" xml:lang="en-US">Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions_0" xml:lang="en-US">Proceeds from exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions_1" xml:lang="en-US">Proceeds from exercise of share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions_2" xml:lang="en-US">Stock options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares_0" xml:lang="en-US">Proceeds from issue of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares_1" xml:lang="en-US">Gross proceeds of common stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_0" xml:lang="en-US">Proceeds from issuing shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_1" xml:lang="en-US">Proceeds from issuing shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_2" xml:lang="en-US">Proceeds from issuance of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_3" xml:lang="en-US">Proceeds from issuance of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0" xml:lang="en-US">Proceeds from sales of investments other than investments accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1" xml:lang="en-US">Proceeds from sale of investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2" xml:lang="en-US">Proceeds from sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProductionSupplies_0" xml:lang="en-US">Current production supplies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProductionSupplies_1" xml:lang="en-US">Supplies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_0" xml:lang="en-US">Professional fees expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_1" xml:lang="en-US">Professional fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ProfitLoss_0" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLoss_1" xml:lang="en-US">Profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLoss_2" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLoss_3" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLoss_4" xml:lang="en-US">Net comprehensive loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAbstract_0" xml:lang="en-US">Profit (loss) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossAbstract_1" xml:lang="en-US">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_0" xml:lang="en-US">Profit (loss), attributable to ordinary equity holders of parent entity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_1" xml:lang="en-US">Loss attributable to Class B shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_0" xml:lang="en-US">Profit (loss) from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_1" xml:lang="en-US">Loss before the undernoted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_0" xml:lang="en-US">Profit (loss) from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_1" xml:lang="en-US">Loss from operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_2" xml:lang="en-US">Property Plant And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_3" xml:lang="en-US">Property, plant and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xml:lang="en-US">Property, plant and equipment [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentMember_0" xml:lang="en-US">Property, plant and equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0" xml:lang="en-US">Proportion of ownership interest in subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1" xml:lang="en-US">Ownership percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_0" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1" xml:lang="en-US">Purchase of intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2" xml:lang="en-US">Additions to intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfInvestmentProperty_0" xml:lang="en-US">Purchase of other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfInvestmentProperty_1" xml:lang="en-US">Purchase of investment property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0" xml:lang="en-US">Purchase of other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1" xml:lang="en-US">Purchase of investments other than investments accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0" xml:lang="en-US">Purchase of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_3" xml:lang="en-US">Purchase of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangeAxis_0" xml:lang="en-US">Range [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesMember_0" xml:lang="en-US">Ranges [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_0" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">Ranges of exercise prices for outstanding share options [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RawMaterials_0" xml:lang="en-US">Current raw materials</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RawMaterials_1" xml:lang="en-US">Raw materials</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RentalIncome_0" xml:lang="en-US">Rental income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RentalIncome_1" xml:lang="en-US">Rental income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RepairsAndMaintenanceExpense_0" xml:lang="en-US">Repairs and maintenance expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RepairsAndMaintenanceExpense_1" xml:lang="en-US">Repairs, maintenance and utilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_0" xml:lang="en-US">Reserve of exchange differences on translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_1" xml:lang="en-US">Foreign exchange translation reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_0" xml:lang="en-US">Reserve of exchange differences on translation [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_1" xml:lang="en-US">Foreign exchange translation reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_0" xml:lang="en-US">Reserve of share-based payments [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_1" xml:lang="en-US">Contributed surplus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_RetainedEarnings_0" xml:lang="en-US">Deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_RetainedEarnings_1" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarnings_2" xml:lang="en-US">Retained earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RetainedEarnings_3" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarnings_4" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarningsMember_0" xml:lang="en-US">Retained earnings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarningsMember_1" xml:lang="en-US">Accumulated Deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Revenue_0" xml:lang="en-US">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Revenue_1" xml:lang="en-US">Total revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_RightofuseAssets_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_RightofuseAssets_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssets_2" xml:lang="en-US">Right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RightofuseAssets_3" xml:lang="en-US">Right-of-use asset, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xml:lang="en-US">Selling, general and administrative expense [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SeparateManagementEntitiesAxis_0" xml:lang="en-US">Separate management entities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SeparateManagementEntitiesMember_0" xml:lang="en-US">Separate management entities [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharebasedPaymentArrangementsMember_0" xml:lang="en-US">Share-based payment arrangements [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_0" xml:lang="en-US">Share issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_1" xml:lang="en-US">Share issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_2" xml:lang="en-US">Share issue related cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_3" xml:lang="en-US">Shareholder and public company costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_4" xml:lang="en-US">Commissions and corporate finance fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharePremium_0" xml:lang="en-US">Contributed surplus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermBorrowingsMember_0" xml:lang="en-US">Short-term borrowings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShorttermBorrowingsMember_1" xml:lang="en-US">Short-term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_0" xml:lang="en-US">Subsidiaries [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of cash flows [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract_0" xml:lang="en-US">Statement of changes in equity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems_0" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable_0" xml:lang="en-US">Statement of changes in equity [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of financial position [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SubsidiariesMember_0" xml:lang="en-US">Subsidiaries [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_SubsidiariesMember_1" xml:lang="en-US">FV Pharma Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_0" xml:lang="en-US">Tax effect of expense not deductible in determining taxable profit (tax loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1" xml:lang="en-US">Non-deductible expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2" xml:lang="en-US">Permanent differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_0" xml:lang="en-US">Tax expense (income) at applicable tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1" xml:lang="en-US">Income tax recovery at the statutory tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_0" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_0" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TopOfRangeMember_0" xml:lang="en-US">Top of range [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TopOfRangeMember_1" xml:lang="en-US">Top of range</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables_0" xml:lang="en-US">Trade and other current payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables_1" xml:lang="en-US">Total trade and other current payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables_2" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xml:lang="en-US">Trade and other current payables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_0" xml:lang="en-US">Trade and other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_1" xml:lang="en-US">Total trade and other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_2" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayables_0" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherPayables_1" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayables_2" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayables_3" xml:lang="en-US">Total trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Trade and other payables recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Total trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_3" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherReceivables_0" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TradeAndOtherReceivables_1" xml:lang="en-US">Total trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherReceivables_2" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherReceivablesAbstract_0" xml:lang="en-US">Trade and other receivables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TravelExpense_0" xml:lang="en-US">Travel expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TravelExpense_1" xml:lang="en-US">Travel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfRisksAxis_0" xml:lang="en-US">Types of risks [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfRisksMember_0" xml:lang="en-US">Risks [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0" xml:lang="en-US">Types of share-based payment arrangements [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_0" xml:lang="en-US">Undiscounted operating lease payments to be received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_1" xml:lang="en-US">Total undiscounted lease payments payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Useful life of intellectual property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_0" xml:lang="en-US">Useful life measured as period of time, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ValueAtRisk_0" xml:lang="en-US">Value at risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ValueAtRisk_1" xml:lang="en-US">Profit or loss on other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WagesAndSalaries_0" xml:lang="en-US">Wages and salaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WagesAndSalaries_1" xml:lang="en-US">Salaries, wages and benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price, Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Exercise price of exercisable Share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price, Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options expired in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price, Cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price, Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price, Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_3" xml:lang="en-US">Exercise price of options outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_0" xml:lang="en-US">Weighted average fair value at measurement date, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_1" xml:lang="en-US">Fair Values</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_0" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_0" xml:lang="en-US">Weighted average share price, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1" xml:lang="en-US">Grant date share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_2" xml:lang="en-US">Share issued price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageShares_0" xml:lang="en-US">Weighted average number of ordinary shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageShares_1" xml:lang="en-US">Weighted average number of shares outstanding - basic (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_0" xml:lang="en-US">Weighted average ordinary shares and adjusted weighted average ordinary shares [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_1" xml:lang="en-US">Weighted average number of Class B subordinate voting shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_2" xml:lang="en-US">Weighted average number of Class B shares:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WorkInProgress_0" xml:lang="en-US">Current work in progress</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WorkInProgress_1" xml:lang="en-US">Work in process</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_PresidentMember_0" xml:lang="en-US">President [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_PresidentMember_1" xml:lang="en-US">President</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_1" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_2" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_3" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_4" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_5" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_6" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_7" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_8" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_9" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_10" xlink:to="lab_dei_EntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_11" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod_12" xlink:to="lab_dei_EntityExTransitionPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_13" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_14" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_15" xlink:to="lab_dei_LegalEntityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_16" xlink:to="lab_huge_AcquisitionOfPrismicPharmaceuticalsInc_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_16" xlink:to="lab_huge_AcquisitionOfPrismicPharmaceuticalsInc_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_16" xlink:to="lab_huge_AcquisitionOfPrismicPharmaceuticalsInc_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdditionalInvestmentInExchangeForShares_17" xlink:to="lab_huge_AdditionalInvestmentInExchangeForShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdditionalInvestmentInExchangeForShares_17" xlink:to="lab_huge_AdditionalInvestmentInExchangeForShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdditionalInvestmentInExchangeForShares_17" xlink:to="lab_huge_AdditionalInvestmentInExchangeForShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdditionalRemuneration_18" xlink:to="lab_huge_AdditionalRemuneration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdditionalRemuneration_18" xlink:to="lab_huge_AdditionalRemuneration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdditionalRemuneration_18" xlink:to="lab_huge_AdditionalRemuneration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_19" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_19" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_20" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_20" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_20" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_20" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_21" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_21" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_21" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits_22" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_23" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_23" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_23" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_23" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_24" xlink:to="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_24" xlink:to="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_24" xlink:to="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_24" xlink:to="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForListingExpense_25" xlink:to="lab_huge_AdjustmentsForListingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForListingExpense_25" xlink:to="lab_huge_AdjustmentsForListingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForListingExpense_25" xlink:to="lab_huge_AdjustmentsForListingExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_26" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_26" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_27" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_27" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_27" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_27" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_28" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_28" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_28" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_29" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_29" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_29" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_30" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_30" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_30" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_31" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_31" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_31" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToLeaseCommitments_32" xlink:to="lab_huge_AdjustmentToLeaseCommitments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToLeaseCommitments_32" xlink:to="lab_huge_AdjustmentToLeaseCommitments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToLeaseCommitments_32" xlink:to="lab_huge_AdjustmentToLeaseCommitments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_33" xlink:to="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_33" xlink:to="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_33" xlink:to="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_34" xlink:to="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_34" xlink:to="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_34" xlink:to="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AggregateDiscountForSharesInEscrow_35" xlink:to="lab_huge_AggregateDiscountForSharesInEscrow_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AggregateDiscountForSharesInEscrow_35" xlink:to="lab_huge_AggregateDiscountForSharesInEscrow_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AggregateDiscountForSharesInEscrow_35" xlink:to="lab_huge_AggregateDiscountForSharesInEscrow_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AggregateUnpaidAccounts_36" xlink:to="lab_huge_AggregateUnpaidAccounts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AggregateUnpaidAccounts_36" xlink:to="lab_huge_AggregateUnpaidAccounts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AggregateUnpaidAccounts_36" xlink:to="lab_huge_AggregateUnpaidAccounts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AllowanceForImpairment_37" xlink:to="lab_huge_AllowanceForImpairment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AllowanceForImpairment_37" xlink:to="lab_huge_AllowanceForImpairment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AllowanceForImpairment_37" xlink:to="lab_huge_AllowanceForImpairment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmortizedCostOfFinancialAssetsMember_38" xlink:to="lab_huge_AmortizedCostOfFinancialAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmortizedCostOfFinancialAssetsMember_38" xlink:to="lab_huge_AmortizedCostOfFinancialAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmortizedCostOfFinancialAssetsMember_38" xlink:to="lab_huge_AmortizedCostOfFinancialAssetsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_39" xlink:to="lab_huge_AmortizedCostOfFinancialLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_39" xlink:to="lab_huge_AmortizedCostOfFinancialLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_39" xlink:to="lab_huge_AmortizedCostOfFinancialLiabilitiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_40" xlink:to="lab_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_40" xlink:to="lab_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_40" xlink:to="lab_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfAgreementFallBelowMinimumValue_41" xlink:to="lab_huge_AmountOfAgreementFallBelowMinimumValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfAgreementFallBelowMinimumValue_41" xlink:to="lab_huge_AmountOfAgreementFallBelowMinimumValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfAgreementFallBelowMinimumValue_41" xlink:to="lab_huge_AmountOfAgreementFallBelowMinimumValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_42" xlink:to="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_42" xlink:to="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_42" xlink:to="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_42" xlink:to="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_42" xlink:to="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfDepositPaidToSupplier_43" xlink:to="lab_huge_AmountOfDepositPaidToSupplier_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfDepositPaidToSupplier_43" xlink:to="lab_huge_AmountOfDepositPaidToSupplier_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfDepositPaidToSupplier_43" xlink:to="lab_huge_AmountOfDepositPaidToSupplier_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_44" xlink:to="lab_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_44" xlink:to="lab_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_44" xlink:to="lab_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_45" xlink:to="lab_huge_AmountOfPurchasePricePaidAsSupplierLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_45" xlink:to="lab_huge_AmountOfPurchasePricePaidAsSupplierLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_45" xlink:to="lab_huge_AmountOfPurchasePricePaidAsSupplierLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_46" xlink:to="lab_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_46" xlink:to="lab_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_46" xlink:to="lab_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AnthonyDurkaczMember_47" xlink:to="lab_huge_AnthonyDurkaczMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AnthonyDurkaczMember_47" xlink:to="lab_huge_AnthonyDurkaczMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AnthonyDurkaczMember_47" xlink:to="lab_huge_AnthonyDurkaczMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_48" xlink:to="lab_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_48" xlink:to="lab_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_48" xlink:to="lab_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Apr82018Member_49" xlink:to="lab_huge_Apr82018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Apr82018Member_49" xlink:to="lab_huge_Apr82018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Apr82018Member_49" xlink:to="lab_huge_Apr82018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Apr92018Member_50" xlink:to="lab_huge_Apr92018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Apr92018Member_50" xlink:to="lab_huge_Apr92018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Apr92018Member_50" xlink:to="lab_huge_Apr92018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_April182018Member_51" xlink:to="lab_huge_April182018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_April182018Member_51" xlink:to="lab_huge_April182018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_April182018Member_51" xlink:to="lab_huge_April182018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug142018Member_52" xlink:to="lab_huge_Aug142018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug142018Member_52" xlink:to="lab_huge_Aug142018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug142018Member_52" xlink:to="lab_huge_Aug142018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug152018Member_53" xlink:to="lab_huge_Aug152018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug152018Member_53" xlink:to="lab_huge_Aug152018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug152018Member_53" xlink:to="lab_huge_Aug152018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug82018Member_54" xlink:to="lab_huge_Aug82018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug82018Member_54" xlink:to="lab_huge_Aug82018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug82018Member_54" xlink:to="lab_huge_Aug82018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AuraHealthIncMember_55" xlink:to="lab_huge_AuraHealthIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AuraHealthIncMember_55" xlink:to="lab_huge_AuraHealthIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AuraHealthIncMember_55" xlink:to="lab_huge_AuraHealthIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AuxlyCannabisGroupIncMember_56" xlink:to="lab_huge_AuxlyCannabisGroupIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AuxlyCannabisGroupIncMember_56" xlink:to="lab_huge_AuxlyCannabisGroupIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AuxlyCannabisGroupIncMember_56" xlink:to="lab_huge_AuxlyCannabisGroupIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AverageExpectedLifeOfWarrants_57" xlink:to="lab_huge_AverageExpectedLifeOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AverageExpectedLifeOfWarrants_57" xlink:to="lab_huge_AverageExpectedLifeOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AverageExpectedLifeOfWarrants_57" xlink:to="lab_huge_AverageExpectedLifeOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BasisOfPresentationAbstract_58" xlink:to="lab_huge_BasisOfPresentationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BiologicalAssetFairValueAdjustmentMember_59" xlink:to="lab_huge_BiologicalAssetFairValueAdjustmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BiologicalAssetFairValueAdjustmentMember_59" xlink:to="lab_huge_BiologicalAssetFairValueAdjustmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BiologicalAssetFairValueAdjustmentMember_59" xlink:to="lab_huge_BiologicalAssetFairValueAdjustmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BonusExpenseToBePaidInSubsequentPeriod_60" xlink:to="lab_huge_BonusExpenseToBePaidInSubsequentPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BonusExpenseToBePaidInSubsequentPeriod_60" xlink:to="lab_huge_BonusExpenseToBePaidInSubsequentPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BonusExpenseToBePaidInSubsequentPeriod_60" xlink:to="lab_huge_BonusExpenseToBePaidInSubsequentPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BrokerWarrants_61" xlink:to="lab_huge_BrokerWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BrokerWarrants_61" xlink:to="lab_huge_BrokerWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BrokerWarrantsIssuedInPrivatePlacements_62" xlink:to="lab_huge_BrokerWarrantsIssuedInPrivatePlacements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BrokerWarrantsIssuedInPrivatePlacements_62" xlink:to="lab_huge_BrokerWarrantsIssuedInPrivatePlacements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BrokerWarrantsIssuedInPrivatePlacements_62" xlink:to="lab_huge_BrokerWarrantsIssuedInPrivatePlacements_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionDomain_63" xlink:to="lab_huge_BusinessAcquisitionDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionDomain_63" xlink:to="lab_huge_BusinessAcquisitionDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionsAxis_64" xlink:to="lab_huge_BusinessAcquisitionsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionsAxis_64" xlink:to="lab_huge_BusinessAcquisitionsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionsBenefitsAxis_65" xlink:to="lab_huge_BusinessAcquisitionsBenefitsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionsBenefitsAxis_65" xlink:to="lab_huge_BusinessAcquisitionsBenefitsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionsBenefitsDomain_66" xlink:to="lab_huge_BusinessAcquisitionsBenefitsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionsBenefitsDomain_66" xlink:to="lab_huge_BusinessAcquisitionsBenefitsDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessLicenseFees_67" xlink:to="lab_huge_BusinessLicenseFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessLicenseFees_67" xlink:to="lab_huge_BusinessLicenseFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessLicenseFees_67" xlink:to="lab_huge_BusinessLicenseFees_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CannaraBiotechIncMember_68" xlink:to="lab_huge_CannaraBiotechIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CannaraBiotechIncMember_68" xlink:to="lab_huge_CannaraBiotechIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CannaraBiotechIncMember_68" xlink:to="lab_huge_CannaraBiotechIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_69" xlink:to="lab_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_69" xlink:to="lab_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_69" xlink:to="lab_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CapitalizedCostMember_70" xlink:to="lab_huge_CapitalizedCostMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CapitalizedCostMember_70" xlink:to="lab_huge_CapitalizedCostMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CapitalizedCostMember_70" xlink:to="lab_huge_CapitalizedCostMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CapitalizedCosts_71" xlink:to="lab_huge_CapitalizedCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CapitalizedCosts_71" xlink:to="lab_huge_CapitalizedCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CapitalizedCosts_71" xlink:to="lab_huge_CapitalizedCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashAcquiredOnAcquisition_72" xlink:to="lab_huge_CashAcquiredOnAcquisition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashAcquiredOnAcquisition_72" xlink:to="lab_huge_CashAcquiredOnAcquisition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashAcquiredOnAcquisition_72" xlink:to="lab_huge_CashAcquiredOnAcquisition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CenturyAndFvPharmaMember_73" xlink:to="lab_huge_CenturyAndFvPharmaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CenturyAndFvPharmaMember_73" xlink:to="lab_huge_CenturyAndFvPharmaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CenturyAndFvPharmaMember_73" xlink:to="lab_huge_CenturyAndFvPharmaMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueOfInvestment_74" xlink:to="lab_huge_ChangeInFairValueOfInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueOfInvestment_74" xlink:to="lab_huge_ChangeInFairValueOfInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_75" xlink:to="lab_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_75" xlink:to="lab_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_75" xlink:to="lab_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_76" xlink:to="lab_huge_ChangesInNonCashWorkingCapitalItemsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_76" xlink:to="lab_huge_ChangesInNonCashWorkingCapitalItemsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInShareCapitalTransactionDateAxis_77" xlink:to="lab_huge_ChangesInShareCapitalTransactionDateAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInShareCapitalTransactionDateAxis_77" xlink:to="lab_huge_ChangesInShareCapitalTransactionDateAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInShareCapitalTransactionDateDomain_78" xlink:to="lab_huge_ChangesInShareCapitalTransactionDateDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInShareCapitalTransactionDateDomain_78" xlink:to="lab_huge_ChangesInShareCapitalTransactionDateDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_79" xlink:to="lab_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_79" xlink:to="lab_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_79" xlink:to="lab_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefExecutiveOfficersMember_80" xlink:to="lab_huge_ChiefExecutiveOfficersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefExecutiveOfficersMember_80" xlink:to="lab_huge_ChiefExecutiveOfficersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefExecutiveOfficersMember_80" xlink:to="lab_huge_ChiefExecutiveOfficersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefFinancialOfficersMember_81" xlink:to="lab_huge_ChiefFinancialOfficersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefFinancialOfficersMember_81" xlink:to="lab_huge_ChiefFinancialOfficersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefFinancialOfficersMember_81" xlink:to="lab_huge_ChiefFinancialOfficersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefOperatingConsultantMember_82" xlink:to="lab_huge_ChiefOperatingConsultantMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefOperatingConsultantMember_82" xlink:to="lab_huge_ChiefOperatingConsultantMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefOperatingConsultantMember_82" xlink:to="lab_huge_ChiefOperatingConsultantMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimForLienComponent_83" xlink:to="lab_huge_ClaimForLienComponent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimForLienComponent_83" xlink:to="lab_huge_ClaimForLienComponent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimForLienComponent_83" xlink:to="lab_huge_ClaimForLienComponent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_84" xlink:to="lab_huge_ClaimIssuedByContractorForVariousPurportedDamages_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_84" xlink:to="lab_huge_ClaimIssuedByContractorForVariousPurportedDamages_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_84" xlink:to="lab_huge_ClaimIssuedByContractorForVariousPurportedDamages_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_85" xlink:to="lab_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_85" xlink:to="lab_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_85" xlink:to="lab_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassACommonStockSharesMember_86" xlink:to="lab_huge_ClassACommonStockSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassACommonStockSharesMember_86" xlink:to="lab_huge_ClassACommonStockSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassACommonStockSharesMember_86" xlink:to="lab_huge_ClassACommonStockSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBCommonStockSharesMember_87" xlink:to="lab_huge_ClassBCommonStockSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBCommonStockSharesMember_87" xlink:to="lab_huge_ClassBCommonStockSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBCommonStockSharesMember_87" xlink:to="lab_huge_ClassBCommonStockSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSharesHeldInEscrowMember_88" xlink:to="lab_huge_ClassBSharesHeldInEscrowMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSharesHeldInEscrowMember_88" xlink:to="lab_huge_ClassBSharesHeldInEscrowMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSharesHeldInEscrowMember_88" xlink:to="lab_huge_ClassBSharesHeldInEscrowMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSubordinateVotingSharesMember_89" xlink:to="lab_huge_ClassBSubordinateVotingSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSubordinateVotingSharesMember_89" xlink:to="lab_huge_ClassBSubordinateVotingSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSubordinateVotingSharesMember_89" xlink:to="lab_huge_ClassBSubordinateVotingSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBVotingSharesMember_90" xlink:to="lab_huge_ClassBVotingSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBVotingSharesMember_90" xlink:to="lab_huge_ClassBVotingSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBVotingSharesMember_90" xlink:to="lab_huge_ClassBVotingSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfInventoriesLineItems_91" xlink:to="lab_huge_ClassesOfInventoriesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfInventoriesLineItems_91" xlink:to="lab_huge_ClassesOfInventoriesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfInventoriesTable_92" xlink:to="lab_huge_ClassesOfInventoriesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfInventoriesTable_92" xlink:to="lab_huge_ClassesOfInventoriesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfWarrantsAxis_93" xlink:to="lab_huge_ClassesOfWarrantsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfWarrantsAxis_93" xlink:to="lab_huge_ClassesOfWarrantsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfWarrantsDomain_94" xlink:to="lab_huge_ClassesOfWarrantsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfWarrantsDomain_94" xlink:to="lab_huge_ClassesOfWarrantsDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_95" xlink:to="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_95" xlink:to="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_95" xlink:to="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_95" xlink:to="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CollectiveCommitmentToPurchaseProduct_96" xlink:to="lab_huge_CollectiveCommitmentToPurchaseProduct_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CollectiveCommitmentToPurchaseProduct_96" xlink:to="lab_huge_CollectiveCommitmentToPurchaseProduct_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentsEquityInstruments_97" xlink:to="lab_huge_CommitmentsEquityInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentsEquityInstruments_97" xlink:to="lab_huge_CommitmentsEquityInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentsEquityInstruments_97" xlink:to="lab_huge_CommitmentsEquityInstruments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentsLineItems_98" xlink:to="lab_huge_CommitmentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentsTable_99" xlink:to="lab_huge_CommitmentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_100" xlink:to="lab_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_100" xlink:to="lab_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_100" xlink:to="lab_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConsultingFeesExpenses_101" xlink:to="lab_huge_ConsultingFeesExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConsultingFeesExpenses_101" xlink:to="lab_huge_ConsultingFeesExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConsultingFeesExpenses_101" xlink:to="lab_huge_ConsultingFeesExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConsultingFeesExpenses_101" xlink:to="lab_huge_ConsultingFeesExpenses_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_102" xlink:to="lab_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_102" xlink:to="lab_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_102" xlink:to="lab_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_103" xlink:to="lab_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_103" xlink:to="lab_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_103" xlink:to="lab_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleDebentureMember_104" xlink:to="lab_huge_ConvertibleDebentureMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleDebentureMember_104" xlink:to="lab_huge_ConvertibleDebentureMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleDebentureMember_104" xlink:to="lab_huge_ConvertibleDebentureMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotes_105" xlink:to="lab_huge_ConvertibleNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotes_105" xlink:to="lab_huge_ConvertibleNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotes_105" xlink:to="lab_huge_ConvertibleNotes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotes_105" xlink:to="lab_huge_ConvertibleNotes_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotesMember_106" xlink:to="lab_huge_ConvertibleNotesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotesMember_106" xlink:to="lab_huge_ConvertibleNotesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotesMember_106" xlink:to="lab_huge_ConvertibleNotesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CorporateInformationAndNatureOfOperationsAbstract_107" xlink:to="lab_huge_CorporateInformationAndNatureOfOperationsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CriticalAccountingEstimatesAndJudgmentsAbstract_108" xlink:to="lab_huge_CriticalAccountingEstimatesAndJudgmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CurrentNotesPayable_109" xlink:to="lab_huge_CurrentNotesPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CurrentNotesPayable_109" xlink:to="lab_huge_CurrentNotesPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CurrentNotesPayable_109" xlink:to="lab_huge_CurrentNotesPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CurrentNotesPayable_109" xlink:to="lab_huge_CurrentNotesPayable_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DateOfExpiryOfShareOptions_110" xlink:to="lab_huge_DateOfExpiryOfShareOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DateOfExpiryOfShareOptions_110" xlink:to="lab_huge_DateOfExpiryOfShareOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DateOfExpiryOfShareOptions_110" xlink:to="lab_huge_DateOfExpiryOfShareOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DebtConversionRatio_111" xlink:to="lab_huge_DebtConversionRatio_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DebtConversionRatio_111" xlink:to="lab_huge_DebtConversionRatio_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec122017Member_112" xlink:to="lab_huge_Dec122017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec122017Member_112" xlink:to="lab_huge_Dec122017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec122017Member_112" xlink:to="lab_huge_Dec122017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec152018Member_113" xlink:to="lab_huge_Dec152018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec152018Member_113" xlink:to="lab_huge_Dec152018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec152018Member_113" xlink:to="lab_huge_Dec152018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec212017Member_114" xlink:to="lab_huge_Dec212017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec212017Member_114" xlink:to="lab_huge_Dec212017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec212017Member_114" xlink:to="lab_huge_Dec212017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec232017Member_115" xlink:to="lab_huge_Dec232017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec232017Member_115" xlink:to="lab_huge_Dec232017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec232017Member_115" xlink:to="lab_huge_Dec232017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec292017Member_116" xlink:to="lab_huge_Dec292017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec292017Member_116" xlink:to="lab_huge_Dec292017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec292017Member_116" xlink:to="lab_huge_Dec292017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_December292017Member_117" xlink:to="lab_huge_December292017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_December292017Member_117" xlink:to="lab_huge_December292017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_December292017Member_117" xlink:to="lab_huge_December292017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_118" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_118" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_118" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_119" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_119" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_119" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_120" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_120" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_120" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_121" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_121" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_121" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_122" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_122" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_122" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_123" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_123" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_123" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_124" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_124" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_124" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetLiabilityNotRecognized_125" xlink:to="lab_huge_DeferredTaxAssetLiabilityNotRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetLiabilityNotRecognized_125" xlink:to="lab_huge_DeferredTaxAssetLiabilityNotRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetLiabilityNotRecognized_125" xlink:to="lab_huge_DeferredTaxAssetLiabilityNotRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetLiabilityNotRecognized_125" xlink:to="lab_huge_DeferredTaxAssetLiabilityNotRecognized_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetNotRecognized_126" xlink:to="lab_huge_DeferredTaxAssetNotRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetNotRecognized_126" xlink:to="lab_huge_DeferredTaxAssetNotRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetNotRecognized_126" xlink:to="lab_huge_DeferredTaxAssetNotRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_127" xlink:to="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_127" xlink:to="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_127" xlink:to="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_127" xlink:to="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsLiabilitiesAxis_128" xlink:to="lab_huge_DeferredTaxAssetsLiabilitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsLiabilitiesAxis_128" xlink:to="lab_huge_DeferredTaxAssetsLiabilitiesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsLiabilitiesDomain_129" xlink:to="lab_huge_DeferredTaxAssetsLiabilitiesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsLiabilitiesDomain_129" xlink:to="lab_huge_DeferredTaxAssetsLiabilitiesDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsOtherInvestments_130" xlink:to="lab_huge_DeferredTaxAssetsOtherInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsOtherInvestments_130" xlink:to="lab_huge_DeferredTaxAssetsOtherInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsOtherInvestments_130" xlink:to="lab_huge_DeferredTaxAssetsOtherInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsOtherInvestments_130" xlink:to="lab_huge_DeferredTaxAssetsOtherInvestments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_131" xlink:to="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_131" xlink:to="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_131" xlink:to="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_131" xlink:to="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveBusinessCombinationAgreementMember_132" xlink:to="lab_huge_DefinitiveBusinessCombinationAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveBusinessCombinationAgreementMember_132" xlink:to="lab_huge_DefinitiveBusinessCombinationAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveBusinessCombinationAgreementMember_132" xlink:to="lab_huge_DefinitiveBusinessCombinationAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveCollaborationProfitSharingAgreementMember_133" xlink:to="lab_huge_DefinitiveCollaborationProfitSharingAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveCollaborationProfitSharingAgreementMember_133" xlink:to="lab_huge_DefinitiveCollaborationProfitSharingAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveCollaborationProfitSharingAgreementMember_133" xlink:to="lab_huge_DefinitiveCollaborationProfitSharingAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_134" xlink:to="lab_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_134" xlink:to="lab_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_134" xlink:to="lab_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_135" xlink:to="lab_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_135" xlink:to="lab_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_136" xlink:to="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_136" xlink:to="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_136" xlink:to="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_136" xlink:to="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfOptionLifeWarrantsGranted_137" xlink:to="lab_huge_DescriptionOfOptionLifeWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfOptionLifeWarrantsGranted_137" xlink:to="lab_huge_DescriptionOfOptionLifeWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfOptionLifeWarrantsGranted_137" xlink:to="lab_huge_DescriptionOfOptionLifeWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfOptionLifeWarrantsGranted_137" xlink:to="lab_huge_DescriptionOfOptionLifeWarrantsGranted_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_138" xlink:to="lab_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_138" xlink:to="lab_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_138" xlink:to="lab_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfReverseShareSplit_139" xlink:to="lab_huge_DescriptionOfReverseShareSplit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfReverseShareSplit_139" xlink:to="lab_huge_DescriptionOfReverseShareSplit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_140" xlink:to="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_140" xlink:to="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_140" xlink:to="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_140" xlink:to="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfVotingRights_141" xlink:to="lab_huge_DescriptionOfVotingRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfVotingRights_141" xlink:to="lab_huge_DescriptionOfVotingRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfVotingRights_141" xlink:to="lab_huge_DescriptionOfVotingRights_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsAndOfficersMember_142" xlink:to="lab_huge_DirectorsAndOfficersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsAndOfficersMember_142" xlink:to="lab_huge_DirectorsAndOfficersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsAndOfficersMember_142" xlink:to="lab_huge_DirectorsAndOfficersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsAndOfficersMember_142" xlink:to="lab_huge_DirectorsAndOfficersMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsRemunerationPayable_143" xlink:to="lab_huge_DirectorsRemunerationPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsRemunerationPayable_143" xlink:to="lab_huge_DirectorsRemunerationPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsRemunerationPayable_143" xlink:to="lab_huge_DirectorsRemunerationPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfBiologicalAssetsExplanatory_144" xlink:to="lab_huge_DisclosureOfBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfBiologicalAssetsExplanatory_144" xlink:to="lab_huge_DisclosureOfBiologicalAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfBiologicalAssetsExplanatory_144" xlink:to="lab_huge_DisclosureOfBiologicalAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfCapitalManagementAbstract_145" xlink:to="lab_huge_DisclosureOfCapitalManagementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_146" xlink:to="lab_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_146" xlink:to="lab_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_146" xlink:to="lab_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfCommitmentsAbstract_147" xlink:to="lab_huge_DisclosureOfCommitmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_148" xlink:to="lab_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_149" xlink:to="lab_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_149" xlink:to="lab_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_149" xlink:to="lab_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_150" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_150" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_150" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_151" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_151" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_151" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_152" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_152" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_152" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_153" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_153" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_153" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_153" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_154" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_154" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_154" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_155" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_155" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_155" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_156" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_156" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_156" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_157" xlink:to="lab_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_157" xlink:to="lab_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_157" xlink:to="lab_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_158" xlink:to="lab_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_158" xlink:to="lab_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_159" xlink:to="lab_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_159" xlink:to="lab_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_159" xlink:to="lab_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_160" xlink:to="lab_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_160" xlink:to="lab_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_160" xlink:to="lab_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_161" xlink:to="lab_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_161" xlink:to="lab_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_161" xlink:to="lab_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfGeneralAndAdministrativeExpenses_162" xlink:to="lab_huge_DisclosureOfGeneralAndAdministrativeExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfGeneralAndAdministrativeExpenses_162" xlink:to="lab_huge_DisclosureOfGeneralAndAdministrativeExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_163" xlink:to="lab_huge_DisclosureOfNatureOfBusinessAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_163" xlink:to="lab_huge_DisclosureOfNatureOfBusinessAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_163" xlink:to="lab_huge_DisclosureOfNatureOfBusinessAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_164" xlink:to="lab_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_164" xlink:to="lab_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_164" xlink:to="lab_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessLineItems_165" xlink:to="lab_huge_DisclosureOfNatureOfBusinessLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessTable_166" xlink:to="lab_huge_DisclosureOfNatureOfBusinessTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessTable_166" xlink:to="lab_huge_DisclosureOfNatureOfBusinessTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_167" xlink:to="lab_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_167" xlink:to="lab_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_167" xlink:to="lab_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_168" xlink:to="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_168" xlink:to="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_168" xlink:to="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_169" xlink:to="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_169" xlink:to="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_169" xlink:to="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_170" xlink:to="lab_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_170" xlink:to="lab_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_170" xlink:to="lab_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfOtherInvestmentsAbstract_171" xlink:to="lab_huge_DisclosureOfOtherInvestmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_172" xlink:to="lab_huge_DisclosureOfOtherInvestmentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_173" xlink:to="lab_huge_DisclosureOfOtherInvestmentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_173" xlink:to="lab_huge_DisclosureOfOtherInvestmentsTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_174" xlink:to="lab_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_174" xlink:to="lab_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_174" xlink:to="lab_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_175" xlink:to="lab_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_175" xlink:to="lab_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_175" xlink:to="lab_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfReverseTakeoverTransactionAbstract_176" xlink:to="lab_huge_DisclosureOfReverseTakeoverTransactionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_177" xlink:to="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_177" xlink:to="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_177" xlink:to="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_177" xlink:to="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_178" xlink:to="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_179" xlink:to="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_179" xlink:to="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_179" xlink:to="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_180" xlink:to="lab_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_180" xlink:to="lab_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_180" xlink:to="lab_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory_181" xlink:to="lab_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory_181" xlink:to="lab_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory_181" xlink:to="lab_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_182" xlink:to="lab_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_182" xlink:to="lab_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_182" xlink:to="lab_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_183" xlink:to="lab_huge_DisclosureOfWarrantsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_183" xlink:to="lab_huge_DisclosureOfWarrantsLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfWarrantsTable_184" xlink:to="lab_huge_DisclosureOfWarrantsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfWarrantsTable_184" xlink:to="lab_huge_DisclosureOfWarrantsTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_185" xlink:to="lab_huge_DiscountOnProceedsOfSharesAndWarrantsSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_185" xlink:to="lab_huge_DiscountOnProceedsOfSharesAndWarrantsSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_185" xlink:to="lab_huge_DiscountOnProceedsOfSharesAndWarrantsSold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_186" xlink:to="lab_huge_DocumentAndEntityInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_187" xlink:to="lab_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_187" xlink:to="lab_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_187" xlink:to="lab_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EmployeeRelatedLiability_188" xlink:to="lab_huge_EmployeeRelatedLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EmployeeRelatedLiability_188" xlink:to="lab_huge_EmployeeRelatedLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EpitechLicenseAgreementMember_189" xlink:to="lab_huge_EpitechLicenseAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EpitechLicenseAgreementMember_189" xlink:to="lab_huge_EpitechLicenseAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EpitechLicenseAgreementMember_189" xlink:to="lab_huge_EpitechLicenseAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EstimatedCostOfRestorationInCommitment_190" xlink:to="lab_huge_EstimatedCostOfRestorationInCommitment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EstimatedCostOfRestorationInCommitment_190" xlink:to="lab_huge_EstimatedCostOfRestorationInCommitment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEighteenPointZeroNineMember_191" xlink:to="lab_huge_ExercisePriceEighteenPointZeroNineMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEighteenPointZeroNineMember_191" xlink:to="lab_huge_ExercisePriceEighteenPointZeroNineMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEighteenPointZeroNineMember_191" xlink:to="lab_huge_ExercisePriceEighteenPointZeroNineMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEightyEightPointFortyFourMember_192" xlink:to="lab_huge_ExercisePriceEightyEightPointFortyFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEightyEightPointFortyFourMember_192" xlink:to="lab_huge_ExercisePriceEightyEightPointFortyFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEightyEightPointFortyFourMember_192" xlink:to="lab_huge_ExercisePriceEightyEightPointFortyFourMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEightySixPointFortyThreeMember_193" xlink:to="lab_huge_ExercisePriceEightySixPointFortyThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEightySixPointFortyThreeMember_193" xlink:to="lab_huge_ExercisePriceEightySixPointFortyThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEightySixPointFortyThreeMember_193" xlink:to="lab_huge_ExercisePriceEightySixPointFortyThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_194" xlink:to="lab_huge_ExercisePriceFiftyFivePointTwentyEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_194" xlink:to="lab_huge_ExercisePriceFiftyFivePointTwentyEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_194" xlink:to="lab_huge_ExercisePriceFiftyFivePointTwentyEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyNinePointThirtyMember_195" xlink:to="lab_huge_ExercisePriceFiftyNinePointThirtyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyNinePointThirtyMember_195" xlink:to="lab_huge_ExercisePriceFiftyNinePointThirtyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyNinePointThirtyMember_195" xlink:to="lab_huge_ExercisePriceFiftyNinePointThirtyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_196" xlink:to="lab_huge_ExercisePriceFiftyPointTwentyFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_196" xlink:to="lab_huge_ExercisePriceFiftyPointTwentyFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_196" xlink:to="lab_huge_ExercisePriceFiftyPointTwentyFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_197" xlink:to="lab_huge_ExercisePriceFiftySixPointTwentyEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_197" xlink:to="lab_huge_ExercisePriceFiftySixPointTwentyEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_197" xlink:to="lab_huge_ExercisePriceFiftySixPointTwentyEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_198" xlink:to="lab_huge_ExercisePriceFiftyTwoPointTwentySixMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_198" xlink:to="lab_huge_ExercisePriceFiftyTwoPointTwentySixMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_198" xlink:to="lab_huge_ExercisePriceFiftyTwoPointTwentySixMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFivePointFourThreeMember_199" xlink:to="lab_huge_ExercisePriceFivePointFourThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFivePointFourThreeMember_199" xlink:to="lab_huge_ExercisePriceFivePointFourThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFivePointFourThreeMember_199" xlink:to="lab_huge_ExercisePriceFivePointFourThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFivePointZeroThreeMember_200" xlink:to="lab_huge_ExercisePriceFivePointZeroThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFivePointZeroThreeMember_200" xlink:to="lab_huge_ExercisePriceFivePointZeroThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFivePointZeroThreeMember_200" xlink:to="lab_huge_ExercisePriceFivePointZeroThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_201" xlink:to="lab_huge_ExercisePriceFortyFourPointTwentyTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_201" xlink:to="lab_huge_ExercisePriceFortyFourPointTwentyTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_201" xlink:to="lab_huge_ExercisePriceFortyFourPointTwentyTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortyPointTwentyMember_202" xlink:to="lab_huge_ExercisePriceFortyPointTwentyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortyPointTwentyMember_202" xlink:to="lab_huge_ExercisePriceFortyPointTwentyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortyPointTwentyMember_202" xlink:to="lab_huge_ExercisePriceFortyPointTwentyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_203" xlink:to="lab_huge_ExercisePriceFortySevenPointTwentyFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_203" xlink:to="lab_huge_ExercisePriceFortySevenPointTwentyFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_203" xlink:to="lab_huge_ExercisePriceFortySevenPointTwentyFourMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFourPointFourTwoMember_204" xlink:to="lab_huge_ExercisePriceFourPointFourTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFourPointFourTwoMember_204" xlink:to="lab_huge_ExercisePriceFourPointFourTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFourPointFourTwoMember_204" xlink:to="lab_huge_ExercisePriceFourPointFourTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfExercisableShareOptions_205" xlink:to="lab_huge_ExercisePriceOfExercisableShareOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfExercisableShareOptions_205" xlink:to="lab_huge_ExercisePriceOfExercisableShareOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrants_206" xlink:to="lab_huge_ExercisePriceOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrants_206" xlink:to="lab_huge_ExercisePriceOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrantsGranted_207" xlink:to="lab_huge_ExercisePriceOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrantsGranted_207" xlink:to="lab_huge_ExercisePriceOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrantsGranted_207" xlink:to="lab_huge_ExercisePriceOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_208" xlink:to="lab_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_208" xlink:to="lab_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_208" xlink:to="lab_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_209" xlink:to="lab_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_209" xlink:to="lab_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_209" xlink:to="lab_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_210" xlink:to="lab_huge_ExercisePriceOneHundredTwentyPointSixtyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_210" xlink:to="lab_huge_ExercisePriceOneHundredTwentyPointSixtyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_210" xlink:to="lab_huge_ExercisePriceOneHundredTwentyPointSixtyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointFiftyMember_211" xlink:to="lab_huge_ExercisePriceSevenPointFiftyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointFiftyMember_211" xlink:to="lab_huge_ExercisePriceSevenPointFiftyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointFiftyMember_211" xlink:to="lab_huge_ExercisePriceSevenPointFiftyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointSeventeenMember_212" xlink:to="lab_huge_ExercisePriceSevenPointSeventeenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointSeventeenMember_212" xlink:to="lab_huge_ExercisePriceSevenPointSeventeenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointSeventeenMember_212" xlink:to="lab_huge_ExercisePriceSevenPointSeventeenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointSixtyThreeMember_213" xlink:to="lab_huge_ExercisePriceSevenPointSixtyThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointSixtyThreeMember_213" xlink:to="lab_huge_ExercisePriceSevenPointSixtyThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointSixtyThreeMember_213" xlink:to="lab_huge_ExercisePriceSevenPointSixtyThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointZeroZeroMember_214" xlink:to="lab_huge_ExercisePriceSevenPointZeroZeroMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointZeroZeroMember_214" xlink:to="lab_huge_ExercisePriceSevenPointZeroZeroMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointZeroZeroMember_214" xlink:to="lab_huge_ExercisePriceSevenPointZeroZeroMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventeenPointEightNineMember_215" xlink:to="lab_huge_ExercisePriceSeventeenPointEightNineMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventeenPointEightNineMember_215" xlink:to="lab_huge_ExercisePriceSeventeenPointEightNineMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventeenPointEightNineMember_215" xlink:to="lab_huge_ExercisePriceSeventeenPointEightNineMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_216" xlink:to="lab_huge_ExercisePriceSeventyFivePointThirtyEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_216" xlink:to="lab_huge_ExercisePriceSeventyFivePointThirtyEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_216" xlink:to="lab_huge_ExercisePriceSeventyFivePointThirtyEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_217" xlink:to="lab_huge_ExercisePriceSeventyOnePointZeroSevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_217" xlink:to="lab_huge_ExercisePriceSeventyOnePointZeroSevenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_217" xlink:to="lab_huge_ExercisePriceSeventyOnePointZeroSevenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixPointSixteenMember_218" xlink:to="lab_huge_ExercisePriceSixPointSixteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixPointSixteenMember_218" xlink:to="lab_huge_ExercisePriceSixPointSixteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixPointSixteenMember_218" xlink:to="lab_huge_ExercisePriceSixPointSixteenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixteenPointZeroEightMember_219" xlink:to="lab_huge_ExercisePriceSixteenPointZeroEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixteenPointZeroEightMember_219" xlink:to="lab_huge_ExercisePriceSixteenPointZeroEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixteenPointZeroEightMember_219" xlink:to="lab_huge_ExercisePriceSixteenPointZeroEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_220" xlink:to="lab_huge_ExercisePriceSixtyEightPointZeroOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_220" xlink:to="lab_huge_ExercisePriceSixtyEightPointZeroOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_220" xlink:to="lab_huge_ExercisePriceSixtyEightPointZeroOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTenPointSixFiveMember_221" xlink:to="lab_huge_ExercisePriceTenPointSixFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTenPointSixFiveMember_221" xlink:to="lab_huge_ExercisePriceTenPointSixFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTenPointSixFiveMember_221" xlink:to="lab_huge_ExercisePriceTenPointSixFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThirteenPointFourSevenMember_222" xlink:to="lab_huge_ExercisePriceThirteenPointFourSevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThirteenPointFourSevenMember_222" xlink:to="lab_huge_ExercisePriceThirteenPointFourSevenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThirteenPointFourSevenMember_222" xlink:to="lab_huge_ExercisePriceThirteenPointFourSevenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThirteenPointZeroSevenMember_223" xlink:to="lab_huge_ExercisePriceThirteenPointZeroSevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThirteenPointZeroSevenMember_223" xlink:to="lab_huge_ExercisePriceThirteenPointZeroSevenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThirteenPointZeroSevenMember_223" xlink:to="lab_huge_ExercisePriceThirteenPointZeroSevenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyFourPointTwelveMember_224" xlink:to="lab_huge_ExercisePriceTwentyFourPointTwelveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyFourPointTwelveMember_224" xlink:to="lab_huge_ExercisePriceTwentyFourPointTwelveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyFourPointTwelveMember_224" xlink:to="lab_huge_ExercisePriceTwentyFourPointTwelveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointElevenMember_225" xlink:to="lab_huge_ExercisePriceTwentyOnePointElevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointElevenMember_225" xlink:to="lab_huge_ExercisePriceTwentyOnePointElevenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointElevenMember_225" xlink:to="lab_huge_ExercisePriceTwentyOnePointElevenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_226" xlink:to="lab_huge_ExercisePriceTwentyOnePointNinetyOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_226" xlink:to="lab_huge_ExercisePriceTwentyOnePointNinetyOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_226" xlink:to="lab_huge_ExercisePriceTwentyOnePointNinetyOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_227" xlink:to="lab_huge_ExercisePriceTwentyOnePointTwentyTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_227" xlink:to="lab_huge_ExercisePriceTwentyOnePointTwentyTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_227" xlink:to="lab_huge_ExercisePriceTwentyOnePointTwentyTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyPointOneZeroMember_228" xlink:to="lab_huge_ExercisePriceTwentyPointOneZeroMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyPointOneZeroMember_228" xlink:to="lab_huge_ExercisePriceTwentyPointOneZeroMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyPointOneZeroMember_228" xlink:to="lab_huge_ExercisePriceTwentyPointOneZeroMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentySixPointThirteenMember_229" xlink:to="lab_huge_ExercisePriceTwentySixPointThirteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentySixPointThirteenMember_229" xlink:to="lab_huge_ExercisePriceTwentySixPointThirteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentySixPointThirteenMember_229" xlink:to="lab_huge_ExercisePriceTwentySixPointThirteenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwoPointSixOneMember_230" xlink:to="lab_huge_ExercisePriceTwoPointSixOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwoPointSixOneMember_230" xlink:to="lab_huge_ExercisePriceTwoPointSixOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwoPointSixOneMember_230" xlink:to="lab_huge_ExercisePriceTwoPointSixOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_231" xlink:to="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_231" xlink:to="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_231" xlink:to="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_231" xlink:to="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendYieldOfWarrants_232" xlink:to="lab_huge_ExpectedDividendYieldOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendYieldOfWarrants_232" xlink:to="lab_huge_ExpectedDividendYieldOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendYieldOfWarrants_232" xlink:to="lab_huge_ExpectedDividendYieldOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendYieldOfWarrantsGranted_233" xlink:to="lab_huge_ExpectedDividendYieldOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendYieldOfWarrantsGranted_233" xlink:to="lab_huge_ExpectedDividendYieldOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendYieldOfWarrantsGranted_233" xlink:to="lab_huge_ExpectedDividendYieldOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedGrowthCycle_234" xlink:to="lab_huge_ExpectedGrowthCycle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedGrowthCycle_234" xlink:to="lab_huge_ExpectedGrowthCycle_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedGrowthCycle_234" xlink:to="lab_huge_ExpectedGrowthCycle_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedGrowthCycleCompleted_235" xlink:to="lab_huge_ExpectedGrowthCycleCompleted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedGrowthCycleCompleted_235" xlink:to="lab_huge_ExpectedGrowthCycleCompleted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedGrowthCycleCompleted_235" xlink:to="lab_huge_ExpectedGrowthCycleCompleted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedLifeOfWarrants_236" xlink:to="lab_huge_ExpectedLifeOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedLifeOfWarrants_236" xlink:to="lab_huge_ExpectedLifeOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedLifeOfWarrants_236" xlink:to="lab_huge_ExpectedLifeOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedNetSellingPricePerGramOfDriedFlower_237" xlink:to="lab_huge_ExpectedNetSellingPricePerGramOfDriedFlower_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedNetSellingPricePerGramOfDriedFlower_237" xlink:to="lab_huge_ExpectedNetSellingPricePerGramOfDriedFlower_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedNetSellingPricePerGramOfTrim_238" xlink:to="lab_huge_ExpectedNetSellingPricePerGramOfTrim_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedNetSellingPricePerGramOfTrim_238" xlink:to="lab_huge_ExpectedNetSellingPricePerGramOfTrim_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedNetSellingPricePerGramOfTrim_238" xlink:to="lab_huge_ExpectedNetSellingPricePerGramOfTrim_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedSellingPricePerGramOfDriedFlower_239" xlink:to="lab_huge_ExpectedSellingPricePerGramOfDriedFlower_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedSellingPricePerGramOfDriedFlower_239" xlink:to="lab_huge_ExpectedSellingPricePerGramOfDriedFlower_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedSellingPricePerGramOfTrim_240" xlink:to="lab_huge_ExpectedSellingPricePerGramOfTrim_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedSellingPricePerGramOfTrim_240" xlink:to="lab_huge_ExpectedSellingPricePerGramOfTrim_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedSellingPricePerGramOfTrim_240" xlink:to="lab_huge_ExpectedSellingPricePerGramOfTrim_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedTermOfWarrants_241" xlink:to="lab_huge_ExpectedTermOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedTermOfWarrants_241" xlink:to="lab_huge_ExpectedTermOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedTermOfWarrants_241" xlink:to="lab_huge_ExpectedTermOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrants_242" xlink:to="lab_huge_ExpectedVolatilityOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrants_242" xlink:to="lab_huge_ExpectedVolatilityOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrants_242" xlink:to="lab_huge_ExpectedVolatilityOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrants_242" xlink:to="lab_huge_ExpectedVolatilityOfWarrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrantsGranted_243" xlink:to="lab_huge_ExpectedVolatilityOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrantsGranted_243" xlink:to="lab_huge_ExpectedVolatilityOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrantsGranted_243" xlink:to="lab_huge_ExpectedVolatilityOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_244" xlink:to="lab_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_244" xlink:to="lab_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_244" xlink:to="lab_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_245" xlink:to="lab_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_245" xlink:to="lab_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_245" xlink:to="lab_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldOfDryFlower_246" xlink:to="lab_huge_ExpectedYieldOfDryFlower_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldOfDryFlower_246" xlink:to="lab_huge_ExpectedYieldOfDryFlower_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldOfDryFlower_246" xlink:to="lab_huge_ExpectedYieldOfDryFlower_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldOfDryTrim_247" xlink:to="lab_huge_ExpectedYieldOfDryTrim_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldOfDryTrim_247" xlink:to="lab_huge_ExpectedYieldOfDryTrim_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldOfDryTrim_247" xlink:to="lab_huge_ExpectedYieldOfDryTrim_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpiryDateOfWarrants_248" xlink:to="lab_huge_ExpiryDateOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpiryDateOfWarrants_248" xlink:to="lab_huge_ExpiryDateOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpiryDateOfWarrants_248" xlink:to="lab_huge_ExpiryDateOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpiryTermOfWarrantsGranted_249" xlink:to="lab_huge_ExpiryTermOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpiryTermOfWarrantsGranted_249" xlink:to="lab_huge_ExpiryTermOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpiryTermOfWarrantsGranted_249" xlink:to="lab_huge_ExpiryTermOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FacilityRelatedExpenditures_250" xlink:to="lab_huge_FacilityRelatedExpenditures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FacilityRelatedExpenditures_250" xlink:to="lab_huge_FacilityRelatedExpenditures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FacilityRelatedExpenditures_250" xlink:to="lab_huge_FacilityRelatedExpenditures_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FacilityUnderDevelopmentMember_251" xlink:to="lab_huge_FacilityUnderDevelopmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FacilityUnderDevelopmentMember_251" xlink:to="lab_huge_FacilityUnderDevelopmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FacilityUnderDevelopmentMember_251" xlink:to="lab_huge_FacilityUnderDevelopmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueAdjustmentsOnInventorySold_252" xlink:to="lab_huge_FairValueAdjustmentsOnInventorySold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueAdjustmentsOnInventorySold_252" xlink:to="lab_huge_FairValueAdjustmentsOnInventorySold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueAdjustmentsOnInventorySold_252" xlink:to="lab_huge_FairValueAdjustmentsOnInventorySold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueAdjustmentsOnInventorySold_252" xlink:to="lab_huge_FairValueAdjustmentsOnInventorySold_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfShares_253" xlink:to="lab_huge_FairValueOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfShares_253" xlink:to="lab_huge_FairValueOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfShares_253" xlink:to="lab_huge_FairValueOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfSharesAndWarrantsAcquired_254" xlink:to="lab_huge_FairValueOfSharesAndWarrantsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfSharesAndWarrantsAcquired_254" xlink:to="lab_huge_FairValueOfSharesAndWarrantsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfSharesAndWarrantsAcquired_254" xlink:to="lab_huge_FairValueOfSharesAndWarrantsAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrants_255" xlink:to="lab_huge_FairValueOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrants_255" xlink:to="lab_huge_FairValueOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrants_255" xlink:to="lab_huge_FairValueOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrants_255" xlink:to="lab_huge_FairValueOfWarrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Feb252018Member_256" xlink:to="lab_huge_Feb252018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Feb252018Member_256" xlink:to="lab_huge_Feb252018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Feb252018Member_256" xlink:to="lab_huge_Feb252018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FindersFee_257" xlink:to="lab_huge_FindersFee_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FindersFee_257" xlink:to="lab_huge_FindersFee_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FindersFee_257" xlink:to="lab_huge_FindersFee_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FindersFeeShares_258" xlink:to="lab_huge_FindersFeeShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FindersFeeShares_258" xlink:to="lab_huge_FindersFeeShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FirstRepublicCapitalCorporationMember_259" xlink:to="lab_huge_FirstRepublicCapitalCorporationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FirstRepublicCapitalCorporationMember_259" xlink:to="lab_huge_FirstRepublicCapitalCorporationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FirstRepublicCapitalCorporationMember_259" xlink:to="lab_huge_FirstRepublicCapitalCorporationMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerCEOMember_260" xlink:to="lab_huge_FormerCEOMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerCEOMember_260" xlink:to="lab_huge_FormerCEOMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerChiefExecutiveOfficerMember_261" xlink:to="lab_huge_FormerChiefExecutiveOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerChiefExecutiveOfficerMember_261" xlink:to="lab_huge_FormerChiefExecutiveOfficerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerChiefExecutiveOfficerMember_261" xlink:to="lab_huge_FormerChiefExecutiveOfficerMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerChiefOperatingOfficerMember_262" xlink:to="lab_huge_FormerChiefOperatingOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerChiefOperatingOfficerMember_262" xlink:to="lab_huge_FormerChiefOperatingOfficerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerChiefOperatingOfficerMember_262" xlink:to="lab_huge_FormerChiefOperatingOfficerMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FSDBiosciencesMember_263" xlink:to="lab_huge_FSDBiosciencesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FSDBiosciencesMember_263" xlink:to="lab_huge_FSDBiosciencesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FSDBiosciencesMember_263" xlink:to="lab_huge_FSDBiosciencesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FurnitureFixturesAndEquipmentMember_264" xlink:to="lab_huge_FurnitureFixturesAndEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FurnitureFixturesAndEquipmentMember_264" xlink:to="lab_huge_FurnitureFixturesAndEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FurnitureFixturesAndEquipmentMember_264" xlink:to="lab_huge_FurnitureFixturesAndEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FvPharmaIncMember_265" xlink:to="lab_huge_FvPharmaIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FvPharmaIncMember_265" xlink:to="lab_huge_FvPharmaIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FvPharmaIncMember_265" xlink:to="lab_huge_FvPharmaIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnChangeInFairValueOfDerivativeLiability_266" xlink:to="lab_huge_GainLossOnChangeInFairValueOfDerivativeLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnChangeInFairValueOfDerivativeLiability_266" xlink:to="lab_huge_GainLossOnChangeInFairValueOfDerivativeLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrantDateAxis_267" xlink:to="lab_huge_GrantDateAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrantDateAxis_267" xlink:to="lab_huge_GrantDateAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrantDateDomain_268" xlink:to="lab_huge_GrantDateDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrantDateDomain_268" xlink:to="lab_huge_GrantDateDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrossLossProfitBeforeFairValueAdjustments_269" xlink:to="lab_huge_GrossLossProfitBeforeFairValueAdjustments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrossLossProfitBeforeFairValueAdjustments_269" xlink:to="lab_huge_GrossLossProfitBeforeFairValueAdjustments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrossLossProfitBeforeFairValueAdjustments_269" xlink:to="lab_huge_GrossLossProfitBeforeFairValueAdjustments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GuaranteedMinimumLiquidationValueOfShares_270" xlink:to="lab_huge_GuaranteedMinimumLiquidationValueOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GuaranteedMinimumLiquidationValueOfShares_270" xlink:to="lab_huge_GuaranteedMinimumLiquidationValueOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HarvestedCannabisMember_271" xlink:to="lab_huge_HarvestedCannabisMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HarvestedCannabisMember_271" xlink:to="lab_huge_HarvestedCannabisMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HarvestedCannabisMember_271" xlink:to="lab_huge_HarvestedCannabisMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HempProductsMember_272" xlink:to="lab_huge_HempProductsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HempProductsMember_272" xlink:to="lab_huge_HempProductsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HempProductsMember_272" xlink:to="lab_huge_HempProductsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HeritageBuildingRestorationCommitmentMember_273" xlink:to="lab_huge_HeritageBuildingRestorationCommitmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HeritageBuildingRestorationCommitmentMember_273" xlink:to="lab_huge_HeritageBuildingRestorationCommitmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HeritageBuildingRestorationCommitmentMember_273" xlink:to="lab_huge_HeritageBuildingRestorationCommitmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HighTideIncMember_274" xlink:to="lab_huge_HighTideIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HighTideIncMember_274" xlink:to="lab_huge_HighTideIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HighTideIncMember_274" xlink:to="lab_huge_HighTideIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HugeShopsMember_275" xlink:to="lab_huge_HugeShopsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HugeShopsMember_275" xlink:to="lab_huge_HugeShopsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HugeShopsMember_275" xlink:to="lab_huge_HugeShopsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpactOfPresentValue_276" xlink:to="lab_huge_ImpactOfPresentValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpactOfPresentValue_276" xlink:to="lab_huge_ImpactOfPresentValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpactOfPresentValue_276" xlink:to="lab_huge_ImpactOfPresentValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpactOfPresentValueOnLeaseObligations_277" xlink:to="lab_huge_ImpactOfPresentValueOnLeaseObligations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpactOfPresentValueOnLeaseObligations_277" xlink:to="lab_huge_ImpactOfPresentValueOnLeaseObligations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpactOfPresentValueOnLeaseObligations_277" xlink:to="lab_huge_ImpactOfPresentValueOnLeaseObligations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_278" xlink:to="lab_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_278" xlink:to="lab_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_278" xlink:to="lab_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_279" xlink:to="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_279" xlink:to="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_279" xlink:to="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentMember_280" xlink:to="lab_huge_ImpairmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentMember_280" xlink:to="lab_huge_ImpairmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentMember_280" xlink:to="lab_huge_ImpairmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_281" xlink:to="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_281" xlink:to="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_281" xlink:to="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_281" xlink:to="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_282" xlink:to="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_282" xlink:to="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_282" xlink:to="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_283" xlink:to="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_283" xlink:to="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_283" xlink:to="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_284" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_284" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_284" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_284" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_285" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_285" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_285" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_286" xlink:to="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_286" xlink:to="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_286" xlink:to="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_287" xlink:to="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_287" xlink:to="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_287" xlink:to="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_288" xlink:to="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_288" xlink:to="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_288" xlink:to="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_289" xlink:to="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_289" xlink:to="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_289" xlink:to="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisition_290" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisition_290" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisition_290" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_291" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_291" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_291" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_291" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_292" xlink:to="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_292" xlink:to="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_292" xlink:to="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_292" xlink:to="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_293" xlink:to="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_293" xlink:to="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_293" xlink:to="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_293" xlink:to="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuations_294" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuations_294" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuations_294" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_295" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_295" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_295" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_295" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_296" xlink:to="lab_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_296" xlink:to="lab_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_296" xlink:to="lab_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IndependentDirectorMember_297" xlink:to="lab_huge_IndependentDirectorMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IndependentDirectorMember_297" xlink:to="lab_huge_IndependentDirectorMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IndependentDirectorMember_297" xlink:to="lab_huge_IndependentDirectorMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IndependentDirectorMember_297" xlink:to="lab_huge_IndependentDirectorMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfShares_298" xlink:to="lab_huge_IssuanceOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfShares_298" xlink:to="lab_huge_IssuanceOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfShares_298" xlink:to="lab_huge_IssuanceOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jan52018Member_299" xlink:to="lab_huge_Jan52018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jan52018Member_299" xlink:to="lab_huge_Jan52018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jan52018Member_299" xlink:to="lab_huge_Jan52018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jan52018WarrantMember_300" xlink:to="lab_huge_Jan52018WarrantMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jan52018WarrantMember_300" xlink:to="lab_huge_Jan52018WarrantMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jan52018WarrantMember_300" xlink:to="lab_huge_Jan52018WarrantMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jun112018Member_301" xlink:to="lab_huge_Jun112018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jun112018Member_301" xlink:to="lab_huge_Jun112018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jun112018Member_301" xlink:to="lab_huge_Jun112018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jun122018Member_302" xlink:to="lab_huge_Jun122018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jun122018Member_302" xlink:to="lab_huge_Jun122018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jun122018Member_302" xlink:to="lab_huge_Jun122018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_KeyManagementPersonnelCarAllowance_303" xlink:to="lab_huge_KeyManagementPersonnelCarAllowance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_KeyManagementPersonnelCarAllowance_303" xlink:to="lab_huge_KeyManagementPersonnelCarAllowance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_KeyManagementPersonnelCarAllowance_303" xlink:to="lab_huge_KeyManagementPersonnelCarAllowance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LeaseTermOnOfficeSpace_304" xlink:to="lab_huge_LeaseTermOnOfficeSpace_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LeaseTermOnOfficeSpace_304" xlink:to="lab_huge_LeaseTermOnOfficeSpace_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LeaseTermOnOfficeSpace_304" xlink:to="lab_huge_LeaseTermOnOfficeSpace_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LegalEntitiesAxis_305" xlink:to="lab_huge_LegalEntitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LegalEntitiesAxis_305" xlink:to="lab_huge_LegalEntitiesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LegalEntitiesDomain_306" xlink:to="lab_huge_LegalEntitiesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LegalEntitiesDomain_306" xlink:to="lab_huge_LegalEntitiesDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ListingExpense_307" xlink:to="lab_huge_ListingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ListingExpense_307" xlink:to="lab_huge_ListingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ListingExpense_307" xlink:to="lab_huge_ListingExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_308" xlink:to="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_308" xlink:to="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_308" xlink:to="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_308" xlink:to="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossOnSettlementOfFinancialLiability_309" xlink:to="lab_huge_LossOnSettlementOfFinancialLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossOnSettlementOfFinancialLiability_309" xlink:to="lab_huge_LossOnSettlementOfFinancialLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossOnSettlementOfFinancialLiability_309" xlink:to="lab_huge_LossOnSettlementOfFinancialLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ManagementAndConsultingContractsMember_310" xlink:to="lab_huge_ManagementAndConsultingContractsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ManagementAndConsultingContractsMember_310" xlink:to="lab_huge_ManagementAndConsultingContractsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ManagementAndConsultingContractsMember_310" xlink:to="lab_huge_ManagementAndConsultingContractsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ManagementFees_311" xlink:to="lab_huge_ManagementFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ManagementFees_311" xlink:to="lab_huge_ManagementFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ManagementFees_311" xlink:to="lab_huge_ManagementFees_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Mar222018Member_312" xlink:to="lab_huge_Mar222018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Mar222018Member_312" xlink:to="lab_huge_Mar222018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Mar222018Member_312" xlink:to="lab_huge_Mar222018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Mar282018Member_313" xlink:to="lab_huge_Mar282018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Mar282018Member_313" xlink:to="lab_huge_Mar282018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Mar282018Member_313" xlink:to="lab_huge_Mar282018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March262018Member_314" xlink:to="lab_huge_March262018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March262018Member_314" xlink:to="lab_huge_March262018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March262018Member_314" xlink:to="lab_huge_March262018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March282018Member_315" xlink:to="lab_huge_March282018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March282018Member_315" xlink:to="lab_huge_March282018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March282018Member_315" xlink:to="lab_huge_March282018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March92018Member_316" xlink:to="lab_huge_March92018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March92018Member_316" xlink:to="lab_huge_March92018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March92018Member_316" xlink:to="lab_huge_March92018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceOfShares_317" xlink:to="lab_huge_MarketPriceOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceOfShares_317" xlink:to="lab_huge_MarketPriceOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceOfShares_317" xlink:to="lab_huge_MarketPriceOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceOfWarrants_318" xlink:to="lab_huge_MarketPriceOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceOfWarrants_318" xlink:to="lab_huge_MarketPriceOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceOfWarrants_318" xlink:to="lab_huge_MarketPriceOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceShareOptionsGranted_319" xlink:to="lab_huge_MarketPriceShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceShareOptionsGranted_319" xlink:to="lab_huge_MarketPriceShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceShareOptionsGranted_319" xlink:to="lab_huge_MarketPriceShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May242018Member_320" xlink:to="lab_huge_May242018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May242018Member_320" xlink:to="lab_huge_May242018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May242018Member_320" xlink:to="lab_huge_May242018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May242018WarrantMember_321" xlink:to="lab_huge_May242018WarrantMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May242018WarrantMember_321" xlink:to="lab_huge_May242018WarrantMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May242018WarrantMember_321" xlink:to="lab_huge_May242018WarrantMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May82018Member_322" xlink:to="lab_huge_May82018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May82018Member_322" xlink:to="lab_huge_May82018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May82018Member_322" xlink:to="lab_huge_May82018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MealsAndEntertainment_323" xlink:to="lab_huge_MealsAndEntertainment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MealsAndEntertainment_323" xlink:to="lab_huge_MealsAndEntertainment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MealsAndEntertainment_323" xlink:to="lab_huge_MealsAndEntertainment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MinimumInvestmentReceivable_324" xlink:to="lab_huge_MinimumInvestmentReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MinimumInvestmentReceivable_324" xlink:to="lab_huge_MinimumInvestmentReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MinimumInvestmentReceivable_324" xlink:to="lab_huge_MinimumInvestmentReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_325" xlink:to="lab_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_325" xlink:to="lab_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_325" xlink:to="lab_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_326" xlink:to="lab_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_326" xlink:to="lab_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_326" xlink:to="lab_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_327" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_327" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_327" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_328" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_328" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_328" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossCarryforwards_329" xlink:to="lab_huge_NonCapitalLossCarryforwards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossCarryforwards_329" xlink:to="lab_huge_NonCapitalLossCarryforwards_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossCarryforwards_329" xlink:to="lab_huge_NonCapitalLossCarryforwards_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossCarryForwardsMember_330" xlink:to="lab_huge_NonCapitalLossCarryForwardsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossCarryForwardsMember_330" xlink:to="lab_huge_NonCapitalLossCarryForwardsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossCarryForwardsMember_330" xlink:to="lab_huge_NonCapitalLossCarryForwardsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossesMember_331" xlink:to="lab_huge_NonCapitalLossesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossesMember_331" xlink:to="lab_huge_NonCapitalLossesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossesMember_331" xlink:to="lab_huge_NonCapitalLossesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA_332" xlink:to="lab_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA_332" xlink:to="lab_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA_333" xlink:to="lab_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA_333" xlink:to="lab_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NotesPayableMember_334" xlink:to="lab_huge_NotesPayableMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NotesPayableMember_334" xlink:to="lab_huge_NotesPayableMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NotesPayableMember_334" xlink:to="lab_huge_NotesPayableMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov12017Member_335" xlink:to="lab_huge_Nov12017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov12017Member_335" xlink:to="lab_huge_Nov12017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov12017Member_335" xlink:to="lab_huge_Nov12017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov122018Member_336" xlink:to="lab_huge_Nov122018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov122018Member_336" xlink:to="lab_huge_Nov122018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov122018Member_336" xlink:to="lab_huge_Nov122018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov142017Member_337" xlink:to="lab_huge_Nov142017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov142017Member_337" xlink:to="lab_huge_Nov142017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov142017Member_337" xlink:to="lab_huge_Nov142017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov152018Member_338" xlink:to="lab_huge_Nov152018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov152018Member_338" xlink:to="lab_huge_Nov152018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov152018Member_338" xlink:to="lab_huge_Nov152018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov212017Member_339" xlink:to="lab_huge_Nov212017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov212017Member_339" xlink:to="lab_huge_Nov212017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov212017Member_339" xlink:to="lab_huge_Nov212017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov262018Member_340" xlink:to="lab_huge_Nov262018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov262018Member_340" xlink:to="lab_huge_Nov262018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov262018Member_340" xlink:to="lab_huge_Nov262018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_341" xlink:to="lab_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_341" xlink:to="lab_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_341" xlink:to="lab_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfAgreement_342" xlink:to="lab_huge_NumberOfAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfAgreement_342" xlink:to="lab_huge_NumberOfAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_343" xlink:to="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_343" xlink:to="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_343" xlink:to="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_343" xlink:to="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesAcquired_344" xlink:to="lab_huge_NumberOfSharesAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesAcquired_344" xlink:to="lab_huge_NumberOfSharesAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesAcquired_344" xlink:to="lab_huge_NumberOfSharesAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesHeld_345" xlink:to="lab_huge_NumberOfSharesHeld_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesHeld_345" xlink:to="lab_huge_NumberOfSharesHeld_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesHeld_345" xlink:to="lab_huge_NumberOfSharesHeld_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_346" xlink:to="lab_huge_NumberOfSharesHeldSubjectToEscrowArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_346" xlink:to="lab_huge_NumberOfSharesHeldSubjectToEscrowArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_346" xlink:to="lab_huge_NumberOfSharesHeldSubjectToEscrowArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedAsFindersFee_347" xlink:to="lab_huge_NumberOfSharesIssuedAsFindersFee_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedAsFindersFee_347" xlink:to="lab_huge_NumberOfSharesIssuedAsFindersFee_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedAsFindersFee_347" xlink:to="lab_huge_NumberOfSharesIssuedAsFindersFee_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_348" xlink:to="lab_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_348" xlink:to="lab_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_348" xlink:to="lab_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForDebtSettlement_349" xlink:to="lab_huge_NumberOfSharesIssuedForDebtSettlement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForDebtSettlement_349" xlink:to="lab_huge_NumberOfSharesIssuedForDebtSettlement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForDebtSettlement_349" xlink:to="lab_huge_NumberOfSharesIssuedForDebtSettlement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_350" xlink:to="lab_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_350" xlink:to="lab_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_350" xlink:to="lab_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInPrivatePlacement_351" xlink:to="lab_huge_NumberOfSharesIssuedInPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInPrivatePlacement_351" xlink:to="lab_huge_NumberOfSharesIssuedInPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInPrivatePlacement_351" xlink:to="lab_huge_NumberOfSharesIssuedInPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInPrivatePlacement_351" xlink:to="lab_huge_NumberOfSharesIssuedInPrivatePlacement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInShareExchange_352" xlink:to="lab_huge_NumberOfSharesIssuedInShareExchange_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInShareExchange_352" xlink:to="lab_huge_NumberOfSharesIssuedInShareExchange_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInShareExchange_352" xlink:to="lab_huge_NumberOfSharesIssuedInShareExchange_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_353" xlink:to="lab_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_353" xlink:to="lab_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_353" xlink:to="lab_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSold_354" xlink:to="lab_huge_NumberOfSharesSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSold_354" xlink:to="lab_huge_NumberOfSharesSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSold_354" xlink:to="lab_huge_NumberOfSharesSold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSubscribed_355" xlink:to="lab_huge_NumberOfSharesSubscribed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSubscribed_355" xlink:to="lab_huge_NumberOfSharesSubscribed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSubscribed_355" xlink:to="lab_huge_NumberOfSharesSubscribed_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSubscribed_355" xlink:to="lab_huge_NumberOfSharesSubscribed_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSubscribed_355" xlink:to="lab_huge_NumberOfSharesSubscribed_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSubscribed_355" xlink:to="lab_huge_NumberOfSharesSubscribed_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsAcquired_356" xlink:to="lab_huge_NumberOfWarrantsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsAcquired_356" xlink:to="lab_huge_NumberOfWarrantsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExercised_357" xlink:to="lab_huge_NumberOfWarrantsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExercised_357" xlink:to="lab_huge_NumberOfWarrantsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExercised_357" xlink:to="lab_huge_NumberOfWarrantsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExercised_357" xlink:to="lab_huge_NumberOfWarrantsExercised_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExpired_358" xlink:to="lab_huge_NumberOfWarrantsExpired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExpired_358" xlink:to="lab_huge_NumberOfWarrantsExpired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExpired_358" xlink:to="lab_huge_NumberOfWarrantsExpired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExpired_358" xlink:to="lab_huge_NumberOfWarrantsExpired_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsGranted_359" xlink:to="lab_huge_NumberOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsGranted_359" xlink:to="lab_huge_NumberOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsGranted_359" xlink:to="lab_huge_NumberOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsGranted_359" xlink:to="lab_huge_NumberOfWarrantsGranted_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsHeld_360" xlink:to="lab_huge_NumberOfWarrantsHeld_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsHeld_360" xlink:to="lab_huge_NumberOfWarrantsHeld_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsHeld_360" xlink:to="lab_huge_NumberOfWarrantsHeld_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsOutstanding_361" xlink:to="lab_huge_NumberOfWarrantsOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsOutstanding_361" xlink:to="lab_huge_NumberOfWarrantsOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsOutstanding_361" xlink:to="lab_huge_NumberOfWarrantsOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsOutstanding_361" xlink:to="lab_huge_NumberOfWarrantsOutstanding_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsOutstanding_361" xlink:to="lab_huge_NumberOfWarrantsOutstanding_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Oct202017Member_362" xlink:to="lab_huge_Oct202017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Oct202017Member_362" xlink:to="lab_huge_Oct202017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Oct202017Member_362" xlink:to="lab_huge_Oct202017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OfficeAndGeneralExpenses_363" xlink:to="lab_huge_OfficeAndGeneralExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OfficeAndGeneralExpenses_363" xlink:to="lab_huge_OfficeAndGeneralExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OfficeAndGeneralExpenses_363" xlink:to="lab_huge_OfficeAndGeneralExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OfficeLeaseAgreementMember_364" xlink:to="lab_huge_OfficeLeaseAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OfficeLeaseAgreementMember_364" xlink:to="lab_huge_OfficeLeaseAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OfficeLeaseAgreementMember_364" xlink:to="lab_huge_OfficeLeaseAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OperatingLeaseImpactOfPresentValue_365" xlink:to="lab_huge_OperatingLeaseImpactOfPresentValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OperatingLeaseImpactOfPresentValue_365" xlink:to="lab_huge_OperatingLeaseImpactOfPresentValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OperatingLeaseImpactOfPresentValue_365" xlink:to="lab_huge_OperatingLeaseImpactOfPresentValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OperatingLeaseImpactOfPresentValue_365" xlink:to="lab_huge_OperatingLeaseImpactOfPresentValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherAllowances_366" xlink:to="lab_huge_OtherAllowances_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherAllowances_366" xlink:to="lab_huge_OtherAllowances_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherFinancialLiabilitiesMember_367" xlink:to="lab_huge_OtherFinancialLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherFinancialLiabilitiesMember_367" xlink:to="lab_huge_OtherFinancialLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherFinancialLiabilitiesMember_367" xlink:to="lab_huge_OtherFinancialLiabilitiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherGeneralAndAdministrativeExpenses_368" xlink:to="lab_huge_OtherGeneralAndAdministrativeExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherGeneralAndAdministrativeExpenses_368" xlink:to="lab_huge_OtherGeneralAndAdministrativeExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherGeneralAndAdministrativeExpenses_368" xlink:to="lab_huge_OtherGeneralAndAdministrativeExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInventoryMember_369" xlink:to="lab_huge_OtherInventoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInventoryMember_369" xlink:to="lab_huge_OtherInventoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInventoryMember_369" xlink:to="lab_huge_OtherInventoryMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentMember_370" xlink:to="lab_huge_OtherInvestmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentMember_370" xlink:to="lab_huge_OtherInvestmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentMember_370" xlink:to="lab_huge_OtherInvestmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_371" xlink:to="lab_huge_OtherInvestmentsNameOfEntityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_371" xlink:to="lab_huge_OtherInvestmentsNameOfEntityAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_372" xlink:to="lab_huge_OtherInvestmentsNameOfEntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_372" xlink:to="lab_huge_OtherInvestmentsNameOfEntityDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OutstandingCommitmentToPurchaseAdditionalProduct_373" xlink:to="lab_huge_OutstandingCommitmentToPurchaseAdditionalProduct_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OutstandingCommitmentToPurchaseAdditionalProduct_373" xlink:to="lab_huge_OutstandingCommitmentToPurchaseAdditionalProduct_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PatentMaintenanceFee_374" xlink:to="lab_huge_PatentMaintenanceFee_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PatentMaintenanceFee_374" xlink:to="lab_huge_PatentMaintenanceFee_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PatentMaintenanceFee_374" xlink:to="lab_huge_PatentMaintenanceFee_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfExpenses_375" xlink:to="lab_huge_PaymentOfExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfExpenses_375" xlink:to="lab_huge_PaymentOfExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfOperatingLease_376" xlink:to="lab_huge_PaymentOfOperatingLease_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfOperatingLease_376" xlink:to="lab_huge_PaymentOfOperatingLease_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfOperatingLease_376" xlink:to="lab_huge_PaymentOfOperatingLease_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfOperatingLease_376" xlink:to="lab_huge_PaymentOfOperatingLease_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfOperatingLease_376" xlink:to="lab_huge_PaymentOfOperatingLease_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfOperatingLease_376" xlink:to="lab_huge_PaymentOfOperatingLease_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_377" xlink:to="lab_huge_PercentageOfAggregateDiscountForSharesInEscrow_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_377" xlink:to="lab_huge_PercentageOfAggregateDiscountForSharesInEscrow_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_377" xlink:to="lab_huge_PercentageOfAggregateDiscountForSharesInEscrow_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfDeclineInFairValueOfInvestment_378" xlink:to="lab_huge_PercentageOfDeclineInFairValueOfInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfDeclineInFairValueOfInvestment_378" xlink:to="lab_huge_PercentageOfDeclineInFairValueOfInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfDeclineInFairValueOfInvestment_378" xlink:to="lab_huge_PercentageOfDeclineInFairValueOfInvestment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_379" xlink:to="lab_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_379" xlink:to="lab_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_380" xlink:to="lab_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_380" xlink:to="lab_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_381" xlink:to="lab_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_381" xlink:to="lab_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_382" xlink:to="lab_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_382" xlink:to="lab_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_383" xlink:to="lab_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_383" xlink:to="lab_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_384" xlink:to="lab_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_384" xlink:to="lab_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PermanentDifferences_385" xlink:to="lab_huge_PermanentDifferences_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PermanentDifferences_385" xlink:to="lab_huge_PermanentDifferences_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PermanentDifferences_385" xlink:to="lab_huge_PermanentDifferences_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmadrugIncMember_386" xlink:to="lab_huge_PharmadrugIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmadrugIncMember_386" xlink:to="lab_huge_PharmadrugIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmadrugIncMember_386" xlink:to="lab_huge_PharmadrugIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmadrugProductionGMBHMember_387" xlink:to="lab_huge_PharmadrugProductionGMBHMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmadrugProductionGMBHMember_387" xlink:to="lab_huge_PharmadrugProductionGMBHMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmadrugProductionGMBHMember_387" xlink:to="lab_huge_PharmadrugProductionGMBHMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmastripCorpMember_388" xlink:to="lab_huge_PharmastripCorpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmastripCorpMember_388" xlink:to="lab_huge_PharmastripCorpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmastripCorpMember_388" xlink:to="lab_huge_PharmastripCorpMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentAndChiefExecutiveOfficerMember_389" xlink:to="lab_huge_PresidentAndChiefExecutiveOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentAndChiefExecutiveOfficerMember_389" xlink:to="lab_huge_PresidentAndChiefExecutiveOfficerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentAndChiefExecutiveOfficerMember_389" xlink:to="lab_huge_PresidentAndChiefExecutiveOfficerMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentAndDirectorMember_390" xlink:to="lab_huge_PresidentAndDirectorMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentAndDirectorMember_390" xlink:to="lab_huge_PresidentAndDirectorMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentAndDirectorMember_390" xlink:to="lab_huge_PresidentAndDirectorMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFsdBiosciencesMember_391" xlink:to="lab_huge_PresidentOfFsdBiosciencesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFsdBiosciencesMember_391" xlink:to="lab_huge_PresidentOfFsdBiosciencesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFsdBiosciencesMember_391" xlink:to="lab_huge_PresidentOfFsdBiosciencesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFSDMember_392" xlink:to="lab_huge_PresidentOfFSDMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFSDMember_392" xlink:to="lab_huge_PresidentOfFSDMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFSDMember_392" xlink:to="lab_huge_PresidentOfFSDMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFVPharmaMember_393" xlink:to="lab_huge_PresidentOfFVPharmaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFVPharmaMember_393" xlink:to="lab_huge_PresidentOfFVPharmaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFVPharmaMember_393" xlink:to="lab_huge_PresidentOfFVPharmaMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentsMember_394" xlink:to="lab_huge_PresidentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentsMember_394" xlink:to="lab_huge_PresidentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrincipalAmountOfBorrowings_395" xlink:to="lab_huge_PrincipalAmountOfBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrincipalAmountOfBorrowings_395" xlink:to="lab_huge_PrincipalAmountOfBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrincipalAmountOfBorrowings_395" xlink:to="lab_huge_PrincipalAmountOfBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrismicPharmaceuticalMember_396" xlink:to="lab_huge_PrismicPharmaceuticalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrismicPharmaceuticalMember_396" xlink:to="lab_huge_PrismicPharmaceuticalMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrismicPharmaceuticalMember_396" xlink:to="lab_huge_PrismicPharmaceuticalMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrismicPharmaceuticalsIncMember_397" xlink:to="lab_huge_PrismicPharmaceuticalsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrismicPharmaceuticalsIncMember_397" xlink:to="lab_huge_PrismicPharmaceuticalsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrismicPharmaceuticalsIncMember_397" xlink:to="lab_huge_PrismicPharmaceuticalsIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromExerciseOfWarrants_398" xlink:to="lab_huge_ProceedsFromExerciseOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromExerciseOfWarrants_398" xlink:to="lab_huge_ProceedsFromExerciseOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromExerciseOfWarrants_398" xlink:to="lab_huge_ProceedsFromExerciseOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromSaleOfSharesAndWarrants_399" xlink:to="lab_huge_ProceedsFromSaleOfSharesAndWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromSaleOfSharesAndWarrants_399" xlink:to="lab_huge_ProceedsFromSaleOfSharesAndWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionAndGrowingExpense_400" xlink:to="lab_huge_ProductionAndGrowingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionAndGrowingExpense_400" xlink:to="lab_huge_ProductionAndGrowingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionAndGrowingExpense_400" xlink:to="lab_huge_ProductionAndGrowingExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionAndGrowingExpenses_401" xlink:to="lab_huge_ProductionAndGrowingExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionAndGrowingExpenses_401" xlink:to="lab_huge_ProductionAndGrowingExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionAndGrowingExpenses_401" xlink:to="lab_huge_ProductionAndGrowingExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionEquipmentMember_402" xlink:to="lab_huge_ProductionEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionEquipmentMember_402" xlink:to="lab_huge_ProductionEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionEquipmentMember_402" xlink:to="lab_huge_ProductionEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionEquipmentMember_402" xlink:to="lab_huge_ProductionEquipmentMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PropertyPlantAndEquipmentsMember_403" xlink:to="lab_huge_PropertyPlantAndEquipmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PropertyPlantAndEquipmentsMember_403" xlink:to="lab_huge_PropertyPlantAndEquipmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PropertyPlantAndEquipmentsMember_403" xlink:to="lab_huge_PropertyPlantAndEquipmentsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_404" xlink:to="lab_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_404" xlink:to="lab_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_404" xlink:to="lab_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_405" xlink:to="lab_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_405" xlink:to="lab_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_405" xlink:to="lab_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_406" xlink:to="lab_huge_QuantitiesAvailableToSupplyInNextFiscalYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_406" xlink:to="lab_huge_QuantitiesAvailableToSupplyInNextFiscalYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_406" xlink:to="lab_huge_QuantitiesAvailableToSupplyInNextFiscalYear_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_407" xlink:to="lab_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_407" xlink:to="lab_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_407" xlink:to="lab_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_408" xlink:to="lab_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_408" xlink:to="lab_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_408" xlink:to="lab_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuotedMarketPriceOfInvestments_409" xlink:to="lab_huge_QuotedMarketPriceOfInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuotedMarketPriceOfInvestments_409" xlink:to="lab_huge_QuotedMarketPriceOfInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuotedMarketPriceOfInvestments_409" xlink:to="lab_huge_QuotedMarketPriceOfInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_410" xlink:to="lab_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_410" xlink:to="lab_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_410" xlink:to="lab_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RentReceivable_411" xlink:to="lab_huge_RentReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RentReceivable_411" xlink:to="lab_huge_RentReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RentReceivable_411" xlink:to="lab_huge_RentReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ResearchAndDevelopmentAgreementMember_412" xlink:to="lab_huge_ResearchAndDevelopmentAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ResearchAndDevelopmentAgreementMember_412" xlink:to="lab_huge_ResearchAndDevelopmentAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ResearchAndDevelopmentAgreementMember_412" xlink:to="lab_huge_ResearchAndDevelopmentAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ReverseTakeoverTransaction_413" xlink:to="lab_huge_ReverseTakeoverTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ReverseTakeoverTransaction_413" xlink:to="lab_huge_ReverseTakeoverTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ReverseTakeoverTransaction_413" xlink:to="lab_huge_ReverseTakeoverTransaction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RightOfUseAssetsAndLeaseObligations_414" xlink:to="lab_huge_RightOfUseAssetsAndLeaseObligations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RightOfUseAssetsAndLeaseObligations_414" xlink:to="lab_huge_RightOfUseAssetsAndLeaseObligations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RightOfUseAssetsAndLeaseObligations_414" xlink:to="lab_huge_RightOfUseAssetsAndLeaseObligations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrants_415" xlink:to="lab_huge_RiskFreeInterestRateOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrants_415" xlink:to="lab_huge_RiskFreeInterestRateOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrants_415" xlink:to="lab_huge_RiskFreeInterestRateOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrantsGranted_416" xlink:to="lab_huge_RiskFreeInterestRateOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrantsGranted_416" xlink:to="lab_huge_RiskFreeInterestRateOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrantsGranted_416" xlink:to="lab_huge_RiskFreeInterestRateOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeRateOfWarrants_417" xlink:to="lab_huge_RiskFreeRateOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeRateOfWarrants_417" xlink:to="lab_huge_RiskFreeRateOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeRateOfWarrants_417" xlink:to="lab_huge_RiskFreeRateOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SalesTaxRecoverable_418" xlink:to="lab_huge_SalesTaxRecoverable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SalesTaxRecoverable_418" xlink:to="lab_huge_SalesTaxRecoverable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SalesTaxRecoverable_418" xlink:to="lab_huge_SalesTaxRecoverable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SalesTaxRecoverable_418" xlink:to="lab_huge_SalesTaxRecoverable_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_419" xlink:to="lab_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_419" xlink:to="lab_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_419" xlink:to="lab_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfStockClassLineItems_420" xlink:to="lab_huge_ScheduleOfStockClassLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfStockClassLineItems_420" xlink:to="lab_huge_ScheduleOfStockClassLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfStockClassTable_421" xlink:to="lab_huge_ScheduleOfStockClassTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfStockClassTable_421" xlink:to="lab_huge_ScheduleOfStockClassTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfWarrantTable_422" xlink:to="lab_huge_ScheduleOfWarrantTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfWarrantTable_422" xlink:to="lab_huge_ScheduleOfWarrantTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_423" xlink:to="lab_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_423" xlink:to="lab_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_423" xlink:to="lab_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScicannTherapeuticsIncMember_424" xlink:to="lab_huge_ScicannTherapeuticsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScicannTherapeuticsIncMember_424" xlink:to="lab_huge_ScicannTherapeuticsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScicannTherapeuticsIncMember_424" xlink:to="lab_huge_ScicannTherapeuticsIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SecuritiesExchangeAgreementMember_425" xlink:to="lab_huge_SecuritiesExchangeAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SecuritiesExchangeAgreementMember_425" xlink:to="lab_huge_SecuritiesExchangeAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_426" xlink:to="lab_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_426" xlink:to="lab_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_426" xlink:to="lab_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep102018Member_427" xlink:to="lab_huge_Sep102018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep102018Member_427" xlink:to="lab_huge_Sep102018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep102018Member_427" xlink:to="lab_huge_Sep102018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep112018Member_428" xlink:to="lab_huge_Sep112018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep112018Member_428" xlink:to="lab_huge_Sep112018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep112018Member_428" xlink:to="lab_huge_Sep112018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep142018Member_429" xlink:to="lab_huge_Sep142018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep142018Member_429" xlink:to="lab_huge_Sep142018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep152017Member_430" xlink:to="lab_huge_Sep152017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep152017Member_430" xlink:to="lab_huge_Sep152017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep152017Member_430" xlink:to="lab_huge_Sep152017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep152018Member_431" xlink:to="lab_huge_Sep152018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep152018Member_431" xlink:to="lab_huge_Sep152018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep152018Member_431" xlink:to="lab_huge_Sep152018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep172017Member_432" xlink:to="lab_huge_Sep172017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep172017Member_432" xlink:to="lab_huge_Sep172017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep172017Member_432" xlink:to="lab_huge_Sep172017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep262018Member_433" xlink:to="lab_huge_Sep262018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep262018Member_433" xlink:to="lab_huge_Sep262018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep262018Member_433" xlink:to="lab_huge_Sep262018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_September292018Member_434" xlink:to="lab_huge_September292018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_September292018Member_434" xlink:to="lab_huge_September292018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_September292018Member_434" xlink:to="lab_huge_September292018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_September302017Member_435" xlink:to="lab_huge_September302017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_September302017Member_435" xlink:to="lab_huge_September302017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_September302017Member_435" xlink:to="lab_huge_September302017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareholderAndPublicCompanyCosts_436" xlink:to="lab_huge_ShareholderAndPublicCompanyCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareholderAndPublicCompanyCosts_436" xlink:to="lab_huge_ShareholderAndPublicCompanyCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareholderAndPublicCompanyCosts_436" xlink:to="lab_huge_ShareholderAndPublicCompanyCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareholdersAndPublicCompanyCosts_437" xlink:to="lab_huge_ShareholdersAndPublicCompanyCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareholdersAndPublicCompanyCosts_437" xlink:to="lab_huge_ShareholdersAndPublicCompanyCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareholdersAndPublicCompanyCosts_437" xlink:to="lab_huge_ShareholdersAndPublicCompanyCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssueCostsMember_438" xlink:to="lab_huge_ShareIssueCostsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssueCostsMember_438" xlink:to="lab_huge_ShareIssueCostsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssueCostsMember_438" xlink:to="lab_huge_ShareIssueCostsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssuePricePerShare_439" xlink:to="lab_huge_ShareIssuePricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssuePricePerShare_439" xlink:to="lab_huge_ShareIssuePricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareOptionsAbstract_440" xlink:to="lab_huge_ShareOptionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePriceOfSharesAndWarrants_441" xlink:to="lab_huge_SharePriceOfSharesAndWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePriceOfSharesAndWarrants_441" xlink:to="lab_huge_SharePriceOfSharesAndWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePrices_442" xlink:to="lab_huge_SharePrices_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePrices_442" xlink:to="lab_huge_SharePrices_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePrices_442" xlink:to="lab_huge_SharePrices_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePrices_442" xlink:to="lab_huge_SharePrices_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePurchaseAndSaleAgreementsMember_443" xlink:to="lab_huge_SharePurchaseAndSaleAgreementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePurchaseAndSaleAgreementsMember_443" xlink:to="lab_huge_SharePurchaseAndSaleAgreementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePurchaseAndSaleAgreementsMember_443" xlink:to="lab_huge_SharePurchaseAndSaleAgreementsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareSplitRatio_444" xlink:to="lab_huge_ShareSplitRatio_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareSplitRatio_444" xlink:to="lab_huge_ShareSplitRatio_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareSplitRatio_444" xlink:to="lab_huge_ShareSplitRatio_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShortTermNotes_445" xlink:to="lab_huge_ShortTermNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShortTermNotes_445" xlink:to="lab_huge_ShortTermNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShortTermNotes_445" xlink:to="lab_huge_ShortTermNotes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShortTermNotes_445" xlink:to="lab_huge_ShortTermNotes_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SolarvestBioEnergyIncMember_446" xlink:to="lab_huge_SolarvestBioEnergyIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SolarvestBioEnergyIncMember_446" xlink:to="lab_huge_SolarvestBioEnergyIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SolarvestBioEnergyIncMember_446" xlink:to="lab_huge_SolarvestBioEnergyIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SpecialWarrantsMember_447" xlink:to="lab_huge_SpecialWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SpecialWarrantsMember_447" xlink:to="lab_huge_SpecialWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SpecialWarrantsMember_447" xlink:to="lab_huge_SpecialWarrantsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockOptionsMember_448" xlink:to="lab_huge_StockOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockOptionsMember_448" xlink:to="lab_huge_StockOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockOptionsMember_448" xlink:to="lab_huge_StockOptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockOptionsOfAcquirer_449" xlink:to="lab_huge_StockOptionsOfAcquirer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockOptionsOfAcquirer_449" xlink:to="lab_huge_StockOptionsOfAcquirer_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockOptionsOfAcquirer_449" xlink:to="lab_huge_StockOptionsOfAcquirer_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockPromotionExpenses_450" xlink:to="lab_huge_StockPromotionExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockPromotionExpenses_450" xlink:to="lab_huge_StockPromotionExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockPromotionExpenses_450" xlink:to="lab_huge_StockPromotionExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StrategicInvestmentValue_451" xlink:to="lab_huge_StrategicInvestmentValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StrategicInvestmentValue_451" xlink:to="lab_huge_StrategicInvestmentValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StrategicInvestmentValue_451" xlink:to="lab_huge_StrategicInvestmentValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubscriptionPricePerShare_452" xlink:to="lab_huge_SubscriptionPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubscriptionPricePerShare_452" xlink:to="lab_huge_SubscriptionPricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubscriptionPricePerShare_452" xlink:to="lab_huge_SubscriptionPricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsequentEventsMember_453" xlink:to="lab_huge_SubsequentEventsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsequentEventsMember_453" xlink:to="lab_huge_SubsequentEventsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsequentEventsMember_453" xlink:to="lab_huge_SubsequentEventsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsidiariesOneMember_454" xlink:to="lab_huge_SubsidiariesOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsidiariesOneMember_454" xlink:to="lab_huge_SubsidiariesOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsidiariesTwoMember_455" xlink:to="lab_huge_SubsidiariesTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsidiariesTwoMember_455" xlink:to="lab_huge_SubsidiariesTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsidiariesTwoMember_455" xlink:to="lab_huge_SubsidiariesTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_456" xlink:to="lab_huge_SummaryOfSignificantAccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_457" xlink:to="lab_huge_SummaryOfSignificantAccountingPoliciesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_457" xlink:to="lab_huge_SummaryOfSignificantAccountingPoliciesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplementalInformationAbstract_458" xlink:to="lab_huge_SupplementalInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplementalInformationAbstract_458" xlink:to="lab_huge_SupplementalInformationAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementMember_459" xlink:to="lab_huge_SupplyAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementMember_459" xlink:to="lab_huge_SupplyAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementMember_459" xlink:to="lab_huge_SupplyAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchaseAmount_460" xlink:to="lab_huge_SupplyAgreementOptionToPurchaseAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchaseAmount_460" xlink:to="lab_huge_SupplyAgreementOptionToPurchaseAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchaseAmount_460" xlink:to="lab_huge_SupplyAgreementOptionToPurchaseAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchasePeriod_461" xlink:to="lab_huge_SupplyAgreementOptionToPurchasePeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchasePeriod_461" xlink:to="lab_huge_SupplyAgreementOptionToPurchasePeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchasePeriod_461" xlink:to="lab_huge_SupplyAgreementOptionToPurchasePeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_462" xlink:to="lab_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_462" xlink:to="lab_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_462" xlink:to="lab_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_463" xlink:to="lab_huge_TaxEffectOfDeferredTaxAssetNotRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_463" xlink:to="lab_huge_TaxEffectOfDeferredTaxAssetNotRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_463" xlink:to="lab_huge_TaxEffectOfDeferredTaxAssetNotRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TaxEffectOfTemporaryDifferences_464" xlink:to="lab_huge_TaxEffectOfTemporaryDifferences_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TaxEffectOfTemporaryDifferences_464" xlink:to="lab_huge_TaxEffectOfTemporaryDifferences_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TaxEffectOfTemporaryDifferences_464" xlink:to="lab_huge_TaxEffectOfTemporaryDifferences_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TemporaryDifferences_465" xlink:to="lab_huge_TemporaryDifferences_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TemporaryDifferences_465" xlink:to="lab_huge_TemporaryDifferences_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TemporaryDifferences_465" xlink:to="lab_huge_TemporaryDifferences_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TermsOfWarrantGranted_466" xlink:to="lab_huge_TermsOfWarrantGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TermsOfWarrantGranted_466" xlink:to="lab_huge_TermsOfWarrantGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TermsOfWarrantGranted_466" xlink:to="lab_huge_TermsOfWarrantGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ThomasFairfullMember_467" xlink:to="lab_huge_ThomasFairfullMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ThomasFairfullMember_467" xlink:to="lab_huge_ThomasFairfullMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ThomasFairfullMember_467" xlink:to="lab_huge_ThomasFairfullMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TypeOfArrangementsAxis_468" xlink:to="lab_huge_TypeOfArrangementsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TypeOfArrangementsDomain_469" xlink:to="lab_huge_TypeOfArrangementsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TypeOfInventoriesAxis_470" xlink:to="lab_huge_TypeOfInventoriesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TypeOfInventoriesAxis_470" xlink:to="lab_huge_TypeOfInventoriesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TypeOfInventoriesDomain_471" xlink:to="lab_huge_TypeOfInventoriesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TypeOfInventoriesDomain_471" xlink:to="lab_huge_TypeOfInventoriesDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UndiscountedLeasePaymentsPayable_472" xlink:to="lab_huge_UndiscountedLeasePaymentsPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UndiscountedLeasePaymentsPayable_472" xlink:to="lab_huge_UndiscountedLeasePaymentsPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UndiscountedLeasePaymentsPayable_472" xlink:to="lab_huge_UndiscountedLeasePaymentsPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_473" xlink:to="lab_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_473" xlink:to="lab_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_473" xlink:to="lab_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_474" xlink:to="lab_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_474" xlink:to="lab_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_474" xlink:to="lab_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrestrictedClassBSharesMember_475" xlink:to="lab_huge_UnrestrictedClassBSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrestrictedClassBSharesMember_475" xlink:to="lab_huge_UnrestrictedClassBSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrestrictedClassBSharesMember_475" xlink:to="lab_huge_UnrestrictedClassBSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_476" xlink:to="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_476" xlink:to="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_476" xlink:to="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_476" xlink:to="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesAcquired_477" xlink:to="lab_huge_ValueOfSharesAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesAcquired_477" xlink:to="lab_huge_ValueOfSharesAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesAcquired_477" xlink:to="lab_huge_ValueOfSharesAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssued_478" xlink:to="lab_huge_ValueOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssued_478" xlink:to="lab_huge_ValueOfSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_479" xlink:to="lab_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_479" xlink:to="lab_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_479" xlink:to="lab_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedForDebtSettlement_480" xlink:to="lab_huge_ValueOfSharesIssuedForDebtSettlement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedForDebtSettlement_480" xlink:to="lab_huge_ValueOfSharesIssuedForDebtSettlement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedForDebtSettlement_480" xlink:to="lab_huge_ValueOfSharesIssuedForDebtSettlement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedInPrivatePlacement_481" xlink:to="lab_huge_ValueOfSharesIssuedInPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedInPrivatePlacement_481" xlink:to="lab_huge_ValueOfSharesIssuedInPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedInPrivatePlacement_481" xlink:to="lab_huge_ValueOfSharesIssuedInPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedInShareExchange_482" xlink:to="lab_huge_ValueOfSharesIssuedInShareExchange_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedInShareExchange_482" xlink:to="lab_huge_ValueOfSharesIssuedInShareExchange_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedInShareExchange_482" xlink:to="lab_huge_ValueOfSharesIssuedInShareExchange_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfStockOptionsExercised_483" xlink:to="lab_huge_ValueOfStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfStockOptionsExercised_483" xlink:to="lab_huge_ValueOfStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfStockOptionsExercised_483" xlink:to="lab_huge_ValueOfStockOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_484" xlink:to="lab_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_484" xlink:to="lab_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_484" xlink:to="lab_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfWarrantsExercised_485" xlink:to="lab_huge_ValueOfWarrantsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfWarrantsExercised_485" xlink:to="lab_huge_ValueOfWarrantsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfWarrantsExercised_485" xlink:to="lab_huge_ValueOfWarrantsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantExercisePrice_486" xlink:to="lab_huge_WarrantExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantExercisePrice_486" xlink:to="lab_huge_WarrantExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantExercisePrice_486" xlink:to="lab_huge_WarrantExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantLineItems_487" xlink:to="lab_huge_WarrantLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantLineItems_487" xlink:to="lab_huge_WarrantLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Warrants_488" xlink:to="lab_huge_Warrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Warrants_488" xlink:to="lab_huge_Warrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Warrants_488" xlink:to="lab_huge_Warrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsAbstract_489" xlink:to="lab_huge_WarrantsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtAugust1st2021Member_490" xlink:to="lab_huge_WarrantsByExpiryDateAtAugust1st2021Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtAugust1st2021Member_490" xlink:to="lab_huge_WarrantsByExpiryDateAtAugust1st2021Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtAugust1st2021Member_490" xlink:to="lab_huge_WarrantsByExpiryDateAtAugust1st2021Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtDecember12st2019Member_491" xlink:to="lab_huge_WarrantsByExpiryDateAtDecember12st2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtDecember12st2019Member_491" xlink:to="lab_huge_WarrantsByExpiryDateAtDecember12st2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtDecember12st2019Member_491" xlink:to="lab_huge_WarrantsByExpiryDateAtDecember12st2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtDecember29th2019Member_492" xlink:to="lab_huge_WarrantsByExpiryDateAtDecember29th2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtDecember29th2019Member_492" xlink:to="lab_huge_WarrantsByExpiryDateAtDecember29th2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtDecember29th2019Member_492" xlink:to="lab_huge_WarrantsByExpiryDateAtDecember29th2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary16th2026Member_493" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary16th2026Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary16th2026Member_493" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary16th2026Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary16th2026Member_493" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary16th2026Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary20th2026Member_494" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary20th2026Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary20th2026Member_494" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary20th2026Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary20th2026Member_494" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary20th2026Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary5th2020Member_495" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary5th2020Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary5th2020Member_495" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary5th2020Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary5th2020Member_495" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary5th2020Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJuly24th2023Member_496" xlink:to="lab_huge_WarrantsByExpiryDateAtJuly24th2023Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJuly24th2023Member_496" xlink:to="lab_huge_WarrantsByExpiryDateAtJuly24th2023Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJuly24th2023Member_496" xlink:to="lab_huge_WarrantsByExpiryDateAtJuly24th2023Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay10th2025Member_497" xlink:to="lab_huge_WarrantsByExpiryDateAtMay10th2025Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay10th2025Member_497" xlink:to="lab_huge_WarrantsByExpiryDateAtMay10th2025Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay10th2025Member_497" xlink:to="lab_huge_WarrantsByExpiryDateAtMay10th2025Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay17th2025Member_498" xlink:to="lab_huge_WarrantsByExpiryDateAtMay17th2025Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay17th2025Member_498" xlink:to="lab_huge_WarrantsByExpiryDateAtMay17th2025Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay17th2025Member_498" xlink:to="lab_huge_WarrantsByExpiryDateAtMay17th2025Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay20th2023Member_499" xlink:to="lab_huge_WarrantsByExpiryDateAtMay20th2023Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay20th2023Member_499" xlink:to="lab_huge_WarrantsByExpiryDateAtMay20th2023Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay20th2023Member_499" xlink:to="lab_huge_WarrantsByExpiryDateAtMay20th2023Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay24th2022Member_500" xlink:to="lab_huge_WarrantsByExpiryDateAtMay24th2022Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay24th2022Member_500" xlink:to="lab_huge_WarrantsByExpiryDateAtMay24th2022Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay24th2022Member_500" xlink:to="lab_huge_WarrantsByExpiryDateAtMay24th2022Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay31st2025Member_501" xlink:to="lab_huge_WarrantsByExpiryDateAtMay31st2025Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay31st2025Member_501" xlink:to="lab_huge_WarrantsByExpiryDateAtMay31st2025Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay31st2025Member_501" xlink:to="lab_huge_WarrantsByExpiryDateAtMay31st2025Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay4th2025Member_502" xlink:to="lab_huge_WarrantsByExpiryDateAtMay4th2025Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay4th2025Member_502" xlink:to="lab_huge_WarrantsByExpiryDateAtMay4th2025Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay4th2025Member_502" xlink:to="lab_huge_WarrantsByExpiryDateAtMay4th2025Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember14th2019Member_503" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember14th2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember14th2019Member_503" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember14th2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember14th2019Member_503" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember14th2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember1st2019Member_504" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember1st2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember1st2019Member_504" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember1st2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember1st2019Member_504" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember1st2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember21st2019Member_505" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember21st2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember21st2019Member_505" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember21st2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember21st2019Member_505" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember21st2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember30th2020Member_506" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember30th2020Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember30th2020Member_506" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember30th2020Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember30th2020Member_506" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember30th2020Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtOctober20th2019Member_507" xlink:to="lab_huge_WarrantsByExpiryDateAtOctober20th2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtOctober20th2019Member_507" xlink:to="lab_huge_WarrantsByExpiryDateAtOctober20th2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtOctober20th2019Member_507" xlink:to="lab_huge_WarrantsByExpiryDateAtOctober20th2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtSeptember11th2023Member_508" xlink:to="lab_huge_WarrantsByExpiryDateAtSeptember11th2023Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtSeptember11th2023Member_508" xlink:to="lab_huge_WarrantsByExpiryDateAtSeptember11th2023Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtSeptember11th2023Member_508" xlink:to="lab_huge_WarrantsByExpiryDateAtSeptember11th2023Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtSeptember15th2022Member_509" xlink:to="lab_huge_WarrantsByExpiryDateAtSeptember15th2022Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtSeptember15th2022Member_509" xlink:to="lab_huge_WarrantsByExpiryDateAtSeptember15th2022Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtSeptember15th2022Member_509" xlink:to="lab_huge_WarrantsByExpiryDateAtSeptember15th2022Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsIssueDateAxis_510" xlink:to="lab_huge_WarrantsIssueDateAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsIssueDateAxis_510" xlink:to="lab_huge_WarrantsIssueDateAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsIssueDateDomain_511" xlink:to="lab_huge_WarrantsIssueDateDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsIssueDateDomain_511" xlink:to="lab_huge_WarrantsIssueDateDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsMember_512" xlink:to="lab_huge_WarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsMember_512" xlink:to="lab_huge_WarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsMember_512" xlink:to="lab_huge_WarrantsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsMember_512" xlink:to="lab_huge_WarrantsMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsOptionsOfAcquirer_513" xlink:to="lab_huge_WarrantsOptionsOfAcquirer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsOptionsOfAcquirer_513" xlink:to="lab_huge_WarrantsOptionsOfAcquirer_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsOptionsOfAcquirer_513" xlink:to="lab_huge_WarrantsOptionsOfAcquirer_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantExercised_514" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantExercised_514" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantExercised_514" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantExpired_515" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantExpired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantExpired_515" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantExpired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantExpired_515" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantExpired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantGranted_516" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantGranted_516" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantGranted_516" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_517" xlink:to="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_517" xlink:to="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_517" xlink:to="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_517" xlink:to="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_517" xlink:to="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageSharePriceOfWarrants_518" xlink:to="lab_huge_WeightedAverageSharePriceOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageSharePriceOfWarrants_518" xlink:to="lab_huge_WeightedAverageSharePriceOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageSharePriceOfWarrants_518" xlink:to="lab_huge_WeightedAverageSharePriceOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WorkingCapitalSurplus_519" xlink:to="lab_huge_WorkingCapitalSurplus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WorkingCapitalSurplus_519" xlink:to="lab_huge_WorkingCapitalSurplus_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WorkingCapitalSurplus_519" xlink:to="lab_huge_WorkingCapitalSurplus_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ZeeshanSaeedMember_520" xlink:to="lab_huge_ZeeshanSaeedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ZeeshanSaeedMember_520" xlink:to="lab_huge_ZeeshanSaeedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ZeeshanSaeedMember_520" xlink:to="lab_huge_ZeeshanSaeedMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccountingProfit_521" xlink:to="lab_ifrs-full_AccountingProfit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccountingProfit_521" xlink:to="lab_ifrs-full_AccountingProfit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_522" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_522" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_522" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_523" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_523" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_523" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_523" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_524" xlink:to="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_524" xlink:to="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_524" xlink:to="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsFromPurchasesBiologicalAssets_525" xlink:to="lab_ifrs-full_AdditionsFromPurchasesBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsFromPurchasesBiologicalAssets_525" xlink:to="lab_ifrs-full_AdditionsFromPurchasesBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_526" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_526" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_527" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_527" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_528" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_528" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_528" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_528" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_529" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_529" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_529" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_530" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_530" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_530" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_531" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_531" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_532" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationExpense_533" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_534" xlink:to="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_534" xlink:to="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_535" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_535" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_535" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_535" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_535" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_536" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_536" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_536" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_537" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_537" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_537" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_538" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_538" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_539" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_539" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_539" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForInterestExpense_540" xlink:to="lab_ifrs-full_AdjustmentsForInterestExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForInterestExpense_540" xlink:to="lab_ifrs-full_AdjustmentsForInterestExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_541" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_541" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_542" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_542" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_542" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdministrativeExpense_543" xlink:to="lab_ifrs-full_AdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdministrativeExpense_543" xlink:to="lab_ifrs-full_AdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdministrativeExpense_543" xlink:to="lab_ifrs-full_AdministrativeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdvertisingExpense_544" xlink:to="lab_ifrs-full_AdvertisingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdvertisingExpense_544" xlink:to="lab_ifrs-full_AdvertisingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_545" xlink:to="lab_ifrs-full_AggregatedMeasurementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_546" xlink:to="lab_ifrs-full_AggregatedTimeBandsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_547" xlink:to="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_548" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_548" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_548" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_549" xlink:to="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_549" xlink:to="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate_550" xlink:to="lab_ifrs-full_ApplicableTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate_550" xlink:to="lab_ifrs-full_ApplicableTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_551" xlink:to="lab_ifrs-full_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_551" xlink:to="lab_ifrs-full_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract_552" xlink:to="lab_ifrs-full_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AtFairValueMember_553" xlink:to="lab_ifrs-full_AtFairValueMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AtFairValueMember_553" xlink:to="lab_ifrs-full_AtFairValueMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare_554" xlink:to="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare_554" xlink:to="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare_554" xlink:to="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare_554" xlink:to="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_555" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_555" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssets_556" xlink:to="lab_ifrs-full_BiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssets_556" xlink:to="lab_ifrs-full_BiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssets_556" xlink:to="lab_ifrs-full_BiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssets_556" xlink:to="lab_ifrs-full_BiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssetsByGroupAxis_557" xlink:to="lab_ifrs-full_BiologicalAssetsByGroupAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssetsGroupMember_558" xlink:to="lab_ifrs-full_BiologicalAssetsGroupMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsAbstract_559" xlink:to="lab_ifrs-full_BorrowingsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_560" xlink:to="lab_ifrs-full_BorrowingsInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_560" xlink:to="lab_ifrs-full_BorrowingsInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_561" xlink:to="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_561" xlink:to="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_561" xlink:to="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember_562" xlink:to="lab_ifrs-full_BottomOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember_562" xlink:to="lab_ifrs-full_BottomOfRangeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_563" xlink:to="lab_ifrs-full_BusinessCombinationsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsMember_564" xlink:to="lab_ifrs-full_BusinessCombinationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_565" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountMember_566" xlink:to="lab_ifrs-full_CarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_567" xlink:to="lab_ifrs-full_Cash_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_567" xlink:to="lab_ifrs-full_Cash_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_567" xlink:to="lab_ifrs-full_Cash_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAbstract_568" xlink:to="lab_ifrs-full_CashAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_569" xlink:to="lab_ifrs-full_CashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_569" xlink:to="lab_ifrs-full_CashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_569" xlink:to="lab_ifrs-full_CashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_569" xlink:to="lab_ifrs-full_CashAndCashEquivalents_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_569" xlink:to="lab_ifrs-full_CashAndCashEquivalents_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_570" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_570" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_570" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_571" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_571" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_571" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_572" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_572" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_573" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_573" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_574" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_574" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_575" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_575" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_576" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_576" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases_577" xlink:to="lab_ifrs-full_CashOutflowForLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases_577" xlink:to="lab_ifrs-full_CashOutflowForLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases_577" xlink:to="lab_ifrs-full_CashOutflowForLeases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases_577" xlink:to="lab_ifrs-full_CashOutflowForLeases_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases_577" xlink:to="lab_ifrs-full_CashOutflowForLeases_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_578" xlink:to="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_578" xlink:to="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashTransferred_579" xlink:to="lab_ifrs-full_CashTransferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_580" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_581" xlink:to="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_582" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_583" xlink:to="lab_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_584" xlink:to="lab_ifrs-full_ClassesOfContingentLiabilitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_585" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_586" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_587" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_588" xlink:to="lab_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_589" xlink:to="lab_ifrs-full_ClassesOfOrdinarySharesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_590" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_591" xlink:to="lab_ifrs-full_ClassesOfShareCapitalAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_592" xlink:to="lab_ifrs-full_ClassesOfShareCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClosingForeignExchangeRate_593" xlink:to="lab_ifrs-full_ClosingForeignExchangeRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClosingForeignExchangeRate_593" xlink:to="lab_ifrs-full_ClosingForeignExchangeRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CommercialPapersIssued_594" xlink:to="lab_ifrs-full_CommercialPapersIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CommercialPapersIssued_594" xlink:to="lab_ifrs-full_CommercialPapersIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_595" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_596" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_596" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_597" xlink:to="lab_ifrs-full_ComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_597" xlink:to="lab_ifrs-full_ComprehensiveIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_597" xlink:to="lab_ifrs-full_ComprehensiveIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_597" xlink:to="lab_ifrs-full_ComprehensiveIncome_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_598" xlink:to="lab_ifrs-full_ComputerEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_598" xlink:to="lab_ifrs-full_ComputerEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_598" xlink:to="lab_ifrs-full_ComputerEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConstructionInProgressMember_599" xlink:to="lab_ifrs-full_ConstructionInProgressMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConstructionInProgressMember_599" xlink:to="lab_ifrs-full_ConstructionInProgressMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_600" xlink:to="lab_ifrs-full_ContingentLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractualCapitalCommitments_601" xlink:to="lab_ifrs-full_ContractualCapitalCommitments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractualCapitalCommitments_601" xlink:to="lab_ifrs-full_ContractualCapitalCommitments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractualCapitalCommitments_601" xlink:to="lab_ifrs-full_ContractualCapitalCommitments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_602" xlink:to="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_602" xlink:to="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_603" xlink:to="lab_ifrs-full_CostOfSales_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_603" xlink:to="lab_ifrs-full_CostOfSales_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_603" xlink:to="lab_ifrs-full_CostOfSales_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesAxis_604" xlink:to="lab_ifrs-full_CounterpartiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesMember_605" xlink:to="lab_ifrs-full_CounterpartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CreditRiskMember_606" xlink:to="lab_ifrs-full_CreditRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CreditRiskMember_606" xlink:to="lab_ifrs-full_CreditRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_607" xlink:to="lab_ifrs-full_CurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_607" xlink:to="lab_ifrs-full_CurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_608" xlink:to="lab_ifrs-full_CurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_608" xlink:to="lab_ifrs-full_CurrentAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_609" xlink:to="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_609" xlink:to="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_609" xlink:to="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBiologicalAssets_610" xlink:to="lab_ifrs-full_CurrentBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBiologicalAssets_610" xlink:to="lab_ifrs-full_CurrentBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBiologicalAssets_610" xlink:to="lab_ifrs-full_CurrentBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBiologicalAssets_610" xlink:to="lab_ifrs-full_CurrentBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDebtInstrumentsIssued_611" xlink:to="lab_ifrs-full_CurrentDebtInstrumentsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDebtInstrumentsIssued_611" xlink:to="lab_ifrs-full_CurrentDebtInstrumentsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_612" xlink:to="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_612" xlink:to="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_613" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_613" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_613" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_614" xlink:to="lab_ifrs-full_CurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_614" xlink:to="lab_ifrs-full_CurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_615" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_615" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_616" xlink:to="lab_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_616" xlink:to="lab_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_616" xlink:to="lab_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_617" xlink:to="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_617" xlink:to="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_617" xlink:to="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaidExpenses_618" xlink:to="lab_ifrs-full_CurrentPrepaidExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaidExpenses_618" xlink:to="lab_ifrs-full_CurrentPrepaidExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaidExpenses_618" xlink:to="lab_ifrs-full_CurrentPrepaidExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_619" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_619" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_619" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_619" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_620" xlink:to="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_620" xlink:to="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_620" xlink:to="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_620" xlink:to="lab_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets_621" xlink:to="lab_ifrs-full_DeferredTaxAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets_621" xlink:to="lab_ifrs-full_DeferredTaxAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_622" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_622" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_622" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_623" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_623" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_624" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_624" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_624" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_624" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_624" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_624" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_625" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_625" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_625" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_625" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationBiologicalAssets_626" xlink:to="lab_ifrs-full_DepreciationBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationBiologicalAssets_626" xlink:to="lab_ifrs-full_DepreciationBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationBiologicalAssets_626" xlink:to="lab_ifrs-full_DepreciationBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationExpense_627" xlink:to="lab_ifrs-full_DepreciationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationExpense_627" xlink:to="lab_ifrs-full_DepreciationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_628" xlink:to="lab_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_628" xlink:to="lab_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_629" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_629" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_630" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_630" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_630" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialLiabilities_631" xlink:to="lab_ifrs-full_DerivativeFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_632" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_632" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory_633" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_634" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_635" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_635" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_636" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_636" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_637" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_637" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_638" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_638" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_639" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_640" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_641" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_641" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_642" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_642" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_643" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_643" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_644" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_645" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_645" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_646" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_646" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_647" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_648" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_649" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_649" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_650" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_650" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_650" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_651" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_651" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_651" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_652" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_652" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_652" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_653" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_653" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_653" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_654" xlink:to="lab_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_655" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_655" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_655" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_656" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_656" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_657" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_657" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_658" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_658" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_658" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_659" xlink:to="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_659" xlink:to="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_660" xlink:to="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DirectorsRemunerationExpense_661" xlink:to="lab_ifrs-full_DirectorsRemunerationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DirectorsRemunerationExpense_661" xlink:to="lab_ifrs-full_DirectorsRemunerationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_662" xlink:to="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_662" xlink:to="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_663" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_663" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_664" xlink:to="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_664" xlink:to="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_665" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_665" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_666" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_666" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_666" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_667" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_668" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_669" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_669" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_670" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_671" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_672" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_672" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsExplanatory_673" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsExplanatory_673" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_674" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_675" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_675" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_676" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_677" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_678" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_678" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_679" xlink:to="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_679" xlink:to="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_680" xlink:to="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_680" xlink:to="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_681" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_682" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_682" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_683" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_684" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_685" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_686" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_686" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_686" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_687" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_687" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_687" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_688" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_688" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_689" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_689" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_690" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_690" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_690" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_691" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_692" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_692" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_693" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_694" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_695" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_696" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_697" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_698" xlink:to="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_698" xlink:to="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_698" xlink:to="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_699" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_699" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_700" xlink:to="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_700" xlink:to="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_701" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_701" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_702" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_702" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_703" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_704" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory_705" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory_705" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_706" xlink:to="lab_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_706" xlink:to="lab_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLeasesExplanatory_707" xlink:to="lab_ifrs-full_DisclosureOfLeasesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLeasesExplanatory_707" xlink:to="lab_ifrs-full_DisclosureOfLeasesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLiquidityRiskExplanatory_708" xlink:to="lab_ifrs-full_DisclosureOfLiquidityRiskExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLiquidityRiskExplanatory_708" xlink:to="lab_ifrs-full_DisclosureOfLiquidityRiskExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_709" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_709" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_709" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_710" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_711" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_712" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_713" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_713" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_714" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_715" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_716" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_716" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_717" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_717" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_718" xlink:to="lab_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_718" xlink:to="lab_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_719" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_720" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_720" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_721" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_721" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_722" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_723" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_724" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_725" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_725" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_726" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_727" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_728" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_729" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_729" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_730" xlink:to="lab_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_730" xlink:to="lab_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_730" xlink:to="lab_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_731" xlink:to="lab_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_732" xlink:to="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_732" xlink:to="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_733" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_733" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_733" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_734" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_734" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_735" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_736" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_737" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_737" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_738" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_738" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_739" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_740" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_741" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_742" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_743" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_744" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_744" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_745" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_746" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_747" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_748" xlink:to="lab_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_748" xlink:to="lab_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_749" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_749" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_749" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DistributionCosts_750" xlink:to="lab_ifrs-full_DistributionCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DistributionCosts_750" xlink:to="lab_ifrs-full_DistributionCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_751" xlink:to="lab_ifrs-full_EarningsPerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_751" xlink:to="lab_ifrs-full_EarningsPerShareAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory_752" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory_752" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory_752" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_753" xlink:to="lab_ifrs-full_EarningsPerShareLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareTable_754" xlink:to="lab_ifrs-full_EarningsPerShareTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_755" xlink:to="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_756" xlink:to="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_757" xlink:to="lab_ifrs-full_EntitysTotalForSubsidiariesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_758" xlink:to="lab_ifrs-full_Equity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_758" xlink:to="lab_ifrs-full_Equity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_758" xlink:to="lab_ifrs-full_Equity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_758" xlink:to="lab_ifrs-full_Equity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_758" xlink:to="lab_ifrs-full_Equity_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_758" xlink:to="lab_ifrs-full_Equity_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract_759" xlink:to="lab_ifrs-full_EquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_760" xlink:to="lab_ifrs-full_EquityAndLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_760" xlink:to="lab_ifrs-full_EquityAndLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_761" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_761" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_762" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_762" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_762" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_762" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_762" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityMember_763" xlink:to="lab_ifrs-full_EquityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_764" xlink:to="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_765" xlink:to="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_765" xlink:to="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_766" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_766" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_766" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNature_767" xlink:to="lab_ifrs-full_ExpenseByNature_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNature_767" xlink:to="lab_ifrs-full_ExpenseByNature_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_768" xlink:to="lab_ifrs-full_ExpenseByNatureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_768" xlink:to="lab_ifrs-full_ExpenseByNatureAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_769" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_769" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_769" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfDesignatedFinancialAssetsThatAreHeldOutsideLegalEntityThatIssuesContractsWithinScopeOfIFRS4_770" xlink:to="lab_ifrs-full_ExplanationOfDesignatedFinancialAssetsThatAreHeldOutsideLegalEntityThatIssuesContractsWithinScopeOfIFRS4_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory_771" xlink:to="lab_ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory_771" xlink:to="lab_ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FairValueOfAcquiredReceivables_772" xlink:to="lab_ifrs-full_FairValueOfAcquiredReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FairValueOfAcquiredReceivables_772" xlink:to="lab_ifrs-full_FairValueOfAcquiredReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_773" xlink:to="lab_ifrs-full_FinanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_773" xlink:to="lab_ifrs-full_FinanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_773" xlink:to="lab_ifrs-full_FinanceCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_774" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_774" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_775" xlink:to="lab_ifrs-full_FinancialAssetsCategoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_776" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_776" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesCategoryMember_777" xlink:to="lab_ifrs-full_FinancialLiabilitiesCategoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinishedGoods_778" xlink:to="lab_ifrs-full_FinishedGoods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinishedGoods_778" xlink:to="lab_ifrs-full_FinishedGoods_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixturesAndFittingsMember_779" xlink:to="lab_ifrs-full_FixturesAndFittingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixturesAndFittingsMember_779" xlink:to="lab_ifrs-full_FixturesAndFittingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_780" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_780" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_781" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_781" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_781" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_781" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_781" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_782" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_782" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_782" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_782" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense_783" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense_783" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_784" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_784" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_784" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLeaseLiabilities_785" xlink:to="lab_ifrs-full_GrossLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLoanCommitments_786" xlink:to="lab_ifrs-full_GrossLoanCommitments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLoanCommitments_786" xlink:to="lab_ifrs-full_GrossLoanCommitments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_787" xlink:to="lab_ifrs-full_GrossProfit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_787" xlink:to="lab_ifrs-full_GrossProfit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_787" xlink:to="lab_ifrs-full_GrossProfit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_788" xlink:to="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_788" xlink:to="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_789" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_789" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_789" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_789" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_789" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_789" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLoss_790" xlink:to="lab_ifrs-full_ImpairmentLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLoss_790" xlink:to="lab_ifrs-full_ImpairmentLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLoss_790" xlink:to="lab_ifrs-full_ImpairmentLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_791" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_791" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_792" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_792" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeStatementAbstract_793" xlink:to="lab_ifrs-full_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_794" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_795" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_795" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_796" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_796" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_796" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_797" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_797" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_797" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_798" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_798" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_799" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_799" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_800" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_800" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InsuranceExpense_801" xlink:to="lab_ifrs-full_InsuranceExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InsuranceExpense_801" xlink:to="lab_ifrs-full_InsuranceExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_802" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_802" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_802" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_802" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_802" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_802" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_803" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_804" xlink:to="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_804" xlink:to="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_805" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_805" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivable_806" xlink:to="lab_ifrs-full_InterestReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivable_806" xlink:to="lab_ifrs-full_InterestReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_807" xlink:to="lab_ifrs-full_Inventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_807" xlink:to="lab_ifrs-full_Inventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_807" xlink:to="lab_ifrs-full_Inventories_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryWritedown2011_808" xlink:to="lab_ifrs-full_InventoryWritedown2011_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryWritedown2011_808" xlink:to="lab_ifrs-full_InventoryWritedown2011_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_809" xlink:to="lab_ifrs-full_IssuedCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_809" xlink:to="lab_ifrs-full_IssuedCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_809" xlink:to="lab_ifrs-full_IssuedCapital_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_809" xlink:to="lab_ifrs-full_IssuedCapital_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_810" xlink:to="lab_ifrs-full_IssueOfEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_810" xlink:to="lab_ifrs-full_IssueOfEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_811" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_811" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_811" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_812" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_812" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_812" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_812" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_813" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_813" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_813" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_813" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_814" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_814" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandMember_815" xlink:to="lab_ifrs-full_LandMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandMember_815" xlink:to="lab_ifrs-full_LandMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember_816" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember_816" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember_816" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_817" xlink:to="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_817" xlink:to="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_818" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_818" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_819" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_819" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_819" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearMember_820" xlink:to="lab_ifrs-full_LaterThanOneYearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearMember_820" xlink:to="lab_ifrs-full_LaterThanOneYearMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearMember_820" xlink:to="lab_ifrs-full_LaterThanOneYearMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_821" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_821" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_821" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_822" xlink:to="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_822" xlink:to="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_822" xlink:to="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_823" xlink:to="lab_ifrs-full_LeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_823" xlink:to="lab_ifrs-full_LeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_823" xlink:to="lab_ifrs-full_LeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_823" xlink:to="lab_ifrs-full_LeaseLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_823" xlink:to="lab_ifrs-full_LeaseLiabilities_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_823" xlink:to="lab_ifrs-full_LeaseLiabilities_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_824" xlink:to="lab_ifrs-full_LeaseLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_825" xlink:to="lab_ifrs-full_LegalProceedingsContingentLiabilityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_825" xlink:to="lab_ifrs-full_LegalProceedingsContingentLiabilityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level1OfFairValueHierarchyMember_826" xlink:to="lab_ifrs-full_Level1OfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level1OfFairValueHierarchyMember_826" xlink:to="lab_ifrs-full_Level1OfFairValueHierarchyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level2OfFairValueHierarchyMember_827" xlink:to="lab_ifrs-full_Level2OfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level2OfFairValueHierarchyMember_827" xlink:to="lab_ifrs-full_Level2OfFairValueHierarchyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level3OfFairValueHierarchyMember_828" xlink:to="lab_ifrs-full_Level3OfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level3OfFairValueHierarchyMember_828" xlink:to="lab_ifrs-full_Level3OfFairValueHierarchyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_829" xlink:to="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_830" xlink:to="lab_ifrs-full_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_830" xlink:to="lab_ifrs-full_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_830" xlink:to="lab_ifrs-full_Liabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_830" xlink:to="lab_ifrs-full_Liabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_830" xlink:to="lab_ifrs-full_Liabilities_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_830" xlink:to="lab_ifrs-full_Liabilities_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_830" xlink:to="lab_ifrs-full_Liabilities_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesAbstract_831" xlink:to="lab_ifrs-full_LiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesAbstract_831" xlink:to="lab_ifrs-full_LiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_832" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_833" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesIncurred_834" xlink:to="lab_ifrs-full_LiabilitiesIncurred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesIncurred_834" xlink:to="lab_ifrs-full_LiabilitiesIncurred_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesIncurred_834" xlink:to="lab_ifrs-full_LiabilitiesIncurred_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiquidityRiskMember_835" xlink:to="lab_ifrs-full_LiquidityRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiquidityRiskMember_835" xlink:to="lab_ifrs-full_LiquidityRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LoansAndReceivablesCategoryMember_836" xlink:to="lab_ifrs-full_LoansAndReceivablesCategoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LoansAndReceivablesCategoryMember_836" xlink:to="lab_ifrs-full_LoansAndReceivablesCategoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_837" xlink:to="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_837" xlink:to="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_837" xlink:to="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MachineryMember_838" xlink:to="lab_ifrs-full_MachineryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MachineryMember_838" xlink:to="lab_ifrs-full_MachineryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MarketRiskMember_839" xlink:to="lab_ifrs-full_MarketRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MarketRiskMember_839" xlink:to="lab_ifrs-full_MarketRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis_840" xlink:to="lab_ifrs-full_MaturityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementAxis_841" xlink:to="lab_ifrs-full_MeasurementAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MediaProductionExpense_842" xlink:to="lab_ifrs-full_MediaProductionExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MediaProductionExpense_842" xlink:to="lab_ifrs-full_MediaProductionExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_843" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsMember_844" xlink:to="lab_ifrs-full_NonadjustingEventsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_845" xlink:to="lab_ifrs-full_NoncurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_845" xlink:to="lab_ifrs-full_NoncurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_846" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_846" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_847" xlink:to="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_847" xlink:to="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_847" xlink:to="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_847" xlink:to="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_848" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_848" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_848" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_849" xlink:to="lab_ifrs-full_NoncurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_849" xlink:to="lab_ifrs-full_NoncurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_850" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_850" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotesAndDebenturesIssued_851" xlink:to="lab_ifrs-full_NotesAndDebenturesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotesAndDebenturesIssued_851" xlink:to="lab_ifrs-full_NotesAndDebenturesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_852" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_852" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_852" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_853" xlink:to="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_853" xlink:to="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_854" xlink:to="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_854" xlink:to="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_855" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_855" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_855" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_856" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_856" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_856" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_856" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_857" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_857" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_857" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_858" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_858" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_858" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_859" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_859" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_859" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_860" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_860" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_860" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_861" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_861" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_861" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_861" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_862" xlink:to="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_862" xlink:to="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_862" xlink:to="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_863" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_863" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_863" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_864" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_864" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_864" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_865" xlink:to="lab_ifrs-full_NumberOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_865" xlink:to="lab_ifrs-full_NumberOfSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_865" xlink:to="lab_ifrs-full_NumberOfSharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_865" xlink:to="lab_ifrs-full_NumberOfSharesIssued_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_865" xlink:to="lab_ifrs-full_NumberOfSharesIssued_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_865" xlink:to="lab_ifrs-full_NumberOfSharesIssued_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_866" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_866" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_866" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_866" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_866" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OccupancyExpense_867" xlink:to="lab_ifrs-full_OccupancyExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OccupancyExpense_867" xlink:to="lab_ifrs-full_OccupancyExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OrdinarySharesMember_868" xlink:to="lab_ifrs-full_OrdinarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OrdinarySharesMember_868" xlink:to="lab_ifrs-full_OrdinarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_869" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_870" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_870" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_870" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_871" xlink:to="lab_ifrs-full_OtherIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_871" xlink:to="lab_ifrs-full_OtherIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_871" xlink:to="lab_ifrs-full_OtherIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_871" xlink:to="lab_ifrs-full_OtherIncome_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReceivables_872" xlink:to="lab_ifrs-full_OtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReceivables_872" xlink:to="lab_ifrs-full_OtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTangibleOrIntangibleAssetsTransferred_873" xlink:to="lab_ifrs-full_OtherTangibleOrIntangibleAssetsTransferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_874" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_874" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_874" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_874" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_875" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_875" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_875" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_876" xlink:to="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_876" xlink:to="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlantsMember_877" xlink:to="lab_ifrs-full_PlantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlantsMember_877" xlink:to="lab_ifrs-full_PlantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_878" xlink:to="lab_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_878" xlink:to="lab_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfOptions_879" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfOptions_879" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfOptions_879" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_880" xlink:to="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_880" xlink:to="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_881" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_881" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_881" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_881" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_882" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_882" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_882" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductionSupplies_883" xlink:to="lab_ifrs-full_ProductionSupplies_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductionSupplies_883" xlink:to="lab_ifrs-full_ProductionSupplies_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_884" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_884" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_885" xlink:to="lab_ifrs-full_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_885" xlink:to="lab_ifrs-full_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_885" xlink:to="lab_ifrs-full_ProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_885" xlink:to="lab_ifrs-full_ProfitLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_885" xlink:to="lab_ifrs-full_ProfitLoss_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAbstract_886" xlink:to="lab_ifrs-full_ProfitLossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAbstract_886" xlink:to="lab_ifrs-full_ProfitLossAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_887" xlink:to="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_887" xlink:to="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_888" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_888" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_889" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_889" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_890" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_890" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_890" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_890" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_891" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_892" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_893" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_893" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_894" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_894" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_894" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentProperty_895" xlink:to="lab_ifrs-full_PurchaseOfInvestmentProperty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentProperty_895" xlink:to="lab_ifrs-full_PurchaseOfInvestmentProperty_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_896" xlink:to="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_896" xlink:to="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_896" xlink:to="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_897" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_897" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_897" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_897" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis_898" xlink:to="lab_ifrs-full_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesMember_899" xlink:to="lab_ifrs-full_RangesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_900" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_901" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RawMaterials_902" xlink:to="lab_ifrs-full_RawMaterials_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RawMaterials_902" xlink:to="lab_ifrs-full_RawMaterials_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RentalIncome_903" xlink:to="lab_ifrs-full_RentalIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RentalIncome_903" xlink:to="lab_ifrs-full_RentalIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepairsAndMaintenanceExpense_904" xlink:to="lab_ifrs-full_RepairsAndMaintenanceExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepairsAndMaintenanceExpense_904" xlink:to="lab_ifrs-full_RepairsAndMaintenanceExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_905" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_905" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_906" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_906" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_907" xlink:to="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_907" xlink:to="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_908" xlink:to="lab_ifrs-full_RetainedEarnings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_908" xlink:to="lab_ifrs-full_RetainedEarnings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_908" xlink:to="lab_ifrs-full_RetainedEarnings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_908" xlink:to="lab_ifrs-full_RetainedEarnings_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_908" xlink:to="lab_ifrs-full_RetainedEarnings_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember_909" xlink:to="lab_ifrs-full_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember_909" xlink:to="lab_ifrs-full_RetainedEarningsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_910" xlink:to="lab_ifrs-full_Revenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_910" xlink:to="lab_ifrs-full_Revenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_911" xlink:to="lab_ifrs-full_RightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_911" xlink:to="lab_ifrs-full_RightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_911" xlink:to="lab_ifrs-full_RightofuseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_911" xlink:to="lab_ifrs-full_RightofuseAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_912" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SeparateManagementEntitiesAxis_913" xlink:to="lab_ifrs-full_SeparateManagementEntitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SeparateManagementEntitiesMember_914" xlink:to="lab_ifrs-full_SeparateManagementEntitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_915" xlink:to="lab_ifrs-full_SharebasedPaymentArrangementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_916" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_916" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_916" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_916" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_916" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremium_917" xlink:to="lab_ifrs-full_SharePremium_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermBorrowingsMember_918" xlink:to="lab_ifrs-full_ShorttermBorrowingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermBorrowingsMember_918" xlink:to="lab_ifrs-full_ShorttermBorrowingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_919" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_920" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_921" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_922" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_923" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_924" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SubsidiariesMember_925" xlink:to="lab_ifrs-full_SubsidiariesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SubsidiariesMember_925" xlink:to="lab_ifrs-full_SubsidiariesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_926" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_926" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_926" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_927" xlink:to="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_927" xlink:to="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_928" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_929" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember_930" xlink:to="lab_ifrs-full_TopOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember_930" xlink:to="lab_ifrs-full_TopOfRangeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_931" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_931" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_931" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_932" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_933" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_933" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_933" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayables_934" xlink:to="lab_ifrs-full_TradeAndOtherPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayables_934" xlink:to="lab_ifrs-full_TradeAndOtherPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayables_934" xlink:to="lab_ifrs-full_TradeAndOtherPayables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayables_934" xlink:to="lab_ifrs-full_TradeAndOtherPayables_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_935" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_935" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_935" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_935" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_936" xlink:to="lab_ifrs-full_TradeAndOtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_936" xlink:to="lab_ifrs-full_TradeAndOtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_936" xlink:to="lab_ifrs-full_TradeAndOtherReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_937" xlink:to="lab_ifrs-full_TradeAndOtherReceivablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TravelExpense_938" xlink:to="lab_ifrs-full_TravelExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TravelExpense_938" xlink:to="lab_ifrs-full_TravelExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksAxis_939" xlink:to="lab_ifrs-full_TypesOfRisksAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksMember_940" xlink:to="lab_ifrs-full_TypesOfRisksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_941" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_942" xlink:to="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_942" xlink:to="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_943" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_943" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_944" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ValueAtRisk_945" xlink:to="lab_ifrs-full_ValueAtRisk_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ValueAtRisk_945" xlink:to="lab_ifrs-full_ValueAtRisk_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries_946" xlink:to="lab_ifrs-full_WagesAndSalaries_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries_946" xlink:to="lab_ifrs-full_WagesAndSalaries_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_947" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_947" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_947" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_948" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_948" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_949" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_949" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_950" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_950" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_951" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_951" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_952" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_952" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_952" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_952" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_953" xlink:to="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_953" xlink:to="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_954" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_955" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_955" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_955" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_956" xlink:to="lab_ifrs-full_WeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_956" xlink:to="lab_ifrs-full_WeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_957" xlink:to="lab_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_957" xlink:to="lab_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_957" xlink:to="lab_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WorkInProgress_958" xlink:to="lab_ifrs-full_WorkInProgress_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WorkInProgress_958" xlink:to="lab_ifrs-full_WorkInProgress_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_PresidentMember_959" xlink:to="lab_srt_PresidentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_PresidentMember_959" xlink:to="lab_srt_PresidentMember_1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>huge-20191231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#AcquisitionOfPrismicPharmaceutical" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceutical"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#AcquisitionOfPrismicPharmaceuticalNarrativeDetails" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#AcquisitionOfPrismicPharmaceuticalTables" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#BasisOfPresentation" roleURI="http://www.fsdpharma.com/role/BasisOfPresentation"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#BiologicalAssets" roleURI="http://www.fsdpharma.com/role/BiologicalAssets"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#BiologicalAssetsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/BiologicalAssetsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#BiologicalAssetsScheduleOfBiologicalAssetsDetails" roleURI="http://www.fsdpharma.com/role/BiologicalAssetsScheduleOfBiologicalAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#BiologicalAssetsScheduleOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsDetails" roleURI="http://www.fsdpharma.com/role/BiologicalAssetsScheduleOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#BiologicalAssetsTables" roleURI="http://www.fsdpharma.com/role/BiologicalAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CapitalManagement" roleURI="http://www.fsdpharma.com/role/CapitalManagement"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CapitalManagementNarrativeDetails" roleURI="http://www.fsdpharma.com/role/CapitalManagementNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CommitmentsAndContingencies" roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingencies"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CommitmentsAndContingenciesNarrativeDetails" roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails" roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CommitmentsAndContingenciesTables" roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#DocumentAndEntityInformation" roleURI="http://www.fsdpharma.com/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#FinancialInstrumentsAndRiskManagement" roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskManagement"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#GeneralAndAdministrative" roleURI="http://www.fsdpharma.com/role/GeneralAndAdministrative"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#GeneralAndAdministrativeDetails" roleURI="http://www.fsdpharma.com/role/GeneralAndAdministrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#GeneralAndAdministrativeTables" roleURI="http://www.fsdpharma.com/role/GeneralAndAdministrativeTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IncomeTaxes" roleURI="http://www.fsdpharma.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IncometaxesTables" roleURI="http://www.fsdpharma.com/role/IncometaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IntangibleAssets" roleURI="http://www.fsdpharma.com/role/IntangibleAssets"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IntangibleAssetsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/IntangibleAssetsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IntangibleAssetsScheduleOfIntangibleAssetsDetails" roleURI="http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#IntangibleAssetsTables" roleURI="http://www.fsdpharma.com/role/IntangibleAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#Inventory" roleURI="http://www.fsdpharma.com/role/Inventory"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#InventoryNarrativeDetails" roleURI="http://www.fsdpharma.com/role/InventoryNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#InventoryScheduleOfInventoriesDetails" roleURI="http://www.fsdpharma.com/role/InventoryScheduleOfInventoriesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#InventoryTables" roleURI="http://www.fsdpharma.com/role/InventoryTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#LeaseObligations" roleURI="http://www.fsdpharma.com/role/LeaseObligations"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#LeaseObligationsScheduleOfLeaseObligationsDetails" roleURI="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfLeaseObligationsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails" roleURI="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#LeaseObligationsTables" roleURI="http://www.fsdpharma.com/role/LeaseObligationsTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#LossPerShare" roleURI="http://www.fsdpharma.com/role/LossPerShare"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#LossPerShareDetails" roleURI="http://www.fsdpharma.com/role/LossPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#LossPerShareTables" roleURI="http://www.fsdpharma.com/role/LossPerShareTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#NatureOfBusiness" roleURI="http://www.fsdpharma.com/role/NatureOfBusiness"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#NatureOfBusinessNarrativeDetails" roleURI="http://www.fsdpharma.com/role/NatureOfBusinessNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails" roleURI="http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#NatureOfBusinessTable" roleURI="http://www.fsdpharma.com/role/NatureOfBusinessTable"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#NotesPayable" roleURI="http://www.fsdpharma.com/role/NotesPayable"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#NotesPayableNarrativeDetails" roleURI="http://www.fsdpharma.com/role/NotesPayableNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#NotesPayableScheduleOfNotesPayableDetails" roleURI="http://www.fsdpharma.com/role/NotesPayableScheduleOfNotesPayableDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#NotesPayableTables" roleURI="http://www.fsdpharma.com/role/NotesPayableTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#OtherInvestments" roleURI="http://www.fsdpharma.com/role/OtherInvestments"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#OtherInvestmentsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#OtherInvestmentsScheduleOfOtherInvestmentsDetails" roleURI="http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#OtherinvestmentsTables" roleURI="http://www.fsdpharma.com/role/OtherinvestmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#PropertyPlantAndEquipment" roleURI="http://www.fsdpharma.com/role/PropertyPlantAndEquipment"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#PropertyplantandequipmentDetails1" roleURI="http://www.fsdpharma.com/role/PropertyplantandequipmentDetails1"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#PropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails" roleURI="http://www.fsdpharma.com/role/PropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#PropertyplantandequipmentTables" roleURI="http://www.fsdpharma.com/role/PropertyplantandequipmentTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#RelatedPartyTransactions" roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#RelatedPartyTransactionsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails" roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#RelatedPartyTransactionsTables" roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ReverseTakeoverTransaction" roleURI="http://www.fsdpharma.com/role/ReverseTakeoverTransaction"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#RightofuseAsset" roleURI="http://www.fsdpharma.com/role/RightofuseAsset"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#RightofuseAssetScheduleOfRightofuseAssetDetails" roleURI="http://www.fsdpharma.com/role/RightofuseAssetScheduleOfRightofuseAssetDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#RightofuseAssetTables" roleURI="http://www.fsdpharma.com/role/RightofuseAssetTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SegmentedInformation" roleURI="http://www.fsdpharma.com/role/SegmentedInformation"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SharebasedCompensation" roleURI="http://www.fsdpharma.com/role/SharebasedCompensation"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SharebasedCompensationNarrativeDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SharebasedCompensationTables" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ShareCapital" roleURI="http://www.fsdpharma.com/role/ShareCapital"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ShareCapitalNarrativeDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#ShareCapitalTables" roleURI="http://www.fsdpharma.com/role/ShareCapitalTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SignificantAccountingPolicies" roleURI="http://www.fsdpharma.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesPolicies"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SignificantAccountingPoliciesScheduleOfAppliedTheDefinitionOfALeaseUnderIFRS16ToContractsDetails" roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfAppliedTheDefinitionOfALeaseUnderIFRS16ToContractsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails" roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SignificantAccountingPoliciesTables" roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SubsequentEvents" roleURI="http://www.fsdpharma.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#SubsequentEventsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#TradeAndOtherReceivables" roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails" roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20191231.xsd#TradeAndOtherReceivablesTables" roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivablesTables"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceutical">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBVotingSharesMember" xlink:label="loc_huge_ClassBVotingSharesMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsGranted" xlink:label="loc_huge_NumberOfWarrantsGranted_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_4" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4" xlink:to="loc_huge_ClassBVotingSharesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4" xlink:to="loc_huge_StockOptionsMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4" xlink:to="loc_huge_WarrantsMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_huge_ShareIssuePricePerShare_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_ifrs-full_IssueOfEquity_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_huge_NumberOfWarrantsGranted_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareOptionsAbstract" xlink:label="loc_huge_ShareOptionsAbstract_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsAbstract" xlink:label="loc_huge_WarrantsAbstract_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageSharePriceOfWarrants" xlink:label="loc_huge_WeightedAverageSharePriceOfWarrants_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedDividendYieldOfWarrantsGranted" xlink:label="loc_huge_ExpectedDividendYieldOfWarrantsGranted_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_RangeAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_4" xlink:to="loc_ifrs-full_RangesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_4" xlink:to="loc_ifrs-full_BottomOfRangeMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_4" xlink:to="loc_ifrs-full_TopOfRangeMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_8" xlink:to="loc_huge_ShareOptionsAbstract_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ShareOptionsAbstract_8" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ShareOptionsAbstract_8" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ShareOptionsAbstract_8" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ShareOptionsAbstract_8" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ShareOptionsAbstract_8" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ShareOptionsAbstract_8" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_8" xlink:to="loc_huge_WarrantsAbstract_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantsAbstract_15" xlink:to="loc_huge_WeightedAverageSharePriceOfWarrants_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantsAbstract_15" xlink:to="loc_huge_ExercisePriceOfWarrantsGranted_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantsAbstract_15" xlink:to="loc_huge_ExpectedDividendYieldOfWarrantsGranted_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantsAbstract_15" xlink:to="loc_huge_RiskFreeInterestRateOfWarrantsGranted_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantsAbstract_15" xlink:to="loc_huge_ExpectedLifeOfWarrants_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantsAbstract_15" xlink:to="loc_huge_ExpectedVolatilityOfWarrantsGranted_20" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/BasisOfPresentation">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BasisOfPresentationAbstract" xlink:label="loc_huge_BasisOfPresentationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_BasisOfPresentationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/BiologicalAssets">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/BiologicalAssetsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedYieldOfDryFlower" xlink:label="loc_huge_ExpectedYieldOfDryFlower_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedYieldOfDryTrim" xlink:label="loc_huge_ExpectedYieldOfDryTrim_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedGrowthCycleCompleted" xlink:label="loc_huge_ExpectedGrowthCycleCompleted_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedGrowthCycle" xlink:label="loc_huge_ExpectedGrowthCycle_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_ExpectedYieldOfDryFlower_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_ExpectedYieldOfDryTrim_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_ExpectedGrowthCycleCompleted_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_ExpectedGrowthCycle_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/BiologicalAssetsScheduleOfBiologicalAssetsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssets" xlink:label="loc_ifrs-full_BiologicalAssets_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsFromPurchasesBiologicalAssets" xlink:label="loc_ifrs-full_AdditionsFromPurchasesBiologicalAssets_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssets" xlink:label="loc_ifrs-full_BiologicalAssets_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_BiologicalAssets_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_AdditionsFromPurchasesBiologicalAssets_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_BiologicalAssets_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/BiologicalAssetsScheduleOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant" xlink:label="loc_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant" xlink:label="loc_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedGrowthCycleCompleted" xlink:label="loc_huge_ExpectedGrowthCycleCompleted_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedSellingPricePerGramOfDriedFlower" xlink:label="loc_huge_ExpectedSellingPricePerGramOfDriedFlower_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedSellingPricePerGramOfTrim" xlink:label="loc_huge_ExpectedSellingPricePerGramOfTrim_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower" xlink:label="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim" xlink:label="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_ExpectedGrowthCycleCompleted_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_ExpectedSellingPricePerGramOfDriedFlower_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_ExpectedSellingPricePerGramOfTrim_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/BiologicalAssetsTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfBiologicalAssetsExplanatory" xlink:label="loc_huge_DisclosureOfBiologicalAssetsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory" xlink:label="loc_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_DisclosureOfBiologicalAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CapitalManagement">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfCapitalManagementAbstract" xlink:label="loc_huge_DisclosureOfCapitalManagementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfCapitalManagementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CapitalManagementNarrativeDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfCapitalManagementAbstract" xlink:label="loc_huge_DisclosureOfCapitalManagementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfCapitalManagementAbstract_0" xlink:to="loc_ifrs-full_IssuedCapital_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CommitmentsAndContingencies">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract" xlink:label="loc_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember" xlink:label="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AuxlyCannabisGroupIncMember" xlink:label="loc_huge_AuxlyCannabisGroupIncMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementMember" xlink:label="loc_huge_SupplyAgreementMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_EpitechLicenseAgreementMember" xlink:label="loc_huge_EpitechLicenseAgreementMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DefinitiveStrategicAllianceAndStreamingAgreementMember" xlink:label="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HeritageBuildingRestorationCommitmentMember" xlink:label="loc_huge_HeritageBuildingRestorationCommitmentMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember" xlink:label="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AnticipatedPurchasePricePlusApplicableTaxesValue" xlink:label="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfPurchasePricePaidAsSupplierLoan" xlink:label="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfDepositPaidToSupplier" xlink:label="loc_huge_AmountOfDepositPaidToSupplier_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OutstandingCommitmentToPurchaseAdditionalProduct" xlink:label="loc_huge_OutstandingCommitmentToPurchaseAdditionalProduct_21"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CollectiveCommitmentToPurchaseProduct" xlink:label="loc_huge_CollectiveCommitmentToPurchaseProduct_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementOptionToPurchaseAmount" xlink:label="loc_huge_SupplyAgreementOptionToPurchaseAmount_23"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementOptionToPurchasePeriod" xlink:label="loc_huge_SupplyAgreementOptionToPurchasePeriod_24"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted" xlink:label="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_25"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA" xlink:label="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA_26"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA" xlink:label="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA_27"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_28"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_30"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition" xlink:label="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_31"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_32"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdditionalInvestmentInExchangeForShares" xlink:label="loc_huge_AdditionalInvestmentInExchangeForShares_33"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_EstimatedCostOfRestorationInCommitment" xlink:label="loc_huge_EstimatedCostOfRestorationInCommitment_34"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClaimIssuedByContractorForVariousPurportedDamages" xlink:label="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_35"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClaimForLienComponent" xlink:label="loc_huge_ClaimForLienComponent_36"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees" xlink:label="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_37"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_EmployeeRelatedLiability" xlink:label="loc_huge_EmployeeRelatedLiability_38"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_39"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_40"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_1" xlink:to="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_1" xlink:to="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_CounterpartiesAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_5" xlink:to="loc_ifrs-full_CounterpartiesMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_5" xlink:to="loc_huge_AuxlyCannabisGroupIncMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsAxis_8" xlink:to="loc_huge_TypeOfArrangementsDomain_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_8" xlink:to="loc_huge_SupplyAgreementMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_8" xlink:to="loc_huge_EpitechLicenseAgreementMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_8" xlink:to="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_8" xlink:to="loc_huge_HeritageBuildingRestorationCommitmentMember_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_dei_LegalEntityAxis_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_14" xlink:to="loc_dei_EntityDomain_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_14" xlink:to="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_ifrs-full_Inventories_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_AmountOfDepositPaidToSupplier_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_OutstandingCommitmentToPurchaseAdditionalProduct_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_CollectiveCommitmentToPurchaseProduct_22" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_SupplyAgreementOptionToPurchaseAmount_23" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_SupplyAgreementOptionToPurchasePeriod_24" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_25" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA_26" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA_27" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_28" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_29" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_30" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_31" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_32" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_AdditionalInvestmentInExchangeForShares_33" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_EstimatedCostOfRestorationInCommitment_34" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_35" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_ClaimForLienComponent_36" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_37" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_EmployeeRelatedLiability_38" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_39" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_17" xlink:to="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_40" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PharmadrugProductionGMBHMember" xlink:label="loc_huge_PharmadrugProductionGMBHMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SupplyAgreementMember" xlink:label="loc_huge_SupplyAgreementMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FvPharmaIncMember" xlink:label="loc_huge_FvPharmaIncMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInNextFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInSecondFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInThirdFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInFifthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuantitiesAvailableToSupplyInFourthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_CounterpartiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_1" xlink:to="loc_ifrs-full_CounterpartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_1" xlink:to="loc_huge_PharmadrugProductionGMBHMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsAxis_4" xlink:to="loc_huge_TypeOfArrangementsDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_4" xlink:to="loc_huge_SupplyAgreementMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_dei_LegalEntityAxis_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_7" xlink:to="loc_dei_EntityDomain_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_7" xlink:to="loc_huge_FvPharmaIncMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10" xlink:to="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10" xlink:to="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10" xlink:to="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10" xlink:to="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10" xlink:to="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CommitmentsAndContingenciesTables">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract" xlink:label="loc_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory" xlink:label="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_0" xlink:to="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForListingExpense" xlink:label="loc_huge_AdjustmentsForListingExpense_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="loc_ifrs-full_AdjustmentsForInterestExpense_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" xlink:label="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LossOnSettlementOfFinancialLiability" xlink:label="loc_huge_LossOnSettlementOfFinancialLiability_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AllowanceForImpairment" xlink:label="loc_huge_AllowanceForImpairment_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChangesInNonCashWorkingCapitalItemsAbstract" xlink:label="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CashAcquiredOnAcquisition" xlink:label="loc_huge_CashAcquiredOnAcquisition_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ReverseTakeoverTransaction" xlink:label="loc_huge_ReverseTakeoverTransaction_23"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PaymentOfOperatingLease" xlink:label="loc_huge_PaymentOfOperatingLease_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentProperty" xlink:label="loc_ifrs-full_PurchaseOfInvestmentProperty_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_34"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProceedsFromExerciseOfWarrants" xlink:label="loc_huge_ProceedsFromExerciseOfWarrants_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_40"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_ProfitLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_huge_AdjustmentsForListingExpense_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForInterestExpense_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_10" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_huge_LossOnSettlementOfFinancialLiability_11" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_huge_AllowanceForImpairment_12" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14" xlink:to="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_22" xlink:to="loc_huge_CashAcquiredOnAcquisition_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_22" xlink:to="loc_huge_ReverseTakeoverTransaction_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_22" xlink:to="loc_huge_PaymentOfOperatingLease_24" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_22" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_22" xlink:to="loc_ifrs-full_PurchaseOfInvestmentProperty_26" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_22" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_27" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_22" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_28" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_22" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_29" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_31" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_32" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_33" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfOptions_34" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_huge_ProceedsFromExerciseOfWarrants_35" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_38" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_39" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_40" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughReverseAcquisition" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisition_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughReverseAcquisitionShares" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughWarrantValuations" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuations_21"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughWarrantValuationsShares" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_24"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_25"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfStockOptionsExercised" xlink:label="loc_huge_ValueOfStockOptionsExercised_26"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughStockOptionsCancelled" xlink:label="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_28"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfWarrantsExercised" xlink:label="loc_huge_ValueOfWarrantsExercised_30"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_31"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_35"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_huge_ClassACommonStockSharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_5" xlink:to="loc_huge_WarrantsMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_5" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_5" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_5" xlink:to="loc_ifrs-full_RetainedEarningsMember_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_5" xlink:to="loc_ifrs-full_EquityMember_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_Equity_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_IssueOfEquity_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IssuanceOfShares_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_17" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_18" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughReverseAcquisition_19" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_20" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughWarrantValuations_21" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_22" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_23" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_24" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_25" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_ValueOfStockOptionsExercised_26" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_27" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_28" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_29" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_ValueOfWarrantsExercised_30" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_31" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_32" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_ComprehensiveIncome_33" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_Equity_34" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_35" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScheduleOfStockClassTable" xlink:label="loc_huge_ScheduleOfStockClassTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScheduleOfStockClassLineItems" xlink:label="loc_huge_ScheduleOfStockClassLineItems_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_Warrants" xlink:label="loc_huge_Warrants_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_36"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_huge_ScheduleOfStockClassTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ScheduleOfStockClassTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassACommonStockSharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ScheduleOfStockClassTable_1" xlink:to="loc_huge_ScheduleOfStockClassLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ScheduleOfStockClassLineItems_5" xlink:to="loc_ifrs-full_AssetsAbstract_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_5" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_CashAndCashEquivalents_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_Inventories_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_CurrentBiologicalAssets_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_CurrentAssets_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_5" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_12" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_12" xlink:to="loc_ifrs-full_RightofuseAssets_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_12" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_12" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_5" xlink:to="loc_ifrs-full_Assets_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ScheduleOfStockClassLineItems_5" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_19" xlink:to="loc_ifrs-full_LiabilitiesAbstract_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_19" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_19" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_19" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_19" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_19" xlink:to="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_22" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_19" xlink:to="loc_ifrs-full_CurrentLiabilities_23" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_19" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_25" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_25" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_25" xlink:to="loc_ifrs-full_Liabilities_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_19" xlink:to="loc_ifrs-full_EquityAbstract_29" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_29" xlink:to="loc_ifrs-full_IssuedCapital_29" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_29" xlink:to="loc_huge_Warrants_30" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_29" xlink:to="loc_ifrs-full_SharePremium_31" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_29" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_32" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_29" xlink:to="loc_ifrs-full_RetainedEarnings_33" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_29" xlink:to="loc_ifrs-full_Equity_34" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_19" xlink:to="loc_ifrs-full_EquityAndLiabilities_36" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_GrossLossProfitBeforeFairValueAdjustments" xlink:label="loc_huge_GrossLossProfitBeforeFairValueAdjustments_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FairValueAdjustmentsOnInventorySold" xlink:label="loc_huge_FairValueAdjustmentsOnInventorySold_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AllowanceForImpairment" xlink:label="loc_huge_AllowanceForImpairment_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-full_ExpenseByNature_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LossOnSettlementOfFinancialLiability" xlink:label="loc_huge_LossOnSettlementOfFinancialLiability_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_LossGainOnChangesInFairValueOfOtherInvestments" xlink:label="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicAndDilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_25"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_Revenue_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_CostOfSales_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_huge_GrossLossProfitBeforeFairValueAdjustments_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_huge_FairValueAdjustmentsOnInventorySold_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_GrossProfit_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ExpenseByNatureAbstract_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_huge_AllowanceForImpairment_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_ifrs-full_ExpenseByNature_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_ifrs-full_OtherIncome_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_ifrs-full_FinanceCosts_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_huge_LossOnSettlementOfFinancialLiability_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_17" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_7" xlink:to="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_18" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLoss_20" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeAbstract_21" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_21" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_21" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_21" xlink:to="loc_ifrs-full_ComprehensiveIncome_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_21" xlink:to="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare_24" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_21" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DocumentAndEntityInformationAbstract" xlink:label="loc_huge_DocumentAndEntityInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityRegistrantName_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCentralIndexKey_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCurrentReportingStatus_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentType_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentPeriodEndDate_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_AmendmentFlag_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentFiscalYearFocus_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_11" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityExTransitionPeriod_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskManagement">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/GeneralAndAdministrative">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/GeneralAndAdministrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockPromotionExpenses" xlink:label="loc_huge_StockPromotionExpenses_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConsultingFeesExpenses" xlink:label="loc_huge_ConsultingFeesExpenses_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdministrativeExpense" xlink:label="loc_ifrs-full_AdministrativeExpense_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepairsAndMaintenanceExpense" xlink:label="loc_ifrs-full_RepairsAndMaintenanceExpense_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OfficeAndGeneralExpenses" xlink:label="loc_huge_OfficeAndGeneralExpenses_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareholdersAndPublicCompanyCosts" xlink:label="loc_huge_ShareholdersAndPublicCompanyCosts_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ListingExpense" xlink:label="loc_huge_ListingExpense_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_huge_StockPromotionExpenses_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_WagesAndSalaries_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_huge_ConsultingFeesExpenses_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_AdministrativeExpense_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_RepairsAndMaintenanceExpense_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_huge_OfficeAndGeneralExpenses_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_huge_ShareholdersAndPublicCompanyCosts_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_huge_ListingExpense_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/GeneralAndAdministrativeTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxAssetsOtherInvestments" xlink:label="loc_huge_DeferredTaxAssetsOtherInvestments_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward" xlink:label="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeferredTaxAssetLiabilityNotRecognized" xlink:label="loc_huge_DeferredTaxAssetLiabilityNotRecognized_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeferredTaxAssetsOtherInvestments_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeferredTaxAssetLiabilityNotRecognized_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NonCapitalLossCarryforwards" xlink:label="loc_huge_NonCapitalLossCarryforwards_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalLossCarryforwards_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccountingProfit" xlink:label="loc_ifrs-full_AccountingProfit_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TaxEffectOfTemporaryDifferences" xlink:label="loc_huge_TaxEffectOfTemporaryDifferences_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TaxEffectOfDeferredTaxAssetNotRecognized" xlink:label="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_AccountingProfit_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_ApplicableTaxRate_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_TaxEffectOfTemporaryDifferences_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncometaxesTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfProvisionForIncomeTaxesExplanatory" xlink:label="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory" xlink:label="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock" xlink:label="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IntangibleAssets">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IntangibleAssetsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AcquisitionOfPrismicPharmaceuticalsInc" xlink:label="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" xlink:to="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IntangibleAssetsTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/Inventory">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInventoriesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/InventoryNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryWritedown2011" xlink:label="loc_ifrs-full_InventoryWritedown2011_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_InventoryWritedown2011_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/InventoryScheduleOfInventoriesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfInventoriesTable" xlink:label="loc_huge_ClassesOfInventoriesTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfInventoriesAxis" xlink:label="loc_huge_TypeOfInventoriesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfInventoriesDomain" xlink:label="loc_huge_TypeOfInventoriesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HarvestedCannabisMember" xlink:label="loc_huge_HarvestedCannabisMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HempProductsMember" xlink:label="loc_huge_HempProductsMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInventoryMember" xlink:label="loc_huge_OtherInventoryMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CapitalizedCostMember" xlink:label="loc_huge_CapitalizedCostMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BiologicalAssetFairValueAdjustmentMember" xlink:label="loc_huge_BiologicalAssetFairValueAdjustmentMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ImpairmentMember" xlink:label="loc_huge_ImpairmentMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfInventoriesLineItems" xlink:label="loc_huge_ClassesOfInventoriesLineItems_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RawMaterials" xlink:label="loc_ifrs-full_RawMaterials_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WorkInProgress" xlink:label="loc_ifrs-full_WorkInProgress_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductionSupplies" xlink:label="loc_ifrs-full_ProductionSupplies_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_huge_ClassesOfInventoriesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfInventoriesTable_1" xlink:to="loc_huge_TypeOfInventoriesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfInventoriesAxis_1" xlink:to="loc_huge_TypeOfInventoriesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfInventoriesDomain_1" xlink:to="loc_huge_HarvestedCannabisMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfInventoriesDomain_1" xlink:to="loc_huge_HempProductsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfInventoriesDomain_1" xlink:to="loc_huge_OtherInventoryMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfInventoriesTable_1" xlink:to="loc_ifrs-full_MeasurementAxis_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_6" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_6" xlink:to="loc_huge_CapitalizedCostMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_6" xlink:to="loc_huge_BiologicalAssetFairValueAdjustmentMember_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_6" xlink:to="loc_huge_ImpairmentMember_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfInventoriesTable_1" xlink:to="loc_huge_ClassesOfInventoriesLineItems_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfInventoriesLineItems_11" xlink:to="loc_ifrs-full_RawMaterials_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfInventoriesLineItems_11" xlink:to="loc_ifrs-full_WorkInProgress_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfInventoriesLineItems_11" xlink:to="loc_ifrs-full_FinishedGoods_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfInventoriesLineItems_11" xlink:to="loc_ifrs-full_ProductionSupplies_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfInventoriesLineItems_11" xlink:to="loc_ifrs-full_Inventories_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/InventoryTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LeaseObligations">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfLeasesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfLeaseObligationsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_LeaseLiabilities_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_CashOutflowForLeases_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_LeaseLiabilities_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_UndiscountedLeasePaymentsPayable" xlink:label="loc_huge_UndiscountedLeasePaymentsPayable_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OperatingLeaseImpactOfPresentValue" xlink:label="loc_huge_OperatingLeaseImpactOfPresentValue_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_huge_UndiscountedLeasePaymentsPayable_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_huge_OperatingLeaseImpactOfPresentValue_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_ifrs-full_LeaseLiabilities_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LeaseObligationsTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOperatingLeaseObligationsTableTextBlock" xlink:label="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LossPerShare">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LossPerShareDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareTable" xlink:label="loc_ifrs-full_EarningsPerShareTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_EarningsPerShareTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareTable_1" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" xlink:to="loc_ifrs-full_OrdinarySharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OrdinarySharesMember_1" xlink:to="loc_huge_WarrantsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OrdinarySharesMember_1" xlink:to="loc_huge_StockOptionsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareTable_1" xlink:to="loc_ifrs-full_EarningsPerShareLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_5" xlink:to="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_5" xlink:to="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LossPerShareTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_EarningsPerShareExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NatureOfBusiness">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessAbstract" xlink:label="loc_huge_DisclosureOfNatureOfBusinessAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock" xlink:label="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_0" xlink:to="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NatureOfBusinessNarrativeDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessAbstract" xlink:label="loc_huge_DisclosureOfNatureOfBusinessAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessTable" xlink:label="loc_huge_DisclosureOfNatureOfBusinessTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessLineItems" xlink:label="loc_huge_DisclosureOfNatureOfBusinessLineItems_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfReverseShareSplit" xlink:label="loc_huge_DescriptionOfReverseShareSplit_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WorkingCapitalSurplus" xlink:label="loc_huge_WorkingCapitalSurplus_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_0" xlink:to="loc_huge_DisclosureOfNatureOfBusinessTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessTable_1" xlink:to="loc_huge_DisclosureOfNatureOfBusinessLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessLineItems_4" xlink:to="loc_huge_DescriptionOfReverseShareSplit_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessLineItems_4" xlink:to="loc_ifrs-full_RetainedEarnings_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessLineItems_4" xlink:to="loc_ifrs-full_ProfitLoss_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessLineItems_4" xlink:to="loc_huge_WorkingCapitalSurplus_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessAbstract" xlink:label="loc_huge_DisclosureOfNatureOfBusinessAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SubsidiariesMember" xlink:label="loc_ifrs-full_SubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubsidiariesOneMember" xlink:label="loc_huge_SubsidiariesOneMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubsidiariesTwoMember" xlink:label="loc_huge_SubsidiariesTwoMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_ifrs-full_SubsidiariesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_huge_SubsidiariesOneMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_huge_SubsidiariesTwoMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_6" xlink:to="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_6" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NatureOfBusinessTable">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNatureOfBusinessAbstract" xlink:label="loc_huge_DisclosureOfNatureOfBusinessAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NotesPayable">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NotesPayableNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConvertibleNotesMember" xlink:label="loc_huge_ConvertibleNotesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NotesPayableMember" xlink:label="loc_huge_NotesPayableMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_huge_ConvertibleNotesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_ifrs-full_ShorttermBorrowingsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_huge_NotesPayableMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_ifrs-full_BorrowingsInterestRate_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NotesPayableScheduleOfNotesPayableDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConvertibleNotesMember" xlink:label="loc_huge_ConvertibleNotesMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NotesPayableMember" xlink:label="loc_huge_NotesPayableMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_ifrs-full_ShorttermBorrowingsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_huge_ConvertibleNotesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_huge_NotesPayableMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NotesPayableTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/OtherInvestments">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsAbstract" xlink:label="loc_huge_DisclosureOfOtherInvestmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsAbstract" xlink:label="loc_huge_DisclosureOfOtherInvestmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsTable" xlink:label="loc_huge_DisclosureOfOtherInvestmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HighTideIncMember" xlink:label="loc_huge_HighTideIncMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HugeShopsMember" xlink:label="loc_huge_HugeShopsMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScicannTherapeuticsIncMember" xlink:label="loc_huge_ScicannTherapeuticsIncMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePurchaseAndSaleAgreementsMember" xlink:label="loc_huge_SharePurchaseAndSaleAgreementsMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBSubordinateVotingSharesMember" xlink:label="loc_huge_ClassBSubordinateVotingSharesMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_UnrestrictedClassBSharesMember" xlink:label="loc_huge_UnrestrictedClassBSharesMember_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBSharesHeldInEscrowMember" xlink:label="loc_huge_ClassBSharesHeldInEscrowMember_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_23"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubsequentEventsMember" xlink:label="loc_huge_SubsequentEventsMember_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_26"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_26"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsLineItems" xlink:label="loc_huge_DisclosureOfOtherInvestmentsLineItems_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesAcquired" xlink:label="loc_huge_NumberOfSharesAcquired_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_30"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesAcquired" xlink:label="loc_huge_ValueOfSharesAcquired_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_32"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssued" xlink:label="loc_huge_ValueOfSharesIssued_33"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedInShareExchange" xlink:label="loc_huge_NumberOfSharesIssuedInShareExchange_34"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_35"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssuedInShareExchange" xlink:label="loc_huge_ValueOfSharesIssuedInShareExchange_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_37"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement" xlink:label="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_38"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesHeld" xlink:label="loc_huge_NumberOfSharesHeld_39"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsHeld" xlink:label="loc_huge_NumberOfWarrantsHeld_40"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePriceOfSharesAndWarrants" xlink:label="loc_huge_SharePriceOfSharesAndWarrants_41"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DiscountOnProceedsOfSharesAndWarrantsSold" xlink:label="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_42"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProceedsFromSaleOfSharesAndWarrants" xlink:label="loc_huge_ProceedsFromSaleOfSharesAndWarrants_43"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubscriptionPricePerShare" xlink:label="loc_huge_SubscriptionPricePerShare_44"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfDeclineInFairValueOfInvestment" xlink:label="loc_huge_PercentageOfDeclineInFairValueOfInvestment_45"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChangeInFairValueOfInvestment" xlink:label="loc_huge_ChangeInFairValueOfInvestment_46"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsAcquired" xlink:label="loc_huge_NumberOfWarrantsAcquired_47"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PrincipalAmountOfBorrowings" xlink:label="loc_huge_PrincipalAmountOfBorrowings_48"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FairValueOfSharesAndWarrantsAcquired" xlink:label="loc_huge_FairValueOfSharesAndWarrantsAcquired_49"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOfWarrants" xlink:label="loc_huge_ExercisePriceOfWarrants_50"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesHeldSubjectToEscrowArrangement" xlink:label="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_51"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_QuotedMarketPriceOfInvestments" xlink:label="loc_huge_QuotedMarketPriceOfInvestments_52"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PercentageOfAggregateDiscountForSharesInEscrow" xlink:label="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_53"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AggregateDiscountForSharesInEscrow" xlink:label="loc_huge_AggregateDiscountForSharesInEscrow_54"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_55"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FairValueOfShares" xlink:label="loc_huge_FairValueOfShares_56"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FairValueOfWarrants" xlink:label="loc_huge_FairValueOfWarrants_57"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_MarketPriceOfShares" xlink:label="loc_huge_MarketPriceOfShares_58"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_59"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_GuaranteedMinimumLiquidationValueOfShares" xlink:label="loc_huge_GuaranteedMinimumLiquidationValueOfShares_60"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RiskFreeRateOfWarrants" xlink:label="loc_huge_RiskFreeRateOfWarrants_61"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedVolatilityOfWarrants" xlink:label="loc_huge_ExpectedVolatilityOfWarrants_62"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedTermOfWarrants" xlink:label="loc_huge_ExpectedTermOfWarrants_63"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedDividendYieldOfWarrants" xlink:label="loc_huge_ExpectedDividendYieldOfWarrants_64"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DebtConversionRatio" xlink:label="loc_huge_DebtConversionRatio_65"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" xlink:label="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_66"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_67"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsAbstract_0" xlink:to="loc_huge_DisclosureOfOtherInvestmentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_PharmadrugIncMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_CannaraBiotechIncMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_HighTideIncMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_HugeShopsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_ScicannTherapeuticsIncMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_SolarvestBioEnergyIncMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsAxis_10" xlink:to="loc_huge_TypeOfArrangementsDomain_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_10" xlink:to="loc_huge_SecuritiesExchangeAgreementMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_10" xlink:to="loc_huge_SharePurchaseAndSaleAgreementsMember_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_14" xlink:to="loc_ifrs-full_OrdinarySharesMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OrdinarySharesMember_14" xlink:to="loc_huge_ClassBSubordinateVotingSharesMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OrdinarySharesMember_14" xlink:to="loc_huge_UnrestrictedClassBSharesMember_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OrdinarySharesMember_14" xlink:to="loc_huge_ClassBSharesHeldInEscrowMember_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_19" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_19" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_19" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_19" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_23" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_23" xlink:to="loc_ifrs-full_NonadjustingEventsMember_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_23" xlink:to="loc_huge_SubsequentEventsMember_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_26" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_26" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_26" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_26" xlink:to="loc_huge_ClassBCommonStockSharesMember_26" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_NumberOfSharesAcquired_29" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_SharePrices_30" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_ValueOfSharesAcquired_31" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_ifrs-full_NumberOfSharesIssued_32" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_ValueOfSharesIssued_33" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_NumberOfSharesIssuedInShareExchange_34" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_ShareIssuePricePerShare_35" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_ValueOfSharesIssuedInShareExchange_36" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_37" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_38" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_NumberOfSharesHeld_39" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_NumberOfWarrantsHeld_40" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_SharePriceOfSharesAndWarrants_41" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_42" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_ProceedsFromSaleOfSharesAndWarrants_43" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_SubscriptionPricePerShare_44" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_PercentageOfDeclineInFairValueOfInvestment_45" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_ChangeInFairValueOfInvestment_46" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_NumberOfWarrantsAcquired_47" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_PrincipalAmountOfBorrowings_48" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_FairValueOfSharesAndWarrantsAcquired_49" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_ExercisePriceOfWarrants_50" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_51" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_QuotedMarketPriceOfInvestments_52" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_53" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_AggregateDiscountForSharesInEscrow_54" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_55" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_FairValueOfShares_56" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_FairValueOfWarrants_57" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_MarketPriceOfShares_58" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_59" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_GuaranteedMinimumLiquidationValueOfShares_60" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_RiskFreeRateOfWarrants_61" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_ExpectedVolatilityOfWarrants_62" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_ExpectedTermOfWarrants_63" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_ExpectedDividendYieldOfWarrants_64" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_DebtConversionRatio_65" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_66" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_29" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_67" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsAbstract" xlink:label="loc_huge_DisclosureOfOtherInvestmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsTable" xlink:label="loc_huge_DisclosureOfOtherInvestmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HighTideIncMember" xlink:label="loc_huge_HighTideIncMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_HugeShopsMember" xlink:label="loc_huge_HugeShopsMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ScicannTherapeuticsIncMember" xlink:label="loc_huge_ScicannTherapeuticsIncMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConvertibleDebentureMember" xlink:label="loc_huge_ConvertibleDebentureMember_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsLineItems" xlink:label="loc_huge_DisclosureOfOtherInvestmentsLineItems_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_22"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsAbstract_0" xlink:to="loc_huge_DisclosureOfOtherInvestmentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_ifrs-full_MeasurementAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_1" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_1" xlink:to="loc_ifrs-full_AtFairValueMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_4" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_PharmadrugIncMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_CannaraBiotechIncMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_HighTideIncMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_HugeShopsMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_ScicannTherapeuticsIncMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_SolarvestBioEnergyIncMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_13" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_13" xlink:to="loc_ifrs-full_OrdinarySharesMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_13" xlink:to="loc_huge_WarrantsMember_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_13" xlink:to="loc_huge_ConvertibleDebentureMember_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsTable_1" xlink:to="loc_huge_DisclosureOfOtherInvestmentsLineItems_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_18" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_18" xlink:to="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_18" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_18" xlink:to="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsLineItems_18" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_22" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/OtherinvestmentsTables">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfOtherInvestmentsAbstract" xlink:label="loc_huge_DisclosureOfOtherInvestmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfOtherInvestmentsAbstract_0" xlink:to="loc_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/PropertyPlantAndEquipment">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/PropertyplantandequipmentDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationBiologicalAssets" xlink:label="loc_ifrs-full_DepreciationBiologicalAssets_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DepreciationBiologicalAssets_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/PropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FurnitureFixturesAndEquipmentMember" xlink:label="loc_huge_FurnitureFixturesAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FacilityUnderDevelopmentMember" xlink:label="loc_huge_FacilityUnderDevelopmentMember_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProductionEquipmentMember" xlink:label="loc_huge_ProductionEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-full_LandMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_huge_FurnitureFixturesAndEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ComputerEquipmentMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_huge_FacilityUnderDevelopmentMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_huge_ProductionEquipmentMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_LandMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8" xlink:to="loc_ifrs-full_CarryingAmountMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_8" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_8" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/PropertyplantandequipmentTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RelatedPartyTransactions">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FvPharmaIncMember" xlink:label="loc_huge_FvPharmaIncMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FSDBiosciencesMember" xlink:label="loc_huge_FSDBiosciencesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PresidentAndChiefExecutiveOfficerMember" xlink:label="loc_huge_PresidentAndChiefExecutiveOfficerMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FormerChiefExecutiveOfficerMember" xlink:label="loc_huge_FormerChiefExecutiveOfficerMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChiefExecutiveOfficersMember" xlink:label="loc_huge_ChiefExecutiveOfficersMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PresidentsMember" xlink:label="loc_huge_PresidentsMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PresidentOfFSDMember" xlink:label="loc_huge_PresidentOfFSDMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChiefFinancialOfficersMember" xlink:label="loc_huge_ChiefFinancialOfficersMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ChiefOperatingConsultantMember" xlink:label="loc_huge_ChiefOperatingConsultantMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_FormerChiefOperatingOfficerMember" xlink:label="loc_huge_FormerChiefOperatingOfficerMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IndependentDirectorMember" xlink:label="loc_huge_IndependentDirectorMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DirectorsAndOfficersMember" xlink:label="loc_huge_DirectorsAndOfficersMember_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_21"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherAllowances" xlink:label="loc_huge_OtherAllowances_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PaymentOfExpenses" xlink:label="loc_huge_PaymentOfExpenses_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_26"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ConsultingFeesExpenses" xlink:label="loc_huge_ConsultingFeesExpenses_27"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ManagementFees" xlink:label="loc_huge_ManagementFees_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdditionalRemuneration" xlink:label="loc_huge_AdditionalRemuneration_30"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DirectorsRemunerationPayable" xlink:label="loc_huge_DirectorsRemunerationPayable_31"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedInPrivatePlacement_32"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_33"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_ValueOfSharesIssuedInPrivatePlacement_34"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesSubscribed" xlink:label="loc_huge_NumberOfSharesSubscribed_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_36"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_dei_LegalEntityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_huge_FvPharmaIncMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_huge_FSDBiosciencesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_PresidentAndChiefExecutiveOfficerMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_FormerChiefExecutiveOfficerMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_ChiefExecutiveOfficersMember_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_PresidentsMember_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_PresidentOfFSDMember_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_ChiefFinancialOfficersMember_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_ChiefOperatingConsultantMember_11" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_FormerChiefOperatingOfficerMember_12" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_IndependentDirectorMember_13" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_DirectorsAndOfficersMember_14" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_17" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_17" xlink:to="loc_huge_ClassBCommonStockSharesMember_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_huge_OtherAllowances_22" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_huge_PaymentOfExpenses_23" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_24" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_25" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_ifrs-full_TradeAndOtherPayables_26" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_huge_ConsultingFeesExpenses_27" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_huge_ManagementFees_28" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_ifrs-full_DirectorsRemunerationExpense_29" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_huge_AdditionalRemuneration_30" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_huge_DirectorsRemunerationPayable_31" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_huge_NumberOfSharesIssuedInPrivatePlacement_32" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_huge_ShareIssuePricePerShare_33" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_huge_ValueOfSharesIssuedInPrivatePlacement_34" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_huge_NumberOfSharesSubscribed_35" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_20" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_36" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RelatedPartyTransactionsTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ReverseTakeoverTransaction">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfReverseTakeoverTransactionAbstract" xlink:label="loc_huge_DisclosureOfReverseTakeoverTransactionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfReverseTakeoverTransactionExplanatory" xlink:label="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfReverseTakeoverTransactionAbstract_0" xlink:to="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RightofuseAsset">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RightofuseAssetScheduleOfRightofuseAssetDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ImpairmentLossRecognisedInRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_ifrs-full_RightofuseAssets_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_ifrs-full_RightofuseAssets_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RightofuseAssetTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailedInformationAboutRightOfUseAssets" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SegmentedInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensation">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_BonusExpenseToBePaidInSubsequentPeriod" xlink:label="loc_huge_BonusExpenseToBePaidInSubsequentPeriod_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_huge_BonusExpenseToBePaidInSubsequentPeriod_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_13" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_14" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_15" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_16" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_17" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwoPointSixOneMember" xlink:label="loc_huge_ExercisePriceTwoPointSixOneMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFourPointFourTwoMember" xlink:label="loc_huge_ExercisePriceFourPointFourTwoMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFivePointZeroThreeMember" xlink:label="loc_huge_ExercisePriceFivePointZeroThreeMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFivePointFourThreeMember" xlink:label="loc_huge_ExercisePriceFivePointFourThreeMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTenPointSixFiveMember" xlink:label="loc_huge_ExercisePriceTenPointSixFiveMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceThirteenPointZeroSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointZeroSevenMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceThirteenPointFourSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointFourSevenMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSixteenPointZeroEightMember" xlink:label="loc_huge_ExercisePriceSixteenPointZeroEightMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSeventeenPointEightNineMember" xlink:label="loc_huge_ExercisePriceSeventeenPointEightNineMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceEighteenPointZeroNineMember" xlink:label="loc_huge_ExercisePriceEighteenPointZeroNineMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyPointOneZeroMember" xlink:label="loc_huge_ExercisePriceTwentyPointOneZeroMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyOnePointElevenMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointElevenMember_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyFourPointTwelveMember" xlink:label="loc_huge_ExercisePriceTwentyFourPointTwelveMember_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentySixPointThirteenMember" xlink:label="loc_huge_ExercisePriceTwentySixPointThirteenMember_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFortyPointTwentyMember" xlink:label="loc_huge_ExercisePriceFortyPointTwentyMember_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFortyFourPointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFortySevenPointTwentyFourMember" xlink:label="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftyPointTwentyFiveMember" xlink:label="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_21"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftyTwoPointTwentySixMember" xlink:label="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftyFivePointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_23"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftySixPointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_24"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceFiftyNinePointThirtyMember" xlink:label="loc_huge_ExercisePriceFiftyNinePointThirtyMember_25"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSixPointSixteenMember" xlink:label="loc_huge_ExercisePriceSixPointSixteenMember_26"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSevenPointZeroZeroMember" xlink:label="loc_huge_ExercisePriceSevenPointZeroZeroMember_27"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSevenPointSeventeenMember" xlink:label="loc_huge_ExercisePriceSevenPointSeventeenMember_28"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSevenPointFiftyMember" xlink:label="loc_huge_ExercisePriceSevenPointFiftyMember_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSeventyFivePointThirtyEightMember" xlink:label="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_30"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSevenPointSixtyThreeMember" xlink:label="loc_huge_ExercisePriceSevenPointSixtyThreeMember_31"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceEightySixPointFortyThreeMember" xlink:label="loc_huge_ExercisePriceEightySixPointFortyThreeMember_32"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceEightyEightPointFortyFourMember" xlink:label="loc_huge_ExercisePriceEightyEightPointFortyFourMember_33"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOneHundredTwentyPointSixtyMember" xlink:label="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_34"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_35"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyOnePointNinetyOneMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_36"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceTwentyOnePointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_37"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_38"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSixtyEightPointZeroOneMember" xlink:label="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_39"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceSeventyOnePointZeroSevenMember" xlink:label="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_40"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_44"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_45"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_46"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_47"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_4" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwoPointSixOneMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFourPointFourTwoMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFivePointZeroThreeMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFivePointFourThreeMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTenPointSixFiveMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceThirteenPointZeroSevenMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceThirteenPointFourSevenMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSixteenPointZeroEightMember_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSeventeenPointEightNineMember_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceEighteenPointZeroNineMember_13" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwentyPointOneZeroMember_14" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwentyOnePointElevenMember_15" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwentyFourPointTwelveMember_16" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwentySixPointThirteenMember_17" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFortyPointTwentyMember_18" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_19" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_20" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_21" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_22" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_23" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_24" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFiftyNinePointThirtyMember_25" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSixPointSixteenMember_26" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSevenPointZeroZeroMember_27" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSevenPointSeventeenMember_28" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSevenPointFiftyMember_29" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_30" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSevenPointSixtyThreeMember_31" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceEightySixPointFortyThreeMember_32" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceEightyEightPointFortyFourMember_33" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_34" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_35" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_36" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_37" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_38" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_39" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_40" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_43" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_43" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_43" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_43" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_44" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_43" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_45" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_43" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_46" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_43" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_47" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangeAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_4" xlink:to="loc_ifrs-full_RangesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_4" xlink:to="loc_ifrs-full_BottomOfRangeMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_4" xlink:to="loc_ifrs-full_TopOfRangeMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapital">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfVotingRights" xlink:label="loc_huge_DescriptionOfVotingRights_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesAcquired" xlink:label="loc_huge_NumberOfSharesAcquired_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesAcquired" xlink:label="loc_huge_ValueOfSharesAcquired_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedInShareExchange" xlink:label="loc_huge_NumberOfSharesIssuedInShareExchange_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssuedInShareExchange" xlink:label="loc_huge_ValueOfSharesIssuedInShareExchange_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_NumberOfSharesIssuedForDebtSettlement_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_ValueOfSharesIssuedForDebtSettlement_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareSplitRatio" xlink:label="loc_huge_ShareSplitRatio_21"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfReverseShareSplit" xlink:label="loc_huge_DescriptionOfReverseShareSplit_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedInPrivatePlacement_23"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_24"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ValueOfSharesIssued" xlink:label="loc_huge_ValueOfSharesIssued_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_28"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability" xlink:label="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_29"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_30"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassACommonStockSharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsAxis_5" xlink:to="loc_huge_TypeOfArrangementsDomain_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_5" xlink:to="loc_huge_SecuritiesExchangeAgreementMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_8" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_8" xlink:to="loc_huge_PharmadrugIncMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_8" xlink:to="loc_huge_SolarvestBioEnergyIncMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_DescriptionOfVotingRights_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_NumberOfSharesAcquired_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_SharePrices_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_ValueOfSharesAcquired_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_ifrs-full_NumberOfSharesIssued_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_NumberOfSharesIssuedInShareExchange_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_ValueOfSharesIssuedInShareExchange_18" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_NumberOfSharesIssuedForDebtSettlement_19" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_ValueOfSharesIssuedForDebtSettlement_20" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_ShareSplitRatio_21" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_DescriptionOfReverseShareSplit_22" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_NumberOfSharesIssuedInPrivatePlacement_23" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_ShareIssuePricePerShare_24" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_ValueOfSharesIssued_25" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_26" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_27" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_28" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_29" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_12" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_30" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract" xlink:label="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsGranted" xlink:label="loc_huge_NumberOfWarrantsGranted_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsExercised" xlink:label="loc_huge_NumberOfWarrantsExercised_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsExpired" xlink:label="loc_huge_NumberOfWarrantsExpired_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageExercisePricesWarrantGranted" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantGranted_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageExercisePricesWarrantExercised" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantExercised_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageExercisePricesWarrantExpired" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantExpired_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_NumberOfWarrantsOutstanding_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_NumberOfWarrantsGranted_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_NumberOfWarrantsExercised_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_NumberOfWarrantsExpired_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_NumberOfWarrantsOutstanding_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_WeightedAverageExercisePricesWarrantGranted_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_WeightedAverageExercisePricesWarrantExercised_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_WeightedAverageExercisePricesWarrantExpired_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract" xlink:label="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfWarrantsTable" xlink:label="loc_huge_DisclosureOfWarrantsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfWarrantsLineItems" xlink:label="loc_huge_DisclosureOfWarrantsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageSharePriceOfWarrants" xlink:label="loc_huge_WeightedAverageSharePriceOfWarrants_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedDividendYieldOfWarrantsGranted" xlink:label="loc_huge_ExpectedDividendYieldOfWarrantsGranted_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_DisclosureOfWarrantsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsTable_1" xlink:to="loc_huge_DisclosureOfWarrantsLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_5" xlink:to="loc_huge_WeightedAverageSharePriceOfWarrants_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_5" xlink:to="loc_huge_ExercisePriceOfWarrantsGranted_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_5" xlink:to="loc_huge_ExpectedDividendYieldOfWarrantsGranted_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_5" xlink:to="loc_huge_RiskFreeInterestRateOfWarrantsGranted_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_5" xlink:to="loc_huge_ExpectedLifeOfWarrants_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_5" xlink:to="loc_huge_ExpectedVolatilityOfWarrantsGranted_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughReverseAcquisition" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisition_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughReverseAcquisitionShares" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughWarrantValuations" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuations_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughWarrantValuationsShares" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_21"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_22"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughStockOptionsCancelled" xlink:label="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_24"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_25"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_26"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_29"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_huge_WarrantsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_4" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_4" xlink:to="loc_huge_ClassACommonStockSharesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_4" xlink:to="loc_huge_ClassBCommonStockSharesMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_Equity_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_IssueOfEquity_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IssuanceOfShares_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_14" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_15" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughReverseAcquisition_16" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_17" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughWarrantValuations_18" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_19" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_20" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_21" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_22" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_23" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_24" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_25" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_26" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_27" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_Equity_28" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_29" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract" xlink:label="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfWarrantsTable" xlink:label="loc_huge_DisclosureOfWarrantsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfWarrantsAxis" xlink:label="loc_huge_ClassesOfWarrantsAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassesOfWarrantsDomain" xlink:label="loc_huge_ClassesOfWarrantsDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtNovember30th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember30th2020Member_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtSeptember15th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember15th2022Member_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtAugust1st2021Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust1st2021Member_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtSeptember11th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember11th2023Member_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtJanuary5th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary5th2020Member_5"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtJuly24th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJuly24th2023Member_6"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay20th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay20th2023Member_7"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay24th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay24th2022Member_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay4th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay4th2025Member_9"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay10th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay10th2025Member_10"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay17th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay17th2025Member_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtMay31st2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay31st2025Member_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtJanuary16th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary16th2026Member_13"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtJanuary20th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary20th2026Member_14"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtOctober20th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtOctober20th2019Member_15"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtNovember1st2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember1st2019Member_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtNovember14th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember14th2019Member_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtNovember21st2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember21st2019Member_18"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtDecember12st2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember12st2019Member_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WarrantsByExpiryDateAtDecember29th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember29th2019Member_20"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfWarrantsLineItems" xlink:label="loc_huge_DisclosureOfWarrantsLineItems_23"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_23"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_24"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_DisclosureOfWarrantsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsTable_1" xlink:to="loc_huge_ClassesOfWarrantsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsAxis_1" xlink:to="loc_huge_ClassesOfWarrantsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember30th2020Member_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtSeptember15th2022Member_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtAugust1st2021Member_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtSeptember11th2023Member_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJanuary5th2020Member_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJuly24th2023Member_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay20th2023Member_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay24th2022Member_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay4th2025Member_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay10th2025Member_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay17th2025Member_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay31st2025Member_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJanuary16th2026Member_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJanuary20th2026Member_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtOctober20th2019Member_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember1st2019Member_16" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember14th2019Member_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember21st2019Member_18" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtDecember12st2019Member_19" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtDecember29th2019Member_20" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsTable_1" xlink:to="loc_huge_DisclosureOfWarrantsLineItems_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_23" xlink:to="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_23" xlink:to="loc_huge_NumberOfWarrantsOutstanding_24" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory" xlink:label="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SignificantAccountingPoliciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_IncrementalBorrowingRateToDiscountLeaseLiabilities" xlink:label="loc_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_LeaseLiabilities_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_12"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory" xlink:label="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfAppliedTheDefinitionOfALeaseUnderIFRS16ToContractsDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossLoanCommitments" xlink:label="loc_ifrs-full_GrossLoanCommitments_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_AdjustmentToLeaseCommitments" xlink:label="loc_huge_AdjustmentToLeaseCommitments_2"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ImpactOfPresentValueOnLeaseObligations" xlink:label="loc_huge_ImpactOfPresentValueOnLeaseObligations_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_GrossLoanCommitments_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_huge_AdjustmentToLeaseCommitments_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_huge_ImpactOfPresentValueOnLeaseObligations_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_LeaseLiabilities_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ProductionEquipmentMember" xlink:label="loc_huge_ProductionEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-full_ConstructionInProgressMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-full_LandMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationMethodPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_4" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_4" xlink:to="loc_ifrs-full_ComputerEquipmentMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_4" xlink:to="loc_huge_ProductionEquipmentMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_4" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_4" xlink:to="loc_ifrs-full_ConstructionInProgressMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_4" xlink:to="loc_ifrs-full_LandMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_11" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_11" xlink:to="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_11" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory" xlink:label="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory" xlink:label="loc_ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SubsequentEventsMember" xlink:label="loc_huge_SubsequentEventsMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SharePurchaseAndSaleAgreementsMember" xlink:label="loc_huge_SharePurchaseAndSaleAgreementsMember_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_16"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" xlink:label="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_17"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares" xlink:label="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesIncurred" xlink:label="loc_ifrs-full_LiabilitiesIncurred_19"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_NumberOfSharesSold" xlink:label="loc_huge_NumberOfSharesSold_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_21"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_4" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_SolarvestBioEnergyIncMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_CannaraBiotechIncMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_8" xlink:to="loc_ifrs-full_NonadjustingEventsMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_8" xlink:to="loc_huge_SubsequentEventsMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsAxis_11" xlink:to="loc_huge_TypeOfArrangementsDomain_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_11" xlink:to="loc_huge_SecuritiesExchangeAgreementMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_11" xlink:to="loc_huge_SharePurchaseAndSaleAgreementsMember_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_15" xlink:to="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_15" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_15" xlink:to="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_15" xlink:to="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_15" xlink:to="loc_ifrs-full_LiabilitiesIncurred_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_15" xlink:to="loc_huge_NumberOfSharesSold_20" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_15" xlink:to="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_21" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/TradeAndOtherReceivables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_SalesTaxRecoverable" xlink:label="loc_huge_SalesTaxRecoverable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_RentReceivable" xlink:label="loc_huge_RentReceivable_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_huge_SalesTaxRecoverable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_huge_RentReceivable_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_OtherReceivables_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_TradeAndOtherReceivables_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/TradeAndOtherReceivablesTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20191231.xsd#huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory" xlink:label="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>exhibit99-2xauditor1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-2xauditor1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#H17AI9@  34T *@    @ ! $[  (
M   *   (2H=I  0    !   (5)R=  $    4   0S.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%N<V]N($QI
M=0  !9 #  (    4   0HI $  (    4   0MI*1  (    #-S@  )*2  (
M   #-S@  .H<  <   @,   (E@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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/P*** Y8K9&I11104?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>exhibit99-2xauditor2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-2xauditor2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#H17AI9@  34T *@    @ ! $[  (
M   *   (2H=I  0    !   (5)R=  $    4   0S.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%N<V]N($QI
M=0  !9 #  (    4   0HI $  (    4   0MI*1  (    #-#0  )*2  (
M   #-#0  .H<  <   @,   (E@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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D* $HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>exhibit99-2xauditor3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-2xauditor3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#H17AI9@  34T *@    @ ! $[  (
M   *   (2H=I  0    !   (5)R=  $    4   0S.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%N<V]N($QI
M=0  !9 #  (    4   0HI $  (    4   0MI*1  (    #.34  )*2  (
M   #.34  .H<  <   @,   (E@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M** "BBB@ HHH) &2<"@ HIGFQ_WU_.CS8_[Z_G0 ^BF>;'_?7\Z/-C_OK^=
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MH,T88GRWSZ!B,D8( JK:>"-9N-#\1V%O:'1]/O84^PZ=-="81RJ=Q((SM4X
MQFO4RZ@@$@%N@)ZTUY8X\[W5<#)R<47%["%K?UJ</;V/B+7?$V@W6JZ0NEV^
MCB1W8W*RF9V39A0O0=\FCP39:]I.@'0M1T5H47[0PNQ<QLK%W9E&T'(^]^E=
MND\4F?+D1\==K TY)$D&48,/4'-%RE22=[_UI_D>>?\ "*:O_P *IT/1?LR_
M;[2>V>:/S%PH24,W.<'BGR^!;K4;SQ%/+_H=W+J*WFE7BL"T;+$JYX[$@@@]
M17H#R(F-[!<G R<9H+J& ) )Z#/6B[%[&'4\NTGP=XDTWP_X>OA;0R:QHUW=
M2R6;2@+,DS-NPPR <$$9KJM /B*[\4WVH:O9R:=I[VT<<%I)<K)B0$[FPI(&
M1BNH#J6*@C<!DC/2@NH8*2 3T&>M%QQHJ-K/^MA:X_5M!U#Q)XVLI+^'[/HV
MD,+B%@XWW,_;H<JJ_AFNN,BJ<,P!QGD]J8MQ"P)65&QUPPXH+E%2T9+7+W.E
M7X^)D>M16^^TCT>2VW!P"93*K!<9SR!UZ5TY90P4D9/09ZTAD0.%+ ,>@)ZT
MARBI;GE4/@7Q-;16WB 77F:NNHG4)-/VH!ESM=/,STV<8SCBK^M^%_$.L^(7
M\3QQ1P7VE2*NE6;LA$T8/SEV[%LG'/&*]%:1$QO95STR<9IS,JKEB /4T[F/
ML(6L,@=Y+>-Y8C$[*"T;$$J?3(XJ2BBD=!0UK5[/0]'N-0U*X6WMX5RTA&<>
MG'<Y[5XG<6F@>*+@ZG?:!J]Y%=OA-2U#4UMS+_URCZ$>@ KV3Q-H5MXBT?[!
M?9-OYT<LB?WPCAMOXXQ7F_A+5EEO[;Q1J:@OJ&J2Z?;+C(MH$C<I$@[$LO;K
MQ5(XZZYI*+V+5GX3OM!MH;1[F[O?#=X0H2X8?:=,D/W)$8=MQ&<8QU]:T--\
M0W>M_"KQ)%J;;M1TN"[L[B11@2,D;8?\01^-=R-0M;K2S>6K"ZA9-R^4-V_V
M'O7*:+X7FB\ ZW:%XCJ6L_:9)RK91)9%*A<CJ%X!/L:!^SY7:&UF>0R6GAK3
M?A?IVHPWMQ;>+)T$UN(9Y-[GS2H.!P!A3^5:MS%I=]\0K^Y^()E2&WT:UFN
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MJ%<[X^O+C3_ &LW=E,\$\-JS1R(<%3ZBNBJAK>DP:]H=WI=VSK!=QF-S&<,
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MPO$NUA?WA=<88RGJ% '\LX]S4$/A ".TDGU*Y:\MK?R/M"':7&[=D@YKI**
M]G'L87_"+QEF)U&^W%RP82X*\YQ_/\Z?:^'!:W$<HU&\D\LJ=KR9!PI7GZY_
M2MJBD')$YU?!UK&H$5Y=QXD+_*X&1QQTZ<?GS2?\(;;F*.)[^]>.--@1I.#S
MD'&*Z.B@/9Q[%33;$Z?:F%IY)SO9M[G)P3P/H!@?A5NBB@I*RL%0W<L$%I++
M=NL<"*2[.< "IJJZE81ZGITUG,S(DRX+(1N7N",^] .]M"DEYHCK$R7$!$T;
MR1_/]Y4^^?P[^E$=[H<T44D5S;LDLJPQL'X=V4,JCU)4@U1N/!5K=W45U=7]
M]+<11M&LF]1PV_=P% YWD'CL*K1_#G2H85AAN;V.-)_M,2K* (Y=J*&'';9P
M.GS'CIAZ&7[SLC9@UG1HX+B2&^MUC@D$<QW_ '&+;0#^/%6KG5+&SN8K>ZNH
MHI9@2B.V"P')K F^'^G7,,\-S=WLD<TF]AYBKQEV"\*. TC'UZ<\5H7WAN+4
M9+,W-Y<LMK$T93Y,2Y7:6;Y?O8)Y&,9-&@TYVV+46O:5.D;1:A;L)%=T_>#E
M5^\?H.]6;.]M]0M5N+.99H6SAT.1P<&LBU\)65M;PQ-+-.(O-W&7:?,\Q=K;
ML #IZ5?T;2(-$TU+*U:1D5F<M(V69F)))/U-(J//?4OT444%A1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@
M>+M8U+0])^V:;:V\R1D><T\A&T%E'"@<DY]1C%;]9GB+2GUO0;C3XY5B:;;A
MV&0,,&_I03._*[;E?Q3KDN@Z3%=0K%^\G2%I9R?+@#'[[XYP/ZBL>+Q1JESX
M6N-7BDT^)+225'E,;R1W*J<*T6&!Y/ '//>M/7-#O]7"8NK9?LMVEQ;1R0ED
M8!<%9!GGDD@C&./2J5MX-FCM(X9KF';)JJZA<Q0Q%(L*!B-%SP-RJQSU.?6G
MH92]HY:;#+_5O%5EI>GRD:6+Z\,<2VAAD/[UN2,[^BKDD_[)JYXHUC5="L&O
MK?[ \4:KF*7?YEPY.-B8/!/;K5^YTF2Y\26FI22J8K."1(XL?\M'(^?_ +Y!
M'XUD3Z!KTVOV^J2W6F7#V]N(XXYH7VQ.2=[J W!(P/8"@&I*]KB2>);U_&4N
MD+=:;9I&L#)'=*QEFW@E@N& R,8Z'K5[2]8U*X\5:AI>HVMO D%M%<0F*0NS
M*[R+\Q( S^[S@#OU-,UG0]2UN>&"XN;..PCGBG.R%C,2C!L!B<#)'7&<58FT
MB\7Q!>ZK97$*R3V4-M&LJ%@I1Y&).",@B3'X4#7/?YE36-;U32M9LHMME+;W
MERL,=NF[SRI'S..V%ZD8Z=ZIZ7XPO+N^TXW,5HMIJDDT5NJ.?-B9-V-^>#D*
M>@&#@<U9M=!UBU\47FJM/83BYD4*TL;^9#" !Y:G.!W/N33(?"#GQ&NK7":=
M#)"9'A^R6VQG=@0&D8DYP">!W.:-"?WE[H?!K>L_\)'+I$RZ?-,;-[A3 7 @
M8, JR9S][)Y&#P>*L>']:OK_ %;4K"^%K+]B\O\ TFTW"-F;.4.2?F7 SS_$
M*S-.\,:_8>'[S3X[[3TN;J)]]]'$_FO,W_+1B3]?IQ6UX;TR\TBQ%E<+8I!$
MH$0M$923W+;B<D]<_6@<>>ZN:5X+HVK_ &!X4N/X&F4LH^H!!_6N>\.:]J-Y
M:K=:W+8QQRW+VD*6\+AC(KLO)+'@[2:ZBL32-(O-(TV.UAN(6/VR2:5F0G,;
MNS%1SP>1S[=*#22?,FB#QGXH/AG1);BUA6YO?+=XH2>-JC+,V.B@?J0.]+>Z
MUJ=KXJTJQ-K;"POF=/.,A,A*Q,_"XP!E<=3GVJ+Q3X+MO$=M>,L]Q;WMQ:&V
M659W5 O) 900",GIWJY<:"9+[1)8YV*:8\A82L7>0-$R?>)SGYLY-&A#]IS/
MMI_P3.T#Q:=?U4K!=Z:EL6<1VWF%KEU4D;\9P,D9Q@\=Z76O$=Y9^+(M)@N]
M-LHY+995DOE8^8Y<KL7#*.U0V7@VZM)["$WEN;#3+F2YM56$B7+!@%9LX*C>
M>@YP*MZWHFLZ[I1TRYN[!+:XA6.Y=;=O,S_$4RV![9SBC0G]YRZ[E.Y\8W=M
MJ$\C16@TZVU&/3Y5+D3EGVC>!TQN<<8Z9.:ELO%QU+Q)+96UWIL,$-PUOY4T
MA,\Y7[Q4 @ 9R!G.<9IVH^#_ .U=<BN;M-/6WBFCEWQVW^DR;,%5:0GIN /
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7 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tmpxu001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmpxu001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
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M-=^$OB/?81:M*XBMI?E-OJ,&Y9%_X$JLO^]$M?H)^T?XMO\ PM\*=0M]#?\
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M,'@*'QAXWUBR\'QV3BT\-^'66U5_W\F7N9&5O.;=_#M55KH_^"M7_)N6A_\
M8R0?^DUS7K7[!I_XQ'^' _Z<)/\ T?+4<S]DF7RIUW'R/SF^+7PRNOV'?VM_
M"<?A'6KZ:Q>2TOK:2Y;;*T$D[1R02;=JLORLOW?NM7[+KTS[5^5__!3[_DZ[
MX??]@FS_ /2VXK]4%;"@>U%;6,&/#*U2:1-1117*>@-/*U\6Z3\,OCE!^V1=
M_%>;1M&'AJ]M_P"QGTO^U1Y\=@-NT_=V^9N7S<?[RYK[1#4O%5&5C.4;GCO[
M4WP4A_:!^"OB#PF4C_M.2/[1IDKG'EW<?S1?-_"&^XW^R[5F_L=?!&3X!? C
M0O#=[#'#K;[KS5/+96S<O]Y=R_>VJ%7/^S7NG&*#C;1SRY;"]G'G]H?G)^V'
M^Q[\8_C]\=9_%NA66CVVE6=O#9:?]JU+;+(D;,WF,NWY=S.WRU]_^&9=3N?#
MVGRZW:16&K/;J;JUAE\U(Y,?,JM_$,UMY'%!/6B523BD33HQIRE)=1]%%%2;
MGS7^U/\ L8>&OVE;:VU,7,GASQE8IMM-;MT#%E!W+'(O\2YZ-]Y>WI2_#K6/
MCY\/M'BT/QAX,L/B*]JOEQ>(-!UB&WEG4?=:6"Y\OYO=6KZ07#=*4K5>T?+9
MF/LU>Z/@3]I;]F7XQ_MC^,-"DU33-(^'/AC1XY%@BO-06^NW:1EWNRQ+MZ(O
MR[O^!5]@>&/AS9Z;\)=)\!ZPZZ_8V^CQ:/=-<0[5NHEA$3;E_AW+5+XE?'_X
M>_!Z OXP\7:7HSA=_P!EEFWW+#_9@7=(WX+7:Z)J=MKFDV6IV3;[2]@2XB8C
M&Y&4,OZ$4Y5).,284X*4K;GQ+\,_V7OB=^Q_\3M4U;X81VGCWP%KA5;G0;Z]
M%E>Q!6_=LLC?NV9-S?-_$K-\M=;\<OA+\6?VM[33O"^LZ;:?"_P'#<I=:D9;
M]+_4+YE^ZJK%^[55Y^\WWMK?P[:^O\ TF *KVDN:XO8KEY.AR7PV^'^B_"CP
M3I7A/P[:?9='TR$0P1]6;^\SM_$S-N9F]6KS+]L_X$/^T%\#=5\/V$,<WB"V
M9;_22Y5?])3^'<WW=RLR_P# J]\(+=Z3I64924N8VE"+C8\W_9[^%MM\%O@Y
MX7\'P!?,TZS5;EU_Y:7#?-,WXR,U<K^U-^S)HG[3O@)=&U"?^S]6LY3/I>J1
MIO:WDZ%64_>C;^)?9?[M>Z#!H.!3YI<UR?9KEY3\W_A#\)/VP/V:HG\,^%K;
MP]XK\+J[& 7U[&UO#N;EH]S1RK_>V?=KZM^%'@'XFW.I6_B7XK^*+2[U. YM
M/#OAV)X=.M"PV[Y&^]<2<G[WRKV_O5[CCWI"P]:TE-O4SITE3ZGYZ?MK_LD?
M%_\ :*^,MOXA\/V6CV^C:7916-B]SJ6V6;;(TC2,NWY?F;[O^S7W+X'N-=O?
M">G2>)]/ATO73$HN[:VF$T:R?Q%6_NDUTY(XHR.:B4I.-BHTHQDWW/DK]OGX
M'_$/]H?P=H/A7P;8::;*WOO[1O+O4;WR?F57C6-5V_\ 31FW>RUZ#^Q[X!\8
M_"KX':-X/\965E;:CHK2P0R6-UYR30M(SJWW?E(W[<?[->Z\&C@"CVDN3V8>
MSCS\Y^>7[9O[(WQA_: ^.=OXJ\/6.CV^D:9:P6=C)=:CMEDV.TGF,NWY?F;[
MM?>GAV;4KG0M/EU>UCL=5DA4W5M#+YJ128^95;^(9K87! -)NSFB523BD$*<
M82<NY)1114FXAZ5^3'[;WC?X@?#S]JE_#OAOXC>+-)TG6%M+N.TAUFX\JW:5
MMK*J[OE7<K-M_AW5^LYZ5^1/_!2"6.R_;2T.:618X$L=,DD8_P *K.U=.&^,
MX<7\!^KNAZ/'H6BV6F+<75VEK$(5FOIVFGDVC[S2-\S-[U\>_P#!3;6O$?@7
MX5>'_%?A?Q5KGAO4(M76QF32]2FMHYH9(I&^95;:S*T:\_[35] ?\-6?" _\
MU%\/_P#@<M?)7_!2WXV>!?B'\ ]+TSPUXKTO6]0CUZ&=H+*X61A&L,ZEO_'E
MI48OVB*KSC[%V9[5_P $\9M:\0_LXZ5XG\0^(]7\2ZQK-U<RR3:O?S7)B6.9
MXTC7S&;:/DW?+_>KZ9DOK:WN(X'GC267[B%OF?Z"OF+_ ()\:>NI?L7^$8)6
MDCCG&HIN@=HI%4W=PORLO*M_M+7R)^Q]:ZCI7_!1/5](OM8U'7'TFXUFQCN]
M0N&GEDCC\R-69F_W:<J7-*3[$1K>SA!=S]8V? JI;W\%Y)+'#,DCPMMD5&SL
M;T:O _VY=%N=2_9G\975EJVI:-?:3:&_BGT^[> R>7RR2;6^=&7<-K5XQ_P2
M0GDF^#'C.661I96U_<SLVYF_T>*L_9_N_:'1[3]YR'W'/>PVHC,TJ1;V$:[C
MC+'HOUJ*?4[.TN(;>:[@BGG)$4<DJJ\G^ZO\5?DK\7X?%'A[_@HKIF@67B*^
M\13VNOV$^E)X@O9IDMVF6.15;_IFK2?P_P *UZY^T-_P3U^)7CSXI:%XFT'Q
MTVN7%PJ'5-5UNZ:&6SN5;=YD$:+\L>W;MC7[NW_@57[&*M>1C[>4KVCL<U_P
M5Y\,:98>*O 6N6]I'#JNH6UW!=7,:[6E6-H?+W?WMOF-7Z+?"9=OPN\'_P#8
M&L__ $2E?GM_P5UMY+6+X3PRS-<21PZ@K3'[SM_HWS5]E:]\5K'X)?LL67C6
M^C\^/2O#UI(D&[;YTS11K''_ ,"9E%:U-:4#.GRJM.1Z_J&I6NF6_G7EW#9Q
M=Y)Y%1?S:G6%_:ZC;I+9W$5U"?NR0N&7\Q7PC^Q)X'D_:?L]?^,'Q9*^+[^X
MU![+1]-U)/-L;&*,*S-' WR_>;;_ ,!;^]7'_M?F?]B;XX>!O'WPX T+1]=\
MU=6\.VC>58W31-'O_=?=7=')_#]UEW5A[+W^3J;?6/<]I;0_222XCC^5G7=Z
M$TZ.59!\A!^AKX4_X*-? BV^(?PEB^*WA820ZWIENEU=M;LR_:[!E^\VW^)-
MRMN_NAZV/^"5WB+2M6_9YU"SMV7^V[+6)AJ1=MTLFY5:)V]MOR_]LVI>S]SV
M@>U?M?9GVA),D1"EUS[FI001N'-?#?[0/P TOXZ_MN^%+ +)%IUGX?&K>)3;
M2-']H19VC@C;;_$VW;_>VK_LU]J:9IEIHFGV]C8V\=K96\:Q100KM6-5^ZJK
M42C%)&T)-R9J4445)J%%%% !1110 4444 %%%% #>V:_([_@HN=W[;7A[_KS
MTS_T>U?KCQBOS4_:S_9(^-?QJ_:(N_&NA>'[%=+L_L\&G_:M4A5Y%B_C9<_*
M&8LVVNG#2C"=V<6*C*4-#])/LT./]4G_ 'R*^*_^"L,"1?LX:2411_Q4=MT7
M_IC/7V'X?N;V_P!'LKC4K'^S-0DA!N+/S5E\F3'S+N7Y6^M?,/\ P4%^#GQ
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MX5>#;G2H[AUM9I=4&Z2'=\K?\?"\[?55IJ-S.4K'UIG_ &?Y49_V?Y5\>?\
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7@HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tmpxu002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmpxu002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
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M-Q(4>2;R5W,T>?+W'J=NX[?[M8L_PN\'SWEO<R>%-&EN(6_<S/IT+-'\S/\
M*VWY?F9F_P!YJKFB8\LCFO!?CFZL_!OBC5=3>[U1[#7=2MXHX(6D?9'=-''&
MJQKN(4!1]VO-E^-6L7OA/1=8FO-8N(_^$MUFQO(]/L6AGFM;>WOY(XHXY%5O
ME\F)O[WR;6W-N6OHG1='L]"M9+6Q@2VB>>6=D7^)Y)&DD8_[3,S-^-5U\-:7
M'<1.FEV2-#</=QLENF4FDW>:Z\?*S;VW-]YMS4<T2N61XQ;^-_$FGZ-X2O)_
M%5IK<L]_H]IJDVEK"]O;K<*JMN7[TGGM(FUE5=NX-]U6W?0O#5S]CX/T'2Y(
M&L]$T^V>%B83#:HAC;YC\N!\OWF_[Z-=!N I2=QQBT.HHHI%A1110 4444 %
M%%% !1110 4444 %%%% !1110!Y9XR^*FH>&_$U[IUKHD.H6]D-,:XF:]\EL
M7MS);IM7RVW;6CW'YEX:JVE_%^]UL)8V_AQ9_$ AU.:;3TO5\IOL=T;5ECE9
M5R9)/N[E7Y?O;:[F\\)Z-J=S<W-Y8PRW%U]F$SN.9/L\K20?]\R,S+6?<_#K
MPW>36LC:7$DMM//<PS1,R.CSR>9/\RMG;(WS,OW6[UIH8\LCB=2^.MQIMUJ4
MTFB8TO3(]1DNV\YFN(_LLJPJK)MVQF=F5H]S<QAFJ]JOQ@?PYXG;3=3T9;:W
M@O+>"_OUNV:&V6YBD-M(O[KYMTT7DLIV[6=&^;=5C0/@MI^G:Y=ZE?21Z@]V
MUWYZ^2R"Z6X;YEN%WLDF%^7[JUUT/@W1X+>XM!IUL]O<2)++'+&)/,:/;Y9;
M=G.W8FW^[M6CW1>^<EH?Q0U/5];?3QX:F6XM+N'3]1,4S.EI,UJMP3NV;6C7
MS(UW?*WS?=KGE^.FM2^%]%U8^%;19=6\/W'B*VB_M=MHMXH;61E=O(^63_26
M7T^3[WS?+Z1_PA.D?\)!-K<=CY>I3!1-.C,OG%5VHS*#M9E7Y59N5I5\">'C
M8V5HNEVPM;&P?2[:,+\L5K(J*\*_[++''Q_LK4WB7:9Y[/\ $W5[#QIJ$RVO
M]H:!/_8,7EO=>4UI]MN'@W1J(CYGS-&S!F7Y5_X#5K4/CE+IVB7-^VAJWD67
MB"[,7VW[QTRX\G;NV?\ +3[V[^'_ &J[MO V@RLY.E6QW?9-WR]?LTF^W_[]
MM\RU3D^%OA"6?4)7T&Q:2_6XCNB81^\6X_UX/_73^+^]3O$+3.%\1?$K6?!W
MBP3ZO:I%;/8;8M-M+HS1O-)?PV]L[,8E96;SEW?*VW_:K5O/BQJVGWME;W?A
MMK(Z@E[!8_:;AH_/O(F7R8?N?*LR;F5OO?(WR5V>M>!M"UX,NI:;!>K):_8F
M\Y=V8=RML_[Z53_P&L^3P7%)?:/Y<D;Z/I3FXALI+=I9FN=K*LC3NS-\JLW\
M.[=_%_#1S1)Y9$.L>-[FQ\4'0=,TEM4U&&TCO[B*.Z6(+')+Y?R[OO-\LC?P
M_=_VJY>X^.J1:)%K/]DG[%>:/J&L6!6[P\B6NUBLB[?W;,K*W\6WE6KL!\//
M#:WME=1Z/!#=VTL\D4L.Y&S++YLN[;C<K2?,RM\NZIV\!Z$T%W'_ &7:^3=Q
M3P3Q>7\K1SG=,GLKL=S8^\:7NE>\<9:_%K55\51Z->>'8+6&;4+>S:YM]1WL
MJW$#20OM\M>?W;*R[OE^7:S5Z]FN:;P7HDM^EXVG0M<K-%,LN/FWPJRQM]55
MF7\:Z7%3*PXWZBT444%A1110 4444 %%%% '&6GC.:]^(NI>%DTV0P6&GV][
M+J7G+MW3/*JIMW;O^6+51^)/Q$7P-!9&&**\NY[^PMY8Y)-OE0W%[#;,_P#Y
M$^5?XBI_NM5Z?P#IEQK5WJD+WEK=WK6KW$EO=21K(;=]Z?=;[O\ "R_=9?E-
M0^-OA=X6^(45O_;^AV6H2P2P/%<R6Z-.HBF695#L"VW<OS+W!;UI^[S&7O6.
M1U;XW36FKW6D#2G.I)X@ETF$VZRW.(8[*.ZDN&CC7<WRR;=B_P 17YOXJ[+3
M_B=X<U715U'3M9L]362&*:..WF42,)-OE_(WS+NW+][UJ%OA=HD>H3W\27$=
M])J3:NLZ2D/%<- MNVW_ &6C4+M^[6C;> =!B\,VOAZ31[2[T:V14BL;N%9H
MQM'RY#[LGWI^Z'OGD,O[3;V>@?VI>VEC9-'I;:J\$MQQ=(MU)%)#;-_'(JQ[
MO^VL0V_-FNN\)?'#3/$.I72W<RZ1:FXO$L'O(9(ENHK64Q32>:RK']Y6;:K,
M=NUO[RKJZ3\&O#.E>%=,\-6MHT7A^SE\]=/1MD<C>9YG[S;]Y=W.W[K?Q;JT
M=+^'FA:+J4=];P2[H9[F>WB>1FC@DN&W3-&O\.YBQ_X$V/O57N$QC4,F[^(-
M[?>+[W2-(M+&XMK>QT^_.JR76Z-;>X:[5I-GRAE7[,OW6^;S/]FN=M/C'K9T
MKPKJE[H$6GVFMW%C!&))6'F--(RN^_[L:JNV15?_ %F[:OS5V'B7X8:1XJU#
M4KNXGO[6XOH+:UN&M+DQ^9# \DD:X_N[IY,^M1/\)M&G15O7OM33=;-*+ZY:
M;[0UO,TL+2;NNV1MWX+_ ':/=*]\7P3\0U\6>,?$&DQ6\"6&FVUG=6MPDF6G
M6<SKNV_PK^Y^7U#5WX.:XCPQ\+?#'@GQ/JFLZ'HUGI=YJ-O#!<?8[=8EVQEM
MNU5'R_>.?[V%_NUVX&*SE;H5'FZBT444%A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tmpxu003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmpxu003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
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M:K)\K7#?[*K\U=CJGAO1_P!E+]D76-,TYY#9>']!G_?LW[V:=E;=(W^TTC4
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M^VW\;M6\,_#7Q'X8\#VT.H>(9X8[*^N?.VKIJW#>7'N_VFW?*M+\3OA/\6=
M_:.N_B)\,[?0=2@UK18]+O%UNX:/[')&S;9%5?O?>^[6+\1_V8?$GA_]GK4;
M#26D\>?$34=<M-<UB]ED6%M0DCF5F5=WW8U5=JK0!+XEU-_V=?@5\//@AX-A
MFG\:Z]8KI-K/ NY;-I%_?7<G]U=S,U;7[#VBVNE6OQ#2RDFET_3M<_L"SDD^
M[)%9PK'N7_>;<U<MI'BL?LVS>)OB+\8]22_^)7B\XTWPKHZM<M;6T*MY=M O
M_CS-]VO0_P!@K3+NS_9F\,W]YM\_7)KO6OE/W5N+AI%5O]K:PH ^B:^+O^"C
MUHWC1?A!X"BCFG?7/%4,DT$#;6:&/YFK[1KYI_:O^!GCKXF^+_ASXF\!SZ3%
MJ?AFZN'9=69E1?,CVK)\OWMO]V@#0^./QPU[PU>V7PV^%&F6_B+XD742KMN9
M/]%TF#;_ *^Y;_T%?XJ^:?@]XITO]G?XG_$34O%6J3>)=7\/QK8+!:0JUYJV
MM7G^D7:VT:_,RK^[5?[JU]=?LZ?L_0? _0+N34-4D\3^,]8D^TZUXBNU_>W4
MG]U?[L:_PK4OA#]F+P)X0^*_B3XC0:8+OQ5K=RMR]Y=XD^S?*J[8?[H^6@#C
M?A[X#OK?7]>^./Q*?=JWV%FTO3-GRZ'8+'N955O^6C?Q51_8/EF\5_#_ ,5?
M$6X=I&\;>(+G4X=W_/NO[N+_ ,=6OHO7-&M_$6BWVEWB^9:7D+V\R_WE9=K5
ME_#SX?Z+\+?!VF^&/#EFMCI&GQ^5;P+_  B@#IJ*** "BBB@ HHHH **** (
M;BWCNHVBEC62-OO*Z[E-3444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %<[XX\967@+PKJ.O:@?]%LX6D*J?FD;^%5_WJZ*ODC_ (*(
M:#XQUCP#X3N/#EEJ&HZ-IVNV]YKD6G_,WV567<6C^](O^RM 'E_BVWU;3?A7
MX^^+OCV-;7Q[\0U70_"^B;MT^FVDC>7''#_TT96\QMM?;OPR\)6_@/X>>&_#
MUJGEP:780VJJHZ;445\[OX8_X:9_:'\+>)K7S#\./ $7F64DL.V#4-1D5?FC
M5OO+&O\ %_>^6OK*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"**WCMX
E]D2+&GH@Q4M%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>form40fax001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form40fax001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" "= -T# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[^IK;1U-
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M^'5\/V8;KQSXMU#Q5XJ\9WV@R:JN-;NH621H?,2&&.&157;\O\/WO^^:J_\
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M2@ HHHH 3BOGWX[>";/XG_%;Q9X&NBH;4/ 5J]I*?^6-PM[<-$__ 'UM_P"
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M))L=I/,9=OR_,WW:^N/#LFI3Z%9RZO:1VFH20J;J"*7S%BDQ\RJW\0S6BN"
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<RY1114&@4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>form40fax002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form40fax002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" !2 *8# 2(  A$! Q$!_\0
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M[,JLOS?Q(O\ >KGO"^L^,[OP?IUS_P ).MYJUQJ'E) UM&J+%#J,RW,LK?\
M//R%55^[M95VLS-7J_\ 9=A]L>Z^PVQFD*-)+Y*[F:/.S<>IV[CM_NUF3^"?
M!\MW#<R>%-&DFA;]S*VG1,T?S,_RMM^7YF9O]YJKFB9\LC"\&>)KJW\&Z]JV
MIO=W[6&NZA!$D4+2/LCN6C2-5C7<0H"C[M<0/B/K%QX3TS5YKW6)XQXMU:SO
M$LK%HIIK:""^D2...15;Y?)B;^]\FUMS;EKVC1=.L]+M7M;&!8(WGDF95_B>
M21I'8_[3,S-^-0IHVEI/&Z:79*T-P]S&5MTRDLF[S'7CY6;>VYOO-N:CFB/E
MD>8P>)?$EIH_AV\G\5V>JR3W^DVVJ2Z>L306ZSJJMN7[TGG-(FUE5=NX-]U6
MW>Q\&LBQ\/Z!9/$UGHFGP-"Q,)BM44QM\Q^7 ^7[S?\ ?1K7R!2D[CC%H6BB
MBD4%%%% !1110 4444 %%%% !1110 4444 %%%% '!>,O'.H:/XENM.M=$AO
M(;(:<UQ*U[Y38O+B2!=J^6V[:T>X_,O#5#I?Q O=2VV-MX=676!#J,LUDMZO
MEM]DN3;,L<K*N3))]W<J_+][;757F@Z->W4]S>6$,DUU]G$S,.9/(D:2'_OF
M1F9:J7/A#PW<302-I<2R6T\T\,L;,CH\S^9-\RMG;(WS,OW6[U?NF?+(Y74O
MB?<6=U?32:'BPTR._>[;SF:>/[-*L2JR;=L9F9E:/<W,89JMZM\09-(\3G3=
M4T=888+R"&_O%NV:*V6XBD-O(O[OYMTT?E,IV[6=&^;=4V@?#G3[/7+C4KZ2
M.\:[:Z\]?)9!=+.WS+.N]DDPOR_=6NCA\/:-%;36@TVV:&XD225)(P_F-'MV
M%MV<[=B;?[NU:/=%^\.=T/QMJ>H:TVG#PU,)K2[BLM1,<S.EI*ULLY.[9M:-
M?,C7=\K?-]VL9?B=K3^%],U8^%;02:MX?GURVC_M=MH@BBMI&5V\GY9/](9?
M3Y/O?-\O;_\ "-Z/_P )!)K<=CMOI@HFF5F7SBJ[59E!VLRK\JLW*T+X8\/?
M8;6S72[<6]C8/IUL@7Y8K:145XE_V66./C_96E>)5IG&S>--6M/&EY,MK]LT
MB?\ L2/8]UY;6GVR=X=T:B,^9\S1LP9E^5?^ U/J'Q,EM-%FOVT-&\BRURY,
M?VW[QTV?R=N[9_RT^]N_A_VJZUO#&@.S$Z5;G=]EW?+U^SOO@_[]M\RU6D\$
M>$'FO)7T"Q+WZSI=$PC]XL_^N!_ZZ?Q?WJ+Q"TSE/$7C+6/#WBP3ZQ:K' ^G
M[8K"VNC*DDLE]#!;NS&-65F\Y=WRMM_VJOWGCO5K2\M;>[\-M:G4$O(;'S[A
MD\^[B9?*B^Y\JRIN96^]\C?)73:UX9T+5 RZEIL%T)+7[(WFKNS%N5MG_?2J
M?^ U4D\.1-?:;LDC;3=*<SPVKP-)*UQM95D:9V9OE5F_AW;OXOX:.:(N61'K
M'B6YMO$YT'3-):_O8;-+RXC2Z6,+')+Y?R[OO-\LC?P_=_VJP;CXGHFAIK/]
MD'[+>:/?:I8%;O#2);;6*R+M_=LRLK?Q;>5:ND_X1+PT+VUNH]'@BN+:69XI
M(MR-F63S9-VW&Y6D^9E;Y=U2MX7T$V]S'_9-KY=W%-#/'Y?RM',=TJ>RNQW-
MC[QH]T?O',6OCW5!XJCT:\\.0013:A!:M/#J.]E6>!I(GV^6O/[ME9=WR_+M
M9J]&S6(WAS0WOUO&TZ%IUFBE63'S;XE94;ZJK,OXUMXJ96'&_4****"@HHHH
M **** "BBB@#FK/Q%-<_$:^\+)IDABL-/@NY;[SEV[I7E54V[MW_ "Q:JOQ*
M\7+X9M[7R8HKFXGO[*&5'DV^5%/>0V[/_P"1/E7^(J?[K5;G\*Z9+K5SJD3W
ML%Q?-;-</#=21K(8'WI]UON_PLOW67Y347C;P1X6\610_P!OZ'97DD$L+Q3O
M;HTRB*9954.P+;=R_,O<%O6G[O,9^]8YS5OB5-;ZQ<:0-)8WJ>()-,A,*R7&
M(H[..Y>=HXUW-\LFW8O\17YOXJZ;3_&GAR^T5=1T[6;.^62&.6-()E$C"3;L
M^1OF7=N7[WK4;>"=$74)K^)+B.[DU)M369)2'BG:!8&V_P"RT:A=OW:N6WA;
M0(_#-OX>DT>TN-,MD58K2YA66,;1\N0^[)]Z?NA[YYQ-\:'M_#_]J7MI8VK1
MZ6VI20R7'%TJW,D3Q6[?QR*L>[_MI&-OS9KH_"/Q+TO5M2N%NYETVW-Q=I8-
M=0R1K=1VTABED\UE6/[RLVU68[=K?WE70TKX=^&+'PK8^&K6T:/1[.7SELD;
M;'(WF>9^\V_>7=SM^ZW\6ZKNE^$M"T[4TOK>"7=#/<36\;2,R023MNE:-?X=
MS%C_ ,";'WJ?[L48U#.N_%E]<^+[K2-(M+&:"WL;&].HO=;HU@G:Z5I-GRAE
M7[.OW6^;?_LUBVOQ#ULZ3X?U2]T"*SM];N+.&,/*P\QII&5WW_=C55VNJO\
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' **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>form40fax003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form40fax003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" !9 ,,# 2(  A$! Q$!_\0
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M_::U:WBDWPZ-;P6*D'(W!!(_Y-(P_P" U^C5Q(L<+NQPJJ22?2OR5^)6L?\
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MM5MI;6W>%,;8VC!5<=, \# JU11<7)%+1&?_ &'I&,#2K'\;=?\ "KL:;!@
M 8' Z"GT4@C%1V0C*&4AAD'J#6>NAZ1WTNR_\!U_PK1HH"48RW11CT?3(I%D
MATZTC=3E66%00?4''6BZTNQNI_-NK"UF;;C?)$&;'7&2.G)J]11<.2-K6T*,
M>CZ;%,LL.G6D<B'*LL*@CW!Q5MD#1[& ((PP/0BGT4 HI;(R8?#/A^+S!%H>
MFIYJE9-MH@WJ3D@X'(R!3K?P]HEN0;?1=.B(<.-EJB_,.AX'49/-:E% <D>P
MU1@8 Z4ZBB@H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
:**** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>form40fax004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form40fax004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1"  X C(# 2(  A$! Q$!_\0
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M%!R2JJ21@#FKFO>(_'NF:YH?A$S^'Y];UUKF5+[[+-':V]O B%LQ>86>0LX
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M1K3K1J?":]%</\6/&%_X+UCP_>M!!<Z-J.HQZ;>Q*#]K268XB>(9_> ,#N0
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M\)NDWA70M1LM,EGO/$3B.QLO-"_-L>1B[_PHJQL2V#V !) (&'ITZ=^0U?\
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8H ,"DP*** # I<"BB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6843579056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies - Schedule of estimated useful lives of assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer hardware and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives</a></td>
<td class="text">30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment', window );">Method of amortized</a></td>
<td class="text">declining balance<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_ProductionEquipmentMember', window );">Production equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives</a></td>
<td class="text">20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment', window );">Method of amortized</a></td>
<td class="text">declining balance<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives</a></td>
<td class="text">20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment', window );">Method of amortized</a></td>
<td class="text">declining balance<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Facility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment', window );">Method of amortized</a></td>
<td class="text">straight-line<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment', window );">Method of amortized</a></td>
<td class="text">Not amortized<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember', window );">Intellectual Property</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives for intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The depreciation method used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationMethodPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of useful life used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of useful life used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_ProductionEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_ProductionEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6823789648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income taxes - Schedule of temporary differences for which deferred tax assets not recognised (Details) - CAD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised', window );">Property, plant and equipment</a></td>
<td class="nump">$ 1,054,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised', window );">Other investments</a></td>
<td class="nump">1,287,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised', window );">Share issuance costs</a></td>
<td class="nump">1,169,642<span></span>
</td>
<td class="nump">$ 3,772,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised', window );">Non-capital losses carried forward - Canada</a></td>
<td class="nump">27,518,609<span></span>
</td>
<td class="nump">29,272,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised', window );">Net operating losses carried forward - US</a></td>
<td class="nump">274,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised', window );">Capital losses carried forward</a></td>
<td class="nump">350,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised', window );">Unrealized fair value on biological assets and inventory</a></td>
<td class="nump">1,098,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Deductible temporary differences for which no deferred tax asset is recognised</a></td>
<td class="nump">$ 32,754,253<span></span>
</td>
<td class="nump">$ 33,044,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of domestic non-capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of foreign non-capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of other Investments for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of Property, plant and equipment for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of share issuance costs for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of unrealized fair value on biological assets and inventory for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6824770608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 04, 2019 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($) </div>
<div>Share</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Key management personnel compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,312,577<span></span>
</td>
<td class="nump">$ 5,029,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Amount of bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,836,192<span></span>
</td>
<td class="nump">1,814,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ConsultingFeesExpenses', window );">Consulting fees expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,288,129<span></span>
</td>
<td class="nump">2,037,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DirectorsRemunerationExpense', window );">Directors' remuneration expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203,521<span></span>
</td>
<td class="nump">66,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DirectorsRemunerationPayable', window );">Director's remuneration payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based payments expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,476,385<span></span>
</td>
<td class="nump">$ 3,215,401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInPrivatePlacement', window );">Number of shares issued in private placement | shares</a></td>
<td class="nump">228,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSharesIssuedInPrivatePlacement', window );">Value of shares issued in private placement</a></td>
<td class="nump">$ 4,598,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentAndChiefExecutiveOfficerMember', window );">Former President and CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Key management personnel compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_FormerChiefExecutiveOfficerMember', window );">Former CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherAllowances', window );">Other allowances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefExecutiveOfficersMember', window );">Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PaymentOfExpenses', window );">Payment of expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">754,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefExecutiveOfficersMember', window );">Chief Executive Officer | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Amount of bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,428,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of share issued for share-based bonus expense | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentsMember', window );">President</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based payments expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentOfFSDMember', window );">President of FSD | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Amount of bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of share issued for share-based bonus expense | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefFinancialOfficersMember', window );">Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ManagementFees', window );">Management fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefOperatingConsultantMember', window );">Chief Operating Consultant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ConsultingFeesExpenses', window );">Consulting fees expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_FormerChiefOperatingOfficerMember', window );">Former Chief Operating Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ConsultingFeesExpenses', window );">Consulting fees expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_IndependentDirectorMember', window );">Independent directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DirectorsRemunerationExpense', window );">Directors' remuneration expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AdditionalRemuneration', window );">Additional remuneration as Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_DirectorsAndOfficersMember', window );">Officers and Directors | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesSubscribed', window );">Number of shares subscribed | shares</a></td>
<td class="nump">164,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=huge_FvPharmaIncMember', window );">FV Pharma Inc | Former President and CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits', window );">Key management personnel compensation, retirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">770,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Key management personnel compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=huge_FvPharmaIncMember', window );">FV Pharma Inc | President | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Amount of bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of share issued for share-based bonus expense | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=huge_FSDBiosciencesMember', window );">FSD Biosciences | President</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ConsultingFeesExpenses', window );">Consulting fees expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 330,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=huge_FSDBiosciencesMember', window );">FSD Biosciences | President | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Amount of bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of share issued for share-based bonus expense | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AdditionalRemuneration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional remuneration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AdditionalRemuneration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ConsultingFeesExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses of consulting fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ConsultingFeesExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DirectorsRemunerationPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the value of directors remuneration payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DirectorsRemunerationPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount paid for management fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedInPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of shares issued in private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedInPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesSubscribed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of number of shares subscribed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesSubscribed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the value of other allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PaymentOfExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of payment of expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PaymentOfExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareIssuePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price per share of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareIssuePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ValueOfSharesIssuedInPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents value of shares issued in private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ValueOfSharesIssuedInPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DirectorsRemunerationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of remuneration paid or payable to the entity's directors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DirectorsRemunerationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of termination benefits. [Refer: Termination benefits expense; Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of instruments granted in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph IG23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IG23&amp;doctype=Implementation%20Guidance<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of trade payables and other payables. [Refer: Trade payables; Other payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentAndChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentAndChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_FormerChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_FormerChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefExecutiveOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefExecutiveOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentOfFSDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentOfFSDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefFinancialOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefFinancialOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefOperatingConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefOperatingConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_FormerChiefOperatingOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_FormerChiefOperatingOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_IndependentDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_IndependentDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_DirectorsAndOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_DirectorsAndOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=huge_FvPharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=huge_FvPharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=huge_FSDBiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=huge_FSDBiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6814840000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfProvisionForIncomeTaxesExplanatory', window );">Schedule of provision for income taxes</a></td>
<td class="text"><div><div style="margin-left:39pt">&#160;</div><table cellpadding="0" cellspacing="0" style="width:90%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2018</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);border-top:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before income taxes</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(52,013,186</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,710,624</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Statutory federal and provincial tax rate</p></td><td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>26.50%</strong></span></span></td><td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.50%</span></span></td><td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Income tax recovery at the statutory tax rate</p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(13,783,494</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6,018,315</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Permanent&#160;</span></span><span style="font-size:10pt">differences</span></p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>7,797,290</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">2,706,000</p></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:0pt;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other adjustment</span></span></p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,334,913</span></span></strong></p></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:0t;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Change in tax benefits not recognized</p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(348,709</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">)</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">3,312,315</p></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#x2014;</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>&#x2014;</strong></p></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory', window );">Schedule of deferred tax assets (liabilities)</a></td>
<td class="text"><table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:90%;word-spacing:0px;margin:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><strong>2019</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)">2018</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Deferred tax liabilities</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(204, 238, 255);border-top:1pt solid black">Other investments</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black"><strong>(168,092</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"><strong>)</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black">(1,334,000</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black">)</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Capital losses carried forward</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><strong>168,092</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">1,334,000</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Deferred tax liabilities not recognized</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><strong>&#x2014;</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory', window );">Schedule of temporary differences for which no deferred tax asset is recognised</a></td>
<td class="text"><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><table style="border:0px;width:100%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"><strong>2019</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)"><strong>2018</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;width:959px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;border-bottom:1pt solid black;text-align:right;background-color:rgb(255, 255, 255)"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;border-bottom:1pt solid black;text-align:right;background-color:rgb(255, 255, 255)"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)">Property, plant and equipment</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"><strong>1,054,843</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)">Other investments</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"><strong>1,287,743</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)">Share issuance costs</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"><strong>1,169,642</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)">3,772,000</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)">Non-capital losses carried forward - Canada</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"><strong>27,518,609</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)">29,272,000</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)">Net operating losses carried forward - US</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"><strong>274,454</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)">Capital losses carried forward</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"><strong>350,465</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)">Unrealized fair value on biological assets and inventory</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"><strong>1,098,497</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:959px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;text-align:right;background-color:rgb(255, 255, 255)"><strong>32,754,253</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;text-align:right;background-color:rgb(255, 255, 255)">33,044,000</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock', window );">Schedule of non-capital loss carryforwards</a></td>
<td class="text"><div><table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:90%;word-spacing:0px;margin:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">2038</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border:1pt none;background-color:rgb(204, 238, 255)">12,492,296</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)">2039</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border:1pt none;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">15,026,313</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">27,518,609</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfProvisionForIncomeTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of provision for income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfProvisionForIncomeTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of temporary differences for which no deferred tax asset is recognised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of non-capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796883200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of property, plant and equipment</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="width:100%;font-size:10pt;border-collapse:collapse;border-color:#000000"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Furniture and</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Computer</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Facility and</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Production</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>fixtures</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>equipment</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>related</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>equipment</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Land</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Total</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Cost</strong></span></span></td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2017</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123,218</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,068,820</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,100,000</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,292,038</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">209,795</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">220,150</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,350,156</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">252,731</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,032,832</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">333,013</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">220,150</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,418,976</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">252,731</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,100,000</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,324,870</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">126,425</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">73,183</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">142,824</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">191,686</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">534,118</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(86,730</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(101,683</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,643</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(215,056</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance, December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>372,708</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>293,333</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>10,460,117</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>417,774</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,100,000</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>12,643,932</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Accumulated depreciation</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2017</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">76,179</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,045</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,970</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,194</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">76,179</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,045</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,970</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,194</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100,652</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">68,186</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">439,903</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">87,084</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">695,825</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(27,754</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,084</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6,394</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(39,232</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance, December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>149,077</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>134,231</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>434,819</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>121,660</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>839,787</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Carrying value</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">256,834</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">154,105</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,418,976</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">211,761</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,100,000</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,141,676</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance, December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>223,631</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>159,102</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>10,025,298</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>296,114</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,100,000</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>11,804,145</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6709019136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReservesWithinEquityAbstract', window );"><strong>Disclosure of reserves within equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory', window );">Schedule of changes in share capital</a></td>
<td class="text"><div><div><div><table cellpadding="0" cellspacing="0" style="width:100%;font-size:10pt;border-collapse:collapse;border-color:#000000"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="4" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Class A shares</strong></span></span></span></span></span></span></span></span></td><td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="4" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Class B shares</strong></span></span></span></span></span></span></span></span></td><td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="4" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Warrants</strong></span></span></span></span></span></span></span></span></td><td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>#</strong></span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>$</strong></span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>#</strong></span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>$</strong></span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>#</strong></span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>$</strong></span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Balance, December 31, 2017</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>72</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>201,500</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>3,794,846</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>12,794,963</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>354,996</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>2,116,900</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Share issued</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>2,268,035</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>47,853,745</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Share issuance costs</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(6,634,405</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Reverse acquisition</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>545,505</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>9,868,179</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>37,313</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>118,875</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Warrant valuations</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(2,366,670</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>198,835</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>2,366,670</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Share-based payments</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>294,287</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Share options exercised</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>190,463</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>5,145,825</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Share options cancelled</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Warrants exercised</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>44,931</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,254,665</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(44,932</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(454,587</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Balance, December 31, 2018</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>72</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>201,500</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>6,843,780</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>67,916,302</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>546,212</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>4,442,145</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Balance, December 31, 2018</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>72</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>201,500</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>6,843,780</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>67,916,302</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>546,212</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>4,442,145</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><i>Shares issued [a] [b] [c] [d] [e] </i></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>408,651</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>11,539,417</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Issued on acquisition of net assets of Prismic</p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pharmaceuticals, Inc. <i>[f]</i></span></span></p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>510,940</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>16,431,818</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>67,598</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,888,086</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Share options exercised</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>130,189</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,782,438</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Warrants exercised</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>12,167</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>145,174</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(12,167</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(50,183</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Warrants expired</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></p></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(134,192</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(535,014</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Balance, December 31, 2019</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>72</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>201,500</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>7,905,727</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>97,815,149</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>467,451</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>5,745,034</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory', window );">Disclosure of changes in warrants outstanding and weighted average exercise price</a></td>
<td class="text"><div><div><div><table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)">Number of warrants</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:16px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)">Weighted average exercise price</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">#</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:16px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">$</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">Outstanding as at December 31, 2017</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)">354,996</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)">5.80</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">Granted</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)">236,148</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)">16.57</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">Exercised</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)">(44,932</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)">17.79</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">Outstanding as at December 31, 2018</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)">546,212</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)">9.47</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">Granted</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)">67,598</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)">10.45</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">Exercised</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)">(12,167</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255)">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)">7.81</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">Expired</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)">(134,192</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)">7.64</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">Outstanding as at December 31, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">467,451</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">10.20</td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory', window );">Disclosure of fair value assumptions of warrants outstanding</a></td>
<td class="text"><div><div><div><table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">2018</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(204, 238, 255)">Grant date share price</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(204, 238, 255)">$32.16</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(204, 238, 255)">$4.42 - $18.09</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)">Exercise price</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255)">$2.61 - $26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255)">$4.42 - $26.13</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(204, 238, 255)">Expected dividend yield</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(204, 238, 255)">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(204, 238, 255)">&#x2014;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)">Risk free interest rate</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255)">1.41% - 1.52%</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255)">1.70% - 2.17%</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(204, 238, 255)">Expected life</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(204, 238, 255)">1.39 - 6.55</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(204, 238, 255)">2 years</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)">Expected volatility</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255)">100%</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255)">100%</td></tr></tbody></table><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:center;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory', window );">Disclosure of number of warrants outstanding and exercise price</a></td>
<td class="text"><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">The following table is a summary of the Company's warrants outstanding as at December 31, 2019:<br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:center;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><strong>Warrants Outstanding</strong></p>&#160;<table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">Exercise price</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">Number outstanding</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:693px">Expiry Date</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">#</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">November 30, 2020</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">2.61</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">16,787</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">September 15, 2022</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">4.42</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">199,005</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">August 1, 2021</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">5.43</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">4,476</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">September 11, 2023</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">5.43</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">22,382</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">January 5, 2020</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">6.03</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">37,313</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">July 24, 2023</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">13.07</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">3,357</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">May 20, 2023</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">16.08</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">7,311</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">May 24, 2022</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">18.09</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">163,535</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">May 4, 2025</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">3,730</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">May 10, 2025</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">1,865</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">May 17, 2025</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">3,730</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">May 31, 2025</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">1,865</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">January 16, 2026</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">1,722</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">January 20, 2026</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">373</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">10.20</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">467,451</td></tr></tbody></table><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><br/>The following table is a summary of the Company's warrants outstanding as at December 31, 2018:<br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:center;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><strong>Warrants Outstanding</strong><br/>&#160;</p><table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)">Exercise price</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)">Number outstanding</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">Expiry Date</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">#</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)">September 15, 2022</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)">4.42</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)">199,005</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">October 20, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)">7.56</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)">11,970</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)">November 1, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)">7.56</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)">69,240</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">November 14, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)">7.56</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)">52,532</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)">November 21, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)">7.56</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)">10,263</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">December 12, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)">7.56</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)">1,084</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)">December 29, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)">7.56</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)">1,072</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">January 5, 2020</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)">6.03</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)">37,313</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)">May 24, 2022</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)">18.09</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)">163,733</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">9.47</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">546,212</td></tr></tbody></table><p>&#160;</p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of changes in warrants outstanding and weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of fair value assumption of warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of number of warrants outstanding and exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of classes of share capital. [Refer: Share capital [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReservesWithinEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReservesWithinEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6819837920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract', window );"><strong>Disclosure Of Commitments And Contingent Liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory', window );">Commitments and contingencies</a></td>
<td class="text"><div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.<strong> Commitments and contingencies</strong></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Commitments</strong></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Supply Agreement with Canntab Therapeutics Ltd. and World Class Extractions Inc.</i></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">On February 12, 2019, the Company announced that it had entered into a three-way supply agreement with Canntab Therapeutics Ltd. ("Canntab"), World Class Extractions Inc. ("World Class") (collectively with the Company, the "Purchasers") and a Supplier to purchase up to 1,000 kg of the Supplier's 2018 organic hemp crop, for which the Company has already purchased a quantity with a value of<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"> $100,000, </span></span>which amount has been recorded in its inventory. The Purchasers intend to extract CBD oil from the 2019-2024 organic hemp crops and process the oil into gel capsules and tablets at the Company's facility in Cobourg. The Purchasers have committed to collectively purchase<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"> $1,000,000 </span></span>worth of hemp plus applicable taxes, from the 2019 crop.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at December 31, 2019, no hemp has been received by the Company. The Company has provided a deposit of $166,667 to the Supplier as at year-end&#160;</span></span>for hemp product to be received. As of December 31, 2019, the Company has an outstanding commitment to purchase an additional $166,667 of hemp product from the Supplier, representing the Company's share of the Purchasers' collective commitment to purchase $1,000,000 of hemp from the 2019 crop.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to the Agreement, the Supplier granted the Purchasers the right and option to purchase up to $5,000,000 of the Supplier's hemp crop for a period of 5 years commencing in 2019 at a purchase price of $100 per kg per 1% of CBD extracted from the flower.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify">Canntab is a Canadian cannabis oral dosage formulation company based in Markham, Ontario, engaged in the research and development of pharmaceutical-grade formulations of cannabinoids and trades on the Canadian Securities Exchange under the symbol PILL. World Class is understood to have developed an extraction process to produce quality, potent cannabis extracts using ultrasound to effectively produce extracts from cannabis and hemp and isolate essential compounds found in plant material. World Class trades on the Canadian Securities Exchange under the symbol PUMP. Certain Officers and Directors of the Company also serve as Directors of World Class.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><i>Epitech License Agreement</i><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Under the terms of the Company's License Agreement with Epitech Group SPA ("Epitech"), the Company has payments due to Epitech pending the achievement of specified milestones. Upon first notification by the Food and Drug Administration ("FDA") of approval of a New Drug Application, the non-refundable sum of USD $700,000 will be due and payable to Epitech. Within ten business days of the first notification of approval of a Supplemental New Drug Application by the FDA, the Company will pay the non-refundable sum of USD $1,000,000 to Epitech.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">For non-prescription drug rights, any one-off lump sum payments received by the Company as consideration for granting a sub-license to a Commercial Partner with respect to a Licensed Product, shall require the Company to pay to Epitech 25% of the lump sum payment received by the Company. For prescription drug rights the Company shall pay 5% of any one-off lump sum payments to Epitech as consideration for granting a sub-license to a Commercial Partner with respect to a Licensed Product. The Company will pay the amounts payable on a quarterly basis within 60 days of the end of each calendar quarter.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The Company shall pay either a) 7% of Net Sales of the Licensed Product in a Product Regulatory Category other than prescription drugs place on the market by the Company; or b) 25% of Net Receipts received by the Company from Commercial Partners where Licensed Products in a Product Regulatory Category other than prescription drugs are placed on the market by such Commercial Partners; or c) 5% of Net Sales or Net Receipts of the Licensed Products in the Product Regulatory Category of prescription drugs. The Company will pay the amounts payable on a quarterly basis within 60 days of the end of each calendar quarter.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><i>Supply Agreement with Pharmadrug Production GMBH ("Pharmadrug")</i></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">FV Pharma has a supply agreement with Pharmadrug whereby FV Pharma has committed to make the following quantities of cannabis available to Pharmadrug to purchase under the terms of the Supply Agreement:</p><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><table border="0" cellpadding="0" cellspacing="0" style="border:0px;width:406px;margin:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(255, 255, 255)"><span style="text-decoration:underline">Year</span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(255, 255, 255)"><span style="text-decoration:underline">Commitment</span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(204, 238, 255)">2020</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(204, 238, 255)">350 kilograms</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(255, 255, 255)">2021</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(255, 255, 255)">650 kilograms</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(204, 238, 255)">2022</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(204, 238, 255)">1,000 kilograms</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(255, 255, 255)">2023</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(255, 255, 255)">1,000 kilograms</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(204, 238, 255)">2024</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(204, 238, 255)">1,000 kilograms</td></tr></tbody></table><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p></div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><i>Heritage Building Restoration Commitment</i><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The Company has a commitment to restore the designated heritage building on the Company's premises. The estimated cost of restoration is $517,000.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Contingencies</strong></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Legal matters</i></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">From time to time, the Company is named as a party to claims or involved in proceedings, including legal, regulatory and tax related, in the ordinary course of its business. While the outcome of these matters may not be estimable at the reporting date, the Company makes provisions, where possible, for the estimated outcome of such claims or proceedings. Should a loss result from the resolution of any claims or proceedings that differs from these estimates, the difference will be accounted for as a charge to profit or loss in that period.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Environmental</i></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management believes that there are no probable environmental related liabilities that will have a material adverse effect on the financial position or operating results of the Company.</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Claims from suppliers</i></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">A dismissed contractor commenced a lien action combined with a breach of contract action in the Cobourg Superior Court of Justice in early 2019 claiming approximately&#160;<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1,700,000 </span></span>in various purported damages, with the claim for lien component of&#160;<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$188,309 </span></span>being registered on November 26, 2018. The Company is defending the action and has taken steps to obtain particulars and inspect documents of the plaintiff which remain unaddressed to date. The Company has paid<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"> $235,387 </span></span>to the Cobourg Superior Court to vacate the lien from title for which the funds stand both as security for the lien claim as well as its costs with the Cobourg Superior Court of Justice. . The 2019 breach of contract claim has not been provisioned as the Company believes these proceedings are without merit and intends to defend itself from this claim.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p></div><div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Former employee</i></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">FSD hired an individual by way of employment agreement. The individual's employment was subsequently terminated in the probationary period due to non-performance/cause in February 2019. The individual retained legal counsel in or around February 15, 2019 demanding that he be provided (i) unpaid wages; (ii) unpaid holiday pay, (iii) payment for wrongful dismissal (one week) and (iv) breach of contract.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">A hearing is scheduled for March 13, 2020 in front of the employment tribunal. The Company is of the view that the outcome will be unfavourable to the Company. For the year ended December 31, 2019, the Company recorded a provision of<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"> $97,320&#160;</span></span>in relation to the claimed amounts for unpaid wages and unpaid holiday pay. No amounts have been provisioned in respect of the claims for wrongful dismissal and breach of contract, as the Company is of the position that they will be able to successfully defend themselves from these claims.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Class Action</i></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">On February 22, 2019, a shareholder in FSD commenced a proposed class action proceeding against the Company by issuing a statement of claim in the Ontario Superior Court. Amongst other causes of action, the individual seeks leave to bring a claim pursuant to s.138 of the Ontario Securities Act, alleging the Company made statements containing misrepresentations related to the build-out of the Company's Cobourg facility.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify">On October 16, 2019 dates for the leave motion were given - May 5-6, 2020. No discoveries have occurred nor has FSD been required to file a statement of defense. Management intends to contest this leave motion, and are in the process of preparing responding materials. The ultimate outcome of the matter cannot be reliably determined at this time and no provision has been recorded for this matter as at December 31, 2019.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Auxly Cannabis Group Inc.</i></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">On March 3, 2018, FSD entered into a Definitive Strategic Alliance and Streaming Agreement (the "Agreement") with Auxly Cannabis Group Inc. ("Auxly"). On February 6, 2019, the Company delivered to Auxly a Notice of Default, thereby terminating the Agreement effective immediately. Subsequent to the issuance of the Notice of Default, Auxly sent a Notice of Default to the Company on February 6, 2019 in response. To date, neither party has taken further legal action against the counter party.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">To fund the development, Auxly purchased 37,313 Class B shares for the aggregate of $7,500,000 </span></span>from the Company's treasury by way of private placement, which funds were placed in trust to be spent on construction and development costs. The funds were placed in a trust account to be administered by Auxly. Due to the termination and subsequent negotiations, it is indeterminable at this point as to the amount, if any, of these funds will be released to the Company. Should any funds be released to the Company, those amounts will be recognized in future periods.</p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796994080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">Share-based compensation</a></td>
<td class="text"><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt">16.<span style="width:5.49pt;text-indent:0pt;display:inline-block"> </span><strong>Share-based compensation</strong><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">The Company has established a share option plan (the "Option Plan") for directors, officers, employees and consultants of the Company. The Company's Board of Directors determines, among other things, the eligibility of individuals to participate in the Option Plan, the term and vesting periods, and the exercise price of options granted to individuals under the Option Plan.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">Each share option converts into one common share of the Company on exercise. No amounts are paid or payable by the individual on receipt of the option. The options carry neither rights to dividends nor voting rights. Options may be exercised at any time from the date of vesting to the date of their expiry.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">Share-based payment arrangements</strong></span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The changes in the number of share options during the years ended December 31, 2019 and 2018 were as follows:</span></span></span></span></p><div><div><table cellpadding="0" cellspacing="0" style="border:0px;width:100%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Number of</strong></p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>options</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Weighted average</strong></p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>exercise price</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>#</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>$</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Outstanding as at December 31, 2017</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>206,219</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.44</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Granted</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>593,781</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>65.80</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Exercised</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(240,214</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11.31</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Cancelled</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(74,627</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.05</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Outstanding as at December 31, 2018</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>485,159</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>74.53</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Granted</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,363,322</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20.68</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Exercised</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(82,094</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.02</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Forfeited</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(12,438</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>56.28</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cancelled</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(299,006</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>115.80</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Outstanding as at December 31, 2019</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>1,454,943</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>21.96</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Exercisable&#160;</strong><strong style="font-size:10pt">as at December 31, 2019</strong></p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>1,200,242</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>21.24</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div></div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Measurement of fair values</strong></span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The fair value of share options granted during the years ended December 31, 2019 and 2018 were estimated at the date of grant using the Black-Scholes option pricing model with the following inputs:</span></span></span></span><br/>&#160;</p><div><table cellpadding="0" cellspacing="0" style="border:0px;width:100%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>2019</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>2018</strong></span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Grant date share price</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>$6.45 &#x2014; $75.38</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$10.05 &#x2014; $142.71</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exercise price</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>$7.17 &#x2014; $75.38</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$10.05 &#x2014; $148.74</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected dividend yield</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>&#x2014;</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Risk free interest rate</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>1.24% &#x2014; 1.90%</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.97% &#x2014; 2.41%</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected life</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>5 years</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5 years</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected volatiity</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>100%</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></td></tr></tbody></table></div><p>&#160;</p><p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected volatility was estimated by using the historical volatility of other companies that the Company considers comparable that have trading and volatility history. The expected option life represents the period of time that options granted are expected to be outstanding. The risk-free interest rate is based on government bonds with a remaining term equal to the expected life of the options.</span></span></span></span></p><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following table is a summary of the Company&#x2019;s share options outstanding as at December 31, 2019:</span></span></span></span><br/>&#160;</p><table cellpadding="0" cellspacing="0" style="border:0px;width:100%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Options outstanding</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:245px">&#160;</td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:493px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Options exercisable</strong></span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:213px;text-align:right">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:228px;text-align:right">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:245px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Weighted average</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:241px;text-align:right">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:252px;text-align:right">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:213px;text-align:right">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:228px;text-align:right">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:245px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">remaining contractual</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:241px;text-align:right">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:252px;text-align:right">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">Exercise price</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:228px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">Number outstanding</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:245px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">life [years]</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:241px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">Exercise price</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:252px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">Number exercisable</p></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px;border-bottom:1pt solid black"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">$</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:228px;border-bottom:1pt solid black"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">#</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:245px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">#</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:241px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">$</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:252px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">#</p></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.61</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>35,065</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.61</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>35,065</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.42</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>99,502</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.42</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>99,502</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.43</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>16,264</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.43</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>16,264</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.65</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,730</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.65</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,730</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13.07</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,855</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13.07</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,855</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13.47</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,418</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13.47</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,418</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>16.08</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18,409</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>16.08</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18,409</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>17.89</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,178</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>17.89</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,178</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18.09</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>37,313</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.34</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18.09</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>37,313</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20.10</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>493,363</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.72</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20.10</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>493,363</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21.11</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,438</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.67</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21.11</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,438</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>24.12</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,950</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.59</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>24.12</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,219</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>26.13</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.62</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>26.13</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>40.20</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>29,851</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.45</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>40.20</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>22,388</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>44.22</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,488</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.41</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>44.22</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,488</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>47.24</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,493</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.37</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>47.24</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,493</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>50.25</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>227,861</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.09</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>50.25</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>129,353</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>52.26</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.21</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>52.26</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>55.28</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.12</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>55.28</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>59.30</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.96</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>59.30</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.17</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>199,005</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.83</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.17</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>199,005</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.50</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.50</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>75.38</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.04</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>75.38</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.63</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>203,750</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.34</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.63</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>58,750</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>86.43</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,244</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.88</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>86.43</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,244</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>88.44</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.87</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>88.44</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>120.60</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,950</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>120.60</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,950</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>142.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,974</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.74</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>142.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,975</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21.96</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,454,943</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.59</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21.24</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,200,242</span></span></span></span></td></tr></tbody></table><p>&#160;</p><p><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The following table is a summary of the Company's share options outstanding as at December 31, 2018:</span></span></p><table cellpadding="0" cellspacing="0" style="border:0px;width:100%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Options outstanding</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px">&#160;</td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:494px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Options exercisable</strong></span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Weighted average</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:251px">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">remaining contractual</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:251px">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Exercise price</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Number outstanding</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">life [years]</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Exercise price</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:251px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Number exercisable</p></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:213px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">$</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:229px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">#</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:243px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">#</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:243px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">$</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:251px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">#</p></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.42</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>149,254</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.42</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>149,254</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.03</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,488</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>0.98</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.03</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,488</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18.09</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>42,289</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.35</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18.09</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>42,289</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20.10</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>33,169</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.27</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20.10</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>16,584</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>26.13</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.62</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>26.13</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>56.28</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,438</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.91</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>56.28</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>59.30</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.96</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>59.30</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>86.43</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,244</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.88</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>86.43</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,244</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>88.44</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.87</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>88.44</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>120.60</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,950</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>120.60</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,950</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>142.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,975</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.74</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>142.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,658</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>148.74</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>199,004</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.70</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>148.74</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>74.53</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>485,159</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.32</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>19.91</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>253,815</span></span></span></span></td></tr></tbody></table></div><p>&#160;</p><p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company recognized $16,061,319 of share-based compensation expenses during the year ended December 31, 2019 (2018 -&#160;$6,440,406), with a corresponding amount recognized in contributed surplus.&#160;</span></span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Included within share-based compensation expense during the year ended December 31, 2019 is $1,730,794 (2018 - nil) for bonus expense to be paid subsequent to December 31, 2019 through the issuance of Class B common shares of the Company.</span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 44<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796922032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmented information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">Segmented information</a></td>
<td class="text"><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt">24.<span style="width:5.49pt;text-indent:0pt;display:inline-block"> </span><strong>Segmented information</strong><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">The Company reports segment information based on internal reports used by the chief operating decision maker ("CODM") to make operating and resource decisions and to assess performance. The CODM is the Chief Executive Officer of the Company. The CODM makes decisions and assesses performance of the Company on a consolidated basis such that the Company is a single reportable operating segment. For the years ended December 31, 2019 and 2018 all revenues generated by the Company were earned by their subsidiary, FV Pharma, who is domiciled in Canada. For the years ended December 31, 2019 and 2018 all property, plant and equipment were held by FV Pharma and the intangible asset is related to the Company's US domiciled subsidiary, Prismic.</p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796899520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_BasisOfPresentationAbstract', window );"><strong>Basis Of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">Basis of presentation</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.<span style="width:10.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Basis of presentation </strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>[a] Statement of compliance </strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These financial statements have been prepared by management in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB"). The policies set out below have been consistently applied to all periods presented, unless otherwise noted. Certain comparative figures have been reclassified to conform to the current year's presentation.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These financial statements were approved and authorized for issuance by the Board of Directors of the Company on March 3, 2020.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>[b] Basis of measurement</strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These financial statements have been prepared on a historical cost basis. Historical costs are generally based upon the fair value of the consideration given in exchange for goods and services.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, regardless of whether that price is directly observable or estimated using another valuation technique. In estimating the fair value of an asset or a liability, the Company takes into account the characteristics of the asset or liability if market participants would take those characteristics into account when pricing the asset or liability at the measurement date. Fair value for measurement and/or disclosure purposes in these financial statements is determined on such a basis, except for share-based payment transactions that are within the scope of IFRS 2 <i>Share-based Payment</i> ("IFRS 2") and measurements that have some similarities to fair value, but are not fair value, such as value in use in IAS 36 <i>Impairment of Assets</i>.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>[c] Basis of presentation</strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying financial statements include the accounts of FSD and its subsidiaries, FV Pharma and Prismic. The financial statements incorporate the assets and liabilities of the Company and its subsidiaries as at December 31, 2019 and 2018 and the results of these subsidiaries for the years then ended.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. All intra-entity assets and liabilities, revenue, expenses and cash flows relating to transactions between subsidiaries of the Company are eliminated in full on consolidation.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>[d] Functional currency and presentation currency</strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These financial statements are presented in Canadian dollars, which is the functional currency of the Company. The functional currencies of the Company's wholly owned subsidiaries is as follows:</span></span></p><table border="0" cellpadding="0" cellspacing="0" style="width:50%;border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(204, 238, 255)"><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">FV Pharma</span></span></td><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canadian Dollars</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prismic</span></span></td><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States Dollars</span></span></td></tr></tbody></table><p style="margin-top:0pt;text-align:justify">&#160;</p><p style="margin-left:21.25pt;text-indent:-21.25pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>[e] Use of estimates and judgments</strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of these financial statements in conformity with IFRS requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities as at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following are the critical judgments, apart from those involving estimations, that management has made in the process of applying the Company's accounting policies and that have the most significant effect on the amounts recognized in the financial statements:</span></span></p><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[i]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Going concern</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At each reporting period, management assesses the basis of preparation of the financial statements. These financial statements have been prepared on a going concern basis in accordance with IFRS. The going concern basis of presentation assumes that the Company will continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in the normal course of business.</span></span></p><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[ii]<span style="width:9pt;text-indent:0pt;display:inline-block">&#160;</span>Estimated useful lives, residual values and depreciation of property, plant and equipment</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation of property, plant and equipment is dependent upon estimates of useful lives and residual values, which are determined through the exercise of judgment. The assessment of any impairment of these assets' is dependent upon estimates of recoverable amounts that take into account factors such as economic and market conditions and the useful lives of assets.</span></span></p><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[iii]<span style="width:7pt;text-indent:0pt;display:inline-block">&#160;</span>Biological assets and inventory</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In calculating the value of the biological assets and inventory, management is required to make a number of estimates, including estimating the stage of growth of the cannabis up to the point of harvest, harvesting costs, selling costs, expected selling and list prices and expected yields for the cannabis plants. In assessing the recoverability of final inventory values, management compares the inventory cost to estimated net realizable value. Further information on estimates used in determining the fair value of biological assets is contained in Note 8.</span></span></p><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[iv]<span style="width:6.5pt;text-indent:0pt;display:inline-block">&#160;</span>Estimated useful life and amortization of intangible assets</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company employs significant estimates to determine the estimated useful lives of intangible assets, considering the nature of the asset, contractual rights, expected use and review of asset useful lives. The Company reviews amortization methods and useful lives annually or when circumstances change and adjusts its amortization methods and assumptions prospectively.</span></span></p><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[v]<span style="width:8.5pt;text-indent:0pt;display:inline-block">&#160;</span>Impairment of property, plant and equipment and intangible assets</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Impairment testing requires management to make estimates related to future cash flow projections and market trends. Impairment of property, plant and equipment and intangible assets is influenced by judgment in defining a cash generating unit and determining the indicators of impairment and estimates used to measure impairment losses.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[vi]<span style="width:6.5pt;text-indent:0pt;display:inline-block">&#160;</span>Valuation of share-based payments and warrants</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management measures the costs for share-based payments and warrants using market-based option valuation techniques. Assumptions are made and estimates are used in applying the valuation techniques. These include estimating the future volatility of the share price, expected dividend yield, expected term, expected risk-free interest rate and the rate of forfeiture. Such estimates and assumptions are inherently uncertain. Changes in these assumptions affect the fair value estimates of share-based payments and warrants.</span></span></p><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[vii]<span style="width:4.5pt;text-indent:0pt;display:inline-block">&#160;</span>Valuation of private company investments</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial information of private companies may not always be available, or such information may be insufficient or unreliable for valuation purposes. In determining the fair value of shares held in private company investments, management is required to make certain estimates and assumptions regarding the fair value as of the reporting date. Assumptions are made and estimates are used in applying the valuation techniques to determine fair value. These include the most recently available financial statements of the investee, price for most recently completed financing, as well as closely comparable public companies and general market and economic conditions. Such investments are classified as Level 3 within the fair value hierarchy. The value at which the Company could ultimately realize upon disposition of these investments may differ from their carrying value and such differences could be material.</span></span></p><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[viii]<span style="width:6.5pt;text-indent:0pt;display:inline-block">&#160;</span>Asset acquisition</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the acquisition of Prismic on June 28, 2019 judgment was required to determine if the acquisition represented either a business combination or an asset purchase. Management concluded that Prismic did not represent a business as the assets acquired were not an integrated set of activities with inputs, processes and outputs. Since it was concluded that the acquisition represented the purchase of assets, there was no goodwill recognized on the transaction and acquisition costs were capitalized to the assets purchased rather than expensed. The fair values of the net assets acquired were determined using estimates and judgments. Refer to Note 5 for additional information on the Company's asset acquisition.</span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_BasisOfPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_BasisOfPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for the preparation of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6824372304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS - CAD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Income Statement [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">$ 257,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of revenue</a></td>
<td class="nump">1,959,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GrossLossProfitBeforeFairValueAdjustments', window );">Gross loss before fair value adjustments</a></td>
<td class="num">(1,702,012)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FairValueAdjustmentsOnInventorySold', window );">Fair value adjustments on inventory sold</a></td>
<td class="nump">22,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets', window );">Unrealized loss on changes in fair value of biological assets</a></td>
<td class="nump">682,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross loss</a></td>
<td class="num">(2,407,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseByNatureAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">14,811,529<span></span>
</td>
<td class="nump">$ 18,740,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based payments</a></td>
<td class="nump">16,061,319<span></span>
</td>
<td class="nump">6,440,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">3,146,680<span></span>
</td>
<td class="nump">183,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AllowanceForImpairment', window );">Allowance for impairment of Auxly funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,499,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset', window );">Impairment of property, plant and equipment and right-of-use asset</a></td>
<td class="nump">243,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total operating expenses</a></td>
<td class="nump">34,262,996<span></span>
</td>
<td class="nump">32,863,937<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Loss from operations</a></td>
<td class="num">(36,669,996)<span></span>
</td>
<td class="num">(32,863,937)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="num">(125,536)<span></span>
</td>
<td class="num">(88,763)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance expense</a></td>
<td class="nump">206,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LossOnSettlementOfFinancialLiability', window );">Loss on settlement of financial liability</a></td>
<td class="nump">24,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Loss on change in fair value of derivative liability</a></td>
<td class="nump">3,568,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LossGainOnChangesInFairValueOfOtherInvestments', window );">Loss (gain) on changes in fair value of other investments</a></td>
<td class="nump">11,669,157<span></span>
</td>
<td class="num">(10,064,550)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="num">(52,013,186)<span></span>
</td>
<td class="num">(22,710,624)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Items that may be subsequently reclassified to income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Exchange loss on translation of foreign operations</a></td>
<td class="num">(112,690)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive loss</a></td>
<td class="num">$ (52,125,876)<span></span>
</td>
<td class="num">$ (22,710,624)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicAndDilutedEarningsLossPerShare', window );">Net loss per share - basic and diluted (in dollars per share)</a></td>
<td class="num">$ (7.37)<span></span>
</td>
<td class="num">$ (3.85)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of shares outstanding - basic and diluted</a></td>
<td class="nump">7,056,245<span></span>
</td>
<td class="nump">5,905,252<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AllowanceForImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to allowance for impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AllowanceForImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_FairValueAdjustmentsOnInventorySold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Fair value adjustments on inventory sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_FairValueAdjustmentsOnInventorySold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_GrossLossProfitBeforeFairValueAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Gross (loss) profit before fair value adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_GrossLossProfitBeforeFairValueAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to impairment Loss of property, plant and equipment and right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LossGainOnChangesInFairValueOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Loss (gain) on changes in fair value of other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LossGainOnChangesInFairValueOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LossOnSettlementOfFinancialLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Loss on settlement of financial liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LossOnSettlementOfFinancialLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicAndDilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of earnings per share when the basic and diluted measurements are equal. [Refer: Basic earnings (loss) per share; Diluted earnings (loss) per share]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicAndDilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs relating to expenses directly or indirectly attributed to the goods or services sold, which may include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, unallocated production overheads and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNatureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNatureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in biological assets resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2019-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in economic benefits during the accounting period in the form of inflows or enhancements of assets or decreases of liabilities that result in an increase in equity, other than those relating to contributions from equity participants.
Effective 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6819816512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsAbstract', window );"><strong>Disclosure Of Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory', window );">Schedule of Other investments</a></td>
<td class="text"><table style="border-collapse:collapse;border:0px;width:100%" width="1440"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Balance at</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Change in fair</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Balance at</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>December 31,</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Proceeds </span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>value through</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>December 31,</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Entity</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Instrument</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Note</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>2018</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Additions</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>from sale</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:25px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:11px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>profit or loss</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>2019</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:25px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:11px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Pharmadrug Inc.</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(i)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>3,000,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(2,660,940</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>339,060</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Cannara Biotech Inc.</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(ii)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>11,215,395</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(2,146,357</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>9,069,038</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Clover Cannastrip</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(iii)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,500,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(1,500,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>High Tide</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(iv)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,798,040</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>614,520</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(1,183,520</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>High Tide</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Warrants</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(iv)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>251,115</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(251,115</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>HUGE Shops</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(v)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,300,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(539,132</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>760,868</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>SciCann Therapeutics</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(vi)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,999,991</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(1,287,743</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>712,248</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Solarvest BioEnergy Inc.</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(vii)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>690,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(255,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>435,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Solarvest BioEnergy Inc.</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Warrants</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(vii)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>385,784</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(269,134</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>116,650</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Solarvest BioEnergy Inc.</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Convertible debenture</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(vii)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,924,216</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(1,576,216</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>348,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>18,064,541</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>6,000,000</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>614,520</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>(11,669,157 </span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>)</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>11,780,864 </span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfDetailedInformationAboutOtherInvestmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796994080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Disclosure of non-adjusting events after reporting period [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory', window );">Subsequent events</a></td>
<td class="text"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25.<span style="width:5.25pt;display:inline-block"> </span><strong>Subsequent events</strong></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 2, 2020, the Company issued 27,580 Class B Common Shares as </span></span>share-based compensation to certain Board of Directors for services performed as directors for the year-ended December 31, 2019.<br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 9, 2020, the Company commenced trading on the NASDAQ under the symbol "HUGE".</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 4, 2020, the Company issued 225,371 Class B Common Shares to Solarvest as settlement under the Share Exchange Agreement to settle derivative liability of $2,646,269.&#160;</span></span>The Company also concurrently announced the appointment of Dr. Edward J. Brennan, President of FSD Pharma's Biosciences Division, to the board of directors of Solarvest.<br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 5, 2020 the Company executed Share Purchase and Sale Agreements with a consortium of buyers to sell the Company's investment in Cannara, consisting of 85,003,750 Class B shares, for gross proceeds of $7,743,492.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Subsequent to December 31, 2019 the Company is considering the continuing use or sale of the Cobourg facility.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of non-adjusting events after the reporting period. [Refer: Non-adjusting events after reporting period [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6708213216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Prismic Pharmaceutical (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract', window );"><strong>Disclosure of detailed information about business combination [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory', window );">Schedule of share options and warrants</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="border:0px;width:100%;margin:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Share Options</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Warrants</strong></span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Grant date share price</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$32.16</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$32.16</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Exercise Price</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$2.61 - $17.89</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$2.61 - $26.73</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Expected dividend yield</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Risk free interest rate</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.39% - 1.66%</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.41% - 1.52%</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected life (years)</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>0.98&#x2014;16.21</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.39&#x2014;6.55</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Annualized volatility</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Schedule of identifiable assets acquired and liabilities assumed</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>Fair value</strong></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>recongized on</strong></span></span></p></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>acquisition</strong></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>$</strong></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2,329</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Prepaids</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>26,174</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Intellectual Property</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>24,648,915</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Trade and other payables</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,867,250</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Short-term notes</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(195,475</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes payable</span></span></p></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,727,484</span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>20,887,209</strong></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about Share Options and Warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Section Disclosures application of paragraphs 59 and 61<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;doctype=Appendix&amp;subtype=B&amp;dita_xref=IFRS03_gB64-B67_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6819875872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Intangible assets</a></td>
<td class="text"><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.<strong> Intangible asset</strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible asset as at December 31, 2019 is as follows:</span></span></p><div><table cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;border-bottom:2pt solid black;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;border-bottom:2pt solid black;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;text-align:right;border-bottom:2pt solid black;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost</span></span></td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Acquisition of Prismic Pharmaceuticals Inc.</p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">24,648,915</p></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">389,640</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(186,463</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance, December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>24,852,092</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Accumulated amortization</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,534,047</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,887</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance, December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,493,160</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Carrying value</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance, December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>22,358,932</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div><p>&#160;</p><p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company acquired intellectual property as part of the acquisition of Prismic on June 28, 2019. Refer to Note 5 for additional details.&#160;The life of the intellectual property has been determined to be 5 years. Amortization of the intellectual property commenced on the date of acquisition.</span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6707992768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Biological assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory', window );">Biological assets</a></td>
<td class="text"><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:black">8.</span></span></span><span><span><span style="color:black"> <strong>Biological assets</strong></span></span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biological assets consist of cannabis plants. The changes in the carrying value of biological assets are as follows:</span></span></p><div><table style="border-collapse:collapse;margin-left:60pt;margin-right:40pt;border:0px;width:90%" width="80%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>$</span></span></strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:12" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:212" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:25" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalized costs</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:12" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:212" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,297,734</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:25" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in fair value less costs to sell due to biological transformation</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:12" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:212" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(682,739</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:25" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transferred to inventory upon harvest</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:12" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:212" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(614,995</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:25" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:12" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:212" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:25" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>Balance, December 31, 2019</span></span></strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:12" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:212" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>&#x2014;</span></span></strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:25" valign="bottom">&#160;</td></tr></tbody></table></div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company measures its biological assets at their fair value less costs to sell. This is determined using a model that estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount by the expected selling price less costs to complete and&#160;sell per gram.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value measurements for biological assets have been categorized as Level 3 fair values based on the inputs to the valuation technique used. The Company's method of accounting for biological assets attributes value accretion on a straight-line basis throughout the life of the biological asset from initial cloning to the point of harvest.<br/><br/>The Company capitalizes costs to biological assets in a manner consistent with the principles in IAS 2 (including but not limited to the determination of what types of costs are capitalized).</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table identifies each significant unobservable input used to estimate the fair value of biological assets:</span></span></p><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><table border="1" cellpadding="3" cellspacing="0" style="border:0px;width:90%;margin:auto"><tbody><tr><td colspan="2" rowspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Assumptions:</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>As at December 31, 2019</strong></span></span></td></tr><tr><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Input</strong></span></span></td></tr><tr><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected yields for cannabis plants (average grams per plant)</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13 grams dry flower<br/>16 grams dry trim</span></span></td></tr><tr><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ii</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average number of growing weeks completed as a percentage of total growing weeks as at period end</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">73%</span></span></td></tr><tr><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iii</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Estimated selling price per gram</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;border:1pt solid black"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1.00 for flower</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$0.50 for trim</span></span></p></td></tr><tr><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iv</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">After harvest cost to complete and sell per gram</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;border:1pt solid black"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1.91 for dry flower</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1.25 for dry trim</span></span></p></td></tr></tbody></table></div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at December 31, 2019 the fair value less costs to complete and sell of biological assets was nil. A change of plus or minus 10% of any of&#160;the&#160;above assumptions would not result in any change in the balance recognized of nil as at December 31, 2019.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company estimates the harvest yields for cannabis at various stages of growth. As of December 31, 2019, it is expected that the Company's cannabis plants will yield approximately 19,532  grams of dry flower and 25,002&#160;grams of dry trim when harvested. It was estimated that these plants as of December 31, 2019 had completed 73% of the expected growth cycle, which is estimated at 12 weeks.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These estimates are subject to volatility in market prices and a number of factors, which could significantly affect the fair value of biological assets in future periods. The Company's estimates are, by their nature, subject to change, and differences from the anticipated yield and the other assumptions will be reflected in the gain or loss on biological assets in future periods.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value adjustments on biological assets are presented separately on the statements of loss and comprehensive loss.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:black;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:13px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biological assets as at December 31, 2018 were determined to have a fair value of nil. </span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 43<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6828798032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory - Schedule of inventories (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">$ 942,939<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=huge_CapitalizedCostMember', window );">Capitalized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">2,041,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=huge_BiologicalAssetFairValueAdjustmentMember', window );">Biological asset fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="num">(415,920)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=huge_ImpairmentMember', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="num">(682,577)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfInventoriesAxis=huge_HarvestedCannabisMember', window );">Harvested cannabis</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Work in process</a></td>
<td class="nump">539,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished good</a></td>
<td class="nump">21,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">560,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfInventoriesAxis=huge_HarvestedCannabisMember', window );">Harvested cannabis | Capitalized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Work in process</a></td>
<td class="nump">1,576,556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished good</a></td>
<td class="nump">82,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">1,659,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfInventoriesAxis=huge_HarvestedCannabisMember', window );">Harvested cannabis | Biological asset fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Work in process</a></td>
<td class="num">(431,627)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished good</a></td>
<td class="nump">15,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="num">(415,920)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfInventoriesAxis=huge_HarvestedCannabisMember', window );">Harvested cannabis | Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Work in process</a></td>
<td class="num">(605,598)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished good</a></td>
<td class="num">(76,979)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="num">(682,577)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfInventoriesAxis=huge_HempProductsMember', window );">Hemp products</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RawMaterials', window );">Raw materials</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfInventoriesAxis=huge_HempProductsMember', window );">Hemp products | Capitalized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RawMaterials', window );">Raw materials</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfInventoriesAxis=huge_HempProductsMember', window );">Hemp products | Biological asset fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RawMaterials', window );">Raw materials</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfInventoriesAxis=huge_HempProductsMember', window );">Hemp products | Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RawMaterials', window );">Raw materials</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfInventoriesAxis=huge_OtherInventoryMember', window );">Other inventory</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProductionSupplies', window );">Supplies</a></td>
<td class="nump">282,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">282,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfInventoriesAxis=huge_OtherInventoryMember', window );">Other inventory | Capitalized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProductionSupplies', window );">Supplies</a></td>
<td class="nump">282,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">282,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfInventoriesAxis=huge_OtherInventoryMember', window );">Other inventory | Biological asset fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfInventoriesAxis=huge_OtherInventoryMember', window );">Other inventory | Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfInventoriesLineItems', window );"><strong>Classes Of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfInventoriesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents class of inventory line item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfInventoriesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 37<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductionSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of supplies to be used for the production process. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 37<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductionSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 37<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WorkInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 37<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WorkInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=huge_CapitalizedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=huge_CapitalizedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=huge_BiologicalAssetFairValueAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=huge_BiologicalAssetFairValueAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=huge_ImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=huge_ImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfInventoriesAxis=huge_HarvestedCannabisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfInventoriesAxis=huge_HarvestedCannabisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfInventoriesAxis=huge_HempProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfInventoriesAxis=huge_HempProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfInventoriesAxis=huge_OtherInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfInventoriesAxis=huge_OtherInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6827241728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Schedule of reconciliation of the share capital (Details) - CAD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance</a></td>
<td class="nump">$ 51,032,428<span></span>
</td>
<td class="nump">$ 12,413,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued</a></td>
<td class="nump">11,539,417<span></span>
</td>
<td class="nump">47,853,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,634,405)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughReverseAcquisition', window );">Reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,012,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share based payments</a></td>
<td class="nump">16,061,319<span></span>
</td>
<td class="nump">6,440,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Share options exercised</a></td>
<td class="nump">732,598<span></span>
</td>
<td class="nump">2,857,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Warrants exercised</a></td>
<td class="nump">94,991<span></span>
</td>
<td class="nump">800,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance</a></td>
<td class="nump">48,222,087<span></span>
</td>
<td class="nump">51,032,428<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember', window );">Class A shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance</a></td>
<td class="nump">$ 201,500<span></span>
</td>
<td class="nump">$ 201,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Beginning balance (shares)</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance</a></td>
<td class="nump">$ 201,500<span></span>
</td>
<td class="nump">$ 201,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ending balance (shares)</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance</a></td>
<td class="nump">$ 67,916,302<span></span>
</td>
<td class="nump">$ 12,794,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Beginning balance (shares)</a></td>
<td class="nump">6,843,780<span></span>
</td>
<td class="nump">3,794,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued</a></td>
<td class="nump">$ 11,539,417<span></span>
</td>
<td class="nump">$ 47,853,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfShares', window );">Shares issued (shares)</a></td>
<td class="nump">408,651<span></span>
</td>
<td class="nump">2,268,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc</a></td>
<td class="nump">$ 16,431,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares)</a></td>
<td class="nump">510,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,634,405)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughReverseAcquisition', window );">Reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,868,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughReverseAcquisitionShares', window );">Reverse acquisition (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">545,505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughWarrantValuations', window );">Warrant valuations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,366,670)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Share options exercised</a></td>
<td class="nump">$ 1,782,438<span></span>
</td>
<td class="nump">$ 5,145,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExerciseOfOptionShares', window );">Share options exercised (shares)</a></td>
<td class="nump">130,189<span></span>
</td>
<td class="nump">190,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Warrants exercised</a></td>
<td class="nump">$ 145,174<span></span>
</td>
<td class="nump">$ 1,254,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares', window );">Warrants exercised (shares)</a></td>
<td class="nump">12,167<span></span>
</td>
<td class="nump">44,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance</a></td>
<td class="nump">$ 97,815,149<span></span>
</td>
<td class="nump">$ 67,916,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ending balance (shares)</a></td>
<td class="nump">7,905,727<span></span>
</td>
<td class="nump">6,843,780<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=huge_WarrantsMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance</a></td>
<td class="nump">$ 4,442,145<span></span>
</td>
<td class="nump">$ 2,116,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Beginning balance (shares)</a></td>
<td class="nump">546,212<span></span>
</td>
<td class="nump">354,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc</a></td>
<td class="nump">$ 1,888,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares)</a></td>
<td class="nump">67,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughReverseAcquisition', window );">Reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughReverseAcquisitionShares', window );">Reverse acquisition (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughWarrantValuations', window );">Warrant valuations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,366,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughWarrantValuationsShares', window );">Warrant valuations (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 294,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Warrants exercised</a></td>
<td class="num">$ (50,183)<span></span>
</td>
<td class="num">$ (454,587)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares', window );">Warrants exercised (shares)</a></td>
<td class="num">(12,167)<span></span>
</td>
<td class="num">(44,932)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue', window );">Warrants expired</a></td>
<td class="num">$ (535,014)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares', window );">Warrants expired (shares)</a></td>
<td class="num">(134,192)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance</a></td>
<td class="nump">$ 5,745,034<span></span>
</td>
<td class="nump">$ 4,442,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ending balance (shares)</a></td>
<td class="nump">467,451<span></span>
</td>
<td class="nump">546,212<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from acquisition of net assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from acquisition of net assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExerciseOfOptionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from exercise of option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExerciseOfOptionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExpiryOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExpiryOfWarrantsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughReverseAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from reverse acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughReverseAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughReverseAcquisitionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from reverse acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughReverseAcquisitionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughWarrantValuations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from warrant valuations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughWarrantValuations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughWarrantValuationsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from warrant valuations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughWarrantValuationsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=huge_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=huge_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6817785200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Schedule of changes in number of share options (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Opening Balance | Share</a></td>
<td class="nump">485,159<span></span>
</td>
<td class="nump">206,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted | Share</a></td>
<td class="nump">1,363,322<span></span>
</td>
<td class="nump">593,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised | Share</a></td>
<td class="num">(82,094)<span></span>
</td>
<td class="num">(240,214)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited | Share</a></td>
<td class="num">(12,438)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement', window );">Cancelled | Share</a></td>
<td class="num">(299,006)<span></span>
</td>
<td class="num">(74,627)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Closing Balance | Share</a></td>
<td class="nump">1,454,943<span></span>
</td>
<td class="nump">485,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable | Share</a></td>
<td class="nump">1,200,242<span></span>
</td>
<td class="nump">253,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement at beginning of period | $ / shares</a></td>
<td class="nump">$ 74.53<span></span>
</td>
<td class="nump">$ 4.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Granted | $ / shares</a></td>
<td class="nump">20.68<span></span>
</td>
<td class="nump">65.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Exercised | $ / shares</a></td>
<td class="nump">10.02<span></span>
</td>
<td class="nump">11.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Forfeited | $ / shares</a></td>
<td class="nump">56.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Cancelled | $ / shares</a></td>
<td class="nump">115.80<span></span>
</td>
<td class="nump">10.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement at end of period | $ / shares</a></td>
<td class="nump">21.96<span></span>
</td>
<td class="nump">74.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Exercisable | $ / shares</a></td>
<td class="nump">$ 21.24<span></span>
</td>
<td class="nump">$ 19.91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796840000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use asset - Schedule of right-of-use asset (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract', window );"><strong>Disclosure of quantitative information about right-of-use assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning balance</a></td>
<td class="nump">$ 243,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation</a></td>
<td class="num">(48,764)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ImpairmentLossRecognisedInRightOfUseAsset', window );">Impairment</a></td>
<td class="num">(67,644)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending balance</a></td>
<td class="nump">$ 127,410<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ImpairmentLossRecognisedInRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ImpairmentLossRecognisedInRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6824057056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Biological assets (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>g</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedYieldOfDryFlower', window );">Expected yield of dry flower</a></td>
<td class="nump">19,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedYieldOfDryTrim', window );">Expected yield of dry trim</a></td>
<td class="nump">25,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedGrowthCycleCompleted', window );">Expected growth cycle completed</a></td>
<td class="nump">73.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedGrowthCycle', window );">Expected growth cycle</a></td>
<td class="text">84 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedGrowthCycle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents period of expected growth cycle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedGrowthCycle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedGrowthCycleCompleted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected growth cycle completed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedGrowthCycleCompleted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedYieldOfDryFlower">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected yield of dry flower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedYieldOfDryFlower</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedYieldOfDryTrim">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected yield of dry trim.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedYieldOfDryTrim</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6823946304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of business (Narrative) (Details) - CAD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 16, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfNatureOfBusinessLineItems', window );"><strong>Disclosure of nature of business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (78,518,005)<span></span>
</td>
<td class="num">$ (26,504,819)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,013,186)<span></span>
</td>
<td class="num">$ (22,710,624)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WorkingCapitalSurplus', window );">Working capital surplus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfNatureOfBusinessLineItems', window );"><strong>Disclosure of nature of business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DescriptionOfReverseShareSplit', window );">Description of reverse share split</a></td>
<td class="text">October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DescriptionOfReverseShareSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the description of reverse share split.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DescriptionOfReverseShareSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfNatureOfBusinessLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfNatureOfBusinessLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WorkingCapitalSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of working capital surplus.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WorkingCapitalSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6709019136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes Payable (Narrative) (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember', window );">Short-term notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Notes payable, interest rate</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=huge_NotesPayableMember', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Notes payable, interest rate</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=huge_NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=huge_NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6823470352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SummaryOfSignificantAccountingPoliciesAbstract', window );"><strong>Summary Of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[a]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Cash</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash consists of cash and cash held in trust accounts. There are no restrictions on cash held in trust.</span></span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, Plant and Equipment</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[b]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Property, Plant and Equipment</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment is measured at cost less accumulated depreciation and impairment losses, with the exception of land which is not depreciated.&#160; &#160; &#160; &#160; &#160; &#160; &#160;</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">When parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) of property, plant and equipment.</span></span></p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The cost of replacing part of an item of property, plant and equipment is recognized in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Company and its cost can be measured reliably. The carrying amount of the replaced part is derecognized. The costs of the day-to-day servicing of property, plant and equipment are recognized in consolidated statements of loss and comprehensive loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent costs are included in the asset's carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the consolidated statements of loss and comprehensive loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount, and are recognized net within other income in the consolidated statements of loss and comprehensive loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation is based on the estimated useful lives of the assets provided as follows:</span></span></p><div><table cellpadding="0" cellspacing="0" style="margin-left:auto;border-collapse:collapse;font-size:10pt;width:90%;margin-right:auto"><tbody><tr style="background-color:rgb(204, 238, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></p></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30% declining balance</span></span></p></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Production equipment</span></span></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20% declining balance</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Furniture and fixtures</span></span></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20% declining balance</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Facility and related</span></span><span style="font-size:10pt">&#160;</span></p></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20 years under straight-line</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Land</span></span></span></p></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Not amortized</span></span></span></p></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">&#160;</td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An item of property, plant and equipment and any significant part initially recognized are derecognized upon disposal or when no future economic benefits are expected from their use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated statements of loss and comprehensive loss when the asset is derecognized. The assets' residual values, useful lives and methods of depreciation and the depreciation charge are adjusted prospectively, if appropriate.</span></span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Finite-lived Intangible Assets</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[c]<span style="width:8.5pt;text-indent:0pt;display:inline-block">&#160;</span>Finite-lived Intangible Assets</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finite-lived intangible assets are recorded at cost less accumulated amortization and accumulated impairment losses. Amortization is recognized in profit or loss on a straight-line basis over the following terms:</span></span></p><div>
              <div><table cellpadding="0" cellspacing="0" style="margin-left:auto;border-collapse:collapse;font-size:10pt;width:90%;margin-right:auto"><tbody><tr style="background-color:rgb(204, 238, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intellectual Property</span></span></p></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5 years</span></span></p></td></tr></tbody></table></div>
              </div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue Recognition</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[d]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Revenue Recognition</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's accounting policy for revenue recognition under IFRS 15, Revenue from Contracts with Customers ("IFRS 15") is to follow a five step model to determine the amount and timing of revenue to be recognized i) identify the contract with a customer; ii) identify the performance obligations in the contract; iii) determine the transaction price; iv) allocate the transaction price to the performance obligations in the contract; and v) recognize revenue when (or as) the Company satisfies a performance obligation.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue from the sale of cannabis is recognized when the Company transfers control of the good to the customer. This is generally considered to have occurred when products have been delivered to the location specified in the sales contract and accepted by the customer.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive taking into account any variation that may result from rights of return.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is required to remit excise tax to the Canada Revenue Agency on the sale of medical cannabis in Canada. The Company becomes liable for these excise duties when cannabis products are delivered to the customer. In accordance with IFRS 15, revenue presented on the Consolidated Statements of Loss and Comprehensive Loss, represents revenue from the sale of goods less applicable excise tax.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Areas of judgment include identifying the customer per the definition within IFRS 15 and determining whether control has passed to the customer.</span></span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Foreign Currency Translation</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[e]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Foreign Currency Translation</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transactions are translated into Canadian dollars at exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies at the statement of financial position date are translated to Canadian dollars at the foreign exchange rate applicable at that date. Realized and unrealized exchange gains and losses are recognized through profit or loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The assets and liabilities of foreign operations with functional currencies other than Canadian dollars, are translated into Canadian dollars at year-end exchange rates. Income and expenses, and cash flows of such foreign operations are translated into Canadian dollars using average exchange rates for the period. Exchange differences resulting from translating foreign operations are recognized in other comprehensive loss&#160;and accumulated in equity.</span></span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory', window );">Financial Instruments</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[f]<span style="width:10.5pt;text-indent:0pt;display:inline-block">&#160;</span>Financial Instruments</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the instruments.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognized immediately in profit or loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Financial assets</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On initial recognition, a financial asset is classified as measured at amortized cost, fair value through other comprehensive income (''FVOCI''), or fair value through profit and loss (''FVTPL''). The classification of financial assets is based on the business model in which a financial asset is managed and its contractual cash flow characteristics.</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:</span></span></p><ul style="padding-left:0pt" type="disc"><li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">It is held within a business model whose objective is to hold assets to collect contractual cash flows; and</span></span></li><li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.</span></span></li></ul><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A financial asset (unless it is a trade receivable without a significant financing component that is initially measured at the transaction price) is initially measured at fair value plus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition.</span></span></p><p style="text-indent:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following accounting policies apply to the subsequent measurement of financial assets.</span></span></p><table cellpadding="0" cellspacing="0" style="margin-left:36.65pt;border:0.75pt solid #000000;border-collapse:collapse;font-size:10pt"><tbody><tr><td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-right:0.75pt solid #000000;border-bottom:0.75pt solid #000000"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets at FVTPL</span></span></p></td><td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.</span></span></p><p style="text-align:justify">&#160;</p></td></tr><tr><td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-right:0.75pt solid #000000"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets at amortized cost</span></span></p></td><td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-left:0.75pt solid #000000"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequently measured at amortized cost using the effective interest method, less any impairment losses. Interest income, foreign exchange gains and losses and impairment losses are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.</span></span></p></td></tr></tbody></table><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Financial liabilities</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company initially recognizes financial liabilities at fair value on the date at which the Company becomes a party to the contractual provisions of the instrument.</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies its financial liabilities as either financial liabilities at FVTPL or amortized cost.</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent to initial recognition, other liabilities are measured at amortized cost using the effective interest method. Financial liabilities at FVTPL are stated at fair value with changes being recognized in profit or loss.</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Financial liabilities and equity instruments</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Classification as debt or equity</span></span></p><p style="margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Debt and equity instruments issued by the Company are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Equity instruments</span></span></p><p style="margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Equity instruments issued by a group entity are recognized at the proceeds received, net of direct issue costs.</span></span></p><p style="margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repurchase of the Company's own equity instruments is recognized and deducted directly in equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the Company's own equity instruments.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Classification of financial instruments</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies its financial assets and liabilities depending on the purpose for which the financial instruments were acquired, their characteristics and management intent as outlined below:</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Classification</strong></span></span></p><table border="0" cellpadding="0" cellspacing="0" style="width:70%;border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(204, 238, 255)"><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></td><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other receivables</span></span></td><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other investments</span></span></td><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value through profit or loss</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other payables</span></span></td><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative liability</span></span></td><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value through profit or loss</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes payable</span></span></td><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td></tr></tbody></table><p style="margin-top:0pt;margin-left:36pt;margin-bottom:0pt;text-align:justify">&#160;</p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Impairment of financial assets</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An expected credit loss ("ECL") model applies to financial assets measured at amortized cost. The Company's financial assets measured at amortized cost and subject to the ECL model consist primarily of trade and other receivables. The Company applies the simplified approach to impairment for trade and other receivables by recognizing a loss allowance based on lifetime expected losses at each reporting date taking into considerations historical credit loss experience and financial factors specific to the debtors and general economic conditions. The Company has assessed the impairment of its trade and other receivables using the expected credit loss model, and no material difference was noted.&#160;</span></span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory', window );">Biological Assets</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[g]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Biological Assets</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's biological assets consist of cannabis plants. The Company capitalizes the direct and indirect costs incurred related to the biological transformation of the biological assets between the point of initial recognition and the point of harvest. The Company then measures the biological assets at fair value less cost to sell up to the point of harvest, which becomes the basis for the cost of inventory after harvest. This is determined using a model that estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount by the expected selling price less costs to sell per gram. The net unrealized gains or losses arising from changes in fair value less cost to sell during the year are included in the results of operations of the related period.</span></span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>[h]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span></span></span>Inventory</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory of harvested work-in-process and finished goods are valued at the lower of cost and net realizable value. Inventory of harvested cannabis is transferred from biological assets at their fair value at harvest, which becomes the initial deemed cost. Any subsequent post-harvest costs are capitalized to inventory to the extent that cost is less than net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Inventory for supplies and consumables are valued at the lower of cost and net realizable value, with cost determined using the average cost basis.</span></span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory', window );">Impairment of long-lived assets</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[i]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Impairment of long-lived assets</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-lived assets, including property, plant and equipment and intangible assets are tested for impairment when there are indicators of impairment at each reporting date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. Intangible assets with an indefinite useful life are tested for impairment at least annually in the fourth quarter and whenever there is an indication that the asset may be impaired.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in net&#160;loss&#160;equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.</span></span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Income Taxes</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[j]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Income Taxes</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense comprises of current and deferred tax. Current tax and deferred tax are recognized in net profit or loss except to the extent that it relates to a business combination or items recognized directly in equity or in other comprehensive loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current income taxes are recognized for the estimated income taxes payable or receivable on taxable income or loss for the current year and any adjustment to income taxes payable in respect of previous years. Current income taxes are determined using tax rates and tax laws that have been enacted or substantively enacted by the year-end date.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets and liabilities are recognized where the carrying amount of an asset or liability differs from its tax base, except for taxable temporary differences arising on the initial recognition of goodwill and temporary differences arising on the initial recognition of an asset or liability in a transaction which is not a business combination and at the time of the transaction affects neither accounting nor taxable profit or loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognition of deferred tax assets for unused tax losses, tax credits and deductible temporary differences is restricted to those instances where it is probable that future taxable profit will be available against which the deferred tax asset can be utilized. At the end of each reporting period, the Company reassesses unrecognized deferred tax assets. The Company recognizes a previously unrecognized deferred tax asset to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.</span></span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based Compensation</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[k]<span style="width:8.5pt;text-indent:0pt;display:inline-block">&#160;</span>Share-based Compensation</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Stock options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Stock options and warrants awarded to employees are accounted for using the fair value method.&#160; The fair value of such stock options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.</span></span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory', window );">Net Loss per Share</a></td>
<td class="text"><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[l]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Net Loss per Share</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per share is calculated based on the loss for the financial year and the weighted average number of common shares outstanding during the year. Diluted net loss per share is calculated using the loss for the financial year adjusted for the effect of any dilutive instruments and the weighted average diluted number of shares [ignoring any potential issue of common shares that would be anti-dilutive] during the year.</span></span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory', window );">New standards, amendments and interpretations adopted by the Company</a></td>
<td class="text"><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>New standards, amendments and interpretations adopted by the Company</strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>IFRS 16 - Leases ["IFRS 16"]</i></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has adopted IFRS 16 with an initial adoption date of January 1, 2019. The Company utilized the modified retrospective method to adopt the new standard and therefore, the comparative information has not been restated and continues to be reported under IAS 17, Leases and related interpretations.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IFRS 16 specifies how leases will be recognized, measured, presented and disclosed and it provides a single lessee model requiring lessees to recognize right-of-use assets and lease liabilities for all major leases. The Company's accounting policy under IFRS 16 is as follows.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of identified asset for a period of time in exchange for consideration. The Company recognized a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of the costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right-of-use assets are depreciated to the earlier of the end of useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of the consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset can be periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, and the Company's incremental borrowing rate. The Company used an incremental borrowing rate to measure the lease liabilities in the opening balance sheet at January 1, 2019 of 7.73%.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from the change in an index or rate, if there is a change in the Company's estimate of the amount expected to be payable under a residual value guarantee, or if the Company changes its assessment of whether it will exercise a purchase, extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, unless it has been reduced to zero.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has elected to apply the practical expedient not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less or to leases of low value assets when applicable. The lease payments associated with those leases is recognized as an expense on a straight-line basis over the lease term. The Company has also elected to apply the practical expedient to grandfather the assessment of which transactions are leases on the date of initial application, as previously assessed under IAS 17 and IFRIC 4 Determining Whether an Arrangement Contains a Lease. The Company applied the definition of a lease under IFRS 16 to contracts entered into or changed on or after January 1, 2019.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On initial application, the Company has elected to record right-of-use assets at the amount of the corresponding lease liability. Right-of-use assets and lease obligations of $243,818 were recorded as at January 1, 2019. When measuring lease liabilities, the Company discounted lease payments using its incremental borrowing rate at January 1, 2019.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table reconciles the Company's operating lease obligations at December 31, 2018, as previously disclosed in the Company's audited financial statements for the year ended December 31, 2018, to the lease obligations recognized on initial application of IFRS 16 at January 1, 2019:</span></span></p><div><table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Aggregate lease commitments as disclosed at December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">315,528</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Adjustment to lease commitments</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,528</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Impact of present value</span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(47,182</span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Opening IFRS 16 lease obligation as at January 1, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>243,818</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company did not have any leases subject to the low-value or short-term lease recognition exemptions upon adoption of IFRS 16 and as at December 31, 2019.</span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents description of recent accounting pronouncements adopted policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SummaryOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SummaryOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for the impairment of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 46<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796892848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory', window );">Schedule of trade and other receivables</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>December 31,</strong></p></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">December 31,</p></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2018</span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales tax recoverable</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,033,535</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">982,663</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rent receivable</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>12,990</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,325</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>23,530</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,070,055</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">990,988</span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for trade and other receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6750599232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfNatureOfBusinessAbstract', window );"><strong>Disclosure of Nature of business [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock', window );">Nature of business</a></td>
<td class="text"><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.<span style="width:10.49pt;text-indent:0pt;display:inline-block"> </span><strong>Nature of business</strong></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">FSD Pharma Inc. ("FSD" or the "Company"), through their wholly owned subsidiary, FV Pharma Inc. ("FV Pharma"), is a licensed producer of cannabis in Canada under the Cannabis Act (Canada) (together with the regulations promulgated thereunder (the "Cannabis Regulations"), the "Cannabis Act") and associated Cannabis Regulations. FV Pharma is focused on producing and extracting high-quality, hydroponic, pharmaceutical-grade cannabis leaf. The Company, through the their wholly owned subsidiary Prismic Pharmaceuticals Inc. ("Prismic"), is focused on bioscience, including research and development ("R&amp;D") and clinical development of synthetic cannabinoid based treatments of certain disease conditions with an aim to improve patient outcomes. The Company's goal is for these compounds to be approved by the FDA and other international regulatory agencies as prescription medications.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company was incorporated under the provisions of the Business Corporations Act (Ontario) (the "OBCA") on November 1, 1998, pursuant to the amalgamation of Olympic ROM World Inc., 1305206 Ontario Corporation, 1305207 Ontario Inc., Century Financial Capital Group Inc. and Dunberry Graphic Associates Ltd. On May 24, 2018, pursuant to the Articles of Amendment, the Company changed its name to "FSD Pharma Inc.".</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's registered office is located at 1 Rossland Road West, Suite 202, Ajax, Ontario, L1Z 1Z2.</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares. All share and per share amounts for all periods presented in these financial statements have been adjusted retrospectively to reflect the reverse share split.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Going concern uncertainty</strong></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated financial statements of the Company for the years ended December 31, 2019 and 2018 (the "financial statements") have been prepared on the basis of accounting principles applicable to a going concern, which assumes that the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities and commitments in the normal course of operations. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that would be necessary should the Company be unable to continue as a going concern. Such adjustments could be material.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is in the preliminary stages of its planned operations and has not yet determined whether its processes and business plans are economically viable. The continued operations of the Company and the recoverability of amounts shown for property and equipment and intangible assets are dependent upon the ability of the Company to obtain sufficient financing to continue its cultivation and production processes and complete the pharmaceutical research and development program centered on the lead asset, micro-palmitoylethanolamide ("micro-PEA").</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at December 31, 2019, the Company has an accumulated deficit of $78.5&#160;million, a net loss of $52&#160;million and a working capital surplus of $2.3 million. Whether, and when, the Company can attain profitability and positive cash flows from operations is subject to material uncertainty. The application of the going concern assumption is dependent upon the Company's ability to generate future profitable operations and obtain necessary financing to do so. The Company will need to raise additional capital in order to fund its planned operations and meet its obligations. While the Company has been successful in obtaining financing to date and believes it will be able to obtain sufficient funds in the future and ultimately achieve profitability and positive cash flows from operations, there can be no assurance that the Company will achieve profitability and be able to do so on terms favourable for the Company. </span></span>The above events and conditions indicate there is a material uncertainty that casts significant doubt about the Company&#x2019;s ability to continue as a going concern.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Subsidiaries</strong></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These financial statements are comprised of the financial results of the Company and its subsidiaries, which are the entities over which FSD has control. An investor controls an investee when it is exposed, or has rights, to variable returns from its involvement with the investee and can affect those returns through its power over the investee.</span></span><br/>&#160;</p><p style="text-align:justify;margin-left:2.25pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-align:start;text-indent:0px;-webkit-text-stroke-width:0px"><span style="color:#000000"><span><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-variant-caps:normal"><span style="font-weight:400"><span style="letter-spacing:normal"><span style="orphans:2"><span style="text-transform:none"><span style="white-space:normal"><span style="widows:2"><span style="word-spacing:0px"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="display:inline"><span style="float:none">The Company has the following subsidiaries</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></p><div><table cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Ownership</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Ownership</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>percentage</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>percentage</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Entity Name</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Country&#160;</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>December 31, 2019</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>December 31, 2018</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>%</strong></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>%</strong></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:2.25pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>FV Pharma Inc.</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Canada</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:2.25pt;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Prismic Pharmaceuticals Inc.</p></td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>USA</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfNatureOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents Nature of business abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfNatureOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents nature of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6824419456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - CAD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash</a></td>
<td class="nump">$ 7,932,737<span></span>
</td>
<td class="nump">$ 21,134,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade and other receivables</a></td>
<td class="nump">2,070,055<span></span>
</td>
<td class="nump">990,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses and deposits</a></td>
<td class="nump">430,381<span></span>
</td>
<td class="nump">444,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">942,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentBiologicalAssets', window );">Biological assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">11,376,112<span></span>
</td>
<td class="nump">22,570,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Other investments</a></td>
<td class="nump">11,780,864<span></span>
</td>
<td class="nump">18,064,541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use asset, net</a></td>
<td class="nump">127,410<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">11,804,145<span></span>
</td>
<td class="nump">12,141,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">22,358,932<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">57,447,463<span></span>
</td>
<td class="nump">52,776,234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="nump">4,467,826<span></span>
</td>
<td class="nump">1,743,806<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease obligations</a></td>
<td class="nump">56,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Derivative liability</a></td>
<td class="nump">2,646,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued', window );">Notes payable</a></td>
<td class="nump">1,908,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">9,078,714<span></span>
</td>
<td class="nump">1,743,806<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease obligations</a></td>
<td class="nump">146,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">9,225,376<span></span>
</td>
<td class="nump">1,743,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDERS' EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">98,016,649<span></span>
</td>
<td class="nump">68,117,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_Warrants', window );">Warrant reserve</a></td>
<td class="nump">5,745,034<span></span>
</td>
<td class="nump">4,442,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Contributed surplus</a></td>
<td class="nump">23,091,099<span></span>
</td>
<td class="nump">4,977,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Foreign exchange translation reserve</a></td>
<td class="num">(112,690)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="num">(78,518,005)<span></span>
</td>
<td class="num">(26,504,819)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">48,222,087<span></span>
</td>
<td class="nump">51,032,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Equity and liabilities</a></td>
<td class="nump">57,447,463<span></span>
</td>
<td class="nump">52,776,234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember', window );">Class A shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDERS' EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">201,500<span></span>
</td>
<td class="nump">201,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">201,500<span></span>
</td>
<td class="nump">201,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDERS' EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">97,815,149<span></span>
</td>
<td class="nump">67,916,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">$ 97,815,149<span></span>
</td>
<td class="nump">$ 67,916,302<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_Warrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_Warrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of resources: (a) controlled by the entity as a result of past events; and (b) from which future economic benefits are expected to flow to the entity.
Effective 2020-01-01: The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_f&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current notes and debentures issued and the current portion of non-current notes and debentures issued. [Refer: Notes and debentures issued]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of present obligations of the entity arising from past events, the settlement of which is expected to result in an outflow from the entity of resources embodying economic benefits.
Effective 2020-01-01: The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Non-current assets; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing exchange differences on translation of financial statements of foreign operations recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2019-01-01<br> -Paragraph 52<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_52_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6819845632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use asset (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract', window );"><strong>Disclosure of quantitative information about right-of-use assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets', window );">Schedule of Right-of-use asset</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="width:60%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><strong>$</strong></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Balance &#x2013; January 1, 2019</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>243,818</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Depreciation</span></span></span></span></p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(48,764</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Impairment</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(67,644</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><strong>Balance &#x2013; December 31, 2019</strong></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><strong>127,410</strong></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information on right of use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfDetailedInformationAboutRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796999136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.<span style="width:5.25pt;display:inline-block">&#160;</span><strong>Property, plant and equipment</strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment as at December 31, 2019 is as follows:</span></span></p><div><table cellpadding="0" cellspacing="0" style="width:100%;font-size:10pt;border-collapse:collapse;border-color:#000000"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Furniture and</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Computer</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Facility and</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Production</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>fixtures</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>equipment</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>related</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>equipment</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Land</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Total</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Cost</strong></span></span></td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2017</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123,218</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,068,820</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,100,000</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,292,038</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">209,795</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">220,150</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,350,156</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">252,731</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,032,832</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">333,013</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">220,150</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,418,976</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">252,731</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,100,000</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,324,870</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">126,425</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">73,183</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">142,824</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">191,686</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">534,118</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(86,730</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(101,683</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,643</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(215,056</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance, December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>372,708</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>293,333</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>10,460,117</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>417,774</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,100,000</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>12,643,932</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Accumulated depreciation</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2017</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">76,179</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,045</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,970</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,194</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">76,179</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,045</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,970</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,194</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100,652</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">68,186</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">439,903</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">87,084</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">695,825</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:5.25pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(27,754</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,084</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6,394</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(39,232</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance, December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>149,077</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>134,231</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>434,819</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>121,660</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>839,787</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Carrying value</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">256,834</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">154,105</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,418,976</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">211,761</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,100,000</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:10%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,141,676</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance, December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>223,631</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>159,102</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>10,025,298</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>296,114</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,100,000</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:10%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>11,804,145</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div><p style="text-align:justify"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the year ended December 31, 2019 the Company capitalized $131,955 (2018 - nil) of depreciation to the production of biological assets and inventory.<br/><br/>During the year, the Company completed a review of the recoverable amount of items of property, plant and equipment for which indicators of impairment were present. The review led to the recognition of an impairment loss of $175,824 which has been recognized in the statement of loss and comprehensive loss.</span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796940592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInventoriesExplanatory', window );">Inventories</a></td>
<td class="text"><div><p style="text-align:justify;margin-left:2.25pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.<strong> &#160; &#160;&#160;Inventory</strong></span></span></p><p style="text-align:justify;margin-left:2.25pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory as at December 31, 2019 is as follows:</span></span></p></div><div><p style="text-align:justify;margin-left:2.25pt">&#160;</p><div><table cellpadding="0" cellspacing="0" style="width:100%;font-size:10pt;border-collapse:collapse;border-color:#000000"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Biological asset</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>fair value</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Capitalized&#160;</strong><strong style="font-size:10pt">cost</strong></p></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>adjustment</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Impairment</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Carrying&#160;</strong><strong style="font-size:10pt">value</strong></p></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Harvested cannabis</i></span></span></td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Work in process</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,576,556</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(431,627</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(605,598</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">539,331</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished good</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">82,463</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,707</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(76,979</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,191</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,659,019</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(415,920</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(682,577</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">560,522</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Hemp products</i></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100,000</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100,000</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100,000</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100,000</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Other inventory</i></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Supplies</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">282,417</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">282,417</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">282,417</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">282,417</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,041,436</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(415,920</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(682,577</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>942,939</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div><p style="text-align:justify;margin-left:2.25pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Costs of sales primarily relate to production related expenditures not capitalized due to start-up costs, underutilization and impairment charges. Prior to the receipt of the Company's Health Canada cultivation license on October 13, 2017, the Company did not incur production related expenditures.</span></span></p><p style="text-align:justify;margin-left:2.25pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the year ended December 31, 2019 the Company recognized in costs of revenue $1,315,941 (2018 &#x2013; nil) related to inventory impairment charges.</span></span></p><p style="text-align:justify;margin-left:2.25pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">There was no inventory as at December 31, 2018.</span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS02_g36-39_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796863904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Biological assets - Schedule of biological assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Biological assets at beginning of period</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsFromPurchasesBiologicalAssets', window );">Capitalized costs</a></td>
<td class="nump">1,297,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets', window );">Change in fair value less costs to sell due to biological transformation</a></td>
<td class="num">(682,739)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseDueToHarvestBiologicalAssets', window );">Transferred to inventory upon harvest</a></td>
<td class="num">(614,995)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Biological assets at end of period</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsFromPurchasesBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to biological assets resulting from purchases. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsFromPurchasesBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of living animals or plants recognised as assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_f&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 43<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseDueToHarvestBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in biological assets due to the detachment of produce from the assets or the cessation of the assets' life processes. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseDueToHarvestBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) arising from changes in fair value less costs to sell of biological assets due to physical changes. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 51<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Section Example 1 XYZ Dairy Ltd<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS41_IE_ex1_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6797146864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Schedule of changes in number of warrants outstanding (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract', window );"><strong>Disclosure of Share based compensation and warrant reserve [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Warrants outstanding, Opening balance</a></td>
<td class="nump">546,212<span></span>
</td>
<td class="nump">354,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsGranted', window );">Warrants, Granted</a></td>
<td class="nump">67,598<span></span>
</td>
<td class="nump">236,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsExercised', window );">Warrants, Exercised</a></td>
<td class="num">(12,167)<span></span>
</td>
<td class="num">(44,932)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsExpired', window );">Warrants, Expired</a></td>
<td class="num">(134,192)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Warrants outstanding, Closing Balance</a></td>
<td class="nump">467,451<span></span>
</td>
<td class="nump">546,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Weighted average exercise price, Warrants outstanding opening balance</a></td>
<td class="nump">$ 9.47<span></span>
</td>
<td class="nump">$ 5.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePricesWarrantGranted', window );">Weighted average exercise price warrants granted</a></td>
<td class="nump">10.45<span></span>
</td>
<td class="nump">16.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePricesWarrantExercised', window );">Weighted average exercise price warrants exercised</a></td>
<td class="nump">7.81<span></span>
</td>
<td class="nump">17.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePricesWarrantExpired', window );">Weighted average exercise price warrants expired</a></td>
<td class="nump">7.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Weighted average exercise price, Warrants outstanding closing balance</a></td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="nump">$ 9.47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of number of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants granted during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageExercisePriceWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise Price warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageExercisePriceWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageExercisePricesWarrantExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise price warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageExercisePricesWarrantExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageExercisePricesWarrantExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise price warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageExercisePricesWarrantExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageExercisePricesWarrantGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise price warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageExercisePricesWarrantGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6817349680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Schedule of fair value assumptions of share options granted (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Year </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>Year </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life | Year</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Annualized volatility</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Grant date share price</a></td>
<td class="nump">$ 6.45<span></span>
</td>
<td class="nump">$ 10.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 7.17<span></span>
</td>
<td class="nump">$ 10.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.24%<span></span>
</td>
<td class="nump">1.97%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Grant date share price</a></td>
<td class="nump">$ 75.38<span></span>
</td>
<td class="nump">$ 142.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 75.38<span></span>
</td>
<td class="nump">$ 148.74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">2.41%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6843185648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment - Schedule of property, plant and equipment (Details) - CAD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">$ 12,141,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="num">(175,824)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">11,804,145<span></span>
</td>
<td class="nump">$ 12,141,676<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">12,324,870<span></span>
</td>
<td class="nump">8,292,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">534,118<span></span>
</td>
<td class="nump">4,032,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="num">(215,056)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">12,643,932<span></span>
</td>
<td class="nump">12,324,870<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">183,194<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="nump">695,825<span></span>
</td>
<td class="nump">183,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="num">(39,232)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">839,787<span></span>
</td>
<td class="nump">183,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_FurnitureFixturesAndEquipmentMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">256,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">223,631<span></span>
</td>
<td class="nump">256,834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_FurnitureFixturesAndEquipmentMember', window );">Furniture and fixtures | Cost:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">333,013<span></span>
</td>
<td class="nump">123,218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">126,425<span></span>
</td>
<td class="nump">209,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="num">(86,730)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">372,708<span></span>
</td>
<td class="nump">333,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_FurnitureFixturesAndEquipmentMember', window );">Furniture and fixtures | Accumulated depreciation:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">76,179<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="nump">100,652<span></span>
</td>
<td class="nump">76,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="num">(27,754)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">149,077<span></span>
</td>
<td class="nump">76,179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">154,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">159,102<span></span>
</td>
<td class="nump">154,105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment | Cost:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">220,150<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">73,183<span></span>
</td>
<td class="nump">220,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">293,333<span></span>
</td>
<td class="nump">220,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment | Accumulated depreciation:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">66,045<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="nump">68,186<span></span>
</td>
<td class="nump">66,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">134,231<span></span>
</td>
<td class="nump">66,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_FacilityUnderDevelopmentMember', window );">Facility and related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">10,418,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">10,025,298<span></span>
</td>
<td class="nump">10,418,976<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_FacilityUnderDevelopmentMember', window );">Facility and related | Cost:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">10,418,976<span></span>
</td>
<td class="nump">7,068,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">142,824<span></span>
</td>
<td class="nump">3,350,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="num">(101,683)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">10,460,117<span></span>
</td>
<td class="nump">10,418,976<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_FacilityUnderDevelopmentMember', window );">Facility and related | Accumulated depreciation:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="nump">439,903<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="num">(5,084)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">434,819<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_ProductionEquipmentMember', window );">Production equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">211,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">296,114<span></span>
</td>
<td class="nump">211,761<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_ProductionEquipmentMember', window );">Production equipment | Cost:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">252,731<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">191,686<span></span>
</td>
<td class="nump">252,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="num">(26,643)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">417,774<span></span>
</td>
<td class="nump">252,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_ProductionEquipmentMember', window );">Production equipment | Accumulated depreciation:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">40,970<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="nump">87,084<span></span>
</td>
<td class="nump">40,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="num">(6,394)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">121,660<span></span>
</td>
<td class="nump">40,970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land | Cost:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land | Accumulated depreciation:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_v&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_FurnitureFixturesAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_FurnitureFixturesAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_FacilityUnderDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_FacilityUnderDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_ProductionEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_ProductionEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6819863920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life of intellectual property</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6708898240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Narrative) (Details) - CAD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryWritedown2011', window );">Cost of inventory impairment charges</a></td>
<td class="nump">$ 1,315,941<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryWritedown2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised related to the write-down of inventories to net realisable value. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryWritedown2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796897216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory', window );">Schedule of key management personnel compensation</a></td>
<td class="text"><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2018</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries, benefits, bonuses and consulting fees</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,836,192</span></span></strong></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,814,115</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based payments</span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,476,385</span></span></strong></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,215,401</span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Total</strong></p></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>17,312,577</strong></p></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">5,029,516</p></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6717008240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of business - Schedule of ownership percentage in subsidiaries (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">FV Pharma Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Country</a></td>
<td class="text">Canada<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=huge_SubsidiariesTwoMember', window );">Prismic Pharmaceuticals Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Country</a></td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The principal place of business of a subsidiary. [Refer: Principal place of business; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 12<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_12_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 19B<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_19B_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=huge_SubsidiariesTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=huge_SubsidiariesTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6815301440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions - Schedule of key management personnel compensation (Details) - CAD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Salaries, benefits, bonuses and consulting fees</a></td>
<td class="nump">$ 4,836,192<span></span>
</td>
<td class="nump">$ 1,814,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based payments</a></td>
<td class="nump">12,476,385<span></span>
</td>
<td class="nump">3,215,401<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total</a></td>
<td class="nump">$ 17,312,577<span></span>
</td>
<td class="nump">$ 5,029,516<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6819871344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income taxes - Schedule of deferred tax assets (liabilities) (Details) - CAD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeferredTaxAssetsOtherInvestments', window );">Other investments</a></td>
<td class="num">$ (168,092)<span></span>
</td>
<td class="num">$ (1,334,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward', window );">Capital losses carried forward</a></td>
<td class="nump">168,092<span></span>
</td>
<td class="nump">1,334,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeferredTaxAssetLiabilityNotRecognized', window );">Deferred tax liabilities not recognized</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeferredTaxAssetLiabilityNotRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax (asset) / liability not recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeferredTaxAssetLiabilityNotRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeferredTaxAssetsOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeferredTaxAssetsOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of capital losses carried forward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6831279872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 12, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 942,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_EmployeeRelatedLiability', window );">Employee Related Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfArrangementsAxis=huge_SupplyAgreementMember', window );">Supply agreement | Canntab Therapeutics Ltd ("Canntab") World Class Extractions Inc ("World Class")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AnticipatedPurchasePricePlusApplicableTaxesValue', window );">Anticipated purchase price plus applicable taxes value</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AmountOfDepositPaidToSupplier', window );">Amount of deposit paid to supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OutstandingCommitmentToPurchaseAdditionalProduct', window );">Outstanding commitment to purchase additional product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_CollectiveCommitmentToPurchaseProduct', window );">Collective commitment to purchase product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SupplyAgreementOptionToPurchaseAmount', window );">Supply agreement, option to purchase amount</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SupplyAgreementOptionToPurchasePeriod', window );">Supply agreement, option purchase period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted', window );">Purchase price per kg per 1% of CBD extracted</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfArrangementsAxis=huge_EpitechLicenseAgreementMember', window );">Epitech License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA', window );">Non refundable sum due and payable upon first notification of FDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA', window );">Non refundable sum payable within ten business days of first notification FDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights', window );">Percentage of lump sum payment received to pay for non prescription drug rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights', window );">Percentage of one off lump sum payment to pay for prescription drug rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition', window );">Percentage of net sales of Licensed Product as first payment condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition', window );">Percentage of net receipts from commercial partners as second payment condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition', window );">Percentage of net sales or net receipts of licensed products as third payment condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfArrangementsAxis=huge_HeritageBuildingRestorationCommitmentMember', window );">Heritage Building Restoration Commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_EstimatedCostOfRestorationInCommitment', window );">Estimated cost of restoration in commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 517,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClaimIssuedByContractorForVariousPurportedDamages', window );">Claim issued by contractor for various purported damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClaimForLienComponent', window );">Claim for lien component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees', window );">Security deposit in respect of amount claimed and estimated legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 235,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember', window );">Contingent liability for construction and development costs | Auxly Cannabis Group Inc. | Definitive Strategic Alliance and Streaming Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement', window );">Number of Class B shares issued from treasury under private placement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement', window );">Amount of Class B shares issued from treasury under private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AmountOfDepositPaidToSupplier">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about amount of deposit paid to supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AmountOfDepositPaidToSupplier</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of shares issued from entity's treasury by way of private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AnticipatedPurchasePricePlusApplicableTaxesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about anticipated purchase price plus applicable taxes value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AnticipatedPurchasePricePlusApplicableTaxesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClaimForLienComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information about claim for lien component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClaimForLienComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClaimIssuedByContractorForVariousPurportedDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information about claim issued by contractor for various purported damages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClaimIssuedByContractorForVariousPurportedDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_CollectiveCommitmentToPurchaseProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to collective commitment to purchase product.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_CollectiveCommitmentToPurchaseProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_EmployeeRelatedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about employee related liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_EmployeeRelatedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_EstimatedCostOfRestorationInCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to estimated cost of restoration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_EstimatedCostOfRestorationInCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to non refundable sum due and payable upon first notification of FDA.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFDA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to non refundable sum payable within ten business days of first notification FDA.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFDA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares issued from entity's treasury by way of private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OutstandingCommitmentToPurchaseAdditionalProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to outstanding commitment to purchase an additional product.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OutstandingCommitmentToPurchaseAdditionalProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of lump sum payment received to pay for non prescription drug rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of net receipts from commercial partners as second payment condition under the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of net sale of licensed product as first payment condition under the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of net sales of net receipts of licensed products as third payment condition under the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of one off lump sum payment to pay for prescription drug rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of security deposit with the court in respect of amount claimed and estimated legal fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SupplyAgreementOptionToPurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about supplier grants Purchasers right and option to purchase amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SupplyAgreementOptionToPurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SupplyAgreementOptionToPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about supplier grants Purchasers right and option to purchase period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SupplyAgreementOptionToPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about supplier grants purchasers right and option to purchase price per kg per 1% of CBD extracted from the flower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_SupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_SupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_EpitechLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_EpitechLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_HeritageBuildingRestorationCommitmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_HeritageBuildingRestorationCommitmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=huge_AuxlyCannabisGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=huge_AuxlyCannabisGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_DefinitiveStrategicAllianceAndStreamingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_DefinitiveStrategicAllianceAndStreamingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6711415104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Schedule of intangible assets</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;border-bottom:2pt solid black;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;border-bottom:2pt solid black;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;text-align:right;border-bottom:2pt solid black;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost</span></span></td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Acquisition of Prismic Pharmaceuticals Inc.</p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">24,648,915</p></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">389,640</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(186,463</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance, December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>24,852,092</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Accumulated amortization</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,534,047</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,887</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance, December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,493,160</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Carrying value</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance, December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>22,358,932</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:none;border-right:none;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6709215440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Disclosure of stock options granted</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="border:0px;width:100%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Number of</strong></p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>options</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Weighted average</strong></p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>exercise price</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>#</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>$</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Outstanding as at December 31, 2017</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>206,219</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.44</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Granted</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>593,781</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>65.80</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Exercised</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(240,214</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11.31</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Cancelled</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(74,627</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.05</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Outstanding as at December 31, 2018</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>485,159</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>74.53</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Granted</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,363,322</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20.68</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Exercised</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(82,094</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.02</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Forfeited</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(12,438</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>56.28</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cancelled</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(299,006</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>115.80</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:510px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Outstanding as at December 31, 2019</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>1,454,943</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>21.96</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:510px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Exercisable&#160;</strong><strong style="font-size:10pt">as at December 31, 2019</strong></p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:11px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>1,200,242</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:101px;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>21.24</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:3px;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Disclosure of fair values of options granted using the Black-Scholes option pricing model</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="border:0px;width:100%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>2019</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>2018</strong></span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Grant date share price</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>$6.45 &#x2014; $75.38</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$10.05 &#x2014; $142.71</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exercise price</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>$7.17 &#x2014; $75.38</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$10.05 &#x2014; $148.74</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected dividend yield</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>&#x2014;</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Risk free interest rate</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>1.24% &#x2014; 1.90%</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.97% &#x2014; 2.41%</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected life</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>5 years</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5 years</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected volatiity</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>100%</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory', window );">Disclosure of number and weighted average remaining contractual life of outstanding and exercisable share options</a></td>
<td class="text"><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following table is a summary of the Company&#x2019;s share options outstanding as at December 31, 2019:</span></span></span></span><br/>&#160;</p><table cellpadding="0" cellspacing="0" style="border:0px;width:100%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Options outstanding</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:245px">&#160;</td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:493px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Options exercisable</strong></span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:213px;text-align:right">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:228px;text-align:right">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:245px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Weighted average</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:241px;text-align:right">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:252px;text-align:right">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:213px;text-align:right">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:228px;text-align:right">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:245px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">remaining contractual</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:241px;text-align:right">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:252px;text-align:right">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">Exercise price</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:228px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">Number outstanding</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:245px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">life [years]</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:241px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">Exercise price</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:252px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">Number exercisable</p></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px;border-bottom:1pt solid black"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">$</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:228px;border-bottom:1pt solid black"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">#</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:245px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">#</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:241px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">$</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:252px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">#</p></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.61</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>35,065</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.61</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>35,065</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.42</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>99,502</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.42</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>99,502</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.43</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>16,264</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.43</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>16,264</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.65</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,730</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.65</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,730</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13.07</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,855</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13.07</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,855</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13.47</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,418</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13.47</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,418</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>16.08</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18,409</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>16.08</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18,409</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>17.89</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,178</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.49</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>17.89</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,178</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18.09</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>37,313</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.34</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18.09</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>37,313</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20.10</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>493,363</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.72</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20.10</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>493,363</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21.11</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,438</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.67</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21.11</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,438</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>24.12</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,950</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.59</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>24.12</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,219</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>26.13</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.62</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>26.13</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>40.20</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>29,851</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.45</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>40.20</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>22,388</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>44.22</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,488</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.41</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>44.22</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,488</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>47.24</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,493</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.37</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>47.24</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,493</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>50.25</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>227,861</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.09</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>50.25</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>129,353</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>52.26</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.21</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>52.26</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>55.28</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.12</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>55.28</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>59.30</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.96</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>59.30</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.17</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>199,005</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.83</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.17</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>199,005</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.50</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.50</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>75.38</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.04</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>75.38</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.63</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>203,750</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.34</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.63</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>58,750</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>86.43</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,244</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.88</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>86.43</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,244</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>88.44</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.87</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>88.44</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>120.60</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,950</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>120.60</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,950</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>142.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,974</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.74</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>142.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,975</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21.96</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:228px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,454,943</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:245px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.59</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:241px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21.24</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:252px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,200,242</span></span></span></span></td></tr></tbody></table><p>&#160;</p><p><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The following table is a summary of the Company's share options outstanding as at December 31, 2018:</span></span></p><table cellpadding="0" cellspacing="0" style="border:0px;width:100%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Options outstanding</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px">&#160;</td><td colspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:494px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Options exercisable</strong></span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Weighted average</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:251px">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">remaining contractual</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:251px">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:213px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Exercise price</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:229px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Number outstanding</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">life [years]</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:243px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Exercise price</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;width:251px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Number exercisable</p></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:213px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">$</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:229px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">#</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:243px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">#</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:243px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">$</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:center;border-bottom:1pt solid black;width:251px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">#</p></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.42</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>149,254</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.42</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>149,254</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.03</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,488</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>0.98</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.03</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,488</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18.09</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>42,289</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.35</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18.09</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>42,289</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20.10</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>33,169</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.27</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20.10</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>16,584</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>26.13</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.62</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>26.13</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>56.28</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,438</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.91</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>56.28</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>59.30</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.96</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>59.30</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>498</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>86.43</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,244</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.88</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>86.43</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,244</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>88.44</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.87</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>88.44</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,925</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>120.60</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,950</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>120.60</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,950</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>142.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,975</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.74</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>142.71</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,658</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>148.74</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>199,004</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.70</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>148.74</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);text-align:right;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:213px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>74.53</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:229px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>485,159</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.32</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:243px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>19.91</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:251px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>253,815</span></span></span></span></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796922032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract', window );"><strong>Disclosure Of Commitments And Contingent Liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory', window );">Disclosure of quantities available to supply by fiscal period</a></td>
<td class="text"><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><table border="0" cellpadding="0" cellspacing="0" style="border:0px;width:406px;margin:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(255, 255, 255)"><span style="text-decoration:underline">Year</span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(255, 255, 255)"><span style="text-decoration:underline">Commitment</span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(204, 238, 255)">2020</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(204, 238, 255)">350 kilograms</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(255, 255, 255)">2021</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(255, 255, 255)">650 kilograms</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(204, 238, 255)">2022</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(204, 238, 255)">1,000 kilograms</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(255, 255, 255)">2023</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(255, 255, 255)">1,000 kilograms</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:144px;background-color:rgb(204, 238, 255)">2024</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:261px;background-color:rgb(204, 238, 255)">1,000 kilograms</td></tr></tbody></table><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of quantities available to supply by fiscal period, under the supply commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>70
<FILENAME>0001062993-20-001379-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001062993-20-001379-xbrl.zip
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M_F ,:QAV()V H>^=2'AMPX2;5:00N-D -Z>6\-5Z]&TXG(XTMNZ0(-Q9CN'
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MUHJH\/I.W>L[>^&K+DY_W?KB]#LCOTY5^"HR"+QTKIG!0? BFK!$ 5O7@1D
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MS@('#V01T&G)LK !JZAQ9DC0A3U818U.(J'63CDV2# \X[WE!F0\._F3 #N
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M>2.WKP&-\KF.'Z>OU""%BCPLNGX;K6K<4\WA:B=_5%;Z W6E7JIXZ59CVVL
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M2IZ)$Y+R[FURX-:.'"LR&$:*7)+Z!=(XRD53Z#L+FY2N'X#D&^4)/1L.1QZ
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MY9):!1L/+ E5?B6V$1 3(Y8MEY>^!+ ;%KM,]G%+.!N4+9W>X6A0:RY8::C
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M70G82F[ -0M:;9<MO@3;%:!=R9;X2:QG_ !@Q,R+F0'FPA,A8$+0(KYP@T?
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M^O#F>^Q%9/E^R)Z/30"R3[E.6JLF-[]WX2]\Q/7#^S??LWY:"[ VQ]C$Q"?
MG## /E7N2VH>V$06NY0[ ?:<PCYAK.=6:2/J"]!<-O92=+$WTPMVY7)<^/RJ
M=\.Z,E'F4XWSC!2<8KN*U,L\$O4P92^!EV,WB*C9Z3CT/"0B]J?]JY\1E<V;
M K8..R_8S0HH[+G/V#X<.\F%P<SUX-TF[9^%#*>PX2QG_ 2)^F !X4!)%]K8
M@ KYE39D5#'G2I&Z0J6<!GGZGUZL'^?$P"4,278.V@-["O9F%O8/HBTVQZX?
ML [*5[U?LA^S7D>LYQXV+H6KX %QA[Z)87F]9\,.2802*MIFU!YY"B*)?8EZ
MY'4\,YPIZ]DV=5' $8PP@V=K3/RN8.@NF:_E\UZR5M3>+FY^#()#K&>F;7R"
M?>X<UI 4FS M#(M^P=K2$ ]8$;517E)-SML+ K'I)09KF/I$@A=D(I@V?\"#
M@)'@O8-31-M1L9YS*133%H$7,) I2#-3GI.X72T=+!LW]EVD<@YO<Y^0&ZR1
MHM<#NX\V!01F^ZCQ#8>J7SIYQMN C&>.]6=(KF"=B*ZG'0H+P$C//S7=;&/*
MP/@#.QDZN ZPE88!:@:J?8R=^. -XU@;Q<]+$6]22AW&%GPZ;U65?V+FE;1U
M%A(GFDG)BRKH?=5+P0-QGKX T/X6/C)C>[FW"#ULS15U9*R27]H:,VXY[-(6
MD3.@(I77"Q0LL@CHZWR8%]B(5$(7QI*^-@4AWJ(;Y1E-!-X'TA^["\HCM %Z
M"K6>+(3Z0^II7]C3J"C2+[G-T%/0:J!]+N.9\M=0M>.[<_B?!:(%;@OK$NZF
MH''1>PK9@+"Y<OIS-D<_$C4'0$C_ BNCI_:307X$Z%A>9 1>TY[&R2B[HE5R
M*],XM3*ES9'.+DU4N*B0IUJ9YE#..]('_&K:TQKFC[WOROOF)>E9^#W? V?V
M9]4;7! XCS?YK&IC7Z-G'^W96=(.F%Z, 9!4N^YT(T" <.8Q4?M2M#SI8@):
M%%P_LRNP?<C0!.U,6.J8BBUK8YCO=QNW,TRW'TNW,R3L*%*QF2%HD5P_0_K)
MAOT,^>.C_N[IMN>X'FS8W) ][:I7( J&2>B\: R>KJAT7'@3;>0+*IT1B,^=
M6A;<./"8$9%I<GMM8V]@N.(RFD$IDG'U!^,+M2F0C3AQK_6D?Z]';+YBN]F%
M(C(V,G#-2P;VM+=!MSMT3J"<<:8XFV2N'?*A<CK8_)_>7>B,H];/U$<<\T[(
MZ6!*]$UG=?.J%J>Q"X[<I3L1%KS'Q%(97MRYE-O!DQ)J91'#=7/ANB*VP U_
MF;DH-NX+&CT9&%I4_[+VA/Z[NH1F54/8QEA<,*1V 1%=^DMUQ9!<<M>^:H6L
MRQ](C;0=:8CQ KU%'D?K)A.C_P-#?^TY-9BTN(XH!T_OX4;7'OA[\*G\YEBH
MYVA,V=^%R:OVMO/[$U%:9Y7R7]<!.=/N6&;YJ9F=CLR'QUY2R?_T?O.IJQG%
M%IA!\J_0G-(UI[-K*(^L,8L@MO4KO) H_DQ-6QJJ1T?:(W^&%L:M4V%]L,KF
M&+6(R761T(J%<GT_G"_2OGUDM!(651_'0S*2V'T<G4^\%-P3P/#P//:[*KPC
M(PXV,=,UW_D\;4"L>#JW3.DUL7%JAEX4<_'B70J^&P!6[S@(4ZW5QS2H8UH3
MC*!%]K2?HE57[,[;1!; XF+A%M=)P>"O:([[0>\/QWVQB3FE5(\V+9".$1C2
M09ZTH3XWECU0K[A7\@?AP28PP[ PW57O-B.*]#*;>NEI;.'(@&46>>'!8X"4
M,W7Q,AXU_@K?^NSU;AIK)#,[CXS=J4.W'O@P&'OQM\1'C.Y!2P_?BA2Q)AP7
M[#4<Z( E!\.D-)Y)GT3=PNRSW?RM,$\V^WBKJ>KI3RZ(9T3JXGU=@=ACIITW
M,H+&53$BAV'^6*=<@-(PO" 2)Y>&W-!Q3G$2>7S!*)[25.@_SPTS1M?"<\<\
MZ(QZ:!G)=6+?5^NC*'9((ZRX,>$G61(]PA0<WWV(-$H15V4:J;:OT/XT@O^V
M_B=_.\\CD!M((OB92C8L4V/B.1W!^#5@PP %DE\Y+M(PQ44-_Z40>4J%6'.+
M=RE\J/NZZ2;;-$U*_LJRW7HP 9A[7'9#/H&#JF92HNE?+-NF420+%U<,4KD+
MOA.71!OA;W@6H?XPUV<H>$\8_8*/0'][!-CW;_: E!V 6Q?@STW9%QFK ,-*
M[AQ,FMC(P3<Y8.70;<308W;?$T_<VUQQME@2JT2QB72>V]0F')F$-E#]F47V
M?,M$<XCNCW#V$  )X#+",>A@8#YNLF&Z%5N_T,A<)+O<K9?J#YO,B>V4+0@E
M-]NB3LP/N#E-0GIGCHI10 L7R-2.6Q3SI:;)*_'&%@-SM&PRN66J)=J(0F&T
M,EM3S#IETO37=2/%]>P9!!?E,5KCF+ S"RZU73DQ6(Y&M&$&=SHN'@:DNW)L
M-Q0^,BUNR7&C/$.+V-P_+;FL$LQ! X+YWG)M=TK-IY2&!&L)'NAZRXZ(UT=P
M1@U['-K)OGTFE^-I]2PS:RLUUJD/:\:.J]%S0KI#EO;Y+_A>7]JHY"_WL8(@
M7CSUW!=8%J.4$L-Q8+'Q05*BS9 %+)-4KF!!PL39B^@'MGKZ 3U!:]NI7]'/
M'*,JC3YGOJW/4R'\V!FE%RTM8IO)HAD/@>H=GV8\,)%/7%8NLVP'"8:&AH*=
M4"O6,BFBL<0U;I D5])\')AIDH/A@!BS99DJ!?JHJ]Y=Z-&<#(L&%+B63.N2
MT&<F<:3.RK,SBFRVV.Z<014@W/_9!7=L>%+JX;E"._2O\E&TAA;N";.S0)^#
M??KO>$D#'!O.U**J/DE?:+_N2&_:DOG"=I=^UE.+00A CI?3C(-O%I:A C$N
MXGRR"+H.K:B?R0*Z8#NG!H\0T0WAE+QCZ@A;[C&"$:]VF9=G-Z'9E7Z65W,"
M+C%/6\N9$DY(<^-<C^U5CRUO',Y!F3FH5GC>&^6]B0SRF6%=]>QTX 7L'1]G
M >^QEZ<D?E72-VQ$^K)90:N-1K:B[2J#^RWPD)I/P->X6O%BML'/%F3NZL6[
M_TB6?Y%Q8A9R8S'PP"S%!6Y7&O:HJSN!-0;$@&:41Q8S6Y$F;#DRV)!8ABF=
M&IY3X1Y-=M4"1&!$FZ<DI^QK.IKLHH>T8#EIZ0MM%]?LJZ,P<:/=G)9):Y4I
MW<QB^8\XI1386I+$R/#Y8GB>X71F??PUD4L.1)_G1^,*4)&NF9TIS[QE@LDO
M=.G*4):%BWLDN9@]#<EFA0,_CJS"3&BV_(DLY!4EY^5S?)E*>7;1?XBL7FK'
MSUCV")C5J778M)YA(7>X;9WZ J4\]:MG^7]<3CQ"/5UZ *U'D_;B#26^\P0T
MG!"+;6,\H/N;W5;,;V!8#IC*[,1)B-$UM&ZO>C=T=4[EX&9N2[;34A9SQE5?
MR\236K4K?6JM>44 \'E&3O/,4>H>\1.2'5$!V534C).6GYY%5_(ES8,V[!=C
MZ=. [+-AV>CPT6TM&N))/P5O>$)@^^%D@ELH#LU3#QU8]EDB)*J91+"CA'/J
MO:YV"2FL_=X,!!5%8P4OU@8!N*BMD$YV2J%D($:<&):$]5FB?=.:+NND)$/(
M:\!X4PJ/>+#3:Q&/RC<&^/@9P0@PDIV[H*<#,L^A!Q@)S0YESW&F%TB %WI^
M!-P(L%T(O\Y@H<%%^&1;XQ2"D #\J$YDSE&:1#'!)!#(-6:*CY1>J8-R\,I/
M!-R.GIH^+9!BSLR"]WCC&<_KXQP+2I)]V5Y]:#/.V,MX@X%&/E%)N+Z5S9U(
M#PQAGMOHAT&,0;]2EO(7XV$BG!*[DC#7*SJ0@^_U@#,GIHSW:Y;1TQ0]8PSR
MS-C3$;7[D6\.)P-'7$5%\N"WOX<@X\J0)^W'7LF+D=5>B3[@^0'I)WHD28X%
M(V1&SW%%^ULHDD^6PW6]EQQ_ @T\GH&M<-7[-1T$9,J%;WY' S4MDRX'\9O2
M+XCRU7E4=LQ'34][TC7$H<;3U#-8Q)/M2F @@>W8T5U'RUF$J,#Y;CU7(&X8
MX,>@(2S<G[0887*#7$4.&I_E$TWV%NA9+SQZ! ]S7'H$D&Y7IO;N^:Y^^M0;
M2VQ)WL.L9SK-,>M72._D46%.CNCE)IJ*_,";$^49F3P-.59DL8[&&&LI05.;
M0<PBK\A?PS08U%(P&AHPU:F:QQQCGO"<B]/F,B+RXE9;6:TKF;-Y78:5W1_#
M.2C%9:823W(R_ M/YMBY_Z.FCI310"L6>2C_\<@Z1SUH78<4Y<L2:=B=&^=1
M=JJ0QG\;5;M[5Z,F"'YC^+..K'<XU*BB E5F-* 6'_6);/C @R'%9^NH%L34
M#[I@X%9X (8I,ZA1SQ;NW%@;=0]23_N%U)<XAOHECJ'>=BPAX\NZ! P>ZS+1
M$Z#;F/3P.: NG(<L%IW)4Z&1XWQ\]B)U1H^>;N8FG$WC*M&A(S1SXF?AH<F8
MZKV=?^P(-WZG9]4-CZ=LXRE),E\?KJ?):I&?%.12BX#J[&P?UQ2\3(B!Q5RH
M^4#H6_S>=W/C7_ %>I^N@_;#]VO?O-^$V0UKTJ[@R2./T[)<')@(+09 <V,W
MH;-5EID:^ZTLL2<.$. 3P<]@YUSAN4\L&R\RMGFL-7;EG\#-G^ ^(ID_N28Z
M["DOG8Z46M=TIR=[@#0^TDQG"#8$=9 CL>6A(^[45PR6T81&/#V>=I5,E-_I
M^DGTPS26EX%["7_Q@A_XR/6[2H6,\<PAVFR0!35'E(<(.@$$P\=J0/AQ5]*T
M\>0PS)ZYA%'E%2MRNSAKJ9< WD*!,UZ:5GA,(Y%7ODF.'V(AH(5GT>(@-'<^
M=;@Z"[I*P,'37*9R$S5-T;L2<$%*I.([JL&'9YQ9O1%T6BPOVJ)$I]:A>;,T
M7$7346/W[[3A\3-,GA_(H:MD+XZ=@6>YB5K*Y3<^13'%*#Y*PP'$Y,?GXU?$
MS,Y![X(YZ5EA15^:*R27IRB-L19(I 1/FE.9K%40K/A0S^KDEW0$PW-QK\S<
MYJ1SRN9FAYYKGG0NG%NN>^"9ISM+?SGL26=U^)>X00=[HWZE+7)-.]A'N5+'
M@;OX84;H+=+B=:,3QGDO)MGC/Y+3@CHV!%G>/+5[Q;G<OBQ(&_R@2G_!ZJHV
MVR-[,FQ<=[:@;N,GP'=#?DL.7(,G:88LR%L7NOL";$LHHFR!M[UTHM@?R@Y?
M@R+T'"L^XS2Q7O'G^N?Z#X&S@]/D8#AKFS8[5*+?GB$-EIL=%:[B"9ZKN;=N
M,"O"7ONW%EJC?'D9-GH$'I[@&3B52PSMGH,.KBI-TA9CK,;C/X% K&%5*[!]
ML@SXC(D'[%C#.I5TNE;S^NX\!]6:#77C:4%4Y;IV? O#4<XR<QJ)!:K!%+3H
M29UTJ)1&PU(?I)+2,+#&S_0X[HJ(*'X:92^G4M3PX!$K^4N?==6[AE%-,1<2
MJPG3.)=GT802?&,TAG0= I83\EUT2),%A&A$/<YRBVLU1BDL\=#C.%X<?RV/
MYM.7?,^.:V2#S=N%Z1C!DN&7[@]$)Z$+9[ +I[2CLU'PTL+6(25%^D->H(#N
M7]'#5KA)D3Y$=8&;+*DP^!EL:X_W>M;J#J6*7-JTWOG'Y!#0=9<.,V8F43S)
M% 6W/7/5QG;F1!]+7$N^+!Y"ZEVGKR_L%0)"0;G$FH)6$\E8I5%QD*@ ;5+A
M!T/[&\>+,>,K_8\()>_5RCM6:FP '"/LH&R4R]%-,_DX!-29E[B;/5O'X"H3
MQ_02U-WER-QOEM577EKP:V)-=6012IU +RF0MJ1I.%'AQ+2MR"(6M(JD#+9_
M1 !JB-[P@_$\X_L&9N/.B1?U?((;WE#+#P\(T_4#5ID)&G)@.2UZ<]<D=O'\
M/C<?J0&&];^GZ9*.</53-F\#7H#<!"I&1B4=$AN1T1OS,?W0L_*7@GJB"=-H
MYKI/P ]>RBHQ3^F3\$ZX-3O(=!8Y/7,#5SU_CR7JW7'4 J!P35Q>I.Z+D0;P
MU'BZ,1FH#?P=39SZ/I,,X<.C_ D]K5/QFJYL<V> 1H]]&C8K3AD52\D:-;%;
M$#=\X47NXU8 D4>"AP.2]EP,'N@VL$<FS8BBVA L!82FM;EC6J_1C/JXT$VF
M='TV0#3@.U57G^(!$8!. CO[%+5&@?GX"5ZY24<60=(@+1Y=1WB6K7+!6>/'
MJ&7MA[A\TS0@CTQL6@LS\@>3WDYI5C+WUV?5XVCS(ZQ5A:HA4ZT*+Z5=&O@#
M:!7))2_JRH#$^SE0C8)-%[I(V=PQ2(_,P9(GK[1R6&"\QOE1M+=OK+"OIZQH
MOI,1ICDQ63.N6*AX*7XC6[/DB6""#:O+QT]^LJ-T_+UFR [^T (E<36C2#Y8
M%"0G&8GH?2PO64C7FP@[R0&@&!NIZ,%#)GKP*8H>W&2B!_CQ17*6*,%E0<6P
M#F+,!6.%CG'2"8F[@IIKC[!#KJG:&.RD:;001EE9$3-PT>!QCXG%+0">:<59
M4JB=$?7]BK0L5FM=H&M;Y/3I1T/(?LW/.]<C,"6PM'@/C$=<Y&RC0W9H-(6X
MC4>F-0PM'\SGQ((E;J$U",9(XH9_'CTHAP? ,[5[T_7#TR^XZOWJ.B3 /LH5
M-<B!-VZZZTQVN-2R"J)R<DF#V.1T=GS:F XA-Y^*V42%4_%%F9FEU8_!UTQV
M1/TKX8<366%M+_HUOGV:3^C,Y5!&A2>SD:"N:+;/KG,Y7\/)N!]=G &,EA=&
MKVAIOUR#2C1.\MQ>YOD7Q@7Y<FPJ5JU/H:XK1$TBYV5]RR+:I(K^TJ6ZHN5.
M<C2VV-JGKI1C-.22.&9.W-%BH/F^Z0+_%_GV4UAG H_LEXR[UOMY8TJLNC@E
M>84356YD9:"O>K?1U^D" <SPI$WIJ(41Z6K\H'Q0V2"MR]?5_!9(LC@4XL L
MW2VH7\VMNTOMI*I(N=34S@/7Z!\=/_#"+I6&2<:>$N=DB<H4U\ZBKN!%1X:_
M03<YEZG#$'%)1)I.SMHSQ/5(8HIU1?=M2+)DLS=])#%3V245_6$';N+U*.Z)
M:P2!9SV%050:O5!8@C70)ED+8^T OTLIWPUNRTR@PC[XGF]^FLR8P?UG@CY>
MNNU@L6MS81!P7^D8RHX11;1.1R7+R%N?JB7$K!I0+:(45/<<W6I6C*:PU]85
M@6!J\561%*7P'+ZOI5P-]9TTZY;E,--KDMH_V@IT7PK-"QKCSLR0%CS.U#Y*
M*XTXIXGB^*(,;F6& #_R]-U?_WKWC_N;CW_]Z_>TC%<U6"-7@-WR^.43W,)/
M4_*Q)?V<"O*1/V<4EXIA0?RXPT[IW%D)+S-U-#19/)**H;F^V;L54SHB+*Y+
M25#)<'XL=TY(U!(H4IKQCGNNPGY\.AU3D**T'7@N96KMC?G0CB:7V49%"O2"
MY0(^QXX<,35LJXS,FGXE:Z64SF[.#J^&_</D+W^DY*:U)7C<RLB#]87V'G*?
M_L6R=O@&U<RUS0CM\"OF$& \H12K/MV:64-IV^H>[;*RR7SE*=+(HVTITKL8
M9E1].^5RQ1:.[]JX^,4E*UE%0I")!0H%J^?+:F^Z44NG^%N>/18&6.(:R;!.
M$R2$?AO:W=$*WX4.C3"SX]$&NH<FX?L;U'1!_+K8P3Z3:QC7[TMJ(S"ZT^!]
MF55:NA?Y??7UJ25D88=@DTU8D3&:'TG+?W%=<Y%Y;%TCUXHJ8&U8ARIK#W'/
M[H@<?<SHZ-*.8U@7,K) _>3\/2=V,7:X89^4K;.FU/Y5'RTWECCU3KH:P&\]
MNIW2^U\2_:=N4E55XE3\4SX92BGF\DAJ,9F'?E:6S<.&Q6Y=-? HI;WDDK:D
M^Q1]3BY8M8,W*W*F!HW0>045HTN8V=!B,B>5+U:XZY]!(^=#YNE>,JPN;;1H
M>4FY:6:'7Y2$[_;E]U54>J\ZW;!G2:0G25; HUI2VX*/,C',VNCMD<=UU.ZN
M,.:\HM1."]W88RXOES^6M'_!=^BSW="B_.>/T<61@!8VV(H[9&7EPM8+=O'@
M1>' Q9K\Z_K1^NV;@I]N%"D5KNMJS""3WE,\1^37"DZFM[Y+*V7O&,OO;$0F
M3=TX#L?Z)%70U8^J+E?2G=IIM/IR1F]UED:I\F#HHY7%-5D4,K\3LIL.O^J5
MRG%"81I-"%B4*X-VNO<\YOTUG@CK6M2D^=42QJ3!FSKHYF="K1'IXHIKV4!.
M.LF8^>9^5-P,:RQBVIUMLU_(ZP(<=[%)40%+?A0T6*;W.+L*K?U1[R:[HV!@
M6M43E45&O9TH-E".1K$/.(MR$+"=VCAU.ZY.6.A[L7)E8;50XZ<7\F*C2%+
MLOHGA06<]@6:DJ134#:9DY5R+=4<[&!S<6:=U9S[@_=MLRK@B("^+F$X#4<[
MR^1H HWI$AKOH)ULDV/55N)DI0L,LGJ1F&&,N)I@ 3F6)D C*38]B9'K\G[5
M*Q(U)5(&-NT-%_$SLSX9#W+'1]+Y(0'P$!W6FX(%HWDR!0U4[X;J(W+L*TEW
MO\@V>7!?2MB9/RC#\K=YTD8<I4\RQWJ?W:PW6^/P<+HIQP5-H[^(,E=B^R+>
M7*XS9F& W*S8E#\!VZ.63U:9HHW-[7EE"PX];#U&-ZH2M[>47JSG2M2!Y2)J
M]Y3-/>#E@)/&8U@7.* -P\+ 9G5MB>V^U-YL;QOUZ;UQ"X\LU-@T-N[OP3:C
M6!@RWH>JL2_%ST=(?ZE]C+]P_O^@I_EU'&D[2NW5Z")2'9!NT3RN-PFV[[&&
M4S5)#EXP[M&+6@Y&=<JCM(#MRTNV:'K[YWCGA/F>%S*OVX:T$Y)]MRYU5@A[
MB; OC*60]-.5] ^$]KNEIWFBZ(L0]G,1=NS=Z$<B+B2<_5AC_[J\<&GB2-6O
M9%J1/W.RD82/24I#2;9A5UW8:R>IBCD&5]X*^.F&-[<WG]Y\SW.]Z?EIEJ=<
M""M4[UQF:E_\M20BL6+3D[6*ILGET08[#(@/A_=1Q!1<("-,D\;#JFW];!&.
M>#*X"6#-X1>VIX#GI0P,>KCI]!5Z1+7ZT1A5C<)Z-"S+CS)A0BO=7(C/>\!K
M2 #43^@=9<8$/8+OS;9/SY1FR=1T\3.'KE,\PP=[%JTWFCV>-C'&<+T?I9V/
M(XKB;I+K95N2E_8A3Y,/"U,@_UAI"DQMR @&AIY6T2M]]KL$=Y3![!"RX\8M
MP=.E5%EOXFPSP;K2U]UCNM/]5L1X;\'2-Z6(ZE1-T*R">4IFP35,I"G2!:]H
M.>(<J),^U5'I7KK3P<Y8\%]89K[E\-I5O*I_)$NI=[.264D3Z4G^ CZX=%'@
MA6MQ^2GFC,0;D/%%,\-#!S<[AP!S%KA*]2M>F4W^L%D;=)^J6)_8=B]<Q-75
M<N^ZX"'A*/N)/I\6-XT.\4>=X]#Y=FA/:;9GE1HLJPU6:-5M1$7LZ Y9W+<[
MHR3X4WI+BS>\G7K&G+V<,9273<!=&);',L:J <_(HXN(@@XO.!P=L&"'9/A>
M<_PJI 0]@4"KS<5$\F,J874??#VC/VZ.I4J'L'Q(;JN3I'PT/=@;9=I@2915
M?###N-,;5F\H[3+(ZB+0;<)4_8.X^R-#)Z^LT%(%V5Q9^^B2_,__/=NOXJS^
MY6,D!AU1I?%X4T*/I0Q<[P\@T"7=%?;C@^^6/T.LTPI?"$X*Y'@+&8P?$!%4
MNI$MAT+"1(1N</#C A7O3-<FC.H/>M'9^%*EQO:?4B)E!*L45Z1D34+FL;&*
M^<>IXT4+^/ RTCI)K\]DI3!9BE\T ZXW@7?Q63)V,)670*-U!,K)\+GDTYRB
MY"7ED\:$627%58+KF6#T>9AT$'IL:SL^M<D'D7Y&W/\5S\#9)+/6Y*]R"++?
M8!.=&W^0N-1;FHVHCOV0&]BL\KSCAW-F^FV+$]YJFEY36#MHO@2O+D.OH(M2
M6Q5>@Q:A556X16Y K66=7=O%DQ6T[OJ6WNYQ:/0I/^[T4:3U_2G*:\P'3$<A
MTE.>3U3QQ2-\K<:"D-2Y0HLHN:["V>,=+ C6B<=RBJR61LI:&%O>.)RSA#4_
M>GRJ]71)VPC#X4=DL3\[YO-8 4M!06FADZ*77J4; O!YLJJ_6)B!Y[R1I.7#
MA*P@@X$E]PTJRTY(L^^Y9IJ 0H)G_AD:'MJ$K$D\GS C&TV7BF865QZ-TZ%H
M#=*GR-LD]4V:8Q^+BDI<\>2*+!R0BL"UB_C(/%TV@'AN@)/E1$:B/--4,9LE
M;=$L+KH 30G?\(K.Q\[A(ERQ6*(7PB#U9.;DHVU-CYM;#CMPSDQ3%\_=AH@A
M[(D2GT"V,<.9,I(EC)"D*4GF(6B&TK$DM6#H&/S4(+Z+[KKD(Z%O WS1HAMO
M;G[^[0TOIE'$:0;2F.#9@\NIA0"7SZSIC*TD-/4EM@,N2LSWB[B"!E]H'9PP
MB,%D1TFZH !.F,O[G.02O[)5;6"]2U1PMBH9*"/#CBOOQ*Y*DIF3'VDTNJ"4
M?E>]WYEZ<O*GLU)6#STN _?18YL5U$A$DG6CP>JHJ4K-&!CR$C?DV<(O(VN"
ME0PN(UQY]QN*PA<WM,U4=>BXR\?,H%&B_'3BBSC)%S@*-_3M<ZCG]J^]F@6L
M6LZC\;K%(;%CN35TR%C1F=<X9!6 +)_58^11 Y[/R1T-+$[,J\,&]-;\MR7'
M&=%RS:5THD N@C+/P JXATZU4JJV"HSM"<NF1G7+ C+/J(]BIBF]K+K*85?6
MR8C:5LROXJ'1*-*4^":9J_EN8,]-1YQI<J/Q2G_D5T?LB0-7_-4LTL(;D[%
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MR[R E+.> I5S!^)YCWPKYJ=)8?'('%(*.P)? GF!@Z,]]*0F8G%328*5#.>
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M4.FL3(!&4@)Z? ;7*$GRK[5EHDHJY6EX;'>>/;.X)^-![JQ9 S_9 3M$;.:
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MR0<6H;_) _3P'>B6V3M \3JRREF&"5,!>Q6P/_LV207L5<!>!>Q5P%X%[%7
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M.O9PK?ZW>YT#6:KH2WE9#97)L^^/LGT&"\3=,6D_U!Y$,>KPC/J3&\3#\^B
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M<_^TM%KB6[K$W\?>F#"$#@IO-O>>,;.DEORV+/F7IC[H]77+-6K(TIH!_^]
MUOV+V;:AIG)E]F;,I[PI;QBES3)DRHM9:\B&KN[TF^[#U(NHM3%C)\QTO-!Y
M:T=:^3>TC<+;V\#0]9GC W+F&'[>88;7'F>P;_5U9W"J&-#!A4-YC&?R& _8
MU^UH30T/TQ7MC,-KB:M&/^==U#*8.B; ]:CK.$;SM?U"5MO6:%=]EMN([8!'
M7(8R?O?OA9\^?^#'19.[R8T 9:X +NY9@\^(H/P+PC._PWXN/DENOOH)_98C
M%Q8A=G^E?<4WM>*BB,>NV[.M<BLNRP ) @$J]*!;->;S3.XSOA#?5T7Z[ $4
M3O#-/RB ((._W9HT^-_0<LJD,7N.;0[,0>-)\RF-1G]Q.+1=B#(<])9Z[%EN
MKV\;;N-I(J#'=J"':9N.O20D@\' &/1VH =K>A=BYYF$O"7L?^^G8/(>IQ*J
M]MWD-Y+>T#,5',VYBD@"Z;RNVC4P^X[E#"U7-CP,K//B)]<TAHXAV@#N3I'#
MT[. ')]1ADZ> "/IC;QW7(DTM[03"M6T5?3Y\-O[90J90\LT!XX]L-TF4RB:
MS:,0FU'>39CX;Z%H:^CAND[?J*!'K^\.!P<A!_WB ^*P4JBICR1FJ)%U5S)K
MA9(YYJ _,(O6Z?,<WDP?=/$3Q3CCE%LQ]_VHXV34 46GT[C#=->'\(FPAJ7)
M;]X,_"9*KEPL&)4061WXR(F$W]\_S^'B&Y291]JS35K&R&@14Y*_XYU2LL9N
M)2IG"GM'@87C9T;-$J$_Y<##.],<Y']@]<$9==;0W'&O^^XQ:.YF-'>-_O8T
M_Q0%7HR7O/&C=R&)'Y\;27NK#Q.W7,<RW=6T=XUKZRBT+\K[ 9:(EY/^)4JW
MB=:F:<'BW1LZUNGEW,P7&],X"*TWS=8Q'?C'[KMK),LRKDUCF]GF'N%O"WPY
MMMJ&+?J"\N<NSAQ$>O\8OL#&1?3L:<UV")4+-5MU@%2VO''B-!H,!\/"OFDW
M"C2.?CLZ.91V0+B!:2[3COLX+Z/=4A^FMR3U_(",/X38$(4._^8A6J3TI9SS
M-^%83.2%'99@UVR"[SJP>TL=EA1>O,*+KQD,N<*+;PBC%%Y\,S#*%%[\6<BN
M\.*;16:%0Z;PXFM05J'PXL]#;H47K_#BV[@^*KSXYA*[Q2[)&9BC\.+/0W>%
M%W]::BN\^/HN$ HO_AQ45WCQY[+["B^^AG$:A1=_0"%7>/&-(?*.9Q%X5<EA
M\O;E(HH_"1*>C&^>2.P]$OH &C:5'T4S-V2,J?TCE4)N4<SH#ES3-HR-Q8S[
MS^T8M*FNC/V=%FPA7;)"$JH?=Q/Z2ZG(!,O 1&'3@Y>0\4?O&0L^J@O#UA;M
M5-'6,"VW[YC.< UM>]>.VPS2OI!8:UAT'\T+_-F&K@/3[-G]U73MN]?VH#Z$
M99\_O__GN\^&^?E_O1 I/;@WC,_LW_N[ST#JMV14^O[XQ*_0CZWH;SFVO:9L
MSS2NC1H)=GWIOY?P6SU[N([XCG7=-U].?;H\KKSU;B*6P:,=KJM>L0:&80^'
M WN[\OLMQO_BV;*ZO'7CM@W;=&"='?9=IQ;CYAIQDWR^FU3+_B:=.( MX51Q
MS:&SABK.M6,UERB[*;B@B..X:TK S<$UGB'=C232D3F>QS^#/WK8E0AM@>F"
M6JVA%>9_"^<%MYA\,PBVZ]*!U+*LGF&LT35:E' N<C7$IQ\X1G\=#?O79K]>
M)*R7^S*T+6>P9D^TY+N?AH#U]1'W]-&'CC'LK=DC+?GH7:?S7L(,^Z#UOOC@
MNN_L1V6ZOA<NS]=T?G%CEFG+<-S^QF5ZBQG7F#3[+,B.V^NY:[8RM&SM^(1Y
MP=*[C4-KX>&DWKFYO^TD]W'9>T[?&:Z;X;'Y^%*S>CA>6T/XN-5VKB&$V$<>
M+,L>KMV6]*[-7>1!7C]8B<%;7CUYDWR$VV'5$[N_XG)RML0"V#;8;/1E!^3C
M J=N%%?#G69S!&(<Q67>RG5P>P/+K2]Y]E6DK4FW#]EL _:O]L Z MFX+A;O
M_">6)I_*M]A*J6RG9QI5T]]A_ >9<.E8\A8VT7&, FK*&8:^IU!O,SWXSQI6
MZO/.TY/ \$@RBOTY ]C!"M?W,2'B./KO7GI"D[^_J^"LD&58'FRS@F+7H.>%
M*-0^5&@F)=?Y&BO)")_Z%28!R-CKU96,-0OV5=$65QO+=0VCFK:6TRS:GB=P
MLHJPMM5WJ]:Q:YQ _0A;WZC5'K:7TM\VAH4MN43_OJ+_D87?AMWAL(KXEF,>
MAOC4YZBZHP:!LGW=!=-QJAPL$%E'A(^VFG']*;27&V#;IE6MT:YU:O(<**"X
M/%?N:UM#NU>Q"3R+*!PBKKARHK;K#.VS,_7DT<65]' ,JS>HI$??:#(]]A(.
M!_ZO4N,M3$'O2HP5RPY;77[Q)_78(>V9@!JXPUZA9NR?Q(N15D7XM^UGWB2:
M[9&9 J-F6N9PB6#T;%4=*';TN&TE-+EI6^"_]0H!2$88][Q$.7.T=A6Q;%S!
MC,,2JQ!.PRLWE**>WAQ56J"A,;2,WL5/'\U_.K]:QMM27+ XD1K.=-F(5$_3
MM4W;AFGV_MG[U1P<89HO\BVK%U+7,2WKF*S9WT>L'+ #UMGL'X?(>X?(5XS4
ML6T'1FK]<XM!KC *XI9_9,<9ZY7I[%N67;&?7[U.;C6AXY#D3/E.VW"L@=M;
MWLK4C$CUS'I:L.,U*E(E!R%>02OSZ^N4]>Q;@UZA9U V_6T'__*I[ISOA#7%
M=BIY=HI!'S'3Z5@&V/673TP2W2T.X6[H!;8/<C;MU(75R.8AD+/Q;'7@S1/R
M6GSX(?\ABE__CT'_^:%T!)R?Y*9M7!%E6WQ!CVZS;W(X[N- <&_7N?*47>M/
M\\)MT)K+A^G/#M"\ZG.&T/S>\V/MR0L6'/NJ'HT*#\[< P*%U$0<]\=M.(L"
MM*.#=%%W8@++R"/%3HG"W=1G/;C*J3BNM$(M"]7+@I?W:JOINE _%3A@W^_:
M]8*OT:C:J7#?G$?-ZB0=1V_G7AXQWZRQW91Y[<YK#Z.WZO.METSK8IA/W&Z^
M?9WD+=VV]@?[/QXW#]P"_C0>Y]8Z7AN NU6?/\9D[OGCI(:2L5+/C^G9;]+S
MVC/4ZNEFWZDA.U<JNEK,3R$76'T5!&24+KQ ^QA'<YC_<PW%1*WN>VF]H_><
M@3XT]\<_5DM\2Y?X^]@;$\T+QUJ$3:.UN?>,F26UY+=ER;\T]4&OKUNN44.6
M[K+LUXNL^W=-V(::RI79FS&?IE&<7J4DGFEAE#;+D"DO9JTA&[JZTV^Z#U,O
MHM;&C)TPT_%"YZT=:>7?T#8*;V\#0]=GC@_(F6/X>8<97GN<P;[5UYW!J6)
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M\N9^"O/Y#_PX7M#;DM2+TZO%7!OA*W0-"$WB1>K#11Y]F!>.-3]K6ZZ-ID
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MV*-]\=,I>W/LAR,?](!>^N'FDV9IE_!5L!CC^( >6ABE,+,9EB2+\0JU9RR
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MR\XM/ET]+*O0RQ1ZF4(O4^AE"KVL9J+697R-XPJ10B_;@V@*O>S\VSF%7M9
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M8?W4TM@;^^$C?S%, ][R72*>,/&" -X61%\RDO$Q7FLW"?TN7,P>@/QP9^4
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M^DZIGZJLK[_Z=:RRWK6'NFE;+58]55??)1XVPM1TQKST>X8^Z"G(>E52W_S
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MXHAK(,,P '& N)H0)Y;X6CK"\XYH #H W=E!1[&-;)L"X@!Q=9FYY:7/@#G
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MQ3R=$@G( ^35N1T0.\BQN^=Q897)8:]GS?RU!R^8>*)( 6M,H+[9FBP1ZNN
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M&+_/'%8-L22D@9 &0AD"\ ?X _SM^]K$.G*I#M #Z-4^_V0A:F#DS/=> ?H
M??6AS[*1Z0+R 'D-G /A. [2':MSX)-JVDD!I&1+:+5H+&:J9#I3KX7E/#4
MT;YL$<K)@#_ '^!OS]#)T!%V7( >0*_^J-UV"*)&2U)& )]*X ._"_@#_,&Z
M"B7 \B\OCKTP;5W! FJ=8#B@U@[X _P!_O9]C0G"%NRO!.35CSQJ(FQ3@!Y
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M&6T%81,4G]N@^'S?,#JTE0\-'$Z)7>2?'!.46T.T4[E[M4AG11IS*;&]-+8
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MQHYO4*_1%<+:2$E]H4,#]LC=Q]N08]ND 3DJJ7KJ!N)M.'(-IS%BJL3;R9J
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MT']"EH#>^6)U[P"@1_&XA=44- *'1B&W<^1NV%>X#;_4\1H"2F?.N<=LAE;
MU;+<!KX!P\8CQU-V6S>R6_^*%9UY3MY$RC0]KVT<%QG0'3M@;P6*\X#XB3O.
MK)B]2BQ^GJ\%J0-GO_Z8"J='3#6MQ*IE6D9+ZZS=)ZG*B-4#IXU.T.-F-5YM
MWV[I,F[O/-I(1KSVBUO7-L=9C53?J644EQMB.CLWQ%18W1.K&_;568E<F[A&
M6R-D<V"X"KD]0&Y+1Y[5R#7-M@Z5@%Q+(;??S7Q6X];RK;8VQ<[ V+'[J,+M
MR=H K<:N8QLM,T.)._!VG#&NL-OI_'C$K4=)FSVU^_QXA=ONYL&[Q#8,PS=:
M8A6[SX-7B#U-TZ+5J 4SN0VU9$!4'*K?[8Y6X]:TS#;<6@-R0=&H/N)V?77>
M:N3:M&W0#W4&1(6D>MMC:35:L2%P2P#9&%"E:OO>G6DU=GW?:<.N-:!*(O>_
ML=-*_!+B.7X+?EV5J>T.OQOUA%J-6HNVS:&V03"K9$'/FTFM1J[MNRTQ1YL.
MJ*.0V_M&5*OQZ]8G+RWBU]YYHI7"[VG.0*Q&K=]:<6'[ U,9S-UWB%G= &LE
M9JEMMQG+[H!<4([OT @Y<N.LU4CU#-]N0ZJMN%6&KELK$6P:I$W5NO; 5*JV
M>WG<TK%K-6J):[>A=N"HB&/O3QZNQJ[9.JK8<U2-8\?HW>@0XFK\VJ;7HGD]
M;V"IV%3G9YO6'T=<C6#7:LL($6H,'&5<=8[AC8\FKD:T3ZV6*#.QZ, ]VZ3]
MN1UKW/6PB4>)91EM$OV<#YM<2C^TU;CW#:?%6K,'QMD::^<F ?8JNP12L W7
M:2GS.>NRRW.CA=W+-)$0J-66Q3KK,LWS)(1=Z\.0&"Q"VLX7GW-]V+D1P^9]
MWU:3@T.<EG,7MG/&&="S)(<=,Z9("J[75O)]UAG3<R.%?>.^2 Z^X[60PUG'
M?<^3'/:($WOX/Y;51@_G'"<^-WK8/ZZ,!&&2UL/69QU7/E^*V#,.C81AT[9\
ML(I#2TP8&[;76TT;KN&UN)_$\@:N4B/'ZLZW&BV>TU931_R!WP7'O@FS891D
M4WC:^#T0;,J&X-P&^ 7><CM^%X3I?P71%'[_>Y*,LMOT$TN?D,X_LB$+G]BH
MNI:_P\M@T6^F*9#^!Y:&R>CM]TD4Q$&>I,\-B4.#&"1/RA1B(_!,BY@VL=RK
M7_\MRG\>A4__=I__C'_FN&5MR*)H$HR0UWZY O,)/V>38%A^SO+GB/UR=9>D
M(Y:^,B;??_X6CO*'5\0P?KB:/>HN&3W//J2SFX+AU_LT >Z\'B91DKY*[^]^
MI+:M:^7_O)P_8E3>-89=7F?A_V/PCDG^,_\X#A[#Z/G5Y_"19=J?[)OV,7D,
M8EWC7^A:!J :__P8I/=A?)TGDU=X8_'Q+LGSY)%_L_%Z@L?)SW\ACL%7]E,^
MZMDB?T8JN ZB\#Y^E2*=_RS04SZ&3'(M2Z)PI-U%\+09C &O<?,&5E^R8E-B
M3WQ+M7L;_\[3)+['3TBH'*3SK\3'RM6;?E!8.2!6O,-CY:<\W50B&!9 T/1Z
M(Q&:U],!GK@^T$9!SK0,U80V0?TE-<O48+O$,OUABA?.P+(UH0F^8VSA9^T%
MKP$^)_G57V2\(,; 6(2_<,Q.*YLDL%:ZP5!I4I^!3&I7XSV227ATZ-QE4G^1
ML4(F84! V4N]L)? 608'G(TT<'/#$8M'VG/(HI'4_-!?'5T73E6V."=YU&/X
M+T%<&44="Z"/8?95&Z>,:6&<LY1EN9:"]R8U _17(=<%$$X3^:&NG<G -WXX
M)V'47UP J-T%Z-.!17Y0EE&_+*,H',LMCGJLCVOBR-:>69!FYR1]^@OZ&K"5
M%=078?.41$$>AOFSU&3?7Z6[8  9RM@YD;$S@_2A9,U/M13Z3SPW/_M4).VK
M]0TG+3QHJWH0LQ!OXM%"Q<5']AB$,3P-BTK28)A/@^AWL#UNQRNJ>_8N=+"(
M;5,/?EPL=)@<G8"[I,7/#TP;)U&4? . :J*H(\RT0,NFC[#09RT9:SE<\SIY
MA#N>YQ:Z_W-69!43@0$MF6-&"^ 1N?8&: 7QJYD$V!#N>;4KV=^E/\UC%K/2
MBLE,RJABE':9-V084"CV2XDY^2Y=J4I]"]0KM] 'W7F[S (7H4KK.+'L#<@*
M'HO[X\5ZO=Z.Y9M])#$V+S@\/(F=B_M2%70K3+^^2[Z*G)-[!R@5>F5^EZ:F
M%@A;\XQ$<PER(CO1V'3K'2C9U;<=2"R[-K!Q3N(:-H,O+;UC[NH6[G'=(^HA
M3)5P.@/AM(%/V2%C-%05]IDC-O-NNP*FB,TM^;12 K078AN3I]K_YJFF_R,Q
M*$D/0'DNC(ZJI'-@%HR^&%EH NAEZ+$-CUYUA:\7\M([=PGZ#=V_2 C=5HCV
M2@>>+W3[H!9EE P;0;<7>G(U[9Y+C>'R(>0F[ZZ#F"T=.(<XN==W,'>=U31M
MW7#L"P!T31=V >B!Y5\"F(D2&R< <TT[RBPVSM&][)4>Q>$(4C/$9F#N6H_Z
MOFX;EP#HKO7H@3HZ]![,'>O1"Q$;7>O1@XD-Y8\>^\30P#*E9@@Y_%'BZ-0Y
M1'N,O@.Z:SVJ_%$E-L[''SV8V%#^Z-&/P@TDCS?*X9":NFL:%P!GI4<OPA^]
M%+'1M2(]E-A0_NBQ&<(<&*[4#"&)0VKHGBVWY%$.:9_ W+4BO1"YT;4B/9C<
M4![I\3G"DILCY/!(B6Z5<R/.&LY*D5Z&1WHA8J-S17H@L:$\TJ/'X >&W/)=
M$H_4TRU#;@FO/-(^@;EK17HA<J-S17HHN:$\TF-CRAUX<DL>.3Q22R>NW))'
M>:1] G/7BO1"Q$;7BO108D-YI$>W> 87X2AUK4=-5S?))90Y=J](S8NHC>Y:
MD5Z(W.A:D1Y,;BB/]-BG[HP!N81JTJXUJ>6;NNG(K4KE\$FM@7L)!QR[5J67
M(CBZ5J6'$QS**STV2Y !D?L(NQQ>*:&Z9<H=WI7#*[4&CMR%,')XI9<B-[I6
MI0>3&\HK/39'6 -R"49\UYK4UWW[$HSX[A6I+7?841*?]$+$1M>*U-$I.7&]
MD?)(=V((9W 1Z;NN]2BQ=)^JLZ2GR),Z<@MX23S2"Y$;72O2@\D-Y9$>VX(W
M!O02/*6N-2GU=<^6.Q@FBTMJR6VPR.&27HK<Z%J34JJ;GJK=E< GM:P!O00;
MOG--JEL'88B^P[EK16H.++GM%3E<TDL1&YTKT@.)#>61'ILAW &5^\R '!XI
MT2U?[EB8+ ZI*7>QD20.Z86(C:[UZ*'$AO)'CXPHVQA<1.JN:SU*J:M[%S'#
ML6M-:E_&(<>N->FE"([.-2GU==-6ITDE\$EM.J".U"PAAT]J^7)'=F7Q2*G<
MYHH<'NFE"(VN]>AAA(;R1X_-#O: RBW=Y?!'9=>A<OBBTI_(D,07O1"A<7$Z
M5/FA.[&#/[B(&9E*AUZ"'VH._$OPCSK7H1<B-"Y.ARH_=!<TN0,B=SV&'&XH
M\7W=,"XAC]2U&K4&GMQU7'*XHA<B-[K6HH>3&\H;/3I'7$23G:XUZ;\%CY.?
M__*=&L3:"L*2@KMK=7IIX.Y<K5Z$$.E:K1Z8JI67>FRVL <7T0JV:^4J>Z17
M%A?5D/MLAB0NZH4(C:Z5J<J62N*?7L1@DJY5*#5,W;T(([YK-6K+/DU-%I?T
M(N1&UUK4]@XD-I0S>F1,><[ DILCY'!&B4XMN06\'.ZH.;B,#E(=Z]%+$1M=
M*])#B0WED!Z;(;R!Y/)=#H_T#-K6R^&0@B*5NR9&#H?T4N1&YXJT@[;URB/=
MK7>&,7#D#CG*X9+*/TE-%I?4E;LG@QPNZ<7(C:Y5Z:'DAO))CV[S4-E%CQQ.
M*=B6[B48\3W0I!<!YJXUZ:7(C:XU*<H-Y9.VF3QW23IB*7\JF>1:ED3A2+N+
MX%'E3_RZ5W$2L_*;XIVT^?J(C>N7AX_!/7L5QF$>!E%?5#<ELA^@[REBNS85
MB&[9P/;GG3SK"KE=VR?2STSO*UZ[GBU+9!] T%/$=FV $9T:ADZM0_1[JQAA
M/^5WR>AY_BFXBUCY:<+_X$>VB&.("R;U'P^PT18X?GY@VCB)HN1;&-]K?&U:
MF&F!EDT?@9R>M62LY7#-Z^01'O3\UTS+'H*4:<DD#Y,XTY)IGN5!/,*[ [@O
MU]ZP(7N\8ZEF$B P@WBOU@!MMDWQ]B&+HDDPPB?^<F5<\<]P_;#\7!JTG)"
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M\3Y$ZP2DTF,PY/9N$%T#B8YJK^."M5A3G(2CPKS!RS)LG\!E7+GV3VPX3<5
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M,8S#+!<5\+#"=V]NP%F&AX.O <8GL"#^S2$H;A N"%XM]A G\77*QL!.XA3
M]!'O^,>G-]H+MU"JW\(H0JL2=\8=O>!9^#"S70(7 \A0J()U?(<B!>70*'B>
M@;MA0TN+Y%J;0P>^:5KQ# 9O;NH(X"N$9:W;T=Q:K*R]&U[JEBG>@2V$<$*;
M?)B&PK(:(;BYO04/0[ "05XGX[$634' (QQG1+[" T(I.@35"#Y/09%H=''K
M#GD@@(?<74<%O_'@$T9#63I$7?$A2/,86)5S'ZP+N",7%Q4<.M(^"/]"1Y<!
M,)YBIW)P':HK0.47/%<YD-H_E%2XN)'5GAP":!5P:N\3*\%7BM>TPZVRK-.
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M6(L1BG!=H>^Y6<N/@8$'79RI*2J?>5TI2_&H!$YM^6D83#.N_F>'E5'H+*X
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M92X9@,$XNX?[J$N& 7^9L/<*;!0!IA4<Q<V=)0[2%PV,.7)GKFZ)X.=YZ*G
M:#8=XCDH[(OS7)H7<.$CB!.T42KA++$VQ:^=:V5Q_.N&NQ?2J^1J7PXZZ\L1
MB'/.P$Y8X8CJ$#1WU?\&-@+B1O^< Z-ZJ(_;TJ"]04%F>=WR1M[(IL61@1Q4
M='FZ2%CPA;HN#D N^ ,#[>81.!*3:+P@FVMJSFGBY4+2571T!JHO P6-K(\G
MS5/Q7O&J2>6P;S8@IE>R[.SE\V-\-YS'(U#U"\?!M4<\9CG;B&BQ!=O&RT!D
MS$Z1%T<PRS!:(==X"O$:78VE4UZE1U2VF;@ IM_U^"W0[^TP3U#G$:>TLS#H
M/_=#.04\)IQ"OV&T\SY\ DUP#5K\6;.O':'$N;X 63],GF!!K- 9R1#(  W6
M&)L7@*!'1BCZ*O#S/!R=8TR^+) TE^49^*Z5T&O%D^2-S#A_A%EMB;KH'I.R
MBO7*3\J*BOZ)L$A0;R7"EBP#KT7&>1J)K,="(JA( _$"9Y$$ G(,00NAUA$F
M,S)VL2">]\)UB*!P82DL]VH1, ZS\NE!<UN*"Z#?OBNMF^GWZ)FW1^+E[>*@
MZ+ETEA+FN"G"@CKGT86^46_8F#?B!#;[A =0098/M9L(. #S@4CI\#4+>)1W
M?ESC1][::?;YZJ4(6JV$I?;C%?_MZN5 JRI6I\D8'P'_/;%"@HA'!B"#\J)_
M ZPX %[618;F;N[7EDIHOLS9$7@M! T]"GEX>@#ZL_2*2Y43%L-)2YG0\#:Q
MD(P[X,N_+_@@&)9=W&1I52=<^'U.BHQR7)PO$YGR>4!V#*H=OQ>.=!FSK1@/
M(D-;W*@$25>"!! YG@K?I-I\HB28>>\QT\76Y46/A-^$'3E7QL$]4.T]5T]C
M[86KVVL3&[-R@+EYA)R:3=/G2MQHDH9/^%1^%$\L3(2K1:B:J_WBF!ZJU72:
ME>V'P/^+>982#[C"#_.L0;7'!@]9"P7;^,2@>&9145 \.RA.O',NA\5R6 VT
M-].9,S]CZN*=\T@6<,P]L)^P'75LAQ=B$4*IK.?5&_#U) F17[/RJ<+MA9MX
MV80^KP4IUE[XH& !L"";6Z2SR$)9EX'G*?D=JR]&^91D\_.#\V?S\8'_3X!G
M/,VG""\>>UOT8><=BP_1(K;2#?<&KAR&$S2ZRT8]'[ ]SH=HFMW,VIM]QNYF
M?*QF4W=96G:7-2BA7_"QGY\GL*B;-,76'F)5W\.,_R1.?LT$\Q_<"OHR8B$O
MC7K+._+-+BX:QWRN="K\/1_Q5AZ<>2I]"4&WB&>U=^NEL$YBP_]8Q%N>.<K_
M*9KU;@N9*E YHF_';T2/L ]!./J<S)HCK>O/*P$$;<,V7>HN]VIVX)]R:&LK
M%"K0NIVW*9N3\>>D!/K-K#]9>9:WN4MS[\'F@2IT+9-Z5BO8M@5'!9*O9_W5
MFNX\!_#9ED.61E37^78C(%3GM=8W=LO/@E?@+7IPGH?8LUS77VI2;M? MQ$X
M-@??!Y%*D@!\C1"S@;8LX^K7#_8_-X./V.\6\.$JA:7_69SP@#_AWR%>.2Z\
MIU&81&]G_>@D@.1:[6';EN$Y2X1(-B7";8%6[_[_<=9+Z-/T$>Q,,)@^B(X.
MV*KI'38V^K/2U^AV_.[-S8Y"L^@-4W2G6 #Z!@+/=BV?N-61W__X!(!RJPR[
MXXY:8%+<*UI ?6;Q;T4)]9O@.8-[%Q_7(7@\^-.T%L%3UP?[[ZX"JH+,@GO8
MTN_3QXEX'B[Z8]%L!:@TP/'R\-H/E>8BV/KJH^@V=&18T17#PGT*7%>%%7 3
MN_K5&%"[@-0!-K<"5+<Q_,_",\MG]0Q*EN-[M %*1A.4MM_7"@#]R7+>WP8
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MM9I%AFB!/0#F@*F'=IXPH.3=&]P>/OP'4$L#!!0    ( +R)<5 @<-3C/3(
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MY"('D8I)_CQI.70J[X]TUNK@FAJM\LS7/%]NMC'9(?01Q1!1MS_H+^+5DHA
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M-*H*GW%X_/4X#==H$["?_P]02P,$%     @ O(EQ4&?KR:6(#@  #LH  !4
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M5E-%,^@"77XGX9I.GT<!R3N'48DD*S^1-Y)FI+$O+%'?!0#5-\YX02>6R\!
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MN'BDSS)]]OT9&<;/Q4L63D+?N03J7O+7GL-9'$[#P(]SEEE9)N!GF]BKC!0
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M/Z=4[-N"HGU5.EK4.K)[3VPUN?H$$_"0(^"W 4W267@(D^V]>-+<?B8I2!:
M["/]D>]39'>:] IVN[@11:!76=1KU7JE@U\55)<F]+0E\Q?6L9"-<6,#S!+V
MD>;=*8"-X^C&$B,(B.+8UT\E,\D\D2"9Q6'&*H W335NO&@)FW5:1,(EJM$O
MDLR/'!FAG^Z=_=21I4\8%-O"5".UBEI9/7H3,.M*O]8UHS.B((ZJ-:=!86'7
MF%>P.ET-,!>8R\VL-;VAV<2*@\RQUOH+ZTQ#R#QE;>E5&9V0.;M -O*&:>J
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MCI!,=QS%H[T+&.UHO>L9=!D.FZ.\"S0UKFO1_HG,BY@K0DF\XI'&9"V?Z%W
MZ$[K7G+-160\%H_V+H"UIB;PU<;6ZDV".=X%S)NXV:>][+;'W(*LY1QYC/Q
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MV=U\5#YK%X6JG67A7;#%RMJ ]@[L?*,8&1TT]^5>HAV*EXS\65!J;]^8>O/
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M+E;]FD0@#@;A:E/X,_[_4(#4X0+"FXJ87+=L 1+OA(T1NI<:A#45*;GN('T
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M[ 'BFOR%K)[F(,X!XE;#7W)U9I@*A#M =)K%Y)<B#E)ZC91/4.E T!Y#ZNP
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M#JJ[Y9(G4H2-W;>&;G_O<%=1S4YS$,=,C/@:!^7=2,).>I1WE*IZI'URR>A
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M\MK%J7C&;FN 8DWV<>9EH4\?KHP*&+N?O#3&9_XPT1TH!*=%#W"MR4^HN.-
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M]"A4>DYL?!?N!XO>!VLA2M=E]:@@9-5C!S-$[9Q[; >@,"OS<5T\8T;GR!Y
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MKZ-"=B==<EA="H!D31['!$R\F)MO*B!J$P @:_(M*A\+)W(<K!V(;TT&=16
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MW1-[ZIOKRJ_\[759@E*LR?#NO*<O>&,@]"+9UV\: @!K<K<[W.&(%#9J^88
MP)H,[([@BT-X'^6+%T($C%5+\ \1 D!K\J@[DI'T$8L/[W.V0)D+0+<FPU(6
M6L77Z/$"-5B3,]6B[QRJ4W*R,FJ :D_&0W(8C"3XY*4Q%DJ3(&LW!B#VY#\=
MV90^E(@$0-F3$Y%'$A<RMTK;N"?VU$B_"Y>K/%D4&5&X3]YM#$"LR3;N203]
M+"4O[BJMH^FQ B58D['<0]P&(4E3B9LNRZM4UAHF!9#69#7]DBHX$ADQ +4F
MNQDZ)ZZ$54X/<*W):)KS9'<$T@T2X+$R.< N!4"R)CNA MZF9!T6:SF2LB$
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M&')]!/5SD@1/833\_O?>W$%5UN1(,C#C;FZ,Y@JJL2;7H@^#G-)W* ;!<NU
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MN.__/U8VH&^)F=%,IN+E5,PPURG9.<"OU /C.)53'@->[+,M Z^6ZHR!_T8
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M2NLX^9>QCA,%ZSBQQCI.%*SC9'+K"*,C#??1,8Y.!HF/HV18CPSOO$YE)!U
M/7821L[1QQ^ML96.T#WFP@D]G<D4RZ.W_R(>I0-%:"K%TCEZ:XF==.056DDC
M[Z0F\NY?QT3>J9C(.WM,Y)V*B;R;W$3&1YUZ*YLM0T]F&=(P XJV)5EM2]MG
M%E,GJT7J_4*\*%]=Q?Z :>S.R9'28:3TK2SG#S_@3S_\<0K#V 4AMHZ6R!:8
MR*[<8CMIRUUI>D*K>8ZVYUX<>P]A]CE-BLVP];#3_16!0RD.]L":Q%3Z)1>;
MC%AR"VRG'XC8AE[P$Z@9$7LEO:H1<1TNR&Q1'3Z15E)@Q$UQD C(^4@U@6D-
MXA$:5PFB+N^!-+A+4E%-9ER#4(3F)83RARWQTNP@?FKP4YQY69CARXG46J@5
M#A9NI>WI-BQ'<> BK4ICY"Q,HF2)3S;2JRMU4;BF<,6 UYVO -2:_KM##T.S
MDL<-3W;W2%SP^>7'CS)6X9'+!A2EYFO_<54^IO;:RAA%8TSMP[W\=TOB(BOK
M.L^3,WHRX"J^+QXR\L^"5$_*B\<=DE9UJO'0VEEY] %?ZZ@9E)6XIQN$:@!'
M7>=\H!JHJH_C#^71")$&)BO&H*@!H='J )SN$[=.T4J3C]W/V#[Q/8'S; -0
M.)5NB:[9N0I\ *E]D$+\$6X*&LT$]PK*HQ3T(;'.R8G)/T<_QH'O5!_#+L_*
MT >=.D=C)DL05?&)/()%WU#-7HLLC$F6<2]K7R1K+Q0?8.3<Q$-)Z'C<F]P!
M)9W (GM1"&VP$IU_3OSOC&#";'@70W;Z'$K]M1 -$EKQ&1@$U:^0P;0$VMOU
M$<JRCJ,_!@P1:[Y&"XOZ5RDKDEK]><:[K<PFO]7%,^8CV>+*KD,?$V.\7:6X
M[EY_GHB1TMN%TWT7'L#@AR@;THMDTYRF%(DLG+((-#R9H= 5V]2#N7].?,DF
M3=G6*1M/L\+>)[#PU;E=@2=?HNF37_A0RPLI7-E2<N]AOB*IMR%%'OK9=1[\
MEJ110 \-?7JFBYGH"'7W^DK6#L_; >:OZ:UFVD5Y,(GK9#KST]9"GVV*, _!
MM<)XM='W6;80_1]^*/_IAS\.:N(//W#_.N%6Y;FW"7,OJJKMZ"^7^PT#>N-[
M"I,601#;;",K+8$TO3V*1!<;7%MT6PQ&=3$P6>Q8R@19V8[P,BN9M(;!CK0R
MPYCVS8MS+UO1Z41*@EG,32STUXOI$\-A3!\9+I\<Y69;4]A-'S2Q 8'T7MD<
MG\KE9)\FM>^77VQ2O/ST]AV_1'>;AMDZ])W;E0=ID$^#GQ<=+I]1,SYH4*3;
MTSBX?&2"#82R&V]-#T-@G6LOGJ0&6J^\0H-BC6E]D<O'4O'3!Z\^"$*;*B%@
M0GSY:PGAY;4N?OJ9[0R+YXRB=Y];+\=-9_*#8$9MM_H]:-F!Z(KWA*.\"WF^
M2I-BN;JE[]3/4OH8&O\4X PD3^= Q?U65H$FP662?LWPT67P;?GV"\E7/?OP
MX_26,]F<#17.P=>TZ>MKK6<'G00EA+9>W/K9JX2D23:NN"P=0N6$'!P%G<!E
M'5[Y0N?W\KJ=S*,>7L/#[^E*-3R1T<%L_":),2^!6?,WP%1FO5<Y66>#1]=*
M>MP>!@X.36U*'D[)Q*%<G(K-1!F:!L[^44*?/XB3^!5-H)]*G.7$RWGP(BS,
M-N$,H0)):T:4V.;-%;T+\*<J>V2=VQ=^@YU>^ZL!3W_[3QGQT#>]*NLYU0;+
M,7"0P]2;:BHHU3;7_K6^[, &G,:WG7HO[GP5DL6G9^(76")TMEB$/DDAZZ]_
M.D\ 30B?+1ZQ?(C,'5*Q@H].V=-Y0O.KG[SRRRZF^-*Z^,4?'('6-$[)A\[I
MFE_/$Z?B-7%M%7W4XM1"C-KKH'Y5\;++RH>>$= S:$O,=NAY@)YO==CW $8:
MXM # #TXIK6L^A&#?2VK>8EB6LOJ ]1O6<UC$S995A^.?LO:P3&M9<TV)/6P
M!O%Y$F=%!/8RM(O'(-0T3D-TT(\AMZ=^&/T6]>(PU";Q@VCZ[4J$9CK3BKP0
M'X^\#DF,+TLFL4)%QW#G9(2/;*CWBH 177"GG"9P6D) (MOJDWDB)R646VA%
M+RBWN@VQP^]G6[!INGJ1I #F5R\-DR*[+=)-DN8DN/#6WK+GB)^"?94'XQ^V
M +KJA2KBD?6#1=-81S!9I#U-9']:RNBW37V\DSE#;=3]EFT'ZA&6GY(@9*!/
MHX@LP</?)/'&VR*;V6*_]T%W#*+LC"K&*[NC2X)EA[3>Z&2OB8Y2C# !H+C+
MNS]G6Z?B11^XK;@Y#3M:)GWBUTA'@5<:#WT?7?#-IQP3679:5GK':DJL</ >
M5=Y.ZVKWM#@3XS>)30\ ZS'>/O$=1C:AB0Y@Z;%%BH45W)O6NL[,6)=?UA"L
MW@^@GR>;TKIZ@?5;UYFMUM6+I=^ZS@YH70K*9U+^0J*@>I=\:(+=+D"Y JKF
M3?*#3DXUQDDOHB%[$B*:[,Z]!(C<F#I IOXBQ4."C\]"7O=K@HL 4O]5HVDH
MG4=*6@'\PP]MQ%/4'E-!-V1T'*7#2"M7-ODZCP*R:5R:AMDIVAH7*^5FQU:N
MIS(U3?MJBVZ'3>D:4M^7F-:V2'E4*8:)24BRZS F]!B+S,!8]E6>Y$+BK0.=
M$"<$XHF,JA=*KV416BZ+HW'^CE3LJ-'$T;^#9H[O!FA_%(24(Z4=GX2!&/H<
M'=G_3BDFV.NHA*^*@_2>=^($KRN 3'W.1RB\Y*1Q$"X6),55"'\7T8364V$8
M.)@D_ 23'\?I :!PX/OE/X4BH@2"([TLG.5IN)FOPO@RC-9SXJ]B6M.-9.=)
MNAE,AI&%T_!PD(F#7!R>C8-\IC Z+81B/Z:!<.J-=3VXXN2F W>ZE$P+B^A=
M9-N-,XDBXK,C7>MU2$^1SY/FM:(D*/H.5]>4[.EN5D0R3_A'BBCU=*Y%"=NX
MNS*JX"=TK+5<&;L$<!6#_17]]>/$]W8;+C]6]R3"AM$4!CL 2^@[&P*'43@<
MR62>90B&T"<.?X@IO\/P[([7_Z'G0:H2]T][6M).-4W@O!7=,2Q7 ]AKQ_1N
MD,H[VN<MQ\0>IV!K S_6+R>SZS[6O(X\ OE(]SU6-=,M>>NK9MB-?$=&00_$
MA?$2JU*5E7;%OJ9Y3+8LJINQ&%8QF*@>6 \"<;2J9<6V5?WGB:J"]0@N-JR6
MDJ<;)D*)A9EY6^+:9*8T=)0&FEV'WD,808B_3%(4$Z(\O11T&@<7Y)%$R0:9
MT;H@0_/BFA^,XY(A.TS.L:2W,8*&Z6356?8 WS.0*O U0WH^B&=)+^!P3&EU
M'0MV O;01<_8'&L(DPX&/.97>%%Y.ZZ=,GO1%VBQBFCB[$7]TYK=BFU^P[J^
M4\C-<S"[AE_6C#U-LDO^TXP*;2WT#8<*<W7;L#,S@E]*9@[';<HQH(U<9>(D
M_K13VCFH(P]AIG%!'@@62B$#/OTL2=/D"6/6TRKT5V"_,;X:0)[9;5E6U<!S
ML@WQPT4(_QW7%<6]F)5$R(A?I.@!O)RFQ^6[AE6E#TP)4[SRC_^U2J)@DNW<
M?JWT6'?5'%Q8V=X&-]X'HL=+[X*PP2YODEQ^/-_GI(^1P*S1G##18[+$.9RJ
MVIGD,HNAXDYIXDQ,F4T<3$Q-6V;2]F34AY=VE/6.N'!Y6'L>8R&*#I"VM<GY
M\<)/9N023>/E$? L7+((*?:-ARYX5EWHP^<(!LO-5%P</N?$*09CA*="&E8'
M?D)M&"_$?_K0%KL7@'6"LCP$@4D&XOZE"):LFM @VI*'TS!Q:BX4=<W'AM?B
MSHL4-[^I+=YZ6Y5S+[OKAM0ZG0TCG\ A"# (+XJQ=J4G*,6=: 5)(+*PKCPK
M3^1X&::E%\1G#OG-$7U?_F0R+R807Q3Y#JYI)1O'DC&SQ:?G39AN9PNZ0#RC
MR;TX>Z,59MA:*1#0A\YI-1HV(9@@X W(+S)S*O\,JSU0^>%OK)I.23.5S0R@
M$%E^*3U236<XY"%G43B#5G?85N5&(I*5B1+2.32R36 V NF%]B(2=T*=^T?'
MX-L^?+^/SG<AB)7N.T?'Z,0_3)Z3=N45#4=.WDE-XQU(\%'--%B!UI9YL&MK
MY<K.$BUE0A/AH?2:R#M4^4<K3(27M]=$F+Q3FLCQT7?O/5H0^DSC^,@:[]&2
MM\\T2GDG-8TWZJ9AN?=H0>DUD3?VF,@;%1-Y,[V)G'S_WN-$Q31.[#&-$Q73
M.)G<-*B >]A'YZKM].5:A9AZ#(:M.QR?_&B-V>R*WF,[;=$GT#(>>,95W#E9
MXT)HNKTH[YSX>&6EW,;%.N8D.P<?$M(RY>!-\(_?<#OS)KD@0)"28.X]GT*[
M_"J[(WZRC,.,B,OS-[TZ=;<.UR\N"U0;WA'MVO%9W[C,CYW_2(^%T/Z=F\2I
M)'! !(?*X%QE3B/%A"/ST/H5#8EY<X 2AG;0:#NOM1UPVFZ>>NK1-MU<87O7
M<0+\2F7GH&R/*CO,G+06":_H8X*2@6I(5<VFJ8*Y20[X*)#:\#ST-QEX]JE'
MP]8-_(MD3;(\]&EU^ZE\0"4$?0E@V$3_51R"4;V;\0U!]178.P7_XR@.\JU$
M/N,&-);4149[5/[*^7IOG?L T"1<QI-ZCU*&_T;.PZ36S?B.1?D-_L=U'.Y+
M"3V'7-^O\'ZK%[S\FVXRW= WDKCWD0[L)FAW#M??OXHW&*E',P,_Z6KUO]?X
M'JE[T5!F]LD]AV;=@+U-,4G)M[<@=XXOCORS".EUA$..7+"'3=GOCP[MF;W,
M4O7]KS**]U6NF>%\6ZMZ0U5-7_NI)/GO-;3W_2"B,3ZH7NO&.ST>@_=9\?07
MO<=TX!#-C@B%98_LDM._RO@>K4PS SL3J/:_UW@>_0%$ UEDJ=:-WZ]Q2M@#
M],U+Q/%92(O:X %C1(IGBJMR;=L##^]&GM8KQK'S4,O$#"^CCK$N,_BOX@(.
M]3W,>(ABY-?Y[^5%#O4-14YF['B9P!&UD=4WHV^2O,3X>Z_?V+&7YAITG.25
MZ?P^Z;A6@B?>M.;@_8'B^Z/S4R_$@YB]_"* (D#QUC8'L(*%)=,.^.TT[ALJ
M(A-=&[ M5V\#&36R+!U/FL-(A,62@:,Y7E[JJVA95N^\M^>BRDXV]B.WBG!;
M#YV&C35V-X!49(1E :,'@IL=^)I/XM?'JC TEV4LX/<GK]Y3W?W<7IZGX4-!
M:S3CO35I;K9(DS6W!D:]T8]M=V2)^0\H=-K5D#TBQ@ F*Z+&*,O/KIM(W5OG
M&O^!)O>[1IS]Q(7Z*<X,2N ,QI#:464.1S=U">\A3 .5L-D_?7^?:: VMO1#
M';#0MQZ>[NZ/8H#,G!?9ZQEG=CN8!D)AO?_'(;$D%.WB>/D]MSVBSJ[XHF!C
MPY9A+3<W1 ?..LB'"#_4J\.4C)-3LG(N#W>84G?0***65$+E:CH/'N:8?G I
MXIWX9.RXD:>([;M*^\(XQ$KH9T46QB3+SI/U SY(A#54EBFA*[!#]7= /EJ>
MK&H[21*ACJ$GG2@9.!4'AV/AU#PLN$^B ;5G<:&"^E!!]3FH]6>TP"+Q 0#O
M(6$%=V#X+,(<-]7">*EBF+N%(X,&N\^SID-Q0_G335 \86N%.:LK0&+5+48.
MX^24K*RT;G7D$B-7_] 6&/Q]CN6GEJ%_&L&L+/;):1S ;\1;*]H\![SFY53,
M*/J:7?/9I[1P+<02(Q<@/A4CMLC0M10@L77U3S[!%T_#1P^EY#*H>Y+G$:15
MJS0IEJOJW$5Y#*-OIESQ:>TD98R3DS-6S:F+ZEC+E+-G?>2C'D4(QJIFNC=N
M+O#YWI#6*: 5EX@/6'Y- !+=@*L>2?N,_]^SA86'&$A)Z3S6I%4Y7':F:9.&
M +C(RM<CO,@O4&VT!;]MSFCJ^_%+UN]KYY.@@Q"F9,Z:>!E6!BPIRX_RL"T/
M.WAESV'6R @"+*(""R.# $'!8I #,X,P.<S<33(NM;Z V /7+,IJ7@QHP\6I
MV#@EGZFFJ%I8>XI]=0UANA"BA48T(Q5]JCLL0VV'0V!5UZ[#!5%U!&7)DPA(
M6H4NJH$\[?#JQZ,PK!BQ@]0V#J=^;(/#:(V%56T91/T81(/G%/A[2]+X._II
M_K E7IK]T8X!=$=\:-_4=X5Y5 Q_]0FK#AO <"$!R ^X/#P4)JL3$G F"<,K
MI>P=KZD?NVEUX'BL!V>31*&_G7CT:2M#85 RGGP%W397IV3K<'RM,'5M98BO
M)#^QBMM>&F0_0O)#XJ#\\/2H(;@0,)V\+)=<&0,D1Y@JG2?KC1=/<0ZQI0:L
M)<F>XKK?0/SKF7-TS)X2E:EEAF2V#/<N&I5GA:7@+)D>W(79MTN8OEZA79$L
MOX/\634O"-< !&QO&Y(H<,KRRM'6\1Z],**'; #][R1-7L& P'?3EOCH:TR7
M"FB1K*S*\.F 2?'I$4CQ8<B5S'QFU.29I'Z851,.>NJYDX.4<P%  +.1'YVG
M,,=I0DIPNQH="(!;E\^<P$PAYV<W])^Z<Y0'@E1T_C)U?J/RA52<*K!QD(]3
M,7*0DXU9CPIBD>>D$!<(,:P@I@>J'ZP?&A0PB?*AGL]FA_/X-<$H=Q<N5[TG
M,%IN\)&V=U)*,/&P:LFN,'Y8>X<16&%2+03B-<Q^[4]G0"$DN)#\X%6-V6(!
M#CT=\0Y)4'&A25%2\IG I/K1"&VJ%AN7T"N"B9^F'\ @M"JAZB<;$?W""\_M
M5"I'V6O:Z0?#'5D7<?D&BN([')BOU NLS7A(.4[3O<DQ"&QX9/ 4SNWAWH[0
MLBX1C*'!\7_$'V)"0\O\*,GHNSW=.W,:2Q5\25-NC^2L>RMN"H-3 RBVO8H6
M ST'ICPS:L,R@R(\X8UI?T6"(J)^8N?^XJ0?JCSK]06D7](UDL&GE=J?J3K3
MUA!/^714"Q5]<S*[BJO\?E;D-'7!K><X^(U@ D:"<J7S4SFYO<6YK6PH<BK
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M;H2?KR" :EC<^]=OW]A@<;T@U T.6)3.C3)Q*!<;[:T7J]#<#O6%],WM,ES
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MME>0,1J/X,!V(;(Q(EHCK#DBVB.B07 )9$V2NDTB&B6\57]=8:06['H$6Z6
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MRM-$,H]DR?WF\5\TKA[RJS(N\I=S&$.7^O69#7](*=J$E2CEK9*H;38$=AE
M6_..R$;(0TY$,T1I)QQ6&K!:\]5LT4#8+#94Y^4U9/4L2C;Y#S%XA[UR!Q65
M$$@7&H'ECF_"(KBL2"I/"\Y+(FO"FC4,7B*0K+C8M\_?N(&"XA];=O*50YD(
MEZ$+ULBFV#91G:6?V*<BWZQOLABCZ'_Y99HK A<RPLY):1P*R.9)TW[CVL>_
M "]=0B*MJW9<>+WH:2<W:"<TTE_2QZH-8SYJ[:!H8<Y:4T*;AS$$[Z(T'P0-
MPO)[7F"&YLK;(T ;3\\B7ST4-"I93_H=YHU;?BY*;],HWI^NK'&1A6C[-X@8
M(CY#'K?D)=I"\;7X&%G77PN$S8-*<1K800MU<X2W1V2#I&DQJ'%\$+ZY!_0B
MQ:AD:#BPX6K8L7]0?>,F<^T,NHZ09*%2'<'HPNV;[#A4'C=T(^!<QF[,:B'U
M4P0>=H;K&]X(3O)_77T368;LSG5;4"*D(I6U QM1NLB<;G<'@'J_Q34!=>QV
M09IPMJG**LKF2;;L'1Q=Y)FX<-8\DNT#S=N6D..CN&G-]Q1AA=AJNE!:0@X'
MV];"X+ 5;BM*VUK:LZ'O<\V=R(XAH60@_9$+/3""[HR>93[1)8X[R[C\5BP"
MH?E.4HG1E< [SRR+BB@4<VP>&:N31\U%+!K38=<\32.3&&E-BR2?7V7F[)=:
M7.8S#5'\A&UX>7=_C-*IDGP+&/=55%3C@)A95P-YI,LDRR;&XC)*M0 ,ZUQE
MK&K*A[ E4:1_;]7I)Y5^Q'#5RO_!@C[>N%+[NEBZA32N/,&X*>P <-HE[.#Q
MMXBL@5Q]HT6<E/:F:"H$8XL6@O6" S$)K5OQO@+9Q85-"76IDXDLXI"16B\X
M-A5,+?BX7K!V&8YD\8!ZP-IF,$)9OYYL'!K'^;76>4TESN'UOQ??A=!#;)^,
M-$Y<-Z5 :9=I?>?A8+AN2GMBYGKM^3W?%#P")U^H!\-\4P:4ED036L-^S=P7
MV7RPW7U?& Z1W'U-&R1^O4T[ ,PG?$TO#L'CM".W>9?;T;1W12M'CK8K!*5*
M,(178;B/GLIIZ83'/_;G)A@JT]BI C@ALS6=^O#$[3P+@V-:3W3A7*1Y"7 ^
M3@=G3$]7P9C/53":>>LXL[@Z>_>ZW]/W(6#]G94A9^_">$_?EQ?KR8J\_JBQ
M6"0Q!-S[1#-:1"E;U-.LU&0MW0U8F?/J_!W:4C0 .S#>@@>.Z+"@9!&2P\O!
M3SW)_2Q&M=*CU-G1NV<&?:9129N7N4Y!3ST^*3;(;N ,+T^:"IYCGAHP&)B3
M<@S^GTBS=4L1P8-6#N!FM8[B:K:X%5/1'U&Z&7P\DM<M2$P);T,X?/(BY!F:
M\4"N86@HR1H\GTUXO$ULPZ@PVGVF9?GWHV!Q./>RP((M68^'Q:DGL;U]<9ZF
M^0NLF <32,-) !<8$.10ET1-90^=I2<]VC-Z4OI5=?,2I X4DAB#?3\\)77@
M>,(W!"5WLA"8%LVKDK1MS),1#+CT1FF?Q2BU_"_"!_"@\R/'HYC!+\OD8I M
M"\_GD *PK H>2,:X3A<8Z@4Y+!*C3N5ZI>N)88.8]#RKE^JP;.]6)E=^5^]6
MP+2$\TLR2-^857FQ'3M^)74#WE)CH#CT/&H%#F*,Z@NN'Y@:P?TS1O@&&BC3
M2BR*^DN<@LNLIT=;U/?F#A7<3 ^I[% (4GZ)5G2VN.(O\\Z_)58KTXS5@84I
M?\\'2XDD(R]/2?P$X8[64;8E3^"FFD"&8EKR,TNYB%4TX)UGN]!M*%>>$*@'
MUUVB)OD3ZOJ+O6]"=9FOHB3[_ZE))?B11A6U)S&K&5%[(\$C<G'Y'O);]I$G
M.$1JXAG>%OE\$^/O$-4W%G'3"L^V(-M1 R.N14O^&.P*>51BD-Q")QFBEN.3
M^I:)S&:3"#H;[(ZH+DB+*$A6;4FO@3Y0N9T3 :U14-X<9U!0V!0?G#&V4(8-
MAJ:]J#:A_5I4YU."MRNC70P8FVYW1?6O]>[AI>LIN=3^@57N</:JPX'I7QRX
MBN-P6>^P!NC*_3"X+-<)C_5:9H26/D+Y^6.:++F5_1&^)SEVSJW0OD<?/YLA
MG>R8)\;1M6XWTN, L"<NDW/>:="AK%569DDA_/*RX/WD,BEC&,RO\T*^QL[$
MNU6;>6#=M @&NNW\*ZJ_0.;R$_RHJ7ZXG<D7K1YF"S<UH%-)BQ1"RS=(ZU9X
M9*XZ[$4FWRQ[XZL;7G3-8F-9.AE*:W->TIB5H3?9=904_.IOMFAW;_C:N&-*
MV0 8#9IH[];:W6L0W7< J,7&I]MUYQ(WZY8+#6Y_*VM[W,/<M0 :AH';_OD
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M$=;*_^-A^#:",E*2=4A>AUPH,'B]$/I="^=!.Z=:VH<W$(AM'O03K,XN0OP
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M0AE&[4$3^%.[S<CK-V-73U+3T.E[\)<B8C%]ZZ Y>1M?P#MCI4RSA8PBJTM
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MP:*G$RU8Q@'C;1+_5P$GQ6_RQ9M-*2\A@^@[<@/?;NC;T>$ZR:*,;0-3Q6?
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M>KW80X5'TT[0LOP[X07([?1O\"QCE*'B8TO<.RH?#O(\)!Q%_I@F2]])1U
MV*'*T0$X;3QV(&!G+4>FD)WDC5YAGSY_AHC>D'/D<QZ)-!;*ZP%]_!!>34R9
MW+?L*4_GU.,YHR,H[319-.WPXR/9$C]M2J$M 5E]!>)U%![,FP:8E&12OB2M
MZ)*'!9XMFF LTGE>?W]7U^&OWYKP,](_RN_M&P)'B2WCC$G-$A4*L&Z'L834
MZQ=^P8AXB#?#S];,2\PVK*+5:SWOOF,7:<0#R2TN<I[#%$)EV7!35 ,KQDW%
M<)A9@VKZVTW&M,Q3$UMA:CM;TE8,%Y+A2O\:0W)"8FC.]_U^#6FXRUF8S+:[
M!6!")?"]>3!1.MF&S<>LARFQ_\,9.F8R08](I&)CK'Y*GR#,HDVU9(/('" P
M"'S</#*/G TD\4:DSAH?' 3#H'??E=SS*)=#A ^V\Z/),KOZ)F+-:AVT97$X
M_H#RA,H*OIVT#3"PW='5U&);*#Y?K6@!4]]MQ+IF>5.6&VV^Z+HH6XM"69+P
MPGZ/#7#Y\:A6>5&]899<^71.9@*O\TQLJF'LK+;Z4:8I"@,-Y87]CC"*['SY
M 3\HZ!/-RN09TJ#D*\I6)-4_V"+B([VC?/V4+!(Z?\C54+)?:#5;/$3?S/-Z
M![U8IL3J]^J7>FSM4A&^;GFDX*W2?!3"V'?C#I^0C/*C+P@.,.W*P(7!TR@5
MO5_B ?>XQE;1%A16;AY+1BWV_72[HSVA84^Y[A$]:(G2)X7/.0 1&ST*!P?H
M1PI3&#,()9ML3@L8F"894&UOQ!#A\9<>JLZ]Q[G&Q-:]QXYW1!=)RI^HU]>C
M &'#*-:LITT>Z+*LNG8.X>V*#@-Z,EQC8*O0^0NL1"?//>O0@3$4NG[0M80O
M]O!SBUB$E&+3PI)]QW3BH5:0\?EYE5"(9("#QRV)/4801T\%S<I'#P/];L&8
M4+!NV$2IW#O"VCJI]*%OE1K--C)NZWCMPB8LFN%H2KE=F&^07._RR\^]VFNV
M3,8M)>4ZBKUM+==;GN^AO&7;6SA3EK'3;[+YAG5OV+/)\Z [7NR>%L],9BA6
MNV6(7QB[4OV1$P:??T8)O)XT7VJ.GDA=NA1?$Z4;-Q#QVU!&P0,K4!<</4VI
MZ,5U<W[OT_.2[63N(UV6!?B]N!A[IIFO0%6JD/AX(H0L(]]I#51)\25,$.K<
M0)2"]=#-:*>8Y[,0513C"-65V>\D7]!Y4MTEY5>3Q+P0&PK+KX$,A'VIT1[7
M2NU)M^+VR92V4]Y/39A*T7*;WQ'5\$IW<H$=U6H^,932BJ*D+NMS'8K*CK(W
M-$V/>$+8@>#GW> 8N[@_%KP%C[9D[GE>M\> 3?L20Y.4000DI.N<U9L$F,O+
M<@'MKQ+;3@?G]86XTR%!UY5R. @K5:X.0<"![Z3(E_2Q4KR93!>U4O-S5J/C
MFA7"?:T)3,"WMK78SFDA6V,$G/?1#AYFGLM@TCA*#/QA@*U1Q N(B:W@MB;9
MD=^P6@R!,SOR8G/!Y]Y+$[^]V)H=$_/"::\V1(GNAFUBT<>HVFKKII0/:/^&
MH3!MX@+4_OCMG'I#==P]G?/!L2-J7\L-YR'6%A V] :U?N)!7"&./GUD_X*$
M>6+E!Z%O1(E;"!N89[/%ESR+S96,K.58Y9ZVKB;7OR+,D2RW%M\#+F=Y]B8>
MKNY_.#JL%O%T$RE_BQCQ[><EC?FQ*_GA](2<O3O])81.<5@E8#TG@(C#-1)Q
M5B/3))H7+>O>N8Y_NO:E#_U$K2^OW],SUTFPSE=^N:$/^:]1 ?%$K [2FASU
M\PT%W\\G4??D. <XPWW!"AB^1?4)S)I]5O@TV>;KI\C"9U<\?MJ2S9I-;!*M
M_R +5OBP8[CCXW/@).0QA^=T#W3%EA)1L;U,%DQ6"B_<K_/B'T])_/0EOZ1"
M?G#/!J WRD).TQGKADE5MTSF;=/<9?4%&F=+%3;PU.J)O@DJL[6*LECW. <<
M1$-XKS9KR..._2"8L9X>/BL<1KL#Z @;+0+6D?M4WL6NF[?[$+Q-T'UQ\7X;
MGKARJ6=X8])(7;\Y8L+S&%DE;!Z_ \(PZF\GR0;FT*<TB(QV\(#(>AS5X-&[
MP=ZT8";,<.]$KJ'3YDZ'"./(62.]+8T\7P0ATF_Y@&2O_BWYC@]-P?3G'A!G
M2TR"IYG/+'P@]%C0HQ=:=:?FHQC&R:E##PA?E9C '-''P\$+1X\0"\LVC'!R
MIYSQHYO$]<%NO4*^4X;IB;J4]1)1R?*3S=5$/W+*U QZ;35^=-5)U^-YYAQ$
MA(]^GA!9DVX0EGY5,_<&SG:3/P@.'Q116/\Y?##*?;J5Y>&IFOPJF!-3 XJA
M3G0D%",89G4HVN%6SM^WSN5K5S8'[4 3*<KJDT7_YK(>O,/J_+8CM'\%_T:K
MIWRN#68UK/@5;^#$'-+*\_;!'BYF,%&'>WF(<=E7J%,5R'B+O193N1EILEZU
MSY3)'YWFBTU)+:=,_[S:$7EX?N1/<]_DBS>L4E@SY X8;(8\GVJQY:!_9V_J
M2P]>U#9 RKA(UL+;Y#R.X<4GV\G?YFD2;Z_SHK]B8=,D0Q7!4D.#LFE/.-G5
M+9(U;Y+?8>RN8?ZLZ+>*/*9Y_-7O>\U]]#'P*.;<ZWK:#.N2\N@7)9R@P]-[
M6C)$]:;HCCX)EM:#O#AI'^2"T@H;<CJ-B DL>TZ*/(,)@JG'NXOUL([DY9HH
M@<7I'>X=2A-AHKR*"F! >4L+'F5S"%)=_K]X."HV_8NPHD%W8A-&K!/#F>[G
M&M[]5/#VM]TX2EH,V)IPV:]ET![2BR&1'+^8:RH%:G81LU7X ,9;[G24UIO:
M QA?1JJ-9?LB@83XP"OB@)624"9(_'55HM0-DQ W3<)Z]NO#+=N2IEE>YC@K
M-^L]Q#XJ0:,+=="F>;9\D[+%^]SSN:@]S%YJE2$*=/'V,ZR$#_=+GBWV00QO
M*%X):A%8E[N6F $VU^E>G>E'X<$#?G$\#U/A.81I!C)='&8@MDN%\5JF9B>E
M:=9J247E\-RV%O2.6Z1+%2G*:KS*SV0-.F=%?X? _"+@NCC8/A")FH^I]%%_
M'-5"\ H;GK= QG(7=PBOB6.'4;<^\VW &P3Q4DP&Y1PB3R>W1IAX?J-1N2G8
M3Y1$.YH)<,)KT8-Q$X6C(YK\?9B&T5X N8Q8LP5IFR:B;<(:;T)\$MX\8>V3
MY@-$^4+ 2QTK!>&O#.L+P-OF O#*;^!N"ZR6!\5MR3"1M)DKXFC\X>]%IXU@
MD;8GW'<BK.KX)89RV*V$:7T]BP94&UCOE+\C=Z&?[O/)_3$J(9,G#[C-S[(B
M[EWD=$BD':3;+]0ICHGZC5<R3EOK";]KM^@;_);DC5!4G=BZ4A7U:GJ)M:[P
M&!^M&B C!<W*4(?'A_R20C"2)*-JXB/(J0R1&]@?,"$_1ZDVZ\!@!WK(2?,-
MHF218H5YZF98\O"_*%\*M1>YJ6MT/YK+C\"/XT[>K1@4Q0.FP%]H^[%7TK7<
M%(C&L61E NA(X%H9L[WU'SE<FL";!=[K9_S7Y2<V6E2:M^1U3?+<5#V1:2MS
M49LL1?50>H$=5HSMYUFVB5)P5530AL-..V 8"QLCME7)'2L0PB6Z$/]SLJ"V
ME!1%2,JJ!$Y%,S8\J:>TU"JJ-D50]#.#,=(.3!4"U>#8L3?&\[!H*7UF*![R
MWR&+7EFQ&8O]6MEBWE=11?6IC)15Q#U4CHIY2<2)'_FXJ<B7O"+_I!4Y7Z_3
MQ)\?M*()R(9P75 *^5O8YRI(,FO;_: N6;#*< G":_,,M(%W15O$Z-X21QQ.
MU[0%AW52#@XJD[HVN?.64+B#ZO>2LA_"@#-X/65S0++AS<EIP^K^+AP#NZ@"
MG5;**EF!*WZKA6<9S61'$T%9WO7%AM[B(;_?<(1N;V%/MDS2#9.D]O$$O\W:
MSQ,WFRA/J*Q O@-/UN^G=66U?7IKP**/I#SW@<B>< 9,NH *$H ,#]'@(&\:
MK-\E&9GG:1H5BA/R)*$6+!G(.L#58L%6H&S'GF=,.SRPDW)=,,N^;" T*5L9
M%FS%%Q5B0Z4Y.9)-$LK;Y,<;;:L=KUPV^F2\89Y[7#8M].$Y2N!^:D%/B,)5
MBSM-U#73ON3HKH9#Q%XP2?.";7]6FXP6PR^'ZPI_(X529<I'Q [$-H#!:7MT
M,#8F*6,VS&X8!Y6CR/_>S)=B\PF+ #G-#]\4-6WU#F[_U30GED!U@P$=R8Y4
M Y[7+ZG$*[=6 RUD4 #HPZ?CD +V8U0FY6S!PP,7_6ON]@S"S?2/T"@/G=,V
MVW4O+IN6P^3 "+7@8<E;193PX,WC)9>*+B^*_ 7688YV;>H%\P!@$!7ZLHL'
M2K_U&2B](SCX6-*RO,A7CXQC?/8V)A_I6F5.JRA)>1PUMKE>R9>6C_F&V4>V
M#'=D==/DSTBV'5!W,VD M2 <50M.RJIAFM&Q?R'F"K.K#4#5><NP#Y&'Z"N%
M2)VJ@TC01!QR9E"2FH 1;XND7"4QN64+[544TPU?#(1)S\_L)S=L+M/M,/8:
M9E)P9TB@=4^YHX?0/\#P/P7R"AH. #3W/:2EW&1:>H)WL<>BB79W*5W$PURV
M#0)&,RC%3W2^207<)[BB+IFENW #M:5+_]5;,JB.BN*T[:D&MH;2)2'@1E7O
M*2]ROCWLILQR[*!M@\+MJ6FRDP@MS.[JI@QTLZV#'_M[+H$C'&_6T&WG8*,0
M+(*PS&&WI>M?DVZJ#@#1E7ZO:109-6X$-DX@&)QF=XW!PIK;,936<[N.DJ',
M[ 6=)Q6XMCAV-5Z/%. 3$V;_0H$-KJ1;6/YMHT10=QT)U:C^1Q@!1QS&:,$-
MF6@WE]"4D>)'&FXGXJ)+E*N>)9%0C&%&MAJE@;"SW7<QB0.5F_8\Y1R.4_IA
M%@]T"+X;=S*@Q9JM+ERY[J*.$,<T=ZT,!.+TZFDX MJASF9WS1W4FM!6'8<X
MK$68'\CB4:N%YD[S0&.A<H/[&@;!D1?5EAIX1>->.'?;(U<Q+KC0)\/*PC7S
MG^C<"MS>%\+N-T]!KF#'J0=]+NGKKO60?7G$';/*_F3.5O[)(HF4ER01Z 6V
M<G &KAZ/L-^SG8*O]U\6VN@_+CE8!]E];O.J>H=)+T,;^U#>UUC '!\[RI8'
MQD<XKXL3H^-(J>0X^J,D-Z*X1J+O\J!Y_-*^%@EPE><:B?YS0$'V+6%@DQAX
MP\:<;_7[G>FS![B1#SMB.\S&2W/B&- >;/\#UE=TJGJPW "<SOP]\V^LKG@M
M$*8M#W2>I#%R4&=*&/P#G!_I^!W(&1*6D\IA\$+34X4Y0HV\(]<@#).Z(V[(
M-?A"X><G"D_>4LBW.X?07< K_A)2O']SFVN6HC&1A;?37/V>+L2%GX,*L!GH
MDQ9T,!.K \*A<XYA$_OGM'52ABY[DR9%0YC+(]?<#)/EFG"UQIR_L16AM:E,
MB!(EQ1]1N@%RYOF\G!7WM'A.8@C"%%-('H"$K;GDD;G9QB:QB+O?,ZV0@:Q:
M(?C@S,0@SR 'YS9(0B @J)0%HN9R830QC<B<2P2;I22H"/Q'53_^K+HS!S9J
MYE[@?2V*; ;5$R4?TRC^^H:--PQN*<N1=9'$4&"5SVD /O_]\Y__H=MVE\&T
M4^991AT?=.PN:[_2+5DUS0+#1+LA3J#N&ADZ#M.BC_W'I>T W^>8_)6<A;N>
M>=^$=\[=AW"@73=BP*"V+7W8!]AM8YP-9">C9.1P[8=-Q5![((HLS+0D/;DG
MRZNT8\*_4 *E"72(D84WJ"K)/V4^LU6J:_]->9TPS;>+![U*@E(!9-U6!4\8
MD>:,2NYO)]*Z:L#/)[3PAE:F[7&>8BXBDB:P69+U*+;5F;/]Y!P""_FWXV\R
M?/1Y%J5;'CYGMN8QKK(E9YW,$^'8Y>J@U"22S8IMG6Q8],@ZE4:0+GUCU#)$
M#2>E!-,3QFABZ) P7RR2F$K$<4@/36W1NNP0'#M#4%L$6WW8;AU<!X9 ]@Y?
M\BR:_VM3@I!7SWQAM6"CRAU=YT75''HYW-M!!N.F14*?Q1(4VB1%W6AS;!C0
M;9Z=(MPF"R==A+A8<%<*.E5L'DNVX8#S+*&#UV)ME['0R=9!C81VNK =!]TX
M'\HHR /3GF?S?]!D^<0VE>>LNT1+>O6-%G'")H,";@BZT7$=AP(1^A8N#U_D
M-T@D/D*H_ H_[U?#Q=37!6&.#7OJ;/CRI*P8X&-DTS@,6>[H*N(IP""N ,QJ
MFXA'L6<KBTU5IU29AD%%_6D>ED!^FT?]YZN0]O.OF5A[Z7>8;8?1+W=?%CV
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MW/K&?932$F(I'#B29Q=Y"5\1P5'"C/<XHD,>0G/#W1@TUU-<,'WY$!H8'@%
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M+/Q%V-_JG8B(/Y.%2"?AK$B>>Z*.[JF5!,[EA=ZOIX;5AR:VH"D+!AR:SF#
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M-87!H]_<=3113W>_7!EE1&UQ-)%OYCY<],-WPM1961XQNAC/:'!/_?F8N+-
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M!EEA@41?%0=+NT:%@Y-=H\+"P-+M,^4O1(5U"YL!+&SL#R$69O:'$ U+"VO
MTL?"BMAQA34)JP4T/.T1(QJF]H@1!5?'*^6L>*S\N,):A;XJ"G9VC@H%'SM'
MA8.!<I*6]>=RHTQIW'M<87G":@$''_O%B(.=_6+$Q]6-.=IQA;4*JP5\7.T>
M(SZN=H\1!U?S<SK9L1V_\,VHL(!A,X"#J7TBQ,'3/A$B8FDF>]WYI3RLL'!A
MJ8^(H[W@0\307O AY*=<$RMM;SVNL"IA-X&0I3V@1,C5'E B9.S&E0?'%18C
M["80,K8'E @9VP-*1(Q5_@D_BSMECBLL5QAK(^)IY]@0L;-S;(@XF5]@F,[V
M<GP5EBFL%A!QLS>,B#C:&T8D7 TS<;<P%CFIL#ZAK8F$FYUB0L+%3C'!<6]!
MW(AXM_2=>B3PAOQ)N"J2Q)F2C=/>)Z;%B>HVX/BX6YQP'-TMSL_"VQ,D./^'
M$M\KW@UR8EJ+L=?#DH==X<&2;UWAP9)7:WZM4LJTK%*I.E+V=80.*1<[0@?-
MS&\L_!W-;I:N3P04T[+)9EEHSC7U&YI-3?U&Q).;<+[P2<)]TS*&I1(BYK1$
M@HA++9% L^N13DI7M)V8UANTQ:$9U<Y[:!:U\QZ:.3](]$)\7[[I+M4 ,>40
M7];Y:'++*/'N_?"WTA%,BP'5;4!S;%<XH=EH\G',Z%P -(GG%2IC;<'VR ZW
MS:![EPHI9Y+)*QJ 9F7_"*'9:6'7J4E?WE839:NUQ'2([03=?XP)FQ<'2Z=V
MZ72M.#3+VGD/S:=VWD,SYZ_0=R+JTVA9PF"7/[65H%G4'1)H1G6'Y'#8!;V2
MHW,JUU9/[=*LK2[&K.D"%\8<Z@(7=$8I>?\^9#=.$#AOE#_YTCLY$EXFXV Q
M,%%_)E#:5=_JEJ Y"H$9FK\0F!%S6XZR"XCMTG-5.XAYW0M>Q)SN!2\*/A<2
M30"S:]X;%5 PM!4"%)QKA0 /BU*1PBZ^KQ7'PZ FWN-A3Q/O 9E#V?+6B4H+
M:*=&?7RS,"!K6GH.R)B6GL.RI2Q+K69*1E'>6 >6.]WA@&52=SB@>'7ON&H.
M_4S$;)IXLH\,/!K%C BNG^F5=EL=*%YUC0.*5UWC@.;5S\ C[):\$S]<S$F0
M7S]WIM??MU2#9E>W:* YUBT:.*91]I?CQV3H_2/FD?2(CX*'0%X3&[+E2^B+
MWO5,+V97J0O'N7YQP;&O7UR'RD.HM97<M]%$O40LOT-Z97ZS)'CN-/ 9/"\:
M^ S.^<R38>!E(]NA^\^8,CFT/=-+WY4JHV%0Y\C0\*QS9 C8N)JOG^E5:EU9
M!%QKY#<")C7R>U]Y O8E)F]B '$TN,P'ZGJ1?+T<&*\;^@O&YX;^@O&8RID8
MOR=$N*K7O M%P%A0RTNPMJ_E)7R+YT-$O7:]41"^]>MZ#,<$QJ-GLHC??.K>
M. L:.?Y-R!8A<R(:YO?9G.DUWFJUX5JC?VR'W&Y@>1^R.6$W=Z/,CW.#$KQ6
M#HQG#?T%XT[BQXR2R=T'<>.(OHL!WX2ZA.4(#*+HUIK ;= +ID-L)^#<EIZ-
M%D1V-\%T'9-!-=Q:$P'W.L>$@'N=8P+CWLOM-0VY2XDHRW,8!ME15QB,8:T]
M!^-1:\_!V!*S0"TKW],/M;H\#+R[?\:TM IX;A .*]0%XU+/N,"8UC,N,!Z^
M/XDIXMQY"-P<A4&]VR@)QK$6/H/QIX7/4-SXYM#@,>1\%-S,G&!*'H*"@GM+
M&'UWY-#OD3IO:C.#@*07^6H;@F(6'&(H7JH]<W)?YO"#<@%'+]>52X&U3@-?
MP>-Z&\X%%X2W>JENO1QX;&OZ"Q=?D5TRPYY8.*'1-9F$XONJV?HAD.A5JNH6
MX-ID=Q@_0SN"?4=C1^U,)MYW&M!Y/'^D8O3G*3%T;>_)A5[;JVX!C*L[Q C%
MU3\=]DYX1+SL&%XV/KO0ZV2F\E!MU)7_^QY_J'[@3S)?B$[*B]UHY;I>YM(4
M!6--*Z_!N-+*:SB&,"IO=;^.J>_18/HLZ)NNFMV$\SF-BHK!A5[FJF,#CE.[
MQ0G'PMWB!.,MG<[&U",%S>)"KX5ME@3C8 N?P?C4PF<P;HC_>9F%BU4WK->]
MULN!\:*AOV"<:.@O%!\>Y@O'C4:3)S&4%SV7&MH+I_4ZFK8P%#/:>P[%D?:>
M8V++*'@D#B>C-Y].U7=03BKU8F#%ZI@8U3TZ3*SK'ATD,RF3@R\E] LWPP5A
MT5+=Q%-<X1/__BR^Q@+)3TZ&G)-(0-:KJVUL0G(84QP@V8XI#CCRXIFXX32@
MG'@/P29JO:);W0(.SO>+$0>?^\4(S]5L4'RI%Z<W"L(SKZ['\#RJZS$8*P*7
MR5'&+4G^65J\'T4SPN1I\GQ5Z5*O/M>S L8G *Q@3 3 ^IDX#'66<]W+\8R%
M\72FSE!S*F<)H\D/$JE/#<]6(2_UBP%-;&')W5WCQI+'N\:-):>MOJ:RS:5^
M4:&!J;U@>>>H]X+CG:-&QO#L67KQS5E(?_.<UJ]]U+."C->]8D7&YEZQ?B8.
M(QMYK;S,[OG(T>K7INK:09NS/>%%F[<]X467N_*R60U:PP):+2OHN-PC5G0\
M[A$K<@YG8T;#VEL=(\@9W"%2Y/SM$"DR]CYP'A-O%&@G+0*Q8?FLB3%D;-XA
M<F3LWB'R?6+[ZBME6'5K87.?N-]G'/8I$_J, [*\>";OA'%2</GU^,JPF%C9
M C+.]X(1&9][P8B>JUE.755;:]MF!SUO.\:+GL,=X_UL?$:F82JOU$<R?0KF
M)N11#KG68J+-%+(LWA%J9+F\(]3(,GI'J+'E=12ZOY+%$W[C"#.^+Z_9OZJU
M=JHW@BV7^T.*+7_[0XHM9_M#BBQ/4SE2JI'908^K6DNEFP:0Y6</")'E90\(
MD>7CAH/Y][/60JC)#';&=HL6.WN[1?NYF SZ=9';DQW_.F0L_"UO4! CU'%X
M2[D;QD&D#A1F%_%1A=BR_%O/%&C^@J$&S6,PU'#Y[!'Y2*UP]I8RXD9A?A/V
ME6DAV%0#CJ_=88!C7W<8#H%+8#T^Y[&<U*PNG+LRK!2O%P1C?V./P;C>V&,H
M9O^G$Y2>&;O2+Y:N%8-B1#-OH=C0S%MH)J0CU:RW.M*O/^I+0_.BC>_0+&GC
M.QAGXF P*'#WY$B_YK5>#HPG#?T%XT9#?R'Y<%SR5[]<LEX.D@]-_(7D0Q-_
MH?CP7V3YW0F<J9HR/A'&PR @_HW#AKX?_I8#( %!K]%7J K%FGY107&K7U10
M#%1RQ)BP^2A(GL-Z63@*B5YO-Q2'8EHWWD,QJAOOX9@S=?R[(%(JEGHSX^1(
M+_ENEH3C2W.?X5A2\"1]/>/D2"\_ZLJBB'4#O\'B3;E\'/#N8T$"+K-1+V"M
M%0.+<B-O]RNV8#U<R+E\D"E[C(EON<;F2*]EU30#QB00M&!,!$'[N9@,I>0G
M#ZB]D"CRU8A[-+FG@1AE4\=?/9QV<J17&RM5ALS1?I%!YF._R*!R;S7S&P;>
M31CPV)<?-_%O$7-63X><#/2"9L7J4(S<#3HH5NX&'3PS[XG<:C/0BZ=KQ>"9
M5L=;>.;4\1:.">RXI)L.]+KI>CDX+C3S%XX-S?R%Y,-ER5^]L+E>#I(/3?R%
MY$,3?P'YX,Z.STL>ZT7*S9* G&CL,R O&OL,RXTRF_6:ZF9)6&XT\QF6&\U\
M!N7&5<EEO0"\41"4&8T\!N5%(X\!6?&+1$^,%O;WG0ST4K"N+" W6OD-R)!6
M?J/@27;-F/!<+T[J2Z/@2D/?4?"EH>\(.*/8FQY7_::>"/<$"+V"N*4: A9U
MB 8!KSI$ \>TY?%I\;-[;!(!R^7@N-3,7SBV-/,7G ]K&Y6/3<J?MC@X.UIY
M#\Z55MX#,J<TK3LVB8-+''/G)MX",J.!MV!,(([/Y?N,XLO&(H<&<F5 .&U0
M![6EP7C1@>]@+.G =S#.T(#.X_EJX\4S<0E]=]Y\(A 8U$-+'3#^=(P#C$L=
MXX#BU0\2O1!?_,U4#;V?"!,C[OE]R&[9\MX/?Q,VG C^_^DPZ;2\N$O TPN2
M#4Q!L1 6-11G85%C9/B8T;D&LUY9K6T(([O[18R1V?TB!F-U&-PX"QHY_D/@
MAG,R=C[D_CC"U8,-9!2,?X?C61AS)_#&,\JBY9U\55D URO"3>V!<1P)?C#&
M(\&_/_S_00,Y--/+VPW-[0_[^T"_/]SO ST\\Z67-PYCRTG(?CO,XP*B7ERW
MU8'G<#<XX-G8#0Y$O+I/?<IDM1.]-K^])B*.=88)$=\ZPX2#>V0%1*_L&XKC
M8%E3[W'PJ:GW@,QY)I,X\*2*]A+/;V,R#+PG9RG_^^<B#.XIX]&/,*(3ZCK)
M.T;WMT,!3[]$T-0>(/=0X =D;\G?U-._:32CP9@$US$7@S7.;YTEEP?&UIQ/
M0J%? .C -!96X(H*'%<BPE-_\UY.+]5KBL*U91NO]S/6<%^3=WF!V$7NL4']
M+A>#8T83;^$8T<1;4"84MQ2<& 3CM7*@7&C@+R@;&O@+R8?3$GU-.FJY'"0?
MFO@+R8<F_D+RX:S$7Y.X6"X'R8<F_D+RH8F_@'PX+G_>3,I?N1P@'QKY"\B'
M1OY"\J%TPO/4I,F]HSA'V]1?2#XT\1>,#['\^=%DZ'GJ65/'3XY=)0]MC\/D
M6IM;PNB[F">_D\)U.*<&(:ZQ13".(8H!&&\1Q0 \%Z:,D&0/[JE!C=PH"<[=
M!CY#<^V:A;\(RP[MI2>J[D,F+Z-15Q;-YY1S]8#>R:E!]:MO"KJE8%!_SK:&
M[DE@4$/=?)BYFO3SZJUT)D]6GAKT57UQZ/QLYSUTGK7S'CI?$G?^)+[TW*##
M;A;%P9BZ7N-@2EVO\3#D)7[[!W&C<7C'A9G?0]DQ3K,AD$&TK6,$#ZOZ1HJ'
MB7TCQ<'>9 8TY/<T\ CCX@LNT!EDY6T5<;"T2T0XV-@E(DRL$R-&];7G--DC
M<R/2(F;+_,;B= _5-Q;&BX? %: -^G8'MC%Q%U-<,&4 IK@@RZ-;\A:M;OT6
MR W*?Z7:R'*A4VS(^-PI-E2<%$7&\EE[D40_Y=?G26FKY,EWW!3KF6$UHI$U
M5)S=,794G-XQ=DR<?P@T8.T+$ENJ8V)U]^@P\;9[=(?-3!RZ;N:>^J^[#U>]
MQ2.@V5>=;'5Q95QWN'#E6G>X<&39*(YXY 0>#:9KBL]-&"1+SES M*^JU#"%
M@Z6[1HV#P[M&C8/A+Z'4YL^JK."HHC@86M=K' RKZS42AL1O@KKT3:[TG559
MPRE40,*6%@B0,*<%@OUG$8XQ:1L$IWN/X P80;8I9;7KX,R^5K=1 ;HO:H\
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MQ ^5HKO^MM[I0+\"4:TV'&_ZQP;'LOZQP7'RG3!.QLXO$HI_&S,GX(Y:YQ*
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M5DM,5K!RN ^L6#G<!U9H#JN;0Y2+\IV,LX%]Y:1<&IJ3;7R'YECN3?I"QMG
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M6#O0E@;C6@>^@_&I ]^A./-_">$S)WAQ"/$R=?)8O[BA*0K%EG9>0_&DG=<
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MA;W]%@Y^[%_<]H=O3RQ<$!8MGWPGB$0W*5\Y6ZB7S,Z.-U9Y.O^-_>$7;)R
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M_6CG/I#C:/.-JY)70R?+I&5[=1SMVA<ZX+:+Q->!>'<."\0058ZI;!.O]=+
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M2XV)(#DU.5-WNW:F!B\CO, !5=4$09P77O]/<8BU(EG$H_1*H_GAJS5JKSS
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MD]666 =F=C^JFA0(D[8TR3>[GR:?2B(HF/G\E%=$6P+F6UY.DS^^!,VWF[C
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MRHU'1"Y,9+!H]BV>O<9YZD?SV2M.LO<[FF2&=[8;#@=TL>K/_H@CKM.$V6A
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M]!MV(K@U@'XTA0+%Y!ON '1'GPH:! OZZ\<IJ-!+\:AG+&9[Q%K'JG $_6@
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M7[<! &AU9V4M,C Q.3$R,S$N>'-D4$L! A0#%     @ O(EQ4&?KR:6(#@
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I9V4M,C Q.3$R,S%?<')E+GAM;%!+!08     !@ & (H!  "_  0    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6603576672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">Financial Instruments and Risk Management</a></td>
<td class="text"><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>23.<span style="width:5.25pt;display:inline-block"> </span><strong>Financial Instruments and Risk Management</strong></span></span></span></span></p><div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>Credit risk</i></span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from deposits with banks and outstanding receivables. The Company trades only with recognized, creditworthy third parties. The Company does not currently have any material outstanding trade receivables with customers.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p></div><div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not hold any collateral as security but mitigates this risk by dealing only with what management believes to be financially sound counterparties and, accordingly, does not anticipate significant loss for non-performance.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>Liquidity risk</i></span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liquidity risk is the risk the Company will not be able to meet its financial obligations as they come due. The Company's exposure to liquidity risk is dependent on the Company's ability to raise additional financing to meet its commitments and sustain operations. The Company mitigates liquidity risk by management of working capital, cash flows, the issuance of share capital and if desired, the issuance of debt. The Company's trade and other payables, derivative liability and notes payables are all due within twelve months from the date of these financial statements.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If unanticipated events occur that impact the Company's ability to complete development of its production facilities and carrying the planned clinical trials, the Company may need to take additional measures to increase its liquidity and capital resources, including issuing debt or additional equity financing or strategically altering the business forecast and plan. In this case, there is no guarantee that the Company will obtain satisfactory financing terms or adequate financing. Failure to obtain adequate financing on satisfactory terms could have a material adverse effect on the Company's results of operations or financial condition.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>Market risk</i></span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Market risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises three types of risk: foreign currency risk, interest rate risk and other price risk.</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block"> </span>Foreign currency risk</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency risk arises on financial instruments that are denominated in a currency other than the functional currency in which they are measured. The Company's primary exposure with respect to foreign currencies is from US dollar denominated notes payable. A 1% change in the foreign exchange rates would not result in any significant impact to the financial statements.</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block"> </span>Interest rate risk</span></span></p><div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt">&#160;</p></div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest rate risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to interest rate risk as at December 31, 2019 as there are no material long-term borrowings outstanding.</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block"> </span>Other price risk</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other price risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices (other than those arising from interest rate risk or currency risk), whether those changes are caused by factors specific to the individual financial instrument or its issuer, or factors affecting all similar financial instruments traded in the market. The Company is not exposed to other price risk as at December 31, 2019.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:48px;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><i>Fair values</i></span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The carrying values of cash, trade and other receivables, trade and other payables and notes payable approximate fair values due to the short-term nature of these items or they are being carried at fair value or, for notes payable, interest payables are close to the current market rates. The risk of material change in fair value is not considered to be significant. The Company does not use derivative financial instruments to manage this risk.</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments recorded at fair value on the consolidated statement of financial position are classified using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company's valuation techniques. A level is assigned to each fair value measurement based on the lowest-level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p></div><div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:51px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2022;<span style="width:14.25pt;display:inline-block"> </span>Level 1 &#x2013; Unadjusted quoted prices as at the measurement date for identical assets or liabilities in active markets.</span></span></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2022;<span style="width:14.25pt;display:inline-block"> </span>Level 2 &#x2013; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can<br/>be corroborated by observable market data.</span></span></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:51px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2022;<span style="width:14.25pt;display:inline-block"> </span>Level 3 &#x2013; Significant unobservable inputs that are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:51px;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The fair value hierarchy requires the use of observable market inputs whenever such inputs exist. A financial instrument is classified to the lowest level of the hierarchy for which a significant input has been considered in measuring fair value.</span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Private company investments measured at fair value are classified as Level 3 financial instruments. The valuation method and significant assumptions used to determine the fair value of private company investments have been disclosed in the Other Investments note. During the year, there were no transfers of amounts between levels.</span></span></span></span></p></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Section Scope<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6604899616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income taxes</a></td>
<td class="text"><div><p style="text-align:justify;margin-top:0pt;margin-left:5.25pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19.<span style="width:5.25pt;display:inline-block">&#160;</span><strong>Income taxes</strong></span></span></p><p style="text-align:justify;margin-left:2.25pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The reconciliation of income tax expense for the years ended December 31, 2019 and 2018 consists of the following:</span></span></p><div><div style="margin-left:39pt">&#160;</div><table cellpadding="0" cellspacing="0" style="width:90%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2018</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);border-top:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before income taxes</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(52,013,186</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,710,624</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Statutory federal and provincial tax rate</p></td><td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>26.50%</strong></span></span></td><td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.50%</span></span></td><td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Income tax recovery at the statutory tax rate</p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(13,783,494</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6,018,315</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Permanent&#160;</span></span><span style="font-size:10pt">differences</span></p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>7,797,290</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">2,706,000</p></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:0pt;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other adjustment</span></span></p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,334,913</span></span></strong></p></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:0t;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Change in tax benefits not recognized</p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(348,709</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">)</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">3,312,315</p></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#x2014;</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>&#x2014;</strong></p></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td></tr></tbody></table></div><div><p>&#160;</p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Deferred taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their tax values. Deferred tax liabilities at December 31, 2019 and 2018 are comprised of the following:</span></span></span></p><table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:90%;word-spacing:0px;margin:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><strong>2019</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)">2018</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Deferred tax liabilities</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(204, 238, 255);border-top:1pt solid black">Other investments</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black"><strong>(168,092</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black"><strong>)</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black">(1,334,000</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black">)</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Capital losses carried forward</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><strong>168,092</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">1,334,000</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:677px;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Deferred tax liabilities not recognized</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><strong>&#x2014;</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(204, 238, 255);border-bottom:2pt solid black;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Deferred taxes are provided as a result of temporary differences that arise due to the differences between the income tax values and the carrying amount of assets and liabilities. Deferred tax assets have not been recognized in respect of the following temporary differences:</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><table style="border:0px;width:100%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"><strong>2019</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)"><strong>2018</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;width:959px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;border-bottom:1pt solid black;text-align:right;background-color:rgb(255, 255, 255)"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;border-bottom:1pt solid black;text-align:right;background-color:rgb(255, 255, 255)"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)">Property, plant and equipment</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"><strong>1,054,843</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)">Other investments</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"><strong>1,287,743</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)">Share issuance costs</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"><strong>1,169,642</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)">3,772,000</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)">Non-capital losses carried forward - Canada</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"><strong>27,518,609</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)">29,272,000</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)">Net operating losses carried forward - US</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"><strong>274,454</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(255, 255, 255)">Capital losses carried forward</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(255, 255, 255)"><strong>350,465</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(255, 255, 255)">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:959px;background-color:rgb(204, 238, 255)">Unrealized fair value on biological assets and inventory</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;text-align:right;background-color:rgb(204, 238, 255)"><strong>1,098,497</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;text-align:right;background-color:rgb(204, 238, 255)">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:959px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:132px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;text-align:right;background-color:rgb(255, 255, 255)"><strong>32,754,253</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:127px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;text-align:right;background-color:rgb(255, 255, 255)">33,044,000</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p></div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The Company&#x2019;s Canadian non-capital income tax losses expire as follows:</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><div><table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:90%;word-spacing:0px;margin:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">2038</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border:1pt none;background-color:rgb(204, 238, 255)">12,492,296</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)">2039</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border:1pt none;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">15,026,313</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:17%;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">27,518,609</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796899520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReservesWithinEquityAbstract', window );"><strong>Disclosure of reserves within equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Share capital</a></td>
<td class="text"><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>15.<span style="width:5.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Share capital</strong></span></span></span></span></p><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>[a]</strong><span style="width:7pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Authorized</strong></span></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company is authorized to issue an unlimited number of Class A multiple voting shares ("Class A shares") and an unlimited number of Class B subordinate voting shares ("Class B shares"), all without par value. All shares are ranked equally with regards to the Company's residual assets.</span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>The holders of Class A shares are entitled to 276,660 votes per class A share held.</span></span></span></span></span></span>&#160;</span></span>Class A shares are held by certain original founders of the Company.<br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong style="color:#000000;font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;letter-spacing:normal;orphans:2;text-align:justify;text-indent:-24px;text-transform:none;white-space:normal;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;text-decoration-style:initial;text-decoration-color:initial">[b]</strong><span style="color:#000000;font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;letter-spacing:normal;orphans:2;text-align:justify;text-transform:none;white-space:normal;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;text-decoration-style:initial;text-decoration-color:initial;width:6.51pt;text-indent:0pt;display:inline-block"> </span><strong style="color:#000000;font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;letter-spacing:normal;orphans:2;text-align:justify;text-indent:-24px;text-transform:none;white-space:normal;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;text-decoration-style:initial;text-decoration-color:initial">Issued and outstanding</strong></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation of the Company's share capital is as follows:</span></span><br/>&#160;</p><div><div><div><table cellpadding="0" cellspacing="0" style="width:100%;font-size:10pt;border-collapse:collapse;border-color:#000000"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="4" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Class A shares</strong></span></span></span></span></span></span></span></span></td><td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="4" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Class B shares</strong></span></span></span></span></span></span></span></span></td><td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td colspan="4" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Warrants</strong></span></span></span></span></span></span></span></span></td><td colspan="1" style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>#</strong></span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>$</strong></span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>#</strong></span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>$</strong></span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>#</strong></span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>$</strong></span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Balance, December 31, 2017</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>72</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>201,500</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>3,794,846</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>12,794,963</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>354,996</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>2,116,900</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Share issued</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>2,268,035</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>47,853,745</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Share issuance costs</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(6,634,405</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Reverse acquisition</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>545,505</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>9,868,179</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>37,313</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>118,875</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Warrant valuations</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(2,366,670</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>198,835</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>2,366,670</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Share-based payments</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>294,287</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Share options exercised</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>190,463</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>5,145,825</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Share options cancelled</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Warrants exercised</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>44,931</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,254,665</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(44,932</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(454,587</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Balance, December 31, 2018</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>72</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>201,500</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>6,843,780</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>67,916,302</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>546,212</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>4,442,145</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Balance, December 31, 2018</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>72</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>201,500</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>6,843,780</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>67,916,302</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>546,212</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>4,442,145</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><i>Shares issued [a] [b] [c] [d] [e] </i></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>408,651</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>11,539,417</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Issued on acquisition of net assets of Prismic</p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pharmaceuticals, Inc. <i>[f]</i></span></span></p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>510,940</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>16,431,818</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>67,598</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,888,086</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Share options exercised</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>130,189</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,782,438</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Warrants exercised</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>12,167</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>145,174</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(12,167</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(50,183</span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Warrants expired</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></p></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(134,192</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(535,014</span></span></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>Balance, December 31, 2019</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>72</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>201,500</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>7,905,727</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>97,815,149</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>467,451</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>5,745,034</strong></span></span></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div></div></div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>[a]<span style="width:7.75pt;display:inline-block"> </span></span></span></span></span></span></span>On April 24, 2019, the Company entered into a share exchange agreement with Aura. Pursuant to the share exchange agreement, FSD acquired<span><span><span><span><span><span> 13,562,386 common shares at $0.2212 per share </span></span></span></span></span></span>in the capital of Aura in exchange for the issuance of<span><span><span><span><span><span> 65,577 Class B shares of the Company at $45.75 for a total value of $3,000,000.</span></span></span></span></span></span></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 20, 2019, the Company issued an additional<span><span><span><span><span><span> 61,892 </span></span></span></span></span></span>Class B shares as part of the adjustment of purchase price related to the share exchange agreement with Aura to settle the related derivative liability. As part of the settlement, the Company recognized a loss on change in the fair value of derivative liability of $1,422,036.</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>[b]<span style="width:7.75pt;display:inline-block"> </span></span></span></span></span></span></span>On May 7, 2019, the Company entered into an agreement with Solarvest. Per the agreement the Company issued 49,751 Class B Shares to Solarvest in exchange for the investment in Solarvest. Refer to note 9 for details regarding the investment in Solarvest.</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>[c]<span style="width:7.75pt;display:inline-block"> </span></span></span></span></span></span></span>On October 4, 2019, the Company issued 3,735 Class B shares in settlement for trade payables of $25,000.</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>[d]<span style="width:6.75pt;display:inline-block"> </span></span></span></span></span></span></span>On October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares. All share and per share amounts for all periods presented in these financial statements have been adjusted retrospectively to reflect the reverse share split.</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>[e]<span style="width:7.75pt;display:inline-block"> </span>On November 4, 2019, the Company completed a private placement </span></span></span></span></span></span>through<span><span><span><span><span><span> the issuance of 228,670 Class B shares at a price of $20.10 per share for total gross proceeds of $4,593,777.</span></span></span></span></span></span></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash transactions costs related to the private placement were $32,705. A portion of the shares issued under the private placement were to related parties of the Company, including Directors and Officers of the Company (refer to Note 21).</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>[f]<span style="width:8.5pt;display:inline-block"> </span></span></span></span></span></span></span>The Company acquired all outstanding common and preferred shares of Prismic through the issuance of an aggregate of 510,940 Class B Shares. The Class B Shares issued to the Prismic shareholders were deposited into escrow upon closing of the transaction, and are subject to an 18-month staggered escrow release.</span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">The changes in the number of warrants outstanding during the years ended December 31, 2019 and 2018 were as follows:<br/>&#160;</p><div><div><div><table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)">Number of warrants</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:16px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)">Weighted average exercise price</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">#</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:16px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">$</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">Outstanding as at December 31, 2017</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)">354,996</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)">5.80</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">Granted</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)">236,148</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)">16.57</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">Exercised</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)">(44,932</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)">17.79</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">Outstanding as at December 31, 2018</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)">546,212</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)">9.47</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">Granted</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)">67,598</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)">10.45</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">Exercised</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255)">(12,167</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255)">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255)">7.81</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">Expired</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(204, 238, 255)">(134,192</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(204, 238, 255)">)</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(204, 238, 255)">7.64</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">Outstanding as at December 31, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:289px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">467,451</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:16px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;width:13px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:276px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">10.20</td></tr></tbody></table></div></div></div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><strong>Measurement of fair values</strong><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">The fair value of warrants outstanding during the years ended December 31, 2019 and 2018 were estimated at the date of grant using the Black-Scholes option pricing model with the following inputs:<br/>&#160;</p><div><div><div><table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">2018</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(204, 238, 255)">Grant date share price</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(204, 238, 255)">$32.16</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(204, 238, 255)">$4.42 - $18.09</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)">Exercise price</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255)">$2.61 - $26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255)">$4.42 - $26.13</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(204, 238, 255)">Expected dividend yield</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(204, 238, 255)">&#x2014;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(204, 238, 255)">&#x2014;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)">Risk free interest rate</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255)">1.41% - 1.52%</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255)">1.70% - 2.17%</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(204, 238, 255)">Expected life</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(204, 238, 255)">1.39 - 6.55</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(204, 238, 255)">2 years</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:777px;background-color:rgb(255, 255, 255)">Expected volatility</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:211px;text-align:right;background-color:rgb(255, 255, 255)">100%</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:195px;text-align:right;background-color:rgb(255, 255, 255)">100%</td></tr></tbody></table><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:center;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p></div></div></div><div><div><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">The following table is a summary of the Company's warrants outstanding as at December 31, 2019:<br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:center;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><strong>Warrants Outstanding</strong></p>&#160;<table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">Exercise price</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">Number outstanding</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:693px">Expiry Date</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">#</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">November 30, 2020</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">2.61</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">16,787</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">September 15, 2022</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">4.42</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">199,005</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">August 1, 2021</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">5.43</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">4,476</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">September 11, 2023</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">5.43</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">22,382</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">January 5, 2020</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">6.03</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">37,313</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">July 24, 2023</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">13.07</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">3,357</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">May 20, 2023</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">16.08</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">7,311</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">May 24, 2022</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">18.09</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">163,535</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">May 4, 2025</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">3,730</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">May 10, 2025</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">1,865</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">May 17, 2025</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">3,730</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">May 31, 2025</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">1,865</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">January 16, 2026</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255)">26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255)">1,722</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(255, 255, 255);width:693px">January 20, 2026</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(255, 255, 255)">26.73</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(255, 255, 255)">373</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;background-color:rgb(204, 238, 255);width:693px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:9px">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:230px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">10.20</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:18px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:10px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:223px;text-align:right;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">467,451</td></tr></tbody></table><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><br/>The following table is a summary of the Company's warrants outstanding as at December 31, 2018:<br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:center;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><strong>Warrants Outstanding</strong><br/>&#160;</p><table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)">Exercise price</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)">Number outstanding</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">Expiry Date</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">$</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">#</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)">September 15, 2022</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)">4.42</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)">199,005</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">October 20, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)">7.56</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)">11,970</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)">November 1, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)">7.56</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)">69,240</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">November 14, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)">7.56</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)">52,532</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)">November 21, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)">7.56</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)">10,263</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">December 12, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)">7.56</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)">1,084</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)">December 29, 2019</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)">7.56</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)">1,072</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">January 5, 2020</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255)">6.03</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255)">37,313</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(204, 238, 255)">May 24, 2022</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(204, 238, 255)">18.09</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(204, 238, 255)">163,733</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center;width:698px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:244px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">9.47</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:8px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:13px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:212px;text-align:right;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial">546,212</td></tr></tbody></table><p>&#160;</p></div></div></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReservesWithinEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReservesWithinEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796940592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsAbstract', window );"><strong>Disclosure Of Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory', window );">Other investments</a></td>
<td class="text"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>9.<span style="width:28.5pt;display:inline-block">&#160;</span><strong>Other investments</strong></span></span></span></span></span></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>The following table outlines changes in other investments.</span></span></span></span></span></span></span></span></p><div style="margin-left:0px"><table style="border-collapse:collapse;border:0px;width:100%" width="1440"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Balance at</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Change in fair</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Balance at</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>December 31,</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Proceeds </span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>value through</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>December 31,</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Entity</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Instrument</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Note</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>2018</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>Additions</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>from sale</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:25px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:11px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>profit or loss</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>2019</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border:1pt none;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:14px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:25px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:11px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom"><strong>$</strong></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Pharmadrug Inc.</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(i)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>3,000,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(2,660,940</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>339,060</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Cannara Biotech Inc.</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(ii)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>11,215,395</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(2,146,357</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>9,069,038</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Clover Cannastrip</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(iii)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,500,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(1,500,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>High Tide</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(iv)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,798,040</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>614,520</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(1,183,520</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>High Tide</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Warrants</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(iv)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>251,115</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(251,115</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>HUGE Shops</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(v)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,300,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(539,132</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>760,868</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>SciCann Therapeutics</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(vi)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,999,991</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(1,287,743</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>712,248</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Solarvest BioEnergy Inc.</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Shares</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(vii)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>690,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(255,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>435,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Solarvest BioEnergy Inc.</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Warrants</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(vii)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>385,784</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(269,134</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>116,650</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Solarvest BioEnergy Inc.</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Convertible debenture</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(vii)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>1,924,216</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>&#x2014;</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(1,576,216</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>)</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>348,000</span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:31" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:140px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:1px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>18,064,541</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>6,000,000</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:14px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:180px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>614,520</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:25px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;width:160px;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>(11,669,157 </span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>)</span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:15" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:156" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong><span><span>11,780,864 </span></span></strong></span></span></span></span></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(204, 238, 255);width:31" valign="bottom">&#160;</td></tr></tbody></table><p>&#160;</p></div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(i) &#160; &#160;</span></span></span></span></span></span></span></span>Pharmadrug Inc. (Formerly known as "Aura Health Inc.")</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:40pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On April 16, 2019, </span></span></span></span></span></span></span></span>the Company entered into a share exchange agreement with Aura Health Inc. ("Aura").<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span> Pursuant to the share exchange agreement, FSD acquired 13,562,386 common shares at $0.2212 per share in the capital of Aura in exchange for the issuance of 65,577 Class B shares of the Company at $45.75 for a total value of $3,000,000. The FSD shares issued to Aura were subject to a purchase price adjustment, such that FSD would be required to issue additional shares to Aura should the weighted average trading price of FSD's shares fall below the issue price. As the number of additional shares to be issued under the agreement were dependent on the FSD share price, it was determined that this created a derivative liability. As a result of the decline in the Company's share price, on September 20, 2019, 61,892 additional Class B shares of the Company were issued to Aura&#160;as part of the adjustment of purchase price and a corresponding loss on change in fair value of derivative liability of $1,422,036 was recorded in the statements of loss and comprehensive loss. The Company's investment in Aura has been classified as level 1 </span></span></span></span></span></span></span></span>within the fair value hierarchy - quoted market price. During the fiscal year 2019, Aura announced a name change to Pharmadrug Inc.</p><p style="text-align:justify;margin-bottom:0pt;margin-left:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(ii)<span style="width:6.75pt;display:inline-block">&#160;</span>Cannara Biotech Inc. ("Cannara")</span></span></span></span></span></span></span></span><br/>&#160;</p><p style="text-align:justify;margin-top:0pt;margin-left:40pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>The Company's investment in 85,003,750 Class B shares of Cannara are subject to an escrow arrangement with timed releases </span></span></span></span></span></span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">of a predetermined quantity of shares at set intervals over a three-year period.</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span> </span></span></span></span></span></span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consequently, unrestricted shares that are not subject to escrow are valued at market price and shares that are held in escrow are subject to a discount rate.</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span> </span></span></span></span></span></span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The valuation at December 31, 2019 was based on the December 31, 2019 quoted market price of&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>$0.125 per share, </span></span></span></span></span></span></span></span><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">subject to an aggregate discount for the escrow conditions determined to be</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span> 19.53% ($1,556,431). </span></span></span></span></span></span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The 21,250,935 unrestricted Class B shares have been classified as level 1 within the fair value hierarchy - quoted market price. The remaining 63,752,815 Class B shares held in escrow has been classified as level 2 within the fair value hierarchy - valuation technique with observable inputs. The Company was a founder of Cannara and previously had common directors during 2018. Subsequent to December 31, 2019, the Company sold all 85,003,750 Class B shares for gross proceeds of $7,743,492 (refer to Note 25).</span></span></p><p style="text-align:justify;margin-bottom:0pt;margin-left:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(iii)<span style="width:6.75pt;display:inline-block">&#160;</span>Clover Cannastrip Thin Film Technologies Corp. ("Clover")</span></span></span></span></span></span></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:40pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>On September 6, 2018, the Company subscribed for $1,500,000 </span></span></span></span></span></span></span></span></span>of equity units in a brokered private placement by Clover. The equity investment is measured at fair value through profit or loss. Clover is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy.As at December 31, 2019, the fair value was determined to be nil based on the financial position of Clover and the Company's ability to recover its investment.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:40pt">&#160;</p><p style="text-align:justify;margin-bottom:0pt;margin-left:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(iv)<span style="width:7.5pt;display:inline-block">&#160;</span>High Tide Inc.</span></span></span></span></span></span></span></span><br/>&#160;</p><p style="text-align:justify;margin-bottom:0pt;margin-left:40pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The investment included<span><span> 4,551,999 shares and 2,000,000 warrants. </span></span>On November 22, 2019 the Company sold the shares and warrants of High Tide Inc.&#160;</span></span></span></span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">for total cash proceeds of</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span> $614,520.</span></span></span></span></span></span><br/>&#160;</p><p style="text-align:justify;margin-bottom:0pt;margin-left:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(v)<span style="width:6.75pt;display:inline-block">&#160;</span>HUGE Shops</span></span></span></span></span></span></span></span><br/>&#160;</p><p style="text-align:justify;margin-top:0pt;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>The investment includes 17,333,333 shares based on the December 2018 subscription price of $0.075 per share. </span></span></span></span></span></span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The equity investment is measured at fair value through profit or loss. Huge Shops is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2019, the Company determined the best information to assess the fair value of the investment was based on movement of comparable public companies share prices and cannabis sector index resulting in decline in the fair value of investment of 41.5% from December 31, 2018. Comparable companies were determined in looking at product offering, relative size of operations, geographical market and other factors. A change in this assumption of plus or minus 10% would result in a corresponding change in fair value of the investment of approximately $54,000.</span></span></p><p style="text-align:justify;margin-bottom:0pt;margin-left:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>(vi)<span style="width:6.75pt;display:inline-block">&#160;</span>SciCann Therapeutics Inc.</span></span></span></span></span></span></span></span><br/>&#160;</p><p style="text-align:justify;margin-bottom:0pt;margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>The investment includes 117,648 shares based on the subscription price in May </span></span></span></span>of 2018&#160;<span><span><span><span>and October </span></span></span></span></span></span>of&#160;<span><span><span><span><span><span>2018 of $17 per share. </span></span></span></span></span></span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The equity investment is measured at fair value through profit or loss. SciCann Therapeutics Inc. is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2019, the Company determined the best information to assess the fair value of the investment was based on movement of comparable public companies share prices and cannabis sector index resulting in decline in the fair value of investment of 64.4% from December 31, 2018. Comparable companies were determined in looking at product offering, relative size of operations, geographical market and other factors. A change in this assumption of plus or minus 10% would result in a corresponding change in fair value of the investment of approximately $129,000.</span></span></p><p style="text-align:justify;margin-bottom:0pt;margin-left:40pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(vii) &#160;Solarvest BioEnergy Inc. ("Solarvest")</span></span></span></span></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt">On May 7, 2019, the Company acquired<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>&#160;3,000,000 common shares, 3,000,000 warrants and a convertible debenture at a principal amount of $2,400,000&#160;</span></span></span></span></span></span>for a total fair value of $3,000,000 of Solarvest in exchange for 49,751 Class B common shares of the Company with a fair value of $2,500,000 based on a market price of $50.25 and recognition of a derivative liability of $500,000. Under the terms of the agreement, the Company has guaranteed a minimum liquidation value of its shares to Solarvest of $3,000,000 resulting in recognition of derivative liability. If the liquidation value of the Company's shares is below $3,000,000, the Company would be required to issue additional shares for the difference in actual value realized and the minimum guaranteed value.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt">As at December 31, 2019, the fair value of the shares was determined based on the quoted market price of the shares at&#160;<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$0.145 per share. The fair value of the associated warrants is based on the Black-Scholes model with the following assumptions: exercise price $0.25, risk free rate 1.71%, expected volatility 94%, expected life 1.35 years and expected dividend yield of 0%. Fair value of the convertible debenture is calculated as: i) principle amount of debt: $2,400,000 multiplied by ii) </span></span></span></span></span></span>conversion<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span> ratio of $1 per share multiplied by iii) SVS share price as at December 31, 2019 of $0.145. </span></span></span></span></span></span>The shares have been classified as level 1 within the fair value hierarchy - quoted market price, and the warrants and convertible debenture have been classified as level 2 - valuation technique with observable market inputs.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt">As at December 31, 2019, the fair value of the derivative liability was $2,646,269 resulting in recognition of loss on change in fair value of derivative liability of $2,146,269. The fair value was determined based on the additional common shares of the Company required to be issued to Solarvest to meet the minimum liquidation value of $3,000,000. Subsequent to December 31, 2019, the Company issued 225,371 shares to Solarvest to settle this derivative liability (refer to Note 25).</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of investments other than investments accounted for using the equity method. [Refer: Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6750623264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Prismic Pharmaceutical<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract', window );"><strong>Disclosure of detailed information about business combination [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory', window );">Acquisition of Prismic Pharmaceutical</a></td>
<td class="text"><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>5<strong>.</strong><span style="width:10.5pt;display:inline-block">&#160;</span><strong>Acquisition of Prismic Pharmaceutical</strong></span></span></span></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On June 28, 2019, the Company closed the acquisition of Prismic by acquiring all of the issued and outstanding Prismic Shares from the holders thereof. Prismic is a U.S.-based specialty research and development pharmaceutical company that is developing non-addictive prescription drugs for the treatment of pain and inflammation. Prismic's goal is to address the opioid crisis based on formulations utilizing micro-PEA's complimentary effect on certain drugs used to impact the body's endocannabinoid system.</span></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>It was determined that the acquisition of Prismic did not qualify as a business combination in accordance with IFRS 3 <i>Business Combinations </i>["IFRS 3"] and therefore it was accounted for as an asset acquisition. The individual identifiable assets acquired and liabilities assumed were identified and the purchase consideration was allocated based on the relative fair values of the acquired assets and assumed liabilities.</span></span></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The total consideration for the purchase of Prismic was<span><span> $20,887,209. </span></span>The purchase consideration consisted of<span><span> $16,431,818 </span></span>of Class B subordinate voting shares,<span><span> $2,567,305 </span></span>of share options and<span><span> $1,888,086 of warrants. </span></span>The fair value of the Class B subordinate voting shares was determined based on a total of 510,940 shares issued and a fair value of $32.16 per share, which reflects the share price on the date of acquisition. The fair value of the 89,898 share options and 67,598 warrants issued as part of the consideration were determined using a black-scholes options pricing model with the following assumptions:</span></span></span></span></p><div><table cellpadding="0" cellspacing="0" style="border:0px;width:100%;margin:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Share Options</strong></span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Warrants</strong></span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Grant date share price</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$32.16</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$32.16</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Exercise Price</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$2.61 - $17.89</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$2.61 - $26.73</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Expected dividend yield</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Risk free interest rate</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.39% - 1.66%</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.41% - 1.52%</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected life (years)</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>0.98&#x2014;16.21</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.39&#x2014;6.55</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Annualized volatility</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></td></tr></tbody></table></div><p style="text-align:justify"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The allocation of the total purchase consideration to the identifiable assets acquired and liabilities assumed as at the date of acquisition was as follows:</span></span></span></span></p><div style="margin-left:2.25pt"><div><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>Fair value</strong></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>recongized on</strong></span></span></p></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>acquisition</strong></span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>$</strong></span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2,329</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Prepaids</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>26,174</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Intellectual Property</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>24,648,915</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Trade and other payables</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,867,250</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Short-term notes</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(195,475</span></span></span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes payable</span></span></p></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,727,484</span></span></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>20,887,209</strong></span></span></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS03_g59-63_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796975280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease obligations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">Lease obligations</a></td>
<td class="text"><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.<span style="width:5.25pt;display:inline-block">&#160;</span><strong>Lease obligations</strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The lease obligations as at December 31, 2019 are as follows:</span></span></p><div><table cellpadding="0" cellspacing="0" style="width:50%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:528px">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:3px">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px">&#160;</td><td style="vertical-align:bottom;text-align:left;width:3px;border:1pt none;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;border:1pt none;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;border:1pt none;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance &#x2013; January 1, 2019</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:3px;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;border:1pt none;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>243,818</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Add: Interest Expense</span></span></td><td style="vertical-align:bottom;text-align:left;width:3px;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,258</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Lease Payments</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:3px;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(56,207</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance &#x2013; December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:3px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>202,869</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:528px">&#160;</td><td style="vertical-align:bottom;width:3px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></td><td style="vertical-align:bottom;text-align:left;width:3px;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,207</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:3px;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">146,662</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance &#x2013; December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:3px;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>202,869</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td></tr></tbody></table></div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Lease obligations are related to the Company's office lease. As of December 31, 2019, the Company did not occupy the leased premise and was in the process of subleasing the space. Subsequent to December 31, 2019 the Company subleased the premise.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets out a maturity analysis of the lease payments payable, showing the undiscounted lease payments to be paid on an annual basis, reconciled to the lease obligation.</span></span></p><div style="margin-left:1.5pt"><div><table cellpadding="0" cellspacing="0" style="width:90%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than one year</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,206</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">One to two years</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59,642</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Two to three years</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59,954</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Three to four years</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59,954</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Therafter</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></p></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total undiscounted lease payments payable</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">235,756</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: impact of present value</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(32,887</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as at December 31, 2019</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">202,869</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table><br/>&#160;</div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Section Presentation<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796880176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SummaryOfSignificantAccountingPoliciesAbstract', window );"><strong>Summary Of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">Significant accounting policies</a></td>
<td class="text"><div><div><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.<span style="width:10.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Significant accounting policies</strong></span></span></p><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[a]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Cash</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash consists of cash and cash held in trust accounts. There are no restrictions on cash held in trust.</span></span></p></div><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[b]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Property, Plant and Equipment</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment is measured at cost less accumulated depreciation and impairment losses, with the exception of land which is not depreciated.&#160; &#160; &#160; &#160; &#160; &#160; &#160;</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">When parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) of property, plant and equipment.</span></span></p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The cost of replacing part of an item of property, plant and equipment is recognized in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Company and its cost can be measured reliably. The carrying amount of the replaced part is derecognized. The costs of the day-to-day servicing of property, plant and equipment are recognized in consolidated statements of loss and comprehensive loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent costs are included in the asset's carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the consolidated statements of loss and comprehensive loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount, and are recognized net within other income in the consolidated statements of loss and comprehensive loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation is based on the estimated useful lives of the assets provided as follows:</span></span></p><div><table cellpadding="0" cellspacing="0" style="margin-left:auto;border-collapse:collapse;font-size:10pt;width:90%;margin-right:auto"><tbody><tr style="background-color:rgb(204, 238, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></p></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30% declining balance</span></span></p></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Production equipment</span></span></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20% declining balance</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Furniture and fixtures</span></span></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20% declining balance</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Facility and related</span></span><span style="font-size:10pt">&#160;</span></p></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20 years under straight-line</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Land</span></span></span></p></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Not amortized</span></span></span></p></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">&#160;</td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An item of property, plant and equipment and any significant part initially recognized are derecognized upon disposal or when no future economic benefits are expected from their use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated statements of loss and comprehensive loss when the asset is derecognized. The assets' residual values, useful lives and methods of depreciation and the depreciation charge are adjusted prospectively, if appropriate.</span></span></p></div><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[c]<span style="width:8.5pt;text-indent:0pt;display:inline-block">&#160;</span>Finite-lived Intangible Assets</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finite-lived intangible assets are recorded at cost less accumulated amortization and accumulated impairment losses. Amortization is recognized in profit or loss on a straight-line basis over the following terms:</span></span></p><div>
              <div><table cellpadding="0" cellspacing="0" style="margin-left:auto;border-collapse:collapse;font-size:10pt;width:90%;margin-right:auto"><tbody><tr style="background-color:rgb(204, 238, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intellectual Property</span></span></p></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5 years</span></span></p></td></tr></tbody></table></div>
              </div></div><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[d]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Revenue Recognition</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's accounting policy for revenue recognition under IFRS 15, Revenue from Contracts with Customers ("IFRS 15") is to follow a five step model to determine the amount and timing of revenue to be recognized i) identify the contract with a customer; ii) identify the performance obligations in the contract; iii) determine the transaction price; iv) allocate the transaction price to the performance obligations in the contract; and v) recognize revenue when (or as) the Company satisfies a performance obligation.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue from the sale of cannabis is recognized when the Company transfers control of the good to the customer. This is generally considered to have occurred when products have been delivered to the location specified in the sales contract and accepted by the customer.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive taking into account any variation that may result from rights of return.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is required to remit excise tax to the Canada Revenue Agency on the sale of medical cannabis in Canada. The Company becomes liable for these excise duties when cannabis products are delivered to the customer. In accordance with IFRS 15, revenue presented on the Consolidated Statements of Loss and Comprehensive Loss, represents revenue from the sale of goods less applicable excise tax.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Areas of judgment include identifying the customer per the definition within IFRS 15 and determining whether control has passed to the customer.</span></span></p></div><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[e]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Foreign Currency Translation</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transactions are translated into Canadian dollars at exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies at the statement of financial position date are translated to Canadian dollars at the foreign exchange rate applicable at that date. Realized and unrealized exchange gains and losses are recognized through profit or loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The assets and liabilities of foreign operations with functional currencies other than Canadian dollars, are translated into Canadian dollars at year-end exchange rates. Income and expenses, and cash flows of such foreign operations are translated into Canadian dollars using average exchange rates for the period. Exchange differences resulting from translating foreign operations are recognized in other comprehensive loss&#160;and accumulated in equity.</span></span></p></div><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[f]<span style="width:10.5pt;text-indent:0pt;display:inline-block">&#160;</span>Financial Instruments</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the instruments.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognized immediately in profit or loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Financial assets</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On initial recognition, a financial asset is classified as measured at amortized cost, fair value through other comprehensive income (''FVOCI''), or fair value through profit and loss (''FVTPL''). The classification of financial assets is based on the business model in which a financial asset is managed and its contractual cash flow characteristics.</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:</span></span></p><ul style="padding-left:0pt" type="disc"><li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">It is held within a business model whose objective is to hold assets to collect contractual cash flows; and</span></span></li><li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.</span></span></li></ul><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A financial asset (unless it is a trade receivable without a significant financing component that is initially measured at the transaction price) is initially measured at fair value plus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition.</span></span></p><p style="text-indent:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following accounting policies apply to the subsequent measurement of financial assets.</span></span></p><table cellpadding="0" cellspacing="0" style="margin-left:36.65pt;border:0.75pt solid #000000;border-collapse:collapse;font-size:10pt"><tbody><tr><td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-right:0.75pt solid #000000;border-bottom:0.75pt solid #000000"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets at FVTPL</span></span></p></td><td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.</span></span></p><p style="text-align:justify">&#160;</p></td></tr><tr><td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-right:0.75pt solid #000000"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets at amortized cost</span></span></p></td><td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-left:0.75pt solid #000000"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequently measured at amortized cost using the effective interest method, less any impairment losses. Interest income, foreign exchange gains and losses and impairment losses are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.</span></span></p></td></tr></tbody></table><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Financial liabilities</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company initially recognizes financial liabilities at fair value on the date at which the Company becomes a party to the contractual provisions of the instrument.</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies its financial liabilities as either financial liabilities at FVTPL or amortized cost.</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent to initial recognition, other liabilities are measured at amortized cost using the effective interest method. Financial liabilities at FVTPL are stated at fair value with changes being recognized in profit or loss.</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Financial liabilities and equity instruments</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Classification as debt or equity</span></span></p><p style="margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Debt and equity instruments issued by the Company are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Equity instruments</span></span></p><p style="margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Equity instruments issued by a group entity are recognized at the proceeds received, net of direct issue costs.</span></span></p><p style="margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repurchase of the Company's own equity instruments is recognized and deducted directly in equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the Company's own equity instruments.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Classification of financial instruments</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies its financial assets and liabilities depending on the purpose for which the financial instruments were acquired, their characteristics and management intent as outlined below:</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Classification</strong></span></span></p><table border="0" cellpadding="0" cellspacing="0" style="width:70%;border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(204, 238, 255)"><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></td><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other receivables</span></span></td><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other investments</span></span></td><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value through profit or loss</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other payables</span></span></td><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative liability</span></span></td><td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value through profit or loss</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes payable</span></span></td><td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td></tr></tbody></table><p style="margin-top:0pt;margin-left:36pt;margin-bottom:0pt;text-align:justify">&#160;</p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Impairment of financial assets</span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An expected credit loss ("ECL") model applies to financial assets measured at amortized cost. The Company's financial assets measured at amortized cost and subject to the ECL model consist primarily of trade and other receivables. The Company applies the simplified approach to impairment for trade and other receivables by recognizing a loss allowance based on lifetime expected losses at each reporting date taking into considerations historical credit loss experience and financial factors specific to the debtors and general economic conditions. The Company has assessed the impairment of its trade and other receivables using the expected credit loss model, and no material difference was noted.&#160;</span></span></p></div><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[g]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Biological Assets</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's biological assets consist of cannabis plants. The Company capitalizes the direct and indirect costs incurred related to the biological transformation of the biological assets between the point of initial recognition and the point of harvest. The Company then measures the biological assets at fair value less cost to sell up to the point of harvest, which becomes the basis for the cost of inventory after harvest. This is determined using a model that estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount by the expected selling price less costs to sell per gram. The net unrealized gains or losses arising from changes in fair value less cost to sell during the year are included in the results of operations of the related period.</span></span></p></div><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>[h]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span></span></span>Inventory</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory of harvested work-in-process and finished goods are valued at the lower of cost and net realizable value. Inventory of harvested cannabis is transferred from biological assets at their fair value at harvest, which becomes the initial deemed cost. Any subsequent post-harvest costs are capitalized to inventory to the extent that cost is less than net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Inventory for supplies and consumables are valued at the lower of cost and net realizable value, with cost determined using the average cost basis.</span></span></p></div><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[i]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Impairment of long-lived assets</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-lived assets, including property, plant and equipment and intangible assets are tested for impairment when there are indicators of impairment at each reporting date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. Intangible assets with an indefinite useful life are tested for impairment at least annually in the fourth quarter and whenever there is an indication that the asset may be impaired.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in net&#160;loss&#160;equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.</span></span></p></div><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[j]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Income Taxes</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense comprises of current and deferred tax. Current tax and deferred tax are recognized in net profit or loss except to the extent that it relates to a business combination or items recognized directly in equity or in other comprehensive loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current income taxes are recognized for the estimated income taxes payable or receivable on taxable income or loss for the current year and any adjustment to income taxes payable in respect of previous years. Current income taxes are determined using tax rates and tax laws that have been enacted or substantively enacted by the year-end date.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets and liabilities are recognized where the carrying amount of an asset or liability differs from its tax base, except for taxable temporary differences arising on the initial recognition of goodwill and temporary differences arising on the initial recognition of an asset or liability in a transaction which is not a business combination and at the time of the transaction affects neither accounting nor taxable profit or loss.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognition of deferred tax assets for unused tax losses, tax credits and deductible temporary differences is restricted to those instances where it is probable that future taxable profit will be available against which the deferred tax asset can be utilized. At the end of each reporting period, the Company reassesses unrecognized deferred tax assets. The Company recognizes a previously unrecognized deferred tax asset to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.</span></span></p></div><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[k]<span style="width:8.5pt;text-indent:0pt;display:inline-block">&#160;</span>Share-based Compensation</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Stock options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Stock options and warrants awarded to employees are accounted for using the fair value method.&#160; The fair value of such stock options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.</span></span></p></div><div><p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[l]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Net Loss per Share</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per share is calculated based on the loss for the financial year and the weighted average number of common shares outstanding during the year. Diluted net loss per share is calculated using the loss for the financial year adjusted for the effect of any dilutive instruments and the weighted average diluted number of shares [ignoring any potential issue of common shares that would be anti-dilutive] during the year.</span></span></p></div><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>New standards, amendments and interpretations adopted by the Company</strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>IFRS 16 - Leases ["IFRS 16"]</i></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has adopted IFRS 16 with an initial adoption date of January 1, 2019. The Company utilized the modified retrospective method to adopt the new standard and therefore, the comparative information has not been restated and continues to be reported under IAS 17, Leases and related interpretations.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IFRS 16 specifies how leases will be recognized, measured, presented and disclosed and it provides a single lessee model requiring lessees to recognize right-of-use assets and lease liabilities for all major leases. The Company's accounting policy under IFRS 16 is as follows.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of identified asset for a period of time in exchange for consideration. The Company recognized a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of the costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right-of-use assets are depreciated to the earlier of the end of useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of the consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset can be periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, and the Company's incremental borrowing rate. The Company used an incremental borrowing rate to measure the lease liabilities in the opening balance sheet at January 1, 2019 of 7.73%.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from the change in an index or rate, if there is a change in the Company's estimate of the amount expected to be payable under a residual value guarantee, or if the Company changes its assessment of whether it will exercise a purchase, extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, unless it has been reduced to zero.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has elected to apply the practical expedient not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less or to leases of low value assets when applicable. The lease payments associated with those leases is recognized as an expense on a straight-line basis over the lease term. The Company has also elected to apply the practical expedient to grandfather the assessment of which transactions are leases on the date of initial application, as previously assessed under IAS 17 and IFRIC 4 Determining Whether an Arrangement Contains a Lease. The Company applied the definition of a lease under IFRS 16 to contracts entered into or changed on or after January 1, 2019.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On initial application, the Company has elected to record right-of-use assets at the amount of the corresponding lease liability. Right-of-use assets and lease obligations of $243,818 were recorded as at January 1, 2019. When measuring lease liabilities, the Company discounted lease payments using its incremental borrowing rate at January 1, 2019.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table reconciles the Company's operating lease obligations at December 31, 2018, as previously disclosed in the Company's audited financial statements for the year ended December 31, 2018, to the lease obligations recognized on initial application of IFRS 16 at January 1, 2019:</span></span></p><div><table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Aggregate lease commitments as disclosed at December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">315,528</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Adjustment to lease commitments</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,528</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Impact of present value</span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(47,182</span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Opening IFRS 16 lease obligation as at January 1, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>243,818</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company did not have any leases subject to the low-value or short-term lease recognition exemptions upon adoption of IFRS 16 and as at December 31, 2019.</span></span></p></div></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SummaryOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SummaryOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6815245552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SummaryOfSignificantAccountingPoliciesAbstract', window );"><strong>Summary Of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory', window );">Schedule of estimated useful lives of assets</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="margin-left:auto;border-collapse:collapse;font-size:10pt;width:90%;margin-right:auto"><tbody><tr style="background-color:rgb(204, 238, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></p></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"><p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30% declining balance</span></span></p></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Production equipment</span></span></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20% declining balance</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Furniture and fixtures</span></span></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20% declining balance</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Facility and related</span></span><span style="font-size:10pt">&#160;</span></p></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20 years under straight-line</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Land</span></span></span></p></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Not amortized</span></span></span></p></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">&#160;</td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div>
              <div><table cellpadding="0" cellspacing="0" style="margin-left:auto;border-collapse:collapse;font-size:10pt;width:90%;margin-right:auto"><tbody><tr style="background-color:rgb(204, 238, 255)"><td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intellectual Property</span></span></p></td><td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5 years</span></span></p></td></tr></tbody></table></div>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory', window );">Schedule of applied the definition of a lease under IFRS 16 to contracts</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Aggregate lease commitments as disclosed at December 31, 2018</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">315,528</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Adjustment to lease commitments</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,528</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Impact of present value</span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(47,182</span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Opening IFRS 16 lease obligation as at January 1, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>243,818</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related to estimated useful lives of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SummaryOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SummaryOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The explanation of the difference between: (a) operating lease commitments disclosed applying IAS 17 at the end of the annual reporting period immediately preceding the date of initial application of IFRS 16, discounted using the incremental borrowing rate at the date of initial application; and (b) lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph C12<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_C12_b&amp;doctype=Appendix&amp;subtype=C<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>79
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( +R)<5 ?(\\#P    !,"   +    7W)E;',O+G)E;'.MDD^+
MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V
M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F'
M.>RGGD7E2B.5^S3%":4A+<TXP)6E/S/WJVR;A5ND9T*YKCM+1[873T$7LF<;
M!I99-G\LCNVW<+ZT+/0:S>,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C
M-R."?S]PN -02P,$%     @ O(EQ4"?HAPZ"    L0   !    !D;V-0<F]P
M<R]A<' N>&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(?
MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MZ-!3 EYR8'*:&$YCU\(5,,$(HTO?!30+<:[^B9T[P,[),=DE-0Q#.31S+N_
MX>WI\65>M[ ^D?(:\Z]D!9T"KMEE\FOSL-EMF:RKNBJJIN"K'5\)7HO;^_?)
M]8??5=CUQN[M/S:^",H6?MV%_ )02P,$%     @ O(EQ4)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M$M!RMNA O:F((0PM?!@P0Q"Z MH5\&%%@X&LR+L.=T[)@7$ 1,^E!$P98M1
MO0+9E("[$BA:08&7<PO&!KJT[SI@+W,14Z;05%D*2 S6*SLTS;)# +<(4)K2
MYY4=HC)N8(F#7-J!UW90A@K B_;$*%".3-^# "2X/B>YN .O[D#S>]Z!^F9L
MC7.T$ C B4DE@R[2)7#'"$HI'P;(RXX!W#) 4<\ [@7&1,W22[",!H<#C&3'
M &X9H#R=.5Z_TQKWB3K27=!%T#XQN=@#K_:@V(X[7+9[%'#.1W":YOU"0!IC
M$.A6Y0ZXAYCH/=] "L ).JM,X 5.L*^4VYB*YH!VLC<!-R=0D6H7_W\?*6!<
M,-H'9BL<F-(-86 QHNQ@R!V,[24[3']C8G4T0%,6!:NCR#XKV>R0FQW;3R*W
M)J."LT.GI8'CDN!,P$Y"PD'#&0T!2'8L)&0((?&B9R'!F:Q+:]E1206@2EZ'
M,.!A*'L8"AX&0 ?*/2QE0S1T[0DXYVT<2!F4K0XEJP.J$W<P<,J!9IE\";)/
M2W8[E-R.9BD*;N<#&ATH?VYBDV3H,5!-EP+2:QP65;8[E.R.;E60^QAH!6%(
M*-G'4/(QEJ7"H<98\(:N*(Z;V$1)4Y6XV<5T?!Y*>MGH4#(ZNB= [@R X#PE
M+GA-']=G)-L'"O8!U"A1.-U8G52B^T,4K*&/ZU^+R-:@A<,-T+L?S2O^!+2!
M.&!#6B[X6CK=$*GO-3_=3))*CMZA/6AN#1.;=BFI8M/R*D/3SC7X@2..EHU$
M2T9")N967WCU)N"B#Y".0_3.0$!:;ZS2=$U(76L54W6/5&;A_DV660#Z8"'M
MTNE!3(":@)B<;"!/],!=G>1BEJI\R76=@(G*>J3Y+0"-2PK3BC,]N]5N?EOY
M/2M?-_MJ]%34=;%KK[%?BJ+.4YOJ2VIMG6>KT\,V?ZF;KSY]+X^_:1P?ZN+0
M_5XS/?UH=/,?4$L#!!0    ( +R)<5"YS)#CV00   46   8    >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL?9C;;N,V$(9?Q?"]5^0,Q4/@&(A=%"W0 L$6
MVUXK-A,;*UFNI,3;MR]U6*_,&6XN8HGZ.0>*_#CB^EHW7]NC]]WB6U6>V\?E
ML>LN#UG6[H^^*MI/]<6?PY/7NJF*+MPV;UE[:7QQ&#I5909"Z*PJ3N?E9CVT
M/3>;=?W>E:>S?VX6[7M5%<U_6U_6U\>E7'YO^'QZ.W9]0[997XHW_Y?OOER>
MFW"7W:P<3I4_MZ?ZO&C\Z^/R23[LU-!A4/Q]\M=V=KWH4WFIZZ_]S>^'QZ7H
M(_*EWW>]B2+\?/B=+\O>4HCCW\GH\N:S[SB__F[]UR'YD,Q+T?I=7?YS.G3'
MQZ5=+@[^M7@ON\_U]3<_)90O%U/V?_@/7P9Y'TGPL:_+=OB_V+^W75U-5D(H
M5?%M_#V=A]_K^$2;J1O? :8.<.L@]4\[X-0!?W100_)C9$.JOQ1=L5DW]771
MC&_K4O230CY@&,Q]WSB,W? L9-N&UH^-E'J=??2&)LUVU,!<<U-DP?K-!7 N
MMD"Z@[WWL&,DCG>!;!8X],>[+ QO0+$&U&! S0Q8B$9AE.A!<AXDJQR$1&FC
M\=HQ2@ CA0;%QY2S,>5,4I8WH%D#FB1EXJ1&23X+%:72VHHH):J3%J5+Y&/8
M< P-1T7A&.(&%"J=R-JR;BQQ(Z6+TK'$CW%.&I>8UXYUY*@CB,9MZVA"0JL\
M,6Y2\&M4T)&3\1H5] UIH</TC'-GE%HIH81.!)4 AV32)U%)&I74VLG<Q%%1
MY4J:/(Q5B@22I<V3!":N>-I/HKMYGVN+(D_XXK$CD?&%L2^D<P! I;+B^20I
MH"3$JV<2W;U9"P93KGCLR)S.-A=[RIF%:J5(..+Q)!D^83PM*'B,<LZ9!-TE
MCQYI*$LA]:YYK$C*%233BG)E)85Q0I/ISBBU5CHYA#R")&40DOE'&83..H@C
MHK*5<Z 3J (>54!1)2&N)X 2:.44N-1$!9Y 0 F$>>R*P<K/U@3P4 $*%16O
M/J!,L9"3+6''Z!2B2>T)P*,'./28."2*GI6TH18Q2"HP5JJL<RDF D\J4,Q2
M2VS@P!,(*($DQ @"!D&8VBN )Q!0 DDD[XLB"(22N4@5P3R"@)8_87..DZ(%
MD)9A"TQ0 7A4 5,"Q:S: 4.@4 2%OU1>/(* *8,(@X"!2XYJ7L].43%")1#L
M+/[[[P&>0\AP".,5BPR'T#JM$L.-/(>0J80(B) !$0KM1%R><<+^I2"D1H!'
M%@)=AY@H\3#Q5<4P!F/&( ..7(-(;-#(4P.9^B9FU!9I?:-RA\;$NRLG5,X:
ME1Q#'D3(@ AC$"$%T0K!B#P.BM.94'3:Q()#'EK(0$O%WQW(U$T(N8O7&Z,#
MFX?@4TN AQLR<%,QW)#"S:DY;J:0J,P*(4QB#T&>@<@P4,7U&E(&YH@P_SZ;
M8J)"I:S14J>.*7A8(@-+%<,2&0:&Y2] NK@\9J128QA5E9CHBL>E8G!)"AQ%
M<0DR4-61+9-1JE!R.9MXAXH'JV+ JF*P3J+Y:8MQ8?W%H-HQ0A+^&%4V.SRK
M?/,VG#.VBWW]?N[Z4ZI9Z^TL\PGZP[>H?2L?=N.)Y \SXP'IGT7S=CJWBY>Z
MZ^IJ.(![K>O.AT#%IS!N1U\<;C>E?^WZ2Q.NF_%@<KSIZLMTZ)K=3GXW_P-0
M2P,$%     @ O(EQ4+W!PLFT 0  TP,  !@   !X;"]W;W)K<VAE971S+W-H
M965T-BYX;6Q]4^UNG# 0?!7+#Q#?<30YG0 IEZAJI%0ZI4KRVP<+6/$'M<V1
MOGW7AA#:HO[!WF5F=M9>9X.Q;ZX%\.1=2>URVGK?'1AS90N*NRO3@<8_M;&*
M>PQMPUQG@5>1I"1+-IMKIKC0M,AB[F2+S/1>"@TG2URO%+>_CB#-D-,M_4@\
MB:;U(<&*K.,-_ #_W)TL1FQ6J80"[831Q$*=T]OMX9@&? 2\"!C<8D]")V=C
MWD+P4.5T$PR!A-('!8[+!>Y RB"$-GY.FG0N&8C+_8?ZU]@[]G+F#NZ,?!65
M;W.ZIZ2"FO?2/YGA&TS]?*%D:OX1+B 1'IQ@C=)(%[^D[)TW:E)!*XJ_CZO0
M<1W&/VDZT=8)R41(9L(^UF%CH>C\GGM>9-8,Q(YGW_%PQ=M#@F=3AF0\BO@/
MS3O,7HIM>IVQ2Q":,,<1DRPQ,X*A^EPB62MQ3/ZA)_MU_F[5XB[R=W]8O%D7
M2%<%TBB0_K?'-<S?+MGB4!78)HZ3(Z7I=1SE17:>V-LD7LHG?!SW[]PV0CMR
M-AZO-EY ;8P'M+*YPAEJ\87-@83:A^T-[NTX9V/@33<](3:_X^(W4$L#!!0
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M S1:._"I)#=^ACK_PQ9#0./"\9,_FVG.)L/I?OY"9/G'Y5]02P,$%     @
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M_]=B"&A<.'[V9S--V60XW<\?B"R_N/P+4$L#!!0    ( +R)<5"17"1$MP$
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M!UL,";4/QT]XMM.8388W_?R#V/*-BW]02P,$%     @ O(EQ4">SZ:6V 0
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M-"X<;_W93%,V&4[W\P<BRR\N_P%02P,$%     @ O(EQ4$G+9E"W 0  TP,
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M?=@><&_'.1L#;[KI";'Y'1=_ %!+ P04    " "\B7%0BX,S&;0!  #3 P
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MN+?3G$V!-_W\A-CRCHLW4$L#!!0    ( +R)<5!T!\A5M $  -,#   9
M>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;'U386^;,!#]*Y9_0)TX-(TB0&I:
M59NT25&G;9\=.,"JC9EM0O?O=S:$L0WM"_8=[[U[9Y_3P=@WUP!X\JY5ZS+:
M>-\=&7-% UJX.]-!BW\J8[7P&-J:N<Z"*"-)*\8WFSW30K8T3V/N;//4]%[)
M%LZ6N%YK87^>0)DAHUMZ2[S*NO$AP?*T$S5\ ?^U.UN,V*Q22@VMDZ8E%JJ,
M/FZ/IR3@(^";A,$M]B1T<C'F+00?RXQN@B%04/B@('"YPA,H%830QH])D\XE
M W&YOZF_Q-ZQEXMP\&34=UGZ)J,'2DJH1*_\JQD^P-3//253\Y_@"@KAP0G6
M*(QR\4N*WGFC)Q6THL7[N,HVKL/X9W^CK1/X1. SX1 );"P4G3\++_+4FH'8
M\>P[$:YX>^1X-D5(QJ.(_]"\P^PUWSXD*;L&H0ES&C%\B9D1#-7G$GRMQ(G_
M0^>'=?YNU>(N\G=_6+Q?%TA6!9(HD/RWQS7,_J\B;'&H&FP=Q\F1PO1M'.5%
M=I[81QXOY3=\'/?/PM:R=>1B/%YMO(#*& ]H97.',]3@"YL#!94/VP?<VW'.
MQL";;GI";'['^2]02P,$%     @ O(EQ4%;-H^JV 0  T0,  !D   !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&UL?5-ACYP@$/TKA!]PK*S7W6[4Y/::IDW:
M9'--V\^LCDH.Q *NUW_? 3UK>J9?@!GFO7DS#-EH[+-K 3QYT:IS.6V][T^,
MN;(%+=R=Z:'#F]I8+3R:MF&NMR"J"-**\=WN'=-"=K3(HN]BB\P,7LD.+I:X
M06MA?Y]!F3&G"7UU/,FF]<'!BJP7#7P#_[V_6+38PE))#9V3IB,6ZIP^)*=S
M&N)CP \)HUN=2:CD:LQS,#Y7.=T%0:"@](%!X':#1U J$*&,7S,G75(&X/K\
MROXQUHZU7(6#1Z-^RLJW.3U24D$M!N6?S/@)YGKN*9F+_P(W4!@>E&".TB@7
M5U(.SAL]LZ 4+5ZF779Q'Z<;_GZ&;0/X#. +X!CSL"E15/Y!>%%DUHS$3KWO
M17CBY,2Q-V5PQE;$.Q3OT'LKTON,W0+/''*>0O@J)%DB&)(O&?A6AC-_ ^?'
M;?Q^4^$^XO?K](?#-D&Z29!&@O1_);X-20[_BF2KEFJP31PF1THS='&05]YE
M7A]X?)*_X=.P?Q6VD9TC5^/Q86/[:V,\H)3='4Y0B_]K,134/AP/>+;3E$V&
M-_W\@=CRBXL_4$L#!!0    ( +R)<5"6/)O&M@$  -,#   9    >&PO=V]R
M:W-H965T<R]S:&5E=#$Y+GAM;'U3VVZ<,!#]%<L?$+/L)J$K0,JFJEJIE5:I
MFCY[80 KOE#;+.G?=VP(12W*B^T9GW/FXG$^&OOB.@!/7I74KJ"=]_V1,5=U
MH+B[,3UHO&F,5=RC:5OF>@N\CB0E69HD=TQQH6F91]_9EKD9O!0:SI:X02EN
M?Y] FK&@._KF>!)MYX.#E7G/6_@._D=_MFBQ1:46"K031A,+34$?=L?3(> C
MX%G Z%9G$BJY&/,2C"]U09.0$$BH?%#@N%WA$:0,0IC&KUF3+B$#<7U^4_\4
M:\=:+MS!HY$_1>V[@F:4U-#P0?HG,WZ&N9Y;2N;BO\(5),)#)ABC,M+%E52#
M\T;-*IB*XJ_3+G3<Q^GF;C_3M@GI3$@70A;CL"E0S/PC][S,K1F)G7K?\_#$
MNV.*O:F",[8BWF'R#KW7<G?_(6?7(#1C3A,F76,6!$/U)42Z%>*4_D=/LVW^
M?C/%?>3OU^&S9%O@L"EPB *'=VO<P&3_5LE6355@VSA.CE1FT'&45]YE8A_2
M^"A_X=.X?^.V%=J1B_'XM/$!&F,\8"K)#<Y0AS]L,20T/ASO\6RG.9L,;_KY
M"['E'Y=_ %!+ P04    " "\B7%0&A^: +8!  #1 P  &0   'AL+W=O<FMS
M:&5E=',O<VAE970R,"YX;6Q]4]MNU# 0_17+'U!OO"E$JR12MPB!!-*J"'CV
M)I.+ZDNPG4WY>\9.&B(:\6)[QN><N7B<3\8^NP[ DQ<EM2MHY_UP8LQ5'2CA
M[LP &F\:8Y7P:-J6N<&"J"-)2<8/AW=,B5[3,H^^BRUS,WK9:[A8XD:EA/U]
M!FFF@B;TU?'4MYT/#E;F@VCA&_COP\6BQ5:5NE>@76\TL= 4]"$YG=. CX ?
M/4QN<R:ADJLQS\'X7!?T$!(""94/"@*W&SR"E$$(T_BU:-(U9"!NSZ_J'V/M
M6,M5.'@T\F=?^ZZ@&24U-&*4_LE,GV"IYYZ2I?@O< .)\) )QJB,='$EU>B\
M48L*IJ+$R[SW.N[3?)-F"VV?P!<"7PE9C,/F0#'S#\*+,K=F(G;N_2#"$R<G
MCKVI@C.V(MYA\@Z]M_*>Y^P6=!;(>8;P#219$0S%UPA\+\*9OZ'S;)]_W,WP
M&/G';?B,[PNDNP)I%$C_5^);2)(=_XG!-BU58-LX3(Y49M1QD#?>=5X?>'R2
MO_!YV+\*V_;:D:OQ^+"Q_8TQ'C"5PQU.4(?_:S4D-#X<W^/9SE,V&]X,RP=B
MZR\N_P!02P,$%     @ O(EQ4#.;W;.Q 0  TP,  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C$N>&UL?5-A;YLP$/TKEG] G1#:11$@-9VF35JEJ-6VSPX<
M8-7V,=N$]M_7-H2Q#NT+]AWOO7MGG[,!S8MM 1QY55+;G+;.=0?&;-F"XO8&
M.]#^3XU&<>=#TS#;&>!5)"G)DLWFCBDN-"VRF#N9(L/>2:'A9(CME>+F[0@2
MAYQNZ37Q))K6A00KLHXW\ SN1W<R/F*S2B44:"M0$P-U3N^WAV,:\!'P4\!@
M%WL2.CDCOH3@6Y7333 $$DH7%+A?+O  4@8A;^/WI$GGDH&XW%_5O\3>?2]G
M;N$!Y2]1N3:G>THJJ'DOW1,.7V'JYY:2J?GO< 'IX<&)KU&BM/%+RMXZ5).*
MMZ+XZ[@*'==ATK_2U@G)1$@^$-A8*#K_S!TO,H,#,>/9=SQ<\?:0^+,I0S(>
M1?SGS5N?O13;?9JQ2Q":,,<1DRPQ,X)Y];E$LE;BF/Q#3_;K_-VJQ5WD[_ZR
M>+LND*X*I%$@_6^/:YB[#T78XE 5F":.DR4E]CJ.\B([3^Q]$B_E#WP<]T=N
M&J$M.:/S5QLOH$9TX*UL;OP,M?Z%S8&$VH7M)[\WXYR-@<-N>D)L?L?%.U!+
M P04    " "\B7%0C[%?K+0!  #3 P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970R,BYX;6Q]4^V.TS 0?!7+#W!NW<*5*HET/81  JDZ!/QVDTUBG3^"[33'
MV[-VTA @\"?V;F9F9^UU-ECW[%N 0%ZT,CZG;0C=D3%?MJ"%O[,=&/Q36Z=%
MP- US'<.1)5(6C&^V;QF6DA#BRSESJ[(;!^4-'!VQ/=:"_?C!,H..=W26^))
M-FV("59DG6C@,X0OW=EAQ&:52FHP7EI#'-0Y?=@>3_N(3X"O$@:_V)/8R<7:
MYQA\J'*ZB89 01FB@L#E"H^@5!1"&]\G33J7C,3E_J;^+O6.O5R$AT>KOLDJ
MM#D]4%)!+7H5GNSP'J9^7E$R-?\1KJ 0'IU@C=(JG[ZD['VP>E)!*UJ\C*LT
M:1W&/[L;;9W )P*?"8=$8&.AY/RM"*+(G!V(&\^^$_&*MT>.9U/&9#J*] _-
M>\Q>B^WA/F/7*#1A3B.&+S$S@J'Z7(*OE3CQO^C\L,[?K5K<)?[N-XO_$-BO
M"NR3P/Z_/:YAWOQ1A"T.58-KTCAY4MK>I%%>9.>)?>#I4G[!QW'_)%PCC2<7
M&_!JTP74U@9 *YL[G*$67]@<**A#W-[CWHUS-@;!=M,38O,[+GX"4$L#!!0
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M/VQL?ZVU Y]*<N4GJ/7_:S8$U"X<K_W9C%,V&DYWTP<B\R\NW@%02P,$%
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M 36B V]E=^-GJ/4O; D4U"YLW_N]F>9L"ASV\Q-BRSLN?@%02P,$%     @
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MPI9 0>W"]M;OS31G4^"PGY\06]YQ\1M02P,$%     @ O(EQ4%6-6PRU 0
MTP,  !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&UL?5-ACY0P$/TK37_
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MH'9A^];OS31G4^"PGY\06]YQ\1M02P,$%     @ O(EQ4,B!QNA@ @  I @
M !D   !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL=5;;CILP$/T5Q >LL0F$
MK A2LE752JT4;=7VV2%.0&LPM9VP_?O:AJ7(#"_X=N:<&9OQ..^%?%,58SIX
M;WBK]F&E=?>,D"HKUE#U)#K6FI6KD W59BAO2'62T8LS:C@B492BAM9M6.1N
M[B2+7-PUKUMVDH&Z-PV5?X^,BWX?XO!CXK6^5=I.H"+OZ(W]8/IG=Y)FA":6
M2]VP5M6B#22[[L,#?C[BU!HXQ*^:]6K6#VPH9R'>[.#K91]&UB/&6:DM!37-
M@[TPSBV3\>//2!I.FM9PWO]@_^R"-\&<J6(O@O^N+[K:AUD87-B5WKE^%?T7
M-@:4A,$8_3?V8-S K2=&HQ1<N6]0WI46S<AB7&GH^]#6K6O[827=C6:P 1D-
MR&20.1TT"#G//U%-BUR*/I##YG?4GC%^)F9O2COIML*M&>>5F7T4!,<Y>EBB
M$7,<,&2&P1,"&?9)@D 21[(P)QEL'X,NQLX^GLLG,4RP 0DVCF S(XBQ%^(2
M0O &UDA C00@2#P1")/"(BDHD@($6T\$PJQL]Q84V0($.T\$P) (%LE D0P@
M\,\$PA!89 >*[  "_]^&,"L'CR,X@R* PC]Z$+1R]G@E4_&" L\H1ITEB)#M
MB@Z8K@=, (K,UX% NQ4=.*UQO*2((U\' JW</AC.?@SD=DQ\'0BT<LE@^ ;
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M$C=99%MJ.DV;M$E1IW6?B7VV4<%X@./NWP^PZWD9_6*XX]U[=QSG;%3ZQ;0
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M^PE=KI6RX%))[EPNK1OCQ1!06[_=N[V>'O-D6-7/<TJ6GT7Q!U!+ P04
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MO(#*& ]H97.%,]3@"YL#!94/VV^XM^.<C8$WW?2$V/R.\W]02P,$%     @
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M!Z@0'?A4-G=^AAK_PV9#0>7"\=Z?S3AGH^&PF[X0F_]Q_@=02P,$%     @
MO(EQ4+)%+\K$ 0  . 0  !D   !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL
M;53M;ML@%'T5Q ,4F\1I%MF6FD[5)K52U&G;;V)??ZA@7,!Q^_8#['A>QI_
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MOI*+4L_>^%+E>.,3 @&E]0S,+5=X!"$\D4OC]\R)%TD?N-Z_LG\*M;M:+LS
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MM]?38YX,J_IY3LGRLRC^ E!+ P04    " "\B7%0'@'0:K@!  #3 P  &0
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MR>_--&=3X+"?GQ!;WG'Q#U!+ P04    " "\B7%0I1CPNMT!   "!0  &0
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MS/J\R>)Z"%"5'PR-<MFW?B@7V7GV'JB_7I_P<7!_,E4UK487:>PE]5>IE-*
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M;+Q%%I6:2U"6:X4,- 6^3X^G7<!'P#.'T:[.*%1RT?HE&%_K B<A(1!0N:#
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M&N.V'^Q>A=X/!R.'>:S)\F\I_P)02P,$%     @ O(EQ4#Q=YIWL 0  !P4
M !D   !X;"]W;W)K<VAE971S+W-H965T-34N>&UL=53;;IPP$/T5Q ?$W$E6
M@)1-%;52*ZU2-7WVPG!1;$QLLZ1_7]NPE++."_:,SYPS8SR338R_B19 .A^4
M]")W6RF' T*B;(%B<<<&Z-5)S3C%4IF\06+@@"L31 D*/"]!%'>]6V3&=^)%
MQD9)NAY.W!$CI9C_.0)A4^[Z[M7QTC6MU Y49 -NX"?(7\.)*PNM+%5'H1<=
MZQT.=>X^^H=CJO$&\-K!)#9[1U=R9NQ-&]^JW/5T0D"@E)H!J^4"3T"()E)I
MO"^<[BJI [?[*_NSJ5W5<L8"GACYW56RS=U[UZF@QB.1+VSZ"DL]L>LLQ7^'
M"Q %UYDHC9(18;Y..0K)Z,*B4J'X8UZ[WJS3?))>P^P!P1(0K %^8FJ9A4SF
M7[#$1<;9Y/#Y[@>L?[%_"-3=E-IIKL*<J>2%\EZ*,$HS=-%$"^8X8X(-QE\1
M2+&O$H%-XAC<A(?1O9T@M.88&H)PJY]$=H+(2A 9@NB_#!YV1<Z8V&#Z6>0A
M#@.[3&R5B6]E8F\G$]_(!+'G?2*36&42BXR_D[%A/A%)K2*IA2#<B=@P^_^"
M-@^1 F],"PJG9&-OVG_C7;O\,3 /^1]\'A$_,&^Z7CAG)E4[F$=;,R9!I>+=
MJ1MMU51:#0*UU-M4[?G<F[,AV;",';3.ON(O4$L#!!0    ( +R)<5 OGF.;
MD@8  #DG   9    >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;)6:VU+;2!"&
M7\7E!\":F9Y3"JC: $EP0E4J6[M[K8  5VR+M05DWWXE63C6=/^*S 4^_=,]
MA_ZZ1R.=OI:;']O'HJ@F/U?+]?9L^EA53^]FL^WM8['*MR?E4[&N?[DO-ZN\
MJC]N'F;;ITV1W[6-5LN9SC(W6^6+]?3\M/WNZ^;\M'RNEHMU\74SV3ZO5OGF
MO_?%LGP]FZKIVQ??%@^/5?/%[/ST*7\H_BRJOYZ^;NI/L[V5N\6J6&\7Y7JR
M*>[/IG^H=S<Q:QJTBK\7Q>OVX/VD&<KWLOS1?+B^.YMF38^*97%;-2;R^N6E
MN"B6R\92W8]_.Z/3O<^FX>'[-^L?VL'7@_F>;XN+<OG/XJYZ/)N&Z>2NN,^?
ME]6W\O53T0W(3B?=Z+\4+\6REC<]J7W<ELMM^W]R^[RMRE5GI>[**O^Y>UVL
MV]?7W2\N=LWD!KIKH/<-% TV,%T#,[8!=0UH; /;-;"_&IC!!JYKX,9Z\%T#
M/[9!Z!J$L0UBUR".;:"RMY7+]DWT\+#5?K'5:"]ORZU&K[=Z6W!EDO68[6*Q
M#>[+O,K/3S?EZV2SX_,I;]* >E=+:^/-MRTN[8]U@&_K;U_.C;6GLY?&4J=Y
MO]/HGL;U-1>2QO<UEY(F]#57DB;V-1\$C<OZFH^21O4UGR2-[FNN)8WI:^9<
MHY-A?18DR:B^2)ZHK[F1-+]6:U8O]7Z]M;S>NK5@>A:<;,'(%DQK@0XLA&3R
MYSN):R7KMX ))@-=)=D1,4?&)2$UWVGL@2>RT7B?Z#X3ZQ%1#)ZTEKMDY2Y9
MUB5*0)A;YDD[<MI%V9&3'3GFZ"#">P:\;,"/7^<@6PC"]"=A?;G3^,/!9B=*
M=A-E-_'WJWP9^>HEJ]SSU&1K,==E@B^P+@KE2S5^8A5@4&G>#Y^EB4>ST%8U
M1=H$Y WPJCBPQJO4VTX4#KQE)UHK@(<"R"J!68]L ,:4/6*& 3Z*\V.\2=._
M8S/L5(BL @@R:V'L 1Z5_SU.UYW(]P+]Q(.TJ0"X2B#74^HJ\!R=M7_ &<!7
M<7[3<O!)<7Y5G7DS U95 WZUP"^*+@WXU4?PJU$-E?A-HTMS?J7HDF0XNC1@
M7 N,L^CJ1".C2P/$M81X&EV:U]O!Z-(@%VA><-/HNM:\X@Y'%\@96LH9:'(
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M<179EII654^ZDZ*>[OI,['5L%8P+).[]_2W8L=*6A[X8=IF9W<% -FCS:AL
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MGX,YD% [/TUQ;L9+,09.]]-]9_.C4_P'4$L#!!0    ( +R)<5!5&_HNWP,
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M)Y7*\$HI.\AL=[XHY+[K3X4Z;\;O"^-%5Q_UMY/@_ %G]3]02P,$%     @
MO(EQ4$B#QAW\ 0  ^00  !D   !X;"]W;W)K<VAE971S+W-H965T-C$N>&UL
M?53;CILP$/T5Q >LN1AR$2!M4JU:J96BK=H^.S!<M#9F;2=L_[ZV(80EJ"_8
M,S[GS!EC.^FY>),U@'(^&&UEZM9*=7N$9%X#(_*)=]#JE9(+1I0.185D)X 4
MEL0H"CPO1HPTK9LE-G<26<(OBC8MG(0C+XP1\?< E/>IZ[NWQ&M3U<HD4)9T
MI(*?H'YU)Z$C-*D4#8-6-KQU!)2I^^SOCY'!6\#O!GHYFSNFDS/G;R;X5J2N
M9PP!A5P9!:*'*QR!4B.D;;R/FNY4TA#G\YOZB^U=]W(F$HZ<_FD*5:?NUG4*
M*,F%JE?>?X6QG\AUQN:_PQ6HAALGND;.J;1?)[](Q=FHHJTP\C&,36O'?M2_
MT=8)P4@()H(?_Y<0CH3P3L"V^<&9;?4+421+!.\=,?RLCI@SX>]#O9FY2=J]
MLVNZ6ZFSUPQC/T%7(S1B#@,FF&'N"*35IQ+!6HE#\$ /MI\K'%<@N_42X6H7
MH>6'<X?;:%T KPI@*X _;4.PV(8!$UM,.Q2)O=@/_=VBFT=@C+&'O7C=4;3J
M*%IQ%"X<18^.-J&WV>&%H4>M$"_-H-F)82 J>[FDD_-+J\ROF66G^_L<F!.W
MR!_TO1ZNX5UF>!1^$%$UK73.7.GS;$]=R;D";=%[TAYK_0Y- 852F>E&S\5P
M&X= \6Y\:-#TVF7_ %!+ P04    " "\B7%0'(8^'E\#  #_#P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970V,BYX;6R55VMOVC 4_2M1?D 3O^*D J05-&W2
M)E6=MGU.P4#4)&9)@.[?SWF4@7-,2SZ0!^>><WV3<VU/CKIZJ;=*-=YKD9?U
MU-\VS>X^".KE5A5I?:=WJC3_K'55I(VYK39!O:M4NNJ"BCR@81@%19J5_FS2
M/7NL9A.];_*L5(^55^^+(JW^/JA<'Z<^\=\>/&6;;=,^"&:37;I1/U3S<_=8
MF;O@Q++*"E76F2Z]2JVG_B=ROV"B#>@0OS)UK,^NO78HSUJ_M#=?5U,_;#-2
MN5HV+45J3@<U5WG>,ID\_@RD_DFS#3R_?F/_W W>#.8YK=5<Y[^S5;.=^K'O
MK=0ZW>?-DSY^4<. A.\-H_^F#BHW\#83H['4>=W]>LM]W>AB8#&I%.EK?\[*
M[GP<^-_"<  = N@I@)*K 6P(8/\#Y-4 /@1P2R'HA]+59I$VZ6Q2Z:-7]:]W
ME[9?$;GGIOK+]F%7[.X_4Y[:/#W,..>3X- 2#9B''D,O,.(2,Q]C&*.7F 7B
MB4Z8P.1Y2I;"9&E'P"X()"9@D(!U!/P\2VNP\QX2=9"R@R2<)BS!,AS*\)$,
MY[&ETV/$N8YD-,0R LH((./(,X($T<?K*2&!?+>>#W)43Q*V!Y:)H4P\'J@(
M+9UX5,]>QR&40*$$"!'KQ25CH<@<CKJ1$-LN!$K4]E1XFY3#X01(,5N*.%Z3
MHWP$&Y10H#5J)W2D):YJ82^3L9FY$+86 %'BT,%F)L#-(K)U.*J?0P>[F0 [
M"]>KQGXF-QB:8$>3L:6YB.U&/C:UO/8"L:L)LG5B2\4W?IC8V 0X.PIM$R 0
ML1.Z#KJ<Q;#Y*3!_9)L?@BS;+MX!72:#VP,%[2&R)T4($@X=Q]P-6D,4V3H(
MY"HN;@L4./ZL8PXZ".2J&VX+%+2%*'908,=3\7&[4NQX&H$L$GNTT;CA$NFT
M$,6=@8+.(%T4V/$TOF' V,@4V$_:4S0%<_2U!L6P3QEPE[1]RL D'<<L="S$
M&'8A P:3]B3-QI,T98+%KB4P-B(#'I/<0>%81K,;%N+8/@S81]J;"C9>)#/)
MB,.H#+N,@7E5VHUG %W,: )],<'9QJK=&G]/JTU6UMZS;LP>K=M)K;5NE"$-
M[PSIUNS&3S>Y6C?MI3375;\E[6\:O1NVV\%ISS_[!U!+ P04    " "\B7%0
M^(@]*<X$  "<&0  &0   'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6R5F=MN
MXS80AE_%\ -$/ TI!8Z!)L:B!5H@V*+MM1+3L;&2Y964>/OVI0[K6N3/P,I%
M+,G#.5#\9H;TZES5WYJ]M>WB1UD<FX?EOFU/]TG2O.YMF3=WU<D>W3>[JB[S
MUMW6;TESJFV^[0>512(8TTF9'X[+]:I_]ERO5]5[6QR.]KE>-.]EF=?_/MJB
M.C\L^?+G@Z^'MWW;/4C6JU/^9O^T[5^GY]K=)1<MVT-IC\VA.BYJNWM8_L+O
M-YJZ ;W$WP=[;JZN%UTH+U7UK;OY;?NP9)U'MK"O;:<B=Q\?]LD61:?)^?%]
M5+J\V.P&7E__U/ZE#]X%\Y(W]JDJ_CELV_W#,ETNMG:7OQ?MU^K\JQT#HN5B
MC/YW^V$+)]YYXFR\5D73_U^\OC=M58Y:G"ME_F/X/!S[S_/PC5;C,#Q C /$
M98 TGPZ0XP!Y&2#TIP/4.$#]/V"8K2&4?FXV>9NO5W5U7M3#ZSWEW2KB]\K-
M_FOWL)_L_CLW/8U[^K%6QJR2CT[1*/,XR(B)3#J5>4(RV51F V12=I%)G)\7
M9P5T5O0*Y$0!QPHD5"![!6JB0'B1##*ZESGV,MQ(+LB?EDTH2$QDQ#7V2$&/
M%/!(>AX-,G1ER,EHGGF>;T(YGG+%.6&'"#I$P"'E.42!(2'2E O_A0,Y)@U3
M&79(0X<T<(@\AS0R1()[_H1BVOT9[(V!WAC@C?:\,8&9++UV9F(FA6928,9;
M?T]I^+J%,EKZL[-)@X4J!2?%(AYET*,L\$A'V.4,9QIV.[T\DJPXF);4SU8<
MK4YM8M[B5,-%8$HJYIL:A,QDW=W%8L(IB:.<E/F&PERC*$LU3R.V<++A(-MD
ML7G!Z8'3C+>(@>:(:#\+\Y#53 N*.8MAY8#6+.8L!I&G,^+%Y/ 0'>7G[J=1
M:)+DB<6J(R9,,&!(1E1@P@2_/5P1*=(A.2KS*\@H=!VN(25YS!1F1P!V DLR
M7$AD6 0<@<$1")Q(6148'#$#'('!$0@<OUD8A2;]BQ(IQ=:]P.@(A(Y?Z$18
MZ=R.(Q.1BBHP8@(4NRRF B,FLAF=(89' GB"DCL*32;7U5(364T20R9!&<MB
M*C!D<DXK'.F%4>'Q5Y,$W3#+TJOT-36%\9$('W\Q2="^DJ)(-RTQ91*TKUFD
MW928,JEG3"V&1X;P7.?R,5X33FVFTUB?(C$\,H2'8HV=Q/#(&? H#(]"\/B9
M>!2:9&+&8C5.8794R([;=4548';4#'849D<A=H)XP\K#X]L-%=D?AN@0B]1T
MA9E0,RJ/PDRH6S9A*FS9U"?O%Z.C$#K!S(9UAW]B"9.C$#F1FJXP.6H&.83)
MH9 <8EYJ?*20'*Z5H=C&'J-#")W(:B2,#LU AS Z%*)#S#]-HA =8^)OF# [
MA Y7_,:;PK)#KK>+E&.*')J$98=8I.P01HQFE!W"[! ZG/ K.H5EQ\6K(F66
M,#N$6C:_H%-X0&&,B$TL)HS"O1/QR"K0F# ]X]Q!8W(T.G?PD](H-#EFD4S)
MR,QJ3)@.=T\4VQ5I3)B6,P+&Y.A;CB5'H5M[0XW1T:AC\Y>2#D\246^87)UZ
M=[];_)'7;X=CLWBIVK8J^V/N756UUJED=T[9WN;;RTUA=VUW:=QU/?Q>,-RT
MU6G\+22Y_""S_@]02P,$%     @ O(EQ4,G;-'*Y 0  V@,  !D   !X;"]W
M;W)K<VAE971S+W-H965T-C0N>&UL?5/M;ML@%'T5Q ,4?R2N$]F6UDS3)FU2
MU&GK;V)?QU;Y\(#$[=L7,+6\U.H?P[V<<S@'0S%*]:P[ (->.!.ZQ)TQPYX0
M77? J;Z3 PB[TDK%J;&E.A,]**"-)W%&DBC*"*>]P%7A>T=5%?)B6"_@J)"^
M<$[5ZP,P.98XQN^-Q_[<&=<@53'0,_P&\V<X*EN16:7I.0C=2X$4M"7^$N\/
MJ<-[P-\>1KV8(Y?D).6S*WXT)8Z<(6!0&Z= [7"% S#FA*R-?T$3SULZXG+^
MKO[-9[=93E3#0;*GOC%=B7.,&FCIA9E'.7Z'D&>+40C_$Z[ +-PYL7O4DFG_
M1?5%&\F#BK7"Z<LT]L*/X[2RC0-MG9 $0C(3XLVGA#00TAL"F9SYJ%^IH56A
MY(C4]+,&ZNY$O$_M8=:NZ<_.K]FTVG:OU39."G)U0@'S,&&2!2;)_X<<5B"[
M&4*L@]E&LFHC\?QTR8^2=8%T52#U IMECML8$R3S$.$ANSR*LVRSNPGS$9CE
M<7R??W!$%J?L;OTOJLZ]T.@DC?UA_EA;*0U8T>C.7J7./K2Y8- :-[VW<S5=
MMZDP<@@OB<S/N7H#4$L#!!0    ( +R)<5#TKUU2*0(  +4&   9    >&PO
M=V]R:W-H965T<R]S:&5E=#8U+GAM;(U5ZVZ;,!1^%<0#%&PNAH@@K8FJ3=JD
MJ-.VWTYR$E -IK83NK>?;2A*@C/E#]CFNYT#-D7/Q9NL )3WT;!6+OU*J6X1
M!')704/E$^^@U4\.7#14Z:DX!K(30/>6U+  AV$:-+1N_;*P:QM1%ORD6-W"
M1GCRU#14_'T&QONEC_S/A=?Z6"FS$)1%1X_P$]2O;B/T+)A4]G4#K:QYZPDX
M+/TO:+%&EF 1OVOHY<78,Z5L.7\SDV_[I1^:1,!@IXP$U;<SK( QHZ1SO(^B
M_N1IB)?C3_476[PN9DLEK#C[4^]5M?0SW]O#@9Z8>N7]5Q@+2GQOK/X[G(%I
MN$FB/7:<27OU=B>I>#.JZ"@-_1CN=6OO_?"$D)'F)N"1@"<"_C\A&@G1HX1X
M),03 >6V6T,IMC=KJFA9"-Y[8GB]'35?$5K$NOL[LVB;;9_I]DB]>BX3%!7!
MV0B-F.<!@Z\P\35FY<(DUYBU"Y-.F$#GG,)B9UAL!:(K >(6B)P"D16(KP2R
MFY0#)K&8UF(P2;+0;1,[;>*9393?R9DX!9+'"TV= JFCT/SFE:7S0G$2$>3V
M(4X?,O?!X8W/@$DO?=(XQ6GN-LJ<1IG#Z$[2W"F0/]Y2%+JW2NC(@&_W2CCK
M:I:$8422.U\0NK,OD<-LMC'1K+6$Q%&<XQNOX.(X, ?Z#RJ.=2N]+5?Z9+'[
M_\"Y BT:/NGLE?Z'3!,&!V6&1(_%<) .$\6[\2<13'^J\A]02P,$%     @
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M%ZZI#T)H,#$&#^;NU6;.3P<&!VVW"[.7P[ ;#EITXR GT]\D_P=02P,$%
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MUK(?<OJ-%MTPP$7C%%G\ U!+ P04    " "\B7%0/U4AH^L!   /!0  &0
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M)PV#N?BO< 6JY283S:@YE?8WJ"]2<3:[Z%08>79C/]AQ<B=Y/(?Y _ <@)<
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MVBY79BW])/,;+;IA2N/Q4U'^ U!+ P04    " "\B7%0-43X85 %  !+'P
M&0   'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6R5F5MOXS84A/^*X7>O1!Y>
MI, QD&Q1M$ +++9H^ZS83&RL9+F2$F__?76+Z^49&DP>8DNF.*0\GT?D69_K
MYEN[=ZY;?*_*8WN_W'?=Z2Y)VNW>547[J3ZY8__)<]U41=<?-B])>VI<L1LO
MJLI$IJE)JN)P7&[6X[DOS69=OW;EX>B^-(OVM:J*YM]'5];G^Z58OI_X>GC9
M=\.)9+,^%2_N#]?]>?K2]$?)I9?=H7+']E ?%XU[OE\^B+M'FPT7C"W^.KAS
M>_5^,4SEJ:Z_#0>_[NZ7Z3 B5[IM-W11]"]O[K,KRZ&G?AS_S)TN+YK#A=?O
MWWO_>9Q\/YFGHG6?Z_+OPZ[;WR^SY6+GGHO7LOM:GW]Q\X3T<C'/_C?WYLJ^
M^3"27F-;E^WX?[%];;NZFGOIAU(5WZ?7PW%\/4^?F/?+\ 5ROD!>+I#37":A
M<>0_%5VQ63?U>=%,-_]4#-^QN)/]O=D.)\=;,7[6#[[MS[YMC-3KY&WH:&[S
M.+615VW$I472]WZ1D$CB4;++=9[B#@B.D<8.Z*H#,@9WH& ':NQ _3!)XTUR
M:F/&-L=IDEEJE%:!N6JHI(&2]92F-OI*R:3C'Q8R4,@ H<P3,EQ(*"T#.A;J
M6*"3>SJ6Z:R$,"87VF*I#$IE7(I23RIC4D+8+,V,PDHY5,J!4N!K%BG&)HWW
MI B0)R)<.3>ZGG#@ZQ,0O@<A(QPY-[I6H5N6%)A301&FG!O%S C#+!#-OB7G
M1C]X4AJ3YBHDAGD6 &AF2L&))LI3$Y+"1 N -,E %QA683_@2@RA !1R5R(,
MI="4ZX 8YE  $+DY\UC#2,RJ3"-L.3>*4<$X2X2S;TO)<5Y)H0R%?BDEIEH"
MJIDM):>Z-V6>4A;0PE1+0#51H N,K%3QOI081(F2U?>EY" *?>-W3&(2)0I7
MWY:2IVM(!<,J4;0R6_)L#:E@GB7BF=F2\[RZ?>,PSQ(%*[-E-,^$>2; ,P7R
MGS"L).(-21A!0L'J&Y(X@L+F61I*(0H\ *-@]0U)T<%*F%)"P>H;DGBPWGJH
M)$PS(9I]5Q*GN7^NS"@LAG$F%*R^*RD:9\(X$\"9 G%(F%7*/N!*3""A1&6N
MY 1*+80(C%9A#!6*5=^4*CI6%295H5CU3:FBGY(5AEDAF'T_*@[SZN9]PS K
ME*>^'54TS"JPY 4P4VC1C"%5^@/K;HR>0DG*5MX</4$WPD=A !7*4^;'Z#Q5
MF%&%\I3YD>=I2 5CK!#&S(\<XU7_""Y"BP:-.=8H3GT_:LZQ-?VR._ HJ3',
M&L!,@2=?C4G5,MZ4&@.H49KZIM0<0)$/?Z'M((RA1IG*-H1XI@;LH@.[3BA.
M?5-J'J<A%0RS1C#[IM0<YI60F;4JL&30F&:-XI2YDM-LA90JY$J,M$8;3Z$N
M,*\ZCW>EP1@:%*>^*TUTG!I,H$%QZOO1\#CMEXWA#4I,JD&9RK8H>::&5##,
M!L'LF])PF/ODUN$989@-RE3?DX;#K.B&%";:H'VG/-!%8(?8?,"3&$*#(I5Y
M,CI2#>;/H$AEGN212IFV66#=9S"G!N4J\V3T M5BE"U"F6V:<Y17TO3I'9B1
MQ4!;%*F^)RT'>MB@UZ%I8: M #JTD+685ON!4H[%$-J88HZ-3E2+^;,QA1P+
MMIMRJ:0(S0B#:F-J.39Z?6H#A9RH2@XJY6AKPE/"2-N86L[<Z+KD1BKCOY3)
M52VS<LW+6,5M%]OZ]=@-I<NKLY=*\8,<:Z'_-Y_*S+\7S<OAV"Z>ZJZKJ['N
M^5S7G>N'DW[J9[UWQ>YR4+KG;G@[?,W-5-Z=#KKZ-)>NDTO]?/,?4$L#!!0
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MX$%*G!9DK%<9APG#@DI@01P!1,HJF8P!TDV9A$%!"!29*8 P*.@"4! &!96
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M9H0O.:7QX/0E+I?BOTQ;&!*^!!(>W0 9MS4,PL^%8Z,P)CS"1.98R6?N@%R
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M4AIAXXD?;-)G>QOI-Z4X&K?,[%JU([G=&-ETUXVHO_.L_P%02P,$%     @
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M@F&<#,3) !SBX60 #J&H6##*0:,<,**>43XSHBRCJ?>P=G.9]^Y\P"E G +
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M4FIA5":1N<JSF8:'126.VKYR\]YV(V&WT/+2C[OQ,'-O_@)02P,$%     @
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MMH0VT 1A#4Q(N1@CL'*E&>W 1/KV->W I-??K33"1@"+2*KI]"70PK/>D:>
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M]L=^\W+]MB/]XGU;_)O_ U!+ P04    " "\B7%0N*1$DS8"  "2!@  &0
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M^^]P :K2M1)U1LFH,+].>1:2-2.+DM*0]V&L6S/VPTZ"1I@=@$8 F@!!_%]
M. +"3P VY@=EQNH7(DF1<]8[?/A:'=%_BF 5JF*6.FAJ9_:46Z&BER)%:>Y=
M--&8LQERT"PGF#(\Q3X=@6Q';- 5?'G"UI*2V8\(K2Y"@P__<7&# %L)L"'
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M)F/VW]1%U5;N2&R,K:Y[_TRVY][H9O1B49KR=7A7K7]?AS^<CV:P 1D-R&2
M\_\:T-& OALPG_Q YE/]5)IRM>CT->F&T3J5;E+@>VJ+N76=OG;^G\VVM[V7
ME:1TD5V<HU&S'C1DIL&3(K/>IQ $"K$FD3F1'R-L $D!AZ!@%M3;TSEA@6 '
M#'3 O /VH0PL*,.@R;VF]1HJ*.(\#Y*)=;C@G' * W$0B - /  :-'P6B!2(
M,!Z,WP;0242YE#!0#@+E %"0^3J/ Y'<UB@<[EB'!4."W!@R 0() $@$0 (
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M\\"8I(H0/*JC.JF).FUJ>I!ZF:@U'\;*L)&L&T=F,,WMS7]02P,$%     @
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MTZTRU5N1)E&&;S9HTAQ&3;S0Q.G_DJ-'LILEV!#,&+$7(W9^LO!'.^(/(-X
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M1>;XH+5/DA49!,[BH%7=*<;Z3X_]>3)OGFR5)T?("92M @&,DCR+"R>1!UB
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M<=-'.U?A'H? R'%^HGCY3U1_ 5!+ P04    " "\B7%0U_>VZ?@!  !K!0
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M*V<N1LV8!%6+]Z#*:-7D6P\$:JFWB=KS^?[/!\F&9;2A=;X6OP%02P,$%
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MB008P 6#&=8._=QX!GB7G=#A8\'1A;'$(P93$J-#X.A..B;J@7> 'HA!]@7
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M((Q0.8PE_*)$'R)9_9U'>9"84'G'8OUG7I,SE"U@M0\>(J%#\3DR;P64%2\
MQB>PZS K"[IX]YP7L;W+[AN2G6ZS8HM4FI0 XM=V%,G[*TKCEX7W#B4&F3BG
MIC]E-5L2RSE.QR67[AI.+2'GOEWLO8V#?Y!S:RQF_U&QK;MC(5GC=1V5P-E<
M^V>C?<A?_!+BZ^ 4#704L#M)S^AHV)FZ.U.QWI.-.1C'A^XY]WR* +@C+P1P
M " UN;R7L9QW<[C88C"LPR $@+A2E/H23%3 \U*=7!]SCNS']IXKF/(MAKPD
M$VMS-H=S7< \]?I:3$=R8OL.,R?;#$QD@.H"),:"!L#Q -:&8Q>&:!X9'& 1
M:[AL=*0R,3I[<$O\9LY<LQV6A3>3Q56V7@?Y7VJ3@K_^]0!X,%Z*L=@Q&HR]
MM1CN<48T;CMBG7L;'5"M:_(8N?@L.+:+HA1Z4'M'RXTDD@PL/T'=#1%0E%Y=
MZ*;8$,EP,]D)U)HKXK;FVY CD>A,2=3VBH.(R55R:5(A6(DLRIL#7O(P:JHZ
M[/$Q8%&!ZF;!@(D6>0P<)'B;C!D5U/84]'%'06_DQB/MT^CLHLU;_QJ;BOP\
MS&[O<E];@K[4*$(&ATZ^0=XBKK52;6(;L8,X9'?WV&0(A@ UVA^S\!ZS)1J6
M+CG>AR3A&<?5^LB@2 "/+"&$(6:SK82H<R,]=]A-6J\?=CN,9GI_F=@OC>O]
M@UI<^@,0)H/D@6DI%($2<,05SU'ZE >FQGCE-?L:Q%OG5Z*30&L"(2WJWWL@
MH!*I6'9\R4[LHP5AD$V)@$;QV*0CD:LUC*Z+:B^TQ+[4>%'(ER=D9,O!<F)_
MQZOFQD+4^I7\E%DM!M^24B(?EHG)&J34+50\Z-ZP+T+@)C$!&<9$D!TJE\3+
MDUWV=XH4V@'M181\]N#,&BNJ93[@%7*QDOWO6W90=%G?'!UGJX5CF#AB<2D>
M+QCW@@U)2EA$$'6L[0+8WB6J1/GNHMH@ S-<BU9*E(04E="5Y-R&M$.)-W/H
M(:*4,+F>Q3),2!RLQ:;D-^K!YZC()KL_W5>G\!\)4)#<L >4HI:].7"GA4('
MQ7YJ@&N8V,W>.:X486(P"B7> C2B-=\W[3W7=A44'NUP3#3IK.%(%9!U*)B!
M;-K&@1D>9^]1FBPJ'WB&>''T*/<&6=T7_<>*?D0MJH7W6W579(U<7H0$([)1
M.B;R>P'_(PPKSAVB((F3?[!@RC=<I<C@>*%RH<JX-T%RI)O"@3$Z5([OC1 ,
M>9U<(LUAHEI!>G%_)PP" RT@@W,0';?J6-ZM29S6U8@H< " &"!-AM\!D"B;
MS&3&?_"AX/[5<>>KKP]U63AC]F7Q=4\Z?<_+0!5=R*G:2<9#B1C@'"UDH%0^
M9XLBXUM\\QU*8FS&@??/'HT >%Z \=9:QM0'5ER0)<G>4D(7\\!(WHAY8G,J
MJR.7L<Z]OF[D<#2,<70,C84!J?<)UKVAP!M"!!!6B<"5?@W6+\)"S8F:C_E<
MB4PZ4=ZYXE4&<TMWB.ZN?C>)IDF>L0DII'._#X\98'[YG41?;?<MKT'+KZ"V
M.RHT$,D=! K[4!PFQ.XUI2HP\J7(.0T%'E#(SVM$C?QT2_%MW?D8N(%Z<TPJ
M"BR.+'G['SL,8V?V_98 P+':#E/(NQ7>$7%6:7R)=TU2 /?S?\*0T2UFCB%X
M5>H#J9IO'09=&)MLAR^1,\'4+VZQDV\L!0F,9FDBU<\8]5^(J5B4I!=P!D 9
M:XUMA0^>$*ZAF916#/NZ1-2!L[H!Q7\#>G7+HBT(2T>. 257UF//.:86>C !
M^H**RWM%8UJ2)+@F:UG37Y,B?A5@1#H&I>W[7 )S(6@D_!(^#1=I%2\R9<!;
MM\\PYHGR&[O?<:Z6QTZ,,(!1W78=&.C6G9!D^RS@_ T,U5R2$:1GFD%XA&2T
ME!H0/IL\0%!WQ5V<H\0CN:@MGXM2>=E  (\D@(?TT:WJAV!)@B3Z:DWN^(V&
M+Q)SLKY?P!7 '!,"19!&V.*%9V.-1@1FV[SQF"#7$Q03'V)M5V=]%;+IQD&:
MXUD%)TE.DQ3-QE%-'X9K@<1,HF&?+T73H@\2T3GP0N*K%*HF T@=,XXSX2.2
MH#:Z!1AYUDJJLY:8.M\56 V&?*W[[*L3#3E\7\_^[(J#G\H  3C7>MM15B"<
M\R*GY/#$F%?97B7S;@YL.2$'CO/SZ9DR%XY.TQ_(FVX7/E$?/15O07%0-]SK
M/.!>;Y5[A27:\''JC3'^Q%O7@L.HF07X3%4/8J#N6 W#>K:=H50)C@JDNDU*
M+&:.=ED(I14A4S;;\M1H\+/>.0P@N4&FU0%#C!O3NI\NTBT(ZJ.0%BERQWRP
M:D7/(?MS >4U&7'0@!W$D]@X+#O!  M\YWLTJO3$<@%D*ALO&"Z72-A>?=@^
M=\-;EYVUE%.WPOWT[$9C-()ZJ*RR^9/-Y**SB?VCEM'D,"I75=-]?A4K,Y'^
MH%$0(9,?)%AB=O< C%R\L]/8"LW90D]]E%J M"J&XWT,F8/SKT< :,?5F?.T
M@EQ7_'&[0"+?W)Y(2F]J;$=L/A8S4;0YS<M-A*)(0$@_L\%]:1SLBKX=-)-W
MK/M1\TM*@11?C"Y)6#%ND+CJDM8HSQ2>@LN)X&C!27S0O:A09JR$&+0D\I8T
M6DJ57B +EY]-4I(YS78UT**-R"TY0-E 1BK7O;$*N ""=B4.N"S[^B!&X&]<
MC%?JK-TR<%,9F8MM.NX*N321;,\EDS4DJ^4!J:5,4T!N'ES@B<'J;_@LV$ /
ML7@F2LZ&*1OJF51&SD:/MU.$6HN [SK7T&6I4EA;7: +O(^':@<P^Q;T**"T
M[L0.Q1?VK+5TJ@'E(H[G?\7B(1U;2TDS"99'(3N!(] BG;=5(!S2KN5VW5"Q
M'9U\__WK?WO_XLWWWS\CGW;_9I6O\">?/KR%3\24VJK]T()O;%9R/C%6O5QP
M;N?>V9^],79A?ZU]M$N4B@2R4.=8O9 3XS8F=4M8KF*O4W&C(#SG2T";C]I)
M8%R"SO/D#4U(OA 1J+)XWW<4IUM1OCT="DGIU]5VHX"C?$72I[NWW;!N]B8"
M"W-F3,;#4 Y*YO#*R48#N P;<L0)A%?$6Q='P9$16"!%BFB[@)!*PX7=KV+@
M\?5^NP[A1+(YV?*<(;_9:)X?75D$%B:-9H$MS>?(.U<)+YJ4@RYJW*GY/NM_
MWZ ^UEY(V6$C]C_RS\K1IL&PCR7NA;HHF\++,2:RNRNF&J,DE(3Y:M)!,ES'
M;>OB9K)TXVDXPKNPR%XL3-K03HXX432H?501$Y6T0TB(B6#7"J/[V+O4Z#TC
M1W(!TUL3M<1VO%24IC"D5TUBKG2I+K\EF+<EZR[WXR.VW;+%MFRP#YCD//L(
M5.^VC;EY%$.SNE-GJ,@?E*RB+#IE8APLV;/ 1F,S>C? J(RW,\"$P(]&M3L[
MN"OSPEB>^V/H9=&Y<ZE$6/=:;LS GU03K45_D7/<Y['3M^ T]NTFX)P^O59\
M?"%SL)8^)EF-NM/0$ZTEKBEUF6HB>Z33_[[,+[P#A)*MG2P=E1"P>7FA$'/T
ME-E7[D9O&6*4(NZUUFF,E13Z=Q6E8'D;![OZ.V'&GISVSCP4SCI^)6:FF:+9
M6IA33H21(M"]TZ'P],9ZT=C=J,F3E^@Z8^&:2.YVJX6I#)A HSL&_PR#[0\W
M;LR0/ F+= X;3;6GQCOD^"!69BO%HA'"1@F%P3!8=:H3'X)9R9@D.H-CED8U
M?%>%%/(1/@H;O)22M2Q5Q<GA<Y#Y\]":NZEL+_GJM2MA>HAXVF2-&.])@H4G
MM38BU4.-RTM(2%.J,791NCU[QDT=D#TG0*$,MF5'-%;>>,ZU!;V(3I$_9R&=
M.]+2*GZUU27*9NOWZ$A]K9?BL;LZ*SUB^*#94CRFO;?J,5T#6 LIR77RY-6+
MMT^>B5#.]4C85Q0?<3^?B&M.?L.G$BOIJFXA4L""9#D2H(7BZRZKBRU'>/<?
M5L@CW&:07A98;8;)+^K8F$G'%5=5CB%[T1$\N/ "!D?VL_KK^MPX'0^FR??%
MSGBH541J9?"1[&$=$H$GHPELB^;,<.":2MI&)@V73<7ZSEHAN@&65=5A3&YG
M(*X%'Q5YXWQ"YB!A1AB2@6/PLB;.#KRC V:+8&F*K1DW.P=>4I3:;U>QZ[2=
MVZ.X8EUHFM444#(7AJF.?:+TK-[)'ZS7@$C,WC"3:$(*O)^;G7 VE#YZ019G
M0P9<CE>'C.:X=9P(%NYACZ)-D-;1D=(6"%M;CO+E_"LJ)G,LZ8P)M,J_-#ZY
MOEW:F(0T^=0NYMEFL45<<D2,M>IP)@G!9U19-)%1.$\#N1[6-^3)^4 U:1A+
M])#<J!46D5L(!$N7F\3J*>OG(IBU<N;8,^R U#@HH8<(IV?XHW!@O ^L&@D9
MSGUP"9D#N[LLM<\AJMK>&?YFRH&TBV,J=JJA^[=K#"G7@_''BL;CJOYR6I2G
MFN8LU*-HKG$W7*BHEO!Y)R1MN:K&I:?7W5E[/7-:?[:MH4% ZD1;YO<V]6)_
M##7U&FURD 24(:&R::P&('KL3Q6O?)AA%)+MT5EN1OYU[VPM;"<3%R39E[O!
M\*[C:705)*3(QY>%:"B'7F$:2D9IDW%ZL2["CN&".B5YPU*3^"U?.5(38]35
M:H^1DL0.PD0Y\JAL#CLF[[\73R1.F=YI40?2",2=8^MT8?[[VZJ\DG@A#=#W
M5IG?D\%'+B;&T:A'G?I8)-2[/S.OFZ%+!!L6CM8*$E5MZ4&83BG#FWCBCK Q
MEY&!P=VHL112/B#,LR:#3K1/+3(/\[ *:-*G+_,C8,CVU']C[_-!-?&FP@3=
MY!^'K$:JSQ'FLF$&&RF$NC,74^$4/I<M1I,AAW^MWCI1$T) 2UYHZBS#="%A
M6176U]/EXW2WI&9N6>$C#9"NMC1;(!F+4'T'+R$M8"71USJAD;42:\-68LSS
M=%5!I?@ I7(VN;=];M&(0"#RF?$NS]L,4FG[%N]]H378@BLG^M5IE#A*;HHG
M+W[\1:L-MC$@0!:JDP:O:^D=;-S =Y24.$=ATP[6ESJ?@Y"P$C<,"';Y!W$T
M)=3PAZLE%YHC?B1703C_!YGX;1%N9.I>HXS7I6O9=T*+$B HI#8V:<8=#*D*
M/"<W' WKE*A.ZLSBHZ10B*Z#6BFY3P_L+IG@))G6=*9*8%#ID:,EKS.2J./M
MN)<$P#>XBNK04!;VWS^KOQZ#E<1?[PK)-K8D#MLPM X6QMUH[V'\-/ZUPRR,
M1QDIL%)\KH/I%GL1;[CR36_"&N>3F(G:UA4I7=/GL??[*!PDVF9M%8 ]0PW>
M5AV\LJH064"RK_1/>5LW[N1I4X?315/[FNZ^9V8T3T&]@V\H$NC2'2G'FQ[9
M4)OOPDG5+C\,_]IFZACS*):7&0G-)!:0^5%:)N@/(EV[F!".W7D9X$-/2:E6
MD(,6^SE"9H)BBJPXF@)S.-L%&<5,;4,]!T 7K.A7WP?1("8XW J649BXRP0D
M6/V!@;HW0KY2ZV0+DK=ZK@#AC+C]T/30CAUR59=*S?[T3K?20"8VNG\,U[SI
M.,Q+RO/FP@2(.N(SPW^SQM\8RV?1#W[B )Q2IZ232SFII,1H<21M)]J$JQSN
MTJ(S4MFLLZ>](<W/.6!1 0J?/V/(2D^LGBI,UN"/U%\*,:&ZZ*E2&WJ]L:^9
M(=$/C=)#.KGX.EW^1X.+#%I]D/&!WQ0V"ISC"U9UKM9?7)?0H(!$!O^2<!EL
M!,A557(M31ED!WH%H!U#8SP-.B+2("ZGZS)P1#<D*;1H;'CSKB+RLI5N$X];
M\#<O5OUAGUI[H""WIG_6*_Q/OHF]!21#*S.F= 14<Q#M*@RY$)N,KR?MO4-:
M,>@RSSA+2-$6"<+ZV@&6)FZM& ?U^2]^KS]LL_67T_/U=45]BFY<9 %5">&@
M#M(U;#V$**+3QS;*W+]M/R<=39G#-03Q,P'G]+9/QSOQ\5U_9V8LXX4A(>T&
MS9$E!CB7=(,N'UJ?A]'1Q6E^C),B)(B7"VY13VCVL'I72.^&M%-UJ^7T;\45
MT',-5;BI$#/(P:+1="$ PI+3R-)/=2&?VQ!YE]\EC=8_!PE5&U4U/CP&J-9>
M':R;RH;[*Y'CV.IY<IJ\12D9EBR)*O,GG]L6:!E#/_+:+/-4^MT%(,/V_C4#
M914XB]36#>FKTG1:#Z L>P2"%E!RCTG>Q+'IU=+L6\^DSC%60C0"4X7=)LUK
MQQR1OM4/SK84*F+7.*(J%3(EU><,=KM(%4(VC2^"\L"!1J.<FN0:2/B6OU0>
MZ E+ZMPQJ0GA)P[-5:5=N)F25DJK!438BB:3RVWGE ?$$'ZL>1::)T.94]7E
MZ:') \&/VN!9\4_;>7$^.*\\=BJUDZ5L4M0\K/9*/!O+0;@\^,QYIT-6[1BU
M1O;[%Q,LC"V=+%!LP/!$7KNC1[X6NDEZ@G_<YO>B<B(,M",0)@S@PX,8.#@M
MH5"+%H/!%M8L.,,UJ"<?N(AZI =JN=:"/DN)$?A=&?*M-"<$Q1O@9JJ1?[KN
M.LJ>6+* 4KL[&JC)K?DM6<1M\ LN"H_+Z9!(>D%73F]<N-"4(M<2$Q*4='MS
M-,;!:-_JT^#2.T6S SJXU1IKNTJ*>H;E6UENWW,9"%U5YROD?K15I5F"E29\
M)CYK*^U<L0H/96-J6$+?(:@ZYPHZ.$$PJ[>%MSB(Y&K-?FJ+:!^L+)D7@XJB
M86]A/J102C)G8WPIU2R0TD!!@I;SM]QD>^RJ88)67*<DC3CMR?EE$)A%B8^D
M<65F12BEX(]2Q1,4Y% H=C5N@XRMK*FPR=J]JPM%KTN-3.*,/ SG0TE=E+0/
M<*(W\'JDPUF-2@\OJJ-D1T&<7Q+>[370]6"@HXMW;'IND 6-T2./Q89JA9Y
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M;.D[3V  BK$>'R+8/'@L8H_%TR[SM:ML0>_;Q3]OI;?$__T4':\315O5'>&
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MT2XP?(PO04<&B&-5(R2$S>JX#+9]#H+5ANVR.K-5%+<H5A,K'Y(I^!B"]4Z
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M*B'5H3UNPL^-6@_HUF?;?>ZD;A<I@LD,@$^LMMQ0Y9TWTN\3'N>BTC.;3:Y
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MFA)J^,.5D,U(TPZ]6*[[.?5L=WXU)R%X?39>EZYEWPDMRCBA&.;8H!H6B<?
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M]2X*AJ.5NKH.QW:M=C2&=* Y1I&JVMAS@L8CI$1C@VZRW@EZ$;#E'+I;,IO
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M7I'N/3^+^W%^54=.$-*@U7>0(EXG\P^>?/%&9^W[:!((U7^/']+U<9\^S5
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MA*;3%F#)&T\&]-ZR^9/QD'$\]LFRU?X$4P_7!\@'2G>X<O2D&^G!V!/E@=!
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M0U+$V<?-%QVH#(9_W.]VA&X53#R;M+??K*\I?CZ7+!U^VV-^8PUN@\.D8Z)
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M'_8\S4DOOE:-WJ^9<<KA%5W@;SXSZX2R%R>%ORB:["NZ$)_#OG<](T_8O:<
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MN2EDI&;ZSBZQ#49XM#];X<%BF+4<*"(\VE\@I36_; N.[^[X!U!+ P04
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MO7R6U7W?H9 1.LQ*&-/<KT0B5YJBB5\.(P$$S *HH,ZFU(\SD=B,KN1VBY$
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M4IOK]>[J7%?]$]'<5O3/OP%02P,$%     @ O(EQ4,6FN>A4 @  )C<  !,
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M2P$"% ,4    " "\B7%0)^B'#H(   "Q    $               @ 'I
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( +R)<5!NIGJH[P   "L"   1
M              "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M +R)<5"97)PC$ 8  )PG   3              "  ;<"  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ O(EQ4&Q1% -> @  A @  !@
M     ( !^ @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M +R)<5"E1 7D<P0   $5   8              "  8P+  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    " "\B7%0I6;+F=0#  "S#P  &
M            @ $U$   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ O(EQ4!N!D!28!0  0!H  !@              ( !/Q0  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( +R)<5"YS)#CV00   46
M   8              "  0T:  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    " "\B7%0O<'"R;0!  #3 P  &               @ $<'P
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ O(EQ4(1S8"2U
M 0  TP,  !@              ( !!B$  'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( +R)<5!>>LEGM0$  -,#   8              "
M ?$B  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "\B7%0
MU778;;8!  #3 P  &               @ '<)   >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ O(EQ4 \QZ :V 0  TP,  !D
M     ( !R"8  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +R)<5!)RV90MP$  -,#   9              "
M 6LP  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ O(EQ
M4(N#,QFT 0  TP,  !D              ( !63(  'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"% ,4    " "\B7%0= ?(5;0!  #3 P  &0
M        @ %$-   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0
M   ( +R)<5!6S:/JM@$  -$#   9              "  2\V  !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ O(EQ4)8\F\:V 0  TP,
M !D              ( !'#@  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"% ,4    " "\B7%0&A^: +8!  #1 P  &0              @ $).@
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( +R)<5 SF]VS
ML0$  -,#   9              "  ?8[  !X;"]W;W)K<VAE971S+W-H965T
M,C$N>&UL4$L! A0#%     @ O(EQ4(^Q7ZRT 0  TP,  !D
M ( !WCT  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "\
MB7%092!M&;<!  #1 P  &0              @ ')/P  >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( +R)<5#MG)-=M0$  -,#   9
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M970R."YX;6Q02P$"% ,4    " "\B7%0U$D?HK4!  #3 P  &0
M    @ %62P  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (
M +R)<5!5C5L,M0$  -,#   9              "  4)-  !X;"]W;W)K<VAE
M971S+W-H965T,S N>&UL4$L! A0#%     @ O(EQ4,B!QNA@ @  I @  !D
M             ( !+D\  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"
M% ,4    " "\B7%0L=@AHKD!  #3 P  &0              @ '%40  >&PO
M=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( +R)<5!B#IK1Q0$
M #@$   9              "  ;53  !X;"]W;W)K<VAE971S+W-H965T,S,N
M>&UL4$L! A0#%     @ O(EQ4'&7\##' 0  . 0  !D              ( !
ML54  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " "\B7%0
M<P"PMK8!  #3 P  &0              @ &O5P  >&PO=V]R:W-H965T<R]S
M:&5E=#,U+GAM;%!+ 0(4 Q0    ( +R)<5 %DDA@N $  -,#   9
M      "  9Q9  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%
M  @ O(EQ4+)%+\K$ 0  . 0  !D              ( !BUL  'AL+W=O<FMS
M:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " "\B7%0$FH7RK@!  #3 P
M&0              @ &&70  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+
M 0(4 Q0    ( +R)<5"B;M-FN $  -,#   9              "  75?  !X
M;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ O(EQ4(Q!)9VX
M 0  TP,  !D              ( !9&$  'AL+W=O<FMS:&5E=',O<VAE970T
M,"YX;6Q02P$"% ,4    " "\B7%0KPXKK[<!  #3 P  &0
M@ %38P  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( +R)
M<5#F=03]QP$  #@$   9              "  4%E  !X;"]W;W)K<VAE971S
M+W-H965T-#(N>&UL4$L! A0#%     @ O(EQ4!X!T&JX 0  TP,  !D
M         ( !/V<  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
M    " "\B7%0I1CPNMT!   "!0  &0              @ $N:0  >&PO=V]R
M:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( +R)<5!(+?>ISP$  )T$
M   9              "  4)K  !X;"]W;W)K<VAE971S+W-H965T-#4N>&UL
M4$L! A0#%     @ O(EQ4$PL\6NX 0  TP,  !D              ( !2&T
M 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " "\B7%0]U.7
M^+D!  #3 P  &0              @ $W;P  >&PO=V]R:W-H965T<R]S:&5E
M=#0W+GAM;%!+ 0(4 Q0    ( +R)<5#"H4SDWP$   (%   9
M  "  2=Q  !X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @
MO(EQ4,M%5G2X 0  TP,  !D              ( !/7,  'AL+W=O<FMS:&5E
M=',O<VAE970T.2YX;6Q02P$"% ,4    " "\B7%038D,F;@!  #3 P  &0
M            @ $L=0  >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4
M Q0    ( +R)<5"RZ/R]3@(  ,H&   9              "  1MW  !X;"]W
M;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ O(EQ4*94,-;E 0
MM@0  !D              ( !H'D  'AL+W=O<FMS:&5E=',O<VAE970U,BYX
M;6Q02P$"% ,4    " "\B7%0:X'"_^4"  #@"@  &0              @ &\
M>P  >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( +R)<5"-
M)%4'W@$  &<$   9              "  =A^  !X;"]W;W)K<VAE971S+W-H
M965T-30N>&UL4$L! A0#%     @ O(EQ4#Q=YIWL 0  !P4  !D
M     ( ![8   'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +R)<5!5&_HNWP,  ,P1   9              "
M >*/  !X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ O(EQ
M4$B#QAW\ 0  ^00  !D              ( !^),  'AL+W=O<FMS:&5E=',O
M<VAE970V,2YX;6Q02P$"% ,4    " "\B7%0'(8^'E\#  #_#P  &0
M        @ $KE@  >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0
M   ( +R)<5#XB#TIS@0  )P9   9              "  <&9  !X;"]W;W)K
M<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ O(EQ4,G;-'*Y 0  V@,
M !D              ( !QIX  'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q0
M2P$"% ,4    " "\B7%0]*]=4BD"  "U!@  &0              @ &VH
M>&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( +R)<5"9'9-C
M%0(  %D&   9              "  1:C  !X;"]W;W)K<VAE971S+W-H965T
M-C8N>&UL4$L! A0#%     @ O(EQ4'$HDZR# @  40H  !D
M ( !8J4  'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " "\
MB7%0/U4AH^L!   /!0  &0              @ $<J   >&PO=V]R:W-H965T
M<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( +R)<5"FY:F?_0,  -,4   9
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M970W,RYX;6Q02P$"% ,4    " "\B7%0[/'S@1X"   V!@  &0
M    @ %ZN0  >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    (
M +R)<5 U1/AA4 4  $L?   9              "  <^[  !X;"]W;W)K<VAE
M971S+W-H965T-S4N>&UL4$L! A0#%     @ O(EQ4$K1OZGY 0  #P4  !D
M             ( !5L$  'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"
M% ,4    " "\B7%0,BKM\QL'  !H+   &0              @ &&PP  >&PO
M=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( +R)<5#SB_L!D0(
M /\(   9              "  =C*  !X;"]W;W)K<VAE971S+W-H965T-S@N
M>&UL4$L! A0#%     @ O(EQ4#78@6D9 @  W04  !D              ( !
MH,T  'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4    " "\B7%0
M>DIS8G0"  !+"0  &0              @ 'PSP  >&PO=V]R:W-H965T<R]S
M:&5E=#@P+GAM;%!+ 0(4 Q0    ( +R)<5"7'1S+X@$  "\%   9
M      "  9O2  !X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%
M  @ O(EQ4%56PP^#!0  =!L  !D              ( !M-0  'AL+W=O<FMS
M:&5E=',O<VAE970X,BYX;6Q02P$"% ,4    " "\B7%0M<:PQ+4"  !!"0
M&0              @ %NV@  >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+
M 0(4 Q0    ( +R)<5!@ZY)CP0(  )X*   9              "  5K=  !X
M;"]W;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ O(EQ4$V=%W@T
M!0  X2   !D              ( !4N   'AL+W=O<FMS:&5E=',O<VAE970X
M-2YX;6Q02P$"% ,4    " "\B7%0&V]Q!1@#  !_"P  &0
M@ &]Y0  >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( +R)
M<5#-DRWGJ (  -8)   9              "  0SI  !X;"]W;W)K<VAE971S
M+W-H965T.#<N>&UL4$L! A0#%     @ O(EQ4**(\WP##0  (E\  !D
M         ( !Z^L  'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4
M    " "\B7%0N*1$DS8"  "2!@  &0              @ $E^0  >&PO=V]R
M:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    ( +R)<5#9[S+9U (  (0)
M   9              "  9+[  !X;"]W;W)K<VAE971S+W-H965T.3 N>&UL
M4$L! A0#%     @ O(EQ4$;$& 9Z @  PP<  !D              ( !G?X
M 'AL+W=O<FMS:&5E=',O<VAE970Y,2YX;6Q02P$"% ,4    " "\B7%0WR;W
MZ.$!  #N!   &0              @ %. 0$ >&PO=V]R:W-H965T<R]S:&5E
M=#DR+GAM;%!+ 0(4 Q0    ( +R)<5#/+$D%3 (   T'   9
M  "  68# 0!X;"]W;W)K<VAE971S+W-H965T.3,N>&UL4$L! A0#%     @
MO(EQ4&7I;$S, 0  ,P0  !D              ( !Z04! 'AL+W=O<FMS:&5E
M=',O<VAE970Y-"YX;6Q02P$"% ,4    " "\B7%0U_>VZ?@!  !K!0  &0
M            @ 'L!P$ >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM;%!+ 0(4
M Q0    ( +R)<5"J!*XP'0(  (T%   9              "  1L* 0!X;"]W
M;W)K<VAE971S+W-H965T.38N>&UL4$L! A0#%     @ O(EQ4-QLV9.SF
MDU0" !0              ( !;PP! 'AL+W-H87)E9%-T<FEN9W,N>&UL4$L!
M A0#%     @ O(EQ4%M /F1( @  A L   T              ( !5*4! 'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " "\B7%01;J>M;<&  #5/@  #P
M        @ ''IP$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ O(EQ4%)T
M6G'5 @  !3D  !H              ( !JZX! 'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ O(EQ4,6FN>A4 @  )C<  !,
M     ( !N+$! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     &D :0#1'
&/;0!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6819776624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Biological assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfBiologicalAssetsExplanatory', window );">Schedule of biological assets</a></td>
<td class="text"><div><table style="border-collapse:collapse;margin-left:60pt;margin-right:40pt;border:0px;width:90%" width="80%"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>$</span></span></strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2018</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:12" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:212" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);border-top:1pt solid black;width:25" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalized costs</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:12" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:212" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,297,734</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);width:25" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in fair value less costs to sell due to biological transformation</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:12" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:212" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(682,739</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:25" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transferred to inventory upon harvest</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:12" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:212" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(614,995</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-bottom:1pt solid black;width:25" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:12" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:212" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255);width:25" valign="bottom">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>Balance, December 31, 2019</span></span></strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:12" valign="bottom">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:212" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>&#x2014;</span></span></strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255);border-top:none;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:25" valign="bottom">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory', window );">Schedule of unobservable input used to estimate fair value of biological assets</a></td>
<td class="text"><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><table border="1" cellpadding="3" cellspacing="0" style="border:0px;width:90%;margin:auto"><tbody><tr><td colspan="2" rowspan="2" style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Assumptions:</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>As at December 31, 2019</strong></span></span></td></tr><tr><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Input</strong></span></span></td></tr><tr><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected yields for cannabis plants (average grams per plant)</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13 grams dry flower<br/>16 grams dry trim</span></span></td></tr><tr><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ii</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average number of growing weeks completed as a percentage of total growing weeks as at period end</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">73%</span></span></td></tr><tr><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iii</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Estimated selling price per gram</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;border:1pt solid black"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1.00 for flower</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$0.50 for trim</span></span></p></td></tr><tr><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:20%;text-align:center;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iv</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:40%;border:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">After harvest cost to complete and sell per gram</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:30%;border:1pt solid black"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1.91 for dry flower</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1.25 for dry trim</span></span></p></td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfBiologicalAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related to Biological assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfBiologicalAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of unobservable input used to estimate fair value of biological assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6825662864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY - CAD ($)<br></strong></div></th>
<th class="th"><div>Class A shares</div></th>
<th class="th"><div>Class B shares</div></th>
<th class="th"><div>Warrants</div></th>
<th class="th"><div>Contributed surplus</div></th>
<th class="th"><div>Foreign exchange translation reserve</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance at Dec. 31, 2017</a></td>
<td class="nump">$ 201,500<span></span>
</td>
<td class="nump">$ 12,794,963<span></span>
</td>
<td class="nump">$ 2,116,900<span></span>
</td>
<td class="nump">$ 1,495,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,195,264)<span></span>
</td>
<td class="nump">$ 12,413,399<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Beginning balance (shares) at Dec. 31, 2017</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">3,794,846<span></span>
</td>
<td class="nump">354,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,853,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,853,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfShares', window );">Shares issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,268,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,634,405)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,634,405)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughReverseAcquisition', window );">Reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,868,179<span></span>
</td>
<td class="nump">$ 118,875<span></span>
</td>
<td class="nump">25,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,012,779<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughReverseAcquisitionShares', window );">Reverse acquisition (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">545,505<span></span>
</td>
<td class="nump">37,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughWarrantValuations', window );">Warrant valuations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,366,670)<span></span>
</td>
<td class="nump">$ 2,366,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughWarrantValuationsShares', window );">Warrant valuations (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 294,287<span></span>
</td>
<td class="nump">6,146,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,440,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Share options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,145,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,288,775)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,857,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExerciseOfOptionShares', window );">Share options exercised (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughStockOptionsCancelled', window );">Share options cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(401,069)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,254,665<span></span>
</td>
<td class="num">$ (454,587)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares', window );">Warrants exercised (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,931<span></span>
</td>
<td class="num">(44,932)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Net comprehensive loss for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,710,624)<span></span>
</td>
<td class="num">(22,710,624)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance at Dec. 31, 2018</a></td>
<td class="nump">$ 201,500<span></span>
</td>
<td class="nump">$ 67,916,302<span></span>
</td>
<td class="nump">$ 4,442,145<span></span>
</td>
<td class="nump">4,977,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,504,819)<span></span>
</td>
<td class="nump">51,032,428<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2018</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">6,843,780<span></span>
</td>
<td class="nump">546,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,539,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,539,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfShares', window );">Shares issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,431,818<span></span>
</td>
<td class="nump">$ 1,888,086<span></span>
</td>
<td class="nump">2,567,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,887,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc. (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,940<span></span>
</td>
<td class="nump">67,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,061,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,061,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Share options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,782,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,049,840)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">732,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExerciseOfOptionShares', window );">Share options exercised (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,174<span></span>
</td>
<td class="num">$ (50,183)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares', window );">Warrants exercised (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,167<span></span>
</td>
<td class="num">(12,167)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue', window );">Warrants expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (535,014)<span></span>
</td>
<td class="nump">535,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares', window );">Warrants expired (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134,192)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Net comprehensive loss for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (112,690)<span></span>
</td>
<td class="num">(52,013,186)<span></span>
</td>
<td class="num">(52,125,876)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">$ 201,500<span></span>
</td>
<td class="nump">$ 97,815,149<span></span>
</td>
<td class="nump">$ 5,745,034<span></span>
</td>
<td class="nump">$ 23,091,099<span></span>
</td>
<td class="num">$ (112,690)<span></span>
</td>
<td class="num">$ (78,518,005)<span></span>
</td>
<td class="nump">$ 48,222,087<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2019</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">7,905,727<span></span>
</td>
<td class="nump">467,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExerciseOfOptionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from exercise of option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExerciseOfOptionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExpiryOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExpiryOfWarrantsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents Increase Decrease Through issued on acquisition of net assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents Increase Decrease Through issued on acquisition of net assets shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughReverseAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from reverse acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughReverseAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughReverseAcquisitionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from reverse acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughReverseAcquisitionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughStockOptionsCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from stock options cancelled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughStockOptionsCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughWarrantValuations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from warrant valuations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughWarrantValuations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughWarrantValuationsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from warrant valuations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughWarrantValuationsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6843519264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other investments (Narrative) (Details) - CAD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 05, 2020</div></th>
<th class="th"><div>Feb. 04, 2020</div></th>
<th class="th"><div>Nov. 04, 2019</div></th>
<th class="th"><div>May 07, 2019</div></th>
<th class="th"><div>Sep. 06, 2018</div></th>
<th class="th"><div>Nov. 22, 2019</div></th>
<th class="th"><div>Sep. 20, 2019</div></th>
<th class="th"><div>Apr. 24, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Loss on change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,568,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,593,777<span></span>
</td>
<td class="nump">$ 44,987,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,646,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,593,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember', window );">Pharmadrug Inc. | Share Exchange Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesAcquired', window );">Number of shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,562,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SharePrices', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember', window );">Pharmadrug Inc. | Share Exchange Agreement | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInShareExchange', window );">Number of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,892<span></span>
</td>
<td class="nump">65,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSharesIssuedInShareExchange', window );">Value of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Loss on change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,422,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember', window );">Pharmadrug Inc. | Share Exchange Agreement | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInShareExchange', window );">Number of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,892<span></span>
</td>
<td class="nump">65,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSharesIssuedInShareExchange', window );">Value of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Loss on change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,422,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember', window );">Cannara Biotech Inc. | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesHeldSubjectToEscrowArrangement', window );">Number of shares held subject to escrow arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,003,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_QuotedMarketPriceOfInvestments', window );">Quoted market price of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfAggregateDiscountForSharesInEscrow', window );">Percentage of aggregate discount for escrow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.53%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AggregateDiscountForSharesInEscrow', window );">Aggregate discount for shares in escrow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,556,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember', window );">Cannara Biotech Inc. | Class B shares | Subsequent events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="nump">$ 7,743,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember', window );">Cannara Biotech Inc. | Unrestricted Class B shares | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesHeldSubjectToEscrowArrangement', window );">Number of shares held subject to escrow arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,250,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember', window );">Cannara Biotech Inc. | Class B shares held in escrow | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesHeldSubjectToEscrowArrangement', window );">Number of shares held subject to escrow arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,752,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CloverCannastripThinFilmTechnologiesCorpMember', window );">Clover Cannastrip Thin Film Technologies Corp.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement', window );">Value of subscribed equity units in brokered private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember', window );">High Tide Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesHeld', window );">Number of shares held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,551,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsHeld', window );">Number of warrants held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ProceedsFromSaleOfSharesAndWarrants', window );">Proceeds from sale of shares and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 614,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember', window );">HUGE Shops</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesHeld', window );">Number of shares held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,333,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SubscriptionPricePerShare', window );">Subscription price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfDeclineInFairValueOfInvestment', window );">Percentage of decline in fair value of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueOfInvestment', window );">Change in fair value of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember', window );">SciCann Therapeutics Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesHeld', window );">Number of shares held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SubscriptionPricePerShare', window );">Subscription price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfDeclineInFairValueOfInvestment', window );">Percentage of decline in fair value of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueOfInvestment', window );">Change in fair value of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 129,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SharePrices', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Loss on change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,146,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesHeld', window );">Number of shares held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsHeld', window );">Number of warrants held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PrincipalAmountOfBorrowings', window );">Principal amount of convertible debenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FairValueOfSharesAndWarrantsAcquired', window );">Fair value of shares and warrants acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrants', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_QuotedMarketPriceOfInvestments', window );">Quoted market price of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeRateOfWarrants', window );">Risk free rate of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.71%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrants', window );">Expected volatility of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedTermOfWarrants', window );">Expected term of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedDividendYieldOfWarrants', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DebtConversionRatio', window );">Debt conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Subsequent events | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability', window );">Number of additional shares issued to settle derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Share Exchange Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GuaranteedMinimumLiquidationValueOfShares', window );">Guaranteed minimum liquidation value of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Share Exchange Agreement | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInShareExchange', window );">Number of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Share Exchange Agreement | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInShareExchange', window );">Number of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSharesIssuedInShareExchange', window );">Value of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AggregateDiscountForSharesInEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to aggregate discount for shares in escrow.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AggregateDiscountForSharesInEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ChangeInFairValueOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to change in fair value of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ChangeInFairValueOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DebtConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Debt conversion ratio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DebtConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfOtherInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfOtherInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExercisePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price per share of excercise price of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExercisePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedDividendYieldOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected dividend yield of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedDividendYieldOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedTermOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expected term of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedTermOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedVolatilityOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected volatility of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedVolatilityOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_FairValueOfSharesAndWarrantsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the fair value of shares and warrants acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_FairValueOfSharesAndWarrantsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_GuaranteedMinimumLiquidationValueOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents guaranteed minimum liquidation value of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_GuaranteedMinimumLiquidationValueOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of additional shares issued to settle derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesHeldSubjectToEscrowArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares held subject to escrow arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesHeldSubjectToEscrowArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedInShareExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares issued in share exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedInShareExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfAggregateDiscountForSharesInEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of Percentage of aggregate discount for shares in escrow.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfAggregateDiscountForSharesInEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfDeclineInFairValueOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of decline in fair value of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfDeclineInFairValueOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to principal amount of borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ProceedsFromSaleOfSharesAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to proceeds from sale of shares and warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ProceedsFromSaleOfSharesAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_QuotedMarketPriceOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price per share related to quoted market price of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_QuotedMarketPriceOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_RiskFreeRateOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the risk free rate of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_RiskFreeRateOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareIssuePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price per share of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareIssuePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SharePrices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents Share price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SharePrices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the subscription price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ValueOfSharesIssuedInShareExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to shares issued in share exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ValueOfSharesIssuedInShareExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the value of subscribed equity units in brokered private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_SecuritiesExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_SecuritiesExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_ClassBSubordinateVotingSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=huge_ClassBSubordinateVotingSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=huge_SubsequentEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=huge_SubsequentEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_UnrestrictedClassBSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=huge_UnrestrictedClassBSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_ClassBSharesHeldInEscrowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=huge_ClassBSharesHeldInEscrowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CloverCannastripThinFilmTechnologiesCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_CloverCannastripThinFilmTechnologiesCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6823668272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Narrative) (Details) - CAD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SummaryOfSignificantAccountingPoliciesAbstract', window );"><strong>Summary Of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities', window );">Incremental borrowing rate to discount lease liabilities</a></td>
<td class="nump">7.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 202,869<span></span>
</td>
<td class="nump">$ 243,818<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage related to incremental borrowing rate to discount the lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncrementalBorrowingRateToDiscountLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SummaryOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SummaryOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6815245552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease obligations - Schedule of lease obligations (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Balance - January 1, 2019</a></td>
<td class="nump">$ 243,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Add: Interest Expense</a></td>
<td class="nump">15,258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Less: Lease Payments</a></td>
<td class="num">(56,207)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Balance - December 31, 2019</a></td>
<td class="nump">202,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current</a></td>
<td class="nump">56,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current</a></td>
<td class="nump">$ 146,662<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6824558016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares', window );">Dilutive effect of convertible instruments on number of ordinary shares</a></td>
<td class="nump">1,922,394<span></span>
</td>
<td class="nump">1,031,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_WarrantsMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares', window );">Dilutive effect of convertible instruments on number of ordinary shares</a></td>
<td class="nump">467,451<span></span>
</td>
<td class="nump">546,212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_StockOptionsMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares', window );">Dilutive effect of share options on number of ordinary shares</a></td>
<td class="nump">1,454,943<span></span>
</td>
<td class="nump">485,159<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=huge_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=huge_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6814501840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade and other receivables- Schedule of trade and other receivables (Details) - CAD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SalesTaxRecoverable', window );">Sales tax recoverable</a></td>
<td class="nump">$ 2,033,535<span></span>
</td>
<td class="nump">$ 982,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RentReceivable', window );">Rent receivable</a></td>
<td class="nump">12,990<span></span>
</td>
<td class="nump">8,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherReceivables', window );">Other</a></td>
<td class="nump">23,530<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Total trade and other receivables</a></td>
<td class="nump">$ 2,070,055<span></span>
</td>
<td class="nump">$ 990,988<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_RentReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_RentReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SalesTaxRecoverable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for sales taxes recoverable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SalesTaxRecoverable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount receivable by the entity that it does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6750600064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes Payable - Schedule of notes payable (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued', window );">Notes payable</a></td>
<td class="nump">$ 1,908,412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember', window );">Short-term notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued', window );">Notes payable</a></td>
<td class="nump">193,996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=huge_NotesPayableMember', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued', window );">Notes payable</a></td>
<td class="nump">$ 1,714,416<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current notes and debentures issued and the current portion of non-current notes and debentures issued. [Refer: Notes and debentures issued]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=huge_NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=huge_NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6816425824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share capital - Schedule of warrants outstanding and exercise price (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="nump">$ 9.47<span></span>
</td>
<td class="nump">$ 5.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">467,451<span></span>
</td>
<td class="nump">546,212<span></span>
</td>
<td class="nump">354,996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember30th2020Member', window );">Warrants by expiry date at November 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">16,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtSeptember15th2022Member', window );">Warrants by expiry date at September 15, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">199,005<span></span>
</td>
<td class="nump">199,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtAugust1st2021Member', window );">Warrants by expiry date at August 1, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">4,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtSeptember11th2023Member', window );">Warrants by expiry date at September 11, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">22,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary5th2020Member', window );">Warrants by expiry date at January 5, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 6.03<span></span>
</td>
<td class="nump">$ 6.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">37,313<span></span>
</td>
<td class="nump">37,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJuly24th2023Member', window );">Warrants by expiry date at July 24, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 13.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">3,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay20th2023Member', window );">Warrants by expiry date at May 20, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 16.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">7,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay24th2022Member', window );">Warrants by expiry date at May 24, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 18.09<span></span>
</td>
<td class="nump">$ 18.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">163,535<span></span>
</td>
<td class="nump">163,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay4th2025Member', window );">Warrants by expiry date at May 4, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay10th2025Member', window );">Warrants by expiry date at May 10, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">1,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay17th2025Member', window );">Warrants by expiry date at May 17, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay31st2025Member', window );">Warrants by expiry date at May 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">1,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary16th2026Member', window );">Warrants by expiry date at January 16, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">1,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary20th2026Member', window );">Warrants by expiry date at January 20, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtOctober20th2019Member', window );">Warrants by expiry date at October 20, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember1st2019Member', window );">Warrants by expiry date at November 1, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember14th2019Member', window );">Warrants by expiry date at November 14, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember21st2019Member', window );">Warrants by expiry date at November 21, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtDecember12st2019Member', window );">Warrants by expiry date at December 12, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtDecember29th2019Member', window );">Warrants by expiry date at December 29, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfWarrantsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfWarrantsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageExercisePriceWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise Price warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageExercisePriceWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember30th2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember30th2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtSeptember15th2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtSeptember15th2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtAugust1st2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtAugust1st2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtSeptember11th2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtSeptember11th2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary5th2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary5th2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJuly24th2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJuly24th2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay20th2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay20th2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay24th2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay24th2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay4th2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay4th2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay10th2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay10th2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay17th2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay17th2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay31st2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay31st2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary16th2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary16th2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary20th2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary20th2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtOctober20th2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtOctober20th2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember1st2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember1st2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember14th2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember14th2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember21st2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember21st2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtDecember12st2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtDecember12st2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtDecember29th2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtDecember29th2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6824086448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other investments - Schedule of Other investments (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2018</a></td>
<td class="nump">$ 18,064,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="nump">6,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">614,520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(11,669,157)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2019</a></td>
<td class="nump">11,780,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember', window );">Pharmadrug Inc. | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2018</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(2,660,940)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2019</a></td>
<td class="nump">339,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember', window );">Cannara Biotech Inc. | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2018</a></td>
<td class="nump">11,215,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(2,146,357)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2019</a></td>
<td class="nump">9,069,038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CloverCannastripThinFilmTechnologiesCorpMember', window );">Clover Cannastrip | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2018</a></td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(1,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember', window );">High Tide Inc. | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2018</a></td>
<td class="nump">1,798,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">614,520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(1,183,520)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember', window );">High Tide Inc. | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2018</a></td>
<td class="nump">251,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(251,115)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember', window );">HUGE Shops | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2018</a></td>
<td class="nump">1,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(539,132)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2019</a></td>
<td class="nump">760,868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember', window );">SciCann Therapeutics Inc. | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2018</a></td>
<td class="nump">1,999,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(1,287,743)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2019</a></td>
<td class="nump">712,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2018</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="nump">690,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(255,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2019</a></td>
<td class="nump">435,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2018</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="nump">385,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(269,134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2019</a></td>
<td class="nump">116,650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Convertible debenture</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOtherInvestmentsLineItems', window );"><strong>Disclosure Of Other Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2018</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="nump">1,924,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(1,576,216)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Balance at December 31, 2019</a></td>
<td class="nump">$ 348,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to change in fair value through profit or loss of investments other than investments accounted for using equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfOtherInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfOtherInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Non-current assets; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of investments other than investments accounted for using equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CloverCannastripThinFilmTechnologiesCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_CloverCannastripThinFilmTechnologiesCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=huge_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=huge_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=huge_ConvertibleDebentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=huge_ConvertibleDebentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796912240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract', window );"><strong>Disclosure of detailed information about borrowings [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory', window );">Schedule of notes payable</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:449px">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:4px;border-bottom:1pt solid black">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:449px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term notes</span></span></td><td style="border:1pt none;vertical-align:bottom;text-align:left;width:4px;background-color:rgb(204, 238, 255)">&#160;</td><td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">193,996</span></span></td><td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:449px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Notes payable</p></td><td style="vertical-align:bottom;text-align:left;width:4px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,714,416</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:449px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as at December 31, 2019</span></span></td><td style="vertical-align:bottom;text-align:left;width:4px;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,908,412</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796882384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and administrative (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling, general and administrative expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory', window );">Schedule of general and administrative expense</a></td>
<td class="text"><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.<span style="width:5.25pt;display:inline-block"> </span><strong>General and administrative</strong></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Components of general and administrative expenses for the years ended December 31, 2019 and 2018 were as follows:</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt">&#160;</p><table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2018</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional fees</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>3,730,556</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,955,253</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Stock promotion</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,902,453</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,803,588</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries, wages and benefits</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,267,308</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,740,720</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consulting fees</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,288,129</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,037,049</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">General office, travel and adminsitration expenditures</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,172,824</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">726,509</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Repairs, maintenance and utilities</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>924,945</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,360,477</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shareholder and public company costs</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>440,746</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">124,973</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Listing expense</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#x2014;</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,991,791</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign exchange loss</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>84,568</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>14,811,529</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,740,360</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of general and administrative expenses. [Refer: Administrative expenses]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6606784288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Capital management (Narrative) (Details) - CAD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfCapitalManagementAbstract', window );"><strong>Disclosure Of Capital Management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">$ 98,016,649<span></span>
</td>
<td class="nump">$ 68,117,802<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfCapitalManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfCapitalManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6823440144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income taxes - Schedule of non-capital loss carryforwards (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight', window );">2038</a></td>
<td class="nump">$ 12,492,296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine', window );">2039</a></td>
<td class="nump">15,026,313<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalLossCarryforwards', window );">Non-capital income tax losses expire</a></td>
<td class="nump">$ 27,518,609<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Non capital income tax losses expire on 2038.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Non capital income tax losses expire on 2039.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of non-capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6815925360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and administrative (Details) - CAD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling, general and administrative expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees</a></td>
<td class="nump">$ 3,730,556<span></span>
</td>
<td class="nump">$ 1,955,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_StockPromotionExpenses', window );">Stock promotion</a></td>
<td class="nump">2,902,453<span></span>
</td>
<td class="nump">2,803,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Salaries, wages and benefits</a></td>
<td class="nump">2,267,308<span></span>
</td>
<td class="nump">1,740,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ConsultingFeesExpenses', window );">Consulting fees</a></td>
<td class="nump">2,288,129<span></span>
</td>
<td class="nump">2,037,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdministrativeExpense', window );">General office, travel and adminsitration expenditures</a></td>
<td class="nump">2,172,824<span></span>
</td>
<td class="nump">726,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepairsAndMaintenanceExpense', window );">Repairs, maintenance and utilities</a></td>
<td class="nump">924,945<span></span>
</td>
<td class="nump">1,360,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareholdersAndPublicCompanyCosts', window );">Shareholder and public company costs</a></td>
<td class="nump">440,746<span></span>
</td>
<td class="nump">124,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ListingExpense', window );">Listing expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,991,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange loss</a></td>
<td class="nump">84,568<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">$ 14,811,529<span></span>
</td>
<td class="nump">$ 18,740,360<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ConsultingFeesExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses of consulting fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ConsultingFeesExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ListingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Listing expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ListingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareholdersAndPublicCompanyCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about shareholder and public company costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareholdersAndPublicCompanyCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_StockPromotionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about stock promotion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_StockPromotionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity classifies as being administrative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2019-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepairsAndMaintenanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepairsAndMaintenanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WagesAndSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 9<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WagesAndSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6830420848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital (Narrative) (Details) - CAD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 04, 2019</div></th>
<th class="th"><div>Oct. 04, 2019</div></th>
<th class="th"><div>May 07, 2019</div></th>
<th class="th"><div>Oct. 16, 2019</div></th>
<th class="th"><div>Sep. 20, 2019</div></th>
<th class="th"><div>Apr. 24, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Loss on change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,568,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,593,777<span></span>
</td>
<td class="nump">$ 44,987,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Share issue costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,705<span></span>
</td>
<td class="nump">$ 3,768,381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SharePrices', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Loss on change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,146,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfArrangementsAxis=huge_SecuritiesExchangeAgreementMember', window );">Share Exchange Agreement | Pharmadrug Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesAcquired', window );">Number of shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,562,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SharePrices', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember', window );">Class A shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DescriptionOfVotingRights', window );">Description of voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The holders of Class A shares are entitled to 276,660 votes per class A share held.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedForDebtSettlement', window );">Number of shares issued for debt settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSharesIssuedForDebtSettlement', window );">Value of shares issued for debt settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DescriptionOfReverseShareSplit', window );">Description of reverse share split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInPrivatePlacement', window );">Number of shares issued in private placement</a></td>
<td class="nump">228,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share</a></td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuance of shares</a></td>
<td class="nump">$ 4,593,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Share issue costs</a></td>
<td class="nump">$ 32,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability', window );"><strong>Recognition of loss on change in fair value of derivative liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares | Share Exchange Agreement | Pharmadrug Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInShareExchange', window );">Number of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,892<span></span>
</td>
<td class="nump">65,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSharesIssuedInShareExchange', window );">Value of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Loss on change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,422,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares | Share Exchange Agreement | Solarvest BioEnergy Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInShareExchange', window );">Number of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DescriptionOfReverseShareSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the description of reverse share split.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DescriptionOfReverseShareSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DescriptionOfVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DescriptionOfVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from acquisition of net assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedForDebtSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares issued for debt settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedForDebtSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedInPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of shares issued in private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedInPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedInShareExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares issued in share exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedInShareExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of recognition of loss on change in fair value of derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareIssuePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price per share of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareIssuePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SharePrices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents Share price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SharePrices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ValueOfSharesIssuedForDebtSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of shares issued for debt settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ValueOfSharesIssuedForDebtSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ValueOfSharesIssuedInShareExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to shares issued in share exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ValueOfSharesIssuedInShareExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_SecuritiesExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_SecuritiesExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796911520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant accounting policies - Schedule of applied the definition of a lease under IFRS 16 to contracts (Details) - CAD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SummaryOfSignificantAccountingPoliciesAbstract', window );"><strong>Summary Of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossLoanCommitments', window );">Aggregate lease commitments as disclosed at December 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AdjustmentToLeaseCommitments', window );">Less: Adjustment to lease commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,528)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ImpactOfPresentValueOnLeaseObligations', window );">Less: Impact of present value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,182)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease obligation</a></td>
<td class="nump">$ 202,869<span></span>
</td>
<td class="nump">$ 243,818<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AdjustmentToLeaseCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents adjustment to lease commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AdjustmentToLeaseCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ImpactOfPresentValueOnLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to impact of present value on lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ImpactOfPresentValueOnLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SummaryOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SummaryOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossLoanCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows for gross commitments to receive a loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph B11D<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B11D_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossLoanCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796880176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related party transactions</a></td>
<td class="text"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21.<span style="width:5.25pt;display:inline-block"> </span><strong>Related party transactions</strong></span></span></span></span></p><div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the entity, directly or indirectly.</span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Compensation paid or payable to key management and directors comprised the following:</span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:40pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2022;<span style="width:12.75pt;text-indent:0pt;display:inline-block"> </span>The Company paid the former President and CEO of FV Pharma&#160;$770,000 in 2019 as a retirement benefit. The Company also paid the former President and CEO of FV Pharma $54,958 in salaries and benefits through a related entity owned by the former President and CEO on top of $96,250 in salaries and benefits and other allowances of $4,500 paid directly to the Former CEO.</span></span></span></span><br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:40pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2022;<span style="width:12.75pt;display:inline-block"> </span>The Company paid expenses of $754,311 to a company owned by the CEO for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under various expense line </span></span></span></span>categories. The Company recognized a share-based bonus expense for the year-ended December 31, 2019 in the amount of $1,428,591 to be paid to the CEO by issuance of 200,927 Class B common shares of the Company. The Class B common shares will be issued subsequent to December 31, 2019. As at December 31, 2019 the Company had an outstanding balance of $95,708 due to a Company controlled by the CEO, included in trade and other payables.<br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:40pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2022;<span style="width:12.75pt;display:inline-block"> </span>The Company paid consulting fees of $330,436 to the President of FSD Biosciences for services rendered for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under consulting fees.&#160;</span></span></span></span>The Company recognized a share-based bonus expense for the year-ended December 31, 2019 in the amount of $109,892 to be paid to the President of FSD Biosciences by issuance of 15,456 Class B common shares of the Company. The Class B common shares will be issued subsequent to December 31, 2019.<br/>&#160;</p></div><div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt">&#x2022;<span style="width:12.56pt;text-indent:0pt;display:inline-block"> </span>The Company recognized a share-based bonus expense for the year-ended December 31, 2019 in the amount of $109,892 to be paid to the President of FSD by issuance of 15,456 Class B common shares of the Company. The Class B common shares will be issued subsequent to December 31, 2019.<br/>&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt">&#x2022;<span style="width:12.56pt;text-indent:0pt;display:inline-block"> </span>The Company recognized a share-based bonus expense for the year-ended December 31, 2019 in the amount of $54,946 to be paid to the President of FV Pharma by issuance of 7,728 Class B common shares of the Company. The Class B common shares will be issued subsequent to December 31, 2019.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2022;<span style="width:12.75pt;display:inline-block"> </span>The Company paid fees of $196,870 to a company owned by the CFO for services rendered for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under salaries, wages and benefits.</span></span></span></span></p>&#160;<p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2022;<span style="width:12.75pt;display:inline-block"> </span>The Company paid consulting fees of $90,000 to a company owned by the Chief Operating Consultant for services rendered for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under consulting fees.</span></span></span></span></p>&#160;<p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2022;<span style="width:12.75pt;display:inline-block"> </span>The Company paid consulting fees of $16,667 to a company owned by the former COO for services rendered for the year ended December 31, 2019, included in the consolidated statement of loss and comprehensive loss under consulting fees.</span></span></span></span></p>&#160;<p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2022;<span style="width:12.75pt;display:inline-block"> </span>The Company pays independent directors&#160;$40,000 per annum, with the Chairman of each respective committee receiving an additional $10,000 per </span></span></span></span>annum<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>. Directors fees for the year ended December 31, 2019 were $203,521 (2018 - $66,667). As of December 31, 2019, $98,521 of </span></span></span></span>director's<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span> fees </span></span></span></span>were due and payable.</p>&#160;<p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2022;<span style="width:12.75pt;display:inline-block"> </span>On November 4, 2019, the Company completed a private placement by the issuance of 228,670 Class B shares at a price of $20.10 per share for total gross proceeds of $4,598,618. 164,755 Class B Shares were subscribed by the Officers and Directors of the Company.</span></span></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt">&#x2022;<span style="width:12.56pt;text-indent:0pt;display:inline-block"> </span>The Company recognized share-based compensation expense of $132,178 for the year-ended December 31, 2019 for services to be provided by a consulting company related to the President of the Company.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Key management personnel compensation during the years ended December 31 comprised of:</span></span></span></span><br/>&#160;</p><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2018</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries, benefits, bonuses and consulting fees</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,836,192</span></span></strong></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,814,115</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based payments</span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,476,385</span></span></strong></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,215,401</span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Total</strong></p></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>17,312,577</strong></p></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">5,029,516</p></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6712469568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Loss per share</a></td>
<td class="text"><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17.&#160;<strong>Loss per share</strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per common share represents net loss attributable to common shareholders divided by the weighted average number of common shares outstanding during the year.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For all the periods presented, diluted loss per share equals basic loss per share due to the anti-dilutive effect of warrants and share options. The outstanding number and type of securities that could potentially dilute basic net loss per share in the future but would have decreased the loss per share (anti-dilutive) for year ended December 31 presented are as follows:</span></span></p><div><table cellpadding="0" cellspacing="0" style="width:60%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2018</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>#</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>#</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>467,451</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">546,212</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share Options</span></span></td><td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,454,943</strong></span></span></td><td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">485,159</span></span></td><td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,922,394</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,031,371</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td></tr></tbody></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6649842464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock', window );">Schedule of lease obligations</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="width:50%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:528px">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:3px">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px">&#160;</td><td style="vertical-align:bottom;text-align:left;width:3px;border:1pt none;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;border:1pt none;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;border:1pt none;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance &#x2013; January 1, 2019</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:3px;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;border:1pt none;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>243,818</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;border:1pt none;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Add: Interest Expense</span></span></td><td style="vertical-align:bottom;text-align:left;width:3px;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,258</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Lease Payments</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:3px;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(56,207</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance &#x2013; December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:3px;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>202,869</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:528px">&#160;</td><td style="vertical-align:bottom;width:3px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></td><td style="vertical-align:bottom;text-align:left;width:3px;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,207</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:3px;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">146,662</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:528px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance &#x2013; December 31, 2019</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:3px;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>202,869</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory', window );">Schedule of maturity analysis of operating lease payments</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="width:90%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than one year</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,206</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">One to two years</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59,642</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Two to three years</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59,954</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Three to four years</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59,954</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Therafter</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></p></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total undiscounted lease payments payable</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">235,756</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: impact of present value</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(32,887</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as at December 31, 2019</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">202,869</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table><br/>&#160;</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfOperatingLeaseObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 97<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_97&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6819854416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Schedule of loss per share</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="width:60%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2018</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>#</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>#</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>467,451</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">546,212</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share Options</span></span></td><td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,454,943</strong></span></span></td><td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">485,159</span></span></td><td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,922,394</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,031,371</span></span></td><td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;background-color:rgb(204, 238, 255);border-top:1pt solid black;border-right:none;border-left:none;border-image:initial">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6843279344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Prismic Pharmaceutical - Schedule of black scholes options pricing model (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 28, 2019 </div>
<div>Year </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Grant date share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedDividendYieldOfWarrantsGranted', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrantsGranted', window );">Annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Grant date share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsGranted', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="nump">$ 4.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.41%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Grant date share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsGranted', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="nump">$ 26.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.52%<span></span>
</td>
<td class="nump">2.17%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Prismic Pharmaceuticals Inc. ("Prismic")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareOptionsAbstract', window );"><strong>Share Options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Grant date share price</a></td>
<td class="nump">$ 32.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Annualized volatility</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Grant date share price</a></td>
<td class="nump">$ 32.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedDividendYieldOfWarrantsGranted', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrantsGranted', window );">Annualized volatility</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Prismic Pharmaceuticals Inc. ("Prismic") | Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareOptionsAbstract', window );"><strong>Share Options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.39%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life | Year</a></td>
<td class="nump">0.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsGranted', window );">Exercise price</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life (years)</a></td>
<td class="text">1 year 4 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Prismic Pharmaceuticals Inc. ("Prismic") | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareOptionsAbstract', window );"><strong>Share Options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 17.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.66%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life | Year</a></td>
<td class="nump">16.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsGranted', window );">Exercise price</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.52%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life (years)</a></td>
<td class="text">6 years 6 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExercisePriceOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the exercise price of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExercisePriceOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedDividendYieldOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected dividend yield of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedDividendYieldOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedLifeOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected life of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedLifeOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedVolatilityOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected volatility of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedVolatilityOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_RiskFreeInterestRateOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents risk free interest rate of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_RiskFreeInterestRateOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageSharePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the weighted average share price of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageSharePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6826853840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent events (Narrative) (Details) - Class B shares - Subsequent events<br></strong></div></th>
<th class="th">
<div>Feb. 05, 2020 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 04, 2020 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 02, 2020 </div>
<div>Share</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of instruments granted in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,580<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Solarvest BioEnergy Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability', window );">Number of additional shares issued to settle derivative liability | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares', window );">Derivative liabilities settled through issuance of shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,646,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Cannara Biotech Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesSold', window );">Number of shares sold for investment in Cannara | shares</a></td>
<td class="nump">85,003,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Gross proceeds of common stock | $</a></td>
<td class="nump">$ 7,743,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to derivative liabilities settled through issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of additional shares issued to settle derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of shares sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of instruments granted in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph IG23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IG23&amp;doctype=Implementation%20Guidance<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=huge_SubsequentEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=huge_SubsequentEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6749713920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies - Schedule of quantities of cannabis available to supply by fiscal period (Details) - Pharmadrug Production GMBH - Supply agreement - FV Pharma Inc<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>kg</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_QuantitiesAvailableToSupplyInNextFiscalYear', window );">2020</a></td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_QuantitiesAvailableToSupplyInSecondFiscalYear', window );">2021</a></td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_QuantitiesAvailableToSupplyInThirdFiscalYear', window );">2022</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_QuantitiesAvailableToSupplyInFifthFiscalYear', window );">2023</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_QuantitiesAvailableToSupplyInFourthFiscalYear', window );">2024</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_QuantitiesAvailableToSupplyInFifthFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the quantities available to supply in fifth fiscal year from the balance sheet fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_QuantitiesAvailableToSupplyInFifthFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_QuantitiesAvailableToSupplyInFourthFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the quantities available to supply in fourth fiscal year from the balance sheet fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_QuantitiesAvailableToSupplyInFourthFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_QuantitiesAvailableToSupplyInNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the quantities available to supply in next fiscal year from the balance sheet fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_QuantitiesAvailableToSupplyInNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_QuantitiesAvailableToSupplyInSecondFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the quantities available to supply in second fiscal year from the balance sheet fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_QuantitiesAvailableToSupplyInSecondFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_QuantitiesAvailableToSupplyInThirdFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the quantities available to supply in third fiscal year from the balance sheet fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_QuantitiesAvailableToSupplyInThirdFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=huge_PharmadrugProductionGMBHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=huge_PharmadrugProductionGMBHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_SupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_SupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=huge_FvPharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=huge_FvPharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6809555328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Schedule of provision for income taxes (Details) - CAD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AccountingProfit', window );">Loss before income taxes</a></td>
<td class="num">$ (52,013,186)<span></span>
</td>
<td class="num">$ (22,710,624)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Statutory federal and provincial tax rate</a></td>
<td class="nump">26.50%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Income tax recovery at the statutory tax rate</a></td>
<td class="num">$ (13,783,494)<span></span>
</td>
<td class="num">$ (6,018,315)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Permanent differences</a></td>
<td class="nump">7,797,290<span></span>
</td>
<td class="nump">2,706,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TaxEffectOfTemporaryDifferences', window );">Other adjustments</a></td>
<td class="nump">6,334,913<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TaxEffectOfDeferredTaxAssetNotRecognized', window );">Change in tax benefits not recognized</a></td>
<td class="num">(348,709)<span></span>
</td>
<td class="nump">3,312,315<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Total Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TaxEffectOfDeferredTaxAssetNotRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to tax effect of deferred tax asset not recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TaxEffectOfDeferredTaxAssetNotRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TaxEffectOfTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to tax effect of temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TaxEffectOfTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccountingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccountingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6812438192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation (Narrative) (Details) - CAD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expenses</a></td>
<td class="nump">$ 16,061,319<span></span>
</td>
<td class="nump">$ 6,440,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_BonusExpenseToBePaidInSubsequentPeriod', window );">Bonus expense to be paid in subsequent period</a></td>
<td class="nump">$ 1,730,794<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_BonusExpenseToBePaidInSubsequentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to bonus expense to be paid in subsequent period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_BonusExpenseToBePaidInSubsequentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>353</ContextCount>
  <ElementCount>465</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>129</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Disclosure - Nature of business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/NatureOfBusiness</Role>
      <ShortName>Nature of business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Disclosure - Basis of presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/BasisOfPresentation</Role>
      <ShortName>Basis of presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Disclosure - Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Disclosure - Reverse Takeover Transaction</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ReverseTakeoverTransaction</Role>
      <ShortName>Reverse Takeover Transaction</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0010 - Disclosure - Acquisition of Prismic Pharmaceutical</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceutical</Role>
      <ShortName>Acquisition of Prismic Pharmaceutical</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0011 - Disclosure - Trade and other receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/TradeAndOtherReceivables</Role>
      <ShortName>Trade and other receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0012 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0013 - Disclosure - Biological assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/BiologicalAssets</Role>
      <ShortName>Biological assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0014 - Disclosure - Other investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/OtherInvestments</Role>
      <ShortName>Other investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0015 - Disclosure - Right-of-use asset</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RightofuseAsset</Role>
      <ShortName>Right-of-use asset</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0016 - Disclosure - Property, plant and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/PropertyPlantAndEquipment</Role>
      <ShortName>Property, plant and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0017 - Disclosure - Intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IntangibleAssets</Role>
      <ShortName>Intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0018 - Disclosure - Lease obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LeaseObligations</Role>
      <ShortName>Lease obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0019 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.fsdpharma.com/role/NotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0020 - Disclosure - Share capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapital</Role>
      <ShortName>Share capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0021 - Disclosure - Share-based compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SharebasedCompensation</Role>
      <ShortName>Share-based compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0022 - Disclosure - Loss per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LossPerShare</Role>
      <ShortName>Loss per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0023 - Disclosure - General and administrative</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/GeneralAndAdministrative</Role>
      <ShortName>General and administrative</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0024 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncomeTaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0025 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0026 - Disclosure - Related party transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related party transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0027 - Disclosure - Capital Management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CapitalManagement</Role>
      <ShortName>Capital Management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0028 - Disclosure - Financial Instruments and Risk Management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskManagement</Role>
      <ShortName>Financial Instruments and Risk Management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0029 - Disclosure - Segmented information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SegmentedInformation</Role>
      <ShortName>Segmented information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0030 - Disclosure - Subsequent events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0031 - Disclosure - Significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0032 - Disclosure - Nature of business (Table)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/NatureOfBusinessTable</Role>
      <ShortName>Nature of business (Table)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/NatureOfBusiness</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0033 - Disclosure - Significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0034 - Disclosure - Acquisition of Prismic Pharmaceutical (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalTables</Role>
      <ShortName>Acquisition of Prismic Pharmaceutical (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceutical</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0035 - Disclosure - Trade and other receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/TradeAndOtherReceivablesTables</Role>
      <ShortName>Trade and other receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/TradeAndOtherReceivables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0036 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/Inventory</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0037 - Disclosure - Biological assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/BiologicalAssetsTables</Role>
      <ShortName>Biological assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/BiologicalAssets</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0038 - Disclosure - Other investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/OtherinvestmentsTables</Role>
      <ShortName>Other investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/OtherInvestments</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0039 - Disclosure - Right-of-use asset (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RightofuseAssetTables</Role>
      <ShortName>Right-of-use asset (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/RightofuseAsset</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0040 - Disclosure - Property, plant and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/PropertyplantandequipmentTables</Role>
      <ShortName>Property, plant and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/PropertyPlantAndEquipment</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0041 - Disclosure - Intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/IntangibleAssets</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0042 - Disclosure - Lease obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LeaseObligationsTables</Role>
      <ShortName>Lease obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/LeaseObligations</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0043 - Disclosure - Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.fsdpharma.com/role/NotesPayableTables</Role>
      <ShortName>Notes Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/NotesPayable</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0044 - Disclosure - Share capital (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapitalTables</Role>
      <ShortName>Share capital (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/ShareCapital</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0045 - Disclosure - Share-based compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SharebasedCompensationTables</Role>
      <ShortName>Share-based compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/SharebasedCompensation</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0046 - Disclosure - Loss per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LossPerShareTables</Role>
      <ShortName>Loss per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/LossPerShare</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0047 - Disclosure - General and administrative (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/GeneralAndAdministrativeTables</Role>
      <ShortName>General and administrative (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/GeneralAndAdministrative</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0048 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncometaxesTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/IncomeTaxes</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0049 - Disclosure - Commitments and contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0050 - Disclosure - Related party transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RelatedPartyTransactionsTables</Role>
      <ShortName>Related party transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/RelatedPartyTransactions</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0051 - Disclosure - Nature of business (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/NatureOfBusinessNarrativeDetails</Role>
      <ShortName>Nature of business (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/NatureOfBusinessTable</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0052 - Disclosure - Significant accounting policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant accounting policies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0053 - Disclosure - Acquisition of Prismic Pharmaceutical (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalNarrativeDetails</Role>
      <ShortName>Acquisition of Prismic Pharmaceutical (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0054 - Disclosure - Inventory (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/InventoryNarrativeDetails</Role>
      <ShortName>Inventory (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/InventoryTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0055 - Disclosure - Biological assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/BiologicalAssetsNarrativeDetails</Role>
      <ShortName>Biological assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/BiologicalAssetsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0056 - Disclosure - Other investments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails</Role>
      <ShortName>Other investments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/OtherinvestmentsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0057 - Disclosure - Property, plant and equipment (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/PropertyplantandequipmentDetails1</Role>
      <ShortName>Property, plant and equipment (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/PropertyplantandequipmentTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0058 - Disclosure - Intangible assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IntangibleAssetsNarrativeDetails</Role>
      <ShortName>Intangible assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/IntangibleAssetsTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0059 - Disclosure - Notes Payable (Narrative) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.fsdpharma.com/role/NotesPayableNarrativeDetails</Role>
      <ShortName>Notes Payable (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/NotesPayableTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0060 - Disclosure - Share capital (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails</Role>
      <ShortName>Share capital (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/ShareCapitalTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0061 - Disclosure - Share-based compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails</Role>
      <ShortName>Share-based compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/SharebasedCompensationTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0062 - Disclosure - Commitments and contingencies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and contingencies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0063 - Disclosure - Related party transactions (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails</Role>
      <ShortName>Related party transactions (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0064 - Disclosure - Capital management (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CapitalManagementNarrativeDetails</Role>
      <ShortName>Capital management (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0066 - Disclosure - Subsequent events (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails</Role>
      <ShortName>Subsequent events (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/SubsequentEvents</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0067 - Disclosure - Nature of business - Schedule of ownership percentage in subsidiaries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails</Role>
      <ShortName>Nature of business - Schedule of ownership percentage in subsidiaries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0068 - Disclosure - Significant accounting policies - Schedule of estimated useful lives of assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails</Role>
      <ShortName>Significant accounting policies - Schedule of estimated useful lives of assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0069 - Disclosure - Significant accounting policies - Schedule of applied the definition of a lease under IFRS 16 to contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfAppliedTheDefinitionOfALeaseUnderIFRS16ToContractsDetails</Role>
      <ShortName>Significant accounting policies - Schedule of applied the definition of a lease under IFRS 16 to contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0070 - Disclosure - Acquisition of Prismic Pharmaceutical - Schedule of black scholes options pricing model (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails</Role>
      <ShortName>Acquisition of Prismic Pharmaceutical - Schedule of black scholes options pricing model (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0071 - Disclosure - Acquisition of Prismic Pharmaceutical - Schedule of identifiable assets acquired and liabilities assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisition of Prismic Pharmaceutical - Schedule of identifiable assets acquired and liabilities assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0072 - Disclosure - Trade and other receivables- Schedule of trade and other receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails</Role>
      <ShortName>Trade and other receivables- Schedule of trade and other receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0073 - Disclosure - Inventory - Schedule of inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/InventoryScheduleOfInventoriesDetails</Role>
      <ShortName>Inventory - Schedule of inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0074 - Disclosure - Biological assets - Schedule of biological assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/BiologicalAssetsScheduleOfBiologicalAssetsDetails</Role>
      <ShortName>Biological assets - Schedule of biological assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0075 - Disclosure - Biological assets - Schedule of unobservable input used to estimate fair value of biological assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/BiologicalAssetsScheduleOfUnobservableInputUsedToEstimateFairValueOfBiologicalAssetsDetails</Role>
      <ShortName>Biological assets - Schedule of unobservable input used to estimate fair value of biological assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0076 - Disclosure - Other investments - Schedule of Other investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails</Role>
      <ShortName>Other investments - Schedule of Other investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0077 - Disclosure - Right-of-use asset - Schedule of right-of-use asset (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RightofuseAssetScheduleOfRightofuseAssetDetails</Role>
      <ShortName>Right-of-use asset - Schedule of right-of-use asset (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0078 - Disclosure - Property, plant and equipment - Schedule of property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/PropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails</Role>
      <ShortName>Property, plant and equipment - Schedule of property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0079 - Disclosure - Intangible assets - Schedule of intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Intangible assets - Schedule of intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0080 - Disclosure - Lease obligations - Schedule of lease obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LeaseObligationsScheduleOfLeaseObligationsDetails</Role>
      <ShortName>Lease obligations - Schedule of lease obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0081 - Disclosure - Lease obligations - Schedule of maturity analysis of operating lease payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails</Role>
      <ShortName>Lease obligations - Schedule of maturity analysis of operating lease payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0082 - Disclosure - Notes Payable - Schedule of notes payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.fsdpharma.com/role/NotesPayableScheduleOfNotesPayableDetails</Role>
      <ShortName>Notes Payable - Schedule of notes payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0083 - Disclosure - Share capital - Schedule of reconciliation of the share capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails</Role>
      <ShortName>Share capital - Schedule of reconciliation of the share capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0084 - Disclosure - Share capital - Schedule of changes in number of warrants outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails</Role>
      <ShortName>Share capital - Schedule of changes in number of warrants outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0085 - Disclosure - Share capital - Schedule of fair value assumptions of warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails</Role>
      <ShortName>Share capital - Schedule of fair value assumptions of warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0086 - Disclosure - Share capital - Schedule of warrants outstanding and exercise price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails</Role>
      <ShortName>Share capital - Schedule of warrants outstanding and exercise price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0087 - Disclosure - Share-based compensation - Schedule of changes in number of share options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails</Role>
      <ShortName>Share-based compensation - Schedule of changes in number of share options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0088 - Disclosure - Share-based compensation - Schedule of fair value assumptions of share options granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails</Role>
      <ShortName>Share-based compensation - Schedule of fair value assumptions of share options granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0089 - Disclosure - Share-based compensation - Schedule of exercise price and weighted average contractual term of share options outstanding  and exercisable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails</Role>
      <ShortName>Share-based compensation - Schedule of exercise price and weighted average contractual term of share options outstanding  and exercisable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0090 - Disclosure - Loss per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LossPerShareDetails</Role>
      <ShortName>Loss per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/LossPerShareTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0091 - Disclosure - General and administrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/GeneralAndAdministrativeDetails</Role>
      <ShortName>General and administrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/GeneralAndAdministrativeTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0092 - Disclosure - Income taxes - Schedule of provision for income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails</Role>
      <ShortName>Income taxes - Schedule of provision for income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0093 - Disclosure - Income taxes - Schedule of deferred tax assets (liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails</Role>
      <ShortName>Income taxes - Schedule of deferred tax assets (liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0094 - Disclosure - Income taxes - Schedule of temporary differences for which deferred tax assets not recognised (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails</Role>
      <ShortName>Income taxes - Schedule of temporary differences for which deferred tax assets not recognised (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0095 - Disclosure - Income taxes - Schedule of non-capital loss carryforwards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails</Role>
      <ShortName>Income taxes - Schedule of non-capital loss carryforwards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0096 - Disclosure - Commitments and contingencies - Schedule of quantities of cannabis available to supply by fiscal period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails</Role>
      <ShortName>Commitments and contingencies - Schedule of quantities of cannabis available to supply by fiscal period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="huge-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0097 - Disclosure - Related party transactions - Schedule of key management personnel compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails</Role>
      <ShortName>Related party transactions - Schedule of key management personnel compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>huge-20191231.xml</File>
    <File>huge-20191231.xsd</File>
    <File>huge-20191231_cal.xml</File>
    <File>huge-20191231_def.xml</File>
    <File>huge-20191231_lab.xml</File>
    <File>huge-20191231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796966064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfCapitalManagementAbstract', window );"><strong>Disclosure Of Capital Management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory', window );">Capital Management</a></td>
<td class="text"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22.<strong><span style="width:5.25pt;display:inline-block"> </span>Capital Management</strong></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The Company's capital management objectives are to maintain financial flexibility in order to complete development of its facilities and extraction processes and the pharmaceutical research and development program centered on the lead asset, micro-PEA. The Company defines capital as the aggregate of its capital stock and borrowings.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">As at December 31, 2019, the Company's Share Capital was<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"> $98,016,649 (2018 - $68,117,802). </span></span>The Company does not have any long-term debt. Outstanding Notes payable were assumed on acquisition of Prismic and are due on demand.</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The Company manages its capital structure in accordance with changes in economic conditions. In order to maintain or adjust its capital structure, the Company may elect to issue or repay financial liabilities, issue shares, repurchase shares, pay dividends or undertake any other activities as deemed appropriate under the specific circumstances. The Company is not subject to any externally imposed capital requirements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfCapitalManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfCapitalManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 134<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_134&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796907968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and administrative<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling, general and administrative expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory', window );">General and administrative</a></td>
<td class="text"><div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.<span style="width:5.25pt;display:inline-block"> </span><strong>General and administrative</strong></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Components of general and administrative expenses for the years ended December 31, 2019 and 2018 were as follows:</span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt">&#160;</p><table style="-webkit-text-stroke-width:0px;border-collapse:collapse;border:0px;font-family:Times New Roman;font-size:10pt;letter-spacing:normal;orphans:2;text-decoration-color:initial;text-decoration-style:initial;text-indent:0px;text-transform:none;widows:2;width:100%;word-spacing:0px"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2018</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional fees</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>3,730,556</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,955,253</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Stock promotion</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,902,453</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,803,588</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries, wages and benefits</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,267,308</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,740,720</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consulting fees</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,288,129</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,037,049</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">General office, travel and adminsitration expenditures</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,172,824</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">726,509</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Repairs, maintenance and utilities</p></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>924,945</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,360,477</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shareholder and public company costs</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>440,746</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">124,973</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Listing expense</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#x2014;</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,991,791</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign exchange loss</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:11px;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>84,568</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:721px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;width:11px;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>14,811,529</strong></span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,740,360</span></span></td><td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of general and administrative expenses. [Refer: Administrative expenses]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6605916048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract', window );"><strong>Disclosure of detailed information about borrowings [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBorrowingsExplanatory', window );">Notes Payable</a></td>
<td class="text"><div><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14.</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong> Notes Payable</strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes payable consists of the following:</span></span></p><div style="margin-left:1.5pt"><div><table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:449px">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:4px;border-bottom:1pt solid black">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:449px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term notes</span></span></td><td style="border:1pt none;vertical-align:bottom;text-align:left;width:4px;background-color:rgb(204, 238, 255)">&#160;</td><td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">193,996</span></span></td><td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);width:449px"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Notes payable</p></td><td style="vertical-align:bottom;text-align:left;width:4px;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,714,416</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255);width:449px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as at December 31, 2019</span></span></td><td style="vertical-align:bottom;text-align:left;width:4px;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,908,412</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div></div><p style="text-align:justify">&#160;</p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Short-term notes</i></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The short-term notes represent notes outstanding that the Company assumed on acquisition of Prismic. The notes have matured, are due on demand and accrue interest a rate of</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"> 10% per annum.&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The notes are held by former Directors and Shareholders of Prismic.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Notes payable</i></span></span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The notes payable represent notes outstanding that the Company assumed on acquisition of Prismic. The notes have matured and are due on demand. The notes accrue interest a rate of 20% per annum. The notes are held by former Directors and Shareholders of Prismic.</span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796966064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use asset<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract', window );"><strong>Disclosure of quantitative information about right-of-use assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Right-of-use asset</a></td>
<td class="text"><div><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>10.<strong> Right-of-use asset</strong></span></span></span></span></p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>The right-of-use asset as at December 31, 2019 is as follows:</span></span></span></span></p><div style="margin-left:1.5pt"><div><table cellpadding="0" cellspacing="0" style="width:60%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><strong>$</strong></span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Balance &#x2013; January 1, 2019</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>243,818</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Depreciation</span></span></span></span></p></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(48,764</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Impairment</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(67,644</span></span></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>)</span></span></span></span></td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><strong>Balance &#x2013; December 31, 2019</strong></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><strong>127,410</strong></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div></div><p style="text-align:justify"><br/><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>The right-of-use asset relates to an office lease. As of December 31, 2019 the Company did not occupy the leased premise and was in the process of subleasing the space. The right-of-use asset has been impaired as of December 31, 2019 and was written down to the present value of the expected future lease payments to be received from subleasing the premise&#160;</span></span>over the remaining term of the lease.</span></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6819874240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">Trade and other receivables</a></td>
<td class="text"><div><p style="text-align:justify;margin-left:2.25pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.<strong> Trade and other receivables</strong></span></span></p><p style="text-align:justify;margin-left:2.25pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's trade and other receivables include the following:</span></span></p><div style="margin-left:2.25pt"><div><table cellpadding="0" cellspacing="0" style="width:70%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>December 31,</strong></p></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">December 31,</p></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2018</span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales tax recoverable</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,033,535</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">982,663</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rent receivable</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>12,990</strong></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,325</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>23,530</strong></span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,070,055</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">990,988</span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6825926816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - CAD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (52,013,186)<span></span>
</td>
<td class="num">$ (22,710,624)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Add (deduct) items not affecting cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">3,146,680<span></span>
</td>
<td class="nump">183,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment of property, plant and equipment and right-of-use asset</a></td>
<td class="nump">243,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AdjustmentsForListingExpense', window );">Listing expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,991,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForInterestExpense', window );">Interest expense</a></td>
<td class="nump">206,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based payments</a></td>
<td class="nump">16,061,319<span></span>
</td>
<td class="nump">6,440,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFairValueGainsLosses', window );">Change in fair value of other investments</a></td>
<td class="nump">11,669,157<span></span>
</td>
<td class="num">(17,564,529)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives', window );">Change in fair value of derivative liability</a></td>
<td class="nump">3,568,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold', window );">Change in fair value adjustments on inventory sold</a></td>
<td class="nump">22,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets', window );">Change in fair value of biological assets</a></td>
<td class="nump">682,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LossOnSettlementOfFinancialLiability', window );">Loss on settlement of financial liability</a></td>
<td class="nump">24,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AllowanceForImpairment', window );">Allowance for impairment of Auxly funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,499,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangesInNonCashWorkingCapitalItemsAbstract', window );"><strong>Changes in non-cash working capital balances</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables', window );">Trade and other receivables</a></td>
<td class="num">(1,079,067)<span></span>
</td>
<td class="num">(664,610)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit', window );">Prepaid expenses and deposits</a></td>
<td class="nump">39,892<span></span>
</td>
<td class="num">(99,264)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Inventories</a></td>
<td class="num">(942,939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets', window );">Biological assets</a></td>
<td class="num">(682,739)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="nump">825,120<span></span>
</td>
<td class="nump">433,754<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Cash used in operating activities</a></td>
<td class="num">(18,227,738)<span></span>
</td>
<td class="num">(18,489,905)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_CashAcquiredOnAcquisition', window );">Cash acquired from acquisition Prismic Pharmaceuticals Inc.</a></td>
<td class="nump">2,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ReverseTakeoverTransaction', window );">Reverse Takeover Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,041,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale of investments</a></td>
<td class="nump">614,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentProperty', window );">Purchase of other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,999,991)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(534,118)<span></span>
</td>
<td class="num">(4,032,832)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Additions to intangible assets</a></td>
<td class="num">(389,640)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Cash used in investing activities</a></td>
<td class="num">(306,909)<span></span>
</td>
<td class="num">(9,991,322)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of lease obligation</a></td>
<td class="num">(56,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuance of shares</a></td>
<td class="nump">4,593,777<span></span>
</td>
<td class="nump">44,987,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Share issue costs</a></td>
<td class="num">(32,705)<span></span>
</td>
<td class="num">(3,768,381)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Proceeds from exercise of share options</a></td>
<td class="nump">732,598<span></span>
</td>
<td class="nump">2,857,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ProceedsFromExerciseOfWarrants', window );">Proceeds from warrants exercised</a></td>
<td class="nump">94,991<span></span>
</td>
<td class="nump">800,078<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Cash provided by financing activities</a></td>
<td class="nump">5,332,454<span></span>
</td>
<td class="nump">44,876,169<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net (decrease) increase in cash during the year</a></td>
<td class="num">(13,202,193)<span></span>
</td>
<td class="nump">16,394,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash, beginning of year</a></td>
<td class="nump">21,134,930<span></span>
</td>
<td class="nump">4,739,988<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash, end of year</a></td>
<td class="nump">$ 7,932,737<span></span>
</td>
<td class="nump">$ 21,134,930<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in prepaid and deposits to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains losses on changes in the fair value of inventory sold to reconcile profit (loss) to net cash flow from used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AdjustmentsForListingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents adjustments for listing expense during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AdjustmentsForListingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AllowanceForImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to allowance for impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AllowanceForImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_CashAcquiredOnAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to cash inflow during acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_CashAcquiredOnAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ChangesInNonCashWorkingCapitalItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ChangesInNonCashWorkingCapitalItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LossOnSettlementOfFinancialLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Loss on settlement of financial liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LossOnSettlementOfFinancialLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ProceedsFromExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents proceeds from exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ProceedsFromExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ReverseTakeoverTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information about reverse takeover transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ReverseTakeoverTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in biological assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Biological assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFairValueGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for fair value losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFairValueGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on changes in the fair value less costs to sell of biological assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Biological assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on changes in the fair value of derivatives to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: At fair value [member]; Derivatives [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of investment property. [Refer: Investment property]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6823601680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FSD Pharma Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001771885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">40-F/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">7,056,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796875616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reverse Takeover Transaction<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfReverseTakeoverTransactionAbstract', window );"><strong>Disclosure Of Reverse Takeover Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfReverseTakeoverTransactionExplanatory', window );">Reverse Takeover Transaction</a></td>
<td class="text"><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.<span style="width:28.5pt;display:inline-block">&#160;</span><strong>Reverse Takeover Transaction</strong></span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Century Financial Capital Group Inc. ("Century") and FV Pharma executed a definitive business combination agreement on March 9, 2018 (the "Definitive Agreement"), whereby FV Pharma would be combined with Century to continue the business of FV Pharma.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the terms of the Definitive Agreement, the Transaction was completed by way of a "three-cornered amalgamation" pursuant to the provisions of the Business Corporations Act (Ontario), whereby 2620756 Ontario Inc., a wholly-owned subsidiary of Century, amalgamated with FV Pharma (the "Amalgamation"), and the amalgamated entity is now a wholly-owned subsidiary of the Company (the "Transaction").</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to the terms of the Definitive Agreement and in connection with the Amalgamation:</span></span></p><p style="text-align:justify;text-indent:-18pt;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:14.25pt;display:inline-block">&#160;</span>Century amended its articles to: (i) amend and designate its outstanding common shares (the "Existing Century Shares") as Class B subordinate voting shares (the "Century Class B Shares"); and (ii) create a new class of Class A multiple voting shares (the "Century Class A Shares");</span></span></p><p style="text-align:justify;text-indent:-18pt;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:14.25pt;display:inline-block">&#160;</span>holders of outstanding Class A common voting shares of FV Pharma (the "FV Class A Shares") received one (1) Century Class A Share for each one (1) FV Class A Share held;</span></span></p><p style="margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:14.25pt;display:inline-block">&#160;</span>holders of outstanding Class B common non-voting shares of FV Pharma (the "FV Class B Shares" and, together with the FV Class A Shares, the "FV Shares"), including FV Class B Shares issued on conversion of the Subscription Receipts, received one (1) Century Class B Share for each one (1) FV Class B Share held; and</span></span></p><p style="margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:14.25pt;display:inline-block">&#160;</span>all outstanding options to purchase FV Pharma Class B shares and options to purchase Century shares were exchanged, on an equivalent basis, for options to purchase Class B shares of the Company, and all outstanding warrants to purchase FV Pharma Class B Shares and warrants to purchase Century shares were exchanged, on an equivalent basis, for warrants to purchase Class B shares of the Company.</span></span></p><p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Transaction has been accounted for as a "reverse takeover" as the issuance of shares to the former shareholders of FV Pharma resulted in the former shareholders of FV Pharma holding a majority of the issued and outstanding shares of the Company. Under this method of accounting, FV Pharma (the legal subsidiary) is deemed to be the acquirer and Century (the legal parent) is deemed to be the acquired company.</span></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfReverseTakeoverTransactionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfReverseTakeoverTransactionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfReverseTakeoverTransactionExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information of reverse takeover transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfReverseTakeoverTransactionExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796957152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of business (Table)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfNatureOfBusinessAbstract', window );"><strong>Disclosure of Nature of business [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory', window );">Schedule of ownership percentage in subsidiaries</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-left:auto;margin-right:auto"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Ownership</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Ownership</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>percentage</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>percentage</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Entity Name</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Country&#160;</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>December 31, 2019</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>December 31, 2018</strong></span></span></span></span></td><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>%</strong></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>%</strong></span></span></span></span></td><td style="vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:2.25pt;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>FV Pharma Inc.</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Canada</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;padding-left:2.25pt;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Prismic Pharmaceuticals Inc.</p></td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>USA</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfNatureOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents Nature of business abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfNatureOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B4<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B4_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6796935984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory', window );">Schedule of inventories</a></td>
<td class="text"><div><table cellpadding="0" cellspacing="0" style="width:100%;font-size:10pt;border-collapse:collapse;border-color:#000000"><tbody><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Biological asset</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>fair value</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Capitalized&#160;</strong><strong style="font-size:10pt">cost</strong></p></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>adjustment</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Impairment</strong></span></span></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Carrying&#160;</strong><strong style="font-size:10pt">value</strong></p></td><td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Harvested cannabis</i></span></span></td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Work in process</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,576,556</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(431,627</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(605,598</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">539,331</span></span></td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished good</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">82,463</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,707</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(76,979</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,191</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,659,019</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(415,920</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(682,577</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">560,522</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Hemp products</i></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100,000</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100,000</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100,000</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100,000</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Other inventory</i></span></span></td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Supplies</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">282,417</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">282,417</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">282,417</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">282,417</span></span></td><td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr><tr style="background-color:rgb(255, 255, 255)"><td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td><td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td></tr><tr style="background-color:rgb(204, 238, 255)"><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,041,436</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(415,920</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(682,577</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(204, 238, 255)">&#160;</td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:12%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>942,939</strong></span></span></td><td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(204, 238, 255)">&#160;</td></tr></tbody></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6819769104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Narrative) (Details) - CAD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationBiologicalAssets', window );">Depreciation on production of biological assets and inventory</a></td>
<td class="nump">$ 131,955<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment loss recognised in profit or loss, property, plant and equipment</a></td>
<td class="nump">$ 175,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation recognised on biological assets. [Refer: Depreciation and amortisation expense; Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_v&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6825420832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Prismic Pharmaceutical (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 28, 2019 </div>
<div>CAD ($) </div>
<div>Share </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,539,417<span></span>
</td>
<td class="nump">$ 47,853,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsGranted', window );">Number of warrants issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,598<span></span>
</td>
<td class="nump">236,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Prismic Pharmaceuticals Inc. ("Prismic")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="nump">$ 20,887,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Prismic Pharmaceuticals Inc. ("Prismic") | Class B subordinate voting shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="nump">$ 16,431,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares) | shares</a></td>
<td class="nump">510,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="nump">$ 32.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Prismic Pharmaceuticals Inc. ("Prismic") | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="nump">$ 2,567,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of instruments or interests issued or issuable | Share</a></td>
<td class="nump">89,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Prismic Pharmaceuticals Inc. ("Prismic") | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="nump">$ 1,888,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of instruments or interests issued or issuable | Share</a></td>
<td class="nump">67,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from acquisition of net assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants granted during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareIssuePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price per share of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareIssuePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityInterestsOfAcquirer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityInterestsOfAcquirer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=huge_ClassBVotingSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=huge_ClassBVotingSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=huge_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=huge_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=huge_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=huge_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6815731168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisition of Prismic Pharmaceutical - Schedule of identifiable assets acquired and liabilities assumed (Details) - Prismic Pharmaceuticals Inc. ("Prismic")<br></strong></div></th>
<th class="th">
<div>Jun. 28, 2019 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash</a></td>
<td class="nump">$ 2,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate', window );">Prepaids</a></td>
<td class="nump">26,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intellectual Property</a></td>
<td class="nump">24,648,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="num">(1,867,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate', window );">Short-term notes</a></td>
<td class="num">(195,475)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Notes payable</a></td>
<td class="num">(1,727,484)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration transferred, acquisition-date fair value</a></td>
<td class="nump">$ 20,887,209<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for current assets acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for current liabilities assumed in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6816061264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Lease obligations - Schedule of maturity analysis of operating lease payments (Details) - CAD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_UndiscountedLeasePaymentsPayable', window );">Total undiscounted lease payments payable</a></td>
<td class="nump">$ 235,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OperatingLeaseImpactOfPresentValue', window );">Less: impact of present value</a></td>
<td class="num">(32,887)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Balance - December 31, 2019</a></td>
<td class="nump">202,869<span></span>
</td>
<td class="nump">$ 243,818<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_UndiscountedLeasePaymentsPayable', window );">Total undiscounted lease payments payable</a></td>
<td class="nump">56,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">One to two years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_UndiscountedLeasePaymentsPayable', window );">Total undiscounted lease payments payable</a></td>
<td class="nump">59,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Two to three years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_UndiscountedLeasePaymentsPayable', window );">Total undiscounted lease payments payable</a></td>
<td class="nump">59,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Three to four years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_UndiscountedLeasePaymentsPayable', window );">Total undiscounted lease payments payable</a></td>
<td class="nump">59,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Therafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_UndiscountedLeasePaymentsPayable', window );">Total undiscounted lease payments payable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OperatingLeaseImpactOfPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents operating lease impact of present value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OperatingLeaseImpactOfPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_UndiscountedLeasePaymentsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to undiscounted lease payments payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_UndiscountedLeasePaymentsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6817562176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Schedule of fair value assumptions of warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Weighted average share price of warrants</a></td>
<td class="nump">$ 32.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedDividendYieldOfWarrantsGranted', window );">Expected dividend yield of warrants granted</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrantsGranted', window );">Expected volatility of warrants granted</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Weighted average share price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsGranted', window );">Exercise price of warrants granted</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="nump">$ 4.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate of warrants granted</a></td>
<td class="nump">1.41%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life of warrants</a></td>
<td class="text">1 year 4 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Weighted average share price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsGranted', window );">Exercise price of warrants granted</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="nump">$ 26.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate of warrants granted</a></td>
<td class="nump">1.52%<span></span>
</td>
<td class="nump">2.17%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life of warrants</a></td>
<td class="text">6 years 6 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfWarrantsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfWarrantsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExercisePriceOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the exercise price of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExercisePriceOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedDividendYieldOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected dividend yield of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedDividendYieldOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedLifeOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected life of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedLifeOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedVolatilityOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected volatility of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedVolatilityOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_RiskFreeInterestRateOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents risk free interest rate of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_RiskFreeInterestRateOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageSharePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the weighted average share price of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageSharePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6708914992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Biological assets - Schedule of unobservable input used to estimate fair value of biological assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($) </div>
<div>g</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant', window );">Expected yield for cannabis plants of dry flower, per plant | g</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant', window );">Expected yield for cannabis plants of dry trim, per plant | g</a></td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedGrowthCycleCompleted', window );">Expected growth cycle completed</a></td>
<td class="nump">73.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedSellingPricePerGramOfDriedFlower', window );">Expected selling price per gram of dried flower</a></td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedSellingPricePerGramOfTrim', window );">Expected selling price per gram of trim</a></td>
<td class="nump">0.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower', window );">After harvest cost to complete and sell per gram for dry flower</a></td>
<td class="nump">1.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim', window );">After harvest cost to complete and sell per gram for dry trim</a></td>
<td class="nump">$ 1.25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents after harvest cost to complete and sell per gram for dry flower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents after harvest cost to complete and sell per gram for dry trim.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedGrowthCycleCompleted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected growth cycle completed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedGrowthCycleCompleted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedSellingPricePerGramOfDriedFlower">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected selling price per gram of dried flower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedSellingPricePerGramOfDriedFlower</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedSellingPricePerGramOfTrim">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected selling price per gram of trim.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedSellingPricePerGramOfTrim</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected yield for cannabis plants of dry flower, per plant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected yield for cannabis plants of dry trim, per plant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6817419488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets - Schedule of intangible assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending balance</a></td>
<td class="nump">22,358,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AcquisitionOfPrismicPharmaceuticalsInc', window );">Acquisition of Prismic Pharmaceuticals Inc</a></td>
<td class="nump">24,648,915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">389,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Effects of foreign exchange</a></td>
<td class="num">(186,463)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending balance</a></td>
<td class="nump">24,852,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="nump">2,534,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Effects of foreign exchange</a></td>
<td class="num">(40,887)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending balance</a></td>
<td class="nump">$ 2,493,160<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AcquisitionOfPrismicPharmaceuticalsInc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Acquisition of Prismic Pharmaceuticals Inc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AcquisitionOfPrismicPharmaceuticalsInc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6825012320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Schedule of exercise price and weighted average contractual term of share options outstanding  and exercisable (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 21.96<span></span>
</td>
<td class="nump">$ 74.53<span></span>
</td>
<td class="nump">$ 4.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">1,454,943<span></span>
</td>
<td class="nump">485,159<span></span>
</td>
<td class="nump">206,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 7 months 2 days<span></span>
</td>
<td class="text">4 years 3 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 21.24<span></span>
</td>
<td class="nump">$ 19.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">1,200,242<span></span>
</td>
<td class="nump">253,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">2.61</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">35,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">35,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">4.42</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">99,502<span></span>
</td>
<td class="nump">149,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 8 months 15 days<span></span>
</td>
<td class="text">3 years 8 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">99,502<span></span>
</td>
<td class="nump">149,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">5.03</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">5.43</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">16,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">16,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">10.65</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 10.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 10.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">13.07</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 13.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">10,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 13.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">10,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">13.47</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 13.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">1,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 13.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">1,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">16.08</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 16.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">18,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 16.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">18,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">17.89</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 17.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">4,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 17.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">4,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">18.09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 18.09<span></span>
</td>
<td class="nump">$ 18.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">37,313<span></span>
</td>
<td class="nump">42,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 4 months 2 days<span></span>
</td>
<td class="text">4 years 4 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 18.09<span></span>
</td>
<td class="nump">$ 18.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">37,313<span></span>
</td>
<td class="nump">42,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">20.10</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">493,363<span></span>
</td>
<td class="nump">33,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 8 months 19 days<span></span>
</td>
<td class="text">4 years 3 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">493,363<span></span>
</td>
<td class="nump">16,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">21.11</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 21.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">12,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 8 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 21.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">12,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">24.12</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 24.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">9,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 7 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 24.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">6,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">26.13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 26.13<span></span>
</td>
<td class="nump">$ 26.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">14,925<span></span>
</td>
<td class="nump">14,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 7 months 13 days<span></span>
</td>
<td class="text">4 years 7 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 26.13<span></span>
</td>
<td class="nump">$ 26.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">14,925<span></span>
</td>
<td class="nump">14,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">40.20</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 40.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">29,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 5 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 40.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">22,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">44.22</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 44.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">2,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 4 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 44.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">2,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">47.24</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 47.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">1,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 4 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 47.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">1,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">50.25</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 50.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">227,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">5 years 1 month 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 50.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">129,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">52.26</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 52.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 2 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 52.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">55.28</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 55.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 1 month 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 55.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">56.28</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 10 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">59.30</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 59.30<span></span>
</td>
<td class="nump">$ 59.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 11 months 15 days<span></span>
</td>
<td class="text">4 years 11 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 59.30<span></span>
</td>
<td class="nump">$ 59.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">7.17</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 7.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">199,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 9 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 7.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">199,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">7.50</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 7.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 7.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">75.38</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 75.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 75.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">7.63</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">203,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">5 years 4 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">58,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">86.43</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 86.43<span></span>
</td>
<td class="nump">$ 86.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">1,244<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 10 months 17 days<span></span>
</td>
<td class="text">4 years 10 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 86.43<span></span>
</td>
<td class="nump">$ 86.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">1,244<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">88.44</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 88.44<span></span>
</td>
<td class="nump">$ 88.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">14,925<span></span>
</td>
<td class="nump">14,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 10 months 13 days<span></span>
</td>
<td class="text">4 years 10 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 88.44<span></span>
</td>
<td class="nump">$ 88.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">14,925<span></span>
</td>
<td class="nump">14,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">120.60</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 120.60<span></span>
</td>
<td class="nump">$ 120.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">9,950<span></span>
</td>
<td class="nump">9,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 8 months 15 days<span></span>
</td>
<td class="text">4 years 8 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 120.60<span></span>
</td>
<td class="nump">$ 120.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">9,950<span></span>
</td>
<td class="nump">9,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">142.71</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 142.71<span></span>
</td>
<td class="nump">$ 142.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">4,974<span></span>
</td>
<td class="nump">4,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 8 months 26 days<span></span>
</td>
<td class="text">4 years 8 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 142.71<span></span>
</td>
<td class="nump">$ 142.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">4,975<span></span>
</td>
<td class="nump">1,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">148.74</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 148.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 148.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwoPointSixOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwoPointSixOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFourPointFourTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFourPointFourTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFivePointZeroThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFivePointZeroThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFivePointFourThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFivePointFourThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTenPointSixFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTenPointSixFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceThirteenPointZeroSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceThirteenPointZeroSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceThirteenPointFourSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceThirteenPointFourSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSixteenPointZeroEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSixteenPointZeroEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSeventeenPointEightNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSeventeenPointEightNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceEighteenPointZeroNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceEighteenPointZeroNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentyPointOneZeroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentyPointOneZeroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentyOnePointElevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentyOnePointElevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentyFourPointTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentyFourPointTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentySixPointThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentySixPointThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFortyPointTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFortyPointTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFortyFourPointTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFortyFourPointTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFortySevenPointTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFortySevenPointTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyPointTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyPointTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyTwoPointTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyTwoPointTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyFivePointTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyFivePointTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftySixPointTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftySixPointTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyNinePointThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyNinePointThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSevenPointSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSevenPointSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSevenPointFiftyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSevenPointFiftyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSeventyFivePointThirtyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSeventyFivePointThirtyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSevenPointSixtyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSevenPointSixtyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceEightySixPointFortyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceEightySixPointFortyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceEightyEightPointFortyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceEightyEightPointFortyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceOneHundredTwentyPointSixtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceOneHundredTwentyPointSixtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
